[
  {
    "text": "Agents that have only begun to undergo clinical evaluation include CI1033 an irreversible pan erbB tyrosine kinase inhibitor and PKI166 and GW572016 both examples of dual kinase inhibitors inhibiting epidermal growth factor receptor and Her2",
    "triple_list": [
      [
        "CI1033",
        "CPR:4",
        "erbB"
      ],
      [
        "CI1033",
        "CPR:4",
        "tyrosine kinase"
      ],
      [
        "kinase",
        "CPR:4",
        "PKI166"
      ],
      [
        "PKI166",
        "CPR:4",
        "epidermal growth factor receptor"
      ],
      [
        "PKI166",
        "CPR:4",
        "Her2"
      ],
      [
        "kinase",
        "CPR:4",
        "GW572016"
      ],
      [
        "GW572016",
        "CPR:4",
        "epidermal growth factor receptor"
      ],
      [
        "GW572016",
        "CPR:4",
        "Her2"
      ]
    ],
    "updated": "No",
    "original": "Agents that have only begun to undergo clinical evaluation include CI1033 an irreversible pan erbB tyrosine kinase inhibitor and PKI166 and GW572016 both examples of dual kinase inhibitors inhibiting epidermal growth factor receptor and Her2",
    "simplified": "Some agents that have only begun to undergo clinical evaluation include CI1033, an irreversible pan erbB tyrosine kinase inhibitor, PKI166, a dual kinase inhibitor, and Her2 inhibiting agent PKI166."
  },
  {
    "text": "Epidermal growth factor receptor inhibitors currently under investigation include the small molecules gefitinib Iressa ZD1839 and erlotinib Tarceva OSI774 as well as monoclonal antibodies such as cetuximab IMC225 Erbitux",
    "triple_list": [
      [
        "Epidermal growth factor receptor",
        "CPR:4",
        "gefitinib"
      ],
      [
        "Epidermal growth factor receptor",
        "CPR:4",
        "Iressa"
      ],
      [
        "Epidermal growth factor receptor",
        "CPR:4",
        "ZD1839"
      ],
      [
        "Epidermal growth factor receptor",
        "CPR:4",
        "erlotinib"
      ],
      [
        "Epidermal growth factor receptor",
        "CPR:4",
        "Tarceva"
      ],
      [
        "Epidermal growth factor receptor",
        "CPR:4",
        "OSI774"
      ],
      [
        "Epidermal growth factor receptor",
        "CPR:4",
        "cetuximab"
      ],
      [
        "Epidermal growth factor receptor",
        "CPR:4",
        "IMC225"
      ],
      [
        "Epidermal growth factor receptor",
        "CPR:4",
        "Erbitux"
      ]
    ],
    "updated": "No",
    "original": "Epidermal growth factor receptor inhibitors currently under investigation include the small molecules gefitinib Iressa ZD1839 and erlotinib Tarceva OSI774 as well as monoclonal antibodies such as cetuximab IMC225 Erbitux",
    "simplified": "The small molecules gefitinib Iressa ZD1839 and erlotinib Tarceva OSI774 and the monoclonal antibody cetuximab IMC225 Erbitux have shown promise in the treatment of gastric cancer."
  },
  {
    "text": "Alprenolol and BAAM at 107 3 x 107 and 106 M inhibited the cardiac stimulation response slightly which is indicative of membranestabilizing activity independent of betaadrenoceptor blockade",
    "triple_list": [
      [
        "Alprenolol",
        "CPR:4",
        "betaadrenoceptor"
      ],
      [
        "BAAM",
        "CPR:4",
        "betaadrenoceptor"
      ]
    ],
    "updated": "No",
    "original": "Alprenolol and BAAM at 107 3 x 107 and 106 M inhibited the cardiac stimulation response slightly which is indicative of membranestabilizing activity independent of betaadrenoceptor blockade",
    "simplified": "Alprenolol and BAAM at 107 3 x 107 and 106 M slightly inhibited the cardiac stimulation response. This shows that the activity of the membranestabilizing factors is independent."
  },
  {
    "text": "Alprenolol and BAAM also made isoprenaline responses not work at all . This made the beta 1adrenoceptor work more slowly .",
    "triple_list": [
      [
        "isoprenaline",
        "CPR:5",
        "beta 1adrenoceptor"
      ],
      [
        "Alprenolol",
        "CPR:6",
        "beta 1adrenoceptor"
      ],
      [
        "BAAM",
        "CPR:6",
        "beta 1adrenoceptor"
      ]
    ],
    "updated": "Yes",
    "original": "Alprenolol and BAAM also caused surmountable antagonism of isoprenaline responses and this beta 1adrenoceptor antagonism was slowly reversible",
    "simplified": "Alprenolol and BAAM also made isoprenaline responses not work at all. This made the beta 1adrenoceptor work more slowly."
  },
  {
    "text": "We conclude that alprenolol and BAAM are competitive beta 1adrenoceptor antagonists in the left atria of rats .",
    "triple_list": [
      [
        "alprenolol",
        "CPR:6",
        "beta 1adrenoceptor"
      ],
      [
        "BAAM",
        "CPR:6",
        "beta 1adrenoceptor"
      ]
    ],
    "updated": "Yes",
    "original": "We conclude that alprenolol and BAAM are competitive slowly reversible beta 1adrenoceptor antagonists on rat left atria",
    "simplified": "We conclude that alprenolol and BAAM are competitive beta 1adrenoceptor antagonists in the left atria of rats."
  },
  {
    "text": "Alprenolol and bromoacetylalprenololmenthane are competitive slowly reversible antagonists at the beta 1adrenoceptors of rat left atria",
    "triple_list": [
      [
        "Alprenolol",
        "CPR:6",
        "beta 1adrenoceptors"
      ],
      [
        "bromoacetylalprenololmenthane",
        "CPR:6",
        "beta 1adrenoceptors"
      ]
    ],
    "updated": "No",
    "original": "Alprenolol and bromoacetylalprenololmenthane are competitive slowly reversible antagonists at the beta 1adrenoceptors of rat left atria",
    "simplified": "Alprenololmenthane and bromoacetylalprenololmenthane are two drugs that are used to treat certain diseases."
  },
  {
    "text": "Discovery and optimization of anthranilic acid sulfonamides as a structural basis for the reduction of albumin binding , a major problem in medicine .",
    "triple_list": [
      [
        "anthranilic acid sulfonamides",
        "CPR:4",
        "albumin"
      ]
    ],
    "updated": "Yes",
    "original": "Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase2 a structural basis for the reduction of albumin binding",
    "simplified": "Discovery and optimization of anthranilic acid sulfonamides as a structural basis for the reduction of albumin binding, a major problem in medicine."
  },
  {
    "text": "Adenine phosphoribosyltransferase is an enzyme . It breaks down adenine to make adenosine monophosphate and riboflavin .",
    "triple_list": [
      [
        "Adenine phosphoribosyltransferase",
        "CPR:9",
        "adenine"
      ],
      [
        "Adenine phosphoribosyltransferase",
        "CPR:9",
        "adenosine monophosphate"
      ]
    ],
    "updated": "Yes",
    "original": "Adenine phosphoribosyltransferase plays a role in purine salvage by catalyzing the direct conversion of adenine to adenosine monophosphate",
    "simplified": "Adenine phosphoribosyltransferase is an enzyme. It breaks down adenine to make adenosine monophosphate and riboflavin."
  },
  {
    "text": "BACKGROUND Since the introduction of the first cholinesterase inhibitor ChEI in 1997 most clinicians and probably most patients would consider the cholinergic drugs donepezil galantamine and rivastigmine to be the first line pharmacotherapy for mild to moderate Alzheimers diseaseThe drugs have slightly different pharmacological properties but they all work by inhibiting the breakdown of acetylcholine an important neurotransmitter associated with memory by blocking the enzyme acetylcholinesterase",
    "triple_list": [
      [
        "cholinesterase",
        "CPR:4",
        "donepezil"
      ],
      [
        "donepezil",
        "CPR:4",
        "acetylcholinesterase"
      ],
      [
        "cholinesterase",
        "CPR:4",
        "galantamine"
      ],
      [
        "galantamine",
        "CPR:4",
        "acetylcholinesterase"
      ],
      [
        "cholinesterase",
        "CPR:4",
        "rivastigmine"
      ],
      [
        "rivastigmine",
        "CPR:4",
        "acetylcholinesterase"
      ],
      [
        "acetylcholine",
        "CPR:9",
        "acetylcholinesterase"
      ]
    ],
    "updated": "No",
    "original": "BACKGROUND Since the introduction of the first cholinesterase inhibitor ChEI in 1997 most clinicians and probably most patients would consider the cholinergic drugs donepezil galantamine and rivastigmine to be the first line pharmacotherapy for mild to moderate Alzheimers diseaseThe drugs have slightly different pharmacological properties but they all work by inhibiting the breakdown of acetylcholine an important neurotransmitter associated with memory by blocking the enzyme acetylcholinesterase",
    "simplified": "Since the introduction of the first cholinesterase inhibitor ChEI in 1997 most clinicians and probably most patients would consider the cholinergic drugs donepezil galantamine and rivastigmine to be the first line pharmacotherapy for mild to moderate Alzheimers disease; however, there is still some disagreement over whether donepezil and rivastigmine are better for people with mild to moderate Alzheimers disease."
  },
  {
    "text": "Mitiglinide KAD1229 a new antidiabetic drug is thought to stimulate insulin secretion by closing the ATPsensitive K KATP channels in pancreatic betacells",
    "triple_list": [
      [
        "KAD1229",
        "CPR:3",
        "insulin"
      ],
      [
        "Mitiglinide",
        "CPR:3",
        "insulin"
      ],
      [
        "KAD1229",
        "CPR:4",
        "ATPsensitive K KATP channels"
      ],
      [
        "Mitiglinide",
        "CPR:4",
        "ATPsensitive K KATP channels"
      ]
    ],
    "updated": "No",
    "original": "Mitiglinide KAD1229 a new antidiabetic drug is thought to stimulate insulin secretion by closing the ATPsensitive K KATP channels in pancreatic betacells",
    "simplified": "A new drug called Mitiglinide KAD1229 is thought to help people with diabetes control insulin by closing the K-KATP channels in the pancreas."
  },
  {
    "text": "Patchclamp analysis using insideout recording configuration showed that mitiglinide inhibits the Kir62 SUR1 channel currents but does not significantly inhibit either Kir62SUR2A or Kir62SUR2B channel currents even at high doses . The IC50 value for mitiglinide is 100 nM .",
    "triple_list": [
      [
        "mitiglinide",
        "CPR:4",
        "Kir62"
      ],
      [
        "mitiglinide",
        "CPR:4",
        "SUR1"
      ]
    ],
    "updated": "Yes",
    "original": "Patchclamp analysis using insideout recording configuration showed that mitiglinide inhibits the Kir62 SUR1 channel currents in a dosedependent manner IC50 value 100 nM but does not significantly inhibit either Kir62SUR2A or Kir62SUR2B channel currents even at high doses more than 10 microM",
    "simplified": "Patchclamp analysis using insideout recording configuration showed that mitiglinide inhibits the Kir62 SUR1 channel currents but does not significantly inhibit either Kir62SUR2A or Kir62SUR2B channel currents even at high doses. The IC50 value for mitiglinide is 100 nM."
  },
  {
    "text": "Nateglinide inhibits Kir62 SUR1 and Kir62 SUR2B channels at 100 nM and inhibits Kir62 SUR2A channels at high concentrations 1 microM",
    "triple_list": [
      [
        "Nateglinide",
        "CPR:4",
        "Kir62"
      ],
      [
        "Nateglinide",
        "CPR:4",
        "SUR1"
      ],
      [
        "Nateglinide",
        "CPR:4",
        "Kir62"
      ],
      [
        "Nateglinide",
        "CPR:4",
        "SUR2B"
      ],
      [
        "Nateglinide",
        "CPR:4",
        "Kir62"
      ],
      [
        "Nateglinide",
        "CPR:4",
        "SUR2A"
      ]
    ],
    "updated": "No",
    "original": "Nateglinide inhibits Kir62 SUR1 and Kir62 SUR2B channels at 100 nM and inhibits Kir62 SUR2A channels at high concentrations 1 microM",
    "simplified": "Nateglinide works by inhibiting the Kir62 SUR1 and Kir62 SUR2 channels. It works best at a concentration of 100 nM."
  },
  {
    "text": "These results indicate that similar to the sulfonylureas mitiglinide is highly specific to the KATP channel in the pancreas and suggest that mitiglinide may be a useful antidiabetic drug .",
    "triple_list": [
      [
        "mitiglinide",
        "CPR:5",
        "KATP channel"
      ]
    ],
    "updated": "Yes",
    "original": "These results indicate that similar to the sulfonylureas mitiglinide is highly specific to the Kir62SUR1 complex ie the pancreatic betacell KATP channel and suggest that mitiglinide may be a clinically useful antidiabetic drug",
    "simplified": "These results indicate that similar to the sulfonylureas mitiglinide is highly specific to the KATP channel in the pancreas and suggest that mitiglinide may be a useful antidiabetic drug."
  },
  {
    "text": "Although generally highly specific for angiotensin II type 1 receptors some ARBs particularly telmisartan are partial agonists at peroxisome proliferatoractivated receptor\u03b3",
    "triple_list": [
      [
        "telmisartan",
        "CPR:5",
        "peroxisome proliferatoractivated receptor\u03b3"
      ],
      [
        "angiotensin II type 1 receptors",
        "CPR:6",
        "telmisartan"
      ]
    ],
    "updated": "No",
    "original": "Although generally highly specific for angiotensin II type 1 receptors some ARBs particularly telmisartan are partial agonists at peroxisome proliferatoractivated receptor\u03b3",
    "simplified": "ARBs are usually very specific for angiotensin II type 1 receptors. Some ARBs are partial agonists at other receptors, for example peroxisome proliferator-activated receptor."
  },
  {
    "text": "In further studies the diuretic effects of the CB1 agonist AM4054 were similar in male and female rats displayed a relatively rapid onset to action and were dosedependently antagonized by 30 minutes pretreatment with rimonabant but not by the vanilloid receptor type I antagonist capsazepine nor were the effects of WIN 55212 antagonized by the CB2 antagonist AM630 6iodo2methyl124morpholinylethyl1Hindol3yl4methoxyphenyl methanone",
    "triple_list": [
      [
        "CB1",
        "CPR:5",
        "AM4054"
      ],
      [
        "WIN 55212",
        "CPR:5",
        "CB2"
      ],
      [
        "CB1",
        "CPR:6",
        "rimonabant"
      ],
      [
        "vanilloid receptor type I",
        "CPR:6",
        "capsazepine"
      ],
      [
        "CB2",
        "CPR:6",
        "AM630"
      ],
      [
        "CB2",
        "CPR:6",
        "6iodo2methyl124morpholinylethyl1Hindol3yl4methoxyphenyl methanone"
      ]
    ],
    "updated": "No",
    "original": "In further studies the diuretic effects of the CB1 agonist AM4054 were similar in male and female rats displayed a relatively rapid onset to action and were dosedependently antagonized by 30 minutes pretreatment with rimonabant but not by the vanilloid receptor type I antagonist capsazepine nor were the effects of WIN 55212 antagonized by the CB2 antagonist AM630 6iodo2methyl124morpholinylethyl1Hindol3yl4methoxyphenyl methanone",
    "simplified": "In further studies the diuretic effects of the CB1 agonist AM4054 were similar in male and female rats and were dosedependently antagonized by 30 minutes pretreatment with rimonabant but not by the vanilloid receptor type I antagonist capsazepine. The effects of WIN 55212 were not antagonized by the vanilloid receptor type I antagonist AM630."
  },
  {
    "text": "Directacting CB1 agonists including \u03949tetrahydrocannabinol WIN 55212 R123dihydro5methyl3morpholinylmethylpyrrolo123de14benzoxazinyl1naphthalenylmethanone mesylate AM2389 9\u03b2hydroxy31hexylcyclobut1ylhexahydrocannabinol and AM4054 9\u03b2hydroxymethyl31adamantylhexahydrocannabinol produced dosedependent increases in diuresis and decreases in colonic temperature with slightly lower ED50 values for diuresis than for hypothermia",
    "triple_list": [
      [
        "CB1",
        "CPR:5",
        "\u03949tetrahydrocannabinol"
      ],
      [
        "CB1",
        "CPR:5",
        "WIN 55212"
      ],
      [
        "CB1",
        "CPR:5",
        "R123dihydro5methyl3morpholinylmethylpyrrolo123de14benzoxazinyl1naphthalenylmethanone mesylate"
      ],
      [
        "CB1",
        "CPR:5",
        "AM2389"
      ],
      [
        "CB1",
        "CPR:5",
        "9\u03b2hydroxy31hexylcyclobut1ylhexahydrocannabinol"
      ],
      [
        "CB1",
        "CPR:5",
        "AM4054"
      ],
      [
        "CB1",
        "CPR:5",
        "9\u03b2hydroxymethyl31adamantylhexahydrocannabinol"
      ]
    ],
    "updated": "No",
    "original": "Directacting CB1 agonists including \u03949tetrahydrocannabinol WIN 55212 R123dihydro5methyl3morpholinylmethylpyrrolo123de14benzoxazinyl1naphthalenylmethanone mesylate AM2389 9\u03b2hydroxy31hexylcyclobut1ylhexahydrocannabinol and AM4054 9\u03b2hydroxymethyl31adamantylhexahydrocannabinol produced dosedependent increases in diuresis and decreases in colonic temperature with slightly lower ED50 values for diuresis than for hypothermia",
    "simplified": "Directacting CB1 agonists like AM2389 9\u03b2hydroxy31hexylcyclobut1ylhexahydrocannabinol and AM4054 9\u03b2hydroxymethyl31adamantylhexahydrocannabinol produced dosedependent increases in diuresis and decreases in colonic temperature, but not as much as the effects of other drugs."
  },
  {
    "text": "Methanandamide 100 mgkg had lesser effect than other CB agonists and the CB2 agonist AM1241 1methylpiperidin2ylmethyl32iodo5nitrobenzoylindole the anandamide transport inhibitor AM404 and the CB antagonist rimonabant did not have diuretic effects",
    "triple_list": [
      [
        "CB2",
        "CPR:5",
        "AM1241"
      ],
      [
        "CB2",
        "CPR:5",
        "1methylpiperidin2ylmethyl32iodo5nitrobenzoylindole"
      ],
      [
        "CB2",
        "CPR:5",
        "AM404"
      ]
    ],
    "updated": "No",
    "original": "Methanandamide 100 mgkg had lesser effect than other CB agonists and the CB2 agonist AM1241 1methylpiperidin2ylmethyl32iodo5nitrobenzoylindole the anandamide transport inhibitor AM404 and the CB antagonist rimonabant did not have diuretic effects",
    "simplified": "Methanandamide 100 mgkg had a lesser effect than other CB agonists and the CB antagonist rimonabant. The anandamide transport inhibitor AM404 and the CB2 agonist AM1241 did not have diuretic effects."
  },
  {
    "text": "N2cyclohexyloxyl4nitrophenylmethanesulfonamide NS398 a selective cyclooxygenase2 inhibitor also inhibited cell proliferation whereas it did not cause apoptosis",
    "triple_list": [
      [
        "N2cyclohexyloxyl4nitrophenylmethanesulfonamide",
        "CPR:4",
        "cyclooxygenase2"
      ],
      [
        "NS398",
        "CPR:4",
        "cyclooxygenase2"
      ]
    ],
    "updated": "No",
    "original": "N2cyclohexyloxyl4nitrophenylmethanesulfonamide NS398 a selective cyclooxygenase2 inhibitor also inhibited cell proliferation whereas it did not cause apoptosis",
    "simplified": "N2cyclohexyloxyl4nitrophenylmethanesulfonamide NS398 did not cause apoptosis, but it did not make the cells grow either."
  },
  {
    "text": "Mutation of arginine 228 to lysine enhances the glucosyltransferase activity of bovine beta14galactosyltransferase I Beta14galactosyltransferase I beta4GalT1 normally transfers Gal from UDPGal to GlcNAc in the presence of Mn2 ion GalT activity and also transfers Glc from UDPGlc to GlcNAc GlcT activity albeit at only 03 efficiency",
    "triple_list": [
      [
        "lysine",
        "CPR:3",
        "glucosyltransferase"
      ],
      [
        "UDPGlc",
        "CPR:9",
        "GlcT"
      ],
      [
        "GalT",
        "CPR:9",
        "UDPGal"
      ],
      [
        "beta4GalT1",
        "CPR:9",
        "UDPGal"
      ]
    ],
    "updated": "No",
    "original": "Mutation of arginine 228 to lysine enhances the glucosyltransferase activity of bovine beta14galactosyltransferase I Beta14galactosyltransferase I beta4GalT1 normally transfers Gal from UDPGal to GlcNAc in the presence of Mn2 ion GalT activity and also transfers Glc from UDPGlc to GlcNAc GlcT activity albeit at only 03 efficiency",
    "simplified": "Bovine beta14galactosyltransferase I beta4GalT1 normally transfers Gal from UDPGal to GlcNAc in the presence of Mn2 ion GalT activity and also transfers Glc from UDPGlc to GlcNAc GlcT activity albeit at only 03 efficiency The activity of bovine beta14galactosyltransferase I beta4GalT1 is known as beta14galactosyltransferase."
  },
  {
    "text": "In this study a novel series of 2hydroxydiarylamide derivatives were synthesized and evaluated for inhibiting TMPRSS4 serine protease activity and suppressing cancer cell invasion",
    "triple_list": [
      [
        "2hydroxydiarylamide",
        "CPR:4",
        "TMPRSS4"
      ],
      [
        "2hydroxydiarylamide",
        "CPR:4",
        "serine protease"
      ]
    ],
    "updated": "No",
    "original": "In this study a novel series of 2hydroxydiarylamide derivatives were synthesized and evaluated for inhibiting TMPRSS4 serine protease activity and suppressing cancer cell invasion",
    "simplified": "In this study a novel series of 2hydroxydiarylamide derivatives were synthesized and evaluated for their ability to inhibit the growth of cancer cells."
  },
  {
    "text": "Discovery of novel 2hydroxydiarylamide derivatives as TMPRSS4 inhibitors",
    "triple_list": [
      [
        "2hydroxydiarylamide",
        "CPR:4",
        "TMPRSS4"
      ]
    ],
    "updated": "No",
    "original": "Discovery of novel 2hydroxydiarylamide derivatives as TMPRSS4 inhibitors",
    "simplified": "2hydroxydiarylamide is a chemical compound. It is a diuretic."
  },
  {
    "text": "In contrast , the selective beta2AR antagonists ICI118551 and butoxamine inhibited isoproterenol-mediated growth with apparent low levels of 222 61 and 9268 512 nM respectively .",
    "triple_list": [
      [
        "beta2AR",
        "CPR:5",
        "isoproterenol"
      ],
      [
        "beta2AR",
        "CPR:6",
        "butoxamine"
      ],
      [
        "beta2AR",
        "CPR:6",
        "ICI118551"
      ]
    ],
    "updated": "Yes",
    "original": "In contrast the selective beta2AR antagonists ICI118551 and butoxamine inhibited isoproterenol mediated enhancement with apparent low affinities Kb of 222 61 and 9268 512 nM respectively",
    "simplified": "In contrast, the selective beta2AR antagonists ICI118551 and butoxamine inhibited isoproterenol-mediated growth with apparent low levels of 222 61 and 9268 512 nM respectively."
  },
  {
    "text": "Together this pharmacological profile of subtypeselective betaAR antagonists indicates that in this model beta1AR activation is responsible for the enhanced hippocampal CA3 network activity initiated by isoproterenol",
    "triple_list": [
      [
        "beta1AR",
        "CPR:5",
        "isoproterenol"
      ]
    ],
    "updated": "No",
    "original": "Together this pharmacological profile of subtypeselective betaAR antagonists indicates that in this model beta1AR activation is responsible for the enhanced hippocampal CA3 network activity initiated by isoproterenol",
    "simplified": "Together this pharmacological profile of subtypeselective betaAR antagonists indicates that isoproterenol is responsible for the enhanced CA3 network activity in the hippocampus in this model."
  },
  {
    "text": "The selective betaAR agonist isoproterenol caused an increase in the activity of the CA3 network in the hippocampus . There was also an increase in spontaneous burst discharges .",
    "triple_list": [
      [
        "betaAR",
        "CPR:5",
        "isoproterenol"
      ]
    ],
    "updated": "Yes",
    "original": "The selective betaAR agonist isoproterenol caused an enhancement of hippocampal CA3 network activity as measured by an increase in frequency of spontaneous burst discharges recorded in the CA3 region",
    "simplified": "The selective betaAR agonist isoproterenol caused an increase in the activity of the CA3 network in the hippocampus. There was also an increase in spontaneous burst discharges."
  },
  {
    "text": "The selective beta1AR antagonists atenolol and metoprolol blocked isoproterenol , but the effects of atenolol and metoprolol are not known .",
    "triple_list": [
      [
        "beta1AR",
        "CPR:5",
        "isoproterenol"
      ],
      [
        "beta1AR",
        "CPR:6",
        "atenolol"
      ],
      [
        "beta1AR",
        "CPR:6",
        "metoprolol"
      ]
    ],
    "updated": "Yes",
    "original": "The selective beta1AR antagonists atenolol and metoprolol blocked isoproterenol induced enhancement with apparent Kb values of 85 36 and 39 17 nM respectively",
    "simplified": "The selective beta1AR antagonists atenolol and metoprolol blocked isoproterenol, but the effects of atenolol and metoprolol are not known."
  },
  {
    "text": "P2Y2 receptor agonist ( INS37217 ) improves functional recovery after subretinal injection in normal and abnormal mice",
    "triple_list": [
      [
        "P2Y2 receptor",
        "CPR:5",
        "INS37217"
      ]
    ],
    "updated": "Yes",
    "original": "P2Y2 receptor agonist INS37217 enhances functional recovery after detachment caused by subretinal injection in normal and rds mice",
    "simplified": "P2Y2 receptor agonist (INS37217) improves functional recovery after subretinal injection in normal and abnormal mice"
  },
  {
    "text": "Inhibition of GluR5 kainate receptors may be a key mechanism by which topiramate can not be taken by people .",
    "triple_list": [
      [
        "GluR5",
        "CPR:4",
        "topiramate"
      ],
      [
        "kainate receptors",
        "CPR:4",
        "topiramate"
      ]
    ],
    "updated": "Yes",
    "original": "Inhibition of GluR5 kainate receptors could represent a key mechanism underlying the anticonvulsant activity of topiramate",
    "simplified": "Inhibition of GluR5 kainate receptors may be a key mechanism by which topiramate can not be taken by people."
  },
  {
    "text": "In wholecell voltageclamp recordings from principal neurons of the rat basolateral amygdala topiramate was selectively inhibited at a concentration of IC50 approximately 05 microm . The kainate receptors containing the GluR5 subunit were selectively inhibited .",
    "triple_list": [
      [
        "topiramate",
        "CPR:4",
        "kainate receptors"
      ],
      [
        "topiramate",
        "CPR:4",
        "GluR5"
      ]
    ],
    "updated": "Yes",
    "original": "In wholecell voltageclamp recordings from principal neurons of the rat basolateral amygdala topiramate at low concentrations IC50 approximately 05 microm selectively inhibited pharmacologically isolated excitatory synaptic currents mediated by kainate receptors containing the GluR5 subunit",
    "simplified": "In wholecell voltageclamp recordings from principal neurons of the rat basolateral amygdala topiramate was selectively inhibited at a concentration of IC50 approximately 05 microm. The kainate receptors containing the GluR5 subunit were selectively inhibited."
  },
  {
    "text": "Topiramate also partially depressed predominantly AMPAreceptor mediated EPSCs but with lower efficacy",
    "triple_list": [
      [
        "Topiramate",
        "CPR:4",
        "AMPAreceptor"
      ]
    ],
    "updated": "No",
    "original": "Topiramate also partially depressed predominantly AMPAreceptor mediated EPSCs but with lower efficacy",
    "simplified": "Topiramate also partially depressed some EPSCs, but this was not as effective as it used to be."
  },
  {
    "text": "Selective antagonism of GluR5 kainatereceptor mediated synaptic currents by topiramate in rat basolateral amygdala neurons",
    "triple_list": [
      [
        "GluR5",
        "CPR:6",
        "topiramate"
      ],
      [
        "kainatereceptor",
        "CPR:6",
        "topiramate"
      ]
    ],
    "updated": "No",
    "original": "Selective antagonism of GluR5 kainatereceptor mediated synaptic currents by topiramate in rat basolateral amygdala neurons",
    "simplified": "Topiramate selectively inhibits GluR5 kainatereceptor mediated synaptic currents in rat basolateral amygdala neurons."
  },
  {
    "text": "Density functional theory calculations using the hybrid functional B3LYP have been performed to study the methyl transfer step in glycine Nmethyltransferase GNMT",
    "triple_list": [
      [
        "methyl",
        "CPR:9",
        "glycine Nmethyltransferase"
      ],
      [
        "methyl",
        "CPR:9",
        "GNMT"
      ]
    ],
    "updated": "No",
    "original": "Density functional theory calculations using the hybrid functional B3LYP have been performed to study the methyl transfer step in glycine Nmethyltransferase GNMT",
    "simplified": "Density functional theory calculations using the hybrid functional B3LYP have been performed to find out how B3LYP changes the shape of an enzyme."
  },
  {
    "text": "The starting point for the calculations is the recent Xray crystal structure of GNMT complexed with SAM and acetate",
    "triple_list": [
      [
        "GNMT",
        "CPR:9",
        "SAM"
      ]
    ],
    "updated": "No",
    "original": "The starting point for the calculations is the recent Xray crystal structure of GNMT complexed with SAM and acetate",
    "simplified": "The starting point for the calculations is a recent X-ray crystal structure of GNMT, as shown in the following table."
  },
  {
    "text": "In this study we demonstrate significant inhibitory activity of dasatinib in the nanomolar range against both wildtype and the KIT D816V mutation in in vitro and cellbased kinase assays",
    "triple_list": [
      [
        "dasatinib",
        "CPR:4",
        "KIT"
      ],
      [
        "dasatinib",
        "CPR:4",
        "KIT"
      ],
      [
        "dasatinib",
        "CPR:4",
        "D816V"
      ]
    ],
    "updated": "Yes",
    "original": "In this study we demonstrate significant inhibitory activity of dasatinib against both wildtype KIT and the KIT D816V mutation in the nanomolar range in in vitro and cellbased kinase assays",
    "simplified": "In this study we demonstrate significant inhibitory activity of dasatinib in the nanomolar range against both wildtype and the KIT D816V mutation in in vitro and cellbased kinase assays"
  },
  {
    "text": "Additionally dasatinib leads to growth inhibition of a KIT D816V harboring human mastocytosis cell line",
    "triple_list": [
      [
        "dasatinib",
        "CPR:4",
        "KIT"
      ],
      [
        "dasatinib",
        "CPR:4",
        "D816V"
      ]
    ],
    "updated": "No",
    "original": "Additionally dasatinib leads to growth inhibition of a KIT D816V harboring human mastocytosis cell line",
    "simplified": "Dasatinib also inhibits the growth of a human mastocytosis cell line in KIT D816V."
  },
  {
    "text": "Dasatinib BMS354825 inhibits a mutation in KIT D816V that causes growth in most patients with systemic mastocytosis .",
    "triple_list": [
      [
        "Dasatinib",
        "CPR:4",
        "KIT"
      ],
      [
        "Dasatinib",
        "CPR:4",
        "D816V"
      ],
      [
        "BMS354825",
        "CPR:4",
        "D816V"
      ]
    ],
    "updated": "Yes",
    "original": "Dasatinib BMS354825 inhibits KIT D816V an imatinibresistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis",
    "simplified": "Dasatinib BMS354825 inhibits a mutation in KIT D816V that causes growth in most patients with systemic mastocytosis."
  },
  {
    "text": "Dasatinib BMS354825 is a novel orally bioavailable SRC ABL inhibitor that is presently showing considerable promise in earlyphase clinical trials of chronic myeloid leukemia CML that has activity against multiple imatinibresistant BCRABL isoforms .",
    "triple_list": [
      [
        "Dasatinib",
        "CPR:4",
        "SRC"
      ],
      [
        "Dasatinib",
        "CPR:4",
        "ABL"
      ],
      [
        "BMS354825",
        "CPR:4",
        "SRC"
      ],
      [
        "BMS354825",
        "CPR:4",
        "ABL"
      ]
    ],
    "updated": "Yes",
    "original": "Dasatinib BMS354825 is a novel orally bioavailable SRC ABL inhibitor that has activity against multiple imatinibresistant BCRABL isoforms in vitro that is presently showing considerable promise in earlyphase clinical trials of chronic myeloid leukemia CML",
    "simplified": "Dasatinib BMS354825 is a novel orally bioavailable SRC ABL inhibitor that is presently showing considerable promise in earlyphase clinical trials of chronic myeloid leukemia CML that has activity against multiple imatinibresistant BCRABL isoforms."
  },
  {
    "text": "The results reinforce previous assumptions that dopamine may interact with eicosanoid metabolism by means of D2 receptor activation , and suggest that COX2 and cPLA2 may also be involved .",
    "triple_list": [
      [
        "dopamine",
        "CPR:3",
        "D2 receptor"
      ]
    ],
    "updated": "Yes",
    "original": "The results reinforce previous assumptions that dopamine may interact with eicosanoid metabolism by means of D2 receptor activation and implicate an involvement of cPLA2 and COX2 in this effect",
    "simplified": "The results reinforce previous assumptions that dopamine may interact with eicosanoid metabolism by means of D2 receptor activation, and suggest that COX2 and cPLA2 may also be involved."
  },
  {
    "text": "The cyclooxygenase ( COX ) inhibitor indomethacin also worked against it . The selective COX2 inhibitor NS398 worked against it , but not the specific COX1 inhibitor valeryl salicylate .",
    "triple_list": [
      [
        "cyclooxygenase",
        "CPR:4",
        "indomethacin"
      ],
      [
        "COX",
        "CPR:4",
        "indomethacin"
      ],
      [
        "COX2",
        "CPR:4",
        "NS398"
      ],
      [
        "COX1",
        "CPR:4",
        "valeryl salicylate"
      ]
    ],
    "updated": "Yes",
    "original": "It was also antagonized by the nonspecific cyclooxygenase COX inhibitor indomethacin and by the selective COX2 inhibitor NS398 but not by the specific COX1 inhibitor valeryl salicylate",
    "simplified": "The cyclooxygenase (COX) inhibitor indomethacin also worked against it. The selective COX2 inhibitor NS398 worked against it, but not the specific COX1 inhibitor valeryl salicylate."
  },
  {
    "text": "Both the nonspecific phospholipase A2 inhibitor quinacrine and an inhibitor of cPLA2 did not work . A selective inhibitor of cPLA2 called AACOF3 did not work either .",
    "triple_list": [
      [
        "phospholipase A2",
        "CPR:4",
        "quinacrine"
      ]
    ],
    "updated": "Yes",
    "original": "Both the nonspecific phospholipase A2 inhibitor quinacrine and an inhibitor of cPLA2 and iPLA2 AACOF3 counteracted the effect in contrast a selective iPLA2 inhibitor BEL and a selective sPLA2 inhibitor TAPC were ineffective",
    "simplified": "Both the nonspecific phospholipase A2 inhibitor quinacrine and an inhibitor of cPLA2 did not work. A selective inhibitor of cPLA2 called AACOF3 did not work either."
  },
  {
    "text": "The effect was counteracted by the D2 antagonist eticlopride pertussis toxin and by chronic pretreatment with the phorbol ester TPA . The effect was counteracted by the D2 antagonist eticlopride pertussis toxin .",
    "triple_list": [
      [
        "D2",
        "CPR:6",
        "eticlopride"
      ]
    ],
    "updated": "Yes",
    "original": "The effect was counteracted by the D2 antagonist eticlopride pertussis toxin the inhibitor of intracellular Ca2 release TMB8 incubation in Ca2free experimental medium and PKC desensitization obtained by chronic pretreatment with the phorbol ester TPA",
    "simplified": "The effect was counteracted by the D2 antagonist eticlopride pertussis toxin and by chronic pretreatment with the phorbol ester TPA. The effect was counteracted by the D2 antagonist eticlopride pertussis toxin."
  },
  {
    "text": "Dopamine D2 receptorinduced COX2 mediated production of prostaglandin E2 in D2transfected Chinese hamster ovary cells without simultaneous administration of a Ca2mobilizing agent",
    "triple_list": [
      [
        "COX2",
        "CPR:9",
        "prostaglandin E2"
      ]
    ],
    "updated": "No",
    "original": "Dopamine D2 receptorinduced COX2 mediated production of prostaglandin E2 in D2transfected Chinese hamster ovary cells without simultaneous administration of a Ca2mobilizing agent",
    "simplified": "Dopamine D2 receptor - mediated production of prostaglandin E2 in Chinese hamster ovary cells without simultaneous administration of Ca2mobilizing agent"
  },
  {
    "text": "At a concentration of 20 \u00b5M the most active HFC glucuronidation catalysts were UGT1A10 followed by UGT1A6 UGT1A7 UGT2A1 and at 300 \u00b5M UGT1A6 was about 10 times better than the other recombinant UGTs .",
    "triple_list": [
      [
        "HFC",
        "CPR:9",
        "UGT1A10"
      ],
      [
        "HFC",
        "CPR:9",
        "UGT1A6"
      ],
      [
        "HFC",
        "CPR:9",
        "UGT1A7"
      ],
      [
        "HFC",
        "CPR:9",
        "UGT2A1"
      ],
      [
        "HFC",
        "CPR:9",
        "UGT1A6"
      ],
      [
        "HFC",
        "CPR:9",
        "UGTs"
      ]
    ],
    "updated": "Yes",
    "original": "At a substrate concentration of 20 \u00b5M the most active HFC glucuronidation catalysts were UGT1A10 followed by UGT1A6 UGT1A7 UGT2A1 whereas at 300 \u00b5M UGT1A6 was about 10 times better catalyst than the other recombinant UGTs",
    "simplified": "At a concentration of 20 \u00b5M the most active HFC glucuronidation catalysts were UGT1A10 followed by UGT1A6 UGT1A7 UGT2A1 and at 300 \u00b5M UGT1A6 was about 10 times better than the other recombinant UGTs."
  },
  {
    "text": "A high throughput assay for the glucuronidation of 7hydroxy4trifluoromethylcoumarin by recombinant human UDPglucuronosyltransferases and liver microsomes",
    "triple_list": [
      [
        "7hydroxy4trifluoromethylcoumarin",
        "CPR:9",
        "human UDPglucuronosyltransferases"
      ]
    ],
    "updated": "No",
    "original": "A high throughput assay for the glucuronidation of 7hydroxy4trifluoromethylcoumarin by recombinant human UDPglucuronosyltransferases and liver microsomes",
    "simplified": "A high throughput assay for the glucuronidation of 7hydroxy4trifluoromethylcoumarin by UDPglucuronosyltransferases in human and animal liver."
  },
  {
    "text": "UGT1A6 exhibited a significantly higher Vmax and Km values toward both HFC and UDP glucuronic acid than the other UGTs",
    "triple_list": [
      [
        "HFC",
        "CPR:9",
        "UGTs"
      ],
      [
        "UGT1A6",
        "CPR:9",
        "HFC"
      ],
      [
        "UDP",
        "CPR:9",
        "UGTs"
      ],
      [
        "UGT1A6",
        "CPR:9",
        "UDP"
      ],
      [
        "glucuronic acid",
        "CPR:9",
        "UGTs"
      ],
      [
        "UGT1A6",
        "CPR:9",
        "glucuronic acid"
      ]
    ],
    "updated": "No",
    "original": "UGT1A6 exhibited a significantly higher Vmax and Km values toward both HFC and UDP glucuronic acid than the other UGTs",
    "simplified": "UGT1A6 had a significantly higher Vmax and Km values than the other UGTs, and was used in the food industry."
  },
  {
    "text": "We have developed a convenient quantitative multiwell plate assay to measure the glucuronidation rate of 7hydroxy4trifluoromethylcoumarin HFC for several UGTs",
    "triple_list": [
      [
        "7hydroxy4trifluoromethylcoumarin",
        "CPR:9",
        "UGTs"
      ],
      [
        "HFC",
        "CPR:9",
        "UGTs"
      ]
    ],
    "updated": "No",
    "original": "We have developed a convenient quantitative multiwell plate assay to measure the glucuronidation rate of 7hydroxy4trifluoromethylcoumarin HFC for several UGTs",
    "simplified": "A convenient multiwell plate assay has been developed to measure the glucuronidation rate of 7hydroxy4trifluoromethylcoumarin for several UGTs."
  },
  {
    "text": "This method has been used to screen 11 recombinant human UGTs for HFC glucuronidation activity and to study the reaction kinetics of the most active enzymes .",
    "triple_list": [
      [
        "human UGTs",
        "CPR:9",
        "HFC"
      ]
    ],
    "updated": "Yes",
    "original": "We have used this method to screen 11 recombinant human UGTs for HFC glucuronidation activity and studied the reaction kinetics with the most active enzymes",
    "simplified": "This method has been used to screen 11 recombinant human UGTs for HFC glucuronidation activity and to study the reaction kinetics of the most active enzymes."
  },
  {
    "text": "When mice were pretreated with the H3R blocker Ralphamethylhistamine , this did not happen .",
    "triple_list": [
      [
        "H3R",
        "CPR:5",
        "Ralphamethylhistamine"
      ]
    ],
    "updated": "Yes",
    "original": "This inhibition was blocked when mice were pretreated with the selective H3R agonist Ralphamethylhistamine 10 mgkg",
    "simplified": "When mice were pretreated with the H3R blocker Ralphamethylhistamine, this did not happen."
  },
  {
    "text": "These results suggest that clomipramine causes hyperglycemia in mice because it blocks the 5HT2B and 5HT2C receptors . These receptors help release adrenaline .",
    "triple_list": [
      [
        "clomipramine",
        "CPR:4",
        "5HT2B"
      ],
      [
        "clomipramine",
        "CPR:4",
        "5HT2C"
      ]
    ],
    "updated": "Yes",
    "original": "These results suggest that clomipramine induces hyperglycemia in mice by blocking the 5HT2B andor 5HT2C receptors which results in facilitation of adrenaline release",
    "simplified": "These results suggest that clomipramine causes hyperglycemia in mice because it blocks the 5HT2B and 5HT2C receptors. These receptors help release adrenaline."
  },
  {
    "text": "The 5HT1257receptor antagonist methysergide and the 5HT2A2B2Creceptor antagonist LY 53857 enhanced clomipramineinduced hyperglycemia while the 5HT1A1Breceptor antagonist propranolol and the 5HT34receptor antagonist tropisetron did not affect it",
    "triple_list": [
      [
        "5HT1A1Breceptor",
        "CPR:6",
        "propranolol"
      ],
      [
        "5HT34receptor",
        "CPR:6",
        "tropisetron"
      ],
      [
        "5HT2A2B2Creceptor",
        "CPR:6",
        "LY 53857"
      ]
    ],
    "updated": "No",
    "original": "The 5HT1257receptor antagonist methysergide and the 5HT2A2B2Creceptor antagonist LY 53857 enhanced clomipramineinduced hyperglycemia while the 5HT1A1Breceptor antagonist propranolol and the 5HT34receptor antagonist tropisetron did not affect it",
    "simplified": "The 5HT1257receptor antagonist methysergide and the 5HT2A2B2Creceptor antagonist LY 53857 made clomipramine make people have problems with their glucose levels. The 5HT34receptor antagonist tropisetron did not affect it."
  },
  {
    "text": "The 5HT2B2Creceptor antagonist SB 206553 helped with hyperglycemia when clomipramine was given . The 5HT2A receptor antagonist ketanserin did not work .",
    "triple_list": [
      [
        "5HT2B2Creceptor",
        "CPR:6",
        "SB 206553"
      ],
      [
        "5HT2A",
        "CPR:6",
        "ketanserin"
      ]
    ],
    "updated": "Yes",
    "original": "The 5HT2B2Creceptor antagonist SB 206553 facilitated hyperglycemia induced by clomipramine although the 5HT2A receptor antagonist ketanserin was without effect",
    "simplified": "The 5HT2B2Creceptor antagonist SB 206553 helped with hyperglycemia when clomipramine was given. The 5HT2A receptor antagonist ketanserin did not work."
  },
  {
    "text": "Phosphatidylserine PtdSer is made in mammalian cells by two PtdSer synthases PSS1 and PSS2",
    "triple_list": [
      [
        "Phosphatidylserine",
        "CPR:9",
        "PtdSer synthases"
      ],
      [
        "Phosphatidylserine",
        "CPR:9",
        "PSS1"
      ],
      [
        "Phosphatidylserine",
        "CPR:9",
        "PSS2"
      ]
    ],
    "updated": "No",
    "original": "Phosphatidylserine PtdSer is made in mammalian cells by two PtdSer synthases PSS1 and PSS2",
    "simplified": "Phosphatidylserine PtdSer is made by two enzymes. They are called PSS1 and PSS2."
  },
  {
    "text": "Moreover a normal level of expression of PSS1 andor PSS2 is not required for generating the pool of PtdSer externalized during apoptosis",
    "triple_list": [
      [
        "PSS1",
        "CPR:9",
        "PtdSer"
      ],
      [
        "PSS2",
        "CPR:9",
        "PtdSer"
      ]
    ],
    "updated": "No",
    "original": "Moreover a normal level of expression of PSS1 andor PSS2 is not required for generating the pool of PtdSer externalized during apoptosis",
    "simplified": "A normal level of expression of PSS1 andor PSS2 is not required for cell division to take place during cell death."
  },
  {
    "text": "I3A induced a higher level of secretion of the inflammatory cytokine interleukin 6 compared with PMA in the WEHI231 cells and displayed a marked biphasic doseresponse curve for the induction",
    "triple_list": [
      [
        "I3A",
        "CPR:3",
        "interleukin 6"
      ],
      [
        "I3A",
        "CPR:3",
        "cytokine"
      ],
      [
        "interleukin 6",
        "CPR:3",
        "PMA"
      ],
      [
        "cytokine",
        "CPR:3",
        "PMA"
      ]
    ],
    "updated": "No",
    "original": "I3A induced a higher level of secretion of the inflammatory cytokine interleukin 6 compared with PMA in the WEHI231 cells and displayed a marked biphasic doseresponse curve for the induction",
    "simplified": "I3A caused a higher level of interleukin 6 secretion in the WEHI231 cells compared with PMA. There was a marked biphasic doseresponse curve for the induction of I3A."
  },
  {
    "text": "The in vitro kinase activity of PKCalpha was lower when I3A was compared with PMA .",
    "triple_list": [
      [
        "PKCalpha",
        "CPR:3",
        "I3A"
      ],
      [
        "PKCalpha",
        "CPR:3",
        "PMA"
      ]
    ],
    "updated": "Yes",
    "original": "The in vitro kinase activity of PKCalpha induced by I3A was lower than that induced by PMA",
    "simplified": "The in vitro kinase activity of PKCalpha was lower when I3A was compared with PMA."
  },
  {
    "text": "PKC isoforms did show different sensitivity and selectivity for downregulation by I3A and phorbol 12myristate 13acetate PMA in WEHI231 HOP92 and Colo205 cells",
    "triple_list": [
      [
        "PKC",
        "CPR:4",
        "I3A"
      ],
      [
        "PKC",
        "CPR:4",
        "phorbol 12myristate 13acetate"
      ],
      [
        "PKC",
        "CPR:4",
        "PMA"
      ]
    ],
    "updated": "No",
    "original": "PKC isoforms did show different sensitivity and selectivity for downregulation by I3A and phorbol 12myristate 13acetate PMA in WEHI231 HOP92 and Colo205 cells",
    "simplified": "However, I3A and phorbol 12myristate 13acetate PMA did show different sensitivity and selectivity for downregulation in different cells."
  },
  {
    "text": "Type I deiodinase liver fattyacid binding protein and cytochrome P450 CYP 3A37 mRNA levels were significantly induced by TCPP while TDCPP induced CYP3A37 and CYP2H1",
    "triple_list": [
      [
        "Type I deiodinase",
        "CPR:3",
        "TCPP"
      ],
      [
        "liver fattyacid binding protein",
        "CPR:3",
        "TCPP"
      ],
      [
        "cytochrome P450 CYP 3A37",
        "CPR:3",
        "TCPP"
      ],
      [
        "TDCPP",
        "CPR:3",
        "CYP3A37"
      ],
      [
        "TDCPP",
        "CPR:3",
        "CYP2H1"
      ]
    ],
    "updated": "No",
    "original": "Type I deiodinase liver fattyacid binding protein and cytochrome P450 CYP 3A37 mRNA levels were significantly induced by TCPP while TDCPP induced CYP3A37 and CYP2H1",
    "simplified": "Type I deiodinase liver fattyacid binding protein and cytochrome P450 levels were changed by TCPP. TDCPP changed CYP3A37 and CYP2H1 levels significantly."
  },
  {
    "text": "The results suggested that both the EtOAc extract and berberine were able to activate PPAR\u03b1\u03b2\u03b3 and Rhizoma Coptis contains potential natural agonists of PPARs besides berberine",
    "triple_list": [
      [
        "EtOAc",
        "CPR:5",
        "PPAR\u03b1\u03b2\u03b3"
      ],
      [
        "berberine",
        "CPR:5",
        "PPAR\u03b1\u03b2\u03b3"
      ],
      [
        "berberine",
        "CPR:5",
        "PPAR\u03b1\u03b2\u03b3"
      ],
      [
        "berberine",
        "CPR:5",
        "PPARs"
      ]
    ],
    "updated": "No",
    "original": "The results suggested that both the EtOAc extract and berberine were able to activate PPAR\u03b1\u03b2\u03b3 and Rhizoma Coptis contains potential natural agonists of PPARs besides berberine",
    "simplified": "The results suggested that both the EtOAc extract and berberine were able to activate PPAR\u03b1\u03b2\u03b3 and that berberine could possibly be a natural PPAR agonist as well."
  },
  {
    "text": "This hypothesis was tested by pretreatment with remikiren in people with essential hypertension . The response to specific renin angiotensin aldosterone system RAAS blockade by remikiren could be predicted from pretreatment .",
    "triple_list": [
      [
        "renin",
        "CPR:4",
        "remikiren"
      ],
      [
        "angiotensin",
        "CPR:4",
        "remikiren"
      ],
      [
        "renin",
        "CPR:4",
        "remikiren"
      ]
    ],
    "updated": "Yes",
    "original": "This hypothesis was tested by investigating whether in subjects with essential hypertension the natriuretic response to specific renin angiotensin aldosterone system RAAS blockade by renininhibitor remikiren could be predicted from pretreatment renal vascular tone",
    "simplified": "This hypothesis was tested by pretreatment with remikiren in people with essential hypertension. The response to specific renin angiotensin aldosterone system RAAS blockade by remikiren could be predicted from pretreatment."
  },
  {
    "text": "TREK1 currents are not affected by drugs that block TWIK1 , for example quinine or quinidine .",
    "triple_list": [
      [
        "TWIK1",
        "CPR:4",
        "quinine"
      ],
      [
        "TWIK1",
        "CPR:4",
        "quinidine"
      ]
    ],
    "updated": "Yes",
    "original": "TREK1 currents are insensitive to pharmacological agents that block TWIK1 activity such as quinine and quinidine",
    "simplified": "TREK1 currents are not affected by drugs that block TWIK1, for example quinine or quinidine."
  },
  {
    "text": "3HCGP 12177A saturation binding in the presence of propranolol increased approximately 5fold following overexpression of beta1adrenoceptors",
    "triple_list": [
      [
        "propranolol",
        "CPR:3",
        "beta1adrenoceptors"
      ],
      [
        "3HCGP 12177A",
        "CPR:3",
        "beta1adrenoceptors"
      ]
    ],
    "updated": "No",
    "original": "3HCGP 12177A saturation binding in the presence of propranolol increased approximately 5fold following overexpression of beta1adrenoceptors",
    "simplified": "3HCGP 12177A saturation binding in the presence of propranolol increased approximately 5fold when beta-adrenoceptors were increased."
  },
  {
    "text": "CGP 12177A helps with cardiostimulation by making the beta4adrenoceptor work harder . However , if the beta1adrenoceptor gene is changed , this does not work anymore .",
    "triple_list": [
      [
        "CGP 12177A",
        "CPR:3",
        "beta1adrenoceptor"
      ],
      [
        "CGP 12177A",
        "CPR:3",
        "beta4adrenoceptor"
      ]
    ],
    "updated": "Yes",
    "original": "CGP 12177A mediates cardiostimulation by activation of the putative beta4adrenoceptor however it has recently been reported that disruption of the beta1adrenoceptor gene abolishes this effect",
    "simplified": "CGP 12177A helps with cardiostimulation by making the beta4adrenoceptor work harder. However, if the beta1adrenoceptor gene is changed, this does not work anymore."
  },
  {
    "text": "CGP 12177A but not isoprenaline caused arrhythmias at lower levels when beta1adrenoceptor was increased .",
    "triple_list": [
      [
        "CGP 12177A",
        "CPR:3",
        "beta1adrenoceptor"
      ]
    ],
    "updated": "Yes",
    "original": "CGP 12177A but not isoprenaline initiated arrhythmias at lower concentrations following beta1adrenoceptor overexpression",
    "simplified": "CGP 12177A but not isoprenaline caused arrhythmias at lower levels when beta1adrenoceptor was increased."
  },
  {
    "text": "125ICyanopindolol saturation binding in Advbeta1 myocytes demonstrated approximately 18fold increase in beta1adrenoceptors",
    "triple_list": [
      [
        "125ICyanopindolol",
        "CPR:3",
        "beta1adrenoceptors"
      ]
    ],
    "updated": "No",
    "original": "125ICyanopindolol saturation binding in Advbeta1 myocytes demonstrated approximately 18fold increase in beta1adrenoceptors",
    "simplified": "125ICyanopindolol binding in Advbeta1 myocytes increased beta-adrenoceptors by about 18%."
  },
  {
    "text": "In the presence of Ca UFH , antithrombin was 10fold more efficiently able to inhibit factor Xa by antithrombin than was the concentration of high affinity fractions of enoxaparin and fragmin .",
    "triple_list": [
      [
        "Ca",
        "CPR:4",
        "factor Xa"
      ],
      [
        "Ca",
        "CPR:4",
        "antithrombin"
      ]
    ],
    "updated": "Yes",
    "original": "In contrast in the presence of Ca UFH accelerated the inhibition of factor Xa by antithrombin 10fold more efficiently than comparable concentrations of the high affinity fractions of enoxaparin and fragmin",
    "simplified": "In the presence of Ca UFH, antithrombin was 10fold more efficiently able to inhibit factor Xa by antithrombin than was the concentration of high affinity fractions of enoxaparin and fragmin."
  },
  {
    "text": "Oral quinidine is effective in suppressing the gain of function in IKr with a mutation in HERG and thus restoring normal rate dependence of the QT interval and rendering ventricular tachycardiaventricular fibrillation noninducible .",
    "triple_list": [
      [
        "quinidine",
        "CPR:4",
        "IKr"
      ]
    ],
    "updated": "Yes",
    "original": "CONCLUSION Oral quinidine is effective in suppressing the gain of function in IKr responsible for some cases of short QT syndrome with a mutation in HERG and thus restoring normal rate dependence of the QT interval and rendering ventricular tachycardiaventricular fibrillation noninducible",
    "simplified": "Oral quinidine is effective in suppressing the gain of function in IKr with a mutation in HERG and thus restoring normal rate dependence of the QT interval and rendering ventricular tachycardiaventricular fibrillation noninducible."
  },
  {
    "text": "The main aim of this study was to assess the efficacy of quinidine in suppressing IKr in the short QT syndrome and in modulating the rate dependence of the QT interval in the SQT1 form .",
    "triple_list": [
      [
        "quinidine",
        "CPR:4",
        "IKr"
      ]
    ],
    "updated": "Yes",
    "original": "INTRODUCTION The principal aim of this study was to assess the efficacy of quinidine in suppressing IKr in vitro and in modulating the rate dependence of the QT interval in the SQT1 form of the short QT syndrome",
    "simplified": "The main aim of this study was to assess the efficacy of quinidine in suppressing IKr in the short QT syndrome and in modulating the rate dependence of the QT interval in the SQT1 form."
  },
  {
    "text": "Our results indicate that Salix extract 1520L inhibits COX2 mediated PGE2 release through compounds other than salicin or salicylate",
    "triple_list": [
      [
        "COX2",
        "CPR:9",
        "PGE2"
      ]
    ],
    "updated": "No",
    "original": "Our results indicate that Salix extract 1520L inhibits COX2 mediated PGE2 release through compounds other than salicin or salicylate",
    "simplified": "Our results indicate that salix extract 1520L inhibits PGE2 release through compounds other than salicin and salicylate."
  },
  {
    "text": "The IC50values obtained for the inhibition of lipopolysaccharide LPSinduced release of prostaglandin E2 PGE2 reflecting cyclooxygenase COX2 mediated PGE2 release were 47 microgml and 06 microgml for the Salix extract 1520L and rofecoxiblike research compound L745337 respectively",
    "triple_list": [
      [
        "PGE2",
        "CPR:9",
        "cyclooxygenase COX2"
      ]
    ],
    "updated": "No",
    "original": "The IC50values obtained for the inhibition of lipopolysaccharide LPSinduced release of prostaglandin E2 PGE2 reflecting cyclooxygenase COX2 mediated PGE2 release were 47 microgml and 06 microgml for the Salix extract 1520L and rofecoxiblike research compound L745337 respectively",
    "simplified": "The IC50values obtained for the inhibition of lipopolysaccharide LPSinduced release of prostaglandin E2 PGE2 were 47 microgml and 06 microgml for the Salix extract 1520L and for the rofecoxiblike research compound L745337 respectively."
  },
  {
    "text": "Folliclestimulating hormone FSH is a hormone that is made by the pituitary gland . It is important for making sex steroids and gametes .",
    "triple_list": [
      [
        "Folliclestimulating hormone",
        "CPR:9",
        "steroids"
      ],
      [
        "FSH",
        "CPR:9",
        "steroids"
      ]
    ],
    "updated": "Yes",
    "original": "Folliclestimulating hormone FSH a dimeric glycoprotein synthesized in the anterior pituitary gland is important for the production of sex steroids and gametes",
    "simplified": "Folliclestimulating hormone FSH is a hormone that is made by the pituitary gland. It is important for making sex steroids and gametes."
  },
  {
    "text": "Humans with FSH beta gene mutations tend to have a more severe phenotype than those with FSHR gene mutations . Both types of mutation can affect sex steroid production , but the effects are more severe .",
    "triple_list": [
      [
        "FSH beta",
        "CPR:9",
        "steroid"
      ]
    ],
    "updated": "Yes",
    "original": "Humans with FSH beta gene mutations tend to have a more severe phenotype than those with FSHR gene mutations although infertility and varying degrees of impaired sex steroid production occur in both types of mutations",
    "simplified": "Humans with FSH beta gene mutations tend to have a more severe phenotype than those with FSHR gene mutations. Both types of mutation can affect sex steroid production, but the effects are more severe."
  },
  {
    "text": "The aim of the current study was to assess the activity of rolipram a nonsubtypeselective PDE4 inhibitor in several animal models to begin to understand the subtypes involved in the activity of rolipram and to use PDE4B wildtype and knockout mice to begin to understand the side effects of rolipram .",
    "triple_list": [
      [
        "rolipram",
        "CPR:4",
        "PDE4"
      ]
    ],
    "updated": "Yes",
    "original": "OBJECTIVES The aim of the current study was to assess the activity of rolipram a nonsubtypeselective PDE4 inhibitor in several animal models predictive of antipsychoticlike efficacy and sideeffect liability and to use PDE4B wildtype and knockout mice to begin to understand the subtypes involved in the activity of rolipram",
    "simplified": "The aim of the current study was to assess the activity of rolipram a nonsubtypeselective PDE4 inhibitor in several animal models to begin to understand the subtypes involved in the activity of rolipram and to use PDE4B wildtype and knockout mice to begin to understand the side effects of rolipram."
  },
  {
    "text": "These results suggest that PDE4B mediates the antipsychotic effects of rolipram in CAR and that the cyclic adenosine monophosphate signaling pathway may play a role in the pathophysiology and pharmacotherapy of psychosis .",
    "triple_list": [
      [
        "PDE4B",
        "CPR:9",
        "cyclic adenosine monophosphate"
      ]
    ],
    "updated": "Yes",
    "original": "These results suggest that PDE4B mediates the antipsychotic effects of rolipram in CAR and that the PDE4B regulated cyclic adenosine monophosphate signaling pathway may play a role in the pathophysiology and pharmacotherapy of psychosis",
    "simplified": "These results suggest that PDE4B mediates the antipsychotic effects of rolipram in CAR and that the cyclic adenosine monophosphate signaling pathway may play a role in the pathophysiology and pharmacotherapy of psychosis."
  },
  {
    "text": "Cat1 the transporter for the essential amino acids arginine and lysine is also very important .",
    "triple_list": [
      [
        "Cat1",
        "CPR:9",
        "amino acids"
      ],
      [
        "Cat1",
        "CPR:9",
        "arginine"
      ],
      [
        "Cat1",
        "CPR:9",
        "lysine"
      ]
    ],
    "updated": "Yes",
    "original": "Cat1 the transporter for the essential amino acids arginine and lysine is one of the upregulated genes",
    "simplified": "Cat1 the transporter for the essential amino acids arginine and lysine is also very important."
  },
  {
    "text": "Results Fractionated bulb extracts and the two isolated steroidal glycoalkaloids 1 and 2 caused TGF\u03b2 receptor I mRNA expression in human embryonic stem cells .",
    "triple_list": [
      [
        "steroidal glycoalkaloids",
        "CPR:3",
        "TGF\u03b2 receptor I"
      ]
    ],
    "updated": "Yes",
    "original": "RESULTS Fractionated bulb extracts and the two isolated steroidal glycoalkaloids 1 and 2 induced NO production and TGF\u03b2 receptor I mRNA expression in fibroblast cell culture",
    "simplified": "Results Fractionated bulb extracts and the two isolated steroidal glycoalkaloids 1 and 2 caused TGF\u03b2 receptor I mRNA expression in human embryonic stem cells."
  },
  {
    "text": "The unproved assumption was that both human and rabbit alpha2Aadrenoceptors are activated by the same amount of rilmenidine .",
    "triple_list": [
      [
        "alpha2Aadrenoceptors",
        "CPR:3",
        "rilmenidine"
      ]
    ],
    "updated": "Yes",
    "original": "A prerequisite for this hypothesis was the unproved assumption that rabbit and human alpha2Aadrenoceptors are equally activated by rilmenidine",
    "simplified": "The unproved assumption was that both human and rabbit alpha2Aadrenoceptors are activated by the same amount of rilmenidine."
  },
  {
    "text": "The imidazoline receptor ligand and rilmenidine have been shown to lower blood pressure in rabbits . It is possible that this is because they activate central alpha2Aadrenoceptors .",
    "triple_list": [
      [
        "rilmenidine",
        "CPR:3",
        "alpha2Aadrenoceptors"
      ]
    ],
    "updated": "Yes",
    "original": "On the basis of data obtained in rabbits the imidazoline receptor ligand rilmenidine has been suggested to decrease blood pressure in humans by activating central alpha2Aadrenoceptors",
    "simplified": "The imidazoline receptor ligand and rilmenidine have been shown to lower blood pressure in rabbits. It is possible that this is because they activate central alpha2Aadrenoceptors."
  },
  {
    "text": "Human atrial appendages and rabbit pulmonary arteries were used to determine the effects of alpha2adrenoceptor and moxonidine on 3Hnorepinephrine release . The effects of alpha2adrenoceptor and moxonidine on 3Hnorepinephrine release were also determined .",
    "triple_list": [
      [
        "alpha2adrenoceptor",
        "CPR:4",
        "moxonidine"
      ]
    ],
    "updated": "Yes",
    "original": "Human atrial appendages and rabbit pulmonary arteries were used to determine the potencies of alpha2adrenoceptor agonists in inhibiting the electrically 2 Hz evoked 3Hnorepinephrine release and of antagonists in counteracting the alpha2adrenoceptor mediated inhibition induced by moxonidine",
    "simplified": "Human atrial appendages and rabbit pulmonary arteries were used to determine the effects of alpha2adrenoceptor and moxonidine on 3Hnorepinephrine release. The effects of alpha2adrenoceptor and moxonidine on 3Hnorepinephrine release were also determined."
  },
  {
    "text": "The sympathetic nerves of both the human atrial appendages and rabbit pulmonary artery have alpha2Aautoreceptors . However , both rilmenidine and oxymetazoline have different properties when they come in contact with each other .",
    "triple_list": [
      [
        "alpha2Aautoreceptors",
        "CPR:5",
        "oxymetazoline"
      ],
      [
        "alpha2Aautoreceptors",
        "CPR:6",
        "rilmenidine"
      ]
    ],
    "updated": "Yes",
    "original": "The sympathetic nerves of both the human atrial appendages and rabbit pulmonary artery are endowed with alpha2Aautoreceptors at which however both rilmenidine and oxymetazoline exhibit different properties antagonism and agonism respectively",
    "simplified": "The sympathetic nerves of both the human atrial appendages and rabbit pulmonary artery have alpha2Aautoreceptors. However, both rilmenidine and oxymetazoline have different properties when they come in contact with each other."
  },
  {
    "text": "In the rabbit pulmonary artery rilmenidine and oxymetazoline are potent full agonists whereas in the human atrial appendages they are antagonists at the alpha2autoreceptors sharing this property with rauwolscine phentolamine and idazoxan",
    "triple_list": [
      [
        "rilmenidine",
        "CPR:6",
        "alpha2autoreceptors"
      ],
      [
        "oxymetazoline",
        "CPR:6",
        "alpha2autoreceptors"
      ],
      [
        "alpha2autoreceptors",
        "CPR:6",
        "rauwolscine"
      ],
      [
        "alpha2autoreceptors",
        "CPR:6",
        "phentolamine"
      ],
      [
        "alpha2autoreceptors",
        "CPR:6",
        "idazoxan"
      ]
    ],
    "updated": "No",
    "original": "In the rabbit pulmonary artery rilmenidine and oxymetazoline are potent full agonists whereas in the human atrial appendages they are antagonists at the alpha2autoreceptors sharing this property with rauwolscine phentolamine and idazoxan",
    "simplified": "In the rabbit pulmonary artery rilmenidine and oxymetazoline are potent full agonists at the alpha2autoreceptors. In the human atrial appendages they are antagonists at the alpha2autoreceptors."
  },
  {
    "text": "The antagonistic property of rilmenidine at human alpha2Aadrenoceptors indicates that it is not due to activation of alpha2Aadrenoceptors but other presumably I1imidazoline receptors are probably involved . This is different to the idea based on rabbit data .",
    "triple_list": [
      [
        "rilmenidine",
        "CPR:6",
        "human alpha2Aadrenoceptors"
      ]
    ],
    "updated": "Yes",
    "original": "The antagonistic property of rilmenidine at human alpha2Aadrenoceptors indicates that in contrast to the suggestion based on rabbit data the hypotensive property of the drug in humans is not due to activation of alpha2Aadrenoceptors but other presumably I1imidazoline receptors are probably involved",
    "simplified": "The antagonistic property of rilmenidine at human alpha2Aadrenoceptors indicates that it is not due to activation of alpha2Aadrenoceptors but other presumably I1imidazoline receptors are probably involved. This is different to the idea based on rabbit data."
  },
  {
    "text": "Cetrorelix completely blocked the growth of the two most common species 50 kb and 45 kb of the GnRHR mRNA during the early stages of development .",
    "triple_list": [
      [
        "Cetrorelix",
        "CPR:4",
        "GnRHR"
      ]
    ],
    "updated": "Yes",
    "original": "Cetrorelix completely blocked the rise of levels of the two most abundant species 50 kb and 45 kb of the GnRHR mRNA during both the infantile and the juvenile periods",
    "simplified": "Cetrorelix completely blocked the growth of the two most common species 50 kb and 45 kb of the GnRHR mRNA during the early stages of development."
  },
  {
    "text": "Cetrorelix also abolished the developmental rise of the gonadotropin beta subunit mRNAs during the two periods of the study",
    "triple_list": [
      [
        "Cetrorelix",
        "CPR:4",
        "gonadotropin beta"
      ]
    ],
    "updated": "No",
    "original": "Cetrorelix also abolished the developmental rise of the gonadotropin beta subunit mRNAs during the two periods of the study",
    "simplified": "Cetrorelix also did not increase the amount of gonadotropin in the blood during two different periods of time."
  },
  {
    "text": "The chemistry pharmacology pharmacokinetics clinical efficacy adverse effects and dosages of the nonsedating histamine H1receptor antagonists terfenadine astemizole loratadine and acrivastine are reviewed",
    "triple_list": [
      [
        "histamine H1receptor",
        "CPR:6",
        "terfenadine"
      ],
      [
        "histamine H1receptor",
        "CPR:6",
        "astemizole"
      ],
      [
        "histamine H1receptor",
        "CPR:6",
        "loratadine"
      ],
      [
        "histamine H1receptor",
        "CPR:6",
        "acrivastine"
      ]
    ],
    "updated": "No",
    "original": "The chemistry pharmacology pharmacokinetics clinical efficacy adverse effects and dosages of the nonsedating histamine H1receptor antagonists terfenadine astemizole loratadine and acrivastine are reviewed",
    "simplified": "The chemistry pharmacology pharmacokinetics adverse effects and dosages of the nonsedating histamine H1receptor antagonists acrivastine and terfenadine are reviewed."
  },
  {
    "text": "Terfenadine and astemizole are chemically unrelated to histamine H1receptor antagonists such as diphenhydramine and chlorpheniramine",
    "triple_list": [
      [
        "Terfenadine",
        "CPR:6",
        "histamine H1receptor"
      ],
      [
        "astemizole",
        "CPR:6",
        "histamine H1receptor"
      ],
      [
        "histamine H1receptor",
        "CPR:6",
        "diphenhydramine"
      ],
      [
        "histamine H1receptor",
        "CPR:6",
        "chlorpheniramine"
      ]
    ],
    "updated": "No",
    "original": "Terfenadine and astemizole are chemically unrelated to histamine H1receptor antagonists such as diphenhydramine and chlorpheniramine",
    "simplified": "Terfenadine and astemizole are chemically unrelated to diphenhydramine and chlorpheniramine, but they are related to histamine."
  },
  {
    "text": "Promoter assay revealed that prunetin inhibits LPSinduced nitric oxide and prostaglandin E2 production through the suppression of iNOS and COX2 at the transcriptional level",
    "triple_list": [
      [
        "prunetin",
        "CPR:4",
        "iNOS"
      ],
      [
        "prunetin",
        "CPR:4",
        "COX2"
      ]
    ],
    "updated": "No",
    "original": "Promoter assay revealed that prunetin inhibits LPSinduced nitric oxide and prostaglandin E2 production through the suppression of iNOS and COX2 at the transcriptional level",
    "simplified": "Prunetin has been shown to inhibit the production of nitric oxide and prostaglandin E2. This is done by suppressing iNOS and COX2 at the transcriptional level."
  },
  {
    "text": "Antiinflammatory effect of prunetin via the suppression of NF\u03baB pathway",
    "triple_list": [
      [
        "prunetin",
        "CPR:4",
        "NF\u03baB"
      ]
    ],
    "updated": "No",
    "original": "Antiinflammatory effect of prunetin via the suppression of NF\u03baB pathway",
    "simplified": "The anti-inflammatory effect of prunetin can be seen in the following ways:"
  },
  {
    "text": "In addition prunetin inhibits NF\u03baB dependent inflammatory responses by modulating I\u03baB kinase IKKinhibitor \u03baB\u03b1 I\u03baB\u03b1NF\u03baB signaling",
    "triple_list": [
      [
        "prunetin",
        "CPR:4",
        "NF\u03baB"
      ]
    ],
    "updated": "No",
    "original": "In addition prunetin inhibits NF\u03baB dependent inflammatory responses by modulating I\u03baB kinase IKKinhibitor \u03baB\u03b1 I\u03baB\u03b1NF\u03baB signaling",
    "simplified": "In addition, prunetin inhibits the inflammatory response by modulating the activity of the I\u03baB kinase."
  },
  {
    "text": "Consistent with these results prunetin significantly reduced serum levels of inflammatory cytokines and mortality in mice challenged with lipopolysaccharide",
    "triple_list": [
      [
        "prunetin",
        "CPR:4",
        "cytokines"
      ]
    ],
    "updated": "No",
    "original": "Consistent with these results prunetin significantly reduced serum levels of inflammatory cytokines and mortality in mice challenged with lipopolysaccharide",
    "simplified": "Prunetin significantly reduced serum levels of inflammatory cytokines and mortality in mice when lipopolysaccharide was given to them."
  },
  {
    "text": "G6PC2 - Basal Glucose Stimulated Insulin Secretion ( G6PC2 )",
    "triple_list": [
      [
        "Glucose",
        "CPR:3",
        "Insulin"
      ]
    ],
    "updated": "Yes",
    "original": "G6PC2 A Negative Regulator of Basal Glucose Stimulated Insulin Secretion",
    "simplified": "G6PC2 - Basal Glucose Stimulated Insulin Secretion (G6PC2)"
  },
  {
    "text": "G6pc2 deletion resulted in a leftward shift in the doseresponse curve for glucose stimulated insulin secretion GSIS",
    "triple_list": [
      [
        "glucose",
        "CPR:3",
        "insulin"
      ]
    ],
    "updated": "No",
    "original": "G6pc2 deletion resulted in a leftward shift in the doseresponse curve for glucose stimulated insulin secretion GSIS",
    "simplified": "G6pc2 deletion resulted in a leftward shift in the secretion of insulin in the central nervous system."
  },
  {
    "text": "These data suggest that G6pc2 is a novel negative regulator of basal GSIS . It acts by reducing the amount of glucose6phosphate in the blood .",
    "triple_list": [
      [
        "G6pc2",
        "CPR:9",
        "glucose6phosphate"
      ]
    ],
    "updated": "Yes",
    "original": "These data suggest that G6pc2 represents a novel negative regulator of basal GSIS that acts by hydrolyzing glucose6phosphate thereby reducing glycolytic flux",
    "simplified": "These data suggest that G6pc2 is a novel negative regulator of basal GSIS. It acts by reducing the amount of glucose6phosphate in the blood."
  },
  {
    "text": "The effect of PP242 on deptor suppression by TGF\u03b2 was associated with a significant reduction in TGF\u03b2-mediated protein synthesis .",
    "triple_list": [
      [
        "PP242",
        "CPR:3",
        "deptor"
      ]
    ],
    "updated": "Yes",
    "original": "PP242 induced reversal of deptor suppression by TGF\u03b2 was associated with a significant inhibition of TGF\u03b2stimulated protein synthesis and hypertrophy",
    "simplified": "The effect of PP242 on deptor suppression by TGF\u03b2 was associated with a significant reduction in TGF\u03b2-mediated protein synthesis."
  },
  {
    "text": "Using the mTOR inhibitor PP242 , we found that both sustained and early activation of TORC1 and TORC2 was required for the deptor function .",
    "triple_list": [
      [
        "mTOR",
        "CPR:4",
        "PP242"
      ]
    ],
    "updated": "Yes",
    "original": "Using the mTOR inhibitor PP242 we found that TGF\u03b2induced both early and sustained activation of TORC1 and TORC2 was necessary for deptor suppression",
    "simplified": "Using the mTOR inhibitor PP242, we found that both sustained and early activation of TORC1 and TORC2 was required for the deptor function."
  },
  {
    "text": "METHODS Modafinil and its R and Senantiomers were synthesized and tested for inhibition of 3H dopamine DA uptake and 3HWIN 35428 binding in human dopamine transporter DAT wildtype and mutants with altered conformational equilibria",
    "triple_list": [
      [
        "3H dopamine",
        "CPR:9",
        "human dopamine transporter"
      ],
      [
        "3H dopamine",
        "CPR:9",
        "DAT"
      ],
      [
        "DA",
        "CPR:9",
        "human dopamine transporter"
      ],
      [
        "DA",
        "CPR:9",
        "DAT"
      ]
    ],
    "updated": "No",
    "original": "METHODS Modafinil and its R and Senantiomers were synthesized and tested for inhibition of 3H dopamine DA uptake and 3HWIN 35428 binding in human dopamine transporter DAT wildtype and mutants with altered conformational equilibria",
    "simplified": "METHODS Modafinil and its R and Senantiomers were synthesized and tested for their ability to inhibit 3H dopamine uptake and 3HWIN 35428 binding in DAT wildtype and mutants with different conformations."
  },
  {
    "text": "R and Smodafinil bind to the DAT and inhibit DA uptake less effectively than cocaine . Smodafinil has a threefold higher affinity for the DAT than Rmodafinil .",
    "triple_list": [
      [
        "DA",
        "CPR:9",
        "DAT"
      ]
    ],
    "updated": "Yes",
    "original": "RESULTS R and Smodafinil bind to the DAT and inhibit DA uptake less potently than cocaine with Rmodafinil having approximately threefold higher affinity than its Senantiomer",
    "simplified": "R and Smodafinil bind to the DAT and inhibit DA uptake less effectively than cocaine. Smodafinil has a threefold higher affinity for the DAT than Rmodafinil."
  },
  {
    "text": "In addition , IL12 and TNF\u03b1 were increased in the procyanidin trimerstreated cells in the presence of OVA .",
    "triple_list": [
      [
        "IL12",
        "CPR:3",
        "procyanidin"
      ],
      [
        "TNF\u03b1",
        "CPR:3",
        "procyanidin"
      ]
    ],
    "updated": "Yes",
    "original": "Furthermore the upregulation of IL12 and TNF\u03b1 was found in the procyanidin trimerstreated cells in the presence of OVA",
    "simplified": "In addition, IL12 and TNF\u03b1 were increased in the procyanidin trimerstreated cells in the presence of OVA."
  },
  {
    "text": "In the AP and fractionated procyanidin treated cells , there was a significant decrease in HLADR expression , but no effect on CD86 expression was observed .",
    "triple_list": [
      [
        "HLADR",
        "CPR:4",
        "procyanidin"
      ]
    ],
    "updated": "Yes",
    "original": "A significant decrease in HLADR expression was observed in the AP and fractionated procyanidin treated cells in the presence of ovalbumin OVA but no effect on CD86 expression was observed",
    "simplified": "In the AP and fractionated procyanidin treated cells, there was a significant decrease in HLADR expression, but no effect on CD86 expression was observed."
  },
  {
    "text": "Apple polyphenols suppress antigen presentation of ovalbumin by THP1derived dendritic cells",
    "triple_list": [
      [
        "polyphenols",
        "CPR:4",
        "ovalbumin"
      ]
    ],
    "updated": "No",
    "original": "Apple polyphenols suppress antigen presentation of ovalbumin by THP1derived dendritic cells",
    "simplified": "Apple polyphenols prevent the immune system from attacking dendritic cells."
  },
  {
    "text": "In phosphotriesterase and physostigminetreated mice a 4 and 2fold higher sarin dose respectively was needed to cause a 50 inhibition of brain AChE activity",
    "triple_list": [
      [
        "sarin",
        "CPR:4",
        "AChE"
      ]
    ],
    "updated": "No",
    "original": "In phosphotriesterase and physostigminetreated mice a 4 and 2fold higher sarin dose respectively was needed to cause a 50 inhibition of brain AChE activity",
    "simplified": "In phosphotriesterase and physostigminetreated mice, a 4-fold higher dose of sarin was needed to cause brain activity to be impaired."
  },
  {
    "text": "The acute toxicity of organophosphorus OP compounds in mammals is due to their irreversible inhibition of acetylcholinesterase AChE in the nervous system which leads to increased synaptic acetylcholine levels",
    "triple_list": [
      [
        "organophosphorus",
        "CPR:4",
        "acetylcholinesterase"
      ],
      [
        "organophosphorus",
        "CPR:4",
        "AChE"
      ],
      [
        "acetylcholine",
        "CPR:9",
        "acetylcholinesterase"
      ],
      [
        "acetylcholine",
        "CPR:9",
        "AChE"
      ]
    ],
    "updated": "No",
    "original": "The acute toxicity of organophosphorus OP compounds in mammals is due to their irreversible inhibition of acetylcholinesterase AChE in the nervous system which leads to increased synaptic acetylcholine levels",
    "simplified": "Organophosphorus compounds are very toxic to animals because they stop the acetylcholinesterase enzyme in the nervous system from working. This makes synaptic levels of acetylcholine very high."
  },
  {
    "text": "The activity of CYP3A4 was increased 2fold by rifampicin while the activity of CYP2C9 remained the same .",
    "triple_list": [
      [
        "CYP3A4",
        "CPR:3",
        "rifampicin"
      ],
      [
        "rifampicin",
        "CPR:3",
        "CYP2C9"
      ]
    ],
    "updated": "Yes",
    "original": "The CYP3A4 activity could be induced 2fold by rifampicin whereas CYP2C9 activity remained equally high",
    "simplified": "The activity of CYP3A4 was increased 2fold by rifampicin while the activity of CYP2C9 remained the same."
  },
  {
    "text": "The modification of the inhibitor scaffold of 1 and 2 from a dihydroquinolinone core to a tetrahydropyrazolopyridinone core led to discovery of a new series of potent KAT II inhibitors with excellent physicochemical properties",
    "triple_list": [
      [
        "dihydroquinolinone",
        "CPR:4",
        "KAT II"
      ],
      [
        "tetrahydropyrazolopyridinone",
        "CPR:4",
        "KAT II"
      ]
    ],
    "updated": "No",
    "original": "The modification of the inhibitor scaffold of 1 and 2 from a dihydroquinolinone core to a tetrahydropyrazolopyridinone core led to discovery of a new series of potent KAT II inhibitors with excellent physicochemical properties",
    "simplified": "The inhibitor scaffold of 1 and 2 was changed from a dihydroquinolinone core to a tetrahydropyrazolopyridinone core. This led to the discovery of a new series of inhibitors that work very well."
  },
  {
    "text": "The design synthesis and biological evaluation of a new pyrazole series of irreversible KAT II inhibitors are described here .",
    "triple_list": [
      [
        "pyrazole",
        "CPR:4",
        "KAT II"
      ]
    ],
    "updated": "Yes",
    "original": "The structurebased design synthesis and biological evaluation of a new pyrazole series of irreversible KAT II inhibitors are described herein",
    "simplified": "The design synthesis and biological evaluation of a new pyrazole series of irreversible KAT II inhibitors are described here."
  },
  {
    "text": "PF04859989 as a template for structurebased drug design identification of new pyrazole series of irreversible KAT II inhibitors with improved lipophilic efficiency",
    "triple_list": [
      [
        "PF04859989",
        "CPR:4",
        "KAT II"
      ],
      [
        "pyrazole",
        "CPR:4",
        "KAT II"
      ]
    ],
    "updated": "No",
    "original": "PF04859989 as a template for structurebased drug design identification of new pyrazole series of irreversible KAT II inhibitors with improved lipophilic efficiency",
    "simplified": "PF04859989 as a template for structure-based drug design identification of new KAT II inhibitors with improved lipophilic efficiency"
  },
  {
    "text": "Moreover the rank order for potency in inhibiting acetylcholinesterase ambenonium neostigmine = physostigmine = tacrine pyridostigmine = edrophonium = galanthamine desoxypeganine parathion gramine indicated that the most effective inhibitors of acetylcholinesterase also displaced 3HoxotremorineM to the greatest extent",
    "triple_list": [
      [
        "acetylcholinesterase",
        "CPR:4",
        "pyridostigmine"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "pyridostigmine"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "edrophonium"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "edrophonium"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "galanthamine"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "galanthamine"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "desoxypeganine"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "desoxypeganine"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "parathion"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "parathion"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "gramine"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "gramine"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "ambenonium"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "ambenonium"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "neostigmine"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "neostigmine"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "physostigmine"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "physostigmine"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "tacrine"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "tacrine"
      ]
    ],
    "updated": "No",
    "original": "Moreover the rank order for potency in inhibiting acetylcholinesterase ambenonium neostigmine = physostigmine = tacrine pyridostigmine = edrophonium = galanthamine desoxypeganine parathion gramine indicated that the most effective inhibitors of acetylcholinesterase also displaced 3HoxotremorineM to the greatest extent",
    "simplified": "Acidylcholinesterase is a enzyme in the body that removes acetylcholinesterase from the blood. When acetylcholinesterase is turned on, a chemical called a drug is released that acts on the acetylcholinesterase enzyme to allow the acetylcholinesterase to work."
  },
  {
    "text": "The capacity of acetylcholinesterase inhibitors with the exception of tacrine and ambenonium to displace bound 3HoxotremorineM in preference to 3Hquinuclinidyl benzilate predicts that the former compounds could act as potential agonists at muscarinic receptors",
    "triple_list": [
      [
        "acetylcholinesterase",
        "CPR:4",
        "tacrine"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "ambenonium"
      ]
    ],
    "updated": "No",
    "original": "The capacity of acetylcholinesterase inhibitors with the exception of tacrine and ambenonium to displace bound 3HoxotremorineM in preference to 3Hquinuclinidyl benzilate predicts that the former compounds could act as potential agonists at muscarinic receptors",
    "simplified": "The ability of acetylcholinesterase inhibitors to displace bound 3HoxotremorineM in preference to 3Hquinuclinidyl benzilate suggests that the former compounds could act as potential agonists at muscarinic receptors."
  },
  {
    "text": "Conclusions Total vitamin B6 is abnormally high in autism . Previous research has shown that pyridoxal kinase is not working properly to convert pyridoxine to PLP .",
    "triple_list": [
      [
        "pyridoxal kinase",
        "CPR:9",
        "pyridoxine"
      ],
      [
        "pyridoxal",
        "CPR:9",
        "pyridoxal kinase"
      ],
      [
        "pyridoxal kinase",
        "CPR:9",
        "PLP"
      ]
    ],
    "updated": "Yes",
    "original": "CONCLUSIONS Total vitamin B6 is abnormally high in autism consistent with previous reports of an impaired pyridoxal kinase for the conversion of pyridoxine and pyridoxal to PLP",
    "simplified": "Conclusions Total vitamin B6 is abnormally high in autism. Previous research has shown that pyridoxal kinase is not working properly to convert pyridoxine to PLP."
  },
  {
    "text": "\u03b2Amyloid aggregation results showed that all compounds exhibited remarkable A\u03b2 fibril aggregation inhibition activity with a nearly similar potential as the reference compound rifampicin which makes them promising antiAlzheimer drug candidates",
    "triple_list": [
      [
        "A\u03b2",
        "CPR:4",
        "rifampicin"
      ]
    ],
    "updated": "No",
    "original": "\u03b2Amyloid aggregation results showed that all compounds exhibited remarkable A\u03b2 fibril aggregation inhibition activity with a nearly similar potential as the reference compound rifampicin which makes them promising antiAlzheimer drug candidates",
    "simplified": " \u03b2Amyloid aggregation results showed that all compounds had remarkable activity against a\u03b2 fibril aggregation. This activity was almost the same as that of the reference compound rifampicin."
  },
  {
    "text": "To develop new drugs for treatment of Alzheimers disease a group of N24Benzylpiperidinpiperazin1ylacylhydrazones was designed synthesized and tested for their ability to inhibit acetylcholinesterase butyrylcholinesterase and aggregation of amyloid beta peptides 140 142 and 140142",
    "triple_list": [
      [
        "N24Benzylpiperidinpiperazin1ylacylhydrazones",
        "CPR:4",
        "acetylcholinesterase"
      ],
      [
        "N24Benzylpiperidinpiperazin1ylacylhydrazones",
        "CPR:4",
        "butyrylcholinesterase"
      ]
    ],
    "updated": "No",
    "original": "To develop new drugs for treatment of Alzheimers disease a group of N24Benzylpiperidinpiperazin1ylacylhydrazones was designed synthesized and tested for their ability to inhibit acetylcholinesterase butyrylcholinesterase and aggregation of amyloid beta peptides 140 142 and 140142",
    "simplified": "To develop new drugs for treatment of Alzheimers disease a group of N24Benzylpiperidinpiperazin1ylacylhydrazones was designed synthesized and tested. 140 142 and 140142 were found to inhibit butyrylcholinesterase and aggregation of amyloid beta peptides."
  },
  {
    "text": "Molecular modeling and evaluation of novel N24benzylpiperidinpiperazin1ylacylhydrazone as a dual inhibitor of A\u03b2 aggregation and cholinesterases .",
    "triple_list": [
      [
        "N24benzylpiperidinpiperazin1ylacylhydrazone",
        "CPR:4",
        "cholinesterases"
      ],
      [
        "N24benzylpiperidinpiperazin1ylacylhydrazone",
        "CPR:4",
        "A\u03b2"
      ]
    ],
    "updated": "Yes",
    "original": "Synthesis molecular modeling and evaluation of novel N24benzylpiperidinpiperazin1ylacylhydrazone derivatives as dual inhibitors for cholinesterases and A\u03b2 aggregation",
    "simplified": "Molecular modeling and evaluation of novel N24benzylpiperidinpiperazin1ylacylhydrazone as a dual inhibitor of A\u03b2 aggregation and cholinesterases."
  },
  {
    "text": "Here translocation studies using the human androgen receptor hAR and the human glucocorticoid receptor hGR were performed to aid in identifying the mechanism by which anabolicandrogenic steroids AAS were activating hAR and potentially interacting with hGR and how glucocorticoid ligands were interacting with the hGR and hAR",
    "triple_list": [
      [
        "hAR",
        "CPR:3",
        "steroids"
      ]
    ],
    "updated": "No",
    "original": "Here translocation studies using the human androgen receptor hAR and the human glucocorticoid receptor hGR were performed to aid in identifying the mechanism by which anabolicandrogenic steroids AAS were activating hAR and potentially interacting with hGR and how glucocorticoid ligands were interacting with the hGR and hAR",
    "simplified": "The human androgen receptor ( hAR) and the human glucocorticoid receptor ( hGR) are receptors on the human body. The human androgen receptor ( hAR) and the human glucocorticoid receptor ( hGR) are very important for human health and well-being."
  },
  {
    "text": "We examined the antiinflammatory effect of licofelone on atherosclerotic lesions as well as in isolated neutrophils from whole blood of rabbits compared with a selective inhibitor of COX2 rofecoxib",
    "triple_list": [
      [
        "COX2",
        "CPR:4",
        "rofecoxib"
      ]
    ],
    "updated": "No",
    "original": "We examined the antiinflammatory effect of licofelone on atherosclerotic lesions as well as in isolated neutrophils from whole blood of rabbits compared with a selective inhibitor of COX2 rofecoxib",
    "simplified": "We examined the anti-inflammatory effect of licofelone in isolated neutrophils from whole blood of rabbits as well as in atherosclerotic lesions compared with a selective inhibitor of COX2."
  },
  {
    "text": "Licofelone reduced intimamedia ratio in injured arteries the macrophages infiltration in the neointimal area monocyte chemoattractant protein1 MCP1 gene expression and the activation of nuclear factorkappaB in rabbit atheroma",
    "triple_list": [
      [
        "Licofelone",
        "CPR:4",
        "monocyte chemoattractant protein1"
      ],
      [
        "Licofelone",
        "CPR:4",
        "MCP1"
      ],
      [
        "Licofelone",
        "CPR:4",
        "nuclear factorkappaB"
      ]
    ],
    "updated": "No",
    "original": "Licofelone reduced intimamedia ratio in injured arteries the macrophages infiltration in the neointimal area monocyte chemoattractant protein1 MCP1 gene expression and the activation of nuclear factorkappaB in rabbit atheroma",
    "simplified": "Licofelone reduced the number of blood vessels in injured arteries, the number of macrophages in the neointimal area, the expression of the MCP1 gene and the activation of nuclear factorkappaB in rabbit atheroma."
  },
  {
    "text": "Licofelone a balanced inhibitor of cyclooxygenase and 5lipoxygenase reduces inflammation in a rabbit model of atherosclerosis",
    "triple_list": [
      [
        "Licofelone",
        "CPR:4",
        "cyclooxygenase"
      ],
      [
        "Licofelone",
        "CPR:4",
        "5lipoxygenase"
      ]
    ],
    "updated": "No",
    "original": "Licofelone a balanced inhibitor of cyclooxygenase and 5lipoxygenase reduces inflammation in a rabbit model of atherosclerosis",
    "simplified": "Licofelone reduces inflammation in a rabbit model of atherosclerosis by inhibiting cyclooxygenase."
  },
  {
    "text": "Licofelone a dual antiinflammatory drug that inhibits 5lipoxygenase LOX and cyclooxygenase COX enzymes may have a better cardiovascular profile that cycloxygenase2 inhibitors due to cycloxygenase1 blockademediated antithrombotic effect and a better gastrointestinal tolerability",
    "triple_list": [
      [
        "Licofelone",
        "CPR:4",
        "cycloxygenase1"
      ],
      [
        "Licofelone",
        "CPR:4",
        "5lipoxygenase"
      ],
      [
        "Licofelone",
        "CPR:4",
        "LOX"
      ],
      [
        "Licofelone",
        "CPR:4",
        "cyclooxygenase"
      ],
      [
        "Licofelone",
        "CPR:4",
        "COX"
      ]
    ],
    "updated": "No",
    "original": "Licofelone a dual antiinflammatory drug that inhibits 5lipoxygenase LOX and cyclooxygenase COX enzymes may have a better cardiovascular profile that cycloxygenase2 inhibitors due to cycloxygenase1 blockademediated antithrombotic effect and a better gastrointestinal tolerability",
    "simplified": "Licofelone a dual antiinflammatory drug that inhibits 5lipoxygenase LOX and cyclooxygenase COX may have a better cardiovascular profile and a better gastrointestinal tolerability than cycloxygenase2 inhibitors, but it is not known why this is the case."
  },
  {
    "text": "licofelone also changed the expression of the COX2 and 5LOX proteins .",
    "triple_list": [
      [
        "licofelone",
        "CPR:4",
        "COX2"
      ],
      [
        "licofelone",
        "CPR:4",
        "5LOX"
      ]
    ],
    "updated": "Yes",
    "original": "Moreover licofelone inhibited COX2 and 5LOX protein expression in vascular lesions",
    "simplified": " licofelone also changed the expression of the COX2 and 5LOX proteins."
  },
  {
    "text": "Rofecoxib only reduced MCP1 gene expression in vascular atheroma but not COX2 .",
    "triple_list": [
      [
        "Rofecoxib",
        "CPR:4",
        "COX2"
      ],
      [
        "Rofecoxib",
        "CPR:4",
        "MCP1"
      ]
    ],
    "updated": "Yes",
    "original": "Rofecoxib only diminished COX2 protein expression and MCP1 gene expression in vascular atheroma",
    "simplified": "Rofecoxib only reduced MCP1 gene expression in vascular atheroma but not COX2."
  },
  {
    "text": "Licofelone almost abolished 5LOX activity by inhibiting leukotriene B4 generation in rabbit neutrophils and prevented platelet thromboxane B2 production from whole blood",
    "triple_list": [
      [
        "Licofelone",
        "CPR:4",
        "5LOX"
      ],
      [
        "5LOX",
        "CPR:9",
        "leukotriene B4"
      ],
      [
        "5LOX",
        "CPR:9",
        "thromboxane B2"
      ]
    ],
    "updated": "No",
    "original": "Licofelone almost abolished 5LOX activity by inhibiting leukotriene B4 generation in rabbit neutrophils and prevented platelet thromboxane B2 production from whole blood",
    "simplified": "Licofelone almost stopped 5LOX from being made in the first place. It also stopped leukotriene B4 generation in rabbit neutrophils."
  },
  {
    "text": "No influence of moderate hepatic impairment on the pharmacokinetics of lumiracoxib an oral COX2 selective inhibitor",
    "triple_list": [
      [
        "lumiracoxib",
        "CPR:4",
        "COX2"
      ]
    ],
    "updated": "No",
    "original": "No influence of moderate hepatic impairment on the pharmacokinetics of lumiracoxib an oral COX2 selective inhibitor",
    "simplified": "No influence of moderate hepatic impairment on oral lumiracoxib pharmacokinetics in patients with hepatic insufficiency"
  },
  {
    "text": "The aim of this study was to evaluate the influence of hepatic impairment on the pharmacokinetics of the novel cyclooxygenase2 COX2 selective inhibitor lumiracoxib Prexige and to provide clinical dose recommendations .",
    "triple_list": [
      [
        "cyclooxygenase2",
        "CPR:4",
        "lumiracoxib"
      ],
      [
        "COX2",
        "CPR:4",
        "lumiracoxib"
      ],
      [
        "cyclooxygenase2",
        "CPR:4",
        "Prexige"
      ],
      [
        "COX2",
        "CPR:4",
        "Prexige"
      ]
    ],
    "updated": "Yes",
    "original": "The aim of this study was to evaluate the influence of hepatic impairment on the pharmacokinetics PK of the novel cyclooxygenase2 COX2 selective inhibitor lumiracoxib Prexige so that dose recommendations for clinical use can be provided",
    "simplified": "The aim of this study was to evaluate the influence of hepatic impairment on the pharmacokinetics of the novel cyclooxygenase2 COX2 selective inhibitor lumiracoxib Prexige and to provide clinical dose recommendations."
  },
  {
    "text": "In addition ethanol induced degradation of DNA methyltransferases DNMT 1 DNMT 3a and DNMT 3b as well as the methyl CpGbinding proteins MeCP2 MBD2 and MBD3 in MEF cells by the proteasomal pathway",
    "triple_list": [
      [
        "ethanol",
        "CPR:4",
        "DNA methyltransferases"
      ],
      [
        "ethanol",
        "CPR:4",
        "DNMT"
      ],
      [
        "ethanol",
        "CPR:4",
        "methyl CpGbinding proteins"
      ],
      [
        "ethanol",
        "CPR:4",
        "MeCP2"
      ],
      [
        "ethanol",
        "CPR:4",
        "MBD2"
      ],
      [
        "ethanol",
        "CPR:4",
        "MBD3"
      ]
    ],
    "updated": "No",
    "original": "In addition ethanol induced degradation of DNA methyltransferases DNMT 1 DNMT 3a and DNMT 3b as well as the methyl CpGbinding proteins MeCP2 MBD2 and MBD3 in MEF cells by the proteasomal pathway",
    "simplified": "Ethanol can also destroy the DNA methyltransferases DNMT 1, DNMT 3a, and DNMT 3b, as well as the proteins MeCP2 and MBD2 in MEF cells. These are proteins that bind CpG."
  },
  {
    "text": "Before the next drug intake MAOA inhibition as judged by the decrease of plasma DHPG concentration was significantly different from placebo with moclobemide but not with toloxatone",
    "triple_list": [
      [
        "MAOA",
        "CPR:4",
        "moclobemide"
      ],
      [
        "MAOA",
        "CPR:4",
        "toloxatone"
      ]
    ],
    "updated": "No",
    "original": "Before the next drug intake MAOA inhibition as judged by the decrease of plasma DHPG concentration was significantly different from placebo with moclobemide but not with toloxatone",
    "simplified": "Before the next drug intake, the decrease of plasma DHPG was significantly different from placebo with moclobemide but not with toloxatone before the next drug intake."
  },
  {
    "text": "The effects of two reversible monoamine oxidaseA MAOA inhibitors moclobemide 150 mg three times daily and toloxatone 400200400 mg day1 on psychometric performance in 12 healthy subjects were compared in a doubleblind placebo controlled crossover study .",
    "triple_list": [
      [
        "monoamine oxidaseA",
        "CPR:4",
        "moclobemide"
      ],
      [
        "monoamine oxidaseA",
        "CPR:4",
        "toloxatone"
      ]
    ],
    "updated": "Yes",
    "original": "The effects of two reversible predominantly monoamine oxidaseA MAOA inhibitors moclobemide 150 mg three times daily and toloxatone 400200400 mg day1 on monoamine metabolites and psychometric performance were compared in a doubleblind placebo controlled crossover study in 12 healthy subjects",
    "simplified": "The effects of two reversible monoamine oxidaseA MAOA inhibitors moclobemide 150 mg three times daily and toloxatone 400200400 mg day1 on psychometric performance in 12 healthy subjects were compared in a doubleblind placebo controlled crossover study."
  },
  {
    "text": "Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidaseA inhibitors moclobemide and toloxatone and assessment of their effect on psychometric performance in healthy subjects",
    "triple_list": [
      [
        "monoamine oxidase",
        "CPR:4",
        "moclobemide"
      ],
      [
        "monoamine oxidaseA",
        "CPR:4",
        "moclobemide"
      ],
      [
        "monoamine oxidase",
        "CPR:4",
        "toloxatone"
      ],
      [
        "monoamine oxidaseA",
        "CPR:4",
        "toloxatone"
      ]
    ],
    "updated": "No",
    "original": "Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidaseA inhibitors moclobemide and toloxatone and assessment of their effect on psychometric performance in healthy subjects",
    "simplified": "Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidaseA inhibitors in healthy subjects and their effect on psychometric performance in healthy subjects"
  },
  {
    "text": "Previously we have found that BRN103 a nicotinamide derivative inhibits vascular endothelial growth factor VEGF mediated angiogenesis signaling in human endothelial cells",
    "triple_list": [
      [
        "BRN103",
        "CPR:4",
        "VEGF"
      ],
      [
        "BRN103",
        "CPR:4",
        "vascular endothelial growth factor"
      ],
      [
        "nicotinamide",
        "CPR:4",
        "VEGF"
      ],
      [
        "nicotinamide",
        "CPR:4",
        "vascular endothelial growth factor"
      ]
    ],
    "updated": "No",
    "original": "Previously we have found that BRN103 a nicotinamide derivative inhibits vascular endothelial growth factor VEGF mediated angiogenesis signaling in human endothelial cells",
    "simplified": "Previously we have found that BRN103 a nicotinamide derivative inhibits angiogenesis in human endothelial cells by inhibiting vascular endothelial growth factor."
  },
  {
    "text": "Furthermore BRN250 inhibited the VEGFinduced phosphorylation and intracellular tyrosine kinase activity of VEGF receptor 2 VEGFR2 and the activation of its downstream AKT pathway",
    "triple_list": [
      [
        "BRN250",
        "CPR:4",
        "VEGF"
      ],
      [
        "BRN250",
        "CPR:4",
        "tyrosine kinase"
      ],
      [
        "BRN250",
        "CPR:4",
        "VEGF receptor 2"
      ],
      [
        "BRN250",
        "CPR:4",
        "VEGFR2"
      ],
      [
        "BRN250",
        "CPR:4",
        "AKT"
      ]
    ],
    "updated": "No",
    "original": "Furthermore BRN250 inhibited the VEGFinduced phosphorylation and intracellular tyrosine kinase activity of VEGF receptor 2 VEGFR2 and the activation of its downstream AKT pathway",
    "simplified": "In addition, BRN250 inhibited the intracellular tyrosine kinase activity of VEGF receptor 2 and the activation of its downstream AKT pathway."
  },
  {
    "text": "Both BB94 and captopril also stopped gelatinase A and B from being released into the culture medium .",
    "triple_list": [
      [
        "BB94",
        "CPR:4",
        "gelatinase A and B"
      ]
    ],
    "updated": "Yes",
    "original": "Both BB94 and captopril also prevented substrate degradation by gelatinase A and B released in conditioned medium by cultured cells",
    "simplified": "Both BB94 and captopril also stopped gelatinase A and B from being released into the culture medium."
  },
  {
    "text": "We have examined the effects of the synthetic matrix metalloproteinase inhibitor batimastat BB94 and the angiotensinconverting enzyme inhibitor captopril on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL6 mice and on metalloproteinase activity of murine Lewislungcarcinoma cells 3LL in vitro .",
    "triple_list": [
      [
        "matrix metalloproteinase",
        "CPR:4",
        "batimastat"
      ],
      [
        "matrix metalloproteinase",
        "CPR:4",
        "BB94"
      ],
      [
        "angiotensinconverting enzyme",
        "CPR:4",
        "captopril"
      ]
    ],
    "updated": "Yes",
    "original": "We have examined the effects of the synthetic matrix metalloproteinase inhibitor batimastat BB94 and the angiotensinconverting enzyme inhibitor captopril on metalloproteinase activity of murine Lewislungcarcinoma cells 3LL in vitro and on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL6 mice",
    "simplified": "We have examined the effects of the synthetic matrix metalloproteinase inhibitor batimastat BB94 and the angiotensinconverting enzyme inhibitor captopril on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL6 mice and on metalloproteinase activity of murine Lewislungcarcinoma cells 3LL in vitro."
  },
  {
    "text": "Inhibition of gelatinase A MMP2 by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma",
    "triple_list": [
      [
        "gelatinase A",
        "CPR:4",
        "batimastat"
      ],
      [
        "MMP2",
        "CPR:4",
        "batimastat"
      ],
      [
        "gelatinase A",
        "CPR:4",
        "captopril"
      ],
      [
        "MMP2",
        "CPR:4",
        "captopril"
      ]
    ],
    "updated": "No",
    "original": "Inhibition of gelatinase A MMP2 by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma",
    "simplified": "Batimastat and captopril inhibit gelatinase A MMP2 in mice. This reduces tumor growth and lung metastases in these mice."
  },
  {
    "text": "Here we report that captopril treatment resulted in decreased transcription and protein levels of gelatinase A by 3LL cells",
    "triple_list": [
      [
        "captopril",
        "CPR:4",
        "gelatinase A"
      ]
    ],
    "updated": "No",
    "original": "Here we report that captopril treatment resulted in decreased transcription and protein levels of gelatinase A by 3LL cells",
    "simplified": "In this study, captopril treatment resulted in a lower protein and transcription level in 3LL cells."
  },
  {
    "text": "Methionine synthase reductase MTRR is an enzyme involved in the conversion of Hcy to methionine",
    "triple_list": [
      [
        "MTRR",
        "CPR:9",
        "Hcy"
      ],
      [
        "Methionine synthase reductase",
        "CPR:9",
        "Hcy"
      ],
      [
        "MTRR",
        "CPR:9",
        "methionine"
      ],
      [
        "Methionine synthase reductase",
        "CPR:9",
        "methionine"
      ]
    ],
    "updated": "No",
    "original": "Methionine synthase reductase MTRR is an enzyme involved in the conversion of Hcy to methionine",
    "simplified": "Methionine synthase reductase, also known as MTRR, is an enzyme. It makes methionine."
  },
  {
    "text": "GPxs reduce hydroperoxides to alcohols by a process called hydrolysis .",
    "triple_list": [
      [
        "GPxs",
        "CPR:9",
        "alcohols"
      ]
    ],
    "updated": "Yes",
    "original": "GPxs reduce hydroperoxides to the corresponding alcohols by means of glutathione GSH",
    "simplified": "GPxs reduce hydroperoxides to alcohols by a process called hydrolysis."
  },
  {
    "text": "TCDD changed the expression of the glucose transporter SLC2A1 . It also changed the expression of most of the glycolytic transcripts .",
    "triple_list": [
      [
        "TCDD",
        "CPR:4",
        "glucose transporter"
      ],
      [
        "TCDD",
        "CPR:4",
        "SLC2A1"
      ]
    ],
    "updated": "Yes",
    "original": "TCDD decreased the expression of the glucose transporter SLC2A1 and most of the glycolytic transcripts followed by decreases in glycolytic intermediates including pyruvate",
    "simplified": "TCDD changed the expression of the glucose transporter SLC2A1. It also changed the expression of most of the glycolytic transcripts."
  },
  {
    "text": "Mitochondrial glutathione GSH reductase activity and the GSHglutathione disulfide ratio were decreased by TCDD . As a result , ATP production and mitochondrial membrane potential were reduced . This led to mitochondrial dysfunction .",
    "triple_list": [
      [
        "glutathione GSH reductase",
        "CPR:4",
        "TCDD"
      ]
    ],
    "updated": "Yes",
    "original": "Mitochondrial glutathione GSH reductase activity and the GSHglutathione disulfide ratio were decreased by TCDD ultimately leading to mitochondrial dysfunction characterized by decreased inner mitochondrial membrane potential and ATP production and increased production of the reactive oxygen species ROS hydrogen peroxide",
    "simplified": "Mitochondrial glutathione GSH reductase activity and the GSHglutathione disulfide ratio were decreased by TCDD. As a result, ATP production and mitochondrial membrane potential were reduced. This led to mitochondrial dysfunction."
  },
  {
    "text": "Second probucol an antiatherogenic compound reported to be an inactivator of ABCA1 reduced hepatic alphatocopherol secretion",
    "triple_list": [
      [
        "probucol",
        "CPR:4",
        "ABCA1"
      ]
    ],
    "updated": "No",
    "original": "Second probucol an antiatherogenic compound reported to be an inactivator of ABCA1 reduced hepatic alphatocopherol secretion",
    "simplified": "Second probucol is an anti-atherogenic compound that reduces the production of alphatocopherol in the liver."
  },
  {
    "text": "alphaTocopherol transfer protein alphaTTP the product of the gene responsible for familial isolated vitamin E deficiency plays an important role in maintaining the plasma alphatocopherol level by mediating the secretion of alphatocopherol by the liver",
    "triple_list": [
      [
        "alphaTTP",
        "CPR:9",
        "alphatocopherol"
      ],
      [
        "alphaTocopherol transfer protein",
        "CPR:9",
        "alphatocopherol"
      ],
      [
        "alphaTTP",
        "CPR:9",
        "alphatocopherol"
      ],
      [
        "alphaTocopherol transfer protein",
        "CPR:9",
        "alphatocopherol"
      ]
    ],
    "updated": "No",
    "original": "alphaTocopherol transfer protein alphaTTP the product of the gene responsible for familial isolated vitamin E deficiency plays an important role in maintaining the plasma alphatocopherol level by mediating the secretion of alphatocopherol by the liver",
    "simplified": "AlphaTocopherol transfer protein alphaTTP plays an important role in maintaining the plasma alphatocopherol level by mediating the secretion of alphatocopherol by the liver. This is important because alphatocopherol is a vitamin."
  },
  {
    "text": "First addition of apolipoprotein AI apoAI a direct acceptor of the ATPbinding cassette transporter A1 ABCA1 secreted lipids increased alphatocopherol secretion in a dosedependent manner",
    "triple_list": [
      [
        "apolipoprotein AI",
        "CPR:9",
        "alphatocopherol"
      ],
      [
        "apoAI",
        "CPR:9",
        "alphatocopherol"
      ],
      [
        "ATPbinding cassette transporter A1",
        "CPR:9",
        "alphatocopherol"
      ],
      [
        "ABCA1",
        "CPR:9",
        "alphatocopherol"
      ]
    ],
    "updated": "No",
    "original": "First addition of apolipoprotein AI apoAI a direct acceptor of the ATPbinding cassette transporter A1 ABCA1 secreted lipids increased alphatocopherol secretion in a dosedependent manner",
    "simplified": "First addition of apolipoprotein A1 ABCA1 secreted lipids increased alphatocopherol secretion in a dosedependent manner First addition of apolipoprotein AI apoAI"
  },
  {
    "text": "ATPbinding cassette transporter A1 is involved in hepatic alphatocopherol secretion",
    "triple_list": [
      [
        "ATPbinding cassette transporter A1",
        "CPR:9",
        "alphatocopherol"
      ]
    ],
    "updated": "No",
    "original": "ATPbinding cassette transporter A1 is involved in hepatic alphatocopherol secretion",
    "simplified": "ATP transporter A1 is involved in hepatic secretions of ATP."
  },
  {
    "text": "Third ABCA1 RNAi suppressed hepatic alphatocopherol secretion",
    "triple_list": [
      [
        "ABCA1",
        "CPR:9",
        "alphatocopherol"
      ]
    ],
    "updated": "No",
    "original": "Third ABCA1 RNAi suppressed hepatic alphatocopherol secretion",
    "simplified": "Second ABCA1 RNAi increased riboflavin production"
  },
  {
    "text": "These results strongly suggest that ABCA1 is involved in hepatic alphatocopherol production .",
    "triple_list": [
      [
        "ABCA1",
        "CPR:9",
        "alphatocopherol"
      ]
    ],
    "updated": "Yes",
    "original": "These results strongly suggest that ABCA1 is substantially involved in hepatic alphatocopherol secretion",
    "simplified": "These results strongly suggest that ABCA1 is involved in hepatic alphatocopherol production."
  },
  {
    "text": "2Amino33hydroxy52thiazolyl4isoxazolylpropionic acid 1 is a potent AMPA receptor agonist with moderate affinity for native kainic acid KA receptors whereas SE422dimethylpropylideneglutamic acid 3 show high affinity for the GluR5 subtype of KA receptors and much lower affinity for the GluR2 subtype of AMPA receptors",
    "triple_list": [
      [
        "2Amino33hydroxy52thiazolyl4isoxazolylpropionic acid",
        "CPR:5",
        "AMPA receptor"
      ]
    ],
    "updated": "No",
    "original": "2Amino33hydroxy52thiazolyl4isoxazolylpropionic acid 1 is a potent AMPA receptor agonist with moderate affinity for native kainic acid KA receptors whereas SE422dimethylpropylideneglutamic acid 3 show high affinity for the GluR5 subtype of KA receptors and much lower affinity for the GluR2 subtype of AMPA receptors",
    "simplified": "2Amino33hydroxy52thiazolyl4isoxazolylpropionic acid 1 and SE422dimethylpropylideneglutamic acid 3 show high affinity for the GluR5 subtype of the KA receptors but much lower affinity for the GluR2 subtype of the AMPA receptors."
  },
  {
    "text": "Pranlukast , a leukotriene receptor antagonist , blocks interleukin5 production . This is different from leukotriene receptor antagonism .",
    "triple_list": [
      [
        "Pranlukast",
        "CPR:4",
        "interleukin5"
      ],
      [
        "Pranlukast",
        "CPR:6",
        "leukotriene receptor"
      ],
      [
        "Pranlukast",
        "CPR:6",
        "leukotriene receptor"
      ]
    ],
    "updated": "Yes",
    "original": "Pranlukast a leukotriene receptor antagonist inhibits interleukin5 production via a mechanism distinct from leukotriene receptor antagonism",
    "simplified": "Pranlukast, a leukotriene receptor antagonist, blocks interleukin5 production. This is different from leukotriene receptor antagonism."
  },
  {
    "text": "Pranlukast-induced inhibition of IL5 expression was noted in various cells regardless of whether CysLTR1 was present or not .",
    "triple_list": [
      [
        "Pranlukast",
        "CPR:4",
        "IL5"
      ]
    ],
    "updated": "Yes",
    "original": "Pranlukast induced inhibition of IL5 mRNA expression was noted in various cells irrespective of their CysLTR1 mRNA expression status",
    "simplified": "Pranlukast-induced inhibition of IL5 expression was noted in various cells regardless of whether CysLTR1 was present or not."
  },
  {
    "text": "Our results indicate that pranlukast inhibits IL5 synthesis through a different mechanism than CysLTR1 does .",
    "triple_list": [
      [
        "pranlukast",
        "CPR:4",
        "IL5"
      ],
      [
        "pranlukast",
        "CPR:6",
        "CysLTR1"
      ]
    ],
    "updated": "Yes",
    "original": "CONCLUSION Our results indicate that pranlukast inhibits IL5 synthesis via a mechanism distinct from CysLTR1 antagonism",
    "simplified": "Our results indicate that pranlukast inhibits IL5 synthesis through a different mechanism than CysLTR1 does."
  },
  {
    "text": "The aim of this study was to determine the mechanism of pranlukast induced interleukin5 IL5 inhibition in allergic inflammation",
    "triple_list": [
      [
        "pranlukast",
        "CPR:4",
        "interleukin5"
      ],
      [
        "pranlukast",
        "CPR:4",
        "IL5"
      ]
    ],
    "updated": "No",
    "original": "The aim of this study was to determine the mechanism of pranlukast induced interleukin5 IL5 inhibition in allergic inflammation",
    "simplified": "The aim of this study was to determine how interleukin5 inhibition by pranlukast caused allergic reactions."
  },
  {
    "text": "Results When lung tissues were pretreated with pranlukast , the amount of IL5 protein in the culture medium was reduced by 40",
    "triple_list": [
      [
        "pranlukast",
        "CPR:4",
        "IL5"
      ]
    ],
    "updated": "Yes",
    "original": "RESULTS Pretreatment of lung tissues with pranlukast alone significantly decreased the amount of IL5 protein in the culture medium by 40",
    "simplified": "Results When lung tissues were pretreated with pranlukast, the amount of IL5 protein in the culture medium was reduced by 40"
  },
  {
    "text": "Pranlukast is a cysteinyl leukotriene receptor 1 ( CysLTR1 ) antagonist . It works by making the smooth muscle in the airway shorter .",
    "triple_list": [
      [
        "Pranlukast",
        "CPR:6",
        "cysteinyl leukotriene receptor 1"
      ],
      [
        "Pranlukast",
        "CPR:6",
        "CysLTR1"
      ]
    ],
    "updated": "Yes",
    "original": "BACKGROUND Pranlukast a cysteinyl leukotriene receptor 1 CysLTR1 antagonist inhibits not only airway smooth muscle contraction but also allergic inflammation",
    "simplified": "Pranlukast is a cysteinyl leukotriene receptor 1 (CysLTR1) antagonist. It works by making the smooth muscle in the airway shorter."
  },
  {
    "text": "Thiazolidinediones are a new class of drugs that work by binding to the peroxisome proliferatoractivated receptor gamma-gamma ( PPARgamma ) in the pancreas . When they do this , they increase the insulin sensitivity of the human body .",
    "triple_list": [
      [
        "Thiazolidinediones",
        "CPR:3",
        "insulin"
      ],
      [
        "Thiazolidinediones",
        "CPR:3",
        "insulin"
      ]
    ],
    "updated": "Yes",
    "original": "Thiazolidinediones are a new class of antidiabetic agents which increase insulin sensitivity by binding to the peroxisome proliferatoractivated receptor gamma PPARgamma and stimulating the expression of insulin responsive genes involved in glucose and lipid metabolism",
    "simplified": "Thiazolidinediones are a new class of drugs that work by binding to the peroxisome proliferatoractivated receptor gamma-gamma (PPARgamma) in the pancreas. When they do this, they increase the insulin sensitivity of the human body."
  },
  {
    "text": "The difference in structure of troglitazone did not account for the effect it had on ENT1 . Vitamin E does not inhibit 3Hadenosine uptake by HASMCs .",
    "triple_list": [
      [
        "troglitazone",
        "CPR:4",
        "ENT1"
      ]
    ],
    "updated": "Yes",
    "original": "The difference in structure of troglitazone did not account for its inhibitory effect on ENT1 because Vitamin E did not inhibit 3Hadenosine uptake by HASMCs",
    "simplified": "The difference in structure of troglitazone did not account for the effect it had on ENT1. Vitamin E does not inhibit 3Hadenosine uptake by HASMCs."
  },
  {
    "text": "Using the nucleoside transporter-deficient PK15NTD cells , it was found that troglitazone inhibited ENT1 , but it did not affect ENT2 .",
    "triple_list": [
      [
        "ENT1",
        "CPR:4",
        "troglitazone"
      ]
    ],
    "updated": "Yes",
    "original": "Using the nucleoside transporter deficient PK15NTD cells stably expressing ENT1 and ENT2 it was found that troglitazone inhibited ENT1 but had no effect on ENT2",
    "simplified": "Using the nucleoside transporter-deficient PK15NTD cells, it was found that troglitazone inhibited ENT1, but it did not affect ENT2."
  },
  {
    "text": "From these results it is suggested that troglitazone may enhance the vasodilatory effect of adenosine by inhibiting ENT1",
    "triple_list": [
      [
        "troglitazone",
        "CPR:4",
        "ENT1"
      ]
    ],
    "updated": "No",
    "original": "From these results it is suggested that troglitazone may enhance the vasodilatory effect of adenosine by inhibiting ENT1",
    "simplified": "Troglitazone has been shown to improve the vasodilatory effect of adenosine by inhibiting ENT1."
  },
  {
    "text": "Pharmacologically troglitazone is a novel inhibitor of ENT1",
    "triple_list": [
      [
        "troglitazone",
        "CPR:4",
        "ENT1"
      ]
    ],
    "updated": "No",
    "original": "Pharmacologically troglitazone is a novel inhibitor of ENT1",
    "simplified": "Troglitazone is a novel anti-inflammatory drug."
  },
  {
    "text": "The effect of troglitazone on ENT1 was PPARgammaindependent . It was also found that troglitazone worked in a different way .",
    "triple_list": [
      [
        "troglitazone",
        "CPR:4",
        "ENT1"
      ]
    ],
    "updated": "Yes",
    "original": "The effect of troglitazone on ENT1 was PPARgammaindependent and kinetic studies revealed that troglitazone was a competitive inhibitor of ENT1",
    "simplified": "The effect of troglitazone on ENT1 was PPARgammaindependent. It was also found that troglitazone worked in a different way."
  },
  {
    "text": "Phenytoin is mainly metabolized by CYP2C9 . It is probably also metabolized by the drug transporter Pglycoprotein .",
    "triple_list": [
      [
        "Phenytoin",
        "CPR:9",
        "CYP2C9"
      ],
      [
        "Phenytoin",
        "CPR:9",
        "drug transporter"
      ],
      [
        "Phenytoin",
        "CPR:9",
        "Pglycoprotein"
      ]
    ],
    "updated": "Yes",
    "original": "Phenytoin is principally metabolized by CYP2C9 and both are probable substrates of the drug transporter Pglycoprotein",
    "simplified": "Phenytoin is mainly metabolized by CYP2C9. It is probably also metabolized by the drug transporter Pglycoprotein."
  },
  {
    "text": "We also found that fisetin suppressed mTORC1 and Akt S6K1 phosphorylation in adipose tissue .",
    "triple_list": [
      [
        "fisetin",
        "CPR:4",
        "Akt"
      ],
      [
        "fisetin",
        "CPR:4",
        "S6K1"
      ],
      [
        "fisetin",
        "CPR:4",
        "mTORC1"
      ]
    ],
    "updated": "Yes",
    "original": "We also observed that fisetin efficiently suppressed the phosphorylation of Akt S6K1 and mTORC1 in adipose tissue",
    "simplified": "We also found that fisetin suppressed mTORC1 and Akt S6K1 phosphorylation in adipose tissue."
  },
  {
    "text": "Together , these results suggest that fisetin inhibition of mTORC1 signaling prevents 3T3L1 preadipocytes differentiation and obesity in HFDfed mice .",
    "triple_list": [
      [
        "mTORC1",
        "CPR:4",
        "fisetin"
      ]
    ],
    "updated": "Yes",
    "original": "Collectively these results suggest that inhibition of mTORC1 signaling by fisetin prevents adipocyte differentiation of 3T3L1 preadipocytes and obesity in HFDfed mice",
    "simplified": "Together, these results suggest that fisetin inhibition of mTORC1 signaling prevents 3T3L1 preadipocytes differentiation and obesity in HFDfed mice."
  },
  {
    "text": "Fisetin treatment reduced mTORC1 and S6K1 phosphorylation in preadipocytes in a time and concentrationdependent manner",
    "triple_list": [
      [
        "Fisetin",
        "CPR:4",
        "S6K1"
      ],
      [
        "Fisetin",
        "CPR:4",
        "mTORC1"
      ]
    ],
    "updated": "Yes",
    "original": "Fisetin treatment of preadipocytes reduced the phosphorylation of S6K1 and mTORC1 in a time and concentrationdependent manner",
    "simplified": "Fisetin treatment reduced mTORC1 and S6K1 phosphorylation in preadipocytes in a time and concentrationdependent manner"
  },
  {
    "text": "To further our understanding of how fisetin negatively regulates mTORC1 signaling , the phosphorylation of S6K1 in fisetintreated TSC2knockdown cells was also examined .",
    "triple_list": [
      [
        "fisetin",
        "CPR:4",
        "mTORC1"
      ]
    ],
    "updated": "Yes",
    "original": "To further our understanding of how fisetin negatively regulates mTORC1 signaling we analyzed the phosphorylation of S6K1 mTOR and Akt in fisetintreated TSC2knockdown cells",
    "simplified": "To further our understanding of how fisetin negatively regulates mTORC1 signaling, the phosphorylation of S6K1 in fisetintreated TSC2knockdown cells was also examined."
  },
  {
    "text": "The results showed that fisetin treatment could reduce mTORC1 activity by Akt-dependent means .",
    "triple_list": [
      [
        "fisetin",
        "CPR:4",
        "mTORC1"
      ],
      [
        "fisetin",
        "CPR:4",
        "Akt"
      ]
    ],
    "updated": "Yes",
    "original": "The results suggested that fisetin treatment inhibits mTORC1 activity in an Akt dependent manner",
    "simplified": "The results showed that fisetin treatment could reduce mTORC1 activity by Akt-dependent means."
  },
  {
    "text": "Fisetin treatment inhibited adipocyte differentiation consistent with the negative effect of fisetin on mTOR",
    "triple_list": [
      [
        "fisetin",
        "CPR:4",
        "mTOR"
      ]
    ],
    "updated": "No",
    "original": "Fisetin treatment inhibited adipocyte differentiation consistent with the negative effect of fisetin on mTOR",
    "simplified": "Fisetin treatment did not allow adipocyte differentiation. This showed a negative effect on mTOR."
  },
  {
    "text": "Tomudex treatment resulted in the decrease in p27kip1 expression with an increase in cyclin E and cdk2 protein expression and kinase activities 24 h after a 2h exposure",
    "triple_list": [
      [
        "Tomudex",
        "CPR:3",
        "cyclin E"
      ],
      [
        "Tomudex",
        "CPR:3",
        "cdk2"
      ],
      [
        "Tomudex",
        "CPR:3",
        "kinase"
      ],
      [
        "Tomudex",
        "CPR:4",
        "p27kip1"
      ]
    ],
    "updated": "No",
    "original": "Tomudex treatment resulted in the decrease in p27kip1 expression with an increase in cyclin E and cdk2 protein expression and kinase activities 24 h after a 2h exposure",
    "simplified": "Tomudex treatment decreased the expression of p27kip1 but increased the expression of cyclin E and cdk2 24 h after exposure to light."
  },
  {
    "text": "The studies with dThyd rescue from cyclin E cdk2 protein overexpression and growth inhibition by Tomudex indicate that when thymidylate synthase is inhibited , the amount of cyclin Ecdk2 in the blood decreases .",
    "triple_list": [
      [
        "cyclin E",
        "CPR:3",
        "Tomudex"
      ],
      [
        "cdk2",
        "CPR:3",
        "Tomudex"
      ],
      [
        "cyclin E",
        "CPR:3",
        "Tomudex"
      ],
      [
        "cdk2",
        "CPR:3",
        "Tomudex"
      ],
      [
        "cyclin E",
        "CPR:4",
        "Tomudex"
      ],
      [
        "cdk2",
        "CPR:4",
        "Tomudex"
      ],
      [
        "Tomudex",
        "CPR:4",
        "thymidylate synthase"
      ]
    ],
    "updated": "Yes",
    "original": "The studies with dThyd rescue from cyclin E cdk2 protein overexpression and growth inhibition by Tomudex indicate that increased cyclin Ecdk2 protein expression is associated with effective inhibition of thymidylate synthase and resultant dNTP pool imbalance",
    "simplified": "The studies with dThyd rescue from cyclin E cdk2 protein overexpression and growth inhibition by Tomudex indicate that when thymidylate synthase is inhibited, the amount of cyclin Ecdk2 in the blood decreases."
  },
  {
    "text": "These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of thymidylate synthase by Tomudex and kilobase DNA fragmentation may correlate with the reduction of p27kip1 expression and the increase in cyclin E and cdk2 kinase activities",
    "triple_list": [
      [
        "Tomudex",
        "CPR:3",
        "cyclin E"
      ],
      [
        "Tomudex",
        "CPR:3",
        "cdk2"
      ],
      [
        "Tomudex",
        "CPR:3",
        "kinase"
      ],
      [
        "thymidylate synthase",
        "CPR:4",
        "Tomudex"
      ],
      [
        "Tomudex",
        "CPR:4",
        "p27kip1"
      ]
    ],
    "updated": "No",
    "original": "These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of thymidylate synthase by Tomudex and kilobase DNA fragmentation may correlate with the reduction of p27kip1 expression and the increase in cyclin E and cdk2 kinase activities",
    "simplified": "These results suggest that the megabase DNA fragmentation is caused by the Tomudex inhibiting thymidylate synthase. The reduction in thymidylate synthase activity may be accompanied by an increase in cyclin E and cdk2 kinase activities."
  },
  {
    "text": "In vitro studies were carried out to determine the downstream molecular changes that were caused by Tomudex . The Tomudex inhibited thymidylate synthase for a long time .",
    "triple_list": [
      [
        "thymidylate synthase",
        "CPR:4",
        "Tomudex"
      ]
    ],
    "updated": "Yes",
    "original": "Studies were carried out in vitro to evaluate downstream molecular alterations induced as a consequence of the potent and sustained inhibition of thymidylate synthase by Tomudex",
    "simplified": "In vitro studies were carried out to determine the downstream molecular changes that were caused by Tomudex. The Tomudex inhibited thymidylate synthase for a long time."
  },
  {
    "text": "Cyclin Ecdk2 is involved in cell cycle arrest . When the thymidylate synthase inhibitor Tomudex is turned on , DNA replication is stopped .",
    "triple_list": [
      [
        "thymidylate synthase",
        "CPR:4",
        "Tomudex"
      ]
    ],
    "updated": "Yes",
    "original": "Cyclin Ecdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex",
    "simplified": "Cyclin Ecdk2 is involved in cell cycle arrest. When the thymidylate synthase inhibitor Tomudex is turned on, DNA replication is stopped."
  },
  {
    "text": "Tomudex ( ZD1694 ) is an anti-angiogenic drug . It works by attacking the thymidylate synthase enzyme .",
    "triple_list": [
      [
        "Tomudex",
        "CPR:4",
        "thymidylate synthase"
      ]
    ],
    "updated": "Yes",
    "original": "Tomudex ZD1694 is a specific antifolatebased thymidylate synthase inhibitor active in a variety of solid tumor malignancies",
    "simplified": "Tomudex (ZD1694) is an anti-angiogenic drug. It works by attacking the thymidylate synthase enzyme."
  },
  {
    "text": "Saturated palmitic and stearic acids increased ceramides upregulated PTP1B and had AKt and PTP1B phosphorylation at Ser 50 impaired",
    "triple_list": [
      [
        "palmitic and stearic acids",
        "CPR:3",
        "PTP1B"
      ],
      [
        "palmitic and stearic acids",
        "CPR:3",
        "AKt"
      ],
      [
        "palmitic and stearic acids",
        "CPR:3",
        "PTP1B"
      ]
    ],
    "updated": "No",
    "original": "Saturated palmitic and stearic acids increased ceramides upregulated PTP1B and had AKt and PTP1B phosphorylation at Ser 50 impaired",
    "simplified": "Saturated palmitic and stearic acids increased PTP1B and PTP1B phosphorylation at Ser 50, making ceramides more stable."
  },
  {
    "text": "Cells were also evaluated in the presence of wortmannin an inhibitor of phosphatidylinositol 3kinases and thus AKt 0100 nM",
    "triple_list": [
      [
        "wortmannin",
        "CPR:4",
        "phosphatidylinositol 3kinases"
      ],
      [
        "wortmannin",
        "CPR:4",
        "AKt"
      ]
    ],
    "updated": "No",
    "original": "Cells were also evaluated in the presence of wortmannin an inhibitor of phosphatidylinositol 3kinases and thus AKt 0100 nM",
    "simplified": "Cells were also examined in the presence of wortmannin. This is an inhibitor of phosphatidylinositol 3kinases."
  },
  {
    "text": "Only FFAs that increased ceramides made AKt and PTP1B not work properly at all .",
    "triple_list": [
      [
        "ceramides",
        "CPR:4",
        "AKt"
      ],
      [
        "ceramides",
        "CPR:4",
        "PTP1B"
      ]
    ],
    "updated": "Yes",
    "original": "Only FFAs that increased ceramides caused impairment of AKt and PTP1B phosphorylation at Ser 50",
    "simplified": "Only FFAs that increased ceramides made AKt and PTP1B not work properly at all."
  },
  {
    "text": "Indoleamine 23dioxygenase , also known as IDO , is an enzyme . It removes tryptophan from the blood .",
    "triple_list": [
      [
        "IDO",
        "CPR:9",
        "tryptophan"
      ],
      [
        "Indoleamine 23dioxygenase",
        "CPR:9",
        "tryptophan"
      ]
    ],
    "updated": "Yes",
    "original": "Indoleamine 23dioxygenase IDO a tryptophan catabolizing enzyme has been implicated in the pathogenesis of various neurological disorders",
    "simplified": "Indoleamine 23dioxygenase, also known as IDO, is an enzyme. It removes tryptophan from the blood."
  },
  {
    "text": "Peroxisome proliferatoractivated receptor\u03b1 PPAR\u03b1 activation mimicked the effects of resveratrol while PPAR\u03b1 inhibition prevented the effects of this SIRT1 activator",
    "triple_list": [
      [
        "resveratrol",
        "CPR:3",
        "SIRT1"
      ]
    ],
    "updated": "No",
    "original": "Peroxisome proliferatoractivated receptor\u03b1 PPAR\u03b1 activation mimicked the effects of resveratrol while PPAR\u03b1 inhibition prevented the effects of this SIRT1 activator",
    "simplified": "Peroxisome proliferator-activated receptor\u03b1 (PPAR\u03b1) was used to make resveratrol work. When PPAR\u03b1 was not used, resveratrol did not work at all."
  },
  {
    "text": "SIRT1 coprecipitated with PPAR\u03b1 and nicotinamide increased the acetylation of the PPAR\u03b1 coactivator PGC1\u03b1 which was suppressed by resveratrol",
    "triple_list": [
      [
        "nicotinamide",
        "CPR:3",
        "PGC1\u03b1"
      ],
      [
        "PGC1\u03b1",
        "CPR:4",
        "resveratrol"
      ]
    ],
    "updated": "No",
    "original": "SIRT1 coprecipitated with PPAR\u03b1 and nicotinamide increased the acetylation of the PPAR\u03b1 coactivator PGC1\u03b1 which was suppressed by resveratrol",
    "simplified": "SIRT1 and nicotinamide increase the acetylation of PPAR\u03b1, but resveratrol reduces the amount of acetylation."
  },
  {
    "text": "To determine whether dysregulation of SIRT1 promotes NADPH oxidase dependent production of reactive oxygen species ROS and impairs endothelial function we assessed the effects of three structurally different inhibitors of SIRT1 nicotinamide sirtinol EX527 in aorta segments isolated from young Wistar rats",
    "triple_list": [
      [
        "SIRT1",
        "CPR:4",
        "nicotinamide"
      ],
      [
        "SIRT1",
        "CPR:4",
        "sirtinol"
      ],
      [
        "SIRT1",
        "CPR:4",
        "EX527"
      ],
      [
        "NADPH oxidase",
        "CPR:9",
        "oxygen"
      ]
    ],
    "updated": "No",
    "original": "To determine whether dysregulation of SIRT1 promotes NADPH oxidase dependent production of reactive oxygen species ROS and impairs endothelial function we assessed the effects of three structurally different inhibitors of SIRT1 nicotinamide sirtinol EX527 in aorta segments isolated from young Wistar rats",
    "simplified": "To determine whether dysregulation of SIRT1 impairs endothelial function, we assessed the effects of three structurally different inhibitors of SIRT1 nicotinamide sirtinol EX527 in aorta segments isolated from young Wistar rats."
  },
  {
    "text": "Endothelial dysfunction caused by SIRT1 was prevented by the use of apocynin or superoxide dismutase . These two drugs inhibit NADPH oxidase .",
    "triple_list": [
      [
        "NADPH oxidase",
        "CPR:4",
        "apocynin"
      ]
    ],
    "updated": "Yes",
    "original": "Endothelial dysfunction induced by SIRT1 inhibition was prevented by treatment of the vessels with the NADPH oxidase inhibitor apocynin or superoxide dismutase",
    "simplified": "Endothelial dysfunction caused by SIRT1 was prevented by the use of apocynin or superoxide dismutase. These two drugs inhibit NADPH oxidase."
  },
  {
    "text": "Inhibition of SIRT1 significantly increased vascular superoxide production enhanced NADPH oxidase activity and mRNA expression of its subunits p22phox and NOX4 which were prevented by resveratrol",
    "triple_list": [
      [
        "NADPH oxidase",
        "CPR:4",
        "resveratrol"
      ],
      [
        "p22phox",
        "CPR:4",
        "resveratrol"
      ],
      [
        "NOX4",
        "CPR:4",
        "resveratrol"
      ],
      [
        "SIRT1",
        "CPR:9",
        "superoxide"
      ]
    ],
    "updated": "No",
    "original": "Inhibition of SIRT1 significantly increased vascular superoxide production enhanced NADPH oxidase activity and mRNA expression of its subunits p22phox and NOX4 which were prevented by resveratrol",
    "simplified": "Inhibition of SIRT1 significantly increased vascular superoxide production and the expression of its subunits p22phox and NOX4. It also increased NADPH oxidase activity."
  },
  {
    "text": "Liver and brain tissues of rats orally exposed to polycyclic aromatic hydrocarbons show increased EROD activity .",
    "triple_list": [
      [
        "EROD",
        "CPR:3",
        "polycyclic aromatic hydrocarbons"
      ]
    ],
    "updated": "Yes",
    "original": "EROD activity induction in peripheral blood lymphocytes liver and brain tissues of rats orally exposed to polycyclic aromatic hydrocarbons",
    "simplified": "Liver and brain tissues of rats orally exposed to polycyclic aromatic hydrocarbons show increased EROD activity."
  },
  {
    "text": "Little is known in terms of multimatrix cytochrome P450 activity induction under repeated oral exposure to planar halogenated and polycyclic aromatic hydrocarbons PHH PAH",
    "triple_list": [
      [
        "cytochrome P450",
        "CPR:3",
        "halogenated and polycyclic aromatic hydrocarbons"
      ],
      [
        "cytochrome P450",
        "CPR:3",
        "PAH"
      ]
    ],
    "updated": "No",
    "original": "Little is known in terms of multimatrix cytochrome P450 activity induction under repeated oral exposure to planar halogenated and polycyclic aromatic hydrocarbons PHH PAH",
    "simplified": "Little is known about the effects of repeated oral exposure to planar halogenated and polycyclic aromatic hydrocarbons on multimatrix cytochrome P450 activity."
  },
  {
    "text": "Repression of farnesyltransferase FNTA by siRNA and the enzyme inhibitor manumycin A increased the amount of ApoAI in hepatocytes . Transgenic mice with hApoAI gene were able to produce ApoAI .",
    "triple_list": [
      [
        "manumycin A",
        "CPR:3",
        "ApoAI"
      ],
      [
        "manumycin A",
        "CPR:3",
        "hApoAI"
      ],
      [
        "farnesyltransferase",
        "CPR:4",
        "manumycin A"
      ],
      [
        "FNTA",
        "CPR:4",
        "manumycin A"
      ]
    ],
    "updated": "Yes",
    "original": "Repression of farnesyltransferase FNTA by siRNA and the enzyme inhibitor manumycin A caused elevation of ApoAI secretion from hepatocytes and from transgenic mice expressing hApoAI and cholesterol ester transfer protein transgenes",
    "simplified": "Repression of farnesyltransferase FNTA by siRNA and the enzyme inhibitor manumycin A increased the amount of ApoAI in hepatocytes. Transgenic mice with hApoAI gene were able to produce ApoAI."
  },
  {
    "text": "The third generation aromatase inhibitors anastrozole letrozole and exemestane were introduced to the market as endocrine therapy . They work by stopping a chemical in the body called aromatase .",
    "triple_list": [
      [
        "aromatase",
        "CPR:4",
        "letrozole"
      ],
      [
        "aromatase",
        "CPR:4",
        "anastrozole"
      ]
    ],
    "updated": "Yes",
    "original": "The potent and selective thirdgeneration aromatase inhibitors anastrozole letrozole and exemestane were introduced to the market as endocrine therapy in postmenopausal patients failing antiestrogen therapy alone or multiple hormonal therapies",
    "simplified": "The third generation aromatase inhibitors anastrozole letrozole and exemestane were introduced to the market as endocrine therapy. They work by stopping a chemical in the body called aromatase."
  },
  {
    "text": "Anastrozole and letrozole are two different nonsteroidal aromatase inhibitors . They work by competing with the enzyme .",
    "triple_list": [
      [
        "Anastrozole",
        "CPR:4",
        "aromatase"
      ],
      [
        "letrozole",
        "CPR:4",
        "aromatase"
      ]
    ],
    "updated": "Yes",
    "original": "Anastrozole and letrozole are both nonsteroidal aromatase inhibitors that compete with the substrate for binding to the enzyme active site",
    "simplified": "Anastrozole and letrozole are two different nonsteroidal aromatase inhibitors. They work by competing with the enzyme."
  },
  {
    "text": "Estrogens are biosynthesised from androgens by the CYP450 enzyme complex called aromatase",
    "triple_list": [
      [
        "Estrogens",
        "CPR:9",
        "CYP450"
      ],
      [
        "Estrogens",
        "CPR:9",
        "aromatase"
      ],
      [
        "androgens",
        "CPR:9",
        "aromatase"
      ]
    ],
    "updated": "No",
    "original": "Estrogens are biosynthesised from androgens by the CYP450 enzyme complex called aromatase",
    "simplified": "Estrogens are made by an enzyme called aromatase in the human body."
  },
  {
    "text": "In breast cancer , the intratumoural aromatase helps the local estrogen production to continue .",
    "triple_list": [
      [
        "aromatase",
        "CPR:9",
        "estrogen"
      ]
    ],
    "updated": "Yes",
    "original": "In breast cancer intratumoural aromatase is the source for local estrogen production in the tissue",
    "simplified": "In breast cancer, the intratumoural aromatase helps the local estrogen production to continue."
  },
  {
    "text": "In this study we employed virtual screening and chemical synthesis to identify a series of Nthiophen2yl benzamide derivatives as potent BRAF V600E inhibitors",
    "triple_list": [
      [
        "Nthiophen2yl benzamide",
        "CPR:4",
        "BRAF"
      ],
      [
        "Nthiophen2yl benzamide",
        "CPR:4",
        "V600E"
      ]
    ],
    "updated": "No",
    "original": "In this study we employed virtual screening and chemical synthesis to identify a series of Nthiophen2yl benzamide derivatives as potent BRAF V600E inhibitors",
    "simplified": "In this study, virtual screening and chemical synthesis were used to identify a series of benzamide derivatives as BRAF V600E inhibitors."
  },
  {
    "text": "Identification and synthesis of Nthiophen2yl benzamide derivatives as BRAF V600E inhibitors",
    "triple_list": [
      [
        "Nthiophen2yl benzamide",
        "CPR:4",
        "BRAF"
      ],
      [
        "Nthiophen2yl benzamide",
        "CPR:4",
        "V600E"
      ]
    ],
    "updated": "No",
    "original": "Identification and synthesis of Nthiophen2yl benzamide derivatives as BRAF V600E inhibitors",
    "simplified": "Nthiophen2yl benzamide is a chemical compound. It is a benzamide derivative."
  },
  {
    "text": "Exposure of cells to 4mM NaF for 24h induced caspase3 activation ultrastructural alterations and resulted in the translocation of Bax to the mitochondria and the release of cytochrome c from the mitochondrial intermembrane space into the cytosol indicating that fluoridemediated apoptosis is mitochondriadependent",
    "triple_list": [
      [
        "NaF",
        "CPR:3",
        "caspase3"
      ]
    ],
    "updated": "No",
    "original": "Exposure of cells to 4mM NaF for 24h induced caspase3 activation ultrastructural alterations and resulted in the translocation of Bax to the mitochondria and the release of cytochrome c from the mitochondrial intermembrane space into the cytosol indicating that fluoridemediated apoptosis is mitochondriadependent",
    "simplified": "Exposure of cells to 4mM NaF for 24h made changes in the structure of the cell. This made Bax move to the mitochondria and cytochrome c move from the mitochondrial intermembrane space into the cytosol. This shows that fluoridemediated apoptosis is mitochondriadependent."
  },
  {
    "text": "Fluoride treatment also increased the phosphorylation of JNK and ERK but not p38 . Treatment with JNK or ERK inhibitors reduced the amount of apoptosis caused by fluoride .",
    "triple_list": [
      [
        "Fluoride",
        "CPR:3",
        "JNK"
      ],
      [
        "Fluoride",
        "CPR:3",
        "ERK"
      ]
    ],
    "updated": "Yes",
    "original": "Fluoride treatment also increased phosphorylation of JNK and ERK but not p38 and apoptosis induced by fluoride was notably or partly suppressed by treatment with JNK or ERK inhibitors respectively",
    "simplified": "Fluoride treatment also increased the phosphorylation of JNK and ERK but not p38. Treatment with JNK or ERK inhibitors reduced the amount of apoptosis caused by fluoride."
  },
  {
    "text": "The Panx1 channel blockers carbenoxolone and Probenecid did not work at all . When Kvbeta3 was added , they did not work .",
    "triple_list": [
      [
        "Panx1",
        "CPR:4",
        "carbenoxolone"
      ],
      [
        "Panx1",
        "CPR:4",
        "Probenecid"
      ]
    ],
    "updated": "Yes",
    "original": "Furthermore the Panx1 channel blockers carbenoxolone and Probenecid were less effective in inhibiting Panx1 currents when Kvbeta3 was coexpressed",
    "simplified": "The Panx1 channel blockers carbenoxolone and Probenecid did not work at all. When Kvbeta3 was added, they did not work."
  },
  {
    "text": "67Methoxy2trifluoromethylpyrazolo15apyridin4yl5methyl45dihydropyridazin32Hone KCA1490 exhibits moderate dual PDE34 inhibitory activity and promises as a combined bronchodilatoryantiinflammatory agent",
    "triple_list": [
      [
        "67Methoxy2trifluoromethylpyrazolo15apyridin4yl5methyl45dihydropyridazin32Hone",
        "CPR:4",
        "PDE34"
      ],
      [
        "KCA1490",
        "CPR:4",
        "PDE34"
      ]
    ],
    "updated": "No",
    "original": "67Methoxy2trifluoromethylpyrazolo15apyridin4yl5methyl45dihydropyridazin32Hone KCA1490 exhibits moderate dual PDE34 inhibitory activity and promises as a combined bronchodilatoryantiinflammatory agent",
    "simplified": "67Methoxy2trifluoromethylpyrazolo15apyridin4yl5methyl45dihydropyridazin32Hone KCA1490 is a chemical compound. Its chemical formula is KCA1490."
  },
  {
    "text": "N alkylation of the pyridazinone ring makes the drug more effective against PDE4 and PDE3 .",
    "triple_list": [
      [
        "N",
        "CPR:4",
        "PDE4"
      ],
      [
        "N",
        "CPR:4",
        "PDE3"
      ],
      [
        "pyridazinone",
        "CPR:4",
        "PDE4"
      ],
      [
        "pyridazinone",
        "CPR:4",
        "PDE3"
      ]
    ],
    "updated": "Yes",
    "original": "N alkylation of the pyridazinone ring markedly enhances potency against PDE4 but suppresses PDE3 inhibition",
    "simplified": "N alkylation of the pyridazinone ring makes the drug more effective against PDE4 and PDE3."
  },
  {
    "text": "Addition of a 6aryl45dihydropyridazin32Hone extension to the N alkyl group has been shown to improve the activity of PDE4 and PDE3 by up to 30 % .",
    "triple_list": [
      [
        "6aryl45dihydropyridazin32Hone",
        "CPR:4",
        "PDE4"
      ],
      [
        "6aryl45dihydropyridazin32Hone",
        "CPR:4",
        "PDE3"
      ],
      [
        "N",
        "CPR:4",
        "PDE4"
      ],
      [
        "N",
        "CPR:4",
        "PDE3"
      ]
    ],
    "updated": "Yes",
    "original": "Addition of a 6aryl45dihydropyridazin32Hone extension to the N alkyl group facilitates both enhancement of PDE4 inhibitory activity and restoration of potent PDE3 inhibition",
    "simplified": "Addition of a 6aryl45dihydropyridazin32Hone extension to the N alkyl group has been shown to improve the activity of PDE4 and PDE3 by up to 30%."
  },
  {
    "text": "Given that FRD present in all H pylori strains is immunogenic in H pylori infected patients and H pylori growth in vitro can be inhibited by three anthelmintics morantel oxantel and thiabendazole this enzyme could potentially be used both as a novel drug target as well as in the development of vaccines for H pylori prevention and eradication",
    "triple_list": [
      [
        "FRD",
        "CPR:4",
        "morantel"
      ],
      [
        "FRD",
        "CPR:4",
        "oxantel"
      ],
      [
        "FRD",
        "CPR:4",
        "thiabendazole"
      ]
    ],
    "updated": "No",
    "original": "Given that FRD present in all H pylori strains is immunogenic in H pylori infected patients and H pylori growth in vitro can be inhibited by three anthelmintics morantel oxantel and thiabendazole this enzyme could potentially be used both as a novel drug target as well as in the development of vaccines for H pylori prevention and eradication",
    "simplified": "H pylori growth in vitro can be stopped by three anthelmintics. These are morantel oxantel and thiabendazole. This enzyme could be used both as a novel drug target as well as in the development of vaccines for H pylori prevention and eradication, because it can be found in all H pylori strains."
  },
  {
    "text": "Fumarate reductase FRD is an enzyme in the body . It is important for fumarate respiration .",
    "triple_list": [
      [
        "FRD",
        "CPR:9",
        "fumarate"
      ],
      [
        "Fumarate reductase",
        "CPR:9",
        "fumarate"
      ]
    ],
    "updated": "Yes",
    "original": "Fumarate reductase FRD is the key enzyme in fumarate respiration induced by anaerobic growth of bacteria",
    "simplified": "Fumarate reductase FRD is an enzyme in the body. It is important for fumarate respiration."
  },
  {
    "text": "The frdA gene coding for subunit A of FRD and two control genes copA and copP associated with the export of copper out of H pylori were inactivated by insertion of the chloramphenicol acetyltransferase cassette into these individual genes",
    "triple_list": [
      [
        "copA",
        "CPR:9",
        "copper"
      ],
      [
        "copP",
        "CPR:9",
        "copper"
      ]
    ],
    "updated": "No",
    "original": "The frdA gene coding for subunit A of FRD and two control genes copA and copP associated with the export of copper out of H pylori were inactivated by insertion of the chloramphenicol acetyltransferase cassette into these individual genes",
    "simplified": "The frdA gene coding for subunit A of FRD and two control genes were inactivated. The chloramphenicol acetyltransferase cassette was put into these individual genes so that they did not work anymore."
  },
  {
    "text": "To begin to examine whether these changes are mediated by alterations in gene expression for tryptophan hydroxylase TPH the ratelimiting enzyme in 5HT biosynthesis we quantitated its mRNA levels by competitive reverse transcriptionpolymerase chain reaction RTPCR",
    "triple_list": [
      [
        "tryptophan hydroxylase",
        "CPR:9",
        "5HT"
      ],
      [
        "TPH",
        "CPR:9",
        "5HT"
      ]
    ],
    "updated": "No",
    "original": "To begin to examine whether these changes are mediated by alterations in gene expression for tryptophan hydroxylase TPH the ratelimiting enzyme in 5HT biosynthesis we quantitated its mRNA levels by competitive reverse transcriptionpolymerase chain reaction RTPCR",
    "simplified": "To begin to examine whether these changes are mediated by alterations in gene expression for tryptophan hydroxylase TPH we quantitated its mRNA levels by competitive reverse transcription (RTPCR) and found that the levels were similar."
  },
  {
    "text": "In contrast there was little change in mRNA levels for GTP cyclohydrolase I GTPCH the rate limiting enzyme in synthesis of the tetrahydrobiopterin BH4 the obligate cofactor for TPH",
    "triple_list": [
      [
        "GTP cyclohydrolase I",
        "CPR:9",
        "tetrahydrobiopterin"
      ],
      [
        "GTPCH",
        "CPR:9",
        "tetrahydrobiopterin"
      ],
      [
        "GTP cyclohydrolase I",
        "CPR:9",
        "BH4"
      ],
      [
        "GTPCH",
        "CPR:9",
        "BH4"
      ]
    ],
    "updated": "No",
    "original": "In contrast there was little change in mRNA levels for GTP cyclohydrolase I GTPCH the rate limiting enzyme in synthesis of the tetrahydrobiopterin BH4 the obligate cofactor for TPH",
    "simplified": "In contrast there was little change in mRNA levels for GTP cyclohydrolase I/O. This enzyme is important because it helps the body make tetrahydrobiopterin (TPH)."
  },
  {
    "text": "In relation to zinc bioavailability \u03b1CPPs \u03b2CPPs \u03b1s1CN 64744P and \u03b2CN 1254P increased zinc uptake",
    "triple_list": [
      [
        "zinc",
        "CPR:9",
        "\u03b1CPPs"
      ],
      [
        "zinc",
        "CPR:9",
        "\u03b2CPPs"
      ],
      [
        "zinc",
        "CPR:9",
        "\u03b1s1CN"
      ],
      [
        "zinc",
        "CPR:9",
        "\u03b2CN"
      ]
    ],
    "updated": "No",
    "original": "In relation to zinc bioavailability \u03b1CPPs \u03b2CPPs \u03b1s1CN 64744P and \u03b2CN 1254P increased zinc uptake",
    "simplified": "When they are exposed to zinc, they increase the amount of zinc they can take in."
  },
  {
    "text": "In contrast to parenteral delivery of rBChE which currently requires posttranslational modification for good plasma stability an unmodified aerrBChE pretreatment given 140h prior to 1 LD50 of aer paraoxon Px was able to stop cholinesterase from working properly .",
    "triple_list": [
      [
        "paraoxon",
        "CPR:3",
        "cholinesterase"
      ]
    ],
    "updated": "Yes",
    "original": "In contrast to parenteral delivery of rBChE which currently requires posttranslational modification for good plasma stability an unmodified aerrBChE pretreatment given 140h prior to 1 LD50 of aer paraoxon Px was able to prevent inhibition of circulating cholinesterase in a dosedependent manner",
    "simplified": "In contrast to parenteral delivery of rBChE which currently requires posttranslational modification for good plasma stability an unmodified aerrBChE pretreatment given 140h prior to 1 LD50 of aer paraoxon Px was able to stop cholinesterase from working properly."
  },
  {
    "text": "Next to Glut4 the most important protein involved in glucose metabolism is PPAR\u03b1 . Its expression is also affected by \u03b3 .",
    "triple_list": [
      [
        "Glut4",
        "CPR:9",
        "glucose"
      ]
    ],
    "updated": "Yes",
    "original": "Next to Glut4 the predominant protein influencing glucose metabolism is PPAR\u03b1 and \u03b3 whose expressions were also positively modulated",
    "simplified": "Next to Glut4 the most important protein involved in glucose metabolism is PPAR\u03b1. Its expression is also affected by \u03b3."
  },
  {
    "text": "The 5 alphareductase inhibitor finasteride is an example of such drug .",
    "triple_list": [
      [
        "5 alphareductase",
        "CPR:4",
        "finasteride"
      ]
    ],
    "updated": "Yes",
    "original": "Both the 5 alphareductase inhibitor finasteride and alpha 1adrenoceptor antagonists eg",
    "simplified": "The 5 alphareductase inhibitor finasteride is an example of such drug."
  },
  {
    "text": "Central 5HT3 receptor stimulation by mCPBG increases blood glucose in rats",
    "triple_list": [
      [
        "5HT3",
        "CPR:3",
        "mCPBG"
      ]
    ],
    "updated": "No",
    "original": "Central 5HT3 receptor stimulation by mCPBG increases blood glucose in rats",
    "simplified": "Central 5HT3 receptor stimulation increases blood sugar levels in animals"
  },
  {
    "text": "Injections of mCPBG a selective 5HT3 receptor agonist induced a significant increase in blood glucose in nonstressed rats in both fasted and in fed states",
    "triple_list": [
      [
        "mCPBG",
        "CPR:5",
        "5HT3"
      ]
    ],
    "updated": "No",
    "original": "Injections of mCPBG a selective 5HT3 receptor agonist induced a significant increase in blood glucose in nonstressed rats in both fasted and in fed states",
    "simplified": "Injections of a selective 5HT3 receptor agonist increased blood glucose in both fasted and fed rats in both nonstressed and stressed states."
  },
  {
    "text": "The hyperglycemic effect of mCPBG central administration was blocked by pretreatment with ondansetron ( a 5HT3 receptor antagonist ) . This means that the effects of mCPBG may be due to its interaction with other 5HT3 receptors .",
    "triple_list": [
      [
        "mCPBG",
        "CPR:5",
        "5HT3"
      ]
    ],
    "updated": "Yes",
    "original": "The hyperglycemic effect of mCPBG central administration was blocked by pretreatment with ondansetron a specific 5HT3 receptor antagonist indicating that the effects here obtained with mCPBG were a result of its interaction with 5HT3 receptors",
    "simplified": "The hyperglycemic effect of mCPBG central administration was blocked by pretreatment with ondansetron (a 5HT3 receptor antagonist). This means that the effects of mCPBG may be due to its interaction with other 5HT3 receptors."
  },
  {
    "text": "The bisindole alkaloid 3RShydroxyvoacamine was found to inhibit acetylcholinesterase . This alkaloid was found from a stem extract of a plant called Tabernaemontana divaricata in a study done in Thailand .",
    "triple_list": [
      [
        "acetylcholinesterase",
        "CPR:4",
        "bisindole alkaloid"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "3RShydroxyvoacamine"
      ]
    ],
    "updated": "Yes",
    "original": "Guided by the acetylcholinesterase inhibiting activity the bisindole alkaloid 3RShydroxyvoacamine was isolated from a stem extract of Tabernaemontana divaricata a plant used in Thailand in traditional rejuvenation remedies for improving the memory",
    "simplified": "The bisindole alkaloid 3RShydroxyvoacamine was found to inhibit acetylcholinesterase. This alkaloid was found from a stem extract of a plant called Tabernaemontana divaricata in a study done in Thailand."
  },
  {
    "text": "3RSHydroxyvoacamine a potent acetylcholinesterase inhibitor from Tabernaemontana divaricata",
    "triple_list": [
      [
        "3RSHydroxyvoacamine",
        "CPR:4",
        "acetylcholinesterase"
      ]
    ],
    "updated": "No",
    "original": "3RSHydroxyvoacamine a potent acetylcholinesterase inhibitor from Tabernaemontana divaricata",
    "simplified": "3RSHydroxyvoacamine, a potent anti-bacterial drug in the human body"
  },
  {
    "text": "\u03b1Amino\u03b1\u00b4Halomethylketones Synthetic Methodologies and Pharmaceutical Applications as Serine and Cysteine Protease Inhibitors",
    "triple_list": [
      [
        "\u03b1Amino\u03b1\u00b4Halomethylketones",
        "CPR:4",
        "Serine and Cysteine Protease"
      ]
    ],
    "updated": "No",
    "original": "\u03b1Amino\u03b1\u00b4Halomethylketones Synthetic Methodologies and Pharmaceutical Applications as Serine and Cysteine Protease Inhibitors",
    "simplified": "Amino\u03b1\u00b4Halomethylketones as Serine and Cysteine Protease Inhibitors: Synthetic Methodologies and Pharmaceutical Applications"
  },
  {
    "text": "Introduction 5Lipoxygenase 5LO is an enzyme in the body that breaks down arachidonic acid to form leukotrienes . The leukotrienes are then turned into leukocytes .",
    "triple_list": [
      [
        "5LO",
        "CPR:9",
        "arachidonic acid"
      ],
      [
        "5Lipoxygenase",
        "CPR:9",
        "arachidonic acid"
      ]
    ],
    "updated": "Yes",
    "original": "Introduction 5Lipoxygenase 5LO is a crucial enzyme of the arachidonic acid AA cascade and catalyzes the formation of bioactive leukotrienes LTs with the help of FLAP the 5LOactivating protein",
    "simplified": "Introduction 5Lipoxygenase 5LO is an enzyme in the body that breaks down arachidonic acid to form leukotrienes. The leukotrienes are then turned into leukocytes."
  },
  {
    "text": "We found that the transport activities of the short OATP2B1 variant towards substrates estrone sulfate and rosuvastatin are similar to the full length variant using a transient heterologous cell expression system .",
    "triple_list": [
      [
        "short OATP2B1",
        "CPR:9",
        "estrone sulfate"
      ],
      [
        "short OATP2B1",
        "CPR:9",
        "rosuvastatin"
      ]
    ],
    "updated": "Yes",
    "original": "Using a transient heterologous cell expression system we find that the transport activities of the short OATP2B1 variant towards substrates estrone sulfate and rosuvastatin are similar to the wellcharacterized full length variant",
    "simplified": "We found that the transport activities of the short OATP2B1 variant towards substrates estrone sulfate and rosuvastatin are similar to the full length variant using a transient heterologous cell expression system."
  },
  {
    "text": "Blockade of NMDA receptor s by memantine could theoretically confer diseasemodifying activity in AD by inhibiting the weak NMDA receptor dependent excitotoxicity . This would mean that AD could be treated with a combination of drugs .",
    "triple_list": [
      [
        "NMDA receptor",
        "CPR:4",
        "memantine"
      ]
    ],
    "updated": "Yes",
    "original": "Blockade of NMDA receptor s by memantine could theoretically confer diseasemodifying activity in AD by inhibiting the weak NMDA receptor dependent excitotoxicity that has been hypothesized to play a role in the progressive neuronal loss that underlies the evolving dementia",
    "simplified": "Blockade of NMDA receptor s by memantine could theoretically confer diseasemodifying activity in AD by inhibiting the weak NMDA receptor dependent excitotoxicity. This would mean that AD could be treated with a combination of drugs."
  },
  {
    "text": "Moreover recent in vitro studies suggest that memantine abrogates betaamyloid Abeta toxicity and possibly inhibits Abeta production",
    "triple_list": [
      [
        "memantine",
        "CPR:4",
        "betaamyloid"
      ],
      [
        "memantine",
        "CPR:4",
        "Abeta"
      ],
      [
        "memantine",
        "CPR:4",
        "Abeta"
      ]
    ],
    "updated": "No",
    "original": "Moreover recent in vitro studies suggest that memantine abrogates betaamyloid Abeta toxicity and possibly inhibits Abeta production",
    "simplified": "In in vitro studies, memantine has been shown to reduce betaamyloid toxicity. It may also reduce abeta production."
  },
  {
    "text": "Memantine is a chemical that blocks the NMDA receptor .",
    "triple_list": [
      [
        "Memantine",
        "CPR:6",
        "NMDA receptor"
      ]
    ],
    "updated": "Yes",
    "original": "Memantine is an uncompetitive channel blocking NMDA receptor antagonist",
    "simplified": "Memantine is a chemical that blocks the NMDA receptor."
  },
  {
    "text": "Like other NMDA receptor antagonists memantine at high concentrations can inhibit mechanisms of synaptic plasticity that are believed to underlie learning and memory",
    "triple_list": [
      [
        "NMDA receptor",
        "CPR:6",
        "memantine"
      ]
    ],
    "updated": "No",
    "original": "Like other NMDA receptor antagonists memantine at high concentrations can inhibit mechanisms of synaptic plasticity that are believed to underlie learning and memory",
    "simplified": "Memantine is an NMDA receptor antagonist. When it is taken at high levels, it can interfere with the plasticity of nerve cells."
  },
  {
    "text": "Many studies have been done to find out why memantine works better than other NMDA receptor antagonists . These drugs are like dissociative anestheticlike agents like ketamine , but memantine works different on the NMDA receptor .",
    "triple_list": [
      [
        "memantine",
        "CPR:6",
        "NMDA receptor"
      ]
    ],
    "updated": "Yes",
    "original": "Considerable attention has focused on the investigation of theories to explain the better tolerability of memantine over other NMDA receptor antagonists particularly those that act by a similar channel blocking mechanism such as dissociative anestheticlike agents phencyclidine ketamine MK801",
    "simplified": "Many studies have been done to find out why memantine works better than other NMDA receptor antagonists. These drugs are like dissociative anestheticlike agents like ketamine, but memantine works different on the NMDA receptor."
  },
  {
    "text": "In general , rifampicin acts on the nuclear pregnane X receptor . This causes cytochromes P450 glucuronosyltransferases and pglycoprotein activities to work .",
    "triple_list": [
      [
        "rifampicin",
        "CPR:3",
        "nuclear pregnane X receptor"
      ],
      [
        "rifampicin",
        "CPR:5",
        "nuclear pregnane X receptor"
      ]
    ],
    "updated": "Yes",
    "original": "In general rifampicin can act on a pattern rifampicin activates the nuclear pregnane X receptor that in turn affects cytochromes P450 glucuronosyltransferases and pglycoprotein activities",
    "simplified": "In general, rifampicin acts on the nuclear pregnane X receptor. This causes cytochromes P450 glucuronosyltransferases and pglycoprotein activities to work."
  },
  {
    "text": "The effects of rifampicin on other drugs , when taken together , can cause their metabolism to change . These changes can be changed by cytochromes P450 or by pglycoprotein in the gastrointestinal tract and liver .",
    "triple_list": [
      [
        "rifampicin",
        "CPR:9",
        "pglycoprotein"
      ],
      [
        "rifampicin",
        "CPR:9",
        "cytochromes P450"
      ]
    ],
    "updated": "Yes",
    "original": "The concomitantly administered effects of rifampicin on other drugs can result in their altered metabolism or transportation that are metabolised by cytochromes P450 or transported by pglycoprotein in the gastrointestinal tract and liver",
    "simplified": "The effects of rifampicin on other drugs, when taken together, can cause their metabolism to change. These changes can be changed by cytochromes P450 or by pglycoprotein in the gastrointestinal tract and liver."
  },
  {
    "text": "We describe here the isolation and biochemical characterization of the marine natural sesquiterpene palinurin as a GSK3\u03b2 inhibitor",
    "triple_list": [
      [
        "sesquiterpene",
        "CPR:4",
        "GSK3\u03b2"
      ],
      [
        "palinurin",
        "CPR:4",
        "GSK3\u03b2"
      ]
    ],
    "updated": "No",
    "original": "We describe here the isolation and biochemical characterization of the marine natural sesquiterpene palinurin as a GSK3\u03b2 inhibitor",
    "simplified": "We describe here the isolation and biochemical characterization of palinurin as a natural marine sesquiterpene inhibitor."
  },
  {
    "text": "Experimental studies have shown that GSK3\u03b2 can not be inhibited by palinurin . The study also shows that the inhibitory mechanism is not ATP-dependent .",
    "triple_list": [
      [
        "GSK3\u03b2",
        "CPR:4",
        "palinurin"
      ]
    ],
    "updated": "Yes",
    "original": "Experimental studies performed for characterizing the inhibitory mechanism indicate that GSK3\u03b2 inhibition by palinurin cannot be competed out by ATP nor peptide substrate",
    "simplified": "Experimental studies have shown that GSK3\u03b2 can not be inhibited by palinurin. The study also shows that the inhibitory mechanism is not ATP-dependent."
  },
  {
    "text": "Molecular dynamics simulations have shown that palinurin can bind to GSK3\u03b2 . This causes GSK3\u03b2 to not work as well .",
    "triple_list": [
      [
        "palinurin",
        "CPR:4",
        "GSK3\u03b2"
      ]
    ],
    "updated": "Yes",
    "original": "Moreover molecular dynamics simulations have identified an allosteric mechanism by which binding of palinurin leads to GSK3\u03b2 inhibition",
    "simplified": "Molecular dynamics simulations have shown that palinurin can bind to GSK3\u03b2. This causes GSK3\u03b2 to not work as well."
  },
  {
    "text": "Plateletinduced COX2 dependent PGE2 synthesis in HT29 cells was involved in downregulation of p21 WAF1 CIP1 and upregulation of cyclinB1 since these effects were prevented by rofecoxib a selective COX2 inhibitor and rescued by exogenous PGE2",
    "triple_list": [
      [
        "p21",
        "CPR:3",
        "rofecoxib"
      ],
      [
        "WAF1",
        "CPR:3",
        "rofecoxib"
      ],
      [
        "CIP1",
        "CPR:3",
        "rofecoxib"
      ],
      [
        "cyclinB1",
        "CPR:4",
        "rofecoxib"
      ],
      [
        "COX2",
        "CPR:4",
        "rofecoxib"
      ],
      [
        "COX2",
        "CPR:9",
        "PGE2"
      ]
    ],
    "updated": "No",
    "original": "Plateletinduced COX2 dependent PGE2 synthesis in HT29 cells was involved in downregulation of p21 WAF1 CIP1 and upregulation of cyclinB1 since these effects were prevented by rofecoxib a selective COX2 inhibitor and rescued by exogenous PGE2",
    "simplified": "Platelet-induced COX2 dependent PGE2 synthesis in HT29 cells was involved in downregulation of p21 WAF1 CIP1 and upregulation of cyclinB1 but these effects were abolished when exogenous PGE2 was added."
  },
  {
    "text": "CyclooxygenaseCOX2 derived prostanoids can influence several processes that are linked to carcinogenesis",
    "triple_list": [
      [
        "CyclooxygenaseCOX2",
        "CPR:9",
        "prostanoids"
      ]
    ],
    "updated": "No",
    "original": "CyclooxygenaseCOX2 derived prostanoids can influence several processes that are linked to carcinogenesis",
    "simplified": "CyclooxygenaseCOX2 can influence several processes in the body. Some of these processes are:"
  },
  {
    "text": "The antihyperthermic effect of Lu AF21934 5 mgkg in the SIH test was inhibited by the benzodiazepine receptor antagonist flumazenil 10 mgkg and was not serotonindependent as it persisted in serotonindeficient mice and upon blockade of either 5HT1A receptors by WAY100635 or 5HT2A2C receptors by ritanserin",
    "triple_list": [
      [
        "5HT1A",
        "CPR:4",
        "WAY100635"
      ],
      [
        "5HT2A2C",
        "CPR:4",
        "ritanserin"
      ],
      [
        "benzodiazepine receptor",
        "CPR:6",
        "flumazenil"
      ]
    ],
    "updated": "No",
    "original": "The antihyperthermic effect of Lu AF21934 5 mgkg in the SIH test was inhibited by the benzodiazepine receptor antagonist flumazenil 10 mgkg and was not serotonindependent as it persisted in serotonindeficient mice and upon blockade of either 5HT1A receptors by WAY100635 or 5HT2A2C receptors by ritanserin",
    "simplified": "The antihyperthermic effect of Lu AF21934 5 mgkg in the SIH test was inhibited by the benzodiazepine receptor antagonist flumazenil 10 mgkg and in serotonindeficient mice it was not serotonindependent as it persisted in serotonindeficient mice."
  },
  {
    "text": "The Group III mGlu receptor selective orthosteric agonist LSP12111 produced anxiolytic but not antidepressant-like effects when it was given to the test subjects .",
    "triple_list": [
      [
        "Group III mGlu receptor",
        "CPR:5",
        "LSP12111"
      ]
    ],
    "updated": "Yes",
    "original": "Previous studies demonstrated that the Group III mGlu receptor selective orthosteric agonist LSP12111 produced anxiolytic but not antidepressantlike effects upon peripheral administration",
    "simplified": "The Group III mGlu receptor selective orthosteric agonist LSP12111 produced anxiolytic but not antidepressant-like effects when it was given to the test subjects."
  },
  {
    "text": "Catalyticsite affinities for cGMP vardenafil sildenafil tadalafil or 3isobutyl1methylxanthine IBMX were respectively weakened 14 123 30 51 and 43fold for Y612A 63 511 43 95 and 61fold for Q817A and 59 448 71 137 and 93fold for F820A",
    "triple_list": [
      [
        "tadalafil",
        "CPR:9",
        "Q817A"
      ]
    ],
    "updated": "No",
    "original": "Catalyticsite affinities for cGMP vardenafil sildenafil tadalafil or 3isobutyl1methylxanthine IBMX were respectively weakened 14 123 30 51 and 43fold for Y612A 63 511 43 95 and 61fold for Q817A and 59 448 71 137 and 93fold for F820A",
    "simplified": "Catalyticsite affinities for 3isobutyl1methylxanthine IBMX were respectively weakened 14 123 30 51 and 43fold for Y612A 63 511 43 95 and 61fold for Q817A and 59 448 71 137 and 93fold for F820A."
  },
  {
    "text": "Allicin treatment showed that proinflammatory cytokines and NO were reduced and HO1 was increased .",
    "triple_list": [
      [
        "Allicin",
        "CPR:3",
        "HO1"
      ],
      [
        "Allicin",
        "CPR:4",
        "cytokines"
      ]
    ],
    "updated": "Yes",
    "original": "Allicin treatment showed reduced production of proinflammatory cytokines and NO and increased HO1 activity",
    "simplified": "Allicin treatment showed that proinflammatory cytokines and NO were reduced and HO1 was increased."
  },
  {
    "text": "Recently it has been shown that the activation of particular T2R bitter taste receptors is partially involved with the bitter aftertaste sensation of saccharin and acesulfameK The question of whether AS could stimulate transient receptor potential vanilloid1 TRPV1 receptors has been addressed , as these receptors are activated by a large range of structurally different chemicals .",
    "triple_list": [
      [
        "T2R",
        "CPR:3",
        "saccharin"
      ],
      [
        "T2R",
        "CPR:3",
        "acesulfameK"
      ]
    ],
    "updated": "Yes",
    "original": "Recently it has been shown that the activation of particular T2R bitter taste receptors is partially involved with the bitter aftertaste sensation of saccharin and acesulfameK To more fully understand the biology behind these phenomena we have addressed the question of whether AS could stimulate transient receptor potential vanilloid1 TRPV1 receptors as these receptors are activated by a large range of structurally different chemicals",
    "simplified": "Recently it has been shown that the activation of particular T2R bitter taste receptors is partially involved with the bitter aftertaste sensation of saccharin and acesulfameK The question of whether AS could stimulate transient receptor potential vanilloid1 TRPV1 receptors has been addressed, as these receptors are activated by a large range of structurally different chemicals."
  },
  {
    "text": "We also found that the TRPV1 receptors are activated by ZnSO4 , FeSO4 and CuSO4 , which are three known metallic salts .",
    "triple_list": [
      [
        "TRPV1",
        "CPR:3",
        "CuSO4"
      ],
      [
        "TRPV1",
        "CPR:3",
        "ZnSO4"
      ],
      [
        "TRPV1",
        "CPR:3",
        "FeSO4"
      ]
    ],
    "updated": "Yes",
    "original": "We also found that TRPV1 receptors are activated by CuSO4 ZnSO4 and FeSO4 three salts known to produce a metallic taste sensation",
    "simplified": "We also found that the TRPV1 receptors are activated by ZnSO4, FeSO4 and CuSO4, which are three known metallic salts."
  },
  {
    "text": "RKetoprofen 1 was previously reported to be a potent and specific noncompetitive inhibitor of CXCL8 induced human PMNs chemotaxis",
    "triple_list": [
      [
        "RKetoprofen",
        "CPR:4",
        "CXCL8"
      ]
    ],
    "updated": "No",
    "original": "RKetoprofen 1 was previously reported to be a potent and specific noncompetitive inhibitor of CXCL8 induced human PMNs chemotaxis",
    "simplified": "RKetoprofen 1 has been reported to be a potent and specific inhibitor of the chemotaxis of human PMNs."
  },
  {
    "text": "2Arylpropionic CXC chemokine receptor 1 ( CXCR1 ) and CXCL8 ( CXCL9 ) as inhibitors",
    "triple_list": [
      [
        "2Arylpropionic",
        "CPR:4",
        "CXCL8"
      ]
    ],
    "updated": "Yes",
    "original": "2Arylpropionic CXC chemokine receptor 1 CXCR1 ligands as novel noncompetitive CXCL8 inhibitors",
    "simplified": "2Arylpropionic CXC chemokine receptor 1 (CXCR1) and CXCL8 (CXCL9) as inhibitors"
  },
  {
    "text": "In isolated rat liver mitochondria , the inhibitory effect of phenformin on complex I respiration was greater than that in heart mitochondria . In insideout structured submitochondrial particles prepared from rat livers and hearts , the inhibitory effect was similar .",
    "triple_list": [
      [
        "phenformin",
        "CPR:4",
        "complex I"
      ],
      [
        "phenformin",
        "CPR:4",
        "complex I"
      ]
    ],
    "updated": "Yes",
    "original": "Inhibition by phenformin of oxygen consumption via complex I respiration in isolated rat liver mitochondria was greater than that in heart mitochondria whereas inhibitory effect of phenformin on complex I respiration was similar in insideout structured submitochondrial particles prepared from rat livers and hearts",
    "simplified": "In isolated rat liver mitochondria, the inhibitory effect of phenformin on complex I respiration was greater than that in heart mitochondria. In insideout structured submitochondrial particles prepared from rat livers and hearts, the inhibitory effect was similar."
  },
  {
    "text": "Role of organic cationcarnitine transporter 1 in uptake of phenformin and inhibitory effect on complex I respiration in mitochondria",
    "triple_list": [
      [
        "phenformin",
        "CPR:4",
        "complex I"
      ],
      [
        "organic cationcarnitine transporter 1",
        "CPR:9",
        "phenformin"
      ]
    ],
    "updated": "No",
    "original": "Role of organic cationcarnitine transporter 1 in uptake of phenformin and inhibitory effect on complex I respiration in mitochondria",
    "simplified": "Organic cationcarnitine transporter 1 plays an important role in complex I respiration in the mitochondria."
  },
  {
    "text": "Phenformin causes lactic acidosis in clinical situations due to inhibition of mitochondrial respiratory chain complex I",
    "triple_list": [
      [
        "Phenformin",
        "CPR:4",
        "mitochondrial respiratory chain complex I"
      ]
    ],
    "updated": "No",
    "original": "Phenformin causes lactic acidosis in clinical situations due to inhibition of mitochondrial respiratory chain complex I",
    "simplified": "Phenformin causes lactic acidosis in people. This is because it stops a part of the mitochondria."
  },
  {
    "text": "These observations suggest that the uptake of phenformin into liver mitochondria is at least partly mediated by OCTN1 , and that complex I respiration may be inhibited by it .",
    "triple_list": [
      [
        "phenformin",
        "CPR:4",
        "complex I"
      ],
      [
        "phenformin",
        "CPR:9",
        "OCTN1"
      ]
    ],
    "updated": "Yes",
    "original": "These observations suggest that uptake of phenformin into liver mitochondria is at least partly mediated by OCTN1 and functionally relevant to its inhibition potential of complex I respiration",
    "simplified": "These observations suggest that the uptake of phenformin into liver mitochondria is at least partly mediated by OCTN1, and that complex I respiration may be inhibited by it."
  },
  {
    "text": "In this study uptake of phenformin and 14Ctetraethylammonium TEA and complex I inhibition by phenformin were examined in isolated liver and heart mitochondria",
    "triple_list": [
      [
        "phenformin",
        "CPR:4",
        "complex I"
      ]
    ],
    "updated": "No",
    "original": "In this study uptake of phenformin and 14Ctetraethylammonium TEA and complex I inhibition by phenformin were examined in isolated liver and heart mitochondria",
    "simplified": "In this study, the uptake of phenformin and 14Ctetraethylammonium TEA in the liver and heart mitochondria was examined in isolated cells."
  },
  {
    "text": "A series of xanthine derivatives in which a methylene was inserted at position 8 of xanthine scaffold was synthesized and evaluated as inhibitors of dipeptidyl peptidase 4 DPP4 for the treatment of type 2 diabetes",
    "triple_list": [
      [
        "xanthine",
        "CPR:4",
        "dipeptidyl peptidase 4"
      ],
      [
        "xanthine",
        "CPR:4",
        "DPP4"
      ],
      [
        "xanthine",
        "CPR:4",
        "dipeptidyl peptidase 4"
      ],
      [
        "xanthine",
        "CPR:4",
        "DPP4"
      ]
    ],
    "updated": "No",
    "original": "A series of xanthine derivatives in which a methylene was inserted at position 8 of xanthine scaffold was synthesized and evaluated as inhibitors of dipeptidyl peptidase 4 DPP4 for the treatment of type 2 diabetes",
    "simplified": "A series of xanthine derivatives in which a methylene was inserted at position 8 of the xanthine scaffold has been shown to be effective in type 2 diabetes mellitus and other conditions."
  },
  {
    "text": "In an earlier report DRD2 E8 AA genotype was associated with reduced responsiveness to the dopamine D2 agonist apomorphine but it is not clear if this is the same as the original finding .",
    "triple_list": [
      [
        "dopamine D2",
        "CPR:5",
        "apomorphine"
      ]
    ],
    "updated": "Yes",
    "original": "In an earlier report DRD2 E8 AA genotype was associated with reduced responsiveness to the dopamine D2 agonist apomorphine however it is not clear whether both findings share the same biological basis",
    "simplified": "In an earlier report DRD2 E8 AA genotype was associated with reduced responsiveness to the dopamine D2 agonist apomorphine but it is not clear if this is the same as the original finding."
  },
  {
    "text": "Functional and biochemical studies indicated that TES signaling involved activity of the phosphoinositide 3 PI3 kinaseprotein kinase B Akt cascade . The androgen receptor is activated by this and this leads to increased production of cGMP .",
    "triple_list": [
      [
        "TES",
        "CPR:3",
        "androgen receptor"
      ]
    ],
    "updated": "Yes",
    "original": "Functional and biochemical studies indicated that TES signaling involved activity of the phosphoinositide 3 PI3 kinaseprotein kinase B Akt cascade initiated by activation of the androgen receptor and culminated in enhanced production of cGMP and microvascular vasodilation",
    "simplified": "Functional and biochemical studies indicated that TES signaling involved activity of the phosphoinositide 3 PI3 kinaseprotein kinase B Akt cascade. The androgen receptor is activated by this and this leads to increased production of cGMP."
  },
  {
    "text": "These findings come from a variety of analytical and functional approaches . They provide evidence for a novel nongenomic signaling mechanism for androgen action in the microvasculature by which xanthine oxidase generated superoxide and NO are converted to peroxynitrite .",
    "triple_list": [
      [
        "peroxynitrite",
        "CPR:9",
        "xanthine oxidase"
      ],
      [
        "xanthine oxidase",
        "CPR:9",
        "superoxide"
      ],
      [
        "xanthine oxidase",
        "CPR:9",
        "NO"
      ]
    ],
    "updated": "Yes",
    "original": "These findings derived from a variety of analytical and functional approaches provide evidence for a novel nongenomic signaling mechanism for androgen action in the microvasculature TESstimulated vasodilation mediated primarily by peroxynitrite formed from xanthine oxidase generated superoxide and NO",
    "simplified": "These findings come from a variety of analytical and functional approaches. They provide evidence for a novel nongenomic signaling mechanism for androgen action in the microvasculature by which xanthine oxidase generated superoxide and NO are converted to peroxynitrite."
  },
  {
    "text": "As predicted TES enhanced the production of both peroxynitrite precursors ie superoxide and nitic oxide and xanthine oxidase was identified as the likely source of TESstimulated superoxide production",
    "triple_list": [
      [
        "TES",
        "CPR:9",
        "xanthine oxidase"
      ],
      [
        "superoxide",
        "CPR:9",
        "xanthine oxidase"
      ]
    ],
    "updated": "No",
    "original": "As predicted TES enhanced the production of both peroxynitrite precursors ie superoxide and nitic oxide and xanthine oxidase was identified as the likely source of TESstimulated superoxide production",
    "simplified": "As expected, TES increased the production of peroxynitrite precursors. Xanthine oxidase was identified as the likely source of TESstimulated superoxide and nitic oxide."
  },
  {
    "text": "DSerine was previously identified in mammalian brain and was shown to be a coagonist at the glycine site of the NmethylDaspartate NMDAtype receptors",
    "triple_list": [
      [
        "DSerine",
        "CPR:5",
        "NmethylDaspartate NMDAtype receptors"
      ]
    ],
    "updated": "No",
    "original": "DSerine was previously identified in mammalian brain and was shown to be a coagonist at the glycine site of the NmethylDaspartate NMDAtype receptors",
    "simplified": "DSerine has been found in the brain of some animals. It is found at the glycine site of the NMDA receptor in the brain."
  },
  {
    "text": "Mouse brain serine racemase catalyzes specific elimination of Lserine to pyruvate",
    "triple_list": [
      [
        "Mouse brain serine racemase",
        "CPR:9",
        "Lserine"
      ],
      [
        "Mouse brain serine racemase",
        "CPR:9",
        "pyruvate"
      ]
    ],
    "updated": "No",
    "original": "Mouse brain serine racemase catalyzes specific elimination of Lserine to pyruvate",
    "simplified": "Mouse brain serine racemase changes serine to pyruvate in the brain."
  },
  {
    "text": "Racemization of serine is catalyzed by serine racemase a pyridoxal 5phosphatedependent enzyme expressed mainly in brain and liver",
    "triple_list": [
      [
        "serine",
        "CPR:9",
        "serine racemase"
      ]
    ],
    "updated": "No",
    "original": "Racemization of serine is catalyzed by serine racemase a pyridoxal 5phosphatedependent enzyme expressed mainly in brain and liver",
    "simplified": "Serine racemase is a pyridoxal 5phosphatedependent enzyme. It is found mainly in the brain and liver."
  },
  {
    "text": "Pharmacogenetic analysis of two genes confirmed their influence on warfarin maintenance dose . They are the metabolic enzyme CYP2C9 and the vitamin K epoxide reductase complex 1 VKORC1 .",
    "triple_list": [
      [
        "warfarin",
        "CPR:9",
        "CYP2C9"
      ]
    ],
    "updated": "Yes",
    "original": "Pharmacogenetic analysis of two genes the warfarin metabolic enzyme CYP2C9 and warfarin target enzyme vitamin K epoxide reductase complex 1 VKORC1 confirmed their influence on warfarin maintenance dose",
    "simplified": "Pharmacogenetic analysis of two genes confirmed their influence on warfarin maintenance dose. They are the metabolic enzyme CYP2C9 and the vitamin K epoxide reductase complex 1 VKORC1."
  },
  {
    "text": "The presence of CYP2C92 or CYP2C9 3 variant alleles that result in reduced enzyme activity is associated with a lower mean warfarin dose .",
    "triple_list": [
      [
        "CYP2C9",
        "CPR:9",
        "warfarin"
      ],
      [
        "CYP2C9",
        "CPR:9",
        "warfarin"
      ]
    ],
    "updated": "Yes",
    "original": "Possession of CYP2C92 or CYP2C9 3 variant alleles which result in decreased enzyme activity is associated with a significant decrease in the mean warfarin dose",
    "simplified": "The presence of CYP2C92 or CYP2C9 3 variant alleles that result in reduced enzyme activity is associated with a lower mean warfarin dose."
  },
  {
    "text": "In addition , PSE inhibited the transcriptional activity of NFAT without interfering with the calcium-induced dephosphorylation of NFAT , which is the main way NFAT is activated .",
    "triple_list": [
      [
        "NFAT",
        "CPR:3",
        "calcium"
      ],
      [
        "PSE",
        "CPR:4",
        "NFAT"
      ]
    ],
    "updated": "Yes",
    "original": "In addition PSE inhibited the transcriptional activity of NFAT without interfering with the calcium induced NFAT dephosphorylation event which represents the major signaling pathway for its activation",
    "simplified": "In addition, PSE inhibited the transcriptional activity of NFAT without interfering with the calcium-induced dephosphorylation of NFAT, which is the main way NFAT is activated."
  },
  {
    "text": "We found that PSE inhibits interleukin2 IL2 and tumor necrosis factor TNF alpha gene transcription in stimulated Jurkat cells a human Tcell leukemia cell line",
    "triple_list": [
      [
        "PSE",
        "CPR:3",
        "tumor necrosis factor TNF alpha"
      ],
      [
        "PSE",
        "CPR:4",
        "interleukin2"
      ],
      [
        "PSE",
        "CPR:4",
        "IL2"
      ]
    ],
    "updated": "No",
    "original": "We found that PSE inhibits interleukin2 IL2 and tumor necrosis factor TNF alpha gene transcription in stimulated Jurkat cells a human Tcell leukemia cell line",
    "simplified": "We found that PSE inhibits TNF alpha gene transcription in stimulated Jurkat cells a human Tcell leukemia cell line by interleukin2 IL2 and tumor necrosis factor"
  },
  {
    "text": "To further characterize the inhibitory mechanisms of PSE at the transcriptional level we examined the transcriptional activities of nuclear factor kappa B NFkappaB nuclear factor of activated T cells NFAT and activator protein1 AP1 transcription factors and found that PSE inhibited NFkappaB dependent transcription without affecting either the degradation of the cytoplasmic NFkappaB inhibitory protein IkappaBalpha or the DNAbinding activity .",
    "triple_list": [
      [
        "PSE",
        "CPR:4",
        "NFkappaB"
      ]
    ],
    "updated": "Yes",
    "original": "To further characterize the inhibitory mechanisms of PSE at the transcriptional level we examined the transcriptional activities of nuclear factor kappa B NFkappaB nuclear factor of activated T cells NFAT and activator protein1 AP1 transcription factors and found that PSE inhibited NFkappaB dependent transcriptional activity without affecting either the phosphorylation the degradation of the cytoplasmic NFkappaB inhibitory protein IkappaBalpha or the DNAbinding activity",
    "simplified": "To further characterize the inhibitory mechanisms of PSE at the transcriptional level we examined the transcriptional activities of nuclear factor kappa B NFkappaB nuclear factor of activated T cells NFAT and activator protein1 AP1 transcription factors and found that PSE inhibited NFkappaB dependent transcription without affecting either the degradation of the cytoplasmic NFkappaB inhibitory protein IkappaBalpha or the DNAbinding activity."
  },
  {
    "text": "Pseudoephedrine inhibits Tcell activation by targeting NFkappaB NFAT and AP1 signaling pathways",
    "triple_list": [
      [
        "Pseudoephedrine",
        "CPR:4",
        "NFkappaB"
      ],
      [
        "Pseudoephedrine",
        "CPR:4",
        "NFAT"
      ],
      [
        "Pseudoephedrine",
        "CPR:4",
        "AP1"
      ]
    ],
    "updated": "No",
    "original": "Pseudoephedrine inhibits Tcell activation by targeting NFkappaB NFAT and AP1 signaling pathways",
    "simplified": "Pseudoephedrine inhibits the transcription of transcription factors by T cells."
  },
  {
    "text": "However , when PSE was applied , the p65 RelA subunit was clearly inhibited by it .",
    "triple_list": [
      [
        "p65",
        "CPR:4",
        "PSE"
      ],
      [
        "RelA",
        "CPR:4",
        "PSE"
      ]
    ],
    "updated": "Yes",
    "original": "However phosphorylation of the p65 RelA subunit was clearly inhibited by PSE in stimulated cells",
    "simplified": "However, when PSE was applied, the p65 RelA subunit was clearly inhibited by it."
  },
  {
    "text": "NFAT works with cJun , a compound of the AP1 complex , to activate target genes . PSE , on the other hand , stopped both JNK and AP1 from working .",
    "triple_list": [
      [
        "PSE",
        "CPR:4",
        "JNK"
      ],
      [
        "AP1",
        "CPR:4",
        "PSE"
      ]
    ],
    "updated": "Yes",
    "original": "NFAT cooperates with cJun a compound of the AP1 complex to activate target genes and we also found that PSE inhibited both JNK activation and AP1 transcriptional activity",
    "simplified": "NFAT works with cJun, a compound of the AP1 complex, to activate target genes. PSE, on the other hand, stopped both JNK and AP1 from working."
  },
  {
    "text": "In addition , studies have shown that treatment with DEC reduces the amount of COX1 in the peritoneal exudate cells .",
    "triple_list": [
      [
        "DEC",
        "CPR:4",
        "COX1"
      ]
    ],
    "updated": "Yes",
    "original": "Furthermore experiments showed that treatment with DEC results in a reduction in the amount of COX1 protein in peritoneal exudate cells",
    "simplified": "In addition, studies have shown that treatment with DEC reduces the amount of COX1 in the peritoneal exudate cells."
  },
  {
    "text": "Micromolar Ntp dosedependently increased the mean open channel probability in ligandfree solution POmax and attenuated the ATP inhibition of KIR62 SUR1 but had no effect on homomeric KIR62 channels",
    "triple_list": [
      [
        "ATP",
        "CPR:4",
        "KIR62"
      ],
      [
        "ATP",
        "CPR:4",
        "SUR1"
      ]
    ],
    "updated": "No",
    "original": "Micromolar Ntp dosedependently increased the mean open channel probability in ligandfree solution POmax and attenuated the ATP inhibition of KIR62 SUR1 but had no effect on homomeric KIR62 channels",
    "simplified": "Micromolar Ntp increased the mean open channel probability in ligandfree solution POmax but had no effect on homomeric KIR62 channels. It also had no effect on ATP inhibition."
  },
  {
    "text": "These effects are similar to those seen when DeltaN of KIR60 was removed and DeltaNKATP channels were used . This decreased their POmax and apparent IC50 for ATP .",
    "triple_list": [
      [
        "DeltaNKATP channels",
        "CPR:4",
        "ATP"
      ]
    ],
    "updated": "Yes",
    "original": "These effects resemble those seen with Nterminal deletions DeltaN of KIR60 and application of Ntp to DeltaNKATP channels decreased their POmax and apparent IC50 for ATP in the absence of Mg2",
    "simplified": "These effects are similar to those seen when DeltaN of KIR60 was removed and DeltaNKATP channels were used. This decreased their POmax and apparent IC50 for ATP."
  },
  {
    "text": "Monocarboxylate transporters MCTs are protonlinked membrane carriers involved in the transport of monocarboxylates such as lactate pyruvate as well as ketone bodies",
    "triple_list": [
      [
        "Monocarboxylate transporters",
        "CPR:9",
        "monocarboxylates"
      ],
      [
        "MCTs",
        "CPR:9",
        "monocarboxylates"
      ],
      [
        "Monocarboxylate transporters",
        "CPR:9",
        "lactate"
      ],
      [
        "MCTs",
        "CPR:9",
        "lactate"
      ],
      [
        "Monocarboxylate transporters",
        "CPR:9",
        "pyruvate"
      ],
      [
        "MCTs",
        "CPR:9",
        "pyruvate"
      ],
      [
        "Monocarboxylate transporters",
        "CPR:9",
        "ketone"
      ],
      [
        "MCTs",
        "CPR:9",
        "ketone"
      ]
    ],
    "updated": "No",
    "original": "Monocarboxylate transporters MCTs are protonlinked membrane carriers involved in the transport of monocarboxylates such as lactate pyruvate as well as ketone bodies",
    "simplified": "Monocarboxylate transporters Monocarboxylate transporters (MCTs) are proteins that transport monocarboxylates. Monocarboxylates are found in many foods."
  },
  {
    "text": "Part of MCT2 immunoreactivity is found at postsynaptic sites . This means that monocarboxylates and their transporters are important in synaptic transmission .",
    "triple_list": [
      [
        "MCT2",
        "CPR:9",
        "monocarboxylates"
      ]
    ],
    "updated": "Yes",
    "original": "Interestingly part of MCT2 immunoreactivity is located at postsynaptic sites suggesting a particular role of monocarboxylates and their transporters in synaptic transmission",
    "simplified": "Part of MCT2 immunoreactivity is found at postsynaptic sites. This means that monocarboxylates and their transporters are important in synaptic transmission."
  },
  {
    "text": "Differentiating the roles of mGlu2 and mGlu3 receptors using LY541850 an mGlu2 agonist mGlu3 antagonist",
    "triple_list": [
      [
        "mGlu2",
        "CPR:5",
        "LY541850"
      ],
      [
        "mGlu3",
        "CPR:6",
        "LY541850"
      ]
    ],
    "updated": "No",
    "original": "Differentiating the roles of mGlu2 and mGlu3 receptors using LY541850 an mGlu2 agonist mGlu3 antagonist",
    "simplified": "The function of mGlu2 and mGlu3 is not yet known, but it is thought to be important."
  },
  {
    "text": "These results confirm the selective mGlu2 agonist and mGlu3 antagonist actions of LY541850",
    "triple_list": [
      [
        "mGlu2",
        "CPR:5",
        "LY541850"
      ],
      [
        "mGlu3",
        "CPR:6",
        "LY541850"
      ]
    ],
    "updated": "No",
    "original": "These results confirm the selective mGlu2 agonist and mGlu3 antagonist actions of LY541850",
    "simplified": "These results confirmed that mGlu3 is a selective mGlu2 agonist and antagonist."
  },
  {
    "text": "LY541850 was found from human mGlu receptors in non-neuronal cells . It was shown to be an mGlu2 agonist and an mGlu3 antagonist .",
    "triple_list": [
      [
        "LY541850",
        "CPR:5",
        "mGlu2"
      ],
      [
        "LY541850",
        "CPR:6",
        "mGlu3"
      ]
    ],
    "updated": "Yes",
    "original": "LY541850 was claimed from human mGlu receptors expressed in nonneuronal cells to be a selective orthosteric mGlu2 agonist and mGlu3 antagonist",
    "simplified": "LY541850 was found from human mGlu receptors in non-neuronal cells. It was shown to be an mGlu2 agonist and an mGlu3 antagonist."
  },
  {
    "text": "When 36 NH42SO4 was added to it , it reduced CBG concentrations to very low levels .",
    "triple_list": [
      [
        "NH42SO4",
        "CPR:4",
        "CBG"
      ]
    ],
    "updated": "Yes",
    "original": "Selective precipitation of cytosol receptors with 36 NH42SO4 reduced CBG concentrations to negligible levels",
    "simplified": "When 36 NH42SO4 was added to it, it reduced CBG concentrations to very low levels."
  },
  {
    "text": "The activity of the human nasal mucosa microsomes was inhibited by 8methoxypsoralen a known CYP2A inhibitor",
    "triple_list": [
      [
        "8methoxypsoralen",
        "CPR:4",
        "CYP2A"
      ]
    ],
    "updated": "No",
    "original": "The activity of the human nasal mucosa microsomes was inhibited by 8methoxypsoralen a known CYP2A inhibitor",
    "simplified": "The activity of the human nasal mucosa microsomes is also affected by these drugs, for example:"
  },
  {
    "text": "Acetylcholinesterase AChE inhibited by the organophosphate soman 122trimethylpropylmethylphosphonofluoridate rapidly becomes resistant to reactivation by oximes due to dealkylation of the somanenzyme complex",
    "triple_list": [
      [
        "Acetylcholinesterase",
        "CPR:3",
        "oximes"
      ],
      [
        "AChE",
        "CPR:3",
        "oximes"
      ],
      [
        "Acetylcholinesterase",
        "CPR:4",
        "organophosphate"
      ],
      [
        "AChE",
        "CPR:4",
        "organophosphate"
      ],
      [
        "Acetylcholinesterase",
        "CPR:4",
        "soman"
      ],
      [
        "AChE",
        "CPR:4",
        "soman"
      ],
      [
        "Acetylcholinesterase",
        "CPR:4",
        "122trimethylpropylmethylphosphonofluoridate"
      ],
      [
        "AChE",
        "CPR:4",
        "122trimethylpropylmethylphosphonofluoridate"
      ]
    ],
    "updated": "No",
    "original": "Acetylcholinesterase AChE inhibited by the organophosphate soman 122trimethylpropylmethylphosphonofluoridate rapidly becomes resistant to reactivation by oximes due to dealkylation of the somanenzyme complex",
    "simplified": "Acetylcholinesterase AChE is inhibited by the organophosphate soman 122. The somanenzyme complex is dealkylated, which makes it resistant to being oxidized by oximes."
  },
  {
    "text": "The effect of the four mono and bisquaternary ammonium compounds tetramethylammonium TMA hexamethonium decamethonium and suxamethonium on the reactivatability of soman inhibited solubilized AChE from human erythrocytes was investigated in vitro",
    "triple_list": [
      [
        "soman",
        "CPR:4",
        "AChE"
      ]
    ],
    "updated": "No",
    "original": "The effect of the four mono and bisquaternary ammonium compounds tetramethylammonium TMA hexamethonium decamethonium and suxamethonium on the reactivatability of soman inhibited solubilized AChE from human erythrocytes was investigated in vitro",
    "simplified": "The effect of the four mono-ammonium compounds tetramethylammonium, hexamethonium, decamethonium, and suxamethonium on the solubilization process of soman in human erythrocytes was investigated in vitro."
  },
  {
    "text": "Effects of some mono and bisquaternary ammonium compounds on the reactivatability of soman inhibited human acetylcholinesterase in vitro",
    "triple_list": [
      [
        "soman",
        "CPR:4",
        "human acetylcholinesterase"
      ]
    ],
    "updated": "No",
    "original": "Effects of some mono and bisquaternary ammonium compounds on the reactivatability of soman inhibited human acetylcholinesterase in vitro",
    "simplified": "Effects of some mono and bisquaternary ammonium compounds on human acetylcholinesterase activity in vitro The"
  },
  {
    "text": "If the effectors were added after 5 min of aging they increased the activity of soman inhibited AChE but to a considerably smaller extent than HI 6",
    "triple_list": [
      [
        "soman",
        "CPR:4",
        "AChE"
      ]
    ],
    "updated": "No",
    "original": "If the effectors were added after 5 min of aging they increased the activity of soman inhibited AChE but to a considerably smaller extent than HI 6",
    "simplified": "If the effectors were added after 5 min of aging they increased AChE activity but to a much smaller extent than when no effectors were added."
  },
  {
    "text": "In addition ADP was shown to strongly antagonize TOP2 mediated DNA cleavage induced by ATP sensitive but not ATPinsensitive TOP2 poisons",
    "triple_list": [
      [
        "TOP2",
        "CPR:3",
        "ATP"
      ]
    ],
    "updated": "No",
    "original": "In addition ADP was shown to strongly antagonize TOP2 mediated DNA cleavage induced by ATP sensitive but not ATPinsensitive TOP2 poisons",
    "simplified": "ADP has also been shown to interfere with the DNA cleavage caused by ATP sensitive but not ATPinsensitive poisons."
  },
  {
    "text": "Second C427A mutant human TOP2alpha which shows reduced ATPase activity was shown to crossresistance to all poisons that do not need ATP to work .",
    "triple_list": [
      [
        "ATP",
        "CPR:4",
        "ATPase"
      ]
    ],
    "updated": "Yes",
    "original": "Second C427A mutant human TOP2alpha which exhibits reduced ATPase activity was shown to exhibit crossresistance to all ATPsensitive but not ATP insensitive TOP2 poisons",
    "simplified": "Second C427A mutant human TOP2alpha which shows reduced ATPase activity was shown to crossresistance to all poisons that do not need ATP to work."
  },
  {
    "text": "Activation of ALDH2 with ethanol attenuates diabetes induced myocardial injury in rats",
    "triple_list": [
      [
        "ALDH2",
        "CPR:3",
        "ethanol"
      ]
    ],
    "updated": "No",
    "original": "Activation of ALDH2 with ethanol attenuates diabetes induced myocardial injury in rats",
    "simplified": "When ALDH2 is activated, diabetes-like symptoms are lessened in rats."
  },
  {
    "text": "This study assessed changes in myocardial ALDH2 expression in the diabetic rat in particular the diabetic rat pretreated with ALDH2 activator ethanol EtOH",
    "triple_list": [
      [
        "ALDH2",
        "CPR:3",
        "ethanol"
      ],
      [
        "ALDH2",
        "CPR:3",
        "EtOH"
      ]
    ],
    "updated": "No",
    "original": "This study assessed changes in myocardial ALDH2 expression in the diabetic rat in particular the diabetic rat pretreated with ALDH2 activator ethanol EtOH",
    "simplified": "This study looked at changes in the myocardial ALDH2 expression in the diabetic rat. The diabetic rat was pretreated with ethanol for 6 weeks."
  },
  {
    "text": "Compared with EtOH DM8W group MDA was increased SOD and ALDH2 group was decreased",
    "triple_list": [
      [
        "SOD",
        "CPR:3",
        "EtOH"
      ],
      [
        "ALDH2",
        "CPR:3",
        "EtOH"
      ]
    ],
    "updated": "Yes",
    "original": "Compared with DM8W group SOD and ALDH2 in EtOH DM8W group was increased MDA was decreased",
    "simplified": "Compared with EtOH DM8W group MDA was increased SOD and ALDH2 group was decreased"
  },
  {
    "text": "HbA1c level in DM12W group was higher than in DM4W group HbA1c level in EtOH DM8W group was lower than in DM8W group",
    "triple_list": [
      [
        "HbA1c",
        "CPR:4",
        "EtOH"
      ]
    ],
    "updated": "No",
    "original": "HbA1c level in DM12W group was higher than in DM4W group HbA1c level in EtOH DM8W group was lower than in DM8W group",
    "simplified": "The HbA1c level was higher in the DM12W group than the DM4W group, but lower in the DM8W group."
  },
  {
    "text": "Further , we have used steadystate and transientstate kinetics to determine the mechanism and consequences of inhibition of QR2 by the quinolines .",
    "triple_list": [
      [
        "QR2",
        "CPR:4",
        "quinolines"
      ],
      [
        "QR2",
        "CPR:4",
        "quinolines"
      ]
    ],
    "updated": "Yes",
    "original": "To investigate the mechanism and consequences of inhibition of QR2 by the quinolines further we have used steadystate and transientstate kinetics to define the mechanism of QR2",
    "simplified": "Further, we have used steadystate and transientstate kinetics to determine the mechanism and consequences of inhibition of QR2 by the quinolines."
  },
  {
    "text": "Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines",
    "triple_list": [
      [
        "quinone oxidoreductase 2",
        "CPR:4",
        "quinolines"
      ]
    ],
    "updated": "No",
    "original": "Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines",
    "simplified": "Quinone oxidoreductase 2 is an enzyme. It breaks down quinone to make other quinolines."
  },
  {
    "text": "Our studies provide a foundation for future studies to determine the possible in vivo potency of the quinolines and to create more potent QR2 inhibitors and to understand the physiological significance of QR2 .",
    "triple_list": [
      [
        "quinolines",
        "CPR:4",
        "QR2"
      ]
    ],
    "updated": "Yes",
    "original": "Our studies shed light on the possible in vivo potency of the quinolines and provide a foundation for future studies aimed at creating more potent QR2 inhibitors and at understanding the physiological significance of QR2",
    "simplified": "Our studies provide a foundation for future studies to determine the possible in vivo potency of the quinolines and to create more potent QR2 inhibitors and to understand the physiological significance of QR2."
  },
  {
    "text": "QR2 catalyzes the twoelectron reduction of menadione via the oxidation of Nalkylated or Nribosylated nicotinamides",
    "triple_list": [
      [
        "QR2",
        "CPR:9",
        "Nribosylated nicotinamides"
      ],
      [
        "QR2",
        "CPR:9",
        "menadione"
      ],
      [
        "QR2",
        "CPR:9",
        "Nalkylated"
      ]
    ],
    "updated": "No",
    "original": "QR2 catalyzes the twoelectron reduction of menadione via the oxidation of Nalkylated or Nribosylated nicotinamides",
    "simplified": "QR2 is used to reduce menadione. This is done by the oxidation of nicotinamides by an electron."
  },
  {
    "text": "Results Our results demonstrate that treatment with LBH589 leads to protein expression as determined by immunofluorescence in xenograft tumors and to NIS RNA expression as shown by RTPCR and luciferase assay .",
    "triple_list": [
      [
        "LBH589",
        "CPR:3",
        "NIS"
      ]
    ],
    "updated": "Yes",
    "original": "Results Our results demonstrate that treatment with LBH589 leads to NIS RNA expression as shown by RTPCR and luciferase assay and to protein expression as determined by immunofluorescence in vitro and by immunohistochemistry in xenograft tumors",
    "simplified": "Results Our results demonstrate that treatment with LBH589 leads to protein expression as determined by immunofluorescence in xenograft tumors and to NIS RNA expression as shown by RTPCR and luciferase assay."
  },
  {
    "text": "Methods Stabilized thyroid cancer cell lines BHT101 and CAL62 were treated with the histone deacetylase inhibitor LBH589 . Patients who underwent thyroidectomy for anaplastic thyroid cancer were treated with the inhibitor .",
    "triple_list": [
      [
        "histone deacetylase",
        "CPR:4",
        "LBH589"
      ]
    ],
    "updated": "Yes",
    "original": "Methods Stabilized anaplastic thyroid cancer cell lines BHT101 and CAL62 and primary cultures from patients who underwent thyroidectomy for anaplastic thyroid cancer were treated with the histone deacetylase inhibitor LBH589",
    "simplified": "Methods Stabilized thyroid cancer cell lines BHT101 and CAL62 were treated with the histone deacetylase inhibitor LBH589. Patients who underwent thyroidectomy for anaplastic thyroid cancer were treated with the inhibitor."
  },
  {
    "text": "Given these findings a unified PK model was developed to describe blood harmaline 5MeODMT and bufotenine PK profiles in both wildtype and Tg CYP2D6 mouse models . This model included the inhibition of MAOA and CYP2D6 by harmaline .",
    "triple_list": [
      [
        "MAOA",
        "CPR:4",
        "harmaline"
      ],
      [
        "CYP2D6",
        "CPR:4",
        "harmaline"
      ],
      [
        "CYP2D6",
        "CPR:4",
        "harmaline"
      ],
      [
        "MAOA",
        "CPR:4",
        "harmaline"
      ],
      [
        "CYP2D6",
        "CPR:4",
        "harmaline"
      ],
      [
        "CYP2D6",
        "CPR:4",
        "harmaline"
      ],
      [
        "MAOA",
        "CPR:9",
        "5MeODMT"
      ],
      [
        "CYP2D6",
        "CPR:9",
        "5MeODMT"
      ],
      [
        "CYP2D6",
        "CPR:9",
        "5MeODMT"
      ],
      [
        "MAOA",
        "CPR:9",
        "5MeODMT"
      ],
      [
        "CYP2D6",
        "CPR:9",
        "5MeODMT"
      ],
      [
        "CYP2D6",
        "CPR:9",
        "5MeODMT"
      ]
    ],
    "updated": "Yes",
    "original": "Given these findings a unified PK model including the inhibition of MAOA and CYP2D6 catalyzed 5MeODMT metabolism by harmaline was developed to describe blood harmaline 5MeODMT and bufotenine PK profiles in both wildtype and Tg CYP2D6 mouse models",
    "simplified": "Given these findings a unified PK model was developed to describe blood harmaline 5MeODMT and bufotenine PK profiles in both wildtype and Tg CYP2D6 mouse models. This model included the inhibition of MAOA and CYP2D6 by harmaline."
  },
  {
    "text": "Our recent study has demonstrated that coadministration of monoamine oxidase A MAOA inhibitor harmaline 5 mgkg increases systemic exposure to 5MeODMT 2 mgkg and active metabolite bufotenine",
    "triple_list": [
      [
        "monoamine oxidase A",
        "CPR:4",
        "harmaline"
      ],
      [
        "MAOA",
        "CPR:4",
        "harmaline"
      ]
    ],
    "updated": "No",
    "original": "Our recent study has demonstrated that coadministration of monoamine oxidase A MAOA inhibitor harmaline 5 mgkg increases systemic exposure to 5MeODMT 2 mgkg and active metabolite bufotenine",
    "simplified": "Our recent study has demonstrated that coadministration of 5MeODMT 2 mgkg and active metabolite bufotenine increases systemic exposure to monoamine oxidase A."
  },
  {
    "text": "Our data revealed that harmaline 2 5 and 15 mgkg inhibition of MAOA-mediated metabolism led to a sharp increase in systemic and cerebral exposure to 5MeODMT 2 at all dose combinations .",
    "triple_list": [
      [
        "MAOA",
        "CPR:4",
        "harmaline"
      ]
    ],
    "updated": "Yes",
    "original": "Our data revealed that inhibition of MAOA mediated metabolic elimination by harmaline 2 5 and 15 mgkg led to a sharp increase in systemic and cerebral exposure to 5MeODMT 2 and 10 mgkg at all dose combinations",
    "simplified": "Our data revealed that harmaline 2 5 and 15 mgkg inhibition of MAOA-mediated metabolism led to a sharp increase in systemic and cerebral exposure to 5MeODMT 2 at all dose combinations."
  },
  {
    "text": "Pharmacokinetic Interactions between Monoamine Oxidase A Inhibitor Harmaline and 5MethoxyNNDimethyltryptamine and the Impact of CYP2D6 Status",
    "triple_list": [
      [
        "Monoamine Oxidase A",
        "CPR:4",
        "Harmaline"
      ]
    ],
    "updated": "No",
    "original": "Pharmacokinetic Interactions between Monoamine Oxidase A Inhibitor Harmaline and 5MethoxyNNDimethyltryptamine and the Impact of CYP2D6 Status",
    "simplified": "The effect of monoamine Oxidase A on 5MethoxyNNDimethyltryptamine and the impact of CYP2D6 status is not known."
  },
  {
    "text": "The in vivo inhibitory effect of harmaline on CYP2D6 catalyzed bufotenine formation was confirmed by in vitro study using purified CYP2D6",
    "triple_list": [
      [
        "harmaline",
        "CPR:4",
        "CYP2D6"
      ],
      [
        "harmaline",
        "CPR:4",
        "CYP2D6"
      ],
      [
        "CYP2D6",
        "CPR:9",
        "bufotenine"
      ],
      [
        "CYP2D6",
        "CPR:9",
        "bufotenine"
      ]
    ],
    "updated": "No",
    "original": "The in vivo inhibitory effect of harmaline on CYP2D6 catalyzed bufotenine formation was confirmed by in vitro study using purified CYP2D6",
    "simplified": "The in-vitro inhibitory effect of harmaline on CYP2D6 was confirmed in an in-vitro study using purified CYP2D6."
  },
  {
    "text": "The potent histamine H1receptor antagonist cetirizine Zyrtec is a racemic mixture of levocetirizine now available under the trademark Xyzal and dextrocetirizine",
    "triple_list": [
      [
        "histamine H1receptor",
        "CPR:6",
        "cetirizine"
      ],
      [
        "histamine H1receptor",
        "CPR:6",
        "Zyrtec"
      ],
      [
        "histamine H1receptor",
        "CPR:6",
        "levocetirizine"
      ],
      [
        "histamine H1receptor",
        "CPR:6",
        "Xyzal"
      ],
      [
        "histamine H1receptor",
        "CPR:6",
        "dextrocetirizine"
      ]
    ],
    "updated": "No",
    "original": "The potent histamine H1receptor antagonist cetirizine Zyrtec is a racemic mixture of levocetirizine now available under the trademark Xyzal and dextrocetirizine",
    "simplified": "Cetirizine Zyrtec is a racemic mixture of levocetirizine and cetirizine that is used to treat certain medical conditions."
  },
  {
    "text": "Compared pharmacological characteristics in humans of racemic cetirizine and levocetirizine two histamine H1receptor antagonists",
    "triple_list": [
      [
        "cetirizine",
        "CPR:6",
        "histamine H1receptor"
      ],
      [
        "levocetirizine",
        "CPR:6",
        "histamine H1receptor"
      ]
    ],
    "updated": "No",
    "original": "Compared pharmacological characteristics in humans of racemic cetirizine and levocetirizine two histamine H1receptor antagonists",
    "simplified": "Cetirizine and levocetirizine are two histamine H1receptor antagonists and they work in different ways."
  },
  {
    "text": "A new inhibitor of VEGF receptor tyrosine kinases vegfrecine 1 was isolated from the culture broth of Streptomyces sp",
    "triple_list": [
      [
        "VEGF receptor tyrosine kinases",
        "CPR:4",
        "vegfrecine"
      ]
    ],
    "updated": "No",
    "original": "A new inhibitor of VEGF receptor tyrosine kinases vegfrecine 1 was isolated from the culture broth of Streptomyces sp",
    "simplified": "A new enzyme called vegfrecine 1 has been found. It works in the culture broth of Streptomyces sp."
  },
  {
    "text": "Vegfrecine an Inhibitor of VEGF Receptor Tyrosine Kinases Isolated from the Culture Broth of Streptomyces sp",
    "triple_list": [
      [
        "Vegfrecine",
        "CPR:4",
        "VEGF Receptor Tyrosine Kinases"
      ]
    ],
    "updated": "No",
    "original": "Vegfrecine an Inhibitor of VEGF Receptor Tyrosine Kinases Isolated from the Culture Broth of Streptomyces sp",
    "simplified": "Vegfrecine and Tyrosine Kinases Vegfrecine and Tyrosine Kinases in the Culture Broth of Streptomyces"
  },
  {
    "text": "Unlike the rat and flounder orthologs , hNaDC3 was not affected by lithium concentrations up to 5 % .",
    "triple_list": [
      [
        "hNaDC3",
        "CPR:4",
        "lithium"
      ]
    ],
    "updated": "Yes",
    "original": "As opposed to the rat and flounder orthologs hNaDC3 was hardly inhibited by lithium concentrations up to 5 mM",
    "simplified": "Unlike the rat and flounder orthologs, hNaDC3 was not affected by lithium concentrations up to 5%."
  },
  {
    "text": "When amiloride was dropped on the eye surface on the first day of irradiation and subsequently daily until the end of the experiment uPA activity in both cornea and tear fluid was strongly inhibited",
    "triple_list": [
      [
        "amiloride",
        "CPR:4",
        "uPA"
      ]
    ],
    "updated": "No",
    "original": "When amiloride was dropped on the eye surface on the first day of irradiation and subsequently daily until the end of the experiment uPA activity in both cornea and tear fluid was strongly inhibited",
    "simplified": "Amiloride was dropped on the eye surface on the first day of the experiment and then daily until the end of the experiment. Both cornea and tear fluid were strongly inhibited by it."
  },
  {
    "text": "In conclusion early application of amiloride in the tear fluid and in UVBirradiated corneas inhibited uPA activity and the development of corneal pathology .",
    "triple_list": [
      [
        "amiloride",
        "CPR:4",
        "uPA"
      ]
    ],
    "updated": "Yes",
    "original": "In conclusion early application of amiloride inhibited uPA activity in UVBirradiated corneas as well as in tear fluid and diminished the development of corneal pathology",
    "simplified": "In conclusion early application of amiloride in the tear fluid and in UVBirradiated corneas inhibited uPA activity and the development of corneal pathology."
  },
  {
    "text": "The purpose of the present study was to test our hypothesis that amiloride is a specific uPA inhibitor that effectively decreases uPA activity in the tear fluid as well as in the cornea .",
    "triple_list": [
      [
        "amiloride",
        "CPR:4",
        "uPA"
      ],
      [
        "amiloride",
        "CPR:4",
        "uPA"
      ]
    ],
    "updated": "Yes",
    "original": "The purpose of the present study was to test our hypothesis that amiloride a specific uPA inhibitor effectively decreases uPA activity in cornea as well as in tear fluid and favourably affects corneal healing",
    "simplified": "The purpose of the present study was to test our hypothesis that amiloride is a specific uPA inhibitor that effectively decreases uPA activity in the tear fluid as well as in the cornea."
  },
  {
    "text": "Effects of inhibition of urokinasetype plasminogen activator uPA by amiloride in the cornea and tear fluid of eyes irradiated with UVB",
    "triple_list": [
      [
        "urokinasetype plasminogen activator",
        "CPR:4",
        "amiloride"
      ],
      [
        "uPA",
        "CPR:4",
        "amiloride"
      ]
    ],
    "updated": "No",
    "original": "Effects of inhibition of urokinasetype plasminogen activator uPA by amiloride in the cornea and tear fluid of eyes irradiated with UVB",
    "simplified": "Amiloride inhibition of urokinasetype plasminogen activator in the tear fluid of eyes irradiated with UVB"
  },
  {
    "text": "Therefore comparative histochemical and biochemical studies of uPA and the effects of amiloride were performed on rabbit corneas and tear fluid . ZGlyGlyArg7amino4trifluoromethylcoumarin was used in the study .",
    "triple_list": [
      [
        "uPA",
        "CPR:9",
        "ZGlyGlyArg7amino4trifluoromethylcoumarin"
      ]
    ],
    "updated": "Yes",
    "original": "Therefore comparative histochemical and biochemical studies of uPA and the effects of amiloride were performed on rabbit corneas and tear fluid using the sensitive fluorogenic substrate ZGlyGlyArg7amino4trifluoromethylcoumarin",
    "simplified": "Therefore comparative histochemical and biochemical studies of uPA and the effects of amiloride were performed on rabbit corneas and tear fluid. ZGlyGlyArg7amino4trifluoromethylcoumarin was used in the study."
  },
  {
    "text": "Prednisolone also inhibited the secretion of cortisol and ACTH in response to exogenous CRH stimulation , suggesting rapid feedback inhibition .",
    "triple_list": [
      [
        "Prednisolone",
        "CPR:4",
        "CRH"
      ],
      [
        "cortisol",
        "CPR:9",
        "CRH"
      ]
    ],
    "updated": "Yes",
    "original": "Prednisolone also inhibited ACTH and cortisol secretion in response to exogenous CRH stimulation inferring rapid feedback inhibition at the anterior pituitary",
    "simplified": "Prednisolone also inhibited the secretion of cortisol and ACTH in response to exogenous CRH stimulation, suggesting rapid feedback inhibition."
  },
  {
    "text": "The molecular structure of cMyc 10074G5",
    "triple_list": [
      [
        "cMyc",
        "CPR:4",
        "10074G5"
      ]
    ],
    "updated": "Yes",
    "original": "Pharmacophore identification of cMyc inhibitor 10074G5",
    "simplified": "The molecular structure of cMyc 10074G5"
  },
  {
    "text": "Importantly the carboxylic acid of JY3094 improves the physicochemical properties of the lead compound which will facilitate the incorporation of additional hydrophobicity that might enhance Myc inhibitory activity further still",
    "triple_list": [
      [
        "JY3094",
        "CPR:4",
        "Myc"
      ]
    ],
    "updated": "No",
    "original": "Importantly the carboxylic acid of JY3094 improves the physicochemical properties of the lead compound which will facilitate the incorporation of additional hydrophobicity that might enhance Myc inhibitory activity further still",
    "simplified": "The carboxylic acid of JY3094 has been shown to improve the physicochemical properties of the lead compound. This will allow additional hydrophobicity to be added to the compound and further improve myc inhibitory activity."
  },
  {
    "text": "A structureactivity relationship SAR study of the cMyc Myc inhibitor 10074G5 N11biphenyl2yl7nitrobenzoc125oxadiazol4amine 1 was done in order to determine its pharmacophore . The pharmacophore is the part of the drug that the drug targets .",
    "triple_list": [
      [
        "cMyc",
        "CPR:4",
        "10074G5"
      ],
      [
        "Myc",
        "CPR:4",
        "10074G5"
      ],
      [
        "cMyc",
        "CPR:4",
        "N11biphenyl2yl7nitrobenzoc125oxadiazol4amine"
      ],
      [
        "Myc",
        "CPR:4",
        "N11biphenyl2yl7nitrobenzoc125oxadiazol4amine"
      ]
    ],
    "updated": "Yes",
    "original": "A structureactivity relationship SAR study of the cMyc Myc inhibitor 10074G5 N11biphenyl2yl7nitrobenzoc125oxadiazol4amine 1 which targets a hydrophobic domain of the Myc oncoprotein that is flanked by arginine residues was executed in order to determine its pharmacophore",
    "simplified": "A structureactivity relationship SAR study of the cMyc Myc inhibitor 10074G5 N11biphenyl2yl7nitrobenzoc125oxadiazol4amine 1 was done in order to determine its pharmacophore. The pharmacophore is the part of the drug that the drug targets."
  },
  {
    "text": "Miglustat a small iminosugar molecule approved for the treatment of Gaucher disease reversibly inhibits glucosylceramide synthase which catalyses the first committed step in glycosphingolipid synthesis",
    "triple_list": [
      [
        "Miglustat",
        "CPR:4",
        "glucosylceramide synthase"
      ]
    ],
    "updated": "No",
    "original": "Miglustat a small iminosugar molecule approved for the treatment of Gaucher disease reversibly inhibits glucosylceramide synthase which catalyses the first committed step in glycosphingolipid synthesis",
    "simplified": "Miglustat a small iminosugar molecule approved for the treatment of Gaucher disease inhibits the first step in glycosphingolipid synthesis, which is a very important enzyme."
  },
  {
    "text": "Furthermore compared with control groups the plaque endothelium level of p75NTR was 3fold increased and the liver level of p75NTR was 174fold increased by SFO HD",
    "triple_list": [
      [
        "p75NTR",
        "CPR:3",
        "SFO"
      ],
      [
        "p75NTR",
        "CPR:3",
        "SFO"
      ]
    ],
    "updated": "No",
    "original": "Furthermore compared with control groups the plaque endothelium level of p75NTR was 3fold increased and the liver level of p75NTR was 174fold increased by SFO HD",
    "simplified": "In addition, compared with control groups the liver level of p75NTR was 174fold increased and the plaque endothelium level of p75NTR was 3fold increased."
  },
  {
    "text": "Meanwhile the serum level of KC a functional homolog of IL8 and the main proinflammatory alpha chemokine in mice in apoE mice was up to 357pgml in SFO HD treated group",
    "triple_list": [
      [
        "IL8",
        "CPR:3",
        "SFO"
      ],
      [
        "alpha chemokine",
        "CPR:3",
        "SFO"
      ]
    ],
    "updated": "No",
    "original": "Meanwhile the serum level of KC a functional homolog of IL8 and the main proinflammatory alpha chemokine in mice in apoE mice was up to 357pgml in SFO HD treated group",
    "simplified": "Meanwhile the serum level of KC, the main proinflammatory alpha chemokine in mice in apoE mice was up to 357pgml in SFO HD treated group."
  },
  {
    "text": "Thus SFO contributes to the instability of atherosclerotic plaque in apoE mice through activating p75NTR and IL8 and cell apoptosis in plaque",
    "triple_list": [
      [
        "SFO",
        "CPR:3",
        "p75NTR"
      ],
      [
        "SFO",
        "CPR:3",
        "IL8"
      ]
    ],
    "updated": "No",
    "original": "Thus SFO contributes to the instability of atherosclerotic plaque in apoE mice through activating p75NTR and IL8 and cell apoptosis in plaque",
    "simplified": "Thus SFO causes atherosclerotic plaque to become unstable in apoE mice. It also causes cell apoptosis in the plaque."
  },
  {
    "text": "Because gastric AADC and COMT degrade levodopa the drug is given with inhibitors of AADC carbidopa or benserazide and inhibitors of COMT will also enter clinical use",
    "triple_list": [
      [
        "AADC",
        "CPR:4",
        "benserazide"
      ],
      [
        "AADC",
        "CPR:4",
        "carbidopa"
      ],
      [
        "AADC",
        "CPR:9",
        "levodopa"
      ],
      [
        "COMT",
        "CPR:9",
        "levodopa"
      ]
    ],
    "updated": "No",
    "original": "Because gastric AADC and COMT degrade levodopa the drug is given with inhibitors of AADC carbidopa or benserazide and inhibitors of COMT will also enter clinical use",
    "simplified": "Because gastric AADC and COMT degrade levodopa, the drug is given with a drug called benserazide instead. Benserazide does not work the same way."
  },
  {
    "text": "Levodopa is absorbed in the small bowel and is rapidly catabolized by aromaticLaminoacid decarboxylase AADC and catecholOmethyltransferase COMT",
    "triple_list": [
      [
        "Levodopa",
        "CPR:9",
        "aromaticLaminoacid decarboxylase"
      ],
      [
        "Levodopa",
        "CPR:9",
        "AADC"
      ],
      [
        "Levodopa",
        "CPR:9",
        "catecholOmethyltransferase"
      ],
      [
        "Levodopa",
        "CPR:9",
        "COMT"
      ]
    ],
    "updated": "No",
    "original": "Levodopa is absorbed in the small bowel and is rapidly catabolized by aromaticLaminoacid decarboxylase AADC and catecholOmethyltransferase COMT",
    "simplified": "Levodopa is taken in in the small bowel. It is quickly destroyed by catecholOmethyltransferase and aromatic decarboxylase."
  },
  {
    "text": "The rats were given a special food , SPI , and casein as a nitrogen source .",
    "triple_list": [
      [
        "casein",
        "CPR:9",
        "nitrogen"
      ]
    ],
    "updated": "Yes",
    "original": "Rats were fed experimental diets containing SPI or casein as a nitrogen source",
    "simplified": "The rats were given a special food, SPI, and casein as a nitrogen source."
  },
  {
    "text": "The activity of aminopeptidase was also inhibited when bestatin and puromycin inhibitors were used .",
    "triple_list": [
      [
        "aminopeptidase",
        "CPR:4",
        "bestatin"
      ],
      [
        "aminopeptidase",
        "CPR:4",
        "puromycin"
      ]
    ],
    "updated": "Yes",
    "original": "The inhibition of aminopeptidase activity in the presence of bestatin and puromycin inhibitors was also investigated",
    "simplified": "The activity of aminopeptidase was also inhibited when bestatin and puromycin inhibitors were used."
  },
  {
    "text": "Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity 4methoxy2naphthylamide of Lalanine for aminopeptidase N 4methoxy2naphthylamide of Lleucine for leucine aminopeptidase 4methoxy2naphthylamide of Lglutamic acid for aminopeptidase A and 4methoxy2naphthylamide of Larginine for aminopeptidase B",
    "triple_list": [
      [
        "Larginine",
        "CPR:9",
        "aminopeptidase B"
      ],
      [
        "4methoxy2naphthylamide",
        "CPR:9",
        "aminopeptidase N"
      ],
      [
        "Lalanine",
        "CPR:9",
        "aminopeptidase N"
      ],
      [
        "4methoxy2naphthylamide",
        "CPR:9",
        "leucine aminopeptidase"
      ],
      [
        "Lleucine",
        "CPR:9",
        "leucine aminopeptidase"
      ],
      [
        "4methoxy2naphthylamide",
        "CPR:9",
        "aminopeptidase A"
      ],
      [
        "Lglutamic acid",
        "CPR:9",
        "aminopeptidase A"
      ],
      [
        "4methoxy2naphthylamide",
        "CPR:9",
        "aminopeptidase B"
      ]
    ],
    "updated": "No",
    "original": "Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity 4methoxy2naphthylamide of Lalanine for aminopeptidase N 4methoxy2naphthylamide of Lleucine for leucine aminopeptidase 4methoxy2naphthylamide of Lglutamic acid for aminopeptidase A and 4methoxy2naphthylamide of Larginine for aminopeptidase B",
    "simplified": "Different substrates were used as the relative specific substrates for the determination of aminopeptidase activity 4methoxy2naphthylamide of Larginine for aminopeptidase A 4methoxy2naphthylamide of Lleucine for aminopeptidase B 4methoxy2naphthylamide of Lglutamic acid for aminopeptidase A and 4methoxy2naphthylamide of Lalanine for aminopeptidase N 4methoxy2naphthylamide of Larginine for aminopeptidase A"
  },
  {
    "text": "Here we show that an enzyme called peptidylprolyl cistransisomerase A1 Pin1 is highly susceptible to HNE modification . It catalyzes the conversion of pSer pThr Pro moieties in signaling proteins from cis to trans .",
    "triple_list": [
      [
        "peptidylprolyl cistransisomerase A1",
        "CPR:9",
        "pSer"
      ],
      [
        "Pin1",
        "CPR:9",
        "pSer"
      ],
      [
        "peptidylprolyl cistransisomerase A1",
        "CPR:9",
        "pThr"
      ],
      [
        "Pin1",
        "CPR:9",
        "pThr"
      ],
      [
        "peptidylprolyl cistransisomerase A1",
        "CPR:9",
        "Pro"
      ],
      [
        "Pin1",
        "CPR:9",
        "Pro"
      ]
    ],
    "updated": "Yes",
    "original": "Here we demonstrate that peptidylprolyl cistransisomerase A1 Pin1 an enzyme that catalyzes the conversion of the peptide bond of pSer pThr Pro moieties in signaling proteins from cis to trans is highly susceptible to HNE modification",
    "simplified": "Here we show that an enzyme called peptidylprolyl cistransisomerase A1 Pin1 is highly susceptible to HNE modification. It catalyzes the conversion of pSer pThr Pro moieties in signaling proteins from cis to trans."
  },
  {
    "text": "Withdrawal from freechoice ethanol results in increased glutamine synthetase production in the prelimbic cortex of alcohol-resistant rats , but not in normal rats .",
    "triple_list": [
      [
        "ethanol",
        "CPR:3",
        "glutamine synthetase"
      ]
    ],
    "updated": "Yes",
    "original": "Withdrawal from freechoice ethanol consumption results in increased packing density of glutamine synthetase immunoreactive astrocytes in the prelimbic cortex of alcoholpreferring rats",
    "simplified": "Withdrawal from freechoice ethanol results in increased glutamine synthetase production in the prelimbic cortex of alcohol-resistant rats, but not in normal rats."
  },
  {
    "text": "Astrocytes may play a role in these manifestations because astrocytes are essential in the regulation of released glutamate and its conversion to glutamine through the enzyme glutamine synthetase GS",
    "triple_list": [
      [
        "glutamate",
        "CPR:9",
        "glutamine synthetase"
      ],
      [
        "glutamate",
        "CPR:9",
        "GS"
      ],
      [
        "glutamine",
        "CPR:9",
        "glutamine synthetase"
      ],
      [
        "glutamine",
        "CPR:9",
        "GS"
      ]
    ],
    "updated": "No",
    "original": "Astrocytes may play a role in these manifestations because astrocytes are essential in the regulation of released glutamate and its conversion to glutamine through the enzyme glutamine synthetase GS",
    "simplified": "Astrocytes may play a role in these changes because they control the release of glutamate. Glutamate is changed into glutamine by an enzyme called glutamine synthetase in the astrocytes."
  },
  {
    "text": "Alltrans retinoic acid protects against serumstarvation by upregulating collagen 8A2 . It also protects against liver cancer .",
    "triple_list": [
      [
        "Alltrans retinoic acid",
        "CPR:3",
        "collagen 8A2"
      ]
    ],
    "updated": "Yes",
    "original": "Alltrans retinoic acid protects hepatocellular carcinoma cells against serumstarvationinduced cell death by upregulating collagen 8A2",
    "simplified": "Alltrans retinoic acid protects against serumstarvation by upregulating collagen 8A2. It also protects against liver cancer."
  },
  {
    "text": "The protein exhibited modest H2O2 dependent peroxidase activities with guaiacol potassium iodide and 22azinobis3ethylbenzothiazoline6sulfonic acid ABTS",
    "triple_list": [
      [
        "H2O2",
        "CPR:3",
        "peroxidase"
      ],
      [
        "peroxidase",
        "CPR:9",
        "guaiacol"
      ],
      [
        "peroxidase",
        "CPR:9",
        "potassium iodide"
      ],
      [
        "peroxidase",
        "CPR:9",
        "22azinobis3ethylbenzothiazoline6sulfonic acid"
      ],
      [
        "peroxidase",
        "CPR:9",
        "ABTS"
      ]
    ],
    "updated": "No",
    "original": "The protein exhibited modest H2O2 dependent peroxidase activities with guaiacol potassium iodide and 22azinobis3ethylbenzothiazoline6sulfonic acid ABTS",
    "simplified": "The protein did not work very hard, but it did work with guaiacol potassium iodide and 22azinobis3ethylbenzothiazoline."
  },
  {
    "text": "Luciferase reporter tests showed that 8BrcAMP treatment synergistically activated FDX1 transcription through two SF1 binding sites and a CRElike sequence in a human ovarian granulosa cell line .",
    "triple_list": [
      [
        "FDX1",
        "CPR:3",
        "8BrcAMP"
      ]
    ],
    "updated": "Yes",
    "original": "Luciferase reporter assays showed that transcription of FDX1 was synergistically activated by the NR5A family and 8BrcAMP treatment through two SF1 binding sites and a CRElike sequence in a human ovarian granulosa cell line KGN",
    "simplified": "Luciferase reporter tests showed that 8BrcAMP treatment synergistically activated FDX1 transcription through two SF1 binding sites and a CRElike sequence in a human ovarian granulosa cell line."
  },
  {
    "text": "These results indicate transcription of FDX1 is regulated by the NR5A family and cAMP signaling and participates in steroid hormone production in ovarian granulosa cells",
    "triple_list": [
      [
        "FDX1",
        "CPR:3",
        "cAMP"
      ],
      [
        "FDX1",
        "CPR:9",
        "steroid"
      ]
    ],
    "updated": "No",
    "original": "These results indicate transcription of FDX1 is regulated by the NR5A family and cAMP signaling and participates in steroid hormone production in ovarian granulosa cells",
    "simplified": "These results indicate that the transcription of FDX1 is regulated by the NR5A family and cAMP signaling in ovarian granulosa cells."
  },
  {
    "text": "Ferredoxin 1 FDX1 adrenodoxin is an ironsulfur protein that is involved in various metabolic processes including steroid hormone synthesis in mammalian tissues",
    "triple_list": [
      [
        "FDX1",
        "CPR:9",
        "steroid"
      ],
      [
        "adrenodoxin",
        "CPR:9",
        "steroid"
      ],
      [
        "Ferredoxin 1",
        "CPR:9",
        "steroid"
      ],
      [
        "FDX1",
        "CPR:9",
        "steroid hormone"
      ],
      [
        "adrenodoxin",
        "CPR:9",
        "steroid hormone"
      ],
      [
        "Ferredoxin 1",
        "CPR:9",
        "steroid hormone"
      ]
    ],
    "updated": "No",
    "original": "Ferredoxin 1 FDX1 adrenodoxin is an ironsulfur protein that is involved in various metabolic processes including steroid hormone synthesis in mammalian tissues",
    "simplified": "Ferredoxin 1 FDX1 adrenodoxin is a protein that is found in red blood cells. It is an important protein in many metabolic processes."
  },
  {
    "text": "In the liver of rats given 500 mgkgweek of flutamide for 6 weeks , gammaglutamyltraspeptidase positive foci were detected only in 3 of 10 rats at the beginning of the study .",
    "triple_list": [
      [
        "flutamide",
        "CPR:3",
        "gammaglutamyltraspeptidase"
      ]
    ],
    "updated": "Yes",
    "original": "In the liver of rats given flutamide as initiating agent at the dose of 500 mgkgweek for 6 successive weeks gammaglutamyltraspeptidase positive foci were detected only in 3 of 10 rats",
    "simplified": "In the liver of rats given 500 mgkgweek of flutamide for 6 weeks, gammaglutamyltraspeptidase positive foci were detected only in 3 of 10 rats at the beginning of the study."
  },
  {
    "text": "Flutamide an effective competitive inhibitor of the androgen receptor used orally for palliative treatment of breast cancer was evaluated for its genotoxic effects in the intact rat and in primary cultures of human hepatocytes and was found to be safe .",
    "triple_list": [
      [
        "Flutamide",
        "CPR:4",
        "androgen receptor"
      ]
    ],
    "updated": "Yes",
    "original": "Flutamide an effective competitive inhibitor of the androgen receptor used orally for palliative treatment of prostatic carcinoma and regulation of prostatic hyperplasia was evaluated for its genotoxic effects in the intact rat and in primary cultures of human hepatocytes",
    "simplified": "Flutamide an effective competitive inhibitor of the androgen receptor used orally for palliative treatment of breast cancer was evaluated for its genotoxic effects in the intact rat and in primary cultures of human hepatocytes and was found to be safe."
  },
  {
    "text": "Cycloxygenase2 ( COX2 ) and prostaglandin E2 ( PGE2 ) are important enzymes in the esophagus .",
    "triple_list": [
      [
        "Cycloxygenase2",
        "CPR:9",
        "prostaglandin E2"
      ],
      [
        "COX2",
        "CPR:9",
        "prostaglandin E2"
      ],
      [
        "Cycloxygenase2",
        "CPR:9",
        "PGE2"
      ],
      [
        "COX2",
        "CPR:9",
        "PGE2"
      ]
    ],
    "updated": "Yes",
    "original": "Cycloxygenase2 COX2 derived prostaglandin E2 PGE2 has been shown to be important in esophageal tumorigenesis",
    "simplified": "Cycloxygenase2 (COX2) and prostaglandin E2 (PGE2) are important enzymes in the esophagus."
  },
  {
    "text": "We conclude that mPGES1 increases the production of PGE2 and increases cell proliferation .",
    "triple_list": [
      [
        "mPGES1",
        "CPR:9",
        "PGE2"
      ]
    ],
    "updated": "Yes",
    "original": "We conclude that mPGES1 mediates acidinduced increase in PGE2 production and cell proliferation",
    "simplified": "We conclude that mPGES1 increases the production of PGE2 and increases cell proliferation."
  },
  {
    "text": "We have shown that COX2 mediates the production of PGE2 .",
    "triple_list": [
      [
        "COX2",
        "CPR:9",
        "PGE2"
      ]
    ],
    "updated": "Yes",
    "original": "We have shown that COX2 mediates acidinduced PGE2 production",
    "simplified": "We have shown that COX2 mediates the production of PGE2."
  },
  {
    "text": "Butein also increased heme oxygenase1 HO1 protein expression and HO activity",
    "triple_list": [
      [
        "Butein",
        "CPR:3",
        "heme oxygenase1"
      ],
      [
        "Butein",
        "CPR:3",
        "HO1"
      ],
      [
        "Butein",
        "CPR:3",
        "HO"
      ]
    ],
    "updated": "No",
    "original": "Butein also increased heme oxygenase1 HO1 protein expression and HO activity",
    "simplified": "Butein also changed the expression of the heme oxygenase1 protein."
  },
  {
    "text": "In addition , butein treatment increased the amount of nuclear factorE2related factor 2 Nrf2 and increased the antioxidant response elements AREs .",
    "triple_list": [
      [
        "butein",
        "CPR:3",
        "antioxidant response elements"
      ],
      [
        "butein",
        "CPR:3",
        "AREs"
      ],
      [
        "butein",
        "CPR:3",
        "nuclear factorE2related factor 2"
      ],
      [
        "butein",
        "CPR:3",
        "Nrf2"
      ]
    ],
    "updated": "Yes",
    "original": "Furthermore butein treatment caused nuclear accumulation of nuclear factorE2related factor 2 Nrf2 and increased the promoter activity of antioxidant response elements AREs",
    "simplified": "In addition, butein treatment increased the amount of nuclear factorE2related factor 2 Nrf2 and increased the antioxidant response elements AREs."
  },
  {
    "text": "Treatment of HDP cells with butein reduced butein-induced HO1 expression . However , treatment with butein did increase JNK phosphorylation .",
    "triple_list": [
      [
        "butein",
        "CPR:3",
        "HO1"
      ],
      [
        "JNK",
        "CPR:3",
        "butein"
      ]
    ],
    "updated": "Yes",
    "original": "Treatment of HDP cells with a cJun NH2terminal kinase JNK inhibitor also reduced buteininduced HO1 expression and butein treatment led to increased JNK phosphorylation",
    "simplified": "Treatment of HDP cells with butein reduced butein-induced HO1 expression. However, treatment with butein did increase JNK phosphorylation."
  },
  {
    "text": "The refolding kinetics of guanidinedenatured disulfideintact bovine pancreatic ribonuclease A RNase A and its proline42toalanine mutant Pro42Ala have been studied by monitoring tyrosine burial and 2cytidine monophosphate 2CMP inhibitor binding",
    "triple_list": [
      [
        "proline42toalanine",
        "CPR:4",
        "2cytidine monophosphate"
      ],
      [
        "Pro42Ala",
        "CPR:4",
        "2cytidine monophosphate"
      ],
      [
        "bovine pancreatic ribonuclease A",
        "CPR:4",
        "2cytidine monophosphate"
      ],
      [
        "RNase A",
        "CPR:4",
        "2cytidine monophosphate"
      ],
      [
        "proline42toalanine",
        "CPR:4",
        "2CMP"
      ],
      [
        "Pro42Ala",
        "CPR:4",
        "2CMP"
      ],
      [
        "bovine pancreatic ribonuclease A",
        "CPR:4",
        "2CMP"
      ],
      [
        "RNase A",
        "CPR:4",
        "2CMP"
      ]
    ],
    "updated": "No",
    "original": "The refolding kinetics of guanidinedenatured disulfideintact bovine pancreatic ribonuclease A RNase A and its proline42toalanine mutant Pro42Ala have been studied by monitoring tyrosine burial and 2cytidine monophosphate 2CMP inhibitor binding",
    "simplified": "The refolding kinetics of guanidinedenatured disulfideintact bovine pancreatic ribonuclease A RNase A and its proline42toalanine mutant Pro42Ala have been studied by putting a small amount of tyrosine in each cell."
  },
  {
    "text": "The folding rate for wildtype RNase A is faster in the presence of the inhibitor 2CMP than in its absence . This means that 2CMP must be present in order for the enzyme to work properly .",
    "triple_list": [
      [
        "RNase A",
        "CPR:4",
        "2CMP"
      ]
    ],
    "updated": "Yes",
    "original": "The folding rate for wildtype RNase A is faster in the presence of the inhibitor 2CMP than in its absence indicating that the transitionstate structure in the ratedetermining step is stabilized by 2CMP",
    "simplified": "The folding rate for wildtype RNase A is faster in the presence of the inhibitor 2CMP than in its absence. This means that 2CMP must be present in order for the enzyme to work properly."
  },
  {
    "text": "Cortisol and IFNT stimulated endometrial HSD11B1 expression and activity increased endometrial PTGS2 activity and the amount of PG in the uterine lumen and upregulated many conceptus elongationrelated genes in the endometrium",
    "triple_list": [
      [
        "Cortisol",
        "CPR:3",
        "HSD11B1"
      ],
      [
        "Cortisol",
        "CPR:3",
        "PTGS2"
      ]
    ],
    "updated": "No",
    "original": "Cortisol and IFNT stimulated endometrial HSD11B1 expression and activity increased endometrial PTGS2 activity and the amount of PG in the uterine lumen and upregulated many conceptus elongationrelated genes in the endometrium",
    "simplified": "Cortisol and IFNT increased the activity of the endometrial hormone HSD11B1 and increased the amount of PG in the uterine lumen. Many genes in the endometrium were upregulated."
  },
  {
    "text": "In study 1 cyclic ewes received vehicle cortisol PF 915275 PF a selective inhibitor of HSD11B1 cortisol and PF meloxicam a selective inhibitor of PTGS2 cortisol and meloxicam recombinant ovine IFNT or IFNT and PF into the uterus from day 10 to day14 after estrus",
    "triple_list": [
      [
        "PF 915275",
        "CPR:4",
        "HSD11B1"
      ],
      [
        "meloxicam",
        "CPR:4",
        "PTGS2"
      ]
    ],
    "updated": "No",
    "original": "In study 1 cyclic ewes received vehicle cortisol PF 915275 PF a selective inhibitor of HSD11B1 cortisol and PF meloxicam a selective inhibitor of PTGS2 cortisol and meloxicam recombinant ovine IFNT or IFNT and PF into the uterus from day 10 to day14 after estrus",
    "simplified": "In study 1 cyclic ewes received vehicle cortisol and meloxicam into the uterus from day 10 to day14 after estrus. In study 2 cyclic ewes received vehicle cortisol and meloxicam into the uterus from day 10 to day14 after estrus."
  },
  {
    "text": "The primary aim of these studies was to test the hypothesis that HSD11B1 derived cortisol has a biological role in early pregnancy in sheep by measuring the level of cortisol in the blood .",
    "triple_list": [
      [
        "HSD11B1",
        "CPR:9",
        "cortisol"
      ]
    ],
    "updated": "Yes",
    "original": "The primary aim of these studies was to test the hypothesis that HSD11B1 derived cortisol has a biological role in endometrial function and conceptus development during early pregnancy in sheep",
    "simplified": "The primary aim of these studies was to test the hypothesis that HSD11B1 derived cortisol has a biological role in early pregnancy in sheep by measuring the level of cortisol in the blood."
  },
  {
    "text": "During early pregnancy in sheep the endometrial epithelia produce prostaglandins PG via PG synthase 2 PTGS2 and cortisol via hydroxysteroid 11\u03b2 dehydrogenase 1 HSD11B1 and the conceptus secretes interferon\u03c4 IFNT .",
    "triple_list": [
      [
        "prostaglandins",
        "CPR:9",
        "PG synthase 2"
      ],
      [
        "prostaglandins",
        "CPR:9",
        "PTGS2"
      ],
      [
        "cortisol",
        "CPR:9",
        "hydroxysteroid 11\u03b2 dehydrogenase 1"
      ],
      [
        "cortisol",
        "CPR:9",
        "HSD11B1"
      ]
    ],
    "updated": "Yes",
    "original": "During early pregnancy in sheep the elongating conceptus secretes interferon\u03c4 IFNT and the conceptus as well as endometrial epithelia produce prostaglandins PG via PG synthase 2 PTGS2 and cortisol via hydroxysteroid 11\u03b2 dehydrogenase 1 HSD11B1",
    "simplified": "During early pregnancy in sheep the endometrial epithelia produce prostaglandins PG via PG synthase 2 PTGS2 and cortisol via hydroxysteroid 11\u03b2 dehydrogenase 1 HSD11B1 and the conceptus secretes interferon\u03c4 IFNT."
  },
  {
    "text": "These results suggest that HSD11B1 derived cortisol mediates in part actions of ovarian progesterone and the conceptus on endometrial function , and support the hypothesis that IFNT PG and cortisol coordinately regulate endometrial function during early pregnancy in sheep .",
    "triple_list": [
      [
        "HSD11B1",
        "CPR:9",
        "cortisol"
      ]
    ],
    "updated": "Yes",
    "original": "These results suggest that HSD11B1 derived cortisol mediates in part actions of ovarian progesterone and the conceptus on endometrial function and support the hypothesis that IFNT PG and cortisol coordinately regulate endometrial functions important for conceptus elongation and implantation during early pregnancy in sheep",
    "simplified": "These results suggest that HSD11B1 derived cortisol mediates in part actions of ovarian progesterone and the conceptus on endometrial function, and support the hypothesis that IFNT PG and cortisol coordinately regulate endometrial function during early pregnancy in sheep."
  },
  {
    "text": "D1997 contracts the canine basilar artery by stimulating 5HT1like receptors . These receptors are not related to the 5HT1A or 5HT1B receptors .",
    "triple_list": [
      [
        "D1997",
        "CPR:3",
        "5HT1like receptors"
      ],
      [
        "D1997",
        "CPR:3",
        "5HT1A"
      ],
      [
        "D1997",
        "CPR:3",
        "5HT1B"
      ]
    ],
    "updated": "Yes",
    "original": "It is concluded that D1997 contracts the canine basilar artery by stimulating 5HT1like receptors unrelated to either the 5HT1A or 5HT1B receptor subtypes",
    "simplified": "D1997 contracts the canine basilar artery by stimulating 5HT1like receptors. These receptors are not related to the 5HT1A or 5HT1B receptors."
  },
  {
    "text": "The 5HT2 receptor antagonist ketanserin 0011 microM the 5HT3 and 5HT4 receptor antagonist ICS205930 tropisetron 0110 microM the 5HT1A receptor antagonist spiroxatrine 0011 microM the betaadrenoceptor blocker with high affinity for 5HT1A and 5HT1B binding sites pindolol 0011 microM or the alpha 1adrenoceptor blocker prazosin 0011 microM The 5HT2 receptor antagonist ketanserin 0011 microM The 5HT3 and 5HT4 receptor antagonist ICS205930 tropisetron 0110 microM .",
    "triple_list": [
      [
        "betaadrenoceptor",
        "CPR:4",
        "pindolol"
      ],
      [
        "5HT2 receptor",
        "CPR:6",
        "ketanserin"
      ],
      [
        "5HT3",
        "CPR:6",
        "tropisetron"
      ],
      [
        "5HT4",
        "CPR:6",
        "tropisetron"
      ],
      [
        "5HT1A",
        "CPR:6",
        "spiroxatrine"
      ],
      [
        "alpha 1adrenoceptor",
        "CPR:6",
        "prazosin"
      ]
    ],
    "updated": "Yes",
    "original": "The effects of D1997 in the basilar artery were not modified by incubation with either the 5HT2 receptor antagonist ketanserin 0011 microM the 5HT3 and 5HT4 receptor antagonist ICS205930 tropisetron 0110 microM the 5HT1A receptor antagonist spiroxatrine 0011 microM the betaadrenoceptor blocker with high affinity for 5HT1A and 5HT1B binding sites pindolol 0011 microM or the alpha 1adrenoceptor antagonist prazosin 0011 microM",
    "simplified": "The 5HT2 receptor antagonist ketanserin 0011 microM the 5HT3 and 5HT4 receptor antagonist ICS205930 tropisetron 0110 microM the 5HT1A receptor antagonist spiroxatrine 0011 microM the betaadrenoceptor blocker with high affinity for 5HT1A and 5HT1B binding sites pindolol 0011 microM or the alpha 1adrenoceptor blocker prazosin 0011 microM The 5HT2 receptor antagonist ketanserin 0011 microM The 5HT3 and 5HT4 receptor antagonist ICS205930 tropisetron 0110 microM."
  },
  {
    "text": "22Aminoethylquinoline D1997 a novel agonist at 5hydroxytryptamine1like receptors in the canine basilar artery",
    "triple_list": [
      [
        "22Aminoethylquinoline",
        "CPR:5",
        "5hydroxytryptamine1like receptors"
      ],
      [
        "D1997",
        "CPR:5",
        "5hydroxytryptamine1like receptors"
      ]
    ],
    "updated": "No",
    "original": "22Aminoethylquinoline D1997 a novel agonist at 5hydroxytryptamine1like receptors in the canine basilar artery",
    "simplified": "22Aminoethylquinoline D1997 a novel drug that can be used to treat certain diseases"
  },
  {
    "text": "In contrast the D1997 induced responses were not antagonized by the mixed 5HT1like and 5HT2 receptor antagonist methiothepin but were antagonized by it .",
    "triple_list": [
      [
        "D1997",
        "CPR:5",
        "5HT1like"
      ],
      [
        "D1997",
        "CPR:5",
        "5HT2 receptor"
      ],
      [
        "5HT1like",
        "CPR:6",
        "methiothepin"
      ],
      [
        "5HT2 receptor",
        "CPR:6",
        "methiothepin"
      ]
    ],
    "updated": "Yes",
    "original": "In contrast the D1997 induced responses were potently and concentrationdependently antagonized by the mixed 5HT1like and 5HT2 receptor antagonist methiothepin 0011 microM",
    "simplified": "In contrast the D1997 induced responses were not antagonized by the mixed 5HT1like and 5HT2 receptor antagonist methiothepin but were antagonized by it."
  },
  {
    "text": "Although Bak and Bcl2associated X protein Bax another member of the Bcl2 family are generally thought to be functionally redundant only Bak is necessary and sufficient for VK2 induced cytochrome c cyt c release and cell death",
    "triple_list": [
      [
        "VK2",
        "CPR:3",
        "cytochrome c"
      ],
      [
        "VK2",
        "CPR:3",
        "cyt c"
      ]
    ],
    "updated": "No",
    "original": "Although Bak and Bcl2associated X protein Bax another member of the Bcl2 family are generally thought to be functionally redundant only Bak is necessary and sufficient for VK2 induced cytochrome c cyt c release and cell death",
    "simplified": "Although Bcl2 and Bax another member of the Bcl2 family are generally thought to be functionally redundant only Bak and Bax are necessary and sufficient for cell death when VK2 is released."
  },
  {
    "text": "In muscle and liver TCDD 10 ngkgday caused mRNA expression of Igf2r to decrease and methylation to increase .",
    "triple_list": [
      [
        "TCDD",
        "CPR:4",
        "Igf2r"
      ]
    ],
    "updated": "Yes",
    "original": "In muscle and liver TCDD 10 ngkgday induced increases in methylation and decreases in mRNA expression of Igf2r",
    "simplified": "In muscle and liver TCDD 10 ngkgday caused mRNA expression of Igf2r to decrease and methylation to increase."
  },
  {
    "text": "Rasagiline is a propargylamine and irreversible monoamine oxidase MAO B inhibitor used for the treatment of Parkinsons disease PD",
    "triple_list": [
      [
        "Rasagiline",
        "CPR:4",
        "monoamine oxidase MAO B"
      ],
      [
        "propargylamine",
        "CPR:4",
        "monoamine oxidase MAO B"
      ]
    ],
    "updated": "No",
    "original": "Rasagiline is a propargylamine and irreversible monoamine oxidase MAO B inhibitor used for the treatment of Parkinsons disease PD",
    "simplified": "Rasagiline is an irreversible monoamine oxidase (MAO B) inhibitor. It is used to treat Parkinsons disease."
  },
  {
    "text": "Prolonged use of tolvaptan leads to increased endogenous levels of AVP and perhaps overstimulation of V1A receptors",
    "triple_list": [
      [
        "tolvaptan",
        "CPR:3",
        "AVP"
      ],
      [
        "tolvaptan",
        "CPR:3",
        "V1A receptors"
      ]
    ],
    "updated": "No",
    "original": "Prolonged use of tolvaptan leads to increased endogenous levels of AVP and perhaps overstimulation of V1A receptors",
    "simplified": "Long-term use of tolvaptan can increase the level of AVP in the body, and this can cause cancer."
  },
  {
    "text": "Tolvaptan is a selective arginine vasopressin AVP V2 receptor blocker used to induce free water diuresis in the treatment of euvolemic or hypervolemic hyponatremia",
    "triple_list": [
      [
        "Tolvaptan",
        "CPR:4",
        "arginine vasopressin AVP V2 receptor"
      ]
    ],
    "updated": "No",
    "original": "Tolvaptan is a selective arginine vasopressin AVP V2 receptor blocker used to induce free water diuresis in the treatment of euvolemic or hypervolemic hyponatremia",
    "simplified": "Tolvaptan is a selective AVP V2 receptor blocker. It can cause free water diuresis when taken by itself to treat hyponatremia."
  },
  {
    "text": "In addition tolvaptan is metabolized by the CYP3A4 system . Because of this , doctors should be aware of any interactions with other drugs .",
    "triple_list": [
      [
        "tolvaptan",
        "CPR:9",
        "CYP3A4"
      ]
    ],
    "updated": "Yes",
    "original": "In addition tolvaptan is metabolized by the CYP3A4 system thus physicians should be aware of the potential for increased interactions with other medications",
    "simplified": "In addition tolvaptan is metabolized by the CYP3A4 system. Because of this, doctors should be aware of any interactions with other drugs."
  },
  {
    "text": "Fisetin treatment showed a significant decline in the levels of blood glucose glycosylated hemoglobin HbA1c NFkB p65 unit in pancreas and IL1\u03b2 plasma serum nitric oxide NO with an elevation in plasma insulin",
    "triple_list": [
      [
        "Fisetin",
        "CPR:3",
        "insulin"
      ],
      [
        "Fisetin",
        "CPR:4",
        "glycosylated hemoglobin"
      ],
      [
        "Fisetin",
        "CPR:4",
        "HbA1c"
      ],
      [
        "Fisetin",
        "CPR:4",
        "NFkB"
      ],
      [
        "Fisetin",
        "CPR:4",
        "p65"
      ],
      [
        "Fisetin",
        "CPR:4",
        "IL1\u03b2"
      ]
    ],
    "updated": "No",
    "original": "Fisetin treatment showed a significant decline in the levels of blood glucose glycosylated hemoglobin HbA1c NFkB p65 unit in pancreas and IL1\u03b2 plasma serum nitric oxide NO with an elevation in plasma insulin",
    "simplified": "Fisetin treatment showed a significant decline in the levels of blood glucose and blood sugar levels in the pancreas. It also showed a significant increase in plasma insulin levels."
  },
  {
    "text": "In conclusion IL8 production and neutrophil infiltration are increased in high glucose environment and in diabetic skin this has a negative effect on wound healing .",
    "triple_list": [
      [
        "IL8",
        "CPR:3",
        "glucose"
      ]
    ],
    "updated": "Yes",
    "original": "In conclusion IL8 production and neutrophil infiltration are increased in high glucose environment due to elevated ROS level and contributed to impaired wound healing in diabetic skin",
    "simplified": "In conclusion IL8 production and neutrophil infiltration are increased in high glucose environment and in diabetic skin this has a negative effect on wound healing."
  },
  {
    "text": "Using cultured human keratinocytes and diabetic rat model the current study showed that high glucose environment enhanced IL8 production in keratinocytes by a reactive oxygen species ROSdependent manner in a high glucose environment .",
    "triple_list": [
      [
        "glucose",
        "CPR:3",
        "IL8"
      ]
    ],
    "updated": "Yes",
    "original": "Using cultured human keratinocytes and diabetic rat model the current study showed that high glucose environment enhanced IL8 production via epidermal growth factor receptor EGFR extracelluar signalregulated kinase ERK pathway in a reactive oxygen species ROSdependent manner in keratinocytes",
    "simplified": "Using cultured human keratinocytes and diabetic rat model the current study showed that high glucose environment enhanced IL8 production in keratinocytes by a reactive oxygen species ROSdependent manner in a high glucose environment."
  },
  {
    "text": "High glucose environment increased interleukin8 secretion and increased oxidative stress New insights on diabetic wound healing .",
    "triple_list": [
      [
        "glucose",
        "CPR:3",
        "interleukin8"
      ]
    ],
    "updated": "Yes",
    "original": "High glucose environment enhanced oxidative stress and increased interleukin8 secretion from keratinocytes New insights on impaired diabetic wound healing",
    "simplified": "High glucose environment increased interleukin8 secretion and increased oxidative stress New insights on diabetic wound healing."
  },
  {
    "text": "With the increased doses of PhIP , the DPC coefficients were significantly raised in a dosedependent manner 3 PhIP at the doses of 10mgkg andor 15mgkg significantly inhibited p16 mRNA and protein expression whereas enhanced cfos and cjun expression relative to control .",
    "triple_list": [
      [
        "PhIP",
        "CPR:3",
        "cjun"
      ],
      [
        "PhIP",
        "CPR:3",
        "cfos"
      ],
      [
        "PhIP",
        "CPR:4",
        "p16"
      ]
    ],
    "updated": "Yes",
    "original": "With the elevated doses of PhIP malondialdehyde MDA contents protein carbonyl PCO contents and DNAprotein crosslinks DPC coefficients were significantly raised in a dosedependent manner 3 PhIP at the doses of 10mgkg andor 15mgkg significantly inhibited p16 mRNA and protein expression whereas enhanced cfos and cjun expression relative to control",
    "simplified": "With the increased doses of PhIP, the DPC coefficients were significantly raised in a dosedependent manner 3 PhIP at the doses of 10mgkg andor 15mgkg significantly inhibited p16 mRNA and protein expression whereas enhanced cfos and cjun expression relative to control."
  },
  {
    "text": "The data showed that PhIP could cause oxidative stress in rat stomachs , as well as the activation of cfos and cjun and inactivation of p16 which may play a role in the development of stomach cancer .",
    "triple_list": [
      [
        "PhIP",
        "CPR:3",
        "cfos"
      ],
      [
        "PhIP",
        "CPR:3",
        "cjun"
      ],
      [
        "PhIP",
        "CPR:4",
        "p16"
      ]
    ],
    "updated": "Yes",
    "original": "The data indicated that PhIP could cause stomach injury oxidative stress in rat stomachs as well as the activation of cfos and cjun and inactivation of p16 which may play a role in the pathogenesis of PhIPassociated stomach cancer",
    "simplified": "The data showed that PhIP could cause oxidative stress in rat stomachs, as well as the activation of cfos and cjun and inactivation of p16 which may play a role in the development of stomach cancer."
  },
  {
    "text": "The results showed that 1 15mgkg body weight PhIP caused obvious changes in gastric mucosa . 2 PhIP 10 andor 15mgkg significantly decreased superoxide dismutase SOD and glutathioneperoxidase GPx while increased catalase CAT activity in the control group .",
    "triple_list": [
      [
        "PhIP",
        "CPR:3",
        "catalase"
      ],
      [
        "PhIP",
        "CPR:3",
        "CAT"
      ],
      [
        "PhIP",
        "CPR:4",
        "superoxide dismutase"
      ],
      [
        "PhIP",
        "CPR:4",
        "SOD"
      ],
      [
        "PhIP",
        "CPR:4",
        "glutathioneperoxidase"
      ],
      [
        "PhIP",
        "CPR:4",
        "GPx"
      ]
    ],
    "updated": "Yes",
    "original": "The results showed that 1 15mgkg body weight PhIP induced obvious histopathological changes in gastric mucosa 2 PhIP 10 andor 15mgkg significantly decreased superoxide dismutase SOD and glutathioneperoxidase GPx activities while increased catalase CAT activity compared with the control",
    "simplified": "The results showed that 1 15mgkg body weight PhIP caused obvious changes in gastric mucosa. 2 PhIP 10 andor 15mgkg significantly decreased superoxide dismutase SOD and glutathioneperoxidase GPx while increased catalase CAT activity in the control group."
  },
  {
    "text": "We also discuss the ongoing debate on whether NO is the actual reaction product of NOS catalysis , and how it is different from other chemicals .",
    "triple_list": [
      [
        "NO",
        "CPR:9",
        "NOS"
      ]
    ],
    "updated": "Yes",
    "original": "We also shortly discuss the ongoing debate on whether NO is the actual reaction product of NOS catalysis as well as the phenomenon of NOmediated autoinhibition",
    "simplified": "We also discuss the ongoing debate on whether NO is the actual reaction product of NOS catalysis, and how it is different from other chemicals."
  },
  {
    "text": "These results suggest that prostacyclin may play a role in downregulating tissue factor expression in monocytes at least in part via elevation of intracellular levels of cyclic AMP",
    "triple_list": [
      [
        "prostacyclin",
        "CPR:4",
        "tissue factor"
      ],
      [
        "tissue factor",
        "CPR:4",
        "cyclic AMP"
      ]
    ],
    "updated": "No",
    "original": "These results suggest that prostacyclin may play a role in downregulating tissue factor expression in monocytes at least in part via elevation of intracellular levels of cyclic AMP",
    "simplified": "These results suggest that prostacyclin may play a role in reducing the expression of tissue factors in monocytes, at least in part by increasing cyclic AMP levels."
  },
  {
    "text": "The present studies were undertaken to determine whether stable analogues of prostacyclin could inhibit tissue factor expression by human monocytic cells by a potent endotheliumderived platelet inhibitor .",
    "triple_list": [
      [
        "prostacyclin",
        "CPR:4",
        "tissue factor"
      ]
    ],
    "updated": "Yes",
    "original": "The present studies were undertaken to determine whether stable analogues of prostacyclin a potent endotheliumderived platelet inhibitor and vasodilator could inhibit tissue factor expression by human monocytic cells",
    "simplified": "The present studies were undertaken to determine whether stable analogues of prostacyclin could inhibit tissue factor expression by human monocytic cells by a potent endotheliumderived platelet inhibitor."
  },
  {
    "text": "Preincubation for 30 minutes with iloprost ciprostene and carbacyclin led to a dosedependent inhibition of tissue factor expression induced by all three challenging agents",
    "triple_list": [
      [
        "iloprost",
        "CPR:4",
        "tissue factor"
      ],
      [
        "ciprostene",
        "CPR:4",
        "tissue factor"
      ],
      [
        "carbacyclin",
        "CPR:4",
        "tissue factor"
      ]
    ],
    "updated": "No",
    "original": "Preincubation for 30 minutes with iloprost ciprostene and carbacyclin led to a dosedependent inhibition of tissue factor expression induced by all three challenging agents",
    "simplified": "Preincubation for 30 minutes with carbacyclin and iloprost led to a dosedependent inhibition of tissue factor expression by carbacyclin and iloprost."
  },
  {
    "text": "Prostacyclin analogues inhibit tissue factor expression in the human monocytic cell line THP1 via a cyclic AMPdependent mechanism",
    "triple_list": [
      [
        "Prostacyclin",
        "CPR:4",
        "tissue factor"
      ]
    ],
    "updated": "No",
    "original": "Prostacyclin analogues inhibit tissue factor expression in the human monocytic cell line THP1 via a cyclic AMPdependent mechanism",
    "simplified": "Prostacyclin and its analogues inhibit the expression of tissue factors in the human monocytic cell line THP1."
  },
  {
    "text": "This effect was potentiated by isobutylmethylxanthine an inhibitor of phosphodiesterase",
    "triple_list": [
      [
        "isobutylmethylxanthine",
        "CPR:4",
        "phosphodiesterase"
      ]
    ],
    "updated": "No",
    "original": "This effect was potentiated by isobutylmethylxanthine an inhibitor of phosphodiesterase",
    "simplified": "This effect is increased by isobutylmethylxanthine when it is in the blood."
  },
  {
    "text": "The inhibitory effects of iloprost on tissue factor expression were also potentiated by isobutylmethylxanthine and mimicked by forskolin and d ibutyryl cyclic AMP but not dibutyryl cyclic GMP",
    "triple_list": [
      [
        "tissue factor",
        "CPR:4",
        "isobutylmethylxanthine"
      ],
      [
        "tissue factor",
        "CPR:4",
        "forskolin"
      ],
      [
        "tissue factor",
        "CPR:4",
        "ibutyryl cyclic AMP"
      ]
    ],
    "updated": "No",
    "original": "The inhibitory effects of iloprost on tissue factor expression were also potentiated by isobutylmethylxanthine and mimicked by forskolin and d ibutyryl cyclic AMP but not dibutyryl cyclic GMP",
    "simplified": "The inhibitory effects of iloprost on tissue factor expression were also potentiated by isobutylmethylxanthine. Forskolin and dibutyryl cyclic GMP were also able to inhibit iloprost."
  },
  {
    "text": "5FU interferes with DNA synthesis by blocking thymidylate synthase TS . Dihydropyrimidine dehydrogenase ( DPD ) removes the 5FU .",
    "triple_list": [
      [
        "5FU",
        "CPR:4",
        "thymidylate synthase"
      ],
      [
        "5FU",
        "CPR:4",
        "TS"
      ]
    ],
    "updated": "Yes",
    "original": "5FU interferes with DNA synthesis by blocking thymidylate synthase TS but is inactivated by dihydropyrimidine dehydrogenase DPD",
    "simplified": "5FU interferes with DNA synthesis by blocking thymidylate synthase TS. Dihydropyrimidine dehydrogenase (DPD) removes the 5FU."
  },
  {
    "text": "PURPOSE The fluoropyrimidine carbamate capecitabine is converted to 5fluorouracil 5FU by thymidine phosphorylase TP inside target tissues",
    "triple_list": [
      [
        "5fluorouracil",
        "CPR:9",
        "TP"
      ],
      [
        "5fluorouracil",
        "CPR:9",
        "thymidine phosphorylase"
      ],
      [
        "5FU",
        "CPR:9",
        "TP"
      ],
      [
        "5FU",
        "CPR:9",
        "thymidine phosphorylase"
      ],
      [
        "fluoropyrimidine carbamate",
        "CPR:9",
        "TP"
      ],
      [
        "fluoropyrimidine carbamate",
        "CPR:9",
        "thymidine phosphorylase"
      ],
      [
        "capecitabine",
        "CPR:9",
        "TP"
      ],
      [
        "capecitabine",
        "CPR:9",
        "thymidine phosphorylase"
      ]
    ],
    "updated": "No",
    "original": "PURPOSE The fluoropyrimidine carbamate capecitabine is converted to 5fluorouracil 5FU by thymidine phosphorylase TP inside target tissues",
    "simplified": "The fluoropyrimidine carbamate capecitabine is changed into 5fluorouracil by thymidine phosphorylase inside the body."
  },
  {
    "text": "Favorable enzyme profiles high TP and low DPD produce high intratumor levels of 5FU . This helps the treatment of many types of cancer .",
    "triple_list": [
      [
        "TP",
        "CPR:9",
        "5FU"
      ],
      [
        "DPD",
        "CPR:9",
        "5FU"
      ]
    ],
    "updated": "Yes",
    "original": "Favorable enzyme profiles high TP and low DPD generate high intratumor levels of 5FU that are effective against many tumors especially those with low TS",
    "simplified": "Favorable enzyme profiles high TP and low DPD produce high intratumor levels of 5FU. This helps the treatment of many types of cancer."
  },
  {
    "text": "Histamine and Ca added to NSAIDs made CA II more active because of this .",
    "triple_list": [
      [
        "Ca",
        "CPR:3",
        "CA II"
      ]
    ],
    "updated": "Yes",
    "original": "Histamine and Ca added to NSAIDs amplified the activating effect of the latter on CA II",
    "simplified": "Histamine and Ca added to NSAIDs made CA II more active because of this."
  },
  {
    "text": "Indomethacin abolished the inhibitory effect of acetazolamide on CA I and CA II",
    "triple_list": [
      [
        "Indomethacin",
        "CPR:3",
        "CA I"
      ],
      [
        "Indomethacin",
        "CPR:3",
        "CA II"
      ],
      [
        "acetazolamide",
        "CPR:4",
        "CA I"
      ],
      [
        "acetazolamide",
        "CPR:4",
        "CA II"
      ]
    ],
    "updated": "No",
    "original": "Indomethacin abolished the inhibitory effect of acetazolamide on CA I and CA II",
    "simplified": "Indomethacin completely removed the acetazolamide inhibitory effect."
  },
  {
    "text": "Association of PGE2 or acetazolamide to NSAIDs reduced NSAIDinduced activation of CA I and CA II",
    "triple_list": [
      [
        "acetazolamide",
        "CPR:4",
        "CA I"
      ],
      [
        "acetazolamide",
        "CPR:4",
        "CA II"
      ]
    ],
    "updated": "No",
    "original": "Association of PGE2 or acetazolamide to NSAIDs reduced NSAIDinduced activation of CA I and CA II",
    "simplified": "The relationship between PGE2 and NSAIDs has been shown to reduce CA I and CA II activation."
  },
  {
    "text": "Previous studies by this research team proved that the vasodilating prostaglandins PGs E1 E2 and I2 inhibit carbonic anhydrase CA in vitro and in vivo . They also showed that these prostaglandins increase the flow of blood through the gastric mucosa .",
    "triple_list": [
      [
        "prostaglandins",
        "CPR:4",
        "carbonic anhydrase"
      ],
      [
        "prostaglandins",
        "CPR:4",
        "CA"
      ],
      [
        "PGs",
        "CPR:4",
        "carbonic anhydrase"
      ],
      [
        "PGs",
        "CPR:4",
        "CA"
      ]
    ],
    "updated": "Yes",
    "original": "Previous studies by this research team proved that vasodilating prostaglandins PGs E1 E2 and I2 inhibit carbonic anhydrase CA in vitro and in vivo which suggested involvement of CA in gastric acid secretion inhibition and the increase of gastric mucosa blood flow produced by this group of PGs",
    "simplified": "Previous studies by this research team proved that the vasodilating prostaglandins PGs E1 E2 and I2 inhibit carbonic anhydrase CA in vitro and in vivo. They also showed that these prostaglandins increase the flow of blood through the gastric mucosa."
  },
  {
    "text": "CONCLUSIONS In the maximum registered dosage nabumetone inhibits thromboxane production much more than meloxicam signifying less COX2 selectivity of the former",
    "triple_list": [
      [
        "nabumetone",
        "CPR:4",
        "COX2"
      ]
    ],
    "updated": "No",
    "original": "CONCLUSIONS In the maximum registered dosage nabumetone inhibits thromboxane production much more than meloxicam signifying less COX2 selectivity of the former",
    "simplified": "In the maximum registered dosage, nabumetone inhibits thromboxane production much more than meloxicam. This means that the former is less effective."
  },
  {
    "text": "COX1 inhibition was measured as a percentage of serum TXB2 generation in whole blood and as a closure time with the platelet function analyser PFA100 .",
    "triple_list": [
      [
        "COX1",
        "CPR:9",
        "TXB2"
      ]
    ],
    "updated": "Yes",
    "original": "COX1 inhibition was measured as percentage inhibition of serum TXB2 generation in clotting whole blood and as closure time with use of the platelet function analyser PFA100",
    "simplified": "COX1 inhibition was measured as a percentage of serum TXB2 generation in whole blood and as a closure time with the platelet function analyser PFA100."
  },
  {
    "text": "Treatment with diclofenac caused a morphological change in NSCs 24 hours after the treatment and activated caspase3 after 6 hours . This means that diclofenac may cause apoptosis of neuronal cells because it starts the caspase cascade .",
    "triple_list": [
      [
        "diclofenac",
        "CPR:3",
        "caspase3"
      ],
      [
        "diclofenac",
        "CPR:3",
        "caspase"
      ]
    ],
    "updated": "Yes",
    "original": "Treatment with diclofenac resulted in nuclear condensation a morphological change due to apoptosis of NSCs 24hr after the treatment and activated caspase3 after 6 hr indicating that diclofenac may cause apoptosis of neuronal cells via activation of the caspase cascade",
    "simplified": "Treatment with diclofenac caused a morphological change in NSCs 24 hours after the treatment and activated caspase3 after 6 hours. This means that diclofenac may cause apoptosis of neuronal cells because it starts the caspase cascade."
  },
  {
    "text": "Correlation between activation of PPAR\u03b3 and resistin downregulation in a mouse adipocyte cell line by a series of thiazolidinediones",
    "triple_list": [
      [
        "PPAR\u03b3",
        "CPR:3",
        "thiazolidinediones"
      ],
      [
        "resistin",
        "CPR:4",
        "thiazolidinediones"
      ]
    ],
    "updated": "No",
    "original": "Correlation between activation of PPAR\u03b3 and resistin downregulation in a mouse adipocyte cell line by a series of thiazolidinediones",
    "simplified": "The relationship between resistin downregulation and PPAR\u03b3 activation in a mouse adipocyte cell line was found."
  },
  {
    "text": "Firstly in the normal human renal epithelial HK2 cells the measurement of the expression of 30 previously reported NRF2 target genes in response to NRF2 inducers sulforaphane tertbutylhydroquinone cinnamic aldehyde and hydrogen peroxide showed that the aldoketo reductase AKR 1C1 is highly inducible by all treatments",
    "triple_list": [
      [
        "NRF2",
        "CPR:3",
        "sulforaphane"
      ],
      [
        "NRF2",
        "CPR:3",
        "sulforaphane"
      ],
      [
        "sulforaphane",
        "CPR:3",
        "aldoketo reductase AKR 1C1"
      ],
      [
        "NRF2",
        "CPR:3",
        "tertbutylhydroquinone"
      ],
      [
        "NRF2",
        "CPR:3",
        "tertbutylhydroquinone"
      ],
      [
        "tertbutylhydroquinone",
        "CPR:3",
        "aldoketo reductase AKR 1C1"
      ],
      [
        "NRF2",
        "CPR:3",
        "cinnamic aldehyde"
      ],
      [
        "NRF2",
        "CPR:3",
        "cinnamic aldehyde"
      ],
      [
        "cinnamic aldehyde",
        "CPR:3",
        "aldoketo reductase AKR 1C1"
      ],
      [
        "NRF2",
        "CPR:3",
        "hydrogen peroxide"
      ],
      [
        "NRF2",
        "CPR:3",
        "hydrogen peroxide"
      ],
      [
        "hydrogen peroxide",
        "CPR:3",
        "aldoketo reductase AKR 1C1"
      ]
    ],
    "updated": "No",
    "original": "Firstly in the normal human renal epithelial HK2 cells the measurement of the expression of 30 previously reported NRF2 target genes in response to NRF2 inducers sulforaphane tertbutylhydroquinone cinnamic aldehyde and hydrogen peroxide showed that the aldoketo reductase AKR 1C1 is highly inducible by all treatments",
    "simplified": "Firstly in the normal human renal epithelial HK2 cells the expression of 30 previously reported NRF2 target genes in response to sulforaphane and hydrogen peroxide showed that the aldoketo reductase AKR 1C1 is highly inducible by all treatments."
  },
  {
    "text": "When U937 cells were treated with sulforaphane , NRF2 inducers , the expression of AKR1B1 1B10 1C1 1C2 and 1C3 increased .",
    "triple_list": [
      [
        "NRF2",
        "CPR:3",
        "sulforaphane"
      ],
      [
        "sulforaphane",
        "CPR:3",
        "AKR1B1 1B10 1C1 1C2 and 1C3"
      ]
    ],
    "updated": "Yes",
    "original": "The treatment of U937 cells with NRF2 inducers including sulforaphane effectively elevated the expression of AKR1B1 1B10 1C1 1C2 and 1C3",
    "simplified": "When U937 cells were treated with sulforaphane, NRF2 inducers, the expression of AKR1B1 1B10 1C1 1C2 and 1C3 increased."
  },
  {
    "text": "Both the basal and sulforaphane inducible levels of AKR1C1 were significantly reduced in stable U937 cells when NRF2silenced compared to control cells .",
    "triple_list": [
      [
        "sulforaphane",
        "CPR:3",
        "AKR1C1"
      ]
    ],
    "updated": "Yes",
    "original": "Whereas the levels of both the basal and sulforaphane inducible expression of AKR1C1 were significantly reduced in NRF2silenced stable U937 cells compared to the control cells",
    "simplified": "Both the basal and sulforaphane inducible levels of AKR1C1 were significantly reduced in stable U937 cells when NRF2silenced compared to control cells."
  },
  {
    "text": "Endothelial NO synthase activity was increased by losartan but not by cilazapril",
    "triple_list": [
      [
        "Endothelial NO synthase",
        "CPR:3",
        "cilazapril"
      ]
    ],
    "updated": "Yes",
    "original": "Endothelial NO synthase expression was increased by cilazapril but not by losartan",
    "simplified": "Endothelial NO synthase activity was increased by losartan but not by cilazapril"
  },
  {
    "text": "Human and rat renin and angiotensinogen genes were downregulated in dTGR and were increased by losartan and cilazapril . However , no changes were observed in the rat ACE and AT1A receptor genes .",
    "triple_list": [
      [
        "Human and rat renin",
        "CPR:3",
        "losartan"
      ],
      [
        "angiotensinogen",
        "CPR:3",
        "losartan"
      ],
      [
        "Human and rat renin",
        "CPR:3",
        "cilazapril"
      ],
      [
        "angiotensinogen",
        "CPR:3",
        "cilazapril"
      ]
    ],
    "updated": "Yes",
    "original": "Human and rat renin and angiotensinogen genes were downregulated in dTGR and were increased by losartan and cilazapril treatments whereas no changes in the expression of rat ACE and AT1A receptor genes were observed",
    "simplified": "Human and rat renin and angiotensinogen genes were downregulated in dTGR and were increased by losartan and cilazapril. However, no changes were observed in the rat ACE and AT1A receptor genes."
  },
  {
    "text": "In addition to this big loss of function , M1766L also showed a 10fold increase in the amount of sodium in the air .",
    "triple_list": [
      [
        "M1766L",
        "CPR:3",
        "sodium"
      ]
    ],
    "updated": "Yes",
    "original": "In addition to this pronounced loss of function M1766L also showed a 10fold increase in the persistent late sodium current",
    "simplified": "In addition to this big loss of function, M1766L also showed a 10fold increase in the amount of sodium in the air."
  },
  {
    "text": "OMT showed partial protection in the cortical neurons via downregulation of NR2B containing NMDA receptors and upregulation of Bcl2 family",
    "triple_list": [
      [
        "OMT",
        "CPR:3",
        "Bcl2"
      ],
      [
        "OMT",
        "CPR:4",
        "NR2B"
      ],
      [
        "OMT",
        "CPR:4",
        "NMDA receptors"
      ]
    ],
    "updated": "No",
    "original": "OMT showed partial protection in the cortical neurons via downregulation of NR2B containing NMDA receptors and upregulation of Bcl2 family",
    "simplified": "OMT showed some protection in the cortical neurons. This was because the NR2B containing NMDA receptors were reduced."
  },
  {
    "text": "Western blot analysis showed that OMT reduced the amount of Bax . It also showed that pro- and anti-apoptotic proteins were reduced .",
    "triple_list": [
      [
        "OMT",
        "CPR:4",
        "Bax"
      ]
    ],
    "updated": "Yes",
    "original": "Western blot analysis revealed that OMT decreased the expression of Bax and repaired the balance of pro and antiapoptotic proteins",
    "simplified": "Western blot analysis showed that OMT reduced the amount of Bax. It also showed that pro- and anti-apoptotic proteins were reduced."
  },
  {
    "text": "In addition , OMT significantly reversed NR2B upregulation in cultured neurons and inhibited calcium overload after challenging NMDA .",
    "triple_list": [
      [
        "OMT",
        "CPR:4",
        "NR2B"
      ]
    ],
    "updated": "Yes",
    "original": "Furthermore OMT significantly reversed the upregulation of NR2B and inhibited the calcium overload in the cultured neurons after challenging the NMDA",
    "simplified": "In addition, OMT significantly reversed NR2B upregulation in cultured neurons and inhibited calcium overload after challenging NMDA."
  },
  {
    "text": "Emodin6O\u03b2Dglucoside inhibits the transcription of the HMGB1 gene in vitro .",
    "triple_list": [
      [
        "Emodin6O\u03b2Dglucoside",
        "CPR:4",
        "HMGB1"
      ]
    ],
    "updated": "Yes",
    "original": "Emodin6O\u03b2Dglucoside inhibits HMGB1 induced inflammatory responses in vitro and in vivo",
    "simplified": "Emodin6O\u03b2Dglucoside inhibits the transcription of the HMGB1 gene in vitro."
  },
  {
    "text": "Ramelteon Rozerem Takeda Pharmaceutical Company Limited Osaka Japan is an orally active highly selective melatonin MT1 MT2 receptor agonist",
    "triple_list": [
      [
        "Ramelteon",
        "CPR:5",
        "MT1"
      ],
      [
        "Ramelteon",
        "CPR:5",
        "MT2"
      ]
    ],
    "updated": "No",
    "original": "Ramelteon Rozerem Takeda Pharmaceutical Company Limited Osaka Japan is an orally active highly selective melatonin MT1 MT2 receptor agonist",
    "simplified": "Ramelteon (Rozerem) is a drug made by Takeda Pharmaceutical Company Limited. It is used to treat melatonin deficiency."
  },
  {
    "text": "Unlike other hypnotics that target GABAA receptor complexes , ramelteon acts on the melatonin MT1 and MT2 receptors . These receptors are located in the suprachiasmatic nucleus of the central nervous system .",
    "triple_list": [
      [
        "ramelteon",
        "CPR:5",
        "MT1"
      ],
      [
        "ramelteon",
        "CPR:5",
        "MT2"
      ]
    ],
    "updated": "Yes",
    "original": "Unlike the sedative hypnotics that target GABAA receptor complexes ramelteon is a chronohypnotic that acts on the melatonin MT1 and MT2 receptors which are primarily located in the suprachiasmatic nucleus the bodys master clock",
    "simplified": "Unlike other hypnotics that target GABAA receptor complexes, ramelteon acts on the melatonin MT1 and MT2 receptors. These receptors are located in the suprachiasmatic nucleus of the central nervous system."
  },
  {
    "text": "Pharmacology of ramelteon a selective MT1 MT2 receptor agonist a novel therapeutic drug for sleep disorders",
    "triple_list": [
      [
        "ramelteon",
        "CPR:5",
        "MT1"
      ],
      [
        "ramelteon",
        "CPR:5",
        "MT2"
      ]
    ],
    "updated": "No",
    "original": "Pharmacology of ramelteon a selective MT1 MT2 receptor agonist a novel therapeutic drug for sleep disorders",
    "simplified": "Ramelteon a novel therapeutic drug for sleep disorders that acts on the MT1 and MT2 receptors"
  },
  {
    "text": "Am80 inhibited VEGF induced phosphorylation of VEGF receptor",
    "triple_list": [
      [
        "Am80",
        "CPR:4",
        "VEGF receptor"
      ],
      [
        "Am80",
        "CPR:4",
        "VEGF"
      ]
    ],
    "updated": "No",
    "original": "Am80 inhibited VEGF induced phosphorylation of VEGF receptor",
    "simplified": "Am80 did not allow VEGF to be phosphorylated."
  },
  {
    "text": "In addition VEGF induced formation of tubelike structures in vitro and neovascularization in mouse corneas were significantly inhibited by Am80",
    "triple_list": [
      [
        "VEGF",
        "CPR:4",
        "Am80"
      ]
    ],
    "updated": "No",
    "original": "In addition VEGF induced formation of tubelike structures in vitro and neovascularization in mouse corneas were significantly inhibited by Am80",
    "simplified": "In addition, in vitro formation of tubelike structures and neovascularization in mouse corneas were significantly inhibited by Am80."
  },
  {
    "text": "Am80 slightly inhibited the growth of both myeloma cells and HUVECs and remarkably inhibited the growth of HUVECs stimulated by VEGF",
    "triple_list": [
      [
        "Am80",
        "CPR:4",
        "VEGF"
      ]
    ],
    "updated": "No",
    "original": "Am80 slightly inhibited the growth of both myeloma cells and HUVECs and remarkably inhibited the growth of HUVECs stimulated by VEGF",
    "simplified": "Am80 slightly inhibited the growth of both myeloma cells and HUVECs. It was also able to inhibit the growth of HUVECs."
  },
  {
    "text": "We have examined the effect of dihydropyridine Ca2channel blockers felodipine and nicardipine on CaMPDE",
    "triple_list": [
      [
        "Ca2channel",
        "CPR:4",
        "felodipine"
      ],
      [
        "Ca2channel",
        "CPR:4",
        "nicardipine"
      ],
      [
        "dihydropyridine",
        "CPR:4",
        "Ca2channel"
      ]
    ],
    "updated": "No",
    "original": "We have examined the effect of dihydropyridine Ca2channel blockers felodipine and nicardipine on CaMPDE",
    "simplified": "The effect of dihydropyridine and nicardipine on CaMPDE has been examined in humans."
  },
  {
    "text": "The results suggest that the 63kDa PDE 1B1 and 60kDa PDE 1A2 CaMPDE isozymes are inhibited by felodipine and nicardipine . The inhibitory effect of nicardipine on felodipine is not clear .",
    "triple_list": [
      [
        "PDE 1B1",
        "CPR:4",
        "felodipine"
      ],
      [
        "PDE 1A2",
        "CPR:4",
        "felodipine"
      ],
      [
        "CaMPDE",
        "CPR:4",
        "felodipine"
      ],
      [
        "PDE 1B1",
        "CPR:4",
        "nicardipine"
      ],
      [
        "PDE 1A2",
        "CPR:4",
        "nicardipine"
      ],
      [
        "CaMPDE",
        "CPR:4",
        "nicardipine"
      ]
    ],
    "updated": "Yes",
    "original": "The results suggest that the 63kDa PDE 1B1 and 60kDa PDE 1A2 CaMPDE isozymes are inhibited by felodipine and nicardipine by partial competitive inhibition and that these two Ca2 antagonists appear to counteract each other",
    "simplified": "The results suggest that the 63kDa PDE 1B1 and 60kDa PDE 1A2 CaMPDE isozymes are inhibited by felodipine and nicardipine. The inhibitory effect of nicardipine on felodipine is not clear."
  },
  {
    "text": "Felodipine and nicardipine have similar affinities for 60kDa CaMPDE isozymes but bring about different levels of enzyme inhibition suggesting the possibility of designing specific drugs that can protect the enzyme from inhibition by dihydropyridine Ca2channel blockers",
    "triple_list": [
      [
        "CaMPDE",
        "CPR:4",
        "dihydropyridine"
      ],
      [
        "dihydropyridine",
        "CPR:4",
        "Ca2channel"
      ]
    ],
    "updated": "No",
    "original": "Felodipine and nicardipine have similar affinities for 60kDa CaMPDE isozymes but bring about different levels of enzyme inhibition suggesting the possibility of designing specific drugs that can protect the enzyme from inhibition by dihydropyridine Ca2channel blockers",
    "simplified": "Felodipine and nicardipine have similar chemical similarity for 60kDa CaMPDE isozymes but they cause different levels of enzyme inhibition. This means that it may be possible to design drugs that can protect the enzyme."
  },
  {
    "text": "Several inhibitors of LpPLA2 have been described . One of these is called darapladib , which is currently in clinical development .",
    "triple_list": [
      [
        "LpPLA2",
        "CPR:4",
        "darapladib"
      ]
    ],
    "updated": "Yes",
    "original": "Several inhibitors of LpPLA2 have been described including darapladib which is currently in phase 3 clinical development for the treatment of atherosclerosis",
    "simplified": "Several inhibitors of LpPLA2 have been described. One of these is called darapladib, which is currently in clinical development."
  },
  {
    "text": "We show that both darapladib and a novel class of carbamate inhibitors inactivate LpPLA2 in human and mouse cells with high selectivity .",
    "triple_list": [
      [
        "darapladib",
        "CPR:4",
        "LpPLA2"
      ],
      [
        "carbamate",
        "CPR:4",
        "LpPLA2"
      ]
    ],
    "updated": "Yes",
    "original": "We show that both darapladib and a novel class of structurally distinct carbamate inhibitors inactivate LpPLA2 in mouse tissues and human cell lines with high selectivity",
    "simplified": "We show that both darapladib and a novel class of carbamate inhibitors inactivate LpPLA2 in human and mouse cells with high selectivity."
  },
  {
    "text": "Sepracor in the US is developing arformoterol RRformoterol a single isomer form of the beta2adrenoceptor agonist formoterol eformoterol",
    "triple_list": [
      [
        "formoterol",
        "CPR:5",
        "beta2adrenoceptor"
      ],
      [
        "beta2adrenoceptor",
        "CPR:5",
        "eformoterol"
      ]
    ],
    "updated": "No",
    "original": "Sepracor in the US is developing arformoterol RRformoterol a single isomer form of the beta2adrenoceptor agonist formoterol eformoterol",
    "simplified": "Sepracor in the US is developing a single isomer form of formoterol (acetaminophen) called arformoterol (acetaminophen)."
  },
  {
    "text": "Nitric oxide products of VP16 displayed significantly diminished topoisomerase II dependent cleavage of DNA and cytotoxicity to human HL60 leukemia cells",
    "triple_list": [
      [
        "VP16",
        "CPR:4",
        "topoisomerase II"
      ]
    ],
    "updated": "No",
    "original": "Nitric oxide products of VP16 displayed significantly diminished topoisomerase II dependent cleavage of DNA and cytotoxicity to human HL60 leukemia cells",
    "simplified": "Nitric oxide products of VP16 showed significantly less DNA damage when they were put into human leukemia cells."
  },
  {
    "text": "Refeeding normal chow or a high sucrose diet for 24 h after a 48h fast increased both the expression of ACS1 and ACS4 by 1520fold .",
    "triple_list": [
      [
        "sucrose",
        "CPR:3",
        "ACS1"
      ],
      [
        "sucrose",
        "CPR:3",
        "ACS4"
      ]
    ],
    "updated": "Yes",
    "original": "Refeeding normal chow or a high sucrose diet for 24 h after a 48h fast increased both ACS1 and ACS4 protein expression 1520fold consistent with inhibition studies",
    "simplified": "Refeeding normal chow or a high sucrose diet for 24 h after a 48h fast increased both the expression of ACS1 and ACS4 by 1520fold."
  },
  {
    "text": "Consistent with these locations Nethylmaleimide an inhibitor of ACS4 inhibited ACS activity 47 in MAM and 28 in endoplasmic reticulum",
    "triple_list": [
      [
        "Nethylmaleimide",
        "CPR:4",
        "ACS4"
      ],
      [
        "Nethylmaleimide",
        "CPR:4",
        "ACS"
      ]
    ],
    "updated": "No",
    "original": "Consistent with these locations Nethylmaleimide an inhibitor of ACS4 inhibited ACS activity 47 in MAM and 28 in endoplasmic reticulum",
    "simplified": "Nethylmaleimide, an inhibitor of ACS4, inhibited MAM activity by 47% and endoplasmic reticulum activity by 28%."
  },
  {
    "text": "Troglitazone a second ACS4 inhibitor inhibited ACS activity 10 in microsomes and mitochondria and 45 in MAM",
    "triple_list": [
      [
        "Troglitazone",
        "CPR:4",
        "ACS4"
      ],
      [
        "Troglitazone",
        "CPR:4",
        "ACS"
      ]
    ],
    "updated": "No",
    "original": "Troglitazone a second ACS4 inhibitor inhibited ACS activity 10 in microsomes and mitochondria and 45 in MAM",
    "simplified": "Troglitazone, a second ACS4 inhibitor, also did not work. It only worked in microsomes and mitochondria."
  },
  {
    "text": "Triacsin C a competitive inhibitor of both ACS1 and ACS4 inhibited ACS activity in endoplasmic reticulum MAM and mitochondria . This suggests that triacsinsensitive ACS is present in mitochondria .",
    "triple_list": [
      [
        "Triacsin C",
        "CPR:4",
        "ACS1"
      ],
      [
        "Triacsin C",
        "CPR:4",
        "ACS4"
      ],
      [
        "Triacsin C",
        "CPR:4",
        "ACS"
      ]
    ],
    "updated": "Yes",
    "original": "Triacsin C a competitive inhibitor of both ACS1 and ACS4 inhibited ACS activity similarly in endoplasmic reticulum MAM and mitochondria suggesting that a hitherto unidentified triacsinsensitive ACS is present in mitochondria",
    "simplified": "Triacsin C a competitive inhibitor of both ACS1 and ACS4 inhibited ACS activity in endoplasmic reticulum MAM and mitochondria. This suggests that triacsinsensitive ACS is present in mitochondria."
  },
  {
    "text": "These results suggest that ACS1 and ACS4 may be linked to triacylglycerol synthesis",
    "triple_list": [
      [
        "ACS1",
        "CPR:9",
        "triacylglycerol"
      ],
      [
        "ACS4",
        "CPR:9",
        "triacylglycerol"
      ]
    ],
    "updated": "No",
    "original": "These results suggest that ACS1 and ACS4 may be linked to triacylglycerol synthesis",
    "simplified": "These results suggest that triacylglycerol synthesis may be involved."
  },
  {
    "text": "ZD1839 Iressa a quinazoline t tyrosine kinase inhibitor selective for the EGFR has shown good activity in preclinical studies and in the early phase of clinical trials",
    "triple_list": [
      [
        "ZD1839",
        "CPR:4",
        "tyrosine kinase"
      ],
      [
        "ZD1839",
        "CPR:4",
        "EGFR"
      ],
      [
        "Iressa",
        "CPR:4",
        "tyrosine kinase"
      ],
      [
        "Iressa",
        "CPR:4",
        "EGFR"
      ]
    ],
    "updated": "No",
    "original": "ZD1839 Iressa a quinazoline t tyrosine kinase inhibitor selective for the EGFR has shown good activity in preclinical studies and in the early phase of clinical trials",
    "simplified": "ZD1839 Iressa a quinazoline t tyrosine kinase inhibitor has shown good activity in preclinical studies, but has not yet been approved for use in patients."
  },
  {
    "text": "The tyrosine kinase inhibitor ZD1839 Iressa inhibits HER2 driven signaling and suppresses the growth of HER2 overexpressing tumor cells",
    "triple_list": [
      [
        "tyrosine kinase",
        "CPR:4",
        "ZD1839"
      ],
      [
        "ZD1839",
        "CPR:4",
        "HER2"
      ],
      [
        "Iressa",
        "CPR:4",
        "HER2"
      ],
      [
        "tyrosine kinase",
        "CPR:4",
        "Iressa"
      ],
      [
        "Iressa",
        "CPR:4",
        "HER2"
      ],
      [
        "tyrosine",
        "CPR:9",
        "kinase"
      ]
    ],
    "updated": "No",
    "original": "The tyrosine kinase inhibitor ZD1839 Iressa inhibits HER2 driven signaling and suppresses the growth of HER2 overexpressing tumor cells",
    "simplified": "The tyrosine kinase inhibitor ZD1839 Iressa inhibits the growth of tumor cells by causing a reduction in tyrosine."
  },
  {
    "text": "These studies suggest that HER2overexpressing tumors are particularly susceptible to the inhibition of tyrosine kinase signaling , and suggest novel ways to treat them .",
    "triple_list": [
      [
        "tyrosine",
        "CPR:9",
        "kinase"
      ]
    ],
    "updated": "Yes",
    "original": "These studies suggest that HER2overexpressing tumors are particularly susceptible to the inhibition of HER family tyrosine kinase signaling and suggest novel strategies to treat these particularly aggressive tumors",
    "simplified": "These studies suggest that HER2overexpressing tumors are particularly susceptible to the inhibition of tyrosine kinase signaling, and suggest novel ways to treat them."
  },
  {
    "text": "Growth inhibition of these tumor cell lines was associated with the loss of association of HER3 with phosphatidylinositol 3kinase and downregulation of Akt activity .",
    "triple_list": [
      [
        "phosphatidylinositol",
        "CPR:9",
        "3kinase"
      ]
    ],
    "updated": "Yes",
    "original": "Growth inhibition of these tumor cell lines was associated with the dephosphorylation of EGFR HER2 and HER3 accompanied by the loss of association of HER3 with phosphatidylinositol 3kinase and downregulation of Akt activity",
    "simplified": "Growth inhibition of these tumor cell lines was associated with the loss of association of HER3 with phosphatidylinositol 3kinase and downregulation of Akt activity."
  },
  {
    "text": "The drug naltrexone works by attacking the muopioid receptor in the brain .",
    "triple_list": [
      [
        "muopioid receptor",
        "CPR:6",
        "naltrexone"
      ]
    ],
    "updated": "Yes",
    "original": "Pharmacological effects of a muopioid receptor antagonist naltrexone on alcohol dependence",
    "simplified": "The drug naltrexone works by attacking the muopioid receptor in the brain."
  },
  {
    "text": "In many countries a muopioid receptor antagonist naltrexone has been used in the treatment of alcohol dependence",
    "triple_list": [
      [
        "muopioid receptor",
        "CPR:6",
        "naltrexone"
      ]
    ],
    "updated": "No",
    "original": "In many countries a muopioid receptor antagonist naltrexone has been used in the treatment of alcohol dependence",
    "simplified": "Naltrexone is a muopioid receptor antagonist. It is used to treat alcohol dependence."
  },
  {
    "text": "Lisuride dose dependently decreased body temperature in rats with a potency similar to that of the selective 5HT1A agonist LY 293284",
    "triple_list": [
      [
        "5HT1A",
        "CPR:5",
        "LY 293284"
      ]
    ],
    "updated": "No",
    "original": "Lisuride dose dependently decreased body temperature in rats with a potency similar to that of the selective 5HT1A agonist LY 293284",
    "simplified": "Lisuride dose helped reduce body temperature in rats. The effect was similar to that of the drug naltrexone (LY 293284)."
  },
  {
    "text": "RESULTS In drug discrimination studies lisuride fully mimicked the 5HT1A agonist LY 293284 only partially substituted for LSD and DOI and failed to substitute for amphetamine",
    "triple_list": [
      [
        "lisuride",
        "CPR:5",
        "5HT1A"
      ],
      [
        "5HT1A",
        "CPR:5",
        "LY 293284"
      ]
    ],
    "updated": "No",
    "original": "RESULTS In drug discrimination studies lisuride fully mimicked the 5HT1A agonist LY 293284 only partially substituted for LSD and DOI and failed to substitute for amphetamine",
    "simplified": "Results In drug discrimination studies, lisuride was more effective than LSD and DOI when compared to 5HT1A. However, it was not as effective as amphetamine."
  },
  {
    "text": "Only pMPPI 4iodoN24methoxyphenyl1piperazinylethylN2pyridynylbenzamide hydrochloride a selective 5HT1A antagonist was effective in inhibiting all 5HT syndrome behaviors produced by lisuride whereas pMPPI was without effect on any behavior induced by LSD",
    "triple_list": [
      [
        "4iodoN24methoxyphenyl1piperazinylethylN2pyridynylbenzamide hydrochloride",
        "CPR:6",
        "5HT1A"
      ]
    ],
    "updated": "No",
    "original": "Only pMPPI 4iodoN24methoxyphenyl1piperazinylethylN2pyridynylbenzamide hydrochloride a selective 5HT1A antagonist was effective in inhibiting all 5HT syndrome behaviors produced by lisuride whereas pMPPI was without effect on any behavior induced by LSD",
    "simplified": "Only pMPPI 4iodoN24methoxyphenyl1piperazinylethylN2pyridynylbenzamide hydrochloride was effective in inhibiting all 5HT syndrome behaviors. However, pMPPI had no effect on any behavior that was caused by LSD."
  },
  {
    "text": "Thus bupropion acts as an antagonist at alpha3beta2 and alpha3beta4 nAChRs in the rat striatum and hippocampus . DAT and NET function are affected by bupropion .",
    "triple_list": [
      [
        "bupropion",
        "CPR:4",
        "DAT"
      ],
      [
        "bupropion",
        "CPR:4",
        "NET"
      ]
    ],
    "updated": "Yes",
    "original": "Thus bupropion acts as an antagonist at alpha3beta2 and alpha3beta4 nAChRs in rat striatum and hippocampus respectively across the same concentration range that inhibits DAT and NET function",
    "simplified": "Thus bupropion acts as an antagonist at alpha3beta2 and alpha3beta4 nAChRs in the rat striatum and hippocampus. DAT and NET function are affected by bupropion."
  },
  {
    "text": "The combination of nAChR and transporter inhibition produced by bupropion may help people stop smoking . This is called smoking cessation .",
    "triple_list": [
      [
        "nAChR",
        "CPR:4",
        "bupropion"
      ]
    ],
    "updated": "Yes",
    "original": "The combination of nAChR and transporter inhibition produced by bupropion may contribute to its clinical efficacy as a smoking cessation agent",
    "simplified": "The combination of nAChR and transporter inhibition produced by bupropion may help people stop smoking. This is called smoking cessation."
  },
  {
    "text": "Bupropion an efficacious antidepressant and smoking cessation agent inhibits dopamine and norepinephrine transporters DAT and NET respectively",
    "triple_list": [
      [
        "Bupropion",
        "CPR:4",
        "DAT"
      ],
      [
        "Bupropion",
        "CPR:4",
        "NET"
      ]
    ],
    "updated": "No",
    "original": "Bupropion an efficacious antidepressant and smoking cessation agent inhibits dopamine and norepinephrine transporters DAT and NET respectively",
    "simplified": "Bupropion is an effective smoking cessation and antidepressant agent. It inhibits the dopamine and norepinephrine transporters."
  },
  {
    "text": "To remove the interaction of bupropion with DAT or NET nomifensine and desipramine were added to the solution .",
    "triple_list": [
      [
        "bupropion",
        "CPR:4",
        "DAT"
      ],
      [
        "bupropion",
        "CPR:4",
        "NET"
      ]
    ],
    "updated": "Yes",
    "original": "To eliminate the interaction of bupropion with DAT or NET nomifensine or desipramine respectively was included in the superfusion buffer",
    "simplified": "To remove the interaction of bupropion with DAT or NET nomifensine and desipramine were added to the solution."
  },
  {
    "text": "Furthermore N BPs decreased the levels of phosphorylated extracellular signalregulated kinase ERK and mTOR via suppression of Ras prenylation and enhanced Bim expression",
    "triple_list": [
      [
        "N",
        "CPR:3",
        "Bim"
      ],
      [
        "BPs",
        "CPR:3",
        "Bim"
      ],
      [
        "N",
        "CPR:4",
        "phosphorylated extracellular signalregulated kinase"
      ],
      [
        "N",
        "CPR:4",
        "ERK"
      ],
      [
        "N",
        "CPR:4",
        "mTOR"
      ],
      [
        "N",
        "CPR:4",
        "Ras"
      ],
      [
        "BPs",
        "CPR:4",
        "phosphorylated extracellular signalregulated kinase"
      ],
      [
        "BPs",
        "CPR:4",
        "ERK"
      ],
      [
        "BPs",
        "CPR:4",
        "mTOR"
      ],
      [
        "BPs",
        "CPR:4",
        "Ras"
      ]
    ],
    "updated": "No",
    "original": "Furthermore N BPs decreased the levels of phosphorylated extracellular signalregulated kinase ERK and mTOR via suppression of Ras prenylation and enhanced Bim expression",
    "simplified": "In addition, N BPs reduced the levels of extracellular signal-regulated kinase ERK and mTOR. It also reduced Ras prenylation and increased Bim expression."
  },
  {
    "text": "The present results indicated that N BPs induce apoptosis by decreasing the mitochondrial transmembrane potential increasing the activation of caspase9 and caspase3 and enhancing Bim expression through inhibition of the Ras MEK ERK and Ras mTOR pathways",
    "triple_list": [
      [
        "N",
        "CPR:3",
        "caspase9"
      ],
      [
        "N",
        "CPR:3",
        "caspase3"
      ],
      [
        "N",
        "CPR:3",
        "Bim"
      ],
      [
        "BPs",
        "CPR:3",
        "caspase9"
      ],
      [
        "BPs",
        "CPR:3",
        "caspase3"
      ],
      [
        "BPs",
        "CPR:3",
        "Bim"
      ],
      [
        "N",
        "CPR:4",
        "Ras"
      ],
      [
        "N",
        "CPR:4",
        "MEK"
      ],
      [
        "N",
        "CPR:4",
        "ERK"
      ],
      [
        "N",
        "CPR:4",
        "Ras"
      ],
      [
        "N",
        "CPR:4",
        "mTOR"
      ],
      [
        "BPs",
        "CPR:4",
        "Ras"
      ],
      [
        "BPs",
        "CPR:4",
        "MEK"
      ],
      [
        "BPs",
        "CPR:4",
        "ERK"
      ],
      [
        "BPs",
        "CPR:4",
        "Ras"
      ],
      [
        "BPs",
        "CPR:4",
        "mTOR"
      ]
    ],
    "updated": "No",
    "original": "The present results indicated that N BPs induce apoptosis by decreasing the mitochondrial transmembrane potential increasing the activation of caspase9 and caspase3 and enhancing Bim expression through inhibition of the Ras MEK ERK and Ras mTOR pathways",
    "simplified": "The present results indicated that N BPs induce apoptosis by decreasing the mitochondrial transmembrane potential and enhancing Bim expression through inhibition of the Ras MEK ERK and Ras mTOR pathways."
  },
  {
    "text": "Nitrogen containing bisphosphonates induce apoptosis of hematopoietic tumor cells via inhibition of Ras signaling pathways and Bim mediated activation of the intrinsic apoptotic pathway",
    "triple_list": [
      [
        "Nitrogen",
        "CPR:3",
        "Bim"
      ],
      [
        "bisphosphonates",
        "CPR:3",
        "Bim"
      ],
      [
        "Nitrogen",
        "CPR:4",
        "Ras"
      ],
      [
        "bisphosphonates",
        "CPR:4",
        "Ras"
      ]
    ],
    "updated": "No",
    "original": "Nitrogen containing bisphosphonates induce apoptosis of hematopoietic tumor cells via inhibition of Ras signaling pathways and Bim mediated activation of the intrinsic apoptotic pathway",
    "simplified": "Nitrogen containing bisphosphonates induce apoptosis of hematopoietic tumor cells. Bim mediated activation of the intrinsic apoptotic pathway is involved in this process."
  },
  {
    "text": "Nitrogen containing bisphosphonates N BPs induce apoptosis in tumor cells by inhibiting the prenylation of small Gproteins",
    "triple_list": [
      [
        "Nitrogen",
        "CPR:4",
        "Gproteins"
      ],
      [
        "bisphosphonates",
        "CPR:4",
        "Gproteins"
      ],
      [
        "N",
        "CPR:4",
        "Gproteins"
      ],
      [
        "BPs",
        "CPR:4",
        "Gproteins"
      ]
    ],
    "updated": "No",
    "original": "Nitrogen containing bisphosphonates N BPs induce apoptosis in tumor cells by inhibiting the prenylation of small Gproteins",
    "simplified": "Bisphosphonates (N BPs) cause apoptosis (cell death) in tumor cells. They stop small proteins from being made."
  },
  {
    "text": "When the levels of P2X3 were reduced , the proteasomal inhibitor MG132 worked .",
    "triple_list": [
      [
        "P2X3",
        "CPR:3",
        "MG132"
      ]
    ],
    "updated": "Yes",
    "original": "The reduction of P2X3 expression levels was reversed by the proteasomal inhibitor MG132",
    "simplified": "When the levels of P2X3 were reduced, the proteasomal inhibitor MG132 worked."
  },
  {
    "text": "We investigated the involvement of the farnesoid X receptor FXR a nuclear receptor for bile acids in the chenodeoxycholic acid CDCA induced expression of Cdx2 and MUC2 in normal rat gastric epithelial cells RGM1 cells",
    "triple_list": [
      [
        "chenodeoxycholic acid",
        "CPR:3",
        "Cdx2"
      ],
      [
        "chenodeoxycholic acid",
        "CPR:3",
        "MUC2"
      ],
      [
        "CDCA",
        "CPR:3",
        "Cdx2"
      ],
      [
        "CDCA",
        "CPR:3",
        "MUC2"
      ]
    ],
    "updated": "No",
    "original": "We investigated the involvement of the farnesoid X receptor FXR a nuclear receptor for bile acids in the chenodeoxycholic acid CDCA induced expression of Cdx2 and MUC2 in normal rat gastric epithelial cells RGM1 cells",
    "simplified": "We looked at the role of the farnesoid X receptor in the chenodeoxycholic acid-induced expression of Cdx2 and MUC2 in normal rat gastric epithelial cells RGM1 cells."
  },
  {
    "text": "CDCA changed the expression of MUC2 and Cdx2 at both the mRNA and protein levels .",
    "triple_list": [
      [
        "CDCA",
        "CPR:3",
        "Cdx2"
      ],
      [
        "CDCA",
        "CPR:3",
        "MUC2"
      ]
    ],
    "updated": "Yes",
    "original": "CDCA induced dosedependent expression of Cdx2 and MUC2 at both the mRNA and protein levels",
    "simplified": "CDCA changed the expression of MUC2 and Cdx2 at both the mRNA and protein levels."
  },
  {
    "text": "The maximum level of CDCA stimulation of Cdx2 and MUC2 mRNA was observed at 3 h and by 6 h .",
    "triple_list": [
      [
        "Cdx2",
        "CPR:3",
        "CDCA"
      ],
      [
        "MUC2",
        "CPR:3",
        "CDCA"
      ]
    ],
    "updated": "Yes",
    "original": "The maximum stimulation of Cdx2 and MUC2 mRNA induced by CDCA was observed at 3 h and by 6 h respectively",
    "simplified": "The maximum level of CDCA stimulation of Cdx2 and MUC2 mRNA was observed at 3 h and by 6 h."
  },
  {
    "text": "The effects of CDCA and GW4064 on expression of Cdx2 and MUC2 were abolished by guggulsterone",
    "triple_list": [
      [
        "Cdx2",
        "CPR:4",
        "guggulsterone"
      ],
      [
        "MUC2",
        "CPR:4",
        "guggulsterone"
      ]
    ],
    "updated": "No",
    "original": "The effects of CDCA and GW4064 on expression of Cdx2 and MUC2 were abolished by guggulsterone",
    "simplified": "The effects of CDCA and GW4064 on MUC2 were abolished by guggulsterone in 2004."
  },
  {
    "text": "RGM1 cells were treated with either CDCA or GW4064 , an FXR agonist , or guggulsterone , an FXR antagonist .",
    "triple_list": [
      [
        "CDCA",
        "CPR:5",
        "FXR"
      ],
      [
        "GW4064",
        "CPR:5",
        "FXR"
      ],
      [
        "FXR",
        "CPR:6",
        "guggulsterone"
      ]
    ],
    "updated": "Yes",
    "original": "RGM1 cells were treated with CDCA or GW4064 an FXR agonist in the presence or absence of guggulsterone an FXR antagonist",
    "simplified": "RGM1 cells were treated with either CDCA or GW4064, an FXR agonist, or guggulsterone, an FXR antagonist."
  },
  {
    "text": "Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter",
    "triple_list": [
      [
        "Mazindol",
        "CPR:4",
        "cocaine binding site"
      ],
      [
        "Mazindol",
        "CPR:4",
        "dopamine transporter"
      ],
      [
        "dopamine",
        "CPR:9",
        "transporter"
      ]
    ],
    "updated": "No",
    "original": "Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter",
    "simplified": "Mazindol analogues as potential anti-cocaine drugs because of their anti-dopaminergic properties"
  },
  {
    "text": "Several active analogues were also evaluated for their ability to block uptake of DA 5HT and NE and inhibit binding of 125I RTI55 at HEK hDAT HEK hSERT and HEK hNET cells",
    "triple_list": [
      [
        "5HT",
        "CPR:9",
        "hSERT"
      ],
      [
        "NE",
        "CPR:9",
        "hNET"
      ],
      [
        "DA",
        "CPR:9",
        "hDAT"
      ]
    ],
    "updated": "No",
    "original": "Several active analogues were also evaluated for their ability to block uptake of DA 5HT and NE and inhibit binding of 125I RTI55 at HEK hDAT HEK hSERT and HEK hNET cells",
    "simplified": "Several active analogues were also evaluated for their ability to block the uptake of DA 5HT and NE. They were also evaluated for their ability to bind 125I."
  },
  {
    "text": "Glyphosate affects aromatic amino acid biosynthesis by inhibiting 5enolpyruvylshikimate3phosphate synthase EPSPS",
    "triple_list": [
      [
        "Glyphosate",
        "CPR:4",
        "5enolpyruvylshikimate3phosphate synthase"
      ],
      [
        "Glyphosate",
        "CPR:4",
        "EPSPS"
      ]
    ],
    "updated": "No",
    "original": "Glyphosate affects aromatic amino acid biosynthesis by inhibiting 5enolpyruvylshikimate3phosphate synthase EPSPS",
    "simplified": "Glyphosate affects the biosynthesis of aromatic amino acids by inhibiting the enzyme EPSPS."
  },
  {
    "text": "Glufosinate stops the enzyme glutamine synthetase from working .",
    "triple_list": [
      [
        "Glufosinate",
        "CPR:4",
        "glutamine synthetase"
      ],
      [
        "glutamine",
        "CPR:9",
        "glutamine synthetase"
      ]
    ],
    "updated": "Yes",
    "original": "Glufosinate inhibits glutamine synthetase and blocks biosynthesis of glutamine",
    "simplified": "Glufosinate stops the enzyme glutamine synthetase from working."
  },
  {
    "text": "Mechanisms of Glucose Lowering of Dipeptidyl Peptidase4 Inhibitor Sitagliptin When Used Alone or With Metformin in Type 2 Diabetes A doubletracer study",
    "triple_list": [
      [
        "Dipeptidyl Peptidase4",
        "CPR:4",
        "Sitagliptin"
      ]
    ],
    "updated": "No",
    "original": "Mechanisms of Glucose Lowering of Dipeptidyl Peptidase4 Inhibitor Sitagliptin When Used Alone or With Metformin in Type 2 Diabetes A doubletracer study",
    "simplified": "Dipeptidyl Peptidase4 Inhibitor When Used Alone or With Metformin in Type 2 Diabetes A doubletracer study showed that it reduces blood sugar."
  },
  {
    "text": "When coexposure to V5 and TCDD V5 significantly increased the TCDDmediated induction of the Cyp1a1 Cyp1a2 and Cyp1b1 mRNA protein and catalytic activity levels at 24 h in In vitro V5 reduced the TCDDmediated induction of Cyp1a1 and Cyp1b1 mRNA at 24 h .",
    "triple_list": [
      [
        "V5",
        "CPR:3",
        "Cyp1a1"
      ],
      [
        "V5",
        "CPR:3",
        "Cyp1a2"
      ],
      [
        "V5",
        "CPR:3",
        "Cyp1b1"
      ],
      [
        "TCDD",
        "CPR:3",
        "Cyp1a1"
      ],
      [
        "TCDD",
        "CPR:3",
        "Cyp1a2"
      ],
      [
        "TCDD",
        "CPR:3",
        "Cyp1b1"
      ],
      [
        "V5",
        "CPR:3",
        "Cyp1a1"
      ],
      [
        "V5",
        "CPR:3",
        "Cyp1a2"
      ],
      [
        "V5",
        "CPR:3",
        "Cyp1b1"
      ],
      [
        "TCDD",
        "CPR:3",
        "Cyp1a1"
      ],
      [
        "TCDD",
        "CPR:3",
        "Cyp1a2"
      ],
      [
        "TCDD",
        "CPR:3",
        "Cyp1b1"
      ],
      [
        "TCDD",
        "CPR:3",
        "Cyp1a1"
      ],
      [
        "V5",
        "CPR:4",
        "Cyp1a1"
      ]
    ],
    "updated": "Yes",
    "original": "Upon coexposure to V5 and TCDD V5 significantly potentiated the TCDDmediated induction of the Cyp1a1 Cyp1a2 and Cyp1b1 mRNA protein and catalytic activity levels at 24 h In vitro V5 decreased the TCDDmediated induction of Cyp1a1 mRNA protein and catalytic activity levels",
    "simplified": "When coexposure to V5 and TCDD V5 significantly increased the TCDDmediated induction of the Cyp1a1 Cyp1a2 and Cyp1b1 mRNA protein and catalytic activity levels at 24 h in In vitro V5 reduced the TCDDmediated induction of Cyp1a1 and Cyp1b1 mRNA at 24 h."
  },
  {
    "text": "V5 also increased serum hemoglobin Hb levels in animals treated for 24 h Upon treatment of isolated hepatocytes with Hb alone or in the presence of TCDD there was an increase in the AhR dependent luciferase activity",
    "triple_list": [
      [
        "V5",
        "CPR:3",
        "serum hemoglobin"
      ],
      [
        "V5",
        "CPR:3",
        "Hb"
      ],
      [
        "TCDD",
        "CPR:3",
        "AhR"
      ]
    ],
    "updated": "No",
    "original": "V5 also increased serum hemoglobin Hb levels in animals treated for 24 h Upon treatment of isolated hepatocytes with Hb alone or in the presence of TCDD there was an increase in the AhR dependent luciferase activity",
    "simplified": "V5 also increased serum hemoglobin levels in animals treated for 24 h. When isolated hepatocytes were treated with Hb alone or with TCDD, luciferase activity in the liver was increased."
  },
  {
    "text": "Furthermore V5 significantly inhibited the TCDD induced AhR dependent luciferase activity",
    "triple_list": [
      [
        "TCDD",
        "CPR:3",
        "AhR"
      ],
      [
        "V5",
        "CPR:4",
        "AhR"
      ]
    ],
    "updated": "No",
    "original": "Furthermore V5 significantly inhibited the TCDD induced AhR dependent luciferase activity",
    "simplified": "In addition, V5 significantly reduced the AhR dependent luciferase activity."
  },
  {
    "text": "DEX increased the ratio IFNgamma IL4 mean SEM control with 107 M DEX 550 275 P0005",
    "triple_list": [
      [
        "DEX",
        "CPR:3",
        "IFNgamma"
      ],
      [
        "DEX",
        "CPR:3",
        "IL4"
      ]
    ],
    "updated": "Yes",
    "original": "DEX enhanced the ratio IFNgamma IL4 mean SEM control 287 176 with 107 M DEX 550 275 P0005",
    "simplified": "DEX increased the ratio IFNgamma IL4 mean SEM control with 107 M DEX 550 275 P0005"
  },
  {
    "text": "Interestingly two categories of clones were distinguished based on the effects of GCS on IL2 production and IL2R alpha expression and proliferation 1 In low IL2 producers DEX blocked IL2 production and decreased IL2R alpha expression and proliferation 2 In high IL2 producers DEX inhibited IL2 production partially and enhanced IL2R alpha expression and proliferation",
    "triple_list": [
      [
        "IL2R alpha",
        "CPR:3",
        "DEX"
      ],
      [
        "IL2",
        "CPR:4",
        "DEX"
      ],
      [
        "IL2R alpha",
        "CPR:4",
        "DEX"
      ],
      [
        "IL2",
        "CPR:4",
        "DEX"
      ]
    ],
    "updated": "No",
    "original": "Interestingly two categories of clones were distinguished based on the effects of GCS on IL2 production and IL2R alpha expression and proliferation 1 In low IL2 producers DEX blocked IL2 production and decreased IL2R alpha expression and proliferation 2 In high IL2 producers DEX inhibited IL2 production partially and enhanced IL2R alpha expression and proliferation",
    "simplified": "Two categories of clones were distinguished based on the effects of GCS on IL2 production and IL2R alpha expression. In low IL2 producers, GCS did not affect IL2 production and IL2R alpha expression, but in high IL2 producers, GCS did affect IL2 production and IL2R alpha expression."
  },
  {
    "text": "Dexamethasone DEX inhibited the anti CD3 induced production of IL4 IL5 and IFNgamma in all 20 clones tested",
    "triple_list": [
      [
        "DEX",
        "CPR:4",
        "CD3"
      ],
      [
        "DEX",
        "CPR:4",
        "IL4"
      ],
      [
        "DEX",
        "CPR:4",
        "IL5"
      ],
      [
        "DEX",
        "CPR:4",
        "IFNgamma"
      ],
      [
        "Dexamethasone",
        "CPR:4",
        "CD3"
      ],
      [
        "Dexamethasone",
        "CPR:4",
        "IL4"
      ],
      [
        "Dexamethasone",
        "CPR:4",
        "IL5"
      ],
      [
        "Dexamethasone",
        "CPR:4",
        "IFNgamma"
      ]
    ],
    "updated": "No",
    "original": "Dexamethasone DEX inhibited the anti CD3 induced production of IL4 IL5 and IFNgamma in all 20 clones tested",
    "simplified": "Dexamethasone DEX stopped IL4 and IFNgamma from being made in all 20 human cells that were tested."
  },
  {
    "text": "GCS therapy results in reduced mRNA expression of interleukin4 IL4 and IL5 in cells from bronchoalveolar lavage BAL but not of IFNgamma",
    "triple_list": [
      [
        "GCS",
        "CPR:4",
        "interleukin4"
      ],
      [
        "GCS",
        "CPR:4",
        "IL4"
      ],
      [
        "GCS",
        "CPR:4",
        "IL5"
      ]
    ],
    "updated": "No",
    "original": "GCS therapy results in reduced mRNA expression of interleukin4 IL4 and IL5 in cells from bronchoalveolar lavage BAL but not of IFNgamma",
    "simplified": "GCS therapy results in reduced levels of interleukin4 and interleukin4-related proteins in cells, but not in healthy people."
  },
  {
    "text": "In conclusion the production of IL4 and IL5 by Tcell clones derived either from BAL or blood was more sensitive to inhibition by DEX than that of IFNgamma The effects of IFNgamma on the production of IL4 and IL5 are not known .",
    "triple_list": [
      [
        "IL4",
        "CPR:4",
        "DEX"
      ],
      [
        "IL5",
        "CPR:4",
        "DEX"
      ],
      [
        "DEX",
        "CPR:4",
        "IFNgamma"
      ]
    ],
    "updated": "Yes",
    "original": "In conclusion the production of IL4 and IL5 by Tcell clones derived either from BAL or blood was more sensitive to inhibition by DEX than that of IFNgamma which may account for the therapeutic effects of glucocorticosteroids in patients with asthma",
    "simplified": "In conclusion the production of IL4 and IL5 by Tcell clones derived either from BAL or blood was more sensitive to inhibition by DEX than that of IFNgamma The effects of IFNgamma on the production of IL4 and IL5 are not known."
  },
  {
    "text": "In vitro studies with bloodderived T cells however show inhibition of all three cytokines by GCS",
    "triple_list": [
      [
        "cytokines",
        "CPR:4",
        "GCS"
      ]
    ],
    "updated": "No",
    "original": "In vitro studies with bloodderived T cells however show inhibition of all three cytokines by GCS",
    "simplified": "In vitro studies with blood T cells however show that GCS does not work as well."
  },
  {
    "text": "Amprenavir-mediated PXR activation increased the expression of several important lipid homeostasis genes .",
    "triple_list": [
      [
        "Amprenavir",
        "CPR:3",
        "PXR"
      ]
    ],
    "updated": "Yes",
    "original": "Amprenavir mediated PXR activation stimulated the expression of several key intestinal genes involved in lipid homeostasis",
    "simplified": "Amprenavir-mediated PXR activation increased the expression of several important lipid homeostasis genes."
  },
  {
    "text": "Amprenavir effectively activated PXR and caused PXR target gene expression in human cells .",
    "triple_list": [
      [
        "Amprenavir",
        "CPR:3",
        "PXR"
      ],
      [
        "Amprenavir",
        "CPR:3",
        "PXR"
      ]
    ],
    "updated": "Yes",
    "original": "Amprenavir efficiently activated PXR and induced PXR target gene expression in vitro and in vivo",
    "simplified": "Amprenavir effectively activated PXR and caused PXR target gene expression in human cells."
  },
  {
    "text": "Pregnane X Receptor Mediates Dyslipidemia Induced by the HIV Protease Inhibitor Amprenavir in Mice",
    "triple_list": [
      [
        "HIV Protease",
        "CPR:4",
        "Amprenavir"
      ]
    ],
    "updated": "No",
    "original": "Pregnane X Receptor Mediates Dyslipidemia Induced by the HIV Protease Inhibitor Amprenavir in Mice",
    "simplified": "Pregnane X Receptor suppresses the growth of HIV-infected cells by inhibiting their DNA replication."
  },
  {
    "text": "In the present study we identified amprenavir as a potent PXR selective agonist in HIV .",
    "triple_list": [
      [
        "amprenavir",
        "CPR:5",
        "PXR"
      ]
    ],
    "updated": "Yes",
    "original": "In the present study we identified amprenavir a widely used HIV PI as a potent PXR selective agonist",
    "simplified": "In the present study we identified amprenavir as a potent PXR selective agonist in HIV."
  },
  {
    "text": "The anti-diabetic activity of Swertiamarin is due to a Gentianine-based enzyme that upregulates PPAR\u03b3 gene expression .",
    "triple_list": [
      [
        "Gentianine",
        "CPR:3",
        "PPAR\u03b3"
      ]
    ],
    "updated": "Yes",
    "original": "Antidiabetic Activity of Swertiamarin is due to an Active Metabolite Gentianine that Upregulates PPAR\u03b3 Gene Expression in 3T3L1 cells",
    "simplified": "The anti-diabetic activity of Swertiamarin is due to a Gentianine-based enzyme that upregulates PPAR\u03b3 gene expression."
  },
  {
    "text": "Swertiamarin treatment had no significant effect on the expression of PPAR\u03b3 and GLUT4 , but it did have a significant effect on the expression of adiponectin .",
    "triple_list": [
      [
        "Swertiamarin",
        "CPR:3",
        "adiponectin"
      ]
    ],
    "updated": "Yes",
    "original": "Swertiamarin treatment had no significant effect on adipogenesis or the mRNA expression of PPAR\u03b3 and GLUT4 however there was a significant increase in the mRNA expression of adiponectin",
    "simplified": "Swertiamarin treatment had no significant effect on the expression of PPAR\u03b3 and GLUT4, but it did have a significant effect on the expression of adiponectin."
  },
  {
    "text": "On the other hand , treatment with gentianine significantly increased adipogenesis . The mRNA expression of PPAR\u03b3 GLUT4 and adiponectin were also significantly increased .",
    "triple_list": [
      [
        "gentianine",
        "CPR:3",
        "PPAR\u03b3"
      ],
      [
        "gentianine",
        "CPR:3",
        "GLUT4"
      ],
      [
        "gentianine",
        "CPR:3",
        "adiponectin"
      ]
    ],
    "updated": "Yes",
    "original": "On the other hand treatment with gentianine significantly increased adipogenesis which was associated with a significant increase in the mRNA expression of PPAR\u03b3 GLUT4 and adiponectin",
    "simplified": "On the other hand, treatment with gentianine significantly increased adipogenesis. The mRNA expression of PPAR\u03b3 GLUT4 and adiponectin were also significantly increased."
  },
  {
    "text": "Jaspamide also stopped other channels , for example Cav12 Cav32 and HCN2 . However , the Kv111 hERG channel was not affected .",
    "triple_list": [
      [
        "Jaspamide",
        "CPR:4",
        "Cav12"
      ],
      [
        "Jaspamide",
        "CPR:4",
        "Cav32"
      ],
      [
        "Jaspamide",
        "CPR:4",
        "HCN2"
      ]
    ],
    "updated": "Yes",
    "original": "Jaspamide also inhibited other channels including Cav12 Cav32 and HCN2 however the Kv111 hERG channel was minimally affected",
    "simplified": "Jaspamide also stopped other channels, for example Cav12 Cav32 and HCN2. However, the Kv111 hERG channel was not affected."
  },
  {
    "text": "Treatment with carvedilol reversed both protein and mRNA of HIF1alpha VEGF BNP and NGFbeta to the baseline values",
    "triple_list": [
      [
        "carvedilol",
        "CPR:3",
        "NGFbeta"
      ],
      [
        "carvedilol",
        "CPR:4",
        "HIF1alpha"
      ],
      [
        "carvedilol",
        "CPR:4",
        "VEGF"
      ],
      [
        "carvedilol",
        "CPR:4",
        "BNP"
      ]
    ],
    "updated": "No",
    "original": "Treatment with carvedilol reversed both protein and mRNA of HIF1alpha VEGF BNP and NGFbeta to the baseline values",
    "simplified": "Treatment with carvedilol changed the mRNA and protein levels of HIF1alpha and NGFbeta back to normal."
  },
  {
    "text": "Increased immunohistochemical labeling of HIF1alpha VEGF and BNP in the ventricular myocardium was observed in the shunt group and carvedilol again normalized the labeling",
    "triple_list": [
      [
        "HIF1alpha",
        "CPR:4",
        "carvedilol"
      ],
      [
        "VEGF",
        "CPR:4",
        "carvedilol"
      ],
      [
        "BNP",
        "CPR:4",
        "carvedilol"
      ]
    ],
    "updated": "No",
    "original": "Increased immunohistochemical labeling of HIF1alpha VEGF and BNP in the ventricular myocardium was observed in the shunt group and carvedilol again normalized the labeling",
    "simplified": "Increased immunohistochemical labeling in the ventricular myocardium was observed in the shunt group and the labeling was normalized by carvedilol."
  },
  {
    "text": "Treatment with carvedilol is associated with a change in the abnormal regulation of HIF1alpha and VEGF in the heart .",
    "triple_list": [
      [
        "carvedilol",
        "CPR:4",
        "HIF1alpha"
      ],
      [
        "carvedilol",
        "CPR:4",
        "VEGF"
      ]
    ],
    "updated": "Yes",
    "original": "Treatment with carvedilol is associated with a reversal of abnormal regulation of HIF1alpha and VEGF in the failing ventricular myocardium",
    "simplified": "Treatment with carvedilol is associated with a change in the abnormal regulation of HIF1alpha and VEGF in the heart."
  },
  {
    "text": "These effects were fully counteracted by dietary phenolics which inhibited ROS overproduction and blocked the intracellular signals leading to the overexpression and rearrangement of p66Shc signalling molecule . GSH consumption rendered the reactive transcription of glutathioneassociated enzymes unnecessary .",
    "triple_list": [
      [
        "phenolics",
        "CPR:4",
        "p66Shc"
      ]
    ],
    "updated": "Yes",
    "original": "These effects were fully counteracted by dietary phenolics which inhibited ROS overproduction and GSH consumption rendered the reactive transcription of glutathioneassociated enzymes unnecessary and blocked the intracellular signals leading to the overexpression and rearrangement of p66Shc signalling molecule",
    "simplified": "These effects were fully counteracted by dietary phenolics which inhibited ROS overproduction and blocked the intracellular signals leading to the overexpression and rearrangement of p66Shc signalling molecule. GSH consumption rendered the reactive transcription of glutathioneassociated enzymes unnecessary."
  },
  {
    "text": "The enzyme requires PLP and divalent cations such as Ca2 Mg2 or Mn2 but not ATP whereas mammalian serine racemase activity is increased by ATP",
    "triple_list": [
      [
        "ATP",
        "CPR:3",
        "serine racemase"
      ]
    ],
    "updated": "No",
    "original": "The enzyme requires PLP and divalent cations such as Ca2 Mg2 or Mn2 but not ATP whereas mammalian serine racemase activity is increased by ATP",
    "simplified": "The enzyme needs PLP and divalent cations (like Ca2 Mg2 or Mn2) but not ATP. When ATP is added, the enzyme makes more serine."
  },
  {
    "text": "These data support the conclusion that renal ecto phosphodiesterase activity is not mediated by PDE1 PDE2 PDE3 PDE4 PDE5 PDE6 PDE7 PDE9 PDE10 or PDE11 and is inhibited by dipyridamole .",
    "triple_list": [
      [
        "phosphodiesterase",
        "CPR:4",
        "dipyridamole"
      ]
    ],
    "updated": "Yes",
    "original": "These data support the conclusion that renal ecto phosphodiesterase activity is not mediated by PDE1 PDE2 PDE3 PDE4 PDE5 PDE6 PDE7 PDE9 PDE10 or PDE11 and is inhibited by high concentrations of dipyridamole",
    "simplified": "These data support the conclusion that renal ecto phosphodiesterase activity is not mediated by PDE1 PDE2 PDE3 PDE4 PDE5 PDE6 PDE7 PDE9 PDE10 or PDE11 and is inhibited by dipyridamole."
  },
  {
    "text": "A broadspectrum phosphodiesterase PDE inhibitor 13isobutyl1methylxanthine 300 microM n=6 and an ectophosphodiesterase inhibitor 13dipropyl8psulfophenylxanthine 1 mM n=6 significantly attenuated cAMPinduced AMP secretion by 60 and 74 respectively",
    "triple_list": [
      [
        "phosphodiesterase",
        "CPR:4",
        "13isobutyl1methylxanthine"
      ],
      [
        "PDE",
        "CPR:4",
        "13isobutyl1methylxanthine"
      ]
    ],
    "updated": "No",
    "original": "A broadspectrum phosphodiesterase PDE inhibitor 13isobutyl1methylxanthine 300 microM n=6 and an ectophosphodiesterase inhibitor 13dipropyl8psulfophenylxanthine 1 mM n=6 significantly attenuated cAMPinduced AMP secretion by 60 and 74 respectively",
    "simplified": "A broadspectrum phosphodiesterase PDE inhibitor 300 microM n=6 and an ectophosphodiesterase inhibitor 1 mM n=6 significantly attenuated cAMPinduced AMP secretion by 60 and 74%, respectively."
  },
  {
    "text": "Blockade of PDE1 8methoxymethyl3isobutyl1methylxanthine 100 microM PDE2 erythro92hydroxy3nonyladenine 30 microM PDE3 milrinone 10 microM cGMP 100 microM PDE4 Ro 201724 43butoxy4methoxybenzylimidazolidin2one 100 microM PDE5 and PDE6 zaprinast 30 microM and PDE7 BRL50481 5nitro2NNtrimethylbenzenesulfonamide 10 microM Blockade of PDE1 , PDE2 , PDE3 , PDE4 , PDE5 , PDE6 , PDE7",
    "triple_list": [
      [
        "PDE3",
        "CPR:4",
        "milrinone"
      ],
      [
        "PDE1",
        "CPR:4",
        "8methoxymethyl3isobutyl1methylxanthine"
      ],
      [
        "PDE2",
        "CPR:4",
        "erythro92hydroxy3nonyladenine"
      ],
      [
        "PDE4",
        "CPR:4",
        "43butoxy4methoxybenzylimidazolidin2one"
      ],
      [
        "PDE5",
        "CPR:4",
        "zaprinast"
      ],
      [
        "PDE6",
        "CPR:4",
        "zaprinast"
      ],
      [
        "PDE7",
        "CPR:4",
        "BRL50481"
      ],
      [
        "PDE7",
        "CPR:4",
        "5nitro2NNtrimethylbenzenesulfonamide"
      ]
    ],
    "updated": "Yes",
    "original": "Blockade of PDE1 8methoxymethyl3isobutyl1methylxanthine 100 microM PDE2 erythro92hydroxy3nonyladenine 30 microM PDE3 milrinone 10 microM cGMP 10 microM PDE4 Ro 201724 43butoxy4methoxybenzylimidazolidin2one 100 microM PDE5 and PDE6 zaprinast 30 microM and PDE7 BRL50481 5nitro2NNtrimethylbenzenesulfonamide 10 microM did not alter renal ectophosphodiesterase activity",
    "simplified": "Blockade of PDE1 8methoxymethyl3isobutyl1methylxanthine 100 microM PDE2 erythro92hydroxy3nonyladenine 30 microM PDE3 milrinone 10 microM cGMP 100 microM PDE4 Ro 201724 43butoxy4methoxybenzylimidazolidin2one 100 microM PDE5 and PDE6 zaprinast 30 microM and PDE7 BRL50481 5nitro2NNtrimethylbenzenesulfonamide 10 microM Blockade of PDE1, PDE2, PDE3, PDE4, PDE5, PDE6, PDE7"
  },
  {
    "text": "Administration of a concentration 100 microM of dipyridamole that blocks PDE8 inhibited ecto phosphodiesterase activity by 44",
    "triple_list": [
      [
        "dipyridamole",
        "CPR:4",
        "PDE8"
      ],
      [
        "dipyridamole",
        "CPR:4",
        "phosphodiesterase"
      ]
    ],
    "updated": "No",
    "original": "Administration of a concentration 100 microM of dipyridamole that blocks PDE8 inhibited ecto phosphodiesterase activity by 44",
    "simplified": "When 100 microM of dipyridamole was added, it stopped ecto phosphodiesterase activity by 44%."
  },
  {
    "text": "A small amount of dipyridamole 3 microM can block PDE9 , PDE10 and PDE11 , but not PDE8 . However , it does not stop ectophosphodiesterase .",
    "triple_list": [
      [
        "dipyridamole",
        "CPR:4",
        "PDE9"
      ],
      [
        "dipyridamole",
        "CPR:4",
        "PDE10"
      ],
      [
        "dipyridamole",
        "CPR:4",
        "PDE11"
      ]
    ],
    "updated": "Yes",
    "original": "However a lower concentration of dipyridamole 3 microM that blocks PDE9 PDE10 and PDE11 but not PDE8 did not inhibit ectophosphodiesterase activity",
    "simplified": "A small amount of dipyridamole 3 microM can block PDE9, PDE10 and PDE11, but not PDE8. However, it does not stop ectophosphodiesterase."
  },
  {
    "text": "In kidneys stimulation of adenylyl cyclase causes egress of cAMP conversion of cAMP to AMP by ecto phosphodiesterase and metabolism of AMP to adenosine by ecto5nucleotidase",
    "triple_list": [
      [
        "cAMP",
        "CPR:9",
        "phosphodiesterase"
      ],
      [
        "AMP",
        "CPR:9",
        "phosphodiesterase"
      ],
      [
        "AMP",
        "CPR:9",
        "ecto5nucleotidase"
      ],
      [
        "adenosine",
        "CPR:9",
        "ecto5nucleotidase"
      ]
    ],
    "updated": "No",
    "original": "In kidneys stimulation of adenylyl cyclase causes egress of cAMP conversion of cAMP to AMP by ecto phosphodiesterase and metabolism of AMP to adenosine by ecto5nucleotidase",
    "simplified": "In the kidneys, stimulation of adenylyl cyclase causes the conversion of cAMP to AMP, and the metabolism of AMP to adenosine, the building block of energy."
  },
  {
    "text": "In summary , ketoconazole had no clinically significant effect on the pharmacokinetics or safety profile of ambrisentan . When the drug is administered concomitantly with known CYP3A4 inhibitors , no changes in dose should be necessary .",
    "triple_list": [
      [
        "ketoconazole",
        "CPR:4",
        "CYP3A4"
      ]
    ],
    "updated": "Yes",
    "original": "In summary ketoconazole had no clinically significant effect on the pharmacokinetics or safety profile of ambrisentan therefore no changes in ambrisentan dose should be necessary when the drug is administered concomitantly with known CYP3A4 inhibitors",
    "simplified": "In summary, ketoconazole had no clinically significant effect on the pharmacokinetics or safety profile of ambrisentan. When the drug is administered concomitantly with known CYP3A4 inhibitors, no changes in dose should be necessary."
  },
  {
    "text": "The potential for ketoconazole the archetypal strong inhibitor of CYP3A4 to alter the pharmacokinetic profile of ambrisentan and its oxidative metabolite 4hydroxymethyl ambrisentan was assessed in an openlabel nonrandomized 2period singlesequence study in 16 healthy men",
    "triple_list": [
      [
        "ketoconazole",
        "CPR:4",
        "CYP3A4"
      ]
    ],
    "updated": "No",
    "original": "The potential for ketoconazole the archetypal strong inhibitor of CYP3A4 to alter the pharmacokinetic profile of ambrisentan and its oxidative metabolite 4hydroxymethyl ambrisentan was assessed in an openlabel nonrandomized 2period singlesequence study in 16 healthy men",
    "simplified": "The potential for ketoconazole to alter the pharmacokinetic profile of ambrisentan and its oxidative metabolite 4hydroxymethyl ambrisentan in 16 healthy men was assessed in an openlabel nonrandomized 2period singlesequence study in 16 healthy men."
  },
  {
    "text": "Ambrisentan is an endothelin type A ETAselective receptor antagonist . Its metabolism is primarily by glucuronidation , but also by CYP3A4 .",
    "triple_list": [
      [
        "Ambrisentan",
        "CPR:6",
        "endothelin type A ETAselective receptor"
      ],
      [
        "Ambrisentan",
        "CPR:9",
        "CYP3A4"
      ]
    ],
    "updated": "Yes",
    "original": "Ambrisentan is an endothelin type A ETAselective receptor antagonist that is metabolized primarily by glucuronidation but also undergoes oxidative metabolism by CYP3A4",
    "simplified": "Ambrisentan is an endothelin type A ETAselective receptor antagonist. Its metabolism is primarily by glucuronidation, but also by CYP3A4."
  },
  {
    "text": "Although thioredoxin reductase TRR inhibitors aurothioglucose and SbIII inhibited cytosolic DMAsV reduction recombinant rat TRR plus NADPH alone or when added to the cytosol failed to support DMAsV reduction",
    "triple_list": [
      [
        "thioredoxin reductase",
        "CPR:4",
        "aurothioglucose"
      ],
      [
        "TRR",
        "CPR:4",
        "aurothioglucose"
      ],
      [
        "thioredoxin reductase",
        "CPR:4",
        "SbIII"
      ],
      [
        "TRR",
        "CPR:4",
        "SbIII"
      ]
    ],
    "updated": "No",
    "original": "Although thioredoxin reductase TRR inhibitors aurothioglucose and SbIII inhibited cytosolic DMAsV reduction recombinant rat TRR plus NADPH alone or when added to the cytosol failed to support DMAsV reduction",
    "simplified": "Thioredoxin reductase TRR inhibitors aurothioglucose and SbIII inhibited cytosolic DMAsV reduction but when added to the cytosol, TRR plus NADPH failed to support DMAsV reduction."
  },
  {
    "text": "Pretreatment of rats with glutathione GSH depletors phorone or BSO delayed the accumulation of RBCbound DMAs while the indirect methyltransferase inhibitor periodateoxidized adenosine did not have an effect .",
    "triple_list": [
      [
        "methyltransferase",
        "CPR:4",
        "adenosine"
      ]
    ],
    "updated": "Yes",
    "original": "Pretreatment of rats with glutathione GSH depletors phorone or BSO delayed the elimination of DMAsV and the accumulation of RBCbound DMAs whereas the indirect methyltransferase inhibitor periodateoxidized adenosine was without effect",
    "simplified": "Pretreatment of rats with glutathione GSH depletors phorone or BSO delayed the accumulation of RBCbound DMAs while the indirect methyltransferase inhibitor periodateoxidized adenosine did not have an effect."
  },
  {
    "text": "Although glutathione Stransferase omega 1 and arsenic methyltransferase have been shown to reduce DMAsV in animals , it is not known if they work in humans or if they can reduce DMAsV at all .",
    "triple_list": [
      [
        "glutathione Stransferase omega 1",
        "CPR:9",
        "DMAsV"
      ],
      [
        "arsenic methyltransferase",
        "CPR:9",
        "DMAsV"
      ]
    ],
    "updated": "Yes",
    "original": "Although glutathione Stransferase omega 1 GSTO1 and arsenic methyltransferase have been shown or thought to catalyze DMAsV reduction their role in DMAsV reduction in vivo or in cell extracts is uncertain",
    "simplified": "Although glutathione Stransferase omega 1 and arsenic methyltransferase have been shown to reduce DMAsV in animals, it is not known if they work in humans or if they can reduce DMAsV at all."
  },
  {
    "text": "The kinase activity of EGFR was little inhibited by TTB in a cellfree system",
    "triple_list": [
      [
        "kinase",
        "CPR:4",
        "TTB"
      ],
      [
        "EGFR",
        "CPR:4",
        "TTB"
      ]
    ],
    "updated": "No",
    "original": "The kinase activity of EGFR was little inhibited by TTB in a cellfree system",
    "simplified": "The activity of EGFR was reduced a little bit when TTB was used."
  },
  {
    "text": "Sorafenib BAY 439006 Nexavar a dualaction inhibitor that targets RAF MEK ERK pathway in tumor cells and tyrosine kinases VEGFR PDGFR in tumor vasculature",
    "triple_list": [
      [
        "Sorafenib",
        "CPR:4",
        "tyrosine kinases"
      ],
      [
        "Sorafenib",
        "CPR:4",
        "VEGFR"
      ],
      [
        "Sorafenib",
        "CPR:4",
        "PDGFR"
      ],
      [
        "Sorafenib",
        "CPR:4",
        "RAF"
      ],
      [
        "Sorafenib",
        "CPR:4",
        "MEK"
      ],
      [
        "Sorafenib",
        "CPR:4",
        "ERK"
      ],
      [
        "BAY 439006",
        "CPR:4",
        "tyrosine kinases"
      ],
      [
        "BAY 439006",
        "CPR:4",
        "VEGFR"
      ],
      [
        "BAY 439006",
        "CPR:4",
        "PDGFR"
      ],
      [
        "BAY 439006",
        "CPR:4",
        "RAF"
      ],
      [
        "BAY 439006",
        "CPR:4",
        "MEK"
      ],
      [
        "BAY 439006",
        "CPR:4",
        "ERK"
      ],
      [
        "Nexavar",
        "CPR:4",
        "tyrosine kinases"
      ],
      [
        "Nexavar",
        "CPR:4",
        "VEGFR"
      ],
      [
        "Nexavar",
        "CPR:4",
        "PDGFR"
      ],
      [
        "Nexavar",
        "CPR:4",
        "RAF"
      ],
      [
        "Nexavar",
        "CPR:4",
        "MEK"
      ],
      [
        "Nexavar",
        "CPR:4",
        "ERK"
      ]
    ],
    "updated": "No",
    "original": "Sorafenib BAY 439006 Nexavar a dualaction inhibitor that targets RAF MEK ERK pathway in tumor cells and tyrosine kinases VEGFR PDGFR in tumor vasculature",
    "simplified": "Sorafenib BAY 439006 Nexavar a dualaction inhibitor that targets tyrosine kinases VEGFR and PDGFR in the central nervous system"
  },
  {
    "text": "Further characterization of sorafenib revealed that this molecule was a multikinase inhibitor that targeted the vascular endothelial growth factor receptor family VEGFR2 and VEGFR3 and plateletderived growth factor receptor family PDGFRbeta and Kit which play key roles in tumor progression and angiogenesis",
    "triple_list": [
      [
        "sorafenib",
        "CPR:4",
        "vascular endothelial growth factor receptor"
      ],
      [
        "sorafenib",
        "CPR:4",
        "VEGFR2"
      ],
      [
        "sorafenib",
        "CPR:4",
        "VEGFR3"
      ],
      [
        "sorafenib",
        "CPR:4",
        "plateletderived growth factor receptor"
      ],
      [
        "sorafenib",
        "CPR:4",
        "PDGFRbeta"
      ],
      [
        "sorafenib",
        "CPR:4",
        "Kit"
      ]
    ],
    "updated": "No",
    "original": "Further characterization of sorafenib revealed that this molecule was a multikinase inhibitor that targeted the vascular endothelial growth factor receptor family VEGFR2 and VEGFR3 and plateletderived growth factor receptor family PDGFRbeta and Kit which play key roles in tumor progression and angiogenesis",
    "simplified": "Further analysis of sorafenib showed that it was a multikinase inhibitor. This means that it could not do many things at once. It could not do anything to the vascular endothelial growth factor receptor family VEGFR2 and VEGFR3 and plateletderived growth factor receptor (PDGFR)."
  },
  {
    "text": "Thus sorafenib may inhibit tumor growth by a dual mechanism acting either directly on the tumor through inhibition of Raf and Kit signaling andor on tumor angiogenesis through inhibition of VEGFR and PDGFR signaling",
    "triple_list": [
      [
        "sorafenib",
        "CPR:4",
        "Raf"
      ],
      [
        "sorafenib",
        "CPR:4",
        "Kit"
      ],
      [
        "sorafenib",
        "CPR:4",
        "VEGFR"
      ],
      [
        "sorafenib",
        "CPR:4",
        "PDGFR"
      ]
    ],
    "updated": "No",
    "original": "Thus sorafenib may inhibit tumor growth by a dual mechanism acting either directly on the tumor through inhibition of Raf and Kit signaling andor on tumor angiogenesis through inhibition of VEGFR and PDGFR signaling",
    "simplified": "Thus sorafenib may inhibit tumor growth by a dual mechanism acting either directly on the tumor through inhibition of VEGFR and PDGFR signaling or on tumor angiogenesis through inhibition of macrophages."
  },
  {
    "text": "A novel class of biaryl urea has been discovered that inhibits CRAF kinase . The method was discovered using chemistry .",
    "triple_list": [
      [
        "biaryl urea",
        "CPR:4",
        "CRAF"
      ],
      [
        "biaryl urea",
        "CPR:4",
        "kinase"
      ]
    ],
    "updated": "Yes",
    "original": "A novel class of biaryl urea that inhibits CRAF kinase was discovered using a combination of medicinal and combinatorial chemistry approaches",
    "simplified": "A novel class of biaryl urea has been discovered that inhibits CRAF kinase. The method was discovered using chemistry."
  },
  {
    "text": "Sorafenib inhibited the kinase activity of both CRAF and BRAF wild type and V600E mutant",
    "triple_list": [
      [
        "Sorafenib",
        "CPR:4",
        "kinase"
      ],
      [
        "Sorafenib",
        "CPR:4",
        "CRAF"
      ],
      [
        "Sorafenib",
        "CPR:4",
        "BRAF"
      ],
      [
        "Sorafenib",
        "CPR:4",
        "V600E"
      ]
    ],
    "updated": "No",
    "original": "Sorafenib inhibited the kinase activity of both CRAF and BRAF wild type and V600E mutant",
    "simplified": "Sorafenib inhibits the action of the enzyme in both wild type and mutant cells."
  },
  {
    "text": "Rapamycin inhibits selected peptidase and proteinase activities in the proteasome at very low concentrations .",
    "triple_list": [
      [
        "Rapamycin",
        "CPR:4",
        "proteinase"
      ],
      [
        "Rapamycin",
        "CPR:4",
        "peptidase"
      ],
      [
        "Rapamycin",
        "CPR:4",
        "proteasome"
      ]
    ],
    "updated": "Yes",
    "original": "Rapamycin inhibits proteinase and selected peptidase activities of the catalytic core proteasome at low micromolar concentrations",
    "simplified": "Rapamycin inhibits selected peptidase and proteinase activities in the proteasome at very low concentrations."
  },
  {
    "text": "Ten IUmL urokinase was also incubated with pooled plasma of stroke patients that was previously oxidized with the singlet oxygen 1O2 donor chloramine T CT to destroy plasmatic PAI1 and alpha2anti plasmin",
    "triple_list": [
      [
        "chloramine T",
        "CPR:4",
        "plasmatic PAI1"
      ],
      [
        "chloramine T",
        "CPR:4",
        "plasmin"
      ],
      [
        "CT",
        "CPR:4",
        "plasmatic PAI1"
      ],
      [
        "CT",
        "CPR:4",
        "plasmin"
      ],
      [
        "singlet oxygen",
        "CPR:4",
        "plasmatic PAI1"
      ],
      [
        "1O2",
        "CPR:4",
        "plasmatic PAI1"
      ]
    ],
    "updated": "No",
    "original": "Ten IUmL urokinase was also incubated with pooled plasma of stroke patients that was previously oxidized with the singlet oxygen 1O2 donor chloramine T CT to destroy plasmatic PAI1 and alpha2anti plasmin",
    "simplified": "Ten IUmL urokinase was also incubated with pooled plasma of stroke patients to destroy plasmatic PAI1 and alpha2anti plasmin. The plasma had been oxidized with chloramine T CT."
  },
  {
    "text": "After 0 to 80 minutes 37 degrees C 50microL samples were withdrawn and added to 100 microL 15 M arginine pH 87 and oxidized with 50 microL of 20 mM CT For determination of plasmin activity 10 microL thereof was incubated with 150 microL 15 M arginine pH 87 and 100 microL 20 mM CT preoxidized 15 minutes 37 degrees C pooled normal citrate buffered EDTAplasma for 30 minutes 37 degrees C",
    "triple_list": [
      [
        "arginine",
        "CPR:9",
        "plasmin"
      ]
    ],
    "updated": "No",
    "original": "After 0 to 80 minutes 37 degrees C 50microL samples were withdrawn and added to 100 microL 15 M arginine pH 87 and oxidized with 50 microL of 20 mM CT For determination of plasmin activity 10 microL thereof was incubated with 150 microL 15 M arginine pH 87 and 100 microL 20 mM CT preoxidized 15 minutes 37 degrees C pooled normal citrate buffered EDTAplasma for 30 minutes 37 degrees C",
    "simplified": "After 0 to 80 minutes 37 degrees C 50microL samples were withdrawn and added to 100 microL 15 M arginine pH 87 and oxidized with 50 microL of 20 mM CT 10 microL of normal citrate buffered EDTAplasma for 30 minutes 37 degrees C After 0 to 80 minutes 37 degrees C 50microL samples were withdrawn and added to 100 microL 15 M arginine pH 87 and oxidized with 50 microL of 20 mM CT."
  },
  {
    "text": "For determination of PA Pli activity arginine was added after this incubation",
    "triple_list": [
      [
        "PA",
        "CPR:9",
        "arginine"
      ],
      [
        "Pli",
        "CPR:9",
        "arginine"
      ]
    ],
    "updated": "No",
    "original": "For determination of PA Pli activity arginine was added after this incubation",
    "simplified": "To determine the activity of arginine, it was added after incubation."
  },
  {
    "text": "KCNK1 a member of the family of twopore K ion channels is specifically induced in the livers of male mice after phenobarbital treatment",
    "triple_list": [
      [
        "KCNK1",
        "CPR:3",
        "phenobarbital"
      ],
      [
        "K ion channels",
        "CPR:3",
        "phenobarbital"
      ]
    ],
    "updated": "No",
    "original": "KCNK1 a member of the family of twopore K ion channels is specifically induced in the livers of male mice after phenobarbital treatment",
    "simplified": "KCNK1 a member of the twopore K ion channel family is specifically found in the livers of male mice, and is activated by phenobarbital."
  },
  {
    "text": "The molecular mechanism of this malespecific activation of the Kcnk1 gene has been determined , and KCNK1 has been characterized as a phenobarbital inducible factor .",
    "triple_list": [
      [
        "Kcnk1",
        "CPR:3",
        "phenobarbital"
      ],
      [
        "KCNK1",
        "CPR:3",
        "phenobarbital"
      ]
    ],
    "updated": "Yes",
    "original": "Here we have determined the molecular mechanism of this malespecific activation of the Kcnk1 gene and characterized KCNK1 as a phenobarbital inducible antihyperplasia factor",
    "simplified": "The molecular mechanism of this malespecific activation of the Kcnk1 gene has been determined, and KCNK1 has been characterized as a phenobarbital inducible factor."
  },
  {
    "text": "Upon activation by phenobarbital nuclear receptor CAR binds the 97bp response element 24412345 within the Kcnk1 promoter",
    "triple_list": [
      [
        "phenobarbital",
        "CPR:3",
        "nuclear receptor"
      ],
      [
        "phenobarbital",
        "CPR:3",
        "CAR"
      ]
    ],
    "updated": "No",
    "original": "Upon activation by phenobarbital nuclear receptor CAR binds the 97bp response element 24412345 within the Kcnk1 promoter",
    "simplified": "When the receptor is activated, CAR binds to the 97bp response element 24412345 within the Kcnk1 promoter."
  },
  {
    "text": "These results indicate that phenobarbital treatment can cause KCNK1 to be activated and inhibit growth .",
    "triple_list": [
      [
        "phenobarbital",
        "CPR:3",
        "KCNK1"
      ]
    ],
    "updated": "Yes",
    "original": "These results indicate that phenobarbital treatment induces KCNK1 to elicit a malespecific and growthsuppressing signal",
    "simplified": "These results indicate that phenobarbital treatment can cause KCNK1 to be activated and inhibit growth."
  },
  {
    "text": "In both OFC and mPFC no strain differences in Vmax or Km for dopamine uptake into synaptosomes were found between vehicletreated SHR mPFC and SHR WKY Methylphenidate increased DAT Vmax in SHR mPFC and decreased DAT Vmax in WKY OFC",
    "triple_list": [
      [
        "Methylphenidate",
        "CPR:3",
        "DAT"
      ],
      [
        "Methylphenidate",
        "CPR:4",
        "DAT"
      ]
    ],
    "updated": "Yes",
    "original": "In both OFC and mPFC no strain differences in Vmax or Km for dopamine uptake into synaptosomes were found between vehicletreated SHR WKY and WIS Methylphenidate increased DAT Vmax in SHR mPFC and decreased DAT Vmax in WKY OFC",
    "simplified": "In both OFC and mPFC no strain differences in Vmax or Km for dopamine uptake into synaptosomes were found between vehicletreated SHR mPFC and SHR WKY Methylphenidate increased DAT Vmax in SHR mPFC and decreased DAT Vmax in WKY OFC"
  },
  {
    "text": "Thus the increase in mPFC DAT function was an SHRspecific long term consequence of methylphenidate treatment during adolescence . The observed increases in cocaine self-administration may be responsible for the treatmentinduced changes .",
    "triple_list": [
      [
        "DAT",
        "CPR:3",
        "methylphenidate"
      ]
    ],
    "updated": "Yes",
    "original": "Thus the increase in mPFC DAT function was an SHRspecific long term consequence of methylphenidate treatment during adolescence which may be responsible for the treatmentinduced alterations in behavior including the observed increases in cocaine selfadministration",
    "simplified": "Thus the increase in mPFC DAT function was an SHRspecific long term consequence of methylphenidate treatment during adolescence. The observed increases in cocaine self-administration may be responsible for the treatmentinduced changes."
  },
  {
    "text": "Methylphenidate an inhibitor of dopamine and norepinephrine transporters DAT and NET respectively is a standard treatment for ADHD",
    "triple_list": [
      [
        "Methylphenidate",
        "CPR:4",
        "dopamine and norepinephrine transporters"
      ],
      [
        "Methylphenidate",
        "CPR:4",
        "DAT"
      ],
      [
        "Methylphenidate",
        "CPR:4",
        "NET"
      ]
    ],
    "updated": "No",
    "original": "Methylphenidate an inhibitor of dopamine and norepinephrine transporters DAT and NET respectively is a standard treatment for ADHD",
    "simplified": "Dopamine and norepinephrine transporters (DATs and NETs) are important for people with ADHD."
  },
  {
    "text": "Also methylphenidate decreased DAT Km in WIS OFC",
    "triple_list": [
      [
        "methylphenidate",
        "CPR:4",
        "DAT"
      ]
    ],
    "updated": "No",
    "original": "Also methylphenidate decreased DAT Km in WIS OFC",
    "simplified": "Methylphenidate also reduces DAT Km."
  },
  {
    "text": "Thus our data suggest that the COX2 preference of meloxicam observed in vitro may not result in clinical advantages when the higher dose of 15 mg is needed",
    "triple_list": [
      [
        "COX2",
        "CPR:4",
        "meloxicam"
      ]
    ],
    "updated": "No",
    "original": "Thus our data suggest that the COX2 preference of meloxicam observed in vitro may not result in clinical advantages when the higher dose of 15 mg is needed",
    "simplified": "Thus our data suggest that the higher dose of 15 mg may not result in clinical advantages when meloxicam preference is observed in vitro."
  },
  {
    "text": "The effects of meloxicam were compared with those of diclofenac a nonselective COX inhibitor",
    "triple_list": [
      [
        "meloxicam",
        "CPR:4",
        "COX"
      ],
      [
        "diclofenac",
        "CPR:4",
        "COX"
      ]
    ],
    "updated": "No",
    "original": "The effects of meloxicam were compared with those of diclofenac a nonselective COX inhibitor",
    "simplified": "The effects of meloxicam were compared with diclofenac. The effects of diclofenac were:"
  },
  {
    "text": "METHODS COX1 inhibition was determined by measuring thromboxane B2 TXB2generation from clotting whole blood ex vivo after single oral doses of 150 mg diclofenac and 75 mg meloxicam and at steady state 15 mg meloxicam and 75 mg diclofenac daily .",
    "triple_list": [
      [
        "COX1",
        "CPR:4",
        "meloxicam"
      ],
      [
        "COX1",
        "CPR:4",
        "diclofenac"
      ],
      [
        "COX1",
        "CPR:4",
        "meloxicam"
      ],
      [
        "COX1",
        "CPR:4",
        "diclofenac"
      ]
    ],
    "updated": "Yes",
    "original": "METHODS COX1 inhibition was determined by measuring thromboxane B2 TXB2generation from clotting whole blood ex vivo after single oral doses of 75 and 15 mg meloxicam and 75 mg diclofenac and at steady state 15 mg meloxicam daily and 150 mg diclofenac daily",
    "simplified": "METHODS COX1 inhibition was determined by measuring thromboxane B2 TXB2generation from clotting whole blood ex vivo after single oral doses of 150 mg diclofenac and 75 mg meloxicam and at steady state 15 mg meloxicam and 75 mg diclofenac daily."
  },
  {
    "text": "OBJECTIVE To evaluate the extent of human cyclooxygenase1 COX1 inhibition by meloxicam which has been reported to preferentially inhibit cyclooxygenase2 COX2",
    "triple_list": [
      [
        "meloxicam",
        "CPR:4",
        "cyclooxygenase2"
      ],
      [
        "meloxicam",
        "CPR:4",
        "COX2"
      ],
      [
        "human cyclooxygenase1",
        "CPR:4",
        "meloxicam"
      ],
      [
        "COX1",
        "CPR:4",
        "meloxicam"
      ]
    ],
    "updated": "No",
    "original": "OBJECTIVE To evaluate the extent of human cyclooxygenase1 COX1 inhibition by meloxicam which has been reported to preferentially inhibit cyclooxygenase2 COX2",
    "simplified": "OBJECTIVE To evaluate the extent of human cyclooxygenase1 COX1 inhibition by meloxicam. The effect of meloxicam on human cyclooxygenase1 COX1"
  },
  {
    "text": "Gelatin zymography showed that DMBT did not work , and that MMP9 did .",
    "triple_list": [
      [
        "DMBT",
        "CPR:4",
        "MMP9"
      ]
    ],
    "updated": "Yes",
    "original": "Gelatin zymography showed that DMBT inhibited secretion and activity of MMP9",
    "simplified": "Gelatin zymography showed that DMBT did not work, and that MMP9 did."
  },
  {
    "text": "Western blotting demonstrated that DMBT effectively suppressed the expression of VEGF pVEGFR2 pEGFR and pAkt",
    "triple_list": [
      [
        "DMBT",
        "CPR:4",
        "VEGF"
      ],
      [
        "DMBT",
        "CPR:4",
        "pVEGFR2"
      ],
      [
        "DMBT",
        "CPR:4",
        "pEGFR"
      ],
      [
        "DMBT",
        "CPR:4",
        "pAkt"
      ]
    ],
    "updated": "No",
    "original": "Western blotting demonstrated that DMBT effectively suppressed the expression of VEGF pVEGFR2 pEGFR and pAkt",
    "simplified": "Western blotting showed that DMBT did not work at all. It did not change the expression of VEGF."
  },
  {
    "text": "Inhibition of angiogenesis and invasion by DMBT through the Akt pathway is mediated by downregulation of MMP9 and VEGF .",
    "triple_list": [
      [
        "DMBT",
        "CPR:4",
        "Akt"
      ],
      [
        "DMBT",
        "CPR:4",
        "VEGF"
      ],
      [
        "DMBT",
        "CPR:4",
        "MMP9"
      ]
    ],
    "updated": "Yes",
    "original": "Inhibition of angiogenesis and invasion by DMBT is mediated by downregulation of VEGF and MMP9 through Akt pathway in MDAMB231 breast cancer cells",
    "simplified": "Inhibition of angiogenesis and invasion by DMBT through the Akt pathway is mediated by downregulation of MMP9 and VEGF."
  },
  {
    "text": "These results suggested that DMBT could inhibit invasion and angiogenesis by downregulation of VEGF and MMP9 resulting from the inhibition of Akt pathway",
    "triple_list": [
      [
        "DMBT",
        "CPR:4",
        "VEGF"
      ],
      [
        "DMBT",
        "CPR:4",
        "MMP9"
      ],
      [
        "DMBT",
        "CPR:4",
        "Akt"
      ]
    ],
    "updated": "No",
    "original": "These results suggested that DMBT could inhibit invasion and angiogenesis by downregulation of VEGF and MMP9 resulting from the inhibition of Akt pathway",
    "simplified": "These results suggested that DMBT could inhibit invasion and angiogenesis. This is because the Akt pathway is inhibited by DMBT."
  },
  {
    "text": "Expression of Ltype pyruvate kinase LPK is upregulated in the liver by dietary carbohydrate",
    "triple_list": [
      [
        "LPK",
        "CPR:3",
        "carbohydrate"
      ],
      [
        "Ltype pyruvate kinase",
        "CPR:3",
        "carbohydrate"
      ]
    ],
    "updated": "No",
    "original": "Expression of Ltype pyruvate kinase LPK is upregulated in the liver by dietary carbohydrate",
    "simplified": "Ltype pyruvate kinase (LPK) is increased in the liver by certain foods."
  },
  {
    "text": "To investigate the possibility that NMDA receptor subtype selectivity could be related to felbamates , we examined the specificity of felbamate block of recombinant NMDA receptors composed of the NR1a subunit and various NR2 subunits .",
    "triple_list": [
      [
        "felbamate",
        "CPR:4",
        "NMDA receptors"
      ],
      [
        "felbamate",
        "CPR:4",
        "NR1a"
      ],
      [
        "felbamate",
        "CPR:4",
        "NR2"
      ]
    ],
    "updated": "Yes",
    "original": "To investigate the possibility that felbamates favorable toxicity profile could be related to NMDA receptor subtype selectivity we examined the specificity of felbamate block of recombinant NMDA receptors composed of the NR1a subunit and various NR2 subunits",
    "simplified": "To investigate the possibility that NMDA receptor subtype selectivity could be related to felbamates, we examined the specificity of felbamate block of recombinant NMDA receptors composed of the NR1a subunit and various NR2 subunits."
  },
  {
    "text": "Felbamate produced a rapid concentrationdependent block of currents evoked by 50 microM NMDA and 10 microM glycine in human embryonic kidney 293 cells expressing the rat NR1a subunit and either the NR2A NR2B or NR2C subunits the IC50 values for block were 26 052 and 24 mM respectively holding potential 60 mV",
    "triple_list": [
      [
        "Felbamate",
        "CPR:4",
        "rat NR1a"
      ],
      [
        "Felbamate",
        "CPR:4",
        "NR2A"
      ],
      [
        "Felbamate",
        "CPR:4",
        "NR2B"
      ],
      [
        "Felbamate",
        "CPR:4",
        "NR2C"
      ]
    ],
    "updated": "No",
    "original": "Felbamate produced a rapid concentrationdependent block of currents evoked by 50 microM NMDA and 10 microM glycine in human embryonic kidney 293 cells expressing the rat NR1a subunit and either the NR2A NR2B or NR2C subunits the IC50 values for block were 26 052 and 24 mM respectively holding potential 60 mV",
    "simplified": "Felbamate produced a fast block of current in human embryonic kidney 293 cells with either the rat NR1a subunit or the rat NR2A subunit. The IC50 values for block were 26 052 and 24 mM respectively holding potential 60 mV in human embryonic kidney 293 cells."
  },
  {
    "text": "Felbamate block of recombinant NmethylDaspartate receptors selectivity for the NR2B subunit",
    "triple_list": [
      [
        "Felbamate",
        "CPR:4",
        "NmethylDaspartate receptors"
      ],
      [
        "Felbamate",
        "CPR:4",
        "NR2B"
      ]
    ],
    "updated": "No",
    "original": "Felbamate block of recombinant NmethylDaspartate receptors selectivity for the NR2B subunit",
    "simplified": "Nmethyl-Daspartate receptor (NR2B) - this receptor is very sensitive to light"
  },
  {
    "text": "The higher affinity of felbamate block of NMDA receptors containing the NR2B subunit could be because these sites are more sensitive to felbamate .",
    "triple_list": [
      [
        "felbamate",
        "CPR:4",
        "NMDA receptors"
      ],
      [
        "felbamate",
        "CPR:4",
        "NR2B"
      ]
    ],
    "updated": "Yes",
    "original": "The higher affinity of felbamate block of NMDA receptors containing the NR2B subunit could be accounted for by more rapid association and slower dissociation from these sites",
    "simplified": "The higher affinity of felbamate block of NMDA receptors containing the NR2B subunit could be because these sites are more sensitive to felbamate."
  },
  {
    "text": "We conclude that felbamate exhibits modest selectivity for NMDA receptors composed of NR1a NR2B subunits",
    "triple_list": [
      [
        "felbamate",
        "CPR:4",
        "NMDA receptors"
      ],
      [
        "felbamate",
        "CPR:4",
        "NR1a"
      ],
      [
        "felbamate",
        "CPR:4",
        "NR2B"
      ]
    ],
    "updated": "No",
    "original": "We conclude that felbamate exhibits modest selectivity for NMDA receptors composed of NR1a NR2B subunits",
    "simplified": "We conclude that felbamate has a small selectivity for the NMDA receptor, but not for other receptors."
  },
  {
    "text": "The anticonvulsant felbamate blocks NmethylDasparate NMDA receptors but fails to exhibit the neurobehavioral toxicity characteristic of other NMDA receptor antagonists",
    "triple_list": [
      [
        "felbamate",
        "CPR:4",
        "NmethylDasparate NMDA receptors"
      ],
      [
        "felbamate",
        "CPR:6",
        "NMDA receptor"
      ]
    ],
    "updated": "No",
    "original": "The anticonvulsant felbamate blocks NmethylDasparate NMDA receptors but fails to exhibit the neurobehavioral toxicity characteristic of other NMDA receptor antagonists",
    "simplified": "The anticonvulsant felbamate works by blocking the NMDA receptors. It does not cause the same problems as other drugs that block these receptors."
  },
  {
    "text": "This selectivity could in part account for the more favorable clinical profile of felbamate compared to other NMDA receptor drugs , because it can be used more efficiently .",
    "triple_list": [
      [
        "felbamate",
        "CPR:6",
        "NMDA receptor"
      ]
    ],
    "updated": "Yes",
    "original": "This selectivity could in part account for the more favorable clinical profile of felbamate in comparison with NMDA receptor antagonists that do not show subunit selectivity",
    "simplified": "This selectivity could in part account for the more favorable clinical profile of felbamate compared to other NMDA receptor drugs, because it can be used more efficiently."
  },
  {
    "text": "In four 10 patients the peak ACTH stimulated cortisol values were lower than 18 \u03bcgdL",
    "triple_list": [
      [
        "ACTH",
        "CPR:9",
        "cortisol"
      ]
    ],
    "updated": "No",
    "original": "In four 10 patients the peak ACTH stimulated cortisol values were lower than 18 \u03bcgdL",
    "simplified": "Four out of 10 patients had a peak cortisol level lower than 18 \u03bcgdL."
  },
  {
    "text": "ACTH stimulated peak cortisol delta cortisol and delta DHEA S levels are decreased during hyperthyroidism probably due to increased turnover",
    "triple_list": [
      [
        "ACTH",
        "CPR:9",
        "cortisol"
      ],
      [
        "ACTH",
        "CPR:9",
        "delta cortisol"
      ],
      [
        "ACTH",
        "CPR:9",
        "delta DHEA"
      ]
    ],
    "updated": "No",
    "original": "ACTH stimulated peak cortisol delta cortisol and delta DHEA S levels are decreased during hyperthyroidism probably due to increased turnover",
    "simplified": "Delta cortisol and delta DHEA S levels are decreased during hyperthyroidism. This is probably because there is more turnover."
  },
  {
    "text": "U50 488H caused the hkor level to go down a lot , although etorphine did not",
    "triple_list": [
      [
        "U50 488H",
        "CPR:4",
        "hkor"
      ]
    ],
    "updated": "Yes",
    "original": "U50 488H caused a significant downregulation of the hkor although etorphine did not",
    "simplified": "U50 488H caused the hkor level to go down a lot, although etorphine did not"
  },
  {
    "text": "Expression of the dominant negative mutants arrestin2319418 or dynamin IK44A significantly reduced U50488H induced downregulation of the hkor",
    "triple_list": [
      [
        "U50488H",
        "CPR:4",
        "hkor"
      ]
    ],
    "updated": "No",
    "original": "Expression of the dominant negative mutants arrestin2319418 or dynamin IK44A significantly reduced U50488H induced downregulation of the hkor",
    "simplified": "The dominant negative mutants arrestin2319418 or dynamin IK44A significantly reduced the amount of hkor in the blood."
  },
  {
    "text": "Coexpression of GRK2 or GRK2 and arrestin2 allowed etorphine to reduce the amount of hkor in the blood . Expression of arrestin2 alone did not .",
    "triple_list": [
      [
        "etorphine",
        "CPR:4",
        "hkor"
      ]
    ],
    "updated": "Yes",
    "original": "Coexpression of GRK2 or GRK2 and arrestin2 permitted etorphine to induce downregulation of the hkor although expression of arrestin2 or dynamin I alone did not",
    "simplified": "Coexpression of GRK2 or GRK2 and arrestin2 allowed etorphine to reduce the amount of hkor in the blood. Expression of arrestin2 alone did not."
  },
  {
    "text": "The dominant negative mutants rab5A N133I or rab7 N125I reduced U50488H but not rabies itself .",
    "triple_list": [
      [
        "rab5A",
        "CPR:4",
        "U50488H"
      ],
      [
        "N133I",
        "CPR:4",
        "U50488H"
      ],
      [
        "rab7",
        "CPR:4",
        "U50488H"
      ],
      [
        "N125I",
        "CPR:4",
        "U50488H"
      ]
    ],
    "updated": "Yes",
    "original": "Expression of the dominant negative mutants rab5A N133I or rab7 N125I blunted U50488H induced downregulation",
    "simplified": "The dominant negative mutants rab5A N133I or rab7 N125I reduced U50488H but not rabies itself."
  },
  {
    "text": "Pretreatment with lysosomal enzyme inhibitors 2S 3StransepoxysuccinylLleucylamido3methylbutane ethyl ester or chloroquine or proteasome inhibitors I MG132 or lactacystin reduced the amount of riboflavin and riboflavin in the blood .",
    "triple_list": [
      [
        "proteasome",
        "CPR:4",
        "MG132"
      ],
      [
        "proteasome",
        "CPR:4",
        "lactacystin"
      ]
    ],
    "updated": "Yes",
    "original": "Pretreatment with lysosomal enzyme inhibitors 2S 3StransepoxysuccinylLleucylamido3methylbutane ethyl ester or chloroquine or proteasome inhibitors proteasome inhibitor I MG132 or lactacystin decreased the extent of U50488Hinduced downregulation",
    "simplified": "Pretreatment with lysosomal enzyme inhibitors 2S 3StransepoxysuccinylLleucylamido3methylbutane ethyl ester or chloroquine or proteasome inhibitors I MG132 or lactacystin reduced the amount of riboflavin and riboflavin in the blood."
  },
  {
    "text": "These results indicate that U50488H induced downregulation of the hkor involves GRK arrestin2 dynamin rab5 and rab7dependent mechanisms and receptors seem to be trafficked to lysosomes and proteasomes for degradation",
    "triple_list": [
      [
        "U50488H",
        "CPR:4",
        "hkor"
      ]
    ],
    "updated": "No",
    "original": "These results indicate that U50488H induced downregulation of the hkor involves GRK arrestin2 dynamin rab5 and rab7dependent mechanisms and receptors seem to be trafficked to lysosomes and proteasomes for degradation",
    "simplified": "These results indicate that GRK arrestin2 dynamin rab5 and rab7dependent mechanisms and receptors seem to be trafficked to lysosomes and proteasomes for degradation by the Hkor gene."
  },
  {
    "text": "Thus U50488H induced internalization and downregulation of the hkor has been shown to work .",
    "triple_list": [
      [
        "U50488H",
        "CPR:4",
        "hkor"
      ]
    ],
    "updated": "Yes",
    "original": "Thus U50488H induced internalization and downregulation of the hkor share initial common mechanisms",
    "simplified": "Thus U50488H induced internalization and downregulation of the hkor has been shown to work."
  },
  {
    "text": "Previously we showed that the human kappaopioid receptor hkor in Chinese hamster ovary cells underwent downregulation after long-term treatment with U50488H .",
    "triple_list": [
      [
        "human kappaopioid receptor",
        "CPR:4",
        "U50488H"
      ],
      [
        "hkor",
        "CPR:4",
        "U50488H"
      ]
    ],
    "updated": "Yes",
    "original": "Previously we showed that the human kappaopioid receptor hkor stably expressed in Chinese hamster ovary CHO cells underwent downregulation after prolonged U50488H treatment",
    "simplified": "Previously we showed that the human kappaopioid receptor hkor in Chinese hamster ovary cells underwent downregulation after long-term treatment with U50488H."
  },
  {
    "text": "In Alexander cells only when they were transfected with FXRRXR GW4064 caused upregulation of SHP and OST\u03b2 and a downregulation of CYP27A1",
    "triple_list": [
      [
        "GW4064",
        "CPR:3",
        "SHP"
      ],
      [
        "GW4064",
        "CPR:3",
        "OST\u03b2"
      ],
      [
        "GW4064",
        "CPR:4",
        "CYP27A1"
      ]
    ],
    "updated": "No",
    "original": "In Alexander cells only when they were transfected with FXRRXR GW4064 caused upregulation of SHP and OST\u03b2 and a downregulation of CYP27A1",
    "simplified": "In Alexander cells only when they were transfected with FXRRXR GW4064, CYP27A1 and OST\u03b2 were changed in the Alexander cells."
  },
  {
    "text": "In addition , GCs have a synergistic effect on GW4064 induced FXR activation , while chenodeoxycholate has an additive effect .",
    "triple_list": [
      [
        "GW4064",
        "CPR:3",
        "FXR"
      ]
    ],
    "updated": "Yes",
    "original": "Moreover GCs have a synergistic effect on GW4064 induced FXR activation whereas chenodeoxycholate and GW4064 have an additive effect",
    "simplified": "In addition, GCs have a synergistic effect on GW4064 induced FXR activation, while chenodeoxycholate has an additive effect."
  },
  {
    "text": "Stereochemical studies showed that PAM inactivation by 4oxo5acetamido62thienylhex2enoic acid is stereospecific with respect to the moiety at the P2 position . This is consistent with previous results with reversible inhibitors .",
    "triple_list": [
      [
        "PAM",
        "CPR:4",
        "4oxo5acetamido62thienylhex2enoic acid"
      ]
    ],
    "updated": "Yes",
    "original": "Stereochemical studies established that PAM inactivation by 4oxo5acetamido62thienylhex2enoic acid is stereospecific with respect to the moiety at the P2 position which is consistent with previous results with substrates and reversible inhibitors",
    "simplified": "Stereochemical studies showed that PAM inactivation by 4oxo5acetamido62thienylhex2enoic acid is stereospecific with respect to the moiety at the P2 position. This is consistent with previous results with reversible inhibitors."
  },
  {
    "text": "In contrast 2 4dioxo5acetamido6phenylhexanoic acid which is a competitive inhibitor with respect to ascorbate exhibits a low degree of stereospecificity in binding to the ascorbate sites of both PAM and dopaminebetahydroxylase",
    "triple_list": [
      [
        "2 4dioxo5acetamido6phenylhexanoic acid",
        "CPR:4",
        "PAM"
      ],
      [
        "2 4dioxo5acetamido6phenylhexanoic acid",
        "CPR:4",
        "dopaminebetahydroxylase"
      ]
    ],
    "updated": "No",
    "original": "In contrast 2 4dioxo5acetamido6phenylhexanoic acid which is a competitive inhibitor with respect to ascorbate exhibits a low degree of stereospecificity in binding to the ascorbate sites of both PAM and dopaminebetahydroxylase",
    "simplified": "In contrast, 2 4dioxo5acetamido6phenylhexanoic acid, which is a competitive inhibitor with respect to ascorbate, does not bind to the ascorbate sites, but it does bind to the PAM sites."
  },
  {
    "text": "Kinetic parameters for PAM inactivation by 4oxo5acetamido6phenylhex2enoic acid and 4oxo5acetamido62thienylhex2enoic acid were obtained by using both the conventional dilution assay method and the more complex progress curve method",
    "triple_list": [
      [
        "PAM",
        "CPR:4",
        "4oxo5acetamido6phenylhex2enoic acid and 4oxo5acetamido62thienylhex2enoic acid"
      ]
    ],
    "updated": "No",
    "original": "Kinetic parameters for PAM inactivation by 4oxo5acetamido6phenylhex2enoic acid and 4oxo5acetamido62thienylhex2enoic acid were obtained by using both the conventional dilution assay method and the more complex progress curve method",
    "simplified": "Kinetic parameters for PAM inactivation by 4oxo5acetamido6phenylhex2enoic acid were obtained by using both the conventional dilution assay method and the more complex progress curve method."
  },
  {
    "text": "Sixteen of 34 CGPs inhibited MRP1 mediated E217\u03b2G uptake by 50 IC50s 0776 \u03bcM",
    "triple_list": [
      [
        "CGPs",
        "CPR:4",
        "MRP1"
      ],
      [
        "MRP1",
        "CPR:9",
        "E217\u03b2G"
      ]
    ],
    "updated": "No",
    "original": "Sixteen of 34 CGPs inhibited MRP1 mediated E217\u03b2G uptake by 50 IC50s 0776 \u03bcM",
    "simplified": "Sixteen out of 34 CGPs did not allow E217\u03b2G to be taken up at all."
  },
  {
    "text": "Of 9 CGPs with IC50s \u22642 \u03bcM two belonged to Class I two to Class III and five to Class V When tested in the intact cells only 4 of 16 CGPs at 10 \u03bcM inhibited MRP1 mediated calcein efflux by 50 III1 V3 4 6 while a fifth I5 inhibited efflux by just 23",
    "triple_list": [
      [
        "CGPs",
        "CPR:4",
        "MRP1"
      ],
      [
        "MRP1",
        "CPR:9",
        "calcein"
      ]
    ],
    "updated": "No",
    "original": "Of 9 CGPs with IC50s \u22642 \u03bcM two belonged to Class I two to Class III and five to Class V When tested in the intact cells only 4 of 16 CGPs at 10 \u03bcM inhibited MRP1 mediated calcein efflux by 50 III1 V3 4 6 while a fifth I5 inhibited efflux by just 23",
    "simplified": "Of 9 CGPs with IC50s \u22642 \u03bcM two belonged to Class I, two to Class III and five to Class V When tested in the intact cells only 4 of 16 CGPs at 10 \u03bcM inhibited calcein efflux by 50 while a fifth I5 inhibited efflux by just 23."
  },
  {
    "text": "The five CGPs also stopped MRP4 from taking up 3HE217\u03b2G",
    "triple_list": [
      [
        "CGPs",
        "CPR:4",
        "MRP4"
      ],
      [
        "3HE217\u03b2G",
        "CPR:9",
        "MRP4"
      ]
    ],
    "updated": "Yes",
    "original": "These five CGPs also inhibited 3HE217\u03b2G uptake by MRP4",
    "simplified": "The five CGPs also stopped MRP4 from taking up 3HE217\u03b2G"
  },
  {
    "text": "Five classes of chalcogenopyrylium dyes CGPs were examined for their ability to modulate transport of 3Hestradiol glucuronide E217\u03b2G a prototypical MRP substrate into MRPenriched insideout membrane vesicles",
    "triple_list": [
      [
        "3Hestradiol glucuronide",
        "CPR:9",
        "MRP"
      ],
      [
        "E217\u03b2G",
        "CPR:9",
        "MRP"
      ]
    ],
    "updated": "No",
    "original": "Five classes of chalcogenopyrylium dyes CGPs were examined for their ability to modulate transport of 3Hestradiol glucuronide E217\u03b2G a prototypical MRP substrate into MRPenriched insideout membrane vesicles",
    "simplified": "Five classes of chalcogenopyrylium dyes were examined. The dyes were used to transport 3Hestradiol glucuronide from the outside of the cell to the inside of the cell."
  },
  {
    "text": "Since gemfibrozil is known to activate peroxisome proliferatoractivated receptoralpha PPARalpha we investigated the role of PPARalpha in gemfibrozil mediated inhibition of iNOS",
    "triple_list": [
      [
        "gemfibrozil",
        "CPR:3",
        "peroxisome proliferatoractivated receptoralpha"
      ],
      [
        "gemfibrozil",
        "CPR:3",
        "PPARalpha"
      ],
      [
        "gemfibrozil",
        "CPR:3",
        "PPARalpha"
      ],
      [
        "gemfibrozil",
        "CPR:4",
        "iNOS"
      ]
    ],
    "updated": "No",
    "original": "Since gemfibrozil is known to activate peroxisome proliferatoractivated receptoralpha PPARalpha we investigated the role of PPARalpha in gemfibrozil mediated inhibition of iNOS",
    "simplified": "Since gemfibrozil is known to activate PPARalpha, we investigated the role of PPARalpha in gemfibrozil mediated inhibition of peroxisome proliferator-activated receptors."
  },
  {
    "text": "Gemfibrozil induced peroxisome proliferatorresponsive element PPRE dependent luciferase activity which was inhibited by the expression of DeltahPPARalpha the dominantnegative mutant of human PPARalpha",
    "triple_list": [
      [
        "Gemfibrozil",
        "CPR:3",
        "peroxisome proliferatorresponsive element"
      ],
      [
        "Gemfibrozil",
        "CPR:3",
        "PPRE"
      ]
    ],
    "updated": "No",
    "original": "Gemfibrozil induced peroxisome proliferatorresponsive element PPRE dependent luciferase activity which was inhibited by the expression of DeltahPPARalpha the dominantnegative mutant of human PPARalpha",
    "simplified": "Gemfibrozil caused luciferase activity to be inhibited by the expression of DeltahPPARalpha. DeltahPPARalpha is the dominantnegative mutant of human PPARalpha."
  },
  {
    "text": "Inhibition of human iNOS promoter driven luciferase activity by gemfibrozil in cytokinestimulated U373MG astroglial cells suggests that this compound inhibits the transcription of iNOS",
    "triple_list": [
      [
        "human iNOS promoter",
        "CPR:4",
        "gemfibrozil"
      ],
      [
        "iNOS",
        "CPR:4",
        "gemfibrozil"
      ]
    ],
    "updated": "No",
    "original": "Inhibition of human iNOS promoter driven luciferase activity by gemfibrozil in cytokinestimulated U373MG astroglial cells suggests that this compound inhibits the transcription of iNOS",
    "simplified": "Human iNOS promoter driven luciferase activity is inhibited by gemfibrozil in cytokinestimulated U373MG astroglial cells. This compound may inhibit iNOS transcription."
  },
  {
    "text": "However , DeltahPPARalpha was unable to abrogate gemfibrozil-mediated inhibition of iNOS , suggesting that PPARalpha may not be involved .",
    "triple_list": [
      [
        "gemfibrozil",
        "CPR:4",
        "iNOS"
      ],
      [
        "gemfibrozil",
        "CPR:4",
        "iNOS"
      ]
    ],
    "updated": "Yes",
    "original": "However DeltahPPARalpha was unable to abrogate gemfibrozilmediated inhibition of iNOS suggesting that gemfibrozil inhibits iNOS independent of PPARalpha",
    "simplified": "However, DeltahPPARalpha was unable to abrogate gemfibrozil-mediated inhibition of iNOS, suggesting that PPARalpha may not be involved."
  },
  {
    "text": "Gemfibrozil , a lipid-lowering drug , blocks nitricoxide synthase in human astrocytes .",
    "triple_list": [
      [
        "Gemfibrozil",
        "CPR:4",
        "nitricoxide synthase"
      ],
      [
        "nitricoxide",
        "CPR:9",
        "synthase"
      ]
    ],
    "updated": "Yes",
    "original": "Gemfibrozil a lipidlowering drug inhibits the induction of nitricoxide synthase in human astrocytes",
    "simplified": "Gemfibrozil, a lipid-lowering drug, blocks nitricoxide synthase in human astrocytes."
  },
  {
    "text": "Gemfibrozil a lipidlowering drug inhibited cytokine induced production of NO and the expression of inducible nitricoxide synthase iNOS in human U373MG astroglial cells and primary astrocytes",
    "triple_list": [
      [
        "Gemfibrozil",
        "CPR:4",
        "inducible nitricoxide synthase"
      ],
      [
        "Gemfibrozil",
        "CPR:4",
        "iNOS"
      ],
      [
        "Gemfibrozil",
        "CPR:4",
        "cytokine"
      ],
      [
        "NO",
        "CPR:9",
        "inducible nitricoxide synthase"
      ],
      [
        "NO",
        "CPR:9",
        "iNOS"
      ],
      [
        "nitricoxide",
        "CPR:9",
        "iNOS"
      ]
    ],
    "updated": "No",
    "original": "Gemfibrozil a lipidlowering drug inhibited cytokine induced production of NO and the expression of inducible nitricoxide synthase iNOS in human U373MG astroglial cells and primary astrocytes",
    "simplified": "Gemfibrozil a lipidlowering drug inhibited cytokine induced production of nitric oxide in human astroglial cells and primary astrocytes by inhibiting the expression of iNOS."
  },
  {
    "text": "Interestingly , gemfibrozil did not work at all in cytokinestimulated astroglial cells where NFkappaB AP1 and CEBPbeta were activated .",
    "triple_list": [
      [
        "gemfibrozil",
        "CPR:4",
        "NFkappaB"
      ],
      [
        "gemfibrozil",
        "CPR:4",
        "AP1"
      ],
      [
        "gemfibrozil",
        "CPR:4",
        "CEBPbeta"
      ]
    ],
    "updated": "Yes",
    "original": "Interestingly gemfibrozil strongly inhibited the activation of NFkappaB AP1 and CEBPbeta but not that of GAS in cytokinestimulated astroglial cells",
    "simplified": "Interestingly, gemfibrozil did not work at all in cytokinestimulated astroglial cells where NFkappaB AP1 and CEBPbeta were activated."
  },
  {
    "text": "These results suggest that gemfibrozil inhibits the induction of iNOS probably by inhibiting NFkappaB AP1 and CEBPbeta and that gemfibrozil may further find its therapeutic use in neuroinflammatory diseases .",
    "triple_list": [
      [
        "gemfibrozil",
        "CPR:4",
        "iNOS"
      ],
      [
        "gemfibrozil",
        "CPR:4",
        "NFkappaB"
      ],
      [
        "gemfibrozil",
        "CPR:4",
        "AP1"
      ],
      [
        "gemfibrozil",
        "CPR:4",
        "CEBPbeta"
      ]
    ],
    "updated": "Yes",
    "original": "These results suggest that gemfibrozil inhibits the induction of iNOS probably by inhibiting the activation of NFkappaB AP1 and CEBPbeta and that gemfibrozil a prescribed drug for humans may further find its therapeutic use in neuroinflammatory diseases",
    "simplified": "These results suggest that gemfibrozil inhibits the induction of iNOS probably by inhibiting NFkappaB AP1 and CEBPbeta and that gemfibrozil may further find its therapeutic use in neuroinflammatory diseases."
  },
  {
    "text": "Similar to gemfibrozil clofibrate another fibrate drug also inhibited the expression of iNOS",
    "triple_list": [
      [
        "gemfibrozil",
        "CPR:4",
        "iNOS"
      ],
      [
        "clofibrate",
        "CPR:4",
        "iNOS"
      ],
      [
        "fibrate",
        "CPR:4",
        "iNOS"
      ]
    ],
    "updated": "No",
    "original": "Similar to gemfibrozil clofibrate another fibrate drug also inhibited the expression of iNOS",
    "simplified": "Similar to gemfibrozil clofibrate, fibrate can stop the blood vessels from clotting."
  },
  {
    "text": "The aim of this study was to determine whether a potent centrally acting alpha2 adrenergic receptor AR agonist dexmedetomidine could reverse the effects of cocaines .",
    "triple_list": [
      [
        "alpha2 adrenergic receptor",
        "CPR:5",
        "dexmedetomidine"
      ],
      [
        "AR",
        "CPR:5",
        "dexmedetomidine"
      ]
    ],
    "updated": "Yes",
    "original": "OBJECTIVES The aim of this study was to determine whether cocaines sympathomimetic actions can be reversed by a potent centrally acting alpha2 adrenergic receptor AR agonist dexmedetomidine",
    "simplified": "The aim of this study was to determine whether a potent centrally acting alpha2 adrenergic receptor AR agonist dexmedetomidine could reverse the effects of cocaines."
  },
  {
    "text": "We have shown that among the three nitrates , only SNP inhibits HIF1 when hypoxia is present .",
    "triple_list": [
      [
        "SNP",
        "CPR:4",
        "HIF1"
      ]
    ],
    "updated": "Yes",
    "original": "We demonstrate that among the three nitrates only SNP inhibits HIF1 activation in response to hypoxia",
    "simplified": "We have shown that among the three nitrates, only SNP inhibits HIF1 when hypoxia is present."
  },
  {
    "text": "SNP inhibits the accumulation of HIF1alpha the regulatory subunit of HIF1 and the transcriptional activation of HIF1alpha via a mechanism that is not dependent on either NO or soluble guanylate cyclase",
    "triple_list": [
      [
        "SNP",
        "CPR:4",
        "HIF1alpha"
      ],
      [
        "SNP",
        "CPR:4",
        "HIF1"
      ],
      [
        "SNP",
        "CPR:4",
        "HIF1alpha"
      ]
    ],
    "updated": "No",
    "original": "SNP inhibits the accumulation of HIF1alpha the regulatory subunit of HIF1 and the transcriptional activation of HIF1alpha via a mechanism that is not dependent on either NO or soluble guanylate cyclase",
    "simplified": "The function of the SNP is to inhibit the accumulation of HIF1alpha and the transcriptional activation of HIF1alpha by a mechanism that is not dependent on either soluble guanylate cyclase or NO."
  },
  {
    "text": "The inhibitory effect of sodium nitroprusside on HIF1 depends on how much nitric oxide there is in the blood .",
    "triple_list": [
      [
        "sodium nitroprusside",
        "CPR:4",
        "HIF1"
      ]
    ],
    "updated": "Yes",
    "original": "The inhibitory effect of sodium nitroprusside on HIF1 activation is not dependent on nitric oxidesoluble guanylyl cyclase pathway",
    "simplified": "The inhibitory effect of sodium nitroprusside on HIF1 depends on how much nitric oxide there is in the blood."
  },
  {
    "text": "Indomethacin completely blocks CA activity .",
    "triple_list": [
      [
        "Indomethacin",
        "CPR:3",
        "CA"
      ]
    ],
    "updated": "Yes",
    "original": "Indomethacin completely antagonizes CA activity ie",
    "simplified": "Indomethacin completely blocks CA activity."
  },
  {
    "text": "Indomethacin activates carbonic anhydrase and antagonizes the effect of acetazolamide by a direct mechanism of action , and is therefore highly effective .",
    "triple_list": [
      [
        "Indomethacin",
        "CPR:3",
        "carbonic anhydrase"
      ],
      [
        "Indomethacin",
        "CPR:3",
        "carbonic anhydrase"
      ],
      [
        "carbonic anhydrase",
        "CPR:4",
        "acetazolamide"
      ],
      [
        "carbonic anhydrase",
        "CPR:4",
        "acetazolamide"
      ]
    ],
    "updated": "Yes",
    "original": "Indomethacin activates carbonic anhydrase and antagonizes the effect of the specific carbonic anhydrase inhibitor acetazolamide by a direct mechanism of action",
    "simplified": "Indomethacin activates carbonic anhydrase and antagonizes the effect of acetazolamide by a direct mechanism of action, and is therefore highly effective."
  },
  {
    "text": "CONCLUSIONS Our results show that indomethacin a known cyclooxygenase COX inhibitor is also an activator of CA",
    "triple_list": [
      [
        "indomethacin",
        "CPR:3",
        "CA"
      ],
      [
        "indomethacin",
        "CPR:4",
        "cyclooxygenase"
      ],
      [
        "indomethacin",
        "CPR:4",
        "COX"
      ]
    ],
    "updated": "No",
    "original": "CONCLUSIONS Our results show that indomethacin a known cyclooxygenase COX inhibitor is also an activator of CA",
    "simplified": "Our results show that indomethacin, a known COX inhibitor, is also an activator of the CA process."
  },
  {
    "text": "Our data also prove that indomethacin is not only an activator of CA but also antagonizes a specific enzyme by which acetazolamide works .",
    "triple_list": [
      [
        "indomethacin",
        "CPR:3",
        "CA"
      ],
      [
        "CA",
        "CPR:4",
        "acetazolamide"
      ]
    ],
    "updated": "Yes",
    "original": "Our data also prove that indomethacin is not only an activator of CA but also antagonizes the effect of acetazolamide a specific inhibitor of this enzyme",
    "simplified": "Our data also prove that indomethacin is not only an activator of CA but also antagonizes a specific enzyme by which acetazolamide works."
  },
  {
    "text": "In view of the role of CA in acidbase balance as well as the fact that an increase or decrease in its activity is accompanied by an increase or decrease in intra and extracellular pH our results suggest that firstly CA activation induced by indomethacin might cause changes in COX activity secondly PGs are synthetized as a consequence of the changes in COX activity a hypothesis that requires further study",
    "triple_list": [
      [
        "CA",
        "CPR:3",
        "indomethacin"
      ]
    ],
    "updated": "No",
    "original": "In view of the role of CA in acidbase balance as well as the fact that an increase or decrease in its activity is accompanied by an increase or decrease in intra and extracellular pH our results suggest that firstly CA activation induced by indomethacin might cause changes in COX activity secondly PGs are synthetized as a consequence of the changes in COX activity a hypothesis that requires further study",
    "simplified": "In view of the role of CA in acidbase balance as well as the fact that an increase or decrease in its activity is accompanied by an increase or decrease in intra and extracellular pH our results suggest that changes in COX activity may be responsible for PGs being synthetized a hypothesis that requires further study."
  },
  {
    "text": "Acetazolamide a specific inhibitor of CA reduces the activity of CA I and CA II from red cells",
    "triple_list": [
      [
        "Acetazolamide",
        "CPR:4",
        "CA"
      ],
      [
        "Acetazolamide",
        "CPR:4",
        "CA I"
      ],
      [
        "Acetazolamide",
        "CPR:4",
        "CA II"
      ]
    ],
    "updated": "No",
    "original": "Acetazolamide a specific inhibitor of CA reduces the activity of CA I and CA II from red cells",
    "simplified": "Acetazolamide, a certain drug, reduces the activity of the CA in red cells."
  },
  {
    "text": "abolishes the inhibitory effect of acetazolamide on CA",
    "triple_list": [
      [
        "acetazolamide",
        "CPR:4",
        "CA"
      ]
    ],
    "updated": "No",
    "original": "abolishes the inhibitory effect of acetazolamide on CA",
    "simplified": "It also reduces the acetazolamide inhibitory effect."
  },
  {
    "text": "These compounds are competitive inhibitors for AChE . The most effective compound is tacrine , but it is threefold less active than AChE .",
    "triple_list": [
      [
        "AChE",
        "CPR:4",
        "tacrine"
      ]
    ],
    "updated": "Yes",
    "original": "These compounds are competitive and in a few cases noncompetitive inhibitors for AChE the most potent being compound 14 though threefold less active than tacrine",
    "simplified": "These compounds are competitive inhibitors for AChE. The most effective compound is tacrine, but it is threefold less active than AChE."
  },
  {
    "text": "The acetylcholinesterase AChE and butyrylcholinesterase BuChE inhibitory activities of a series of pyrano23bquinolines 2 3 18naphthyridines 5 6 4amino23diaryl5678tetrahydrofuro23bquinolines 1113 4amino6789tetrahydro23diphenyl5Hcycloheptaefuro23bpyridine 14 4amino5678tetrahydro23diphenylthieno23bquinoline 15 4amino6789tetrahydro23diphenyl5Hcycloheptaethieno23bpyridine 16 are described",
    "triple_list": [
      [
        "AChE",
        "CPR:4",
        "pyrano23bquinolines"
      ],
      [
        "butyrylcholinesterase",
        "CPR:4",
        "pyrano23bquinolines"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "pyrano23bquinolines"
      ],
      [
        "BuChE",
        "CPR:4",
        "pyrano23bquinolines"
      ],
      [
        "AChE",
        "CPR:4",
        "18naphthyridines"
      ],
      [
        "butyrylcholinesterase",
        "CPR:4",
        "18naphthyridines"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "18naphthyridines"
      ],
      [
        "BuChE",
        "CPR:4",
        "18naphthyridines"
      ],
      [
        "AChE",
        "CPR:4",
        "4amino23diaryl5678tetrahydrofuro23bquinolines"
      ],
      [
        "butyrylcholinesterase",
        "CPR:4",
        "4amino23diaryl5678tetrahydrofuro23bquinolines"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "4amino23diaryl5678tetrahydrofuro23bquinolines"
      ],
      [
        "BuChE",
        "CPR:4",
        "4amino23diaryl5678tetrahydrofuro23bquinolines"
      ],
      [
        "AChE",
        "CPR:4",
        "4amino6789tetrahydro23diphenyl5Hcycloheptaefuro23bpyridine"
      ],
      [
        "butyrylcholinesterase",
        "CPR:4",
        "4amino6789tetrahydro23diphenyl5Hcycloheptaefuro23bpyridine"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "4amino6789tetrahydro23diphenyl5Hcycloheptaefuro23bpyridine"
      ],
      [
        "BuChE",
        "CPR:4",
        "4amino6789tetrahydro23diphenyl5Hcycloheptaefuro23bpyridine"
      ],
      [
        "AChE",
        "CPR:4",
        "4amino5678tetrahydro23diphenylthieno23bquinoline"
      ],
      [
        "butyrylcholinesterase",
        "CPR:4",
        "4amino5678tetrahydro23diphenylthieno23bquinoline"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "4amino5678tetrahydro23diphenylthieno23bquinoline"
      ],
      [
        "BuChE",
        "CPR:4",
        "4amino5678tetrahydro23diphenylthieno23bquinoline"
      ],
      [
        "AChE",
        "CPR:4",
        "4amino6789tetrahydro23diphenyl5Hcycloheptaethieno23bpyridine"
      ],
      [
        "butyrylcholinesterase",
        "CPR:4",
        "4amino6789tetrahydro23diphenyl5Hcycloheptaethieno23bpyridine"
      ],
      [
        "acetylcholinesterase",
        "CPR:4",
        "4amino6789tetrahydro23diphenyl5Hcycloheptaethieno23bpyridine"
      ],
      [
        "BuChE",
        "CPR:4",
        "4amino6789tetrahydro23diphenyl5Hcycloheptaethieno23bpyridine"
      ]
    ],
    "updated": "No",
    "original": "The acetylcholinesterase AChE and butyrylcholinesterase BuChE inhibitory activities of a series of pyrano23bquinolines 2 3 18naphthyridines 5 6 4amino23diaryl5678tetrahydrofuro23bquinolines 1113 4amino6789tetrahydro23diphenyl5Hcycloheptaefuro23bpyridine 14 4amino5678tetrahydro23diphenylthieno23bquinoline 15 4amino6789tetrahydro23diphenyl5Hcycloheptaethieno23bpyridine 16 are described",
    "simplified": "Acetylcholinesterase AChE and butyrylcholinesterase BuChE work by inhibiting the action of a series of pyrano23bquinolines. These are called pyrano23bquinolines."
  },
  {
    "text": "The BuChE inhibitory activity is only significant in compounds 11 and 14 tenfold less active than tacrine",
    "triple_list": [
      [
        "BuChE",
        "CPR:4",
        "tacrine"
      ]
    ],
    "updated": "No",
    "original": "The BuChE inhibitory activity is only significant in compounds 11 and 14 tenfold less active than tacrine",
    "simplified": "The BuChE inhibitory activity is only significant in very small numbers of compounds, e.g."
  },
  {
    "text": "Juglone isolated from Juglans mandshurica Maxim induces apoptosis via downregulation of AR expression in human prostate cancer LNCaP cells",
    "triple_list": [
      [
        "Juglone",
        "CPR:4",
        "AR"
      ]
    ],
    "updated": "No",
    "original": "Juglone isolated from Juglans mandshurica Maxim induces apoptosis via downregulation of AR expression in human prostate cancer LNCaP cells",
    "simplified": "Juglone isolated from Juglans mandshurica Maxim in human prostate cancer LNCaP cells can cause the cell to die."
  },
  {
    "text": "Moreover we found that juglone significantly inhibited the expression levels of androgen receptor AR and prostatespecific antigen PSA in a dosedependent manner as well as abrogated upregulation of AR and PSA genes with andor without dihydrotestosterone DHT",
    "triple_list": [
      [
        "juglone",
        "CPR:4",
        "androgen receptor"
      ],
      [
        "juglone",
        "CPR:4",
        "AR"
      ],
      [
        "juglone",
        "CPR:4",
        "prostatespecific antigen"
      ],
      [
        "juglone",
        "CPR:4",
        "PSA"
      ],
      [
        "juglone",
        "CPR:4",
        "AR"
      ],
      [
        "juglone",
        "CPR:4",
        "PSA"
      ]
    ],
    "updated": "No",
    "original": "Moreover we found that juglone significantly inhibited the expression levels of androgen receptor AR and prostatespecific antigen PSA in a dosedependent manner as well as abrogated upregulation of AR and PSA genes with andor without dihydrotestosterone DHT",
    "simplified": "Moreover, we found that juglone significantly inhibited the expression levels of androgen receptor and prostatespecific antigen PSA in a dosedependent manner, with and without dihydrotestosterone (DHT) supplementation."
  },
  {
    "text": "Together , our results showed that juglone could cause cell death in LNCaP cells by reducing AR expression .",
    "triple_list": [
      [
        "juglone",
        "CPR:4",
        "AR"
      ]
    ],
    "updated": "Yes",
    "original": "Take together our results demonstrated that juglone might induce the apoptosis in LNCaP cell via downregulation of AR expression",
    "simplified": "Together, our results showed that juglone could cause cell death in LNCaP cells by reducing AR expression."
  },
  {
    "text": "The efficacy of astemizole a new long acting oral histamine H1receptor antagonist was compared to placebo for the treatment of allergic rhinitis and conjunctivitis during the grass pollen season of 1982",
    "triple_list": [
      [
        "astemizole",
        "CPR:6",
        "histamine H1receptor"
      ]
    ],
    "updated": "No",
    "original": "The efficacy of astemizole a new long acting oral histamine H1receptor antagonist was compared to placebo for the treatment of allergic rhinitis and conjunctivitis during the grass pollen season of 1982",
    "simplified": "Astemizole is a new long acting oral histamine H1receptor antagonist that does not work the same way as other drugs and does not work the same way either."
  },
  {
    "text": "Astemizole a potent histamine H1receptor antagonist effect in allergic rhinoconjunctivitis Astemizole is a drug that is used to treat allergic rhinoconjunctivitis .",
    "triple_list": [
      [
        "Astemizole",
        "CPR:6",
        "histamine H1receptor"
      ]
    ],
    "updated": "Yes",
    "original": "Astemizole a potent histamine H1receptor antagonist effect in allergic rhinoconjunctivitis on antigen and histamine induced skin weal responses and relationship to serum levels",
    "simplified": "Astemizole a potent histamine H1receptor antagonist effect in allergic rhinoconjunctivitis Astemizole is a drug that is used to treat allergic rhinoconjunctivitis."
  },
  {
    "text": "Tacrine was the first cholinesterase inhibitor to undergo extensive trials for this purpose . It was found to have significant adverse effects , including hepatotoxicity .",
    "triple_list": [
      [
        "Tacrine",
        "CPR:4",
        "cholinesterase"
      ]
    ],
    "updated": "Yes",
    "original": "Tacrine the first of the cholinesterase inhibitors to undergo extensive trials for this purpose was associated with significant adverse effects including hepatotoxicity",
    "simplified": "Tacrine was the first cholinesterase inhibitor to undergo extensive trials for this purpose. It was found to have significant adverse effects, including hepatotoxicity."
  },
  {
    "text": "Other cholinesterase inhibitors , such as rivastigmine , have a better specificity of action . They also have a low risk of side effects .",
    "triple_list": [
      [
        "cholinesterase",
        "CPR:4",
        "rivastigmine"
      ]
    ],
    "updated": "Yes",
    "original": "Other cholinesterase inhibitors including rivastigmine with superior properties in terms of specificity of action and low risk of adverse effects have now been introduced",
    "simplified": "Other cholinesterase inhibitors, such as rivastigmine, have a better specificity of action. They also have a low risk of side effects."
  },
  {
    "text": "However , when 3 mM DMA was added , it significantly increased NHE1 , NHE2 and NHE3 levels .",
    "triple_list": [
      [
        "DMA",
        "CPR:4",
        "NHE1"
      ],
      [
        "DMA",
        "CPR:4",
        "NHE2"
      ],
      [
        "DMA",
        "CPR:4",
        "NHE3"
      ]
    ],
    "updated": "Yes",
    "original": "Nevertheless 3 mM DMA a higher concentration that inhibits NHE1 NHE2 and NHE3 significantly increased DBS",
    "simplified": "However, when 3 mM DMA was added, it significantly increased NHE1, NHE2 and NHE3 levels."
  },
  {
    "text": "In addition , S1611 and S3226 both specific inhibitors of NHE3 only or perfusion with Nafree solutions dose dependently increased DBS without affecting intracellular pH , as shown by pHstat .",
    "triple_list": [
      [
        "S1611",
        "CPR:4",
        "NHE3"
      ],
      [
        "S3226",
        "CPR:4",
        "NHE3"
      ]
    ],
    "updated": "Yes",
    "original": "Moreover S1611 and S3226 both specific inhibitors of NHE3 only or perfusion with Nafree solutions dose dependently increased DBS as measured by pHstat and CO2sensitive electrode without affecting intracellular pH",
    "simplified": "In addition, S1611 and S3226 both specific inhibitors of NHE3 only or perfusion with Nafree solutions dose dependently increased DBS without affecting intracellular pH, as shown by pHstat."
  },
  {
    "text": "However , coperfusion with 01 and 03 mM 5nitro23phenylpropylamino benzoic acid inhibited S3226induced DBS . The cystic fibrosis transmembrane conductor regulator CFTR dose dependently",
    "triple_list": [
      [
        "5nitro23phenylpropylamino benzoic acid",
        "CPR:4",
        "cystic fibrosis transmembrane conductor regulator"
      ],
      [
        "5nitro23phenylpropylamino benzoic acid",
        "CPR:4",
        "CFTR"
      ]
    ],
    "updated": "Yes",
    "original": "Nevertheless coperfusion with 01 and 03 mM 5nitro23phenylpropylamino benzoic acid which inhibits the cystic fibrosis transmembrane conductor regulator CFTR dose dependently inhibited S3226induced DBS",
    "simplified": "However, coperfusion with 01 and 03 mM 5nitro23phenylpropylamino benzoic acid inhibited S3226induced DBS. The cystic fibrosis transmembrane conductor regulator CFTR dose dependently"
  },
  {
    "text": "5NNdimethylamiloride 50 microM DMA a concentration that selectively inhibits the NHE isoforms NHE1 and NHE2 but not NHE3 did not affect DBS",
    "triple_list": [
      [
        "5NNdimethylamiloride",
        "CPR:4",
        "NHE"
      ],
      [
        "5NNdimethylamiloride",
        "CPR:4",
        "NHE1"
      ],
      [
        "5NNdimethylamiloride",
        "CPR:4",
        "NHE2"
      ],
      [
        "5NNdimethylamiloride",
        "CPR:4",
        "NHE3"
      ],
      [
        "DMA",
        "CPR:4",
        "NHE"
      ],
      [
        "DMA",
        "CPR:4",
        "NHE1"
      ],
      [
        "DMA",
        "CPR:4",
        "NHE2"
      ],
      [
        "DMA",
        "CPR:4",
        "NHE3"
      ]
    ],
    "updated": "No",
    "original": "5NNdimethylamiloride 50 microM DMA a concentration that selectively inhibits the NHE isoforms NHE1 and NHE2 but not NHE3 did not affect DBS",
    "simplified": "5NNdimethylamiloride 50 microM DMA a concentration that does not affect DBS does not work on the NHE isoforms NHE1 and NHE2."
  },
  {
    "text": "In conclusion only specific apical NHE3 inhibition increased DBS whereas intracellular HCO3 formation by carbonic anhydrase or prostaglandin synthesis was not involved .",
    "triple_list": [
      [
        "HCO3",
        "CPR:9",
        "carbonic anhydrase"
      ]
    ],
    "updated": "Yes",
    "original": "In conclusion only specific apical NHE3 inhibition increased DBS whereas prostaglandin synthesis NaHCO3 cotransporter activation or intracellular HCO3 formation by carbonic anhydrase was not involved",
    "simplified": "In conclusion only specific apical NHE3 inhibition increased DBS whereas intracellular HCO3 formation by carbonic anhydrase or prostaglandin synthesis was not involved."
  },
  {
    "text": "Mechanisms limiting distribution of the threonineprotein kinase BRaF V600E inhibitor dabrafenib to the brain implications for the treatment of melanoma brain metastases",
    "triple_list": [
      [
        "threonineprotein kinase BRaF",
        "CPR:4",
        "dabrafenib"
      ],
      [
        "V600E",
        "CPR:4",
        "dabrafenib"
      ]
    ],
    "updated": "No",
    "original": "Mechanisms limiting distribution of the threonineprotein kinase BRaF V600E inhibitor dabrafenib to the brain implications for the treatment of melanoma brain metastases",
    "simplified": "Mechanisms limiting the distribution of the threonineprotein kinase BRaF V600E inhibitor in the brain implications for treatment of brain cancer"
  },
  {
    "text": "Another BRAF V600E inhibitor , dabrafenib showed greater brain penetration when compared with vemurafenib .",
    "triple_list": [
      [
        "vemurafenib",
        "CPR:4",
        "BRAF"
      ],
      [
        "vemurafenib",
        "CPR:4",
        "V600E"
      ]
    ],
    "updated": "Yes",
    "original": "Further compared with vemurafenib another BRAF V600E inhibitor dabrafenib showed greater brain penetration with a similar dose",
    "simplified": "Another BRAF V600E inhibitor, dabrafenib showed greater brain penetration when compared with vemurafenib."
  },
  {
    "text": "In vitro accumulation studies have shown that dabrafenib is an avid substrate for both Pgp and BCRP in canine kidney II cells .",
    "triple_list": [
      [
        "dabrafenib",
        "CPR:9",
        "Pgp"
      ],
      [
        "dabrafenib",
        "CPR:9",
        "BCRP"
      ]
    ],
    "updated": "Yes",
    "original": "In vitro accumulation studies conducted in MadinDarby canine kidney II cells indicate that dabrafenib is an avid substrate for both Pgp and BCRP",
    "simplified": "In vitro accumulation studies have shown that dabrafenib is an avid substrate for both Pgp and BCRP in canine kidney II cells."
  },
  {
    "text": "Since the original discovery of azoles analogs as PXR antagonists , an important PXR antagonist pharmacophore has been identified and developed ( see below ) .",
    "triple_list": [
      [
        "azoles",
        "CPR:6",
        "PXR"
      ],
      [
        "azoles",
        "CPR:6",
        "PXR"
      ],
      [
        "azoles",
        "CPR:6",
        "PXR"
      ]
    ],
    "updated": "Yes",
    "original": "Since the original discovery of azoles analogs as PXR antagonists we have preliminarily defined an important PXR antagonist pharmacophore and developed lesstoxic PXR antagonists",
    "simplified": "Since the original discovery of azoles analogs as PXR antagonists, an important PXR antagonist pharmacophore has been identified and developed (see below)."
  },
  {
    "text": "Activation of endogenous somatostatin receptor subtype 2 sst2 by somatostatin14 or activation of transiently transfected rat D2 dopamine receptors rD2 long by quinpirole had no effect",
    "triple_list": [
      [
        "somatostatin receptor subtype 2",
        "CPR:3",
        "somatostatin14"
      ],
      [
        "sst2",
        "CPR:3",
        "somatostatin14"
      ],
      [
        "rat D2 dopamine receptors",
        "CPR:3",
        "quinpirole"
      ],
      [
        "rD2",
        "CPR:3",
        "quinpirole"
      ]
    ],
    "updated": "No",
    "original": "Activation of endogenous somatostatin receptor subtype 2 sst2 by somatostatin14 or activation of transiently transfected rat D2 dopamine receptors rD2 long by quinpirole had no effect",
    "simplified": "The level of somatostatin in the brain can be measured by measuring the amount of somatostatin in the blood. The somatostatin is in the nucleus accumbens."
  },
  {
    "text": "In contrast in the same system N type currents formed from transiently transfected alpha1Balpha2delta1beta3 showed strong Gprotein mediated inhibition",
    "triple_list": [
      [
        "N",
        "CPR:4",
        "Gprotein"
      ]
    ],
    "updated": "No",
    "original": "In contrast in the same system N type currents formed from transiently transfected alpha1Balpha2delta1beta3 showed strong Gprotein mediated inhibition",
    "simplified": "In contrast in the same system N type currents formed from transfected alpha1Balpha2delta1beta3 showed that G protein inhibited them."
  },
  {
    "text": "Cotreatment of astrocytes with antofine and the intracellular Ca2 chelator BAPTAAM prevented downregulation of Cx43 and inhibition of GJIC",
    "triple_list": [
      [
        "BAPTAAM",
        "CPR:3",
        "Cx43"
      ],
      [
        "antofine",
        "CPR:4",
        "Cx43"
      ]
    ],
    "updated": "No",
    "original": "Cotreatment of astrocytes with antofine and the intracellular Ca2 chelator BAPTAAM prevented downregulation of Cx43 and inhibition of GJIC",
    "simplified": "When astrocytes were treated with BAPTAAM, the intracellular Ca2 chelator, Cx43 was reduced and GJIC was inhibited."
  },
  {
    "text": "Together , these findings show that antofine disassembles the Cx43 gap junction by the PKC\u03b2 signaling pathway .",
    "triple_list": [
      [
        "antofine",
        "CPR:3",
        "PKC\u03b2"
      ]
    ],
    "updated": "Yes",
    "original": "Taken together these findings indicate that antofine induces Cx43 gap junction disassembly by the PKC\u03b2 signaling pathway",
    "simplified": "Together, these findings show that antofine disassembles the Cx43 gap junction by the PKC\u03b2 signaling pathway."
  },
  {
    "text": "Levels of Cx43 protein were also decreased in a dose and timedependent manner following antofine treatment",
    "triple_list": [
      [
        "Cx43",
        "CPR:4",
        "antofine"
      ]
    ],
    "updated": "No",
    "original": "Levels of Cx43 protein were also decreased in a dose and timedependent manner following antofine treatment",
    "simplified": "The levels of Cx43 protein were also reduced in a dose and time-dependent manner after treatment."
  },
  {
    "text": "Cotreatment with antofine and a specific PKC\u03b2 inhibitor also helped to prevent GJIC and Cx43 from being downregulated .",
    "triple_list": [
      [
        "antofine",
        "CPR:4",
        "Cx43"
      ]
    ],
    "updated": "Yes",
    "original": "Moreover cotreatment with antofine and a specific PKC\u03b2 inhibitor prevented endocytosis of gap junctions downregulation of Cx43 and inhibition of GJIC",
    "simplified": "Cotreatment with antofine and a specific PKC\u03b2 inhibitor also helped to prevent GJIC and Cx43 from being downregulated."
  },
  {
    "text": "Torasemide inhibits the action of angiotensin II in the aorta . This causes the aorta to become too narrow .",
    "triple_list": [
      [
        "Torasemide",
        "CPR:4",
        "angiotensin II"
      ]
    ],
    "updated": "Yes",
    "original": "Torasemide inhibits angiotensin II induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats",
    "simplified": "Torasemide inhibits the action of angiotensin II in the aorta. This causes the aorta to become too narrow."
  },
  {
    "text": "Isometric contraction was reduced in a dosedependent way by torasemide IC50=05004 micromolL when Ang II 107 molL was taken in .",
    "triple_list": [
      [
        "Ang II",
        "CPR:4",
        "torasemide"
      ]
    ],
    "updated": "Yes",
    "original": "Isometric contraction induced by a submaximal concentration of Ang II 107 molL was reduced in a dosedependent way by torasemide IC50=05004 micromolL",
    "simplified": "Isometric contraction was reduced in a dosedependent way by torasemide IC50=05004 micromolL when Ang II 107 molL was taken in."
  },
  {
    "text": "The effect of Ang II 107 molL on Ca2i was blocked by torasemide IC50=0503 nmolL when the concentration was lower .",
    "triple_list": [
      [
        "Ang II",
        "CPR:4",
        "torasemide"
      ]
    ],
    "updated": "Yes",
    "original": "The stimulatory effect of Ca2i induced by a submaximal concentration of Ang II 107 molL was blocked by torasemide IC50=0503 nmolL",
    "simplified": "The effect of Ang II 107 molL on Ca2i was blocked by torasemide IC50=0503 nmolL when the concentration was lower."
  },
  {
    "text": "Our results suggest that torasemide blocks Ang II vasoconstrictor activity in vitro .",
    "triple_list": [
      [
        "torasemide",
        "CPR:4",
        "Ang II"
      ]
    ],
    "updated": "Yes",
    "original": "Our findings suggest that torasemide blocks the vasoconstrictor action of Ang II in vitro",
    "simplified": "Our results suggest that torasemide blocks Ang II vasoconstrictor activity in vitro."
  },
  {
    "text": "This action can be related to the ability of torasemide to block Ang II in the human blood .",
    "triple_list": [
      [
        "torasemide",
        "CPR:4",
        "Ang II"
      ]
    ],
    "updated": "Yes",
    "original": "This action can be related to the ability of torasemide to block the increase of Ca2i induced by Ang II in VSMCs",
    "simplified": "This action can be related to the ability of torasemide to block Ang II in the human blood."
  },
  {
    "text": "Among the isolated compounds transdihydromorin 8 oxyresveratrol 9 and steppogenin 12 were found to exhibit significant tyrosinase inhibition activities",
    "triple_list": [
      [
        "transdihydromorin",
        "CPR:4",
        "tyrosinase"
      ],
      [
        "oxyresveratrol",
        "CPR:4",
        "tyrosinase"
      ],
      [
        "steppogenin",
        "CPR:4",
        "tyrosinase"
      ]
    ],
    "updated": "No",
    "original": "Among the isolated compounds transdihydromorin 8 oxyresveratrol 9 and steppogenin 12 were found to exhibit significant tyrosinase inhibition activities",
    "simplified": "Transdihydromorin 8 and oxyresveratrol 9 were found to inhibit tyrosinase. Steppogenin 12 was also found to inhibit tyrosinase."
  },
  {
    "text": "It was found that PGE1 selectively reduces both N and Rtype Ca2 currents . In paratracheal ganglion cells , this is probably done by a Gprotein .",
    "triple_list": [
      [
        "PGE1",
        "CPR:3",
        "Gprotein"
      ]
    ],
    "updated": "Yes",
    "original": "It was concluded that PGE1 selectively reduces both N and Rtype Ca2 currents by activating a Gprotein probably through the EP3 receptor in paratracheal ganglion cells",
    "simplified": "It was found that PGE1 selectively reduces both N and Rtype Ca2 currents. In paratracheal ganglion cells, this is probably done by a Gprotein."
  },
  {
    "text": "Prostaglandin E1 E2 STA2 a stable analogue of thromboxane A2 17phenyltrinor PGE2 an EP1 selective agonist and sulprostone an EP3 selective agonist inhibited the HVA Ca2 current HVA ICa dosedependently and the rank order of potency to inhibit HVA Ca2 channels was sulprostone PGE2 PGE1 STA217phenyltrinor PGE2",
    "triple_list": [
      [
        "STA2",
        "CPR:4",
        "HVA Ca2 channels"
      ],
      [
        "thromboxane A2",
        "CPR:4",
        "HVA Ca2 channels"
      ],
      [
        "sulprostone",
        "CPR:4",
        "HVA Ca2 channels"
      ],
      [
        "sulprostone",
        "CPR:4",
        "HVA Ca2 channels"
      ],
      [
        "PGE2",
        "CPR:4",
        "HVA Ca2 channels"
      ],
      [
        "HVA Ca2 channels",
        "CPR:4",
        "PGE1"
      ],
      [
        "STA2",
        "CPR:4",
        "HVA Ca2 channels"
      ],
      [
        "sulprostone",
        "CPR:5",
        "EP3"
      ]
    ],
    "updated": "No",
    "original": "Prostaglandin E1 E2 STA2 a stable analogue of thromboxane A2 17phenyltrinor PGE2 an EP1 selective agonist and sulprostone an EP3 selective agonist inhibited the HVA Ca2 current HVA ICa dosedependently and the rank order of potency to inhibit HVA Ca2 channels was sulprostone PGE2 PGE1 STA217phenyltrinor PGE2",
    "simplified": "Prostaglandin E1 E2 STA2 a stable analogue of thromboxane A2 17phenyltrinor PGE2 an EP1 selective agonist and sulprostone an EP3 selective agonist PGE2 PGE1 STA217phenyltrinor PGE2 PGE1 STA217phenyltrinor PGE2 PGE1 STA217phenyltrinor PGE2 PGE1 STA217phenyltrinor PGE2"
  },
  {
    "text": "SC51089 105 M a selective EP1receptor antagonist showed no effect on the PGE1 or PGE2 induced inhibition of the HVA ICa thereby indicating that PGE1 and PGE2 induced inhibition of the HVA Ca2 channels is possibly mediated by the EP3 receptor",
    "triple_list": [
      [
        "PGE1",
        "CPR:4",
        "HVA Ca2 channels"
      ],
      [
        "PGE2",
        "CPR:4",
        "HVA Ca2 channels"
      ],
      [
        "SC51089",
        "CPR:6",
        "EP1receptor"
      ]
    ],
    "updated": "No",
    "original": "SC51089 105 M a selective EP1receptor antagonist showed no effect on the PGE1 or PGE2 induced inhibition of the HVA ICa thereby indicating that PGE1 and PGE2 induced inhibition of the HVA Ca2 channels is possibly mediated by the EP3 receptor",
    "simplified": "A selective EP1receptor antagonist was found to have no effect on the PGE1 or PGE2 induced inhibition of the HVA ICa. This suggests that the HVA Ca2 channels are affected by the EP3 receptor as well."
  },
  {
    "text": "The inhibitory effect of PGE1 or sulprostone was prevented by pretreatment with IAP or phorbol12myristate13acetate . The protein kinase C PKC inhibitor chelerythrine blocked the action of PMA .",
    "triple_list": [
      [
        "protein kinase C",
        "CPR:4",
        "chelerythrine"
      ],
      [
        "PKC",
        "CPR:4",
        "chelerythrine"
      ]
    ],
    "updated": "Yes",
    "original": "The inhibitory effect of PGE1 or sulprostone was prevented by pretreatment with pertussis toxin islet activating protein IAP or phorbol12myristate13acetate PMA and the protein kinase C PKC inhibitor chelerythrine blocked the action of PMA",
    "simplified": "The inhibitory effect of PGE1 or sulprostone was prevented by pretreatment with IAP or phorbol12myristate13acetate. The protein kinase C PKC inhibitor chelerythrine blocked the action of PMA."
  },
  {
    "text": "In addition , we found that mimosine completely inhibited MCP1 transcription and translation while MIP2 transcription and translation was partially inhibited after 10 and 20 days in encysted diaphragm tissue infected by T spiralis .",
    "triple_list": [
      [
        "MCP1",
        "CPR:4",
        "mimosine"
      ],
      [
        "mimosine",
        "CPR:4",
        "MIP2"
      ]
    ],
    "updated": "Yes",
    "original": "In addition we found that MCP1 transcription and translation was completely inhibited by mimosine while MIP2 transcription and translation was partially inhibited at 30 and 40 days yet it was totally inhibited after 10 and 20 days in encysted diaphragm tissue infected by T spiralis",
    "simplified": "In addition, we found that mimosine completely inhibited MCP1 transcription and translation while MIP2 transcription and translation was partially inhibited after 10 and 20 days in encysted diaphragm tissue infected by T spiralis."
  },
  {
    "text": "Inhibition of MCP1 and MIP2 transcription and translation by mimosine in muscle tissue infected with the parasite Trichinella spiralis",
    "triple_list": [
      [
        "MCP1",
        "CPR:4",
        "mimosine"
      ],
      [
        "MIP2",
        "CPR:4",
        "mimosine"
      ]
    ],
    "updated": "No",
    "original": "Inhibition of MCP1 and MIP2 transcription and translation by mimosine in muscle tissue infected with the parasite Trichinella spiralis",
    "simplified": "Mimosine blocks the transcription and translation of MCP1 and MIP2 in infected muscle tissue by the parasite Trichinella spiralis."
  },
  {
    "text": "This is described in a case study of the expedited review and approval of peramivir a novel neuraminidase inhibitor in Japan in the context of the emergence of new strain of influenza in 2009",
    "triple_list": [
      [
        "peramivir",
        "CPR:4",
        "neuraminidase"
      ]
    ],
    "updated": "No",
    "original": "This is described in a case study of the expedited review and approval of peramivir a novel neuraminidase inhibitor in Japan in the context of the emergence of new strain of influenza in 2009",
    "simplified": "This is described in a case study of the expedited review and approval of a novel neuraminidase inhibitor in Japan after a new strain of influenza was identified in the country."
  },
  {
    "text": "These results suggest that CYP2B6 genotype is the most important patient variable for predicting the level of CYP2B6 activity in women when measured by the metabolism of bupropion",
    "triple_list": [
      [
        "CYP2B6",
        "CPR:9",
        "bupropion"
      ],
      [
        "CYP2B6",
        "CPR:9",
        "bupropion"
      ]
    ],
    "updated": "No",
    "original": "These results suggest that CYP2B6 genotype is the most important patient variable for predicting the level of CYP2B6 activity in women when measured by the metabolism of bupropion",
    "simplified": "These results suggest that the CYP2B6 genotype is the most important patient variable in women, and that the level of CYP2B6 activity in women is important."
  },
  {
    "text": "The bupropion metabolic ratio shows known differences in CYP2B6 activity between different people , depending on their race .",
    "triple_list": [
      [
        "bupropion",
        "CPR:9",
        "CYP2B6"
      ]
    ],
    "updated": "Yes",
    "original": "The bupropion metabolic ratio appears to detect known differences in CYP2B6 activity associated with genetic polymorphism across different ethnic groups",
    "simplified": "The bupropion metabolic ratio shows known differences in CYP2B6 activity between different people, depending on their race."
  },
  {
    "text": "To identify important covariates associated with interindividual variation in CYP2B6 activity in vivo we evaluated these effects in healthy volunteers using bupropion Wellbutrin SR GlaxoSmithKline Research Triangle Park NC as a CYP2B6 probe substrate",
    "triple_list": [
      [
        "CYP2B6",
        "CPR:9",
        "bupropion"
      ],
      [
        "CYP2B6",
        "CPR:9",
        "Wellbutrin SR"
      ]
    ],
    "updated": "No",
    "original": "To identify important covariates associated with interindividual variation in CYP2B6 activity in vivo we evaluated these effects in healthy volunteers using bupropion Wellbutrin SR GlaxoSmithKline Research Triangle Park NC as a CYP2B6 probe substrate",
    "simplified": "To identify important covariates associated with interindividual variation in CYP2B6 activity in healthy volunteers, we evaluated these effects in healthy volunteers using bupropion as a CYP2B6 probe substrate."
  },
  {
    "text": "The influence of sex ethnicity and CYP2B6 genotype on bupropion metabolism as an index of hepatic CYP2B6 activity in humans",
    "triple_list": [
      [
        "CYP2B6",
        "CPR:9",
        "bupropion"
      ]
    ],
    "updated": "No",
    "original": "The influence of sex ethnicity and CYP2B6 genotype on bupropion metabolism as an index of hepatic CYP2B6 activity in humans",
    "simplified": "The influence of sex on CYP2B6 activity in humans The influence of sex on CYP2B6 activity in humans."
  },
  {
    "text": "The identification of the succinate receptor SUCNR1 in platelets is of particular interest because a variety of platelet agonists have been shown to potentiate the effect of low doses of succinate .",
    "triple_list": [
      [
        "succinate",
        "CPR:5",
        "succinate receptor"
      ],
      [
        "succinate",
        "CPR:5",
        "SUCNR1"
      ]
    ],
    "updated": "Yes",
    "original": "The identification of the succinate receptor SUCNR1 in platelets is of particular interest because physiologically relevant concentrations of succinate were shown to potentiate the effect of low doses of a variety of platelet agonists",
    "simplified": "The identification of the succinate receptor SUCNR1 in platelets is of particular interest because a variety of platelet agonists have been shown to potentiate the effect of low doses of succinate."
  },
  {
    "text": "The results demonstrated that in SGC7901 cells treated with \u03b2ionone 25 50 100 and 200 \u03bcmolL for 24 h , apoptosis was induced in a dosedependent manner . In SGC7901 cells treated with \u03b2ionone 25 50 100 and 200 \u03bcmolL for 24 h , caspase3 and bcl2 were cleaved .",
    "triple_list": [
      [
        "\u03b2ionone",
        "CPR:3",
        "caspase3"
      ],
      [
        "\u03b2ionone",
        "CPR:4",
        "bcl2"
      ]
    ],
    "updated": "Yes",
    "original": "The results demonstrated that \u03b2iononeinduced apoptosis in a dosedependent manner in SGC7901 cells treated with \u03b2ionone 25 50 100 and 200 \u03bcmolL for 24 h \u03b2ionone was also shown to induce the expression of cleaved caspase3 and inhibit bcl2 expression in SGC7901 cells in a dosedependent manner",
    "simplified": "The results demonstrated that in SGC7901 cells treated with \u03b2ionone 25 50 100 and 200 \u03bcmolL for 24 h, apoptosis was induced in a dosedependent manner. In SGC7901 cells treated with \u03b2ionone 25 50 100 and 200 \u03bcmolL for 24 h, caspase3 and bcl2 were cleaved."
  },
  {
    "text": "The significantly decreased levels of pPI3K and pAKT expression were observed in SGC7901 cells after \u03b2ionone treatments in a time and dosedependent manner P 001",
    "triple_list": [
      [
        "pPI3K",
        "CPR:4",
        "\u03b2ionone"
      ],
      [
        "pAKT",
        "CPR:4",
        "\u03b2ionone"
      ]
    ],
    "updated": "No",
    "original": "The significantly decreased levels of pPI3K and pAKT expression were observed in SGC7901 cells after \u03b2ionone treatments in a time and dosedependent manner P 001",
    "simplified": "The levels of pPI3K and pAKT were significantly reduced in SGC7901 cells after one treatment at a time and in a dosedependent manner."
  },
  {
    "text": "However AII receptor blockers differ from ACE inhibitors with respect to side effects and induce less cough a side effect which may be related to bradykinin or other mediators such as substance P In terms of chemical structure eprosartan is a nonbiphenyl nontetrazole nonpeptide antagonist with a dual pharmacological mode of action .",
    "triple_list": [
      [
        "AII",
        "CPR:4",
        "eprosartan"
      ]
    ],
    "updated": "Yes",
    "original": "However AII receptor blockers differ from ACE inhibitors with respect to side effects and induce less cough a side effect which may be related to bradykinin or other mediators such as substance P Within the class of AII blockers eprosartan differs from other currently available agents in terms of chemical structure as it is a nonbiphenyl nontetrazole nonpeptide antagonist with a dual pharmacological mode of action",
    "simplified": "However AII receptor blockers differ from ACE inhibitors with respect to side effects and induce less cough a side effect which may be related to bradykinin or other mediators such as substance P In terms of chemical structure eprosartan is a nonbiphenyl nontetrazole nonpeptide antagonist with a dual pharmacological mode of action."
  },
  {
    "text": "In clinical trials eprosartan has been demonstrated to be at least as effective in reducing blood pressure as the ACE inhibitor enalapril and has significantly lower side effects",
    "triple_list": [
      [
        "ACE",
        "CPR:4",
        "enalapril"
      ]
    ],
    "updated": "No",
    "original": "In clinical trials eprosartan has been demonstrated to be at least as effective in reducing blood pressure as the ACE inhibitor enalapril and has significantly lower side effects",
    "simplified": "In clinical trials, eprosartan has been shown to be at least as good as the drug enalapril. It has also been shown to have a lower number of side effects."
  },
  {
    "text": "Based on our findings with structurally similar arylhydroxylamine metabolites of therapeutic drugs , we hypothesized that NADH cytochrome b5 reductase b5R and cytochrome b5 cyt b5 were involved in the reductive detoxification of arylhydroxylamine .",
    "triple_list": [
      [
        "arylhydroxylamine",
        "CPR:9",
        "NADH cytochrome b5 reductase"
      ],
      [
        "arylhydroxylamine",
        "CPR:9",
        "b5R"
      ],
      [
        "arylhydroxylamine",
        "CPR:9",
        "cytochrome b5"
      ],
      [
        "arylhydroxylamine",
        "CPR:9",
        "cyt b5"
      ]
    ],
    "updated": "Yes",
    "original": "On the basis of our findings with structurally similar arylhydroxylamine metabolites of therapeutic drugs we hypothesized that the reductive detoxification of arylhydroxylamine carcinogens was catalyzed by NADH cytochrome b5 reductase b5R and cytochrome b5 cyt b5",
    "simplified": "Based on our findings with structurally similar arylhydroxylamine metabolites of therapeutic drugs, we hypothesized that NADH cytochrome b5 reductase b5R and cytochrome b5 cyt b5 were involved in the reductive detoxification of arylhydroxylamine."
  },
  {
    "text": "We found that by reducing the carcinogenic hydroxylamines of the aromatic amine 4aminobiphenyl 4ABP found in cigarette smoke and the heterocyclic amine 2amino1methyl6phenylimidazo 45b pyridine PhIP found in grilled meats , human b5R and cyt b5 could be reduced .",
    "triple_list": [
      [
        "hydroxylamines",
        "CPR:9",
        "human b5R"
      ],
      [
        "hydroxylamines",
        "CPR:9",
        "cyt b5"
      ],
      [
        "aromatic amine",
        "CPR:9",
        "human b5R"
      ],
      [
        "aromatic amine",
        "CPR:9",
        "cyt b5"
      ],
      [
        "4aminobiphenyl",
        "CPR:9",
        "human b5R"
      ],
      [
        "4aminobiphenyl",
        "CPR:9",
        "cyt b5"
      ],
      [
        "4ABP",
        "CPR:9",
        "human b5R"
      ],
      [
        "4ABP",
        "CPR:9",
        "cyt b5"
      ],
      [
        "heterocyclic amine",
        "CPR:9",
        "human b5R"
      ],
      [
        "heterocyclic amine",
        "CPR:9",
        "cyt b5"
      ],
      [
        "2amino1methyl6phenylimidazo 45b pyridine",
        "CPR:9",
        "human b5R"
      ],
      [
        "2amino1methyl6phenylimidazo 45b pyridine",
        "CPR:9",
        "cyt b5"
      ],
      [
        "PhIP",
        "CPR:9",
        "human b5R"
      ],
      [
        "PhIP",
        "CPR:9",
        "cyt b5"
      ]
    ],
    "updated": "Yes",
    "original": "We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4aminobiphenyl 4ABP found in cigarette smoke and the heterocyclic amine 2amino1methyl6phenylimidazo 45b pyridine PhIP found in grilled meats was indeed catalyzed by a purified system containing only human b5R and cyt b5",
    "simplified": "We found that by reducing the carcinogenic hydroxylamines of the aromatic amine 4aminobiphenyl 4ABP found in cigarette smoke and the heterocyclic amine 2amino1methyl6phenylimidazo 45b pyridine PhIP found in grilled meats, human b5R and cyt b5 could be reduced."
  },
  {
    "text": "Reductive detoxification of arylhydroxylamine carcinogens by human NADH cytochrome b5 reductase and cytochrome b5",
    "triple_list": [
      [
        "arylhydroxylamine",
        "CPR:9",
        "cytochrome b5"
      ],
      [
        "arylhydroxylamine",
        "CPR:9",
        "human NADH cytochrome b5 reductase"
      ]
    ],
    "updated": "No",
    "original": "Reductive detoxification of arylhydroxylamine carcinogens by human NADH cytochrome b5 reductase and cytochrome b5",
    "simplified": "Human NADH cytochrome b5 reductase and cytochrome b5 can reduce arylhydroxylamine carcinogens."
  },
  {
    "text": "Polyclonal antisera to either b5R or cyt b5 significantly inhibited the reduction of Nhydroxy4aminobiphenyl NHOH4ABP by 95 and 89 % , respectively , while individual reduction of both NHOH4ABP and NhydroxyPhIP in individual HLM was significantly correlated with individual reduction of NHOH4ABP .",
    "triple_list": [
      [
        "b5R",
        "CPR:9",
        "Nhydroxy4aminobiphenyl"
      ],
      [
        "cyt b5",
        "CPR:9",
        "Nhydroxy4aminobiphenyl"
      ],
      [
        "b5R",
        "CPR:9",
        "NHOH4ABP"
      ],
      [
        "cyt b5",
        "CPR:9",
        "NHOH4ABP"
      ]
    ],
    "updated": "Yes",
    "original": "Polyclonal antisera to either b5R or cyt b5 significantly inhibited Nhydroxy4aminobiphenyl NHOH4ABP reduction by 95 and 89 respectively and immunoreactive cyt b5 protein content in individual HLM was significantly correlated with individual reduction of both NHOH4ABP and NhydroxyPhIP NHOHPhIP",
    "simplified": "Polyclonal antisera to either b5R or cyt b5 significantly inhibited the reduction of Nhydroxy4aminobiphenyl NHOH4ABP by 95 and 89%, respectively, while individual reduction of both NHOH4ABP and NhydroxyPhIP in individual HLM was significantly correlated with individual reduction of NHOH4ABP."
  },
  {
    "text": "Pranlukast is a new orally active selective inhibitor of CysLt1 leukotriene receptor",
    "triple_list": [
      [
        "Pranlukast",
        "CPR:4",
        "CysLt1"
      ],
      [
        "Pranlukast",
        "CPR:4",
        "leukotriene receptor"
      ]
    ],
    "updated": "No",
    "original": "Pranlukast is a new orally active selective inhibitor of CysLt1 leukotriene receptor",
    "simplified": "Pranlukast is a drug that can be taken orally. It works on the leukotriene receptor."
  },
  {
    "text": "Clinical effects of pranlukast an oral leukotriene receptor antagonist in mildtomoderate asthma a 4 week randomized multicentre controlled trial",
    "triple_list": [
      [
        "pranlukast",
        "CPR:6",
        "leukotriene receptor"
      ]
    ],
    "updated": "No",
    "original": "Clinical effects of pranlukast an oral leukotriene receptor antagonist in mildtomoderate asthma a 4 week randomized multicentre controlled trial",
    "simplified": "Pranlukast - an oral leukotriene receptor antagonist in mildtomoderate asthma: a randomized, double-blind, placebo-controlled trial"
  },
  {
    "text": "We used mutagenesis of these residues combined with an investigation of hERG block by close analogs of clofilium and ibutilide to assess how specific alterations in drug structure affected potency and binding interactions",
    "triple_list": [
      [
        "hERG",
        "CPR:4",
        "clofilium"
      ],
      [
        "hERG",
        "CPR:4",
        "ibutilide"
      ]
    ],
    "updated": "No",
    "original": "We used mutagenesis of these residues combined with an investigation of hERG block by close analogs of clofilium and ibutilide to assess how specific alterations in drug structure affected potency and binding interactions",
    "simplified": "We used mutagenesis of these residues combined with close analogs of clofilium and ibutilide to determine how specific changes in drug structure affected binding interactions and potency."
  },
  {
    "text": "There was also an increase in ckit Trio RhoA Rac3 EGFR Notch4 Dvl2 Ezrin beta catenin and mutant p53 protein expression in the parathion treated cells",
    "triple_list": [
      [
        "ckit",
        "CPR:3",
        "parathion"
      ],
      [
        "Trio",
        "CPR:3",
        "parathion"
      ],
      [
        "RhoA",
        "CPR:3",
        "parathion"
      ],
      [
        "Rac3",
        "CPR:3",
        "parathion"
      ],
      [
        "Notch4",
        "CPR:3",
        "parathion"
      ],
      [
        "Dvl2",
        "CPR:3",
        "parathion"
      ],
      [
        "Ezrin",
        "CPR:3",
        "parathion"
      ],
      [
        "beta catenin",
        "CPR:3",
        "parathion"
      ],
      [
        "p53",
        "CPR:3",
        "parathion"
      ]
    ],
    "updated": "No",
    "original": "There was also an increase in ckit Trio RhoA Rac3 EGFR Notch4 Dvl2 Ezrin beta catenin and mutant p53 protein expression in the parathion treated cells",
    "simplified": "There was also an increase in the amount of beta catenin and mutant p53 protein in the parathion treated cells."
  },
  {
    "text": "Parathion is an inhibitor of the enzyme cholinesterase . This makes body choline esters ( like acetylcholine ) break down .",
    "triple_list": [
      [
        "Parathion",
        "CPR:4",
        "cholinesterase"
      ]
    ],
    "updated": "Yes",
    "original": "Parathion is a cholinesterase inhibitor that induces the hydrolysis of body choline esters including acetylcholine at cholinergic synapses",
    "simplified": "Parathion is an inhibitor of the enzyme cholinesterase. This makes body choline esters (like acetylcholine) break down."
  },
  {
    "text": "The purified phosphodiester alphaGlcNAcase has a specific activity of 498 micromol of 3HGlcNAcalphaphosphomannosealphamethyl per milliliter of air when it is exposed to air for a short time .",
    "triple_list": [
      [
        "phosphodiester alphaGlcNAcase",
        "CPR:9",
        "3HGlcNAcalphaphosphomannosealphamethyl"
      ],
      [
        "phosphodiester alphaGlcNAcase",
        "CPR:9",
        "3HGlcNAcalphaphosphomannosealphamethyl"
      ]
    ],
    "updated": "Yes",
    "original": "The purified phosphodiester alphaGlcNAcase has a specific activity of 498 micromol of 3HGlcNAcalphaphosphomannosealphamethyl cleaved per h per mg of protein using 05 mM 3HGlcNAcalphaphosphomannosealphamethyl as substrate",
    "simplified": "The purified phosphodiester alphaGlcNAcase has a specific activity of 498 micromol of 3HGlcNAcalphaphosphomannosealphamethyl per milliliter of air when it is exposed to air for a short time."
  },
  {
    "text": "NAcetylglucosamine1phosphodiester alphaNAcetylglucosaminidase EC 31445 phosphodiester alphaGlcNAcase catalyzes the second step in the synthesis of the mannose 6phosphate necessary for the lysosomal hydrolases to be able to move from the cytoplasm to the lysosome .",
    "triple_list": [
      [
        "NAcetylglucosamine1phosphodiester alphaNAcetylglucosaminidase",
        "CPR:9",
        "mannose 6phosphate"
      ],
      [
        "EC 31445",
        "CPR:9",
        "mannose 6phosphate"
      ],
      [
        "phosphodiester alphaGlcNAcase",
        "CPR:9",
        "mannose 6phosphate"
      ]
    ],
    "updated": "Yes",
    "original": "NAcetylglucosamine1phosphodiester alphaNAcetylglucosaminidase EC 31445 phosphodiester alphaGlcNAcase catalyzes the second step in the synthesis of the mannose 6phosphate determinant required for efficient intracellular targeting of newly synthesized lysosomal hydrolases to the lysosome",
    "simplified": "NAcetylglucosamine1phosphodiester alphaNAcetylglucosaminidase EC 31445 phosphodiester alphaGlcNAcase catalyzes the second step in the synthesis of the mannose 6phosphate necessary for the lysosomal hydrolases to be able to move from the cytoplasm to the lysosome."
  },
  {
    "text": "In the in vitro assay kinsenoside 20 and 50\u03bcgmL markedly inhibited changes in various biochemical substances nitric oxide NO lactic dehydrogenase LDH superoxide dismutase SOD and catalase CAT in human umbilical vein endothelial cells HUVECs damaged by high glucose 35mM and restored vascular endothelial structure by balancing the matrix metalloproteinasesthe tissue inhibitors of matrix metalloproteinases MMPTIMP system",
    "triple_list": [
      [
        "kinsenoside",
        "CPR:4",
        "lactic dehydrogenase"
      ],
      [
        "kinsenoside",
        "CPR:4",
        "LDH"
      ],
      [
        "kinsenoside",
        "CPR:4",
        "superoxide dismutase"
      ],
      [
        "kinsenoside",
        "CPR:4",
        "SOD"
      ],
      [
        "kinsenoside",
        "CPR:4",
        "catalase"
      ],
      [
        "kinsenoside",
        "CPR:4",
        "CAT"
      ]
    ],
    "updated": "No",
    "original": "In the in vitro assay kinsenoside 20 and 50\u03bcgmL markedly inhibited changes in various biochemical substances nitric oxide NO lactic dehydrogenase LDH superoxide dismutase SOD and catalase CAT in human umbilical vein endothelial cells HUVECs damaged by high glucose 35mM and restored vascular endothelial structure by balancing the matrix metalloproteinasesthe tissue inhibitors of matrix metalloproteinases MMPTIMP system",
    "simplified": "In the in vitro assay kinsenoside 20 and 50\u03bcgmL markedly inhibited changes in various biochemical substances in human umbilical vein endothelial cells HUVECs damaged by high glucose 35mM and restored vascular endothelial structure by balancing the matrix metalloproteinasesthe tissue inhibitors of matrix metalloproteinases MMPTIMP system"
  },
  {
    "text": "The vascular protective effects of kinsenoside were speculated to be attributed to oxidative stress inhibition and the reduction of nuclear factor kappa B NF\u03baB mRNA expression levels in high glucose conditions",
    "triple_list": [
      [
        "kinsenoside",
        "CPR:4",
        "nuclear factor kappa B"
      ],
      [
        "kinsenoside",
        "CPR:4",
        "NF\u03baB"
      ]
    ],
    "updated": "No",
    "original": "The vascular protective effects of kinsenoside were speculated to be attributed to oxidative stress inhibition and the reduction of nuclear factor kappa B NF\u03baB mRNA expression levels in high glucose conditions",
    "simplified": "The vascular protective effects of kinsenoside were thought to be caused by the reduction of nuclear factor kappa B in high glucose conditions. This would reduce oxidative stress."
  },
  {
    "text": "8pCPT2OMecAMPAM potentiation of insulin secretion stimulated by tolbutamide was markedly inhibited by 2APB 25 \u03bcM and enhanced by the PKC inhibitor bisindolylmaleimide I 1 \u03bcM",
    "triple_list": [
      [
        "insulin",
        "CPR:3",
        "bisindolylmaleimide I"
      ],
      [
        "8pCPT2OMecAMPAM",
        "CPR:3",
        "insulin"
      ],
      [
        "insulin",
        "CPR:3",
        "tolbutamide"
      ],
      [
        "PKC",
        "CPR:4",
        "bisindolylmaleimide I"
      ],
      [
        "insulin",
        "CPR:4",
        "2APB"
      ]
    ],
    "updated": "No",
    "original": "8pCPT2OMecAMPAM potentiation of insulin secretion stimulated by tolbutamide was markedly inhibited by 2APB 25 \u03bcM and enhanced by the PKC inhibitor bisindolylmaleimide I 1 \u03bcM",
    "simplified": "8pCPT2OMecAMPAM potentiation of insulin secretion by tolbutamide was inhibited by 2APB 25 \u03bcM and enhanced by bisindolylmaleimide I 1 \u03bcM."
  },
  {
    "text": "Our data demonstrate that the actions of both tolbutamide and gliclazide are strongly potentiated by 8pCPT2OMecAMPAM and that 8pCPT2OMecAMPAM potentiation of tolbutamide action may involve activation of a 2APBsensitive Ca2 influx Our data demonstrate that gliclazide can stimulate phospholipase C activity via a partially pertussis toxinsensitive mechanism .",
    "triple_list": [
      [
        "gliclazide",
        "CPR:3",
        "phospholipase C"
      ]
    ],
    "updated": "Yes",
    "original": "Our data demonstrate that the actions of both tolbutamide and gliclazide are strongly potentiated by 8pCPT2OMecAMPAM that gliclazide can stimulate phospholipase C activity via a partially pertussis toxinsensitive mechanism and that 8pCPT2OMecAMPAM potentiation of tolbutamide action may involve activation of a 2APBsensitive Ca2 influx",
    "simplified": "Our data demonstrate that the actions of both tolbutamide and gliclazide are strongly potentiated by 8pCPT2OMecAMPAM and that 8pCPT2OMecAMPAM potentiation of tolbutamide action may involve activation of a 2APBsensitive Ca2 influx Our data demonstrate that gliclazide can stimulate phospholipase C activity via a partially pertussis toxinsensitive mechanism."
  },
  {
    "text": "Tolbutamide and gliclazide block the KATP channel Kir62 Sur1 causing membrane depolarization and stimulating insulin secretion in pancreatic beta cells",
    "triple_list": [
      [
        "Tolbutamide",
        "CPR:3",
        "insulin"
      ],
      [
        "Tolbutamide",
        "CPR:4",
        "KATP channel"
      ],
      [
        "Tolbutamide",
        "CPR:4",
        "Kir62"
      ],
      [
        "Tolbutamide",
        "CPR:4",
        "Sur1"
      ]
    ],
    "updated": "No",
    "original": "Tolbutamide and gliclazide block the KATP channel Kir62 Sur1 causing membrane depolarization and stimulating insulin secretion in pancreatic beta cells",
    "simplified": "Tolbutamide and gliclazide block the KATP channel in the pancreas. This causes insulin to be released into the blood."
  },
  {
    "text": "Insulin secretion stimulated by both 200 \u03bcM tolbutamide and 20 \u03bcM gliclazide concentrations that had equivalent effects on membrane potential was inhibited by thapsigargin 1 \u03bcM or the Ltype Ca2 channel blocker nicardipine 2 \u03bcM and was potentiated by 8pCPT2OMecAMPAM at concentrations \u22652 \u03bcM in INS1 cells",
    "triple_list": [
      [
        "Insulin",
        "CPR:3",
        "tolbutamide"
      ],
      [
        "Insulin",
        "CPR:3",
        "gliclazide"
      ],
      [
        "Insulin",
        "CPR:3",
        "8pCPT2OMecAMPAM"
      ],
      [
        "Insulin",
        "CPR:4",
        "thapsigargin"
      ],
      [
        "Insulin",
        "CPR:4",
        "nicardipine"
      ],
      [
        "Ltype Ca2 channel",
        "CPR:4",
        "nicardipine"
      ]
    ],
    "updated": "No",
    "original": "Insulin secretion stimulated by both 200 \u03bcM tolbutamide and 20 \u03bcM gliclazide concentrations that had equivalent effects on membrane potential was inhibited by thapsigargin 1 \u03bcM or the Ltype Ca2 channel blocker nicardipine 2 \u03bcM and was potentiated by 8pCPT2OMecAMPAM at concentrations \u22652 \u03bcM in INS1 cells",
    "simplified": "Insulin secretion stimulated by both 200 \u03bcM tolbutamide and 20 \u03bcM gliclazide concentrations that had equivalent effects on membrane potential was inhibited by 8pCPT2OMecAMPAM in INS1 cells and was potentiated by the Ltype Ca2 channel blocker nicardipine 2 \u03bcM in INS1 cells."
  },
  {
    "text": "Both tolbutamide and gliclazide helped phospholipase C to work . However , gliclazide helped it more than tolbutamide did . This is because gliclazide works alone at KATP channels .",
    "triple_list": [
      [
        "tolbutamide",
        "CPR:3",
        "phospholipase C"
      ],
      [
        "gliclazide",
        "CPR:3",
        "phospholipase C"
      ],
      [
        "gliclazide",
        "CPR:3",
        "KATP channels"
      ]
    ],
    "updated": "Yes",
    "original": "Both tolbutamide and gliclazide stimulated phospholipase C activity however only gliclazide did so independently of its activity at KATP channels and this activity was partially inhibited by pertussis toxin",
    "simplified": "Both tolbutamide and gliclazide helped phospholipase C to work. However, gliclazide helped it more than tolbutamide did. This is because gliclazide works alone at KATP channels."
  },
  {
    "text": "Phosphorylation of AMPK at Thr172 increased by 14fold within 5 minutes and stayed at this level for 30 minutes when 2deoxyglucose was added .",
    "triple_list": [
      [
        "AMPK",
        "CPR:3",
        "2deoxyglucose"
      ]
    ],
    "updated": "Yes",
    "original": "Phosphorylation of AMPK at Thr172 increased by 14fold within 5 min and remained elevated throughout a 30min time course in response to 2deoxyglucose",
    "simplified": "Phosphorylation of AMPK at Thr172 increased by 14fold within 5 minutes and stayed at this level for 30 minutes when 2deoxyglucose was added."
  },
  {
    "text": "Phosphorylation of eIF2\u03b1 was also increased but only at 30 min after 2deoxyglucose exposure .",
    "triple_list": [
      [
        "eIF2\u03b1",
        "CPR:3",
        "2deoxyglucose"
      ]
    ],
    "updated": "Yes",
    "original": "Phosphorylation of ERstress marker eIF2\u03b1 was also increased but only at 30 min of 2deoxyglucose exposure",
    "simplified": "Phosphorylation of eIF2\u03b1 was also increased but only at 30 min after 2deoxyglucose exposure."
  },
  {
    "text": "2Deoxyglucose increased phosphorylation of tuberous sclerosis complex 2 TSC2 on AMPK consensus sites but did not change the amount of TSC1 bound to TSC2",
    "triple_list": [
      [
        "2Deoxyglucose",
        "CPR:3",
        "TSC2"
      ],
      [
        "2Deoxyglucose",
        "CPR:3",
        "tuberous sclerosis complex 2"
      ],
      [
        "2Deoxyglucose",
        "CPR:3",
        "TSC2"
      ],
      [
        "2Deoxyglucose",
        "CPR:3",
        "AMPK"
      ]
    ],
    "updated": "No",
    "original": "2Deoxyglucose increased phosphorylation of tuberous sclerosis complex 2 TSC2 on AMPK consensus sites but did not change the amount of TSC1 bound to TSC2",
    "simplified": "2Deoxyglucose increased the amount of TSC1 in the blood but did not change the amount of TSC2 in the blood. TSC2 is a part of tuberous sclerosis."
  },
  {
    "text": "Conivaptan is a nonpeptide dual V1aV2 AVP receptor antagonist",
    "triple_list": [
      [
        "Conivaptan",
        "CPR:6",
        "V1aV2 AVP receptor"
      ]
    ],
    "updated": "No",
    "original": "Conivaptan is a nonpeptide dual V1aV2 AVP receptor antagonist",
    "simplified": "Conivaptan is a chemical compound. It is a nonpeptide."
  },
  {
    "text": "Conivaptan a dual vasopressin receptor v1av2 antagonist corrected",
    "triple_list": [
      [
        "Conivaptan",
        "CPR:6",
        "vasopressin receptor v1av2"
      ]
    ],
    "updated": "No",
    "original": "Conivaptan a dual vasopressin receptor v1av2 antagonist corrected",
    "simplified": "Conivaptan is an anti-inflammatory drug and vasopressin antagonist."
  },
  {
    "text": "H1receptor antagonists have been used since their first chemical synthesis in 1933 . They have been used in the treatment of certain diseases where histamine is thought to be important , and in research to find out what histamine does or does not do to cause a disease .",
    "triple_list": [
      [
        "H1receptor",
        "CPR:5",
        "histamine"
      ],
      [
        "H1receptor",
        "CPR:5",
        "histamine"
      ]
    ],
    "updated": "Yes",
    "original": "H1receptor antagonists have been utilized following their initial chemical synthesis in 1933 both in the treatment of conditions in which histamine is considered to be of pathogenic importance and conversely to help elucidate the role of histamine in disease through an evaluation of their influence on disease expression",
    "simplified": "H1receptor antagonists have been used since their first chemical synthesis in 1933. They have been used in the treatment of certain diseases where histamine is thought to be important, and in research to find out what histamine does or does not do to cause a disease."
  },
  {
    "text": "While there is a lot of indirect evidence that histamine is involved in asthma , it has been difficult to evaluate H1receptor antagonism in this condition because many of the early H1receptor antagonists did more than just stop histamine from working . Some of them also did something else , like make the patient feel better .",
    "triple_list": [
      [
        "histamine",
        "CPR:5",
        "H1receptor"
      ],
      [
        "histamine",
        "CPR:5",
        "H1receptor"
      ]
    ],
    "updated": "Yes",
    "original": "While there is considerable indirect evidence to implicate histamine in the pathogenesis of asthma a critical evaluation of H1receptor antagonism in this condition has until recently proved difficult as many of the early H1receptor antagonists possessed additional actions such as anticholinergic local anaesthetic alphaadrenoceptor antagonistic and antiserotonin activity",
    "simplified": "While there is a lot of indirect evidence that histamine is involved in asthma, it has been difficult to evaluate H1receptor antagonism in this condition because many of the early H1receptor antagonists did more than just stop histamine from working. Some of them also did something else, like make the patient feel better."
  },
  {
    "text": "The recent development of H1receptor antagonists devoid of clinical sedative effects has enabled the administration of doses of H1antihistamines within the airways . This has allowed a better assessment of the role of histamine in this condition .",
    "triple_list": [
      [
        "H1receptor",
        "CPR:5",
        "histamine"
      ],
      [
        "H1receptor",
        "CPR:5",
        "histamine"
      ]
    ],
    "updated": "Yes",
    "original": "The recent development of H1receptor antagonists devoid of clinical sedative effects has enabled the administration of doses of H1antihistamines which achieve a greater degree of H1receptor blockade within the airways thus permitting a better appraisal of the role of histamine in this condition",
    "simplified": "The recent development of H1receptor antagonists devoid of clinical sedative effects has enabled the administration of doses of H1antihistamines within the airways. This has allowed a better assessment of the role of histamine in this condition."
  },
  {
    "text": "Cholesterol esterase CE induced surface erosion and drug release from polyethylene carbonate PEC under mild physiological environment was studied .",
    "triple_list": [
      [
        "Cholesterol esterase",
        "CPR:9",
        "PEC"
      ],
      [
        "CE",
        "CPR:9",
        "PEC"
      ],
      [
        "Cholesterol esterase",
        "CPR:9",
        "polyethylene carbonate"
      ],
      [
        "CE",
        "CPR:9",
        "polyethylene carbonate"
      ]
    ],
    "updated": "Yes",
    "original": "Cholesterol esterase CE induced surface erosion of polyethylene carbonate PEC and drug release from PEC under mild physiological environment was investigated",
    "simplified": "Cholesterol esterase CE induced surface erosion and drug release from polyethylene carbonate PEC under mild physiological environment was studied."
  },
  {
    "text": "Intravenous arginine significantly increased the response to glucagon 129 12 vs 36 6 ngl in controls p 001 without affecting blood glucose .",
    "triple_list": [
      [
        "arginine",
        "CPR:3",
        "glucagon"
      ]
    ],
    "updated": "Yes",
    "original": "Intravenous arginine significantly increased the acute glucagon response 129 12 vs 36 6 ngl in controls p 001 notably without affecting plasma glucose",
    "simplified": "Intravenous arginine significantly increased the response to glucagon 129 12 vs 36 6 ngl in controls p 001 without affecting blood glucose."
  },
  {
    "text": "Isolated islets showed improved glucose stimulated insulin secretion after GRA treatment . Islet1 h1 at 167 mmoll glucose p 0001 without affecting islet glucose oxidation",
    "triple_list": [
      [
        "glucose",
        "CPR:3",
        "insulin"
      ]
    ],
    "updated": "Yes",
    "original": "Isolated islets displayed improved glucose stimulated insulin secretion after GRA treatment 0061 0007 vs 0030 0004 pmol islet1 h1 at 167 mmoll glucose p 0001 without affecting islet glucose oxidation",
    "simplified": "Isolated islets showed improved glucose stimulated insulin secretion after GRA treatment. Islet1 h1 at 167 mmoll glucose p 0001 without affecting islet glucose oxidation"
  },
  {
    "text": "PIP5K1B encodes phosphatidylinositol 4phosphate 5kinase \u03b2 type I pip5k1\u03b2 an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4phosphate PI4P to generate phosphatidylinositol45bisphosphate PI45P2",
    "triple_list": [
      [
        "PIP5K1B",
        "CPR:9",
        "phosphatidylinositol45bisphosphate"
      ],
      [
        "phosphatidylinositol 4phosphate 5kinase \u03b2 type I",
        "CPR:9",
        "phosphatidylinositol45bisphosphate"
      ],
      [
        "pip5k1\u03b2",
        "CPR:9",
        "phosphatidylinositol45bisphosphate"
      ],
      [
        "PIP5K1B",
        "CPR:9",
        "PI45P2"
      ],
      [
        "phosphatidylinositol 4phosphate 5kinase \u03b2 type I",
        "CPR:9",
        "PI45P2"
      ],
      [
        "pip5k1\u03b2",
        "CPR:9",
        "PI45P2"
      ],
      [
        "PIP5K1B",
        "CPR:9",
        "phosphatidylinositol 4phosphate"
      ],
      [
        "phosphatidylinositol 4phosphate",
        "CPR:9",
        "phosphatidylinositol 4phosphate 5kinase \u03b2 type I"
      ],
      [
        "phosphatidylinositol 4phosphate",
        "CPR:9",
        "pip5k1\u03b2"
      ],
      [
        "PIP5K1B",
        "CPR:9",
        "PI4P"
      ],
      [
        "phosphatidylinositol 4phosphate 5kinase \u03b2 type I",
        "CPR:9",
        "PI4P"
      ],
      [
        "pip5k1\u03b2",
        "CPR:9",
        "PI4P"
      ]
    ],
    "updated": "No",
    "original": "PIP5K1B encodes phosphatidylinositol 4phosphate 5kinase \u03b2 type I pip5k1\u03b2 an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4phosphate PI4P to generate phosphatidylinositol45bisphosphate PI45P2",
    "simplified": "PIP5K1B encodes phosphatidylinositol 4phosphate 5kinase \u03b2 type I pip5k1\u03b2 an enzyme that phosphorylates phosphatidylinositol 4phosphate to make phosphatidylinositol45bisphosphate, which is used for cell growth and renewal."
  },
  {
    "text": "Accordingly , the loss of pip5k1\u03b2 function in FRDA cells was accompanied by decreased PI45P2 levels . The decrease in PI45P2 levels caused cell division .",
    "triple_list": [
      [
        "pip5k1\u03b2",
        "CPR:9",
        "PI45P2"
      ]
    ],
    "updated": "Yes",
    "original": "Accordingly loss of pip5k1\u03b2 function in FRDA cells was accompanied by decreased PI45P2 levels and was shown instrumental for destabilization of the actin network and delayed cell spreading",
    "simplified": "Accordingly, the loss of pip5k1\u03b2 function in FRDA cells was accompanied by decreased PI45P2 levels. The decrease in PI45P2 levels caused cell division."
  },
  {
    "text": "The expression of regucalcin is increased through the action of insulin in liver cells in vitro and in vivo . In rats with type I diabetes , when streptozotocin is given to the liver , regucalcin is reduced .",
    "triple_list": [
      [
        "regucalcin",
        "CPR:4",
        "streptozotocin"
      ]
    ],
    "updated": "Yes",
    "original": "The expression of regucalcin is stimulated through the action of insulin in liver cells in vitro and in vivo and it is decreased in the liver of rats with type I diabetes induced by streptozotocin administration in vivo",
    "simplified": "The expression of regucalcin is increased through the action of insulin in liver cells in vitro and in vivo. In rats with type I diabetes, when streptozotocin is given to the liver, regucalcin is reduced."
  },
  {
    "text": "AMPK activators metformin and AICAR partly prevented the cell cycle block oxidative stress and apoptosis The small interfering RNA siRNA targeting of human AMPK in U251 glioma cells induced oxidative stress and apoptosis but failed to induce G2M cell cycle arrest .",
    "triple_list": [
      [
        "AMPK",
        "CPR:3",
        "metformin"
      ],
      [
        "AMPK",
        "CPR:3",
        "AICAR"
      ]
    ],
    "updated": "Yes",
    "original": "AMPK activators metformin and AICAR partly prevented the cell cycle block oxidative stress and apoptosis induced by compound C The small interfering RNA siRNA targeting of human AMPK mimicked compound Cinduced G2M cell cycle arrest but failed to induce oxidative stress and apoptosis in U251 glioma cells",
    "simplified": "AMPK activators metformin and AICAR partly prevented the cell cycle block oxidative stress and apoptosis The small interfering RNA siRNA targeting of human AMPK in U251 glioma cells induced oxidative stress and apoptosis but failed to induce G2M cell cycle arrest."
  },
  {
    "text": "Indomethacin treatment led to an increase in lipid peroxidation glutathione peroxidase and glucose6phosphate dehydrogenase activities and to a decrease in catalase activity and glutathione levels in gastric mucosa",
    "triple_list": [
      [
        "Indomethacin",
        "CPR:3",
        "glutathione peroxidase"
      ],
      [
        "Indomethacin",
        "CPR:3",
        "glucose6phosphate dehydrogenase"
      ],
      [
        "Indomethacin",
        "CPR:4",
        "catalase"
      ]
    ],
    "updated": "No",
    "original": "Indomethacin treatment led to an increase in lipid peroxidation glutathione peroxidase and glucose6phosphate dehydrogenase activities and to a decrease in catalase activity and glutathione levels in gastric mucosa",
    "simplified": "Indomethacin treatment led to a decrease in catalase activity and glutathione levels in gastric mucosa and an increase in lipid peroxidation and glucose6phosphate dehydrogenase activities."
  },
  {
    "text": "Diclofenac\u03b2dglucuronide clopidogrel\u03b2dglucuronide ibuprofen\u03b2dglucuronide Rnaproxen\u03b2dglucuronide and Snaproxen\u03b2dglucuronide selectively inhibited hCES1 with Ki values of 432 \u00b1 047 248 \u00b1 42 355 \u00b1 38 468 \u00b1 21 707 \u00b1 64 \u00b5M respectively but did not significantly inhibit hCES2",
    "triple_list": [
      [
        "clopidogrel\u03b2dglucuronide",
        "CPR:4",
        "hCES1"
      ],
      [
        "ibuprofen\u03b2dglucuronide",
        "CPR:4",
        "hCES1"
      ],
      [
        "Rnaproxen\u03b2dglucuronide",
        "CPR:4",
        "hCES1"
      ],
      [
        "Snaproxen\u03b2dglucuronide",
        "CPR:4",
        "hCES1"
      ],
      [
        "Diclofenac\u03b2dglucuronide",
        "CPR:4",
        "hCES1"
      ]
    ],
    "updated": "No",
    "original": "Diclofenac\u03b2dglucuronide clopidogrel\u03b2dglucuronide ibuprofen\u03b2dglucuronide Rnaproxen\u03b2dglucuronide and Snaproxen\u03b2dglucuronide selectively inhibited hCES1 with Ki values of 432 \u00b1 047 248 \u00b1 42 355 \u00b1 38 468 \u00b1 21 707 \u00b1 64 \u00b5M respectively but did not significantly inhibit hCES2",
    "simplified": "Rnaproxen\u03b2dglucuronide and Snaproxen\u03b2dglucuronide selectively inhibited hCES1 with Ki values of 432 \u00b1 047 248 \u00b1 42 355 \u00b1 38 468 \u00b1 21 707 \u00b1 64 \u00b5M respectively but did not significantly inhibit hCES2."
  },
  {
    "text": "Conclusion Drugdrug interaction studies may be warranted for drugs that metabolize to acyl glucuronides due to the potential inhibition of hCESs",
    "triple_list": [
      [
        "acyl glucuronides",
        "CPR:4",
        "hCESs"
      ]
    ],
    "updated": "No",
    "original": "Conclusion Drugdrug interaction studies may be warranted for drugs that metabolize to acyl glucuronides due to the potential inhibition of hCESs",
    "simplified": "Conclusion Drug-drug interaction studies may be warranted due to the potential inhibition of hCESs for certain drugs."
  },
  {
    "text": "Objective This study explores the ability of acyl glucuronides to act as substrates or inhibitors of human carboxylesterases 1 hCES1 and 2 hCES2",
    "triple_list": [
      [
        "acyl glucuronides",
        "CPR:4",
        "human carboxylesterases 1"
      ],
      [
        "acyl glucuronides",
        "CPR:4",
        "hCES1"
      ],
      [
        "acyl glucuronides",
        "CPR:4",
        "hCES2"
      ],
      [
        "acyl glucuronides",
        "CPR:9",
        "human carboxylesterases 1"
      ],
      [
        "acyl glucuronides",
        "CPR:9",
        "hCES1"
      ],
      [
        "acyl glucuronides",
        "CPR:9",
        "hCES2"
      ]
    ],
    "updated": "No",
    "original": "Objective This study explores the ability of acyl glucuronides to act as substrates or inhibitors of human carboxylesterases 1 hCES1 and 2 hCES2",
    "simplified": "Objective This study explores the ability of acyl glucuronides to act as carboxylesterases 1 hCES1 and 2 hCES2 in human cells."
  },
  {
    "text": "Reversible inhibition of human carboxylesterases by acyl glucuronides",
    "triple_list": [
      [
        "human carboxylesterases",
        "CPR:4",
        "acyl glucuronides"
      ]
    ],
    "updated": "No",
    "original": "Reversible inhibition of human carboxylesterases by acyl glucuronides",
    "simplified": "Human carboxylesterases can be inhibited by acyl glucuronides."
  },
  {
    "text": "Carboxylesterases hydrolyze esters amides and thioesters to produce carboxylic acids and resulting alcohols amines and thiols respectively",
    "triple_list": [
      [
        "Carboxylesterases",
        "CPR:9",
        "alcohols"
      ],
      [
        "Carboxylesterases",
        "CPR:9",
        "esters"
      ],
      [
        "Carboxylesterases",
        "CPR:9",
        "amides"
      ],
      [
        "Carboxylesterases",
        "CPR:9",
        "thioesters"
      ],
      [
        "Carboxylesterases",
        "CPR:9",
        "carboxylic acids"
      ],
      [
        "Carboxylesterases",
        "CPR:9",
        "amines"
      ],
      [
        "Carboxylesterases",
        "CPR:9",
        "thiols"
      ]
    ],
    "updated": "No",
    "original": "Carboxylesterases hydrolyze esters amides and thioesters to produce carboxylic acids and resulting alcohols amines and thiols respectively",
    "simplified": "Carboxylesterases hydrolyze esters and thioesters to make carboxylic acids. The carboxylic acids are used to make alcohols."
  },
  {
    "text": "Uridine 5diphosphate glucuronosyltransferases are colocalized with carboxylesterases . They have the potential to further metabolize carboxylic acids to acyl glucuronides , but it is currently unknown if they also interact with carboxylesterases .",
    "triple_list": [
      [
        "Uridine 5diphosphate glucuronosyltransferases",
        "CPR:9",
        "carboxylic acids"
      ],
      [
        "carboxylesterases",
        "CPR:9",
        "carboxylic acids"
      ],
      [
        "Uridine 5diphosphate glucuronosyltransferases",
        "CPR:9",
        "acyl glucuronides"
      ],
      [
        "carboxylesterases",
        "CPR:9",
        "acyl glucuronides"
      ],
      [
        "Uridine 5diphosphate glucuronosyltransferases",
        "CPR:9",
        "acyl glucuronides"
      ]
    ],
    "updated": "Yes",
    "original": "Uridine 5diphosphate glucuronosyltransferases are colocalized with carboxylesterases and have the potential to further metabolize carboxylic acids to acyl glucuronides but it is currently unknown if acyl glucuronides being esters also interact with carboxylesterases",
    "simplified": "Uridine 5diphosphate glucuronosyltransferases are colocalized with carboxylesterases. They have the potential to further metabolize carboxylic acids to acyl glucuronides, but it is currently unknown if they also interact with carboxylesterases."
  },
  {
    "text": "Methods The stability of six acyl glucuronides in the presence of hCES1 hCES2 and buffer alone 100 mM potassium phosphate pH 74 37\u00b0C were investigated",
    "triple_list": [
      [
        "acyl glucuronides",
        "CPR:9",
        "hCES1"
      ],
      [
        "acyl glucuronides",
        "CPR:9",
        "hCES2"
      ]
    ],
    "updated": "No",
    "original": "Methods The stability of six acyl glucuronides in the presence of hCES1 hCES2 and buffer alone 100 mM potassium phosphate pH 74 37\u00b0C were investigated",
    "simplified": "Methods The stability of six acyl glucuronides in the presence of buffer and hCES1/O. The stability of buffer alone was tested."
  },
  {
    "text": "In addition , DOX treated WT and p65 MEFs differed in their expression of various apoptosisassociated molecules when the former showed a decrease in the percentage of p53positive cells while the latter showed a decrease in the percentage of p65 positive and a more prominent decrease in the percentage of bcl2positive cells .",
    "triple_list": [
      [
        "DOX",
        "CPR:4",
        "p65"
      ]
    ],
    "updated": "Yes",
    "original": "Furthermore DOX treated WT and p65 MEFs differed in their expression of various apoptosisassociated molecules when the former demonstrated a decrease in the percentage of p65 positive and a more prominent decrease in the percentage of p53positive cells while a decreased percentage of I\u03baB\u03b1positive and a more prominent decrease in the percentage of bcl2positive cells was detected among the latter",
    "simplified": "In addition, DOX treated WT and p65 MEFs differed in their expression of various apoptosisassociated molecules when the former showed a decrease in the percentage of p53positive cells while the latter showed a decrease in the percentage of p65 positive and a more prominent decrease in the percentage of bcl2positive cells."
  },
  {
    "text": "Crocin 25 and 50mgkg or vitamin E improved histopathological damages decreased MDA and CKMB increased GSH content and attenuated the increase of Bax Bcl2 ratio activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN",
    "triple_list": [
      [
        "Crocin",
        "CPR:3",
        "caspase 3"
      ],
      [
        "vitamin E",
        "CPR:3",
        "caspase 3"
      ],
      [
        "Bax",
        "CPR:3",
        "DZN"
      ],
      [
        "caspase 3",
        "CPR:3",
        "DZN"
      ],
      [
        "cytochrome c",
        "CPR:3",
        "DZN"
      ],
      [
        "Crocin",
        "CPR:4",
        "CKMB"
      ],
      [
        "Crocin",
        "CPR:4",
        "Bax"
      ],
      [
        "Crocin",
        "CPR:4",
        "Bcl2"
      ],
      [
        "Crocin",
        "CPR:4",
        "cytochrome c"
      ],
      [
        "vitamin E",
        "CPR:4",
        "CKMB"
      ],
      [
        "vitamin E",
        "CPR:4",
        "Bax"
      ],
      [
        "vitamin E",
        "CPR:4",
        "Bcl2"
      ],
      [
        "Bcl2",
        "CPR:4",
        "DZN"
      ]
    ],
    "updated": "No",
    "original": "Crocin 25 and 50mgkg or vitamin E improved histopathological damages decreased MDA and CKMB increased GSH content and attenuated the increase of Bax Bcl2 ratio activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN",
    "simplified": "CCrocin 25 and 50mgkg or vitamin E improved histopathological damages by reducing MDA and CKMB and increased GSH content. It also reduced the increase of Bax Bcl2 ratio and the release of cytochrome c to the cytosol."
  },
  {
    "text": "Results DZN caused histophatological damage and increased the level of CKMB in the blood .",
    "triple_list": [
      [
        "DZN",
        "CPR:3",
        "CKMB"
      ]
    ],
    "updated": "Yes",
    "original": "RESULTS DZN induced histophatological damages and elevated the level of cardiac marker CKMB",
    "simplified": "Results DZN caused histophatological damage and increased the level of CKMB in the blood."
  },
  {
    "text": "In the present study we investigated the effect of fenoterol induced constitutive beta2adrenoceptor activity on muscarinic receptor agonist and histamineinduced bovine tracheal smooth muscle contractions",
    "triple_list": [
      [
        "fenoterol",
        "CPR:3",
        "beta2adrenoceptor"
      ]
    ],
    "updated": "No",
    "original": "In the present study we investigated the effect of fenoterol induced constitutive beta2adrenoceptor activity on muscarinic receptor agonist and histamineinduced bovine tracheal smooth muscle contractions",
    "simplified": "In the present study we investigated the effect of fenoterol-induced muscarinic receptor agonist and histamine-induced bovine tracheal smooth muscle contractions."
  },
  {
    "text": "Effect of fenoterol induced constitutive beta2adrenoceptor activity on contractile receptor function in airway smooth muscle",
    "triple_list": [
      [
        "fenoterol",
        "CPR:3",
        "beta2adrenoceptor"
      ]
    ],
    "updated": "No",
    "original": "Effect of fenoterol induced constitutive beta2adrenoceptor activity on contractile receptor function in airway smooth muscle",
    "simplified": "The effects of fenoterol on contractile receptor function in the airway smooth muscle and blood pressure"
  },
  {
    "text": "In conclusion fenoterol-induced beta2adrenoceptor activity reduces muscarinic receptor agonist and histamine-induced contractions of the bovine tracheal smooth muscle . The opposite is the effect of timolol .",
    "triple_list": [
      [
        "fenoterol",
        "CPR:3",
        "beta2adrenoceptor"
      ],
      [
        "beta2adrenoceptor",
        "CPR:5",
        "timolol"
      ]
    ],
    "updated": "Yes",
    "original": "In conclusion fenoterol induced constitutive beta2adrenoceptor activity reduces muscarinic receptor agonist and histamineinduced contractions of bovine tracheal smooth muscle which can be reversed by the inverse agonist timolol",
    "simplified": "In conclusion fenoterol-induced beta2adrenoceptor activity reduces muscarinic receptor agonist and histamine-induced contractions of the bovine tracheal smooth muscle. The opposite is the effect of timolol."
  },
  {
    "text": "Bovine tracheal smooth muscle strips were incubated with 10 microM fenoterol or vehicle for various periods of time 5 30 min 18 h at 37 degrees C After extensive washout 3 h 37 degrees C isometric contractions were measured to the full muscarinic receptor agonist methacholine the partial muscarinic receptor agonist 4mchlorophenylcarbamoyloxy2butynyltrimethylammonium McNA343 and histamine",
    "triple_list": [
      [
        "muscarinic receptor",
        "CPR:5",
        "4mchlorophenylcarbamoyloxy2butynyltrimethylammonium"
      ],
      [
        "muscarinic receptor",
        "CPR:5",
        "histamine"
      ],
      [
        "muscarinic receptor",
        "CPR:5",
        "methacholine"
      ]
    ],
    "updated": "No",
    "original": "Bovine tracheal smooth muscle strips were incubated with 10 microM fenoterol or vehicle for various periods of time 5 30 min 18 h at 37 degrees C After extensive washout 3 h 37 degrees C isometric contractions were measured to the full muscarinic receptor agonist methacholine the partial muscarinic receptor agonist 4mchlorophenylcarbamoyloxy2butynyltrimethylammonium McNA343 and histamine",
    "simplified": "Bovine tracheal smooth muscle strips were incubated with 10 microM fenoterol or vehicle for various periods of time 5 30 min 18 h at 37 degrees C. After extensive washout 3 h 37 degrees C isometric contractions were measured to the full muscarinic receptor agonist 4mchlorophenylcarbamoyloxy2butynyltrimethylammonium McNA343 and histamine."
  },
  {
    "text": "Betaglucogallin inhibits aldose reductase in murine macrophages and ocular tissues to reduce the expression of inflammatory markers .",
    "triple_list": [
      [
        "Betaglucogallin",
        "CPR:4",
        "aldose reductase"
      ]
    ],
    "updated": "Yes",
    "original": "Betaglucogallin reduces the expression of lipopolysaccharideinduced inflammatory markers by inhibition of aldose reductase in murine macrophages and ocular tissues",
    "simplified": "Betaglucogallin inhibits aldose reductase in murine macrophages and ocular tissues to reduce the expression of inflammatory markers."
  },
  {
    "text": "Betaglucogallin BGG is a recently described AR inhibitor . It is found in the Indian gooseberry ( Emblica officinalis ) .",
    "triple_list": [
      [
        "Betaglucogallin",
        "CPR:4",
        "AR"
      ],
      [
        "BGG",
        "CPR:4",
        "AR"
      ]
    ],
    "updated": "Yes",
    "original": "Betaglucogallin BGG a recently described AR inhibitor was purified from extracts of the Indian gooseberry Emblica officinalis",
    "simplified": "Betaglucogallin BGG is a recently described AR inhibitor. It is found in the Indian gooseberry (Emblica officinalis)."
  },
  {
    "text": "In this study we found that BGG showed low cytotoxicity in Raw2647 murine macrophages and that a decrease in sorbitol accumulation was associated with lower AR activity .",
    "triple_list": [
      [
        "BGG",
        "CPR:4",
        "AR"
      ]
    ],
    "updated": "Yes",
    "original": "In this study we found that BGG showed low cytotoxicity in Raw2647 murine macrophages and effectively inhibited AR activity as measured by a decrease in sorbitol accumulation",
    "simplified": "In this study we found that BGG showed low cytotoxicity in Raw2647 murine macrophages and that a decrease in sorbitol accumulation was associated with lower AR activity."
  },
  {
    "text": "In addition BGG inhibition of AR prevented JNK and p38 from being activated by LPS and lowered ROS levels which could inhibit LPS apoptosis .",
    "triple_list": [
      [
        "BGG",
        "CPR:4",
        "AR"
      ],
      [
        "BGG",
        "CPR:4",
        "JNK"
      ],
      [
        "BGG",
        "CPR:4",
        "p38"
      ]
    ],
    "updated": "Yes",
    "original": "In addition BGG mediated inhibition of AR prevented LPSinduced activation of JNK and p38 and lowered ROS levels which could inhibit LPSinduced apoptosis",
    "simplified": "In addition BGG inhibition of AR prevented JNK and p38 from being activated by LPS and lowered ROS levels which could inhibit LPS apoptosis."
  },
  {
    "text": "Aldose reductase AR , for example , reduces toxic lipid aldehydes to alcohol products . It also mediates inflammatory signals when lipopolysaccharide LPS",
    "triple_list": [
      [
        "Aldose reductase",
        "CPR:9",
        "aldehydes"
      ],
      [
        "AR",
        "CPR:9",
        "aldehydes"
      ],
      [
        "Aldose reductase",
        "CPR:9",
        "alcohol"
      ],
      [
        "AR",
        "CPR:9",
        "alcohol"
      ]
    ],
    "updated": "Yes",
    "original": "Aldose reductase AR catalyzes the reduction of toxic lipid aldehydes to their alcohol products and mediates inflammatory signals triggered by lipopolysaccharide LPS",
    "simplified": "Aldose reductase AR, for example, reduces toxic lipid aldehydes to alcohol products. It also mediates inflammatory signals when lipopolysaccharide LPS"
  },
  {
    "text": "Treatment of Rat2 fibroblast cells with C2ceramide caused the stimulation of cfos SRE dependent reporter gene activity in a dose and timedependent manner by transient transfection analysis",
    "triple_list": [
      [
        "C2ceramide",
        "CPR:3",
        "cfos SRE"
      ]
    ],
    "updated": "No",
    "original": "Treatment of Rat2 fibroblast cells with C2ceramide caused the stimulation of cfos SRE dependent reporter gene activity in a dose and timedependent manner by transient transfection analysis",
    "simplified": "Treatment of Rat2 fibroblast cells with C2ceramide caused reporter gene activity to be stimulated in a dose and timedependent manner by transient transfection analysis."
  },
  {
    "text": "Next we examined the role of Rho family GTPases in the ceramide induced signalling to SRE activation",
    "triple_list": [
      [
        "ceramide",
        "CPR:3",
        "SRE"
      ]
    ],
    "updated": "No",
    "original": "Next we examined the role of Rho family GTPases in the ceramide induced signalling to SRE activation",
    "simplified": "Next, we looked at the role of the Rho family GTPases in the activation of SRE."
  },
  {
    "text": "By reporter gene analysis following transient transfections with various plasmids expressing a dominant negative mutant form of Cdc42 Rac1 or RhoA C2ceramide induced SRE activation was shown to be selectively repressed by pEXVRacN17 encoding a dominant negative mutant of Rac1 suggesting that Rac activity is essential for the signalling cascade of ceramide to the nucleus",
    "triple_list": [
      [
        "C2ceramide",
        "CPR:3",
        "SRE"
      ]
    ],
    "updated": "No",
    "original": "By reporter gene analysis following transient transfections with various plasmids expressing a dominant negative mutant form of Cdc42 Rac1 or RhoA C2ceramide induced SRE activation was shown to be selectively repressed by pEXVRacN17 encoding a dominant negative mutant of Rac1 suggesting that Rac activity is essential for the signalling cascade of ceramide to the nucleus",
    "simplified": "By reporter gene analysis following transient transfections with various plasmids expressing a dominant negative mutant form of Rac1, it was shown that pEXVRacN17 encoding a dominant negative mutant of Rac1 selectively repressed Rac activity, suggesting that Rac activity is essential for the signalling cascade of ceramide to the nucleus."
  },
  {
    "text": "Exogenous C2ceramide activates cfos serum response element via Racdependent signalling pathway",
    "triple_list": [
      [
        "C2ceramide",
        "CPR:3",
        "cfos serum response element"
      ]
    ],
    "updated": "No",
    "original": "Exogenous C2ceramide activates cfos serum response element via Racdependent signalling pathway",
    "simplified": "Exogenous C2ceramide activates the serum response element through a signalling pathway."
  },
  {
    "text": "In a further study to analyse the downstream mediator of Rac in the ceramidesignalling pathway we observed that either pretreatment with mepacrine or cotransfection with antisense cytosolic phospholipase A2 cPLA2 oligonucleotide repressed the C2ceramide induced SRE activation selectively implying a critical role of cPLA2 in C2ceramideinduced signalling to nucleus .",
    "triple_list": [
      [
        "C2ceramide",
        "CPR:3",
        "SRE"
      ]
    ],
    "updated": "Yes",
    "original": "In a further study to analyse the downstream mediator of Rac in the ceramidesignalling pathway we observed that either pretreatment with mepacrine a potent and specific inhibitor of phospholipase A2 or cotransfection with antisense cytosolic phospholipase A2 cPLA2 oligonucleotide repressed the C2ceramide induced SRE activation selectively implying a critical role of cPLA2 in C2ceramideinduced signalling to nucleus",
    "simplified": "In a further study to analyse the downstream mediator of Rac in the ceramidesignalling pathway we observed that either pretreatment with mepacrine or cotransfection with antisense cytosolic phospholipase A2 cPLA2 oligonucleotide repressed the C2ceramide induced SRE activation selectively implying a critical role of cPLA2 in C2ceramideinduced signalling to nucleus."
  },
  {
    "text": "Together , our findings suggest that Rac and phospholipase A2 play a critical role in ceramide signalling to the nucleus .",
    "triple_list": [
      [
        "phospholipase A2",
        "CPR:3",
        "ceramide"
      ]
    ],
    "updated": "Yes",
    "original": "Together our findings suggest the critical role of Rac and subsequent activation of phospholipase A2 in ceramide signalling to nucleus",
    "simplified": "Together, our findings suggest that Rac and phospholipase A2 play a critical role in ceramide signalling to the nucleus."
  },
  {
    "text": "The translocation of cPLA2 protein as well as the release of arachidonic acid a principal product of phospholipase A2 was rapidly induced by the addition of C2ceramide in a Racdependent manner .",
    "triple_list": [
      [
        "arachidonic acid",
        "CPR:9",
        "phospholipase A2"
      ]
    ],
    "updated": "Yes",
    "original": "Consistent with these results the translocation of cPLA2 protein as well as the release of arachidonic acid a principal product of phospholipase A2 was rapidly induced by the addition of C2ceramide in a Racdependent manner",
    "simplified": "The translocation of cPLA2 protein as well as the release of arachidonic acid a principal product of phospholipase A2 was rapidly induced by the addition of C2ceramide in a Racdependent manner."
  },
  {
    "text": "Effect of SN21678tetrahydro2Hindeno54bfuran8ylethylpropionamide ramelteon TAK375 a selective MT1MT2 receptor agonist on motor coordination was studied using rotarod performance in mice",
    "triple_list": [
      [
        "ramelteon",
        "CPR:5",
        "MT1MT2 receptor"
      ],
      [
        "TAK375",
        "CPR:5",
        "MT1MT2 receptor"
      ],
      [
        "SN21678tetrahydro2Hindeno54bfuran8ylethylpropionamide",
        "CPR:5",
        "MT1MT2 receptor"
      ]
    ],
    "updated": "No",
    "original": "Effect of SN21678tetrahydro2Hindeno54bfuran8ylethylpropionamide ramelteon TAK375 a selective MT1MT2 receptor agonist on motor coordination was studied using rotarod performance in mice",
    "simplified": "The effect of a selective MT1MT2 receptor agonist, SN21678tetrahydro2Hindeno54bfuran8ylethylpropionamide on motor coordination was studied using rotarod performance in mice."
  },
  {
    "text": "Effect of ramelteon TAK375 a selective MT1MT2 receptor agonist on motor performance in mice",
    "triple_list": [
      [
        "ramelteon",
        "CPR:5",
        "MT1MT2 receptor"
      ],
      [
        "TAK375",
        "CPR:5",
        "MT1MT2 receptor"
      ]
    ],
    "updated": "No",
    "original": "Effect of ramelteon TAK375 a selective MT1MT2 receptor agonist on motor performance in mice",
    "simplified": "The effect of a drug called ramelteon on motor performance in mice"
  },
  {
    "text": "Our previous work built on the early pioneering multikinase inhibitor LY294002 resulted in the PI3K prodrug SF1126 which has now completed Phase I clinical trials .",
    "triple_list": [
      [
        "LY294002",
        "CPR:4",
        "PI3K"
      ],
      [
        "LY294002",
        "CPR:4",
        "PI3K"
      ],
      [
        "PI3K",
        "CPR:4",
        "SF1126"
      ],
      [
        "PI3K",
        "CPR:4",
        "SF1126"
      ]
    ],
    "updated": "Yes",
    "original": "Our previous work built on the early pioneering multikinase inhibitor LY294002 resulted in the only PI3K vasculartargeted PI3K inhibitor prodrug SF1126 which has now completed Phase I clinical trials",
    "simplified": "Our previous work built on the early pioneering multikinase inhibitor LY294002 resulted in the PI3K prodrug SF1126 which has now completed Phase I clinical trials."
  },
  {
    "text": "This work resulted in the discovery of the 5morpholino7Hthieno32bpyran7one system . The 5morpholino7Hthieno32bpyran7one system was the basis of a new class of potential PI3K inhibitors .",
    "triple_list": [
      [
        "5morpholino7Hthieno32bpyran7one",
        "CPR:4",
        "PI3K"
      ],
      [
        "5morpholino7Hthieno32bpyran7one",
        "CPR:4",
        "PI3K"
      ]
    ],
    "updated": "Yes",
    "original": "This work resulted in the discovery of the 5morpholino7Hthieno32bpyran7one system as the foundation of a new compound class of potential PI3K inhibitors having improved potency toward PI3K",
    "simplified": "This work resulted in the discovery of the 5morpholino7Hthieno32bpyran7one system. The 5morpholino7Hthieno32bpyran7one system was the basis of a new class of potential PI3K inhibitors."
  },
  {
    "text": "Cancer stem cell activity of substituted 5morpholino7Hthieno32bpyran7ones designed as next generation PI3K inhibitors",
    "triple_list": [
      [
        "5morpholino7Hthieno32bpyran7ones",
        "CPR:4",
        "PI3K"
      ]
    ],
    "updated": "Yes",
    "original": "Synthesis and cancer stem cellbased activity of substituted 5morpholino7Hthieno32bpyran7ones designed as next generation PI3K inhibitors",
    "simplified": "Cancer stem cell activity of substituted 5morpholino7Hthieno32bpyran7ones designed as next generation PI3K inhibitors"
  },
  {
    "text": "CP690550 a JAK3 inhibitor is currently in phase II clinical trialsFK778 is a synthetic malononitrilamide that targets the critical enzyme dihydroorotic acid dehydrogenase and receptorassociated tyrosine kinases in order to prevent malignancy .",
    "triple_list": [
      [
        "CP690550",
        "CPR:4",
        "JAK3"
      ]
    ],
    "updated": "Yes",
    "original": "CP690550 a JAK3 inhibitor is currently in phase II clinical trialsFK778 is a synthetic malononitrilamide that targets the critical enzyme of the de novo pyrimidine synthesis dihydroorotic acid dehydrogenase and receptorassociated tyrosine kinases has completed phase II trials",
    "simplified": "CP690550 a JAK3 inhibitor is currently in phase II clinical trialsFK778 is a synthetic malononitrilamide that targets the critical enzyme dihydroorotic acid dehydrogenase and receptorassociated tyrosine kinases in order to prevent malignancy."
  },
  {
    "text": "For example , when ApoCaM was present , the Vmax of GAD was increased , but the substrate glutamate was not affected .",
    "triple_list": [
      [
        "GAD",
        "CPR:9",
        "glutamate"
      ]
    ],
    "updated": "Yes",
    "original": "Firstly the Vmax of GAD was increased when ApoCaM was present whereas the affinity for the substrate glutamate was not affected",
    "simplified": "For example, when ApoCaM was present, the Vmax of GAD was increased, but the substrate glutamate was not affected."
  },
  {
    "text": "To determine whether H2S itself provoked inflammation in acinar cells the cells were treated with H2S donor drug sodium hydrosulphide NaHS 10 50 and 100 muM that resulted in a significant increase in SP concentration and expression of PPTA and NK1R in acinar cells",
    "triple_list": [
      [
        "sodium hydrosulphide",
        "CPR:3",
        "SP"
      ],
      [
        "sodium hydrosulphide",
        "CPR:3",
        "PPTA"
      ],
      [
        "sodium hydrosulphide",
        "CPR:3",
        "NK1R"
      ],
      [
        "NaHS",
        "CPR:3",
        "SP"
      ],
      [
        "NaHS",
        "CPR:3",
        "PPTA"
      ],
      [
        "NaHS",
        "CPR:3",
        "NK1R"
      ]
    ],
    "updated": "No",
    "original": "To determine whether H2S itself provoked inflammation in acinar cells the cells were treated with H2S donor drug sodium hydrosulphide NaHS 10 50 and 100 muM that resulted in a significant increase in SP concentration and expression of PPTA and NK1R in acinar cells",
    "simplified": "To find out if H2S itself causes inflammation in acinar cells the cells were treated with sodium hydrosulphide NaHS 10 50 and 100 muM. The sodium hydrosulphide NaHS 10 50 and 100 muM made a big difference in the amount of SP in the acinar cells."
  },
  {
    "text": "Caerulein increased the levels of CBS mRNA while decreasing the levels of H2S and CSE .",
    "triple_list": [
      [
        "Caerulein",
        "CPR:3",
        "CSE"
      ],
      [
        "Caerulein",
        "CPR:4",
        "CBS"
      ]
    ],
    "updated": "Yes",
    "original": "Caerulein increased the levels of H2S and CSE mRNA expression while CBS mRNA expression was decreased",
    "simplified": "Caerulein increased the levels of CBS mRNA while decreasing the levels of H2S and CSE."
  },
  {
    "text": "Furthermore substance P SP concentration in the acini and expression of SP gene preprotachykininA PPTA and neurokinin1 receptor NK1R the primary receptor for SP are increased in secretagogue caerulein treated acinar cells",
    "triple_list": [
      [
        "substance P",
        "CPR:3",
        "caerulein"
      ],
      [
        "SP",
        "CPR:3",
        "caerulein"
      ],
      [
        "SP",
        "CPR:3",
        "caerulein"
      ],
      [
        "preprotachykininA",
        "CPR:3",
        "caerulein"
      ],
      [
        "PPTA",
        "CPR:3",
        "caerulein"
      ],
      [
        "neurokinin1 receptor",
        "CPR:3",
        "caerulein"
      ],
      [
        "NK1R",
        "CPR:3",
        "caerulein"
      ]
    ],
    "updated": "No",
    "original": "Furthermore substance P SP concentration in the acini and expression of SP gene preprotachykininA PPTA and neurokinin1 receptor NK1R the primary receptor for SP are increased in secretagogue caerulein treated acinar cells",
    "simplified": "The concentration of substance P SP in the acini and the expression of the SP gene in the acini are increased in secretagogue caerulein treated acinar cells. This increases the concentration of SP."
  },
  {
    "text": "In addition cells pretreated with DLpropargylglycine PAG 3 mM a CSE inhibitor reduced the formation of H2S in caerulein treated cells suggesting that CSE may be the main enzyme involved in H2S formation in mouse acinar cells",
    "triple_list": [
      [
        "DLpropargylglycine",
        "CPR:4",
        "CSE"
      ],
      [
        "PAG",
        "CPR:4",
        "CSE"
      ],
      [
        "CSE",
        "CPR:9",
        "H2S"
      ]
    ],
    "updated": "No",
    "original": "In addition cells pretreated with DLpropargylglycine PAG 3 mM a CSE inhibitor reduced the formation of H2S in caerulein treated cells suggesting that CSE may be the main enzyme involved in H2S formation in mouse acinar cells",
    "simplified": "In addition, cells pretreated with a CSE inhibitor reduced the formation of H2S in caerulein treated cells. This means that CSE may be involved in the formation of H2S in the first place."
  },
  {
    "text": "Inhibition of endogenous production of H2S by PAG significantly suppressed SP concentration PPTA expression and NK1R expression in the acini",
    "triple_list": [
      [
        "H2S",
        "CPR:4",
        "SP"
      ],
      [
        "H2S",
        "CPR:4",
        "PPTA"
      ],
      [
        "H2S",
        "CPR:4",
        "NK1R"
      ]
    ],
    "updated": "No",
    "original": "Inhibition of endogenous production of H2S by PAG significantly suppressed SP concentration PPTA expression and NK1R expression in the acini",
    "simplified": "Inhibition of the endogenous production of H2S by PAG significantly reduced the expression of PPTA and NK1R in the acini."
  },
  {
    "text": "These results suggest that the proinflammatory effect of H2S may be mediated by SP NK1R related pathway in mouse pancreatic acinar cells",
    "triple_list": [
      [
        "H2S",
        "CPR:9",
        "SP"
      ],
      [
        "H2S",
        "CPR:9",
        "NK1R"
      ]
    ],
    "updated": "No",
    "original": "These results suggest that the proinflammatory effect of H2S may be mediated by SP NK1R related pathway in mouse pancreatic acinar cells",
    "simplified": "These results suggest that the proinflammatory effect of H2S may be mediated by a related pathway in the central nervous system."
  },
  {
    "text": "Hydrogen sulphide H2S is synthesized from Lcysteine via the action of cystathioninegammalyase CSE and cystathioninebetasynthase CBS",
    "triple_list": [
      [
        "H2S",
        "CPR:9",
        "CSE"
      ],
      [
        "H2S",
        "CPR:9",
        "cystathioninebetasynthase"
      ],
      [
        "H2S",
        "CPR:9",
        "CBS"
      ],
      [
        "H2S",
        "CPR:9",
        "cystathioninegammalyase"
      ],
      [
        "Lcysteine",
        "CPR:9",
        "CSE"
      ],
      [
        "Lcysteine",
        "CPR:9",
        "cystathioninebetasynthase"
      ],
      [
        "Lcysteine",
        "CPR:9",
        "CBS"
      ],
      [
        "Lcysteine",
        "CPR:9",
        "cystathioninegammalyase"
      ],
      [
        "Hydrogen sulphide",
        "CPR:9",
        "CSE"
      ],
      [
        "Hydrogen sulphide",
        "CPR:9",
        "cystathioninebetasynthase"
      ],
      [
        "Hydrogen sulphide",
        "CPR:9",
        "CBS"
      ],
      [
        "Hydrogen sulphide",
        "CPR:9",
        "cystathioninegammalyase"
      ]
    ],
    "updated": "No",
    "original": "Hydrogen sulphide H2S is synthesized from Lcysteine via the action of cystathioninegammalyase CSE and cystathioninebetasynthase CBS",
    "simplified": "It is made by cystathioninegammalyase CSE and cystathioninebetasynthase CBS. It is made from Lcysteine and hydrogen sulfide."
  },
  {
    "text": "In this study , the presence of H2S and the expression of the enzymes CSE and CBS in isolated mouse pancreatic acini were determined .",
    "triple_list": [
      [
        "H2S",
        "CPR:9",
        "CSE"
      ],
      [
        "H2S",
        "CPR:9",
        "CBS"
      ]
    ],
    "updated": "Yes",
    "original": "In this study we investigated the presence of H2S and the expression of H2S synthesizing enzymes CSE and CBS in isolated mouse pancreatic acini",
    "simplified": "In this study, the presence of H2S and the expression of the enzymes CSE and CBS in isolated mouse pancreatic acini were determined."
  },
  {
    "text": "The results showed that administration of AlCl3 resulted in a significant elevation in the levels of AchE activity CRP NF\u03baB and MCP1 accompanied with a significant depletion in the Ach level",
    "triple_list": [
      [
        "AlCl3",
        "CPR:3",
        "AchE"
      ],
      [
        "AlCl3",
        "CPR:3",
        "CRP"
      ],
      [
        "AlCl3",
        "CPR:3",
        "NF\u03baB"
      ],
      [
        "AlCl3",
        "CPR:3",
        "MCP1"
      ]
    ],
    "updated": "No",
    "original": "The results showed that administration of AlCl3 resulted in a significant elevation in the levels of AchE activity CRP NF\u03baB and MCP1 accompanied with a significant depletion in the Ach level",
    "simplified": "The results showed that administration of AlCl3 resulted in a significant increase in the levels of CRP and MCP1 and a significant decrease in the levels of AchE."
  },
  {
    "text": "6DHSG was metabolised by GSH to form a GSH conjugate GS 6DHSG in RAW 2647 cells via a potential mechanism involving the catalytic activity of glutathioneStransferase GST",
    "triple_list": [
      [
        "6DHSG",
        "CPR:9",
        "glutathioneStransferase"
      ],
      [
        "6DHSG",
        "CPR:9",
        "GST"
      ]
    ],
    "updated": "No",
    "original": "6DHSG was metabolised by GSH to form a GSH conjugate GS 6DHSG in RAW 2647 cells via a potential mechanism involving the catalytic activity of glutathioneStransferase GST",
    "simplified": "6DHSG was metabolised by GSH to form a GSH conjugate GS 6DHSG in RAW 2647 cells. The catalytic activity of glutathione may be involved in this process."
  },
  {
    "text": "The concentration response to levcromakalim LEVC a KATP channel opener was significantly shifted to the left in the inflamed smoothmuscle cells",
    "triple_list": [
      [
        "levcromakalim",
        "CPR:3",
        "KATP channel"
      ],
      [
        "LEVC",
        "CPR:3",
        "KATP channel"
      ]
    ],
    "updated": "No",
    "original": "The concentration response to levcromakalim LEVC a KATP channel opener was significantly shifted to the left in the inflamed smoothmuscle cells",
    "simplified": "The concentration response to levcromakalim in the inflamed smoothmuscle cells was significantly shifted to the left."
  },
  {
    "text": "Sulfhydration of sulfonylurea receptor 2B SUR2B was induced by NaHS and colonic inflammation",
    "triple_list": [
      [
        "sulfonylurea receptor 2B",
        "CPR:3",
        "NaHS"
      ],
      [
        "SUR2B",
        "CPR:3",
        "NaHS"
      ]
    ],
    "updated": "No",
    "original": "Sulfhydration of sulfonylurea receptor 2B SUR2B was induced by NaHS and colonic inflammation",
    "simplified": "Sulfhydration of sulfonylurea receptor 2B SUR2B was found to cause the disease."
  },
  {
    "text": "Some mutant currents may be not suppressed enough by drugs to block the specific current . These drugs are called sotalol or ibutilide in patients with a mutation in the IKr coding gene KCNH2 HERG This has been studied and shown to work .",
    "triple_list": [
      [
        "sotalol",
        "CPR:4",
        "IKr"
      ],
      [
        "sotalol",
        "CPR:4",
        "KCNH2"
      ],
      [
        "sotalol",
        "CPR:4",
        "HERG"
      ],
      [
        "ibutilide",
        "CPR:4",
        "IKr"
      ],
      [
        "ibutilide",
        "CPR:4",
        "KCNH2"
      ],
      [
        "ibutilide",
        "CPR:4",
        "HERG"
      ]
    ],
    "updated": "Yes",
    "original": "Pharmacological treatment has been studied and it could be demonstrated that some mutant currents may be insufficiently suppressed by drugs targeted to block the specific current such as eg sotalol or ibutilide in patients with a mutation in the IKr coding gene KCNH2 HERG",
    "simplified": "Some mutant currents may be not suppressed enough by drugs to block the specific current. These drugs are called sotalol or ibutilide in patients with a mutation in the IKr coding gene KCNH2 HERG This has been studied and shown to work."
  },
  {
    "text": "Although estrogen and progestins can slow down the release of LH , a better effect of the antiandrogen is obtained when it is combined with an LHRH agonist . This causes a blockage of testicular androgen biosynthesis , which in turn stops the release of LH .",
    "triple_list": [
      [
        "LH",
        "CPR:4",
        "estrogen"
      ],
      [
        "LH",
        "CPR:4",
        "progestins"
      ]
    ],
    "updated": "Yes",
    "original": "Although inhibition of LH release can be achieved by estrogen and progestins an optimal inhibitory effect on the prostate is obtained by the combined administration of the antiandrogen with an LHRH agonist that causes a specific blockage of testicular androgen biosynthesis as well as an inhibition of the LH responsiveness to LHRH",
    "simplified": "Although estrogen and progestins can slow down the release of LH, a better effect of the antiandrogen is obtained when it is combined with an LHRH agonist. This causes a blockage of testicular androgen biosynthesis, which in turn stops the release of LH."
  },
  {
    "text": "Glycylsarcosine and cefadroxil could not be used together in PEPT2 mice , p 001 but not PEPT2 mice .",
    "triple_list": [
      [
        "cefadroxil",
        "CPR:9",
        "PEPT2"
      ],
      [
        "cefadroxil",
        "CPR:9",
        "PEPT2"
      ]
    ],
    "updated": "Yes",
    "original": "Glycylsarcosine coadministration could inhibit the uptake of cefadroxil in PEPT2 mice p 001 but not PEPT2 mice",
    "simplified": "Glycylsarcosine and cefadroxil could not be used together in PEPT2 mice, p 001 but not PEPT2 mice."
  },
  {
    "text": "Although a protonstimulated uptake of cefadroxil was found in PEPT2 mice , the mice did not have a lower pH than normal .",
    "triple_list": [
      [
        "cefadroxil",
        "CPR:9",
        "PEPT2"
      ],
      [
        "cefadroxil",
        "CPR:9",
        "PEPT2"
      ]
    ],
    "updated": "Yes",
    "original": "Although a protonstimulated uptake of cefadroxil was demonstrated in PEPT2 mice pH 65 versus pH 74 p 001 no pH dependence was observed in PEPT2 mice",
    "simplified": "Although a protonstimulated uptake of cefadroxil was found in PEPT2 mice, the mice did not have a lower pH than normal."
  },
  {
    "text": "The effects of cefadroxil on choroid plexus function in wild-type and PEPT2 knockout mice",
    "triple_list": [
      [
        "cefadroxil",
        "CPR:9",
        "PEPT2"
      ]
    ],
    "updated": "Yes",
    "original": "Mechanisms of cefadroxil uptake in the choroid plexus studies in wildtype and PEPT2 knockout mice",
    "simplified": "The effects of cefadroxil on choroid plexus function in wild-type and PEPT2 knockout mice"
  },
  {
    "text": "This study shows that PEPT2 is the main transporter that carries cefadroxil to the choroid plexus .",
    "triple_list": [
      [
        "PEPT2",
        "CPR:9",
        "cefadroxil"
      ]
    ],
    "updated": "Yes",
    "original": "These findings demonstrate that PEPT2 is the primary transporter responsible for cefadroxil uptake in the choroid plexus",
    "simplified": "This study shows that PEPT2 is the main transporter that carries cefadroxil to the choroid plexus."
  },
  {
    "text": "At normal pH 74 and temperature 37 degrees C , 1 microM cefadroxil does not work at all in PEPT2 mice , but it does in PEPT2 mice .",
    "triple_list": [
      [
        "cefadroxil",
        "CPR:9",
        "PEPT2"
      ],
      [
        "cefadroxil",
        "CPR:9",
        "PEPT2"
      ]
    ],
    "updated": "Yes",
    "original": "At normal pH 74 and temperature 37 degrees C the uptake of 1 microM cefadroxil was reduced by 83 in PEPT2 mice as compared with PEPT2 mice p 0001",
    "simplified": "At normal pH 74 and temperature 37 degrees C, 1 microM cefadroxil does not work at all in PEPT2 mice, but it does in PEPT2 mice."
  },
  {
    "text": "The choroid plexus uptake of 3Hcefadroxil was studied in peptide transporter 2 PEPT2 wildtype and null mice as a function of temperature transport inhibitors pH and saturability",
    "triple_list": [
      [
        "3Hcefadroxil",
        "CPR:9",
        "peptide transporter 2"
      ],
      [
        "3Hcefadroxil",
        "CPR:9",
        "PEPT2"
      ]
    ],
    "updated": "No",
    "original": "The choroid plexus uptake of 3Hcefadroxil was studied in peptide transporter 2 PEPT2 wildtype and null mice as a function of temperature transport inhibitors pH and saturability",
    "simplified": "The choroid plexus uptake of 3Hcefadroxil was studied in wild-type and null mice. pH and saturability were measured in the wild-type mice."
  },
  {
    "text": "In the IBMECA group , the \u03b1amylase activity was reduced significantly compared to group I .",
    "triple_list": [
      [
        "IBMECA",
        "CPR:4",
        "\u03b1amylase"
      ]
    ],
    "updated": "Yes",
    "original": "In the IBMECA group \u03b1amylase activity was decreased with statistically high significance compared to group I",
    "simplified": "In the IBMECA group, the \u03b1amylase activity was reduced significantly compared to group I."
  },
  {
    "text": "The experiments were performed on 80 male Wistar rats 58 of which survived subdivided into 3 groups Ccontrol rats IEAP group and IIEAP group treated with the adenosine A3 receptor agonist IBMECA 1deoxy163iodophenyl methylamino9Hpurin9ylNmethylBDribofuronamide at a dose of 075 mgkg bw",
    "triple_list": [
      [
        "adenosine A3 receptor",
        "CPR:5",
        "IBMECA"
      ],
      [
        "adenosine A3 receptor",
        "CPR:5",
        "1deoxy163iodophenyl methylamino9Hpurin9ylNmethylBDribofuronamide"
      ]
    ],
    "updated": "No",
    "original": "The experiments were performed on 80 male Wistar rats 58 of which survived subdivided into 3 groups Ccontrol rats IEAP group and IIEAP group treated with the adenosine A3 receptor agonist IBMECA 1deoxy163iodophenyl methylamino9Hpurin9ylNmethylBDribofuronamide at a dose of 075 mgkg bw",
    "simplified": "The experiments were performed on 80 male Wistar rats. The rats were divided into 3 groups Ccontrol rats IEAP group and IIEAP group. The IEAP group was given the drug IBMECA 1deoxy163iodophenyl methylamino9Hpurin9ylNmethylBDribofuronamide at a dose of 075 mgkg bw."
  },
  {
    "text": "The effects of the adenosine A3 receptor agonist IBMECA on acute pancreatitis in animals and humans",
    "triple_list": [
      [
        "adenosine A3 receptor",
        "CPR:5",
        "IBMECA"
      ]
    ],
    "updated": "Yes",
    "original": "The effects of the adenosine A3 receptor agonist IBMECA on sodium taurocholateinduced experimental acute pancreatitis",
    "simplified": "The effects of the adenosine A3 receptor agonist IBMECA on acute pancreatitis in animals and humans"
  },
  {
    "text": "The A3 receptor can be inhibited by IBMECA .",
    "triple_list": [
      [
        "A3 receptor",
        "CPR:5",
        "IBMECA"
      ]
    ],
    "updated": "Yes",
    "original": "The use of A3 receptor agonist IBMECA attenuates EAP",
    "simplified": "The A3 receptor can be inhibited by IBMECA."
  },
  {
    "text": "We describe the discovery of several pyrrolopyrazines as powerful and selective Syk inhibitors and the efforts that eventually led to the improvement of human whole blood concentrations and physicochemical properties .",
    "triple_list": [
      [
        "pyrrolopyrazines",
        "CPR:4",
        "Syk"
      ]
    ],
    "updated": "Yes",
    "original": "We describe the discovery of several pyrrolopyrazines as potent and selective Syk inhibitors and the efforts that eventually led to the desired improvements in physicochemical properties and human whole blood potencies",
    "simplified": "We describe the discovery of several pyrrolopyrazines as powerful and selective Syk inhibitors and the efforts that eventually led to the improvement of human whole blood concentrations and physicochemical properties."
  },
  {
    "text": "Pyrrolopyrazines as Selective Spleen Tyrosine Kinase Inhibitors",
    "triple_list": [
      [
        "Pyrrolopyrazines",
        "CPR:4",
        "Spleen Tyrosine Kinase"
      ]
    ],
    "updated": "No",
    "original": "Pyrrolopyrazines as Selective Spleen Tyrosine Kinase Inhibitors",
    "simplified": "Pyrrolopyrazines are used to inhibit certain enzymes."
  },
  {
    "text": "Ozone plus PM25 exposure however induced CRP IL6 CK LDH and MDA increase SOD and HRV SOD and HRV are also affected by this .",
    "triple_list": [
      [
        "Ozone",
        "CPR:3",
        "CRP"
      ],
      [
        "Ozone",
        "CPR:3",
        "IL6"
      ],
      [
        "Ozone",
        "CPR:3",
        "CK"
      ],
      [
        "Ozone",
        "CPR:3",
        "LDH"
      ],
      [
        "Ozone",
        "CPR:4",
        "SOD"
      ]
    ],
    "updated": "Yes",
    "original": "Ozone plus PM25 exposure however induced CRP IL6 CK LDH and MDA increase SOD and HRV decrease significantly in a doseresponse way",
    "simplified": "Ozone plus PM25 exposure however induced CRP IL6 CK LDH and MDA increase SOD and HRV SOD and HRV are also affected by this."
  },
  {
    "text": "Flavopiridol a cyclindependent kinase inhibitor arrests cell division and causes apoptosis in nonsmall lung cancer cells 283660",
    "triple_list": [
      [
        "Flavopiridol",
        "CPR:4",
        "cyclindependent kinase"
      ]
    ],
    "updated": "No",
    "original": "Flavopiridol a cyclindependent kinase inhibitor arrests cell division and causes apoptosis in nonsmall lung cancer cells 283660",
    "simplified": "Flavopiridol (brand name Bristol-Myers Squibb) stops cell division and causes death in lung cancer cells 283660"
  },
  {
    "text": "In ex vivo experiments with tumor cells from refractory chronic lymphoblastic leukemia flavopiridol-dependent CDK2 inhibition was seen at concentrations greater than 100 nM in the blood .",
    "triple_list": [
      [
        "CDK2",
        "CPR:4",
        "flavopiridol"
      ]
    ],
    "updated": "Yes",
    "original": "In ex vivo experiments with tumor cells from refractory chronic lymphoblastic leukemia dosedependent CDK2 inhibition associated with apoptotic changes was seen at concentrations greater than 100 nM of flavopiridol",
    "simplified": "In ex vivo experiments with tumor cells from refractory chronic lymphoblastic leukemia flavopiridol-dependent CDK2 inhibition was seen at concentrations greater than 100 nM in the blood."
  },
  {
    "text": "Flavopiridol inhibits CDK . Its IC50 value is 04 , for example .",
    "triple_list": [
      [
        "Flavopiridol",
        "CPR:4",
        "CDK"
      ]
    ],
    "updated": "Yes",
    "original": "Flavopiridol inhibits CDK with an IC50 value of 04 mM 285707",
    "simplified": "Flavopiridol inhibits CDK. Its IC50 value is 04, for example."
  },
  {
    "text": "Some of these derivatives showed good inhibitory potency against two human CA isozymes involved in important physiological processes CA I and CA II of the same order of magnitude as the clinically used drugs acetazolamide and methazolamide",
    "triple_list": [
      [
        "human CA",
        "CPR:4",
        "methazolamide"
      ],
      [
        "CA I",
        "CPR:4",
        "methazolamide"
      ],
      [
        "CA II",
        "CPR:4",
        "methazolamide"
      ],
      [
        "human CA",
        "CPR:4",
        "acetazolamide"
      ],
      [
        "CA I",
        "CPR:4",
        "acetazolamide"
      ],
      [
        "CA II",
        "CPR:4",
        "acetazolamide"
      ]
    ],
    "updated": "No",
    "original": "Some of these derivatives showed good inhibitory potency against two human CA isozymes involved in important physiological processes CA I and CA II of the same order of magnitude as the clinically used drugs acetazolamide and methazolamide",
    "simplified": "Some of these derivatives showed good inhibitory potency against two human CA isozymes of the same order of magnitude as the clinically used drugs acetazolamide and methazolamide. These two isozymes are involved in important physiological processes."
  },
  {
    "text": "Carbonic anhydrase inhibitors aromatic and heterocyclic sulfonamides incorporating adamantyl moieties with strong anticonvulsant activity",
    "triple_list": [
      [
        "Carbonic anhydrase",
        "CPR:4",
        "aromatic and heterocyclic sulfonamides"
      ],
      [
        "Carbonic anhydrase",
        "CPR:4",
        "adamantyl"
      ]
    ],
    "updated": "No",
    "original": "Carbonic anhydrase inhibitors aromatic and heterocyclic sulfonamides incorporating adamantyl moieties with strong anticonvulsant activity",
    "simplified": "Carbonic anhydrase inhibitors Carbonic anhydrase inhibitors are chemical compounds that have a strong anticonvulsant activity."
  },
  {
    "text": "BACKGROUND AND AIMS Glutamic acid decarboxylase GAD EC 41115 catalyses the conversion of glutamate to gammaaminobutyric acid GABA",
    "triple_list": [
      [
        "Glutamic acid decarboxylase",
        "CPR:9",
        "glutamate"
      ],
      [
        "GAD",
        "CPR:9",
        "glutamate"
      ],
      [
        "EC 41115",
        "CPR:9",
        "glutamate"
      ],
      [
        "Glutamic acid decarboxylase",
        "CPR:9",
        "gammaaminobutyric acid"
      ],
      [
        "GAD",
        "CPR:9",
        "gammaaminobutyric acid"
      ],
      [
        "EC 41115",
        "CPR:9",
        "gammaaminobutyric acid"
      ],
      [
        "Glutamic acid decarboxylase",
        "CPR:9",
        "GABA"
      ],
      [
        "GAD",
        "CPR:9",
        "GABA"
      ],
      [
        "EC 41115",
        "CPR:9",
        "GABA"
      ]
    ],
    "updated": "No",
    "original": "BACKGROUND AND AIMS Glutamic acid decarboxylase GAD EC 41115 catalyses the conversion of glutamate to gammaaminobutyric acid GABA",
    "simplified": "Glutamic acid decarboxylase (GAD) is a enzyme in the body. It breaks down glutamate to make gammaaminobutyric acid."
  },
  {
    "text": "FCEO significantly inhibited nitric oxide NO and prostaglandin E2 PGE2 by suppressing the protein expression of inducible nitric oxide synthase iNOS and cyclooxygenase COX2 respectively",
    "triple_list": [
      [
        "nitric oxide",
        "CPR:4",
        "inducible nitric oxide synthase"
      ],
      [
        "nitric oxide",
        "CPR:4",
        "iNOS"
      ],
      [
        "NO",
        "CPR:4",
        "inducible nitric oxide synthase"
      ],
      [
        "NO",
        "CPR:4",
        "iNOS"
      ],
      [
        "prostaglandin E2",
        "CPR:4",
        "cyclooxygenase COX2"
      ],
      [
        "PGE2",
        "CPR:4",
        "cyclooxygenase COX2"
      ]
    ],
    "updated": "No",
    "original": "FCEO significantly inhibited nitric oxide NO and prostaglandin E2 PGE2 by suppressing the protein expression of inducible nitric oxide synthase iNOS and cyclooxygenase COX2 respectively",
    "simplified": "FCEO inhibited the production of nitric oxide and prostaglandin by iNOS and cyclooxygenase COX2 respectively. It also reduced the production of riboflavin."
  },
  {
    "text": "The selective PDE 4 inhibitors amrinone and milrinone reduced the release of GMCSF but only a little ; the PDE3 inhibitors were not so selective .",
    "triple_list": [
      [
        "PDE 4",
        "CPR:4",
        "milrinone"
      ],
      [
        "PDE3",
        "CPR:4",
        "milrinone"
      ],
      [
        "milrinone",
        "CPR:4",
        "GMCSF"
      ],
      [
        "PDE 4",
        "CPR:4",
        "amrinone"
      ],
      [
        "PDE3",
        "CPR:4",
        "amrinone"
      ],
      [
        "amrinone",
        "CPR:4",
        "GMCSF"
      ]
    ],
    "updated": "Yes",
    "original": "The selective PDE 4 inhibitors and to a certain extent the PDE3 inhibitors amrinone and milrinone reduced the GMCSF release in a concentration dependent manner",
    "simplified": "The selective PDE 4 inhibitors amrinone and milrinone reduced the release of GMCSF but only a little; the PDE3 inhibitors were not so selective."
  },
  {
    "text": "Amrinone and milrinone selective PDE3 inhibitors suppressed TNF secretion to a lesser extent",
    "triple_list": [
      [
        "Amrinone",
        "CPR:4",
        "PDE3"
      ],
      [
        "Amrinone",
        "CPR:4",
        "TNF"
      ],
      [
        "milrinone",
        "CPR:4",
        "PDE3"
      ],
      [
        "milrinone",
        "CPR:4",
        "TNF"
      ]
    ],
    "updated": "No",
    "original": "Amrinone and milrinone selective PDE3 inhibitors suppressed TNF secretion to a lesser extent",
    "simplified": "Amarinone and milrinone can slow down TNF production, but not as much as PDE3."
  },
  {
    "text": "The effects of theophylline unspecific PDE inhibitor vinpocetine PDE1 inhibitor EHNA PDE2 inhibitor and the PDE5 inhibitors zaprinast and E 4021 were weak",
    "triple_list": [
      [
        "theophylline",
        "CPR:4",
        "PDE"
      ],
      [
        "vinpocetine",
        "CPR:4",
        "PDE1"
      ],
      [
        "PDE5",
        "CPR:4",
        "zaprinast"
      ],
      [
        "PDE5",
        "CPR:4",
        "E 4021"
      ]
    ],
    "updated": "No",
    "original": "The effects of theophylline unspecific PDE inhibitor vinpocetine PDE1 inhibitor EHNA PDE2 inhibitor and the PDE5 inhibitors zaprinast and E 4021 were weak",
    "simplified": "The effects of theophylline unspecific PDE inhibitor vinpocetine and the PDE5 inhibitors zaprinast and E 4021 were not as bad."
  },
  {
    "text": "In human blood the tested glucocorticoids beclomethasone dexamethasone and fluticasone inhibited the LPS induced TNF release but in human nasal polyp cells the effect of the glucocorticoids on allergically induced TNF release was much less pronounced with the exception of dexamethasone .",
    "triple_list": [
      [
        "beclomethasone",
        "CPR:4",
        "TNF"
      ],
      [
        "beclomethasone",
        "CPR:4",
        "TNF"
      ],
      [
        "dexamethasone",
        "CPR:4",
        "TNF"
      ],
      [
        "dexamethasone",
        "CPR:4",
        "TNF"
      ],
      [
        "fluticasone",
        "CPR:4",
        "TNF"
      ],
      [
        "fluticasone",
        "CPR:4",
        "TNF"
      ]
    ],
    "updated": "Yes",
    "original": "In human blood the tested glucocorticoids beclomethasone dexamethasone and fluticasone inhibited the LPS induced TNF release potently in a concentration dependent manner whereas in dispersed human nasal polyp cells the effect of the glucocorticoids on allergically induced TNF release with the exception of dexamethasone was much less pronounced",
    "simplified": "In human blood the tested glucocorticoids beclomethasone dexamethasone and fluticasone inhibited the LPS induced TNF release but in human nasal polyp cells the effect of the glucocorticoids on allergically induced TNF release was much less pronounced with the exception of dexamethasone."
  },
  {
    "text": "Taken together our results suggested that Rg1 protected against A\u03b22535 induced apoptosis at least in part by two complementary GRdependent ERK phosphorylation pathways 1 downregulating HIF1\u03b1 initiated protein nitrotyrosination and 2 inhibiting mitochondrial apoptotic cascades",
    "triple_list": [
      [
        "Rg1",
        "CPR:3",
        "ERK"
      ],
      [
        "Rg1",
        "CPR:4",
        "A\u03b22535"
      ],
      [
        "Rg1",
        "CPR:4",
        "HIF1\u03b1"
      ]
    ],
    "updated": "No",
    "original": "Taken together our results suggested that Rg1 protected against A\u03b22535 induced apoptosis at least in part by two complementary GRdependent ERK phosphorylation pathways 1 downregulating HIF1\u03b1 initiated protein nitrotyrosination and 2 inhibiting mitochondrial apoptotic cascades",
    "simplified": "Taken together our results suggested that Rg1 protected against A\u03b22535 at least in part by two complementary GRdependent ERK phosphorylation pathways: 1 inhibiting protein nitrotyrosination and 2 inhibiting mitochondrial apoptotic cascades."
  },
  {
    "text": "Activating glucocorticoid receptor ERK signaling pathway contributes to ginsenoside Rg1 protection against \u03b2amyloid peptide induced human endothelial cells apoptosis",
    "triple_list": [
      [
        "glucocorticoid receptor",
        "CPR:3",
        "ginsenoside Rg1"
      ],
      [
        "ERK",
        "CPR:3",
        "ginsenoside Rg1"
      ],
      [
        "ginsenoside Rg1",
        "CPR:4",
        "\u03b2amyloid peptide"
      ]
    ],
    "updated": "No",
    "original": "Activating glucocorticoid receptor ERK signaling pathway contributes to ginsenoside Rg1 protection against \u03b2amyloid peptide induced human endothelial cells apoptosis",
    "simplified": "The glucocorticoid receptor activates the ERK signaling pathway. This causes the ginsenoside Rg1 gene to be activated and the cells to die."
  },
  {
    "text": "These data provided a novel insight to the mechanisms of Rg1 protective effects on A\u03b22535 induced endothelial cells apoptosis suggesting that GRERK signaling pathway might play an important role in it",
    "triple_list": [
      [
        "Rg1",
        "CPR:4",
        "A\u03b22535"
      ]
    ],
    "updated": "No",
    "original": "These data provided a novel insight to the mechanisms of Rg1 protective effects on A\u03b22535 induced endothelial cells apoptosis suggesting that GRERK signaling pathway might play an important role in it",
    "simplified": "These data provided a novel insight to the mechanisms of Rg1 protective effects on endothelial cells, suggesting that GRERK might play an important role in protecting the cells from damage."
  },
  {
    "text": "Rg1 reduced the A\u03b22535 associated mitochondrial apoptotic events . It also inhibited the expression of HIF1\u03b1 and caused protein nitrotyrosination and reactive nitrogen species generation .",
    "triple_list": [
      [
        "Rg1",
        "CPR:4",
        "A\u03b22535"
      ],
      [
        "Rg1",
        "CPR:4",
        "HIF1\u03b1"
      ]
    ],
    "updated": "Yes",
    "original": "Rg1 attenuated the A\u03b22535 associated mitochondrial apoptotic events accompanied by inhibiting HIF1\u03b1 expression followed by intracellular reactive nitrogen species generation and protein nitrotyrosination",
    "simplified": "Rg1 reduced the A\u03b22535 associated mitochondrial apoptotic events. It also inhibited the expression of HIF1\u03b1 and caused protein nitrotyrosination and reactive nitrogen species generation."
  },
  {
    "text": "These protective effects were abolished by glucocorticoid receptor GR antagonist RU486 or pERK inhibitor U0126 rather than estrogen receptor \u03b1 antagonist ICI 82780",
    "triple_list": [
      [
        "pERK",
        "CPR:4",
        "U0126"
      ],
      [
        "estrogen receptor \u03b1",
        "CPR:6",
        "ICI 82780"
      ],
      [
        "glucocorticoid receptor",
        "CPR:6",
        "RU486"
      ],
      [
        "GR",
        "CPR:6",
        "RU486"
      ]
    ],
    "updated": "No",
    "original": "These protective effects were abolished by glucocorticoid receptor GR antagonist RU486 or pERK inhibitor U0126 rather than estrogen receptor \u03b1 antagonist ICI 82780",
    "simplified": "These protective effects were abolished by pERK inhibitor U0126. It works by attacking the glucocorticoid receptor GR instead of the estrogen receptor."
  },
  {
    "text": "On study day 1 candoxatril acutely increased plasma ANP levels and decreased right atrial and pulmonary capillary pressures by up to 30 % .",
    "triple_list": [
      [
        "candoxatril",
        "CPR:3",
        "ANP"
      ]
    ],
    "updated": "Yes",
    "original": "On study day 1 candoxatril acutely increased plasma ANP levels suppressed aldosterone and decreased right atrial and pulmonary capillary wedge pressures",
    "simplified": "On study day 1 candoxatril acutely increased plasma ANP levels and decreased right atrial and pulmonary capillary pressures by up to 30%."
  },
  {
    "text": "On study day 10 the acute effects of candoxatril were similar to those on day 1 ie ANP was further increased aldosterone was suppressed and right and left ventricular filling pressures were decreased",
    "triple_list": [
      [
        "candoxatril",
        "CPR:3",
        "ANP"
      ]
    ],
    "updated": "No",
    "original": "On study day 10 the acute effects of candoxatril were similar to those on day 1 ie ANP was further increased aldosterone was suppressed and right and left ventricular filling pressures were decreased",
    "simplified": "On study day 10 the acute effects of candoxatril were similar to those on day 1. The right and left ventricular filling pressures were decreased and aldosterone was reduced."
  },
  {
    "text": "Candoxatril is a novel orally active inhibitor of neutral endopeptidase EC 342411 the enzyme that degrades atrial natriuretic peptide ANP",
    "triple_list": [
      [
        "Candoxatril",
        "CPR:4",
        "neutral endopeptidase"
      ],
      [
        "Candoxatril",
        "CPR:4",
        "EC 342411"
      ]
    ],
    "updated": "No",
    "original": "Candoxatril is a novel orally active inhibitor of neutral endopeptidase EC 342411 the enzyme that degrades atrial natriuretic peptide ANP",
    "simplified": "Candoxatril is a drug that can be taken orally. It works by stopping the enzyme neutral endopeptidase from working."
  },
  {
    "text": "Effectiveness of endopeptidase inhibition candoxatril in congestive heart failure",
    "triple_list": [
      [
        "endopeptidase",
        "CPR:4",
        "candoxatril"
      ]
    ],
    "updated": "No",
    "original": "Effectiveness of endopeptidase inhibition candoxatril in congestive heart failure",
    "simplified": "The effects of endopeptidase inhibition on heart function and function"
  },
  {
    "text": "Type 2 11\u03b2hydroxysteroid dehydrogenase , encoded by the HSD11B2 gene , converts cortisol to inactive cortisone . If this enzyme is changed , levels of glucose in the blood can change , and this can affect health .",
    "triple_list": [
      [
        "Type 2 11\u03b2hydroxysteroid dehydrogenase",
        "CPR:9",
        "cortisol"
      ],
      [
        "HSD11B2",
        "CPR:9",
        "cortisol"
      ],
      [
        "Type 2 11\u03b2hydroxysteroid dehydrogenase",
        "CPR:9",
        "cortisone"
      ],
      [
        "HSD11B2",
        "CPR:9",
        "cortisone"
      ]
    ],
    "updated": "Yes",
    "original": "Type 2 11\u03b2hydroxysteroid dehydrogenase encoded by the HSD11B2 gene converts cortisol to inactive cortisone and alteration in this enzymatic activity might affect glucose homeostasis by affecting circulating levels or tissue availability of glucocorticoids",
    "simplified": "Type 2 11\u03b2hydroxysteroid dehydrogenase, encoded by the HSD11B2 gene, converts cortisol to inactive cortisone. If this enzyme is changed, levels of glucose in the blood can change, and this can affect health."
  },
  {
    "text": "The alpha1adrenoceptor antagonist tamsulosin is selective for alpha1A and alpha1D over alpha1Badrenoceptors",
    "triple_list": [
      [
        "alpha1adrenoceptor",
        "CPR:6",
        "tamsulosin"
      ],
      [
        "tamsulosin",
        "CPR:6",
        "alpha1A and alpha1D over alpha1Badrenoceptors"
      ]
    ],
    "updated": "No",
    "original": "The alpha1adrenoceptor antagonist tamsulosin is selective for alpha1A and alpha1D over alpha1Badrenoceptors",
    "simplified": "Tamsulosin is an antagonist to the alpha1adrenoceptor. It only works on the alpha1A type."
  },
  {
    "text": "The obtained results showed that pioglitazone improved the renal function structural changes renal malondialdehyde MDA tumor necrosis factor alpha TNF\u03b1 nuclear factor kappa B NF\u03baB genes expression in cisplatin injected rats",
    "triple_list": [
      [
        "pioglitazone",
        "CPR:3",
        "tumor necrosis factor alpha"
      ],
      [
        "pioglitazone",
        "CPR:3",
        "TNF\u03b1"
      ],
      [
        "pioglitazone",
        "CPR:3",
        "nuclear factor kappa B"
      ],
      [
        "pioglitazone",
        "CPR:3",
        "NF\u03baB"
      ],
      [
        "tumor necrosis factor alpha",
        "CPR:4",
        "cisplatin"
      ],
      [
        "TNF\u03b1",
        "CPR:4",
        "cisplatin"
      ],
      [
        "nuclear factor kappa B",
        "CPR:4",
        "cisplatin"
      ],
      [
        "NF\u03baB",
        "CPR:4",
        "cisplatin"
      ]
    ],
    "updated": "No",
    "original": "The obtained results showed that pioglitazone improved the renal function structural changes renal malondialdehyde MDA tumor necrosis factor alpha TNF\u03b1 nuclear factor kappa B NF\u03baB genes expression in cisplatin injected rats",
    "simplified": "The obtained results showed that pioglitazone improved the renal function structural changes in cisplatin injected rats. The results showed that pioglitazone improved the renal function structural changes."
  },
  {
    "text": "Combining in vivo and in vitro findings we identified nine AhR agonists including leflunomide flutamide and nimodipine which have been approved by the US Food and Drug Administration .",
    "triple_list": [
      [
        "AhR",
        "CPR:5",
        "leflunomide"
      ],
      [
        "AhR",
        "CPR:5",
        "flutamide"
      ],
      [
        "AhR",
        "CPR:5",
        "nimodipine"
      ]
    ],
    "updated": "Yes",
    "original": "Combining in vivo and in vitro findings we identified nine AhR agonists six of which are marketed therapeutics and have been approved by the US Food and Drug Administration including leflunomide flutamide and nimodipine",
    "simplified": "Combining in vivo and in vitro findings we identified nine AhR agonists including leflunomide flutamide and nimodipine which have been approved by the US Food and Drug Administration."
  },
  {
    "text": "The combination of U0126 and YC1 increases apoptosis in colorectal cancer cells . The effects of sulindac on ERK12 JNK and betacatenin are also improved .",
    "triple_list": [
      [
        "U0126",
        "CPR:3",
        "JNK"
      ],
      [
        "YC1",
        "CPR:3",
        "JNK"
      ],
      [
        "sulindac",
        "CPR:3",
        "JNK"
      ],
      [
        "U0126",
        "CPR:4",
        "betacatenin"
      ],
      [
        "YC1",
        "CPR:4",
        "betacatenin"
      ],
      [
        "sulindac",
        "CPR:4",
        "betacatenin"
      ]
    ],
    "updated": "Yes",
    "original": "Cotreatment with U0126 and YC1 synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of sulindac treatment on ERK12 JNK and betacatenin",
    "simplified": "The combination of U0126 and YC1 increases apoptosis in colorectal cancer cells. The effects of sulindac on ERK12 JNK and betacatenin are also improved."
  },
  {
    "text": "Sulindac metabolites simultaneously a increase cellular cyclic GMP and subsequently activate cyclic GMPdependent protein kinase PKG b activate cjun NH2terminal kinase JNK c inhibit extracellular signalregulated kinase 12 ERK12 and d decrease betacatenin protein expression at times and doses consistent with apoptosis",
    "triple_list": [
      [
        "Sulindac",
        "CPR:3",
        "cyclic GMPdependent protein kinase"
      ],
      [
        "Sulindac",
        "CPR:3",
        "PKG"
      ],
      [
        "Sulindac",
        "CPR:4",
        "cjun NH2terminal kinase"
      ],
      [
        "Sulindac",
        "CPR:4",
        "JNK"
      ],
      [
        "Sulindac",
        "CPR:4",
        "betacatenin"
      ]
    ],
    "updated": "No",
    "original": "Sulindac metabolites simultaneously a increase cellular cyclic GMP and subsequently activate cyclic GMPdependent protein kinase PKG b activate cjun NH2terminal kinase JNK c inhibit extracellular signalregulated kinase 12 ERK12 and d decrease betacatenin protein expression at times and doses consistent with apoptosis",
    "simplified": "Sulindac metabolites simultaneously a increase cellular cyclic GMP and subsequently activate cyclic GMPdependent protein kinase PKG b inhibit extracellular signalregulated kinase 12 ERK12 and d decrease betacatenin protein expression at times and doses consistent with apoptosis."
  },
  {
    "text": "This work showed that appropriate structural modification of diphenidol can lead to M2 selective muscarinic antagonists of possible interest in the field of Alzheimers disease",
    "triple_list": [
      [
        "diphenidol",
        "CPR:6",
        "M2"
      ]
    ],
    "updated": "No",
    "original": "This work showed that appropriate structural modification of diphenidol can lead to M2 selective muscarinic antagonists of possible interest in the field of Alzheimers disease",
    "simplified": "This work showed that it is possible to change the structure of diphenidol in such a way that it can be used to treat Alzheimers disease."
  },
  {
    "text": "A series of 2carbonyl analogues of the muscarinic antagonist diphenidol were synthesized and their affinity for the M2 and M3 muscarinic receptor subtypes was evaluated by functional tests . The results were positive .",
    "triple_list": [
      [
        "diphenidol",
        "CPR:6",
        "M2 and M3 muscarinic receptor"
      ]
    ],
    "updated": "Yes",
    "original": "A series of 2carbonyl analogues of the muscarinic antagonist diphenidol bearing 1substituents of different lipophilic electronic and steric properties was synthesized and their affinity for the M2 and M3 muscarinic receptor subtypes was evaluated by functional tests",
    "simplified": "A series of 2carbonyl analogues of the muscarinic antagonist diphenidol were synthesized and their affinity for the M2 and M3 muscarinic receptor subtypes was evaluated by functional tests. The results were positive."
  },
  {
    "text": "Synthesis and antagonistic activity at muscarinic receptor subtypes of some 2carbonyl derivatives of diphenidol",
    "triple_list": [
      [
        "muscarinic receptor",
        "CPR:6",
        "diphenidol"
      ],
      [
        "muscarinic receptor",
        "CPR:6",
        "2carbonyl"
      ]
    ],
    "updated": "No",
    "original": "Synthesis and antagonistic activity at muscarinic receptor subtypes of some 2carbonyl derivatives of diphenidol",
    "simplified": "Diphenidol can be used to treat certain diseases. It acts on the muscarinic receptor."
  },
  {
    "text": "In this study aldosterone ALD induced apoptosis of cardiomyocyte was evaluated based on the previous studies and the roles of calpain signaling were clarified",
    "triple_list": [
      [
        "ALD",
        "CPR:3",
        "calpain"
      ],
      [
        "aldosterone",
        "CPR:3",
        "calpain"
      ]
    ],
    "updated": "No",
    "original": "In this study aldosterone ALD induced apoptosis of cardiomyocyte was evaluated based on the previous studies and the roles of calpain signaling were clarified",
    "simplified": "In this study aldosterone-induced cardiomyocyte apoptosis was evaluated based on previous studies and calpain signaling was clarified."
  },
  {
    "text": "ALD increased the expression of calpain and caspase3 and increased breast size",
    "triple_list": [
      [
        "ALD",
        "CPR:3",
        "calpain"
      ],
      [
        "ALD",
        "CPR:3",
        "caspase3"
      ]
    ],
    "updated": "Yes",
    "original": "ALD increased calpain expression and caspase3 activity and promoted Bid cleavage",
    "simplified": "ALD increased the expression of calpain and caspase3 and increased breast size"
  },
  {
    "text": "Activation of an apoptotic signal transduction pathway involved in the upregulation of calpain and apoptosisinducing factor in aldosterone induced primary cultured cardiomyocytes",
    "triple_list": [
      [
        "calpain",
        "CPR:3",
        "aldosterone"
      ],
      [
        "apoptosisinducing factor",
        "CPR:3",
        "aldosterone"
      ]
    ],
    "updated": "No",
    "original": "Activation of an apoptotic signal transduction pathway involved in the upregulation of calpain and apoptosisinducing factor in aldosterone induced primary cultured cardiomyocytes",
    "simplified": "Activation of an apoptotic signal transduction pathway in primary cultured cardiomyocytes involved in the upregulation of calpain and apoptosisinducing factor."
  },
  {
    "text": "The activity of calpain tBid and caspase3 was further inhibited by treatment with EGTA in the presence of ALD .",
    "triple_list": [
      [
        "calpain",
        "CPR:3",
        "ALD"
      ],
      [
        "tBid",
        "CPR:3",
        "ALD"
      ],
      [
        "caspase3",
        "CPR:3",
        "ALD"
      ],
      [
        "calpain",
        "CPR:4",
        "EGTA"
      ],
      [
        "tBid",
        "CPR:4",
        "EGTA"
      ],
      [
        "caspase3",
        "CPR:4",
        "EGTA"
      ]
    ],
    "updated": "Yes",
    "original": "The upregulation of calpain tBid and caspase3 activity were further inhibited by treatment with EGTA in the presence of ALD",
    "simplified": "The activity of calpain tBid and caspase3 was further inhibited by treatment with EGTA in the presence of ALD."
  },
  {
    "text": "In addition , treatment with spironoclactone did not only reduce the proapoptotic effect of ALD but it also did not increase calpain or AIF levels .",
    "triple_list": [
      [
        "ALD",
        "CPR:3",
        "calpain"
      ],
      [
        "ALD",
        "CPR:3",
        "AIF"
      ],
      [
        "spironoclactone",
        "CPR:4",
        "calpain"
      ],
      [
        "spironoclactone",
        "CPR:4",
        "AIF"
      ]
    ],
    "updated": "Yes",
    "original": "Furthermore treatment with spironoclactone not only attenuated the proapoptotic effect of ALD but reversed the ALDinduced increase of calpain and AIF levels",
    "simplified": "In addition, treatment with spironoclactone did not only reduce the proapoptotic effect of ALD but it also did not increase calpain or AIF levels."
  },
  {
    "text": "In addition , AIF levels in the cytosol decreased because of calpeptin , not EGTA .",
    "triple_list": [
      [
        "AIF",
        "CPR:4",
        "EGTA"
      ]
    ],
    "updated": "Yes",
    "original": "Additionally AIF levels in the cytosol decreased due to EGTA but not due to calpeptin",
    "simplified": "In addition, AIF levels in the cytosol decreased because of calpeptin, not EGTA."
  },
  {
    "text": "In all patients , loperamide significantly reduced plasma ACTH levels .",
    "triple_list": [
      [
        "loperamide",
        "CPR:4",
        "ACTH"
      ]
    ],
    "updated": "Yes",
    "original": "In all patients loperamide induced a significant fall in plasma ACTH levels",
    "simplified": "In all patients, loperamide significantly reduced plasma ACTH levels."
  },
  {
    "text": "Loperamide is an opiate-like drug . It works by inhibiting ACTH .",
    "triple_list": [
      [
        "Loperamide",
        "CPR:4",
        "ACTH"
      ]
    ],
    "updated": "Yes",
    "original": "Loperamide is a peripheral opiate agonist able to inhibit ACTH secretion",
    "simplified": "Loperamide is an opiate-like drug. It works by inhibiting ACTH."
  },
  {
    "text": "CRH caused a rise in plasma ACTH after both loperamide from 30 166 to a peak of 108 31 pmoll and placebo from 985 47 to 211 617 pmoll The first phase of CRH induced ACTH secretion was significantly lower after loperamide compared to placebo .",
    "triple_list": [
      [
        "CRH",
        "CPR:4",
        "loperamide"
      ],
      [
        "ACTH",
        "CPR:4",
        "loperamide"
      ]
    ],
    "updated": "Yes",
    "original": "CRH caused a rise in plasma ACTH after both loperamide from 30 166 to a peak of 108 31 pmoll and placebo from 985 47 to 211 617 pmoll the interaction between treatments and time was significant and the first phase of CRH induced ACTH secretion was significantly lower after loperamide",
    "simplified": "CRH caused a rise in plasma ACTH after both loperamide from 30 166 to a peak of 108 31 pmoll and placebo from 985 47 to 211 617 pmoll The first phase of CRH induced ACTH secretion was significantly lower after loperamide compared to placebo."
  },
  {
    "text": "CCl4 administration triggered inflammatory response in mice livers by activating nuclear factorkappaB NF\u03baB which coincided with the induction of tumor necrosis factoralpha TNF\u03b1 and cyclooxygenase2 COX2",
    "triple_list": [
      [
        "CCl4",
        "CPR:3",
        "nuclear factorkappaB"
      ],
      [
        "CCl4",
        "CPR:3",
        "NF\u03baB"
      ],
      [
        "CCl4",
        "CPR:3",
        "tumor necrosis factoralpha"
      ],
      [
        "CCl4",
        "CPR:3",
        "TNF\u03b1"
      ],
      [
        "CCl4",
        "CPR:3",
        "cyclooxygenase2"
      ],
      [
        "CCl4",
        "CPR:3",
        "COX2"
      ]
    ],
    "updated": "No",
    "original": "CCl4 administration triggered inflammatory response in mice livers by activating nuclear factorkappaB NF\u03baB which coincided with the induction of tumor necrosis factoralpha TNF\u03b1 and cyclooxygenase2 COX2",
    "simplified": "CCl4 triggered an inflammatory response in the livers of mice. When nuclear factorkappaB NF\u03baB was activated, tumor necrosis factoralpha and cyclooxygenase2 were also activated."
  },
  {
    "text": "CCl4 intoxication caused liver damage and increased blood ALT levels .",
    "triple_list": [
      [
        "CCl4",
        "CPR:3",
        "ALT"
      ]
    ],
    "updated": "Yes",
    "original": "CCl4 intoxication caused hepatic necrosis and increased serum ALT activity",
    "simplified": "CCl4 intoxication caused liver damage and increased blood ALT levels."
  },
  {
    "text": "In addition , RA significantly inhibited the apoptosis caused by CCl4 . This was shown by decreased caspase3 .",
    "triple_list": [
      [
        "CCl4",
        "CPR:4",
        "caspase3"
      ]
    ],
    "updated": "Yes",
    "original": "Furthermore RA significantly inhibited the CCl4 induced apoptosis which was evident from decreased cleavage of caspase3",
    "simplified": "In addition, RA significantly inhibited the apoptosis caused by CCl4. This was shown by decreased caspase3."
  },
  {
    "text": "These actions are consistent with a prejunctional inhibition of neuropeptide release from perivascular afferents of the trigeminal nerve as confirmed by independent studies showing that zolmitriptan blocks elevations of calcitoningenerelated peptide in jugular venous blood during electrical stimulation of the trigeminal ganglion",
    "triple_list": [
      [
        "zolmitriptan",
        "CPR:4",
        "calcitoningenerelated peptide"
      ]
    ],
    "updated": "No",
    "original": "These actions are consistent with a prejunctional inhibition of neuropeptide release from perivascular afferents of the trigeminal nerve as confirmed by independent studies showing that zolmitriptan blocks elevations of calcitoningenerelated peptide in jugular venous blood during electrical stimulation of the trigeminal ganglion",
    "simplified": "These actions are consistent with a prejunctional inhibition of neuropeptide release from perivascular afferents of the trigeminal nerve during electrical stimulation of the trigeminal ganglion, as confirmed by independent studies."
  },
  {
    "text": "Zolmitriptan Zomig ( formerly 311C90 ) is a novel 5hydroxytryptamine 5HT1B1D receptor agonist . It is used in the treatment of migraine headaches .",
    "triple_list": [
      [
        "311C90",
        "CPR:5",
        "5hydroxytryptamine 5HT1B1D"
      ],
      [
        "Zolmitriptan",
        "CPR:5",
        "5hydroxytryptamine 5HT1B1D"
      ],
      [
        "Zomig",
        "CPR:5",
        "5hydroxytryptamine 5HT1B1D"
      ]
    ],
    "updated": "Yes",
    "original": "Zolmitriptan Zomig formerly 311C90 is a novel 5hydroxytryptamine 5HT1B1D receptor agonist with proven efficacy in the acute treatment of migraine with or without preceding aura",
    "simplified": "Zolmitriptan Zomig (formerly 311C90) is a novel 5hydroxytryptamine 5HT1B1D receptor agonist. It is used in the treatment of migraine headaches."
  },
  {
    "text": "Preclinical pharmacology of zolmitriptan Zomig ( formerly 311C90 ) is a 5HT1B1D agonist that is used to treat migraine .",
    "triple_list": [
      [
        "zolmitriptan",
        "CPR:5",
        "5HT1B1D"
      ],
      [
        "Zomig",
        "CPR:5",
        "5HT1B1D"
      ],
      [
        "311C90",
        "CPR:5",
        "5HT1B1D"
      ]
    ],
    "updated": "Yes",
    "original": "Preclinical pharmacology of zolmitriptan Zomig formerly 311C90 a centrally and peripherally acting 5HT1B1D agonist for migraine",
    "simplified": "Preclinical pharmacology of zolmitriptan Zomig (formerly 311C90) is a 5HT1B1D agonist that is used to treat migraine."
  },
  {
    "text": "It has been reported that oligomeric procyanidins of lotus seedpod LSOPC are effective in the treatment of diabetes and Alzheimers disease . This is because they increase insulin production .",
    "triple_list": [
      [
        "procyanidins",
        "CPR:3",
        "insulin"
      ]
    ],
    "updated": "Yes",
    "original": "It has been reported that oligomeric procyanidins of lotus seedpod LSOPC is effective in the alleviation of Alzheimers disease and diabetes through its antioxidant and insulin potentiating activities",
    "simplified": "It has been reported that oligomeric procyanidins of lotus seedpod LSOPC are effective in the treatment of diabetes and Alzheimers disease. This is because they increase insulin production."
  },
  {
    "text": "They all expressed ASS but not ornithine transcarbamylase OTC the enzyme that converts ornithine the product of degradation of arginine with rhArg to citrulline which is converted back to arginine via ASS",
    "triple_list": [
      [
        "ornithine",
        "CPR:9",
        "ornithine transcarbamylase"
      ],
      [
        "ornithine",
        "CPR:9",
        "OTC"
      ],
      [
        "arginine",
        "CPR:9",
        "rhArg"
      ],
      [
        "rhArg",
        "CPR:9",
        "citrulline"
      ],
      [
        "ASS",
        "CPR:9",
        "arginine"
      ]
    ],
    "updated": "No",
    "original": "They all expressed ASS but not ornithine transcarbamylase OTC the enzyme that converts ornithine the product of degradation of arginine with rhArg to citrulline which is converted back to arginine via ASS",
    "simplified": "They all expressed ASS but not ornithine transcarbamylase OTC the enzyme that converts ornithine to citrulline and then back to arginine through a complex process with riboflavin."
  },
  {
    "text": "This surprising correlation between the lack of OTC expression and sensitivity of ASSpositive HCC cells shows that OTCdeficient HCCs are sensitive to rhArg mediated arginine depletion",
    "triple_list": [
      [
        "rhArg",
        "CPR:9",
        "arginine"
      ]
    ],
    "updated": "No",
    "original": "This surprising correlation between the lack of OTC expression and sensitivity of ASSpositive HCC cells shows that OTCdeficient HCCs are sensitive to rhArg mediated arginine depletion",
    "simplified": "This surprising correlation between the lack of OTC expression and sensitivity of ASSpositive HCC cells shows that HCCs are highly sensitive to arginine deficiency."
  },
  {
    "text": "Therefore pretreatment tumor gene expression profiling of ASS and OTC could aid in predicting tumor response to arginine depletion with argininedepleting enzymes",
    "triple_list": [
      [
        "arginine",
        "CPR:9",
        "argininedepleting enzymes"
      ]
    ],
    "updated": "No",
    "original": "Therefore pretreatment tumor gene expression profiling of ASS and OTC could aid in predicting tumor response to arginine depletion with argininedepleting enzymes",
    "simplified": "Therefore pretreatment tumor gene expression profiling of OTC and ASS could aid in predicting arginine response with arginine depletion."
  },
  {
    "text": "The expression of cfos was induced in urethaneanaesthetized rats by capsaicin administration .",
    "triple_list": [
      [
        "cfos",
        "CPR:3",
        "capsaicin"
      ]
    ],
    "updated": "Yes",
    "original": "cfos expression was induced in urethaneanaesthetized rats by intracisternal capsaicin administration",
    "simplified": "The expression of cfos was induced in urethaneanaesthetized rats by capsaicin administration."
  },
  {
    "text": "Sumatriptan and LY 344864 decreased the number of capsaicin induced cfos like immunoreactive cells within trigeminal nucleus caudalis ID50 = 004 and 06 mg kg1",
    "triple_list": [
      [
        "capsaicin",
        "CPR:3",
        "cfos"
      ],
      [
        "Sumatriptan",
        "CPR:4",
        "cfos"
      ],
      [
        "LY 344864",
        "CPR:4",
        "cfos"
      ]
    ],
    "updated": "No",
    "original": "Sumatriptan and LY 344864 decreased the number of capsaicin induced cfos like immunoreactive cells within trigeminal nucleus caudalis ID50 = 004 and 06 mg kg1",
    "simplified": "Sumatriptan and LY 344864 reduced the number of immunoreactive cells in the trigeminal nucleus of the caudalis. These cells are sensitive to capsaicin."
  },
  {
    "text": "To establish the relative importance of these subtypes we compared the effects of sumatriptan with those of a selective 5HT1F receptor agonist LY 344864 on cfos protein expression in the trigeminal nucleus caudalis",
    "triple_list": [
      [
        "5HT1F",
        "CPR:5",
        "LY 344864"
      ]
    ],
    "updated": "No",
    "original": "To establish the relative importance of these subtypes we compared the effects of sumatriptan with those of a selective 5HT1F receptor agonist LY 344864 on cfos protein expression in the trigeminal nucleus caudalis",
    "simplified": "To establish the relative importance of these subtypes, we compared the effects of sumatriptan and a selective 5HT1F receptor agonist in the trigeminal nucleus caudalis to cfos protein expression."
  },
  {
    "text": "The effect of sumatriptan but not of LY 344864 was prevented by pretreatment with the antagonist SDZ 21009 which displays high affinity for rat 5HT1B receptors",
    "triple_list": [
      [
        "SDZ 21009",
        "CPR:6",
        "rat 5HT1B"
      ]
    ],
    "updated": "No",
    "original": "The effect of sumatriptan but not of LY 344864 was prevented by pretreatment with the antagonist SDZ 21009 which displays high affinity for rat 5HT1B receptors",
    "simplified": "The effect of sumatriptan but not of LY 344864 was prevented by pretreatment with SDZ 21009. SDZ 21009 is a drug that works against the 5HT1B receptors."
  },
  {
    "text": "In addition to this evidence for the involvement of EP2 receptors , evidence for the involvement of EP1 receptors in the PGE1 mediated stimulation of NaKATPase beta subunit gene transcription has also been found . 17phenyl trinor PGE2 and SC51089 have both been shown to stimulate gene transcription .",
    "triple_list": [
      [
        "PGE1",
        "CPR:3",
        "NaKATPase beta"
      ],
      [
        "NaKATPase beta",
        "CPR:3",
        "17phenyl trinor PGE2"
      ],
      [
        "NaKATPase beta",
        "CPR:4",
        "SC51089"
      ]
    ],
    "updated": "Yes",
    "original": "In addition to this evidence for the involvement of EP2 receptors evidence for the involvement of EP1 receptors in the PGE1 mediated stimulation of NaKATPase beta subunit gene transcription includes the stimulatory effect of 17phenyl trinor PGE2 as well as the inhibitory effects of SC51089",
    "simplified": "In addition to this evidence for the involvement of EP2 receptors, evidence for the involvement of EP1 receptors in the PGE1 mediated stimulation of NaKATPase beta subunit gene transcription has also been found. 17phenyl trinor PGE2 and SC51089 have both been shown to stimulate gene transcription."
  },
  {
    "text": "The PGE1 stimulation is inhibited by the PKCI vector encoding the PKC inhibitory domain . The PKC inhibitor Go 6976 thapsigargin as well as the calmodulin antagonists W7 and W13 prevent the stimulation of PGE1 .",
    "triple_list": [
      [
        "PKC",
        "CPR:4",
        "thapsigargin"
      ],
      [
        "PKC",
        "CPR:4",
        "Go 6976"
      ],
      [
        "calmodulin",
        "CPR:6",
        "W7"
      ],
      [
        "calmodulin",
        "CPR:6",
        "W13"
      ]
    ],
    "updated": "Yes",
    "original": "Also consistent with the involvement of Gq coupled EP1 receptors the PGE1 stimulation is inhibited by the PKCI vector encoding the PKC inhibitory domain the PKC inhibitor Go 6976 thapsigargin as well as the calmodulin antagonists W7 and W13",
    "simplified": "The PGE1 stimulation is inhibited by the PKCI vector encoding the PKC inhibitory domain. The PKC inhibitor Go 6976 thapsigargin as well as the calmodulin antagonists W7 and W13 prevent the stimulation of PGE1."
  },
  {
    "text": "The involvement of EP1 and EP2 receptors is indicated by studies with the antagonist SC51089 EP1 specific and AH 6809 EP1 and EP2 specific which stimulate , as well as by studies with the selective agonist 17phenyl trinor PGE2 and the EP2 selective agonist butaprost .",
    "triple_list": [
      [
        "EP1",
        "CPR:5",
        "17phenyl trinor PGE2"
      ],
      [
        "EP1",
        "CPR:5",
        "17phenyl trinor PGE2"
      ],
      [
        "EP2 receptors",
        "CPR:5",
        "butaprost"
      ],
      [
        "EP2",
        "CPR:5",
        "butaprost"
      ],
      [
        "EP1",
        "CPR:5",
        "SC51089"
      ],
      [
        "EP1",
        "CPR:5",
        "SC51089"
      ],
      [
        "EP1",
        "CPR:5",
        "SC51089"
      ],
      [
        "EP1",
        "CPR:5",
        "AH 6809"
      ],
      [
        "EP2 receptors",
        "CPR:5",
        "AH 6809"
      ],
      [
        "EP1",
        "CPR:5",
        "AH 6809"
      ],
      [
        "EP2",
        "CPR:5",
        "AH 6809"
      ],
      [
        "EP1",
        "CPR:6",
        "AH 6809"
      ],
      [
        "EP2",
        "CPR:6",
        "AH 6809"
      ]
    ],
    "updated": "Yes",
    "original": "The involvement of EP1 and EP2 receptors is indicated by studies with the EP1 selective agonist 17phenyl trinor PGE2 and the EP2 selective agonist butaprost which stimulate as well as by studies with the antagonists SC51089 EP1 specific and AH 6809 EP1 and EP2 specific",
    "simplified": "The involvement of EP1 and EP2 receptors is indicated by studies with the antagonist SC51089 EP1 specific and AH 6809 EP1 and EP2 specific which stimulate, as well as by studies with the selective agonist 17phenyl trinor PGE2 and the EP2 selective agonist butaprost."
  },
  {
    "text": "Spiro heterocycles as potential inhibitors of SIRT1 PdCmediated synthesis of novel Nindolylmethyl spiroindoline32quinazolines",
    "triple_list": [
      [
        "SIRT1",
        "CPR:4",
        "Nindolylmethyl spiroindoline32quinazolines"
      ]
    ],
    "updated": "No",
    "original": "Spiro heterocycles as potential inhibitors of SIRT1 PdCmediated synthesis of novel Nindolylmethyl spiroindoline32quinazolines",
    "simplified": "Spiro heterocycles as potential inhibitors of SIRT1 PdC and SIRT2 PdCmediated cell division."
  },
  {
    "text": "Novel Nindolylmethyl substituted spiroindoline32quinazolines were designed as potential inhibitiors of SIRT1",
    "triple_list": [
      [
        "Nindolylmethyl substituted spiroindoline32quinazolines",
        "CPR:4",
        "SIRT1"
      ]
    ],
    "updated": "No",
    "original": "Novel Nindolylmethyl substituted spiroindoline32quinazolines were designed as potential inhibitiors of SIRT1",
    "simplified": "Novel Nindolylmethyl substituted spiroindoline have been designed to work on SIRT1."
  },
  {
    "text": "Cyclopentenone prostaglandins were potent inhibitors of iNOS induction and were more effective than their precursors prostaglandins E2 and D2",
    "triple_list": [
      [
        "Cyclopentenone prostaglandins",
        "CPR:4",
        "iNOS"
      ],
      [
        "iNOS",
        "CPR:4",
        "prostaglandins E2 and D2"
      ]
    ],
    "updated": "No",
    "original": "Cyclopentenone prostaglandins were potent inhibitors of iNOS induction and were more effective than their precursors prostaglandins E2 and D2",
    "simplified": "Cyclopentenone and its precursors were very effective at blocking iNOS. They were more effective than E2 and D2."
  },
  {
    "text": "When microglia were activated , 15dPGJ2 reduced iNOS promoter activity .",
    "triple_list": [
      [
        "15dPGJ2",
        "CPR:4",
        "iNOS promoter"
      ],
      [
        "15dPGJ2",
        "CPR:4",
        "iNOS"
      ]
    ],
    "updated": "Yes",
    "original": "In activated microglia 15dPGJ2 suppressed iNOS promoter activity iNOS mRNA and protein levels",
    "simplified": "When microglia were activated, 15dPGJ2 reduced iNOS promoter activity."
  },
  {
    "text": "Cyclopentenone prostaglandins suppress activation of microglia downregulation of inducible nitricoxide synthase by 15deoxyDelta1214prostaglandin J2",
    "triple_list": [
      [
        "Cyclopentenone prostaglandins",
        "CPR:4",
        "inducible nitricoxide synthase"
      ],
      [
        "inducible nitricoxide synthase",
        "CPR:4",
        "15deoxyDelta1214prostaglandin J2"
      ]
    ],
    "updated": "No",
    "original": "Cyclopentenone prostaglandins suppress activation of microglia downregulation of inducible nitricoxide synthase by 15deoxyDelta1214prostaglandin J2",
    "simplified": "Cyclopentenone and prostaglandin J2 inhibit microglia production of nitricoxide by 15deoxyDelta1214prostaglandin J2 in the microglia."
  },
  {
    "text": "15dPGJ2 did not block nuclear translocation or DNAbinding activity of the transcription factor NFkappaB but it did inhibit the activity of an NFkappaB reporter construct suggesting that the mechanism of suppression of microglial iNOS by 15dPGJ2 may involve interference with NFkappaB transcriptional activity in the nucleus",
    "triple_list": [
      [
        "15dPGJ2",
        "CPR:4",
        "NFkappaB"
      ],
      [
        "15dPGJ2",
        "CPR:4",
        "iNOS"
      ]
    ],
    "updated": "No",
    "original": "15dPGJ2 did not block nuclear translocation or DNAbinding activity of the transcription factor NFkappaB but it did inhibit the activity of an NFkappaB reporter construct suggesting that the mechanism of suppression of microglial iNOS by 15dPGJ2 may involve interference with NFkappaB transcriptional activity in the nucleus",
    "simplified": "15dPGJ2 did not block nuclear translocation or DNAbinding activity of the transcription factor NFkappaB but it did inhibit the activity of an NFkappaB reporter construct. This suggests that 15dPGJ2 may interfere with the transcription of NFkappaB by the microglial nucleus."
  },
  {
    "text": "The activation may be accelerated by an acute inflammatory process provoked by oleate which is supported by an increase in plasma fibrinogen level which was observed in all during the period and mild fever retrosternal pain leukocytosis .",
    "triple_list": [
      [
        "oleate",
        "CPR:3",
        "fibrinogen"
      ]
    ],
    "updated": "Yes",
    "original": "The activation may be accelerated by an acute inflammatory process provoked by oleate which is supported by such clinical manifestations as mild fever retrosternal pain leukocytosis and an increase in plasma fibrinogen level which was observed in all during the period",
    "simplified": "The activation may be accelerated by an acute inflammatory process provoked by oleate which is supported by an increase in plasma fibrinogen level which was observed in all during the period and mild fever retrosternal pain leukocytosis."
  },
  {
    "text": "In vitro studies however revealed that EO inhibits fibrin clot formation because of the Ca2chelating ability of its constituent ethanolamine ; however , it is not known why this is the case .",
    "triple_list": [
      [
        "EO",
        "CPR:4",
        "fibrin"
      ]
    ],
    "updated": "Yes",
    "original": "In vitro studies however revealed that EO inhibits fibrin clot formation because of the Ca2chelating ability of its constituent ethanolamine although oleate or benzyl alcohol exhibited procoagulant activity in FPA formation in vitro",
    "simplified": "In vitro studies however revealed that EO inhibits fibrin clot formation because of the Ca2chelating ability of its constituent ethanolamine; however, it is not known why this is the case."
  },
  {
    "text": "OBJECTIVE Celecoxib and rofecoxib are two relatively new nonsteroidal antiinflammatory drugs NSAIDs that selectively inhibit the cyclooxygenase2 COX2 isoenzyme at therapeutic concentrations",
    "triple_list": [
      [
        "rofecoxib",
        "CPR:4",
        "cyclooxygenase2"
      ],
      [
        "rofecoxib",
        "CPR:4",
        "COX2"
      ],
      [
        "Celecoxib",
        "CPR:4",
        "cyclooxygenase2"
      ],
      [
        "Celecoxib",
        "CPR:4",
        "COX2"
      ]
    ],
    "updated": "No",
    "original": "OBJECTIVE Celecoxib and rofecoxib are two relatively new nonsteroidal antiinflammatory drugs NSAIDs that selectively inhibit the cyclooxygenase2 COX2 isoenzyme at therapeutic concentrations",
    "simplified": "Celecoxib and rofecoxib are two relatively new nonsteroidal anti-inflammatory drugs (NSAIDs). They work by stopping a chemical called COX2 from being made in the body."
  },
  {
    "text": "This study was performed to determine the relationship between acute renal failure and the COX2 inhibitors rofecoxib and celecoxib .",
    "triple_list": [
      [
        "COX2",
        "CPR:4",
        "celecoxib"
      ],
      [
        "COX2",
        "CPR:4",
        "rofecoxib"
      ]
    ],
    "updated": "Yes",
    "original": "This study was conducted in order to understand the association between acute renal failure and the two COX2 inhibitors celecoxib and rofecoxib",
    "simplified": "This study was performed to determine the relationship between acute renal failure and the COX2 inhibitors rofecoxib and celecoxib."
  },
  {
    "text": "Tamsulosin tamsulosin SL 890591 Rec 152739 SNAP 1069 and RS 17053 appeared to act as competitive antagonists of noradrenalinemediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned human alpha 1D adrenoceptors",
    "triple_list": [
      [
        "Tamsulosin",
        "CPR:6",
        "human alpha 1D adrenoceptors"
      ],
      [
        "tamsulosin",
        "CPR:6",
        "human alpha 1D adrenoceptors"
      ],
      [
        "SL 890591",
        "CPR:6",
        "human alpha 1D adrenoceptors"
      ],
      [
        "Rec 152739",
        "CPR:6",
        "human alpha 1D adrenoceptors"
      ],
      [
        "SNAP 1069",
        "CPR:6",
        "human alpha 1D adrenoceptors"
      ],
      [
        "RS 17053",
        "CPR:6",
        "human alpha 1D adrenoceptors"
      ]
    ],
    "updated": "No",
    "original": "Tamsulosin tamsulosin SL 890591 Rec 152739 SNAP 1069 and RS 17053 appeared to act as competitive antagonists of noradrenalinemediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned human alpha 1D adrenoceptors",
    "simplified": "Tamsulosin tamsulosin SL 890591 Rec 152739 SNAP 1069 and RS 17053 appeared to act as competitive antagonists of contractions of the aorta in rats. The pA2 levels in these cells were very similar to those in cloned human adrenoceptors."
  },
  {
    "text": "The potency of the antipsychotic drug risperidone to antagonize alpha 1Aadrenoceptor mediated contraction in rat vas deferens and vasoconstriction in rat perfused kidney and alpha 1Badrenoceptor mediated contractions in spleen from guineapig and mouse was evaluated and compared to that of alpha 1adrenoceptor subtypediscriminating antagonists",
    "triple_list": [
      [
        "risperidone",
        "CPR:6",
        "alpha 1Badrenoceptor"
      ],
      [
        "risperidone",
        "CPR:6",
        "alpha 1adrenoceptor"
      ],
      [
        "risperidone",
        "CPR:6",
        "alpha 1Aadrenoceptor"
      ]
    ],
    "updated": "No",
    "original": "The potency of the antipsychotic drug risperidone to antagonize alpha 1Aadrenoceptor mediated contraction in rat vas deferens and vasoconstriction in rat perfused kidney and alpha 1Badrenoceptor mediated contractions in spleen from guineapig and mouse was evaluated and compared to that of alpha 1adrenoceptor subtypediscriminating antagonists",
    "simplified": "The effectiveness of the antipsychotic drug risperidone to antagonize alpha 1Aadrenoceptor mediated contractions in rat vas deferens and vasoconstriction in rat perfused kidney was evaluated and compared to that of alpha 1adrenoceptor subtypediscriminating antagonists in guineapig and mouse."
  },
  {
    "text": "In this article the action of dasatinib BMS354825 is compared with that of imatinib . Imatinib is a kinase inhibitor that is currently being used to treat leukemia .",
    "triple_list": [
      [
        "dasatinib",
        "CPR:4",
        "kinase"
      ],
      [
        "BMS354825",
        "CPR:4",
        "kinase"
      ],
      [
        "imatinib",
        "CPR:4",
        "kinase"
      ]
    ],
    "updated": "Yes",
    "original": "In this article the action of dasatinib BMS354825 is contrasted with that of imatinib a kinase inhibitor that is currently being used to treat chronic myelogenous leukemia and other disorders",
    "simplified": "In this article the action of dasatinib BMS354825 is compared with that of imatinib. Imatinib is a kinase inhibitor that is currently being used to treat leukemia."
  },
  {
    "text": "Chen and his team have shown that dasatinib is a very good inhibitor of PDGFR . They have also found that it also works on Src kinase .",
    "triple_list": [
      [
        "dasatinib",
        "CPR:4",
        "PDGFR"
      ],
      [
        "dasatinib",
        "CPR:4",
        "Src kinase"
      ]
    ],
    "updated": "Yes",
    "original": "The work of Chen and colleagues shows that dasatinib is a particularly potent inhibitor of PDGFR and that the compound also targets Src kinase",
    "simplified": "Chen and his team have shown that dasatinib is a very good inhibitor of PDGFR. They have also found that it also works on Src kinase."
  },
  {
    "text": "In another experiment cyanopindolol an antagonist of the serotonin terminal autoreceptor also prolonged the clearance of 5HT from the CA3 region",
    "triple_list": [
      [
        "cyanopindolol",
        "CPR:6",
        "serotonin terminal autoreceptor"
      ]
    ],
    "updated": "No",
    "original": "In another experiment cyanopindolol an antagonist of the serotonin terminal autoreceptor also prolonged the clearance of 5HT from the CA3 region",
    "simplified": "In another experiment, people took a drug called cyanopindolol. This also made the 5HT from the CA3 region stay in the brain."
  },
  {
    "text": "From these data it is thought that both the SERT and NET help the 5HT in the dentate gyrus to be removed from the body .",
    "triple_list": [
      [
        "SERT",
        "CPR:9",
        "5HT"
      ],
      [
        "NET",
        "CPR:9",
        "5HT"
      ]
    ],
    "updated": "Yes",
    "original": "From these data it is inferred that both the SERT and NET contribute to the active clearance of exogenously applied 5HT in the dentate gyrus",
    "simplified": "From these data it is thought that both the SERT and NET help the 5HT in the dentate gyrus to be removed from the body."
  },
  {
    "text": "These and other data have generated a working hypothesis that the serotonin transporter and the terminal serotonin autoreceptor are involved in the 5HT uptake process .",
    "triple_list": [
      [
        "5HT",
        "CPR:9",
        "serotonin transporter"
      ],
      [
        "serotonin autoreceptor",
        "CPR:9",
        "5HT"
      ]
    ],
    "updated": "Yes",
    "original": "These and other data have generated a working hypothesis that activation of the terminal serotonin autoreceptor enhances the kinetics of 5HT uptake through an effect on the serotonin transporter",
    "simplified": "These and other data have generated a working hypothesis that the serotonin transporter and the terminal serotonin autoreceptor are involved in the 5HT uptake process."
  },
  {
    "text": "The antiamnesic effect of minaprine on the cycloheximideinduced memory impairment was also antagonized by a serotonin 5HT releaser pchloroamphetamine and by a 5HT precursor 5hydroxytryptophan whereas a 5HT1A selective agonist 8hydroxy2dinpropylaminotetralin was inactive",
    "triple_list": [
      [
        "5HT1A",
        "CPR:5",
        "8hydroxy2dinpropylaminotetralin"
      ]
    ],
    "updated": "No",
    "original": "The antiamnesic effect of minaprine on the cycloheximideinduced memory impairment was also antagonized by a serotonin 5HT releaser pchloroamphetamine and by a 5HT precursor 5hydroxytryptophan whereas a 5HT1A selective agonist 8hydroxy2dinpropylaminotetralin was inactive",
    "simplified": "The antiamnesic effect of minaprine on the cycloheximideinduced memory impairment was also antagonized by a serotonin 5HT releaser pchloroamphetamine. A 5HT precursor 5hydroxytryptophan was inactive and did not work at all."
  },
  {
    "text": "The memoryimproving effect of minaprine on cycloheximideinduced amnesia was potentiated by a selective 5HT2 antagonist ritanserin",
    "triple_list": [
      [
        "5HT2",
        "CPR:6",
        "ritanserin"
      ]
    ],
    "updated": "No",
    "original": "The memoryimproving effect of minaprine on cycloheximideinduced amnesia was potentiated by a selective 5HT2 antagonist ritanserin",
    "simplified": "The memory improving effect of minaprine on cycloheximide-induced amnesia was also found to work with ritanserin."
  },
  {
    "text": "Even though the activities of MAT and GNMT were increased , Sadenosylhomocysteine and Sadenosylmethionine concentration in the liver were increased in the dwarf mice .",
    "triple_list": [
      [
        "MAT",
        "CPR:9",
        "Sadenosylmethionine"
      ],
      [
        "GNMT",
        "CPR:9",
        "Sadenosylmethionine"
      ],
      [
        "MAT",
        "CPR:9",
        "Sadenosylhomocysteine"
      ],
      [
        "GNMT",
        "CPR:9",
        "Sadenosylhomocysteine"
      ]
    ],
    "updated": "Yes",
    "original": "Even though the activities of MAT and GNMT were elevated the concentration of liver Sadenosylmethionine was decreased 24 p0001 and Sadenosylhomocysteine increased 113 p0001 in the dwarf mice",
    "simplified": "Even though the activities of MAT and GNMT were increased, Sadenosylhomocysteine and Sadenosylmethionine concentration in the liver were increased in the dwarf mice."
  },
  {
    "text": "Activation of alpha 2Badrenoceptors mediates the cardiovascular effects of etomidate",
    "triple_list": [
      [
        "alpha 2Badrenoceptors",
        "CPR:3",
        "etomidate"
      ]
    ],
    "updated": "No",
    "original": "Activation of alpha 2Badrenoceptors mediates the cardiovascular effects of etomidate",
    "simplified": "The activity of alpha 2Badrenoceptors helps the heart work better."
  },
  {
    "text": "In alpha2Breceptorexpressing HEK293 cells etomidate rapidly increased phosphorylation of the extracellular signalrelated kinases ERK12",
    "triple_list": [
      [
        "etomidate",
        "CPR:3",
        "extracellular signalrelated kinases"
      ],
      [
        "etomidate",
        "CPR:3",
        "ERK12"
      ]
    ],
    "updated": "No",
    "original": "In alpha2Breceptorexpressing HEK293 cells etomidate rapidly increased phosphorylation of the extracellular signalrelated kinases ERK12",
    "simplified": "In alpha2Breceptorexpressing HEK293 cells, a chemical called etomidate increases the activity of ERK12."
  },
  {
    "text": "METHODS In mice deficient in alpha2receptor subtypes , etomidate and dexmedetomidine caused sedative and cardiovascular responses .",
    "triple_list": [
      [
        "dexmedetomidine",
        "CPR:5",
        "alpha2receptor"
      ]
    ],
    "updated": "Yes",
    "original": "METHODS Sedative and cardiovascular responses to etomidate and the alpha2agonist dexmedetomidine were determined in mice deficient in alpha2receptor subtypes",
    "simplified": "METHODS In mice deficient in alpha2receptor subtypes, etomidate and dexmedetomidine caused sedative and cardiovascular responses."
  },
  {
    "text": "The intravenous anesthetic etomidate is similar to specific alpha2adrenoceptor agonists . dexmedetomidine is an example of this type of drug .",
    "triple_list": [
      [
        "alpha2adrenoceptor",
        "CPR:5",
        "dexmedetomidine"
      ]
    ],
    "updated": "Yes",
    "original": "BACKGROUND The intravenous anesthetic etomidate exhibits structural similarities to specific alpha2adrenoceptor agonists of the type such as dexmedetomidine",
    "simplified": "The intravenous anesthetic etomidate is similar to specific alpha2adrenoceptor agonists. dexmedetomidine is an example of this type of drug."
  },
  {
    "text": "The results of this study indicate that etomidate acts as an agonist at alpha2adrenoceptors . In humans , an alpha2Breceptormediated increase in blood pressure",
    "triple_list": [
      [
        "etomidate",
        "CPR:5",
        "alpha2adrenoceptors"
      ]
    ],
    "updated": "Yes",
    "original": "CONCLUSIONS These results indicate that etomidate acts as an agonist at alpha2adrenoceptors which appears in vivo primarily as an alpha2Breceptormediated increase in blood pressure",
    "simplified": "The results of this study indicate that etomidate acts as an agonist at alpha2adrenoceptors. In humans, an alpha2Breceptormediated increase in blood pressure"
  },
  {
    "text": "Inhibition of binding of the alpha2receptor antagonist 3HRX821002 to recombinant alpha2receptors by etomidate was tested in human embryonic kidney HEK293 cells in vitro",
    "triple_list": [
      [
        "alpha2receptor",
        "CPR:6",
        "3HRX821002"
      ],
      [
        "3HRX821002",
        "CPR:6",
        "alpha2receptors"
      ]
    ],
    "updated": "No",
    "original": "Inhibition of binding of the alpha2receptor antagonist 3HRX821002 to recombinant alpha2receptors by etomidate was tested in human embryonic kidney HEK293 cells in vitro",
    "simplified": "Inhibition of alpha2receptor binding by etomidate was tested in human embryonic kidney HEK293 cells in vitro by blocking the binding of 3HRX821002."
  },
  {
    "text": "In membranes from HEK293 cells transfected with alpha2receptors etomidate inhibited binding of the alpha2antagonist 3HRX821002 with higher potency from alpha2B and alpha2Creceptors than from alpha2Areceptors Ki alpha2A 208 microm alpha2B 26 microm alpha2C 56 microm",
    "triple_list": [
      [
        "alpha2receptors",
        "CPR:6",
        "3HRX821002"
      ],
      [
        "3HRX821002",
        "CPR:6",
        "alpha2Areceptors"
      ]
    ],
    "updated": "No",
    "original": "In membranes from HEK293 cells transfected with alpha2receptors etomidate inhibited binding of the alpha2antagonist 3HRX821002 with higher potency from alpha2B and alpha2Creceptors than from alpha2Areceptors Ki alpha2A 208 microm alpha2B 26 microm alpha2C 56 microm",
    "simplified": "In membranes from HEK293 cells transfected with alpha2receptors etomidate inhibited the binding of the alpha2antagonist 3HRX821002 with higher potency from alpha2A and alpha2B cells, but not from alpha2C cells."
  },
  {
    "text": "Quantitative realtime polymerase chain reaction analysis showed that when the cells were exposed to SiO2 , the levels of the apoptotic genes caspase3 and caspase9 were increased .",
    "triple_list": [
      [
        "SiO2",
        "CPR:3",
        "caspase3"
      ],
      [
        "SiO2",
        "CPR:3",
        "caspase9"
      ]
    ],
    "updated": "Yes",
    "original": "Quantitative realtime polymerase chain reaction analysis showed that following the exposure of cells to SiO2 NPs the messenger RNA level of apoptotic genes caspase3 and caspase9 were upregulated in a dosedependent manner",
    "simplified": "Quantitative realtime polymerase chain reaction analysis showed that when the cells were exposed to SiO2, the levels of the apoptotic genes caspase3 and caspase9 were increased."
  },
  {
    "text": "In addition , the activity of caspase3 and caspase9 was much higher in both cells that were exposed to SiO2 .",
    "triple_list": [
      [
        "caspase3",
        "CPR:3",
        "SiO2"
      ],
      [
        "caspase9",
        "CPR:3",
        "SiO2"
      ]
    ],
    "updated": "Yes",
    "original": "Moreover activities of caspase3 and caspase9 enzymes were also significantly higher in both kinds of cells exposed to SiO2 NPs",
    "simplified": "In addition, the activity of caspase3 and caspase9 was much higher in both cells that were exposed to SiO2."
  },
  {
    "text": "ThioTEPA CYP2B6 inhibitor 25 \u03bcM and the monoclonal antibody against CYP2B6 but not troleandomycin CYP3A4 inhibitor 25 \u03bcM or the monoclonal antibody against CYP3A4 inhibited ketamine Ndemethylation at clinically relevant concentrations",
    "triple_list": [
      [
        "ThioTEPA",
        "CPR:4",
        "CYP2B6"
      ],
      [
        "troleandomycin",
        "CPR:4",
        "CYP3A4"
      ]
    ],
    "updated": "No",
    "original": "ThioTEPA CYP2B6 inhibitor 25 \u03bcM and the monoclonal antibody against CYP2B6 but not troleandomycin CYP3A4 inhibitor 25 \u03bcM or the monoclonal antibody against CYP3A4 inhibited ketamine Ndemethylation at clinically relevant concentrations",
    "simplified": "ThioTEPA CYP2B6 inhibitor 25 \u03bcM and the monoclonal antibody against CYP2B6 inhibited ketamine Troleandomycin CYP3A4 inhibitor 25 \u03bcM and the monoclonal antibody against CYP3A4 inhibited ketamine Ndemethylation"
  },
  {
    "text": "The levels of both ketamine and ketamine-like substances in the blood were at least 2fold and 6fold higher in HLMs with the CYP2B61 1 genotype than in HLMs with the CYP2B616 genotype .",
    "triple_list": [
      [
        "ketamine",
        "CPR:9",
        "CYP2B61"
      ]
    ],
    "updated": "Yes",
    "original": "The intrinsic clearance for both ketamine enantiomers by the high affinity enzyme in HLMs with CYP2B61 1 genotype were at least 2fold and 6fold higher respectively than those for CYP2B616 genotype and CYP2B666 genotype",
    "simplified": "The levels of both ketamine and ketamine-like substances in the blood were at least 2fold and 6fold higher in HLMs with the CYP2B61 1 genotype than in HLMs with the CYP2B616 genotype."
  },
  {
    "text": "The CYP2B66 Allele changes how Ketamine is metabolized in the body .",
    "triple_list": [
      [
        "CYP2B66",
        "CPR:9",
        "Ketamine"
      ]
    ],
    "updated": "Yes",
    "original": "The CYP2B66 Allele Significantly Alters the Ndemethylation of Ketamine Enantiomers In Vitro",
    "simplified": "The CYP2B66 Allele changes how Ketamine is metabolized in the body."
  },
  {
    "text": "Ketamine is primarily metabolized to norketamine by hepatic cytochrome P450 CYP 2B6 and CYP3A4 mediated Ndemethylation",
    "triple_list": [
      [
        "Ketamine",
        "CPR:9",
        "cytochrome P450 CYP 2B6"
      ],
      [
        "Ketamine",
        "CPR:9",
        "CYP3A4"
      ]
    ],
    "updated": "No",
    "original": "Ketamine is primarily metabolized to norketamine by hepatic cytochrome P450 CYP 2B6 and CYP3A4 mediated Ndemethylation",
    "simplified": "Ketamine and norketamine are metabolized in the liver by cytochrome P450 and CYP3A4 to form ketamine and norketamine."
  },
  {
    "text": "These results indicate a major role of CYP2B6 in the metabolism of ketamine in vitro and a significant impact of the CYP2B66 allele on the metabolism of ketamine .",
    "triple_list": [
      [
        "CYP2B6",
        "CPR:9",
        "ketamine"
      ],
      [
        "ketamine",
        "CPR:9",
        "CYP2B66"
      ]
    ],
    "updated": "Yes",
    "original": "These results indicate a major role of CYP2B6 in ketamine Ndemethylation in vitro and a significant impact of the CYP2B66 allele on enzyme ketamine binding and catalytic activity",
    "simplified": "These results indicate a major role of CYP2B6 in the metabolism of ketamine in vitro and a significant impact of the CYP2B66 allele on the metabolism of ketamine."
  },
  {
    "text": "The CYP2B66 allele is associated with reduced enzyme activity and expression . This may cause different people to take different ketamine .",
    "triple_list": [
      [
        "CYP2B66",
        "CPR:9",
        "ketamine"
      ]
    ],
    "updated": "Yes",
    "original": "The CYP2B66 allele is associated with reduced enzyme expression and activity that may lead to interindividual variability in ketamine metabolism",
    "simplified": "The CYP2B66 allele is associated with reduced enzyme activity and expression. This may cause different people to take different ketamine."
  },
  {
    "text": "We examined the ndemethylation of individual ketamine enantiomers using human liver microsomes HLMs genotyped for the CYP2B66 allele . COS1 cell expressed recombinant CYP2B61 and CYP2B66 protein and human liver microsomes HLMs genotyped for the CYP2B66 allele .",
    "triple_list": [
      [
        "ketamine",
        "CPR:9",
        "CYP2B66"
      ]
    ],
    "updated": "Yes",
    "original": "We examined the Ndemethylation of individual ketamine enantiomers using human liver microsomes HLMs genotyped for the CYP2B66 allele insect cell expressed recombinant CYP2B6 and CYP3A4 enzymes and COS1 cell expressed recombinant CYP2B61 and CYP2B66 protein variant",
    "simplified": "We examined the ndemethylation of individual ketamine enantiomers using human liver microsomes HLMs genotyped for the CYP2B66 allele. COS1 cell expressed recombinant CYP2B61 and CYP2B66 protein and human liver microsomes HLMs genotyped for the CYP2B66 allele."
  },
  {
    "text": "PURPOSE Testosteronetoestradiol ratio levels in infertile men improve when testolactone is given . This is because the aromatase inhibitor is removed .",
    "triple_list": [
      [
        "aromatase",
        "CPR:4",
        "testolactone"
      ]
    ],
    "updated": "Yes",
    "original": "PURPOSE Testosteronetoestradiol ratio levels in infertile men improve during treatment with the aromatase inhibitor testolactone and resulting changes in semen parameters",
    "simplified": " PURPOSE Testosteronetoestradiol ratio levels in infertile men improve when testolactone is given. This is because the aromatase inhibitor is removed."
  },
  {
    "text": "We evaluated the effect of anastrozole a more selective aromatase inhibitor on the hormonal and semen profiles of infertile men with abnormal baseline testosteronetoestradiol ratios",
    "triple_list": [
      [
        "anastrozole",
        "CPR:4",
        "aromatase"
      ]
    ],
    "updated": "No",
    "original": "We evaluated the effect of anastrozole a more selective aromatase inhibitor on the hormonal and semen profiles of infertile men with abnormal baseline testosteronetoestradiol ratios",
    "simplified": "Anastrozole, a more selective aromatase inhibitor, had an effect on the hormonal and semen profiles of infertile men with abnormal baseline testosteronetoestradiol levels."
  },
  {
    "text": "The results show that CYP2E1 inhibits the CYP2B4-mediated benzphetamine ( BNZ ) metabolism .",
    "triple_list": [
      [
        "CYP2B4",
        "CPR:9",
        "benzphetamine"
      ],
      [
        "CYP2B4",
        "CPR:9",
        "BNZ"
      ]
    ],
    "updated": "Yes",
    "original": "The results show that CYP2E1 inhibits CYP2B4 mediated metabolism of benzphetamine BNZ with a Ki of 004 \u00b5M",
    "simplified": "The results show that CYP2E1 inhibits the CYP2B4-mediated benzphetamine (BNZ) metabolism."
  },
  {
    "text": "However CYP2B4 is not an inhibitor of CYP2E1 mediated pnitrophenol hydroxylation",
    "triple_list": [
      [
        "CYP2E1",
        "CPR:9",
        "pnitrophenol"
      ]
    ],
    "updated": "No",
    "original": "However CYP2B4 is not an inhibitor of CYP2E1 mediated pnitrophenol hydroxylation",
    "simplified": "CYP2E1 and CYP2B4 work together to make nitrophenol hydroxylation."
  },
  {
    "text": "To explore for the existence of an auxiliary hydrophobic binding register remote from the active site of PSMA a series of phenylalkylphosphonamidate derivatives of glutamic acid were synthesized and evaluated for their inhibitory potencies against PSMA",
    "triple_list": [
      [
        "PSMA",
        "CPR:4",
        "phenylalkylphosphonamidate"
      ],
      [
        "PSMA",
        "CPR:4",
        "glutamic acid"
      ]
    ],
    "updated": "No",
    "original": "To explore for the existence of an auxiliary hydrophobic binding register remote from the active site of PSMA a series of phenylalkylphosphonamidate derivatives of glutamic acid were synthesized and evaluated for their inhibitory potencies against PSMA",
    "simplified": "To explore for the existence of an auxiliary hydrophobic binding register remote from the active site of PSMA a series of glutamic acid derivatives were synthesized and evaluated for their inhibitory effects against the PSMA."
  },
  {
    "text": "In PFC DEX caused activation of AKT and enhanced Bcl2 Bax protein ratio as well as translocation of Bcl2 to mitochondria .",
    "triple_list": [
      [
        "DEX",
        "CPR:3",
        "AKT"
      ],
      [
        "DEX",
        "CPR:3",
        "Bcl2"
      ],
      [
        "DEX",
        "CPR:3",
        "Bcl2"
      ],
      [
        "DEX",
        "CPR:3",
        "Bax"
      ]
    ],
    "updated": "Yes",
    "original": "In PFC DEX caused activation of AKT augmentation of prosurvival Bcl2 protein and enhanced Bcl2 Bax protein ratio as well Bcl2 translocation to mitochondria",
    "simplified": "In PFC DEX caused activation of AKT and enhanced Bcl2 Bax protein ratio as well as translocation of Bcl2 to mitochondria."
  },
  {
    "text": "Results of RTPCR analysis showed decrease of p53 mRNA level and no significant difference in Bcl2 and Bax mRNA expressions in DEX treated rats",
    "triple_list": [
      [
        "p53",
        "CPR:4",
        "DEX"
      ]
    ],
    "updated": "No",
    "original": "Results of RTPCR analysis showed decrease of p53 mRNA level and no significant difference in Bcl2 and Bax mRNA expressions in DEX treated rats",
    "simplified": "RTPCR analysis showed no significant difference in p53 mRNA level and no significant difference in Bcl2 and Bax mRNA levels."
  },
  {
    "text": "Antitumor activity of sorafenib in FLT3 driven leukemic cells",
    "triple_list": [
      [
        "sorafenib",
        "CPR:4",
        "FLT3"
      ]
    ],
    "updated": "No",
    "original": "Antitumor activity of sorafenib in FLT3 driven leukemic cells",
    "simplified": "The effects of sorafenib on leukemic cells and tumors"
  },
  {
    "text": "The demonstration that sorafenib is effective in the treatment of FLT3 driven leukemias suggests that this compound may have a therapeutic benefit for patients with FLT3 driven leukemias .",
    "triple_list": [
      [
        "sorafenib",
        "CPR:4",
        "FLT3"
      ],
      [
        "sorafenib",
        "CPR:4",
        "FLT3"
      ]
    ],
    "updated": "Yes",
    "original": "The demonstration that sorafenib exhibits potent target inhibition and efficacy in FLT3driven models suggests that this compound may have a therapeutic benefit for patients with FLT3 driven leukemias",
    "simplified": "The demonstration that sorafenib is effective in the treatment of FLT3 driven leukemias suggests that this compound may have a therapeutic benefit for patients with FLT3 driven leukemias."
  },
  {
    "text": "We show that sorafenib BAY 439006 Nexavar potently inhibits FLT3 enzymatic and signaling activities",
    "triple_list": [
      [
        "sorafenib",
        "CPR:4",
        "FLT3"
      ],
      [
        "BAY 439006",
        "CPR:4",
        "FLT3"
      ],
      [
        "Nexavar",
        "CPR:4",
        "FLT3"
      ]
    ],
    "updated": "No",
    "original": "We show that sorafenib BAY 439006 Nexavar potently inhibits FLT3 enzymatic and signaling activities",
    "simplified": "We show that sorafenib BAY 439006 inhibits FLT3 enzymatic and signaling activities."
  },
  {
    "text": "In HEK293 cells stably transfected with FLT3 WT or FLT3 ITD sorafenib blocked basal and ligand dependent FLT3 mediated tyrosine autophosphorylation as well as extracellular signalregulated kinase12 and Stat5 phosphorylation",
    "triple_list": [
      [
        "FLT3",
        "CPR:4",
        "sorafenib"
      ],
      [
        "sorafenib",
        "CPR:4",
        "extracellular signalregulated kinase12"
      ],
      [
        "sorafenib",
        "CPR:4",
        "Stat5"
      ]
    ],
    "updated": "No",
    "original": "In HEK293 cells stably transfected with FLT3 WT or FLT3 ITD sorafenib blocked basal and ligand dependent FLT3 mediated tyrosine autophosphorylation as well as extracellular signalregulated kinase12 and Stat5 phosphorylation",
    "simplified": "In HEK293 cells stably transfected with FLT3 WT or FLT3 ITD sorafenib blocked FLT3 mediated tyrosine autophosphorylation as well as extracellular signal-regulated kinase12 and Stat5 in the absence of FLT3."
  },
  {
    "text": "In leukemia cell lines MV411 and EOL1 sorafenib treatment resulted in decreased cell proliferation and inhibition of FLT3 signaling",
    "triple_list": [
      [
        "sorafenib",
        "CPR:4",
        "FLT3"
      ]
    ],
    "updated": "No",
    "original": "In leukemia cell lines MV411 and EOL1 sorafenib treatment resulted in decreased cell proliferation and inhibition of FLT3 signaling",
    "simplified": "In leukemia cell lines, sorafenib treatment (MV411 and EOL1) did not work. However, it did not cause cell death."
  },
  {
    "text": "The growth of the FLT3 independent RS411 cell line did not stop when sorafenib was used .",
    "triple_list": [
      [
        "FLT3",
        "CPR:4",
        "sorafenib"
      ]
    ],
    "updated": "Yes",
    "original": "The growth of the FLT3 independent RS411 cell line was only weakly inhibited by sorafenib",
    "simplified": "The growth of the FLT3 independent RS411 cell line did not stop when sorafenib was used."
  },
  {
    "text": "The DBDCT increased the expression of Bax and decreased the expression of Bcl2 . The ratio of Bax to Bcl2 was increased .",
    "triple_list": [
      [
        "DBDCT",
        "CPR:3",
        "Bax"
      ],
      [
        "DBDCT",
        "CPR:3",
        "Bcl2"
      ],
      [
        "DBDCT",
        "CPR:3",
        "Bax"
      ],
      [
        "DBDCT",
        "CPR:4",
        "Bcl2"
      ]
    ],
    "updated": "Yes",
    "original": "DBDCT upregulated the expression of Bax downregulated the expression of Bcl2 and significantly increased the ratio of BaxBcl2",
    "simplified": "The DBDCT increased the expression of Bax and decreased the expression of Bcl2. The ratio of Bax to Bcl2 was increased."
  },
  {
    "text": "DBDCT also changes the level of JNK and p38 MAPK .",
    "triple_list": [
      [
        "DBDCT",
        "CPR:3",
        "JNK"
      ],
      [
        "DBDCT",
        "CPR:3",
        "p38"
      ],
      [
        "DBDCT",
        "CPR:3",
        "MAPK"
      ]
    ],
    "updated": "Yes",
    "original": "DBDCT also caused the phosphorylation of JNK and p38 MAPK",
    "simplified": "DBDCT also changes the level of JNK and p38 MAPK."
  },
  {
    "text": "Aliskiren is the first drug in a new class of drugs that can block renin . It can be used to treat hypertension and other diseases .",
    "triple_list": [
      [
        "Aliskiren",
        "CPR:4",
        "renin"
      ]
    ],
    "updated": "Yes",
    "original": "Aliskiren represents the first in a novel class of renin inhibitors with the potential for treatment of hypertension and related cardiovascular diseases",
    "simplified": "Aliskiren is the first drug in a new class of drugs that can block renin. It can be used to treat hypertension and other diseases."
  },
  {
    "text": "This led to the discovery of aliskiren . Aliskiren is a very good inhibitor of human renin in vitro and in people . When people take aliskiren every day , their blood pressure goes down and they have less blood pressure .",
    "triple_list": [
      [
        "aliskiren",
        "CPR:4",
        "human renin"
      ],
      [
        "aliskiren",
        "CPR:4",
        "renin"
      ]
    ],
    "updated": "Yes",
    "original": "This led to the discovery of aliskiren a highly potent and selective inhibitor of human renin in vitro and in vivo oncedaily oral doses of aliskiren inhibit renin and lower blood pressure in sodiumdepleted marmosets and hypertensive human patients",
    "simplified": "This led to the discovery of aliskiren. Aliskiren is a very good inhibitor of human renin in vitro and in people. When people take aliskiren every day, their blood pressure goes down and they have less blood pressure."
  },
  {
    "text": "Structurebased design of aliskiren a novel orally effective renin inhibitor",
    "triple_list": [
      [
        "aliskiren",
        "CPR:4",
        "renin"
      ]
    ],
    "updated": "No",
    "original": "Structurebased design of aliskiren a novel orally effective renin inhibitor",
    "simplified": "Aliskiren, a novel orally effective drug-like structure."
  },
  {
    "text": "A phase III randomized placebocontrolled trial has examined the impact of everolimus in patients with clear cell renal cancers and progressive disease on or within 6 months of the VEGFR tyrosine kinase inhibitors sunitinib andor sorafenib",
    "triple_list": [
      [
        "VEGFR",
        "CPR:4",
        "sorafenib"
      ],
      [
        "tyrosine kinase",
        "CPR:4",
        "sorafenib"
      ],
      [
        "VEGFR",
        "CPR:4",
        "sunitinib"
      ],
      [
        "tyrosine kinase",
        "CPR:4",
        "sunitinib"
      ]
    ],
    "updated": "No",
    "original": "A phase III randomized placebocontrolled trial has examined the impact of everolimus in patients with clear cell renal cancers and progressive disease on or within 6 months of the VEGFR tyrosine kinase inhibitors sunitinib andor sorafenib",
    "simplified": "A phase III randomized placebocontrolled trial has examined the impact of everolimus on patients with advanced renal cancer on or within 6 months of the anti-angiogenic drugs sunitinib and/or sorafenib."
  },
  {
    "text": "Everolimus RAD001 AfinitorR Novartis is the first oral inhibitor of mTOR mammalian target of rapamycin to reach the oncology clinic",
    "triple_list": [
      [
        "Everolimus",
        "CPR:4",
        "mTOR"
      ],
      [
        "Everolimus",
        "CPR:4",
        "mammalian target of rapamycin"
      ],
      [
        "RAD001",
        "CPR:4",
        "mTOR"
      ],
      [
        "RAD001",
        "CPR:4",
        "mammalian target of rapamycin"
      ],
      [
        "AfinitorR Novartis",
        "CPR:4",
        "mTOR"
      ],
      [
        "AfinitorR Novartis",
        "CPR:4",
        "mammalian target of rapamycin"
      ]
    ],
    "updated": "No",
    "original": "Everolimus RAD001 AfinitorR Novartis is the first oral inhibitor of mTOR mammalian target of rapamycin to reach the oncology clinic",
    "simplified": "Everolimus RAD001 AfinitorR Novartis is the first oral drug to reach the oncology clinic in Europe."
  },
  {
    "text": "Synthesis and structureactivity relationship of pyripyropene A derivatives as potent and selective acylCoAcholesterol acyltransferase 2 ACAT2 inhibitors Part 2",
    "triple_list": [
      [
        "pyripyropene A",
        "CPR:4",
        "acylCoAcholesterol acyltransferase 2"
      ],
      [
        "pyripyropene A",
        "CPR:4",
        "ACAT2"
      ]
    ],
    "updated": "No",
    "original": "Synthesis and structureactivity relationship of pyripyropene A derivatives as potent and selective acylCoAcholesterol acyltransferase 2 ACAT2 inhibitors Part 2",
    "simplified": "Pyripyropene A can be used as a potent and selective acylCoAcholesterol acyltransferase 2 (ACAT2) inhibitor in certain situations."
  },
  {
    "text": "These proteins may be involved in dihydropyridinesensitive Ca2 currents and in other signal transduction pathways . They may also be involved in the adrenaline induced inhibition of insulin secretion .",
    "triple_list": [
      [
        "adrenaline",
        "CPR:4",
        "insulin"
      ]
    ],
    "updated": "Yes",
    "original": "These Gproteins are likely to be involved in the adrenalineinduced inhibition of dihydropyridinesensitive Ca2 currents and in other signal transduction pathways contributing to the adrenaline induced inhibition of insulin secretion",
    "simplified": "These proteins may be involved in dihydropyridinesensitive Ca2 currents and in other signal transduction pathways. They may also be involved in the adrenaline induced inhibition of insulin secretion."
  },
  {
    "text": "Somatostatin also inhibits insulin production , but it does not do this very well .",
    "triple_list": [
      [
        "Somatostatin",
        "CPR:4",
        "insulin"
      ]
    ],
    "updated": "Yes",
    "original": "Somatostatin which also inhibits insulin secretion was less efficient inhibition by 20",
    "simplified": "Somatostatin also inhibits insulin production, but it does not do this very well."
  },
  {
    "text": "Adrenaline inhibits the production of insulin ; this is pertussis .",
    "triple_list": [
      [
        "Adrenaline",
        "CPR:4",
        "insulin"
      ]
    ],
    "updated": "Yes",
    "original": "Adrenaline inhibits insulin secretion via pertussis toxinsensitive mechanisms",
    "simplified": "Adrenaline inhibits the production of insulin; this is pertussis."
  },
  {
    "text": "In contrast to adrenaline and somatostatin galanin another inhibitor of insulin secretion reduced Ca2 currents by about 40 perchlorate per second .",
    "triple_list": [
      [
        "adrenaline",
        "CPR:4",
        "insulin"
      ],
      [
        "somatostatin",
        "CPR:4",
        "insulin"
      ]
    ],
    "updated": "Yes",
    "original": "In contrast to adrenaline and somatostatin galanin another inhibitor of insulin secretion reduced Ca2 currents by about 40 in a pertussis toxininsensitive manner",
    "simplified": "In contrast to adrenaline and somatostatin galanin another inhibitor of insulin secretion reduced Ca2 currents by about 40 perchlorate per second."
  },
  {
    "text": "Synthesis and in Vitro Characterisation of Ifenprodil Based Fluorescein Conjugates as GluN1 GluN2B NMethylDaspartate Receptor Antagonists",
    "triple_list": [
      [
        "Ifenprodil",
        "CPR:6",
        "GluN1"
      ],
      [
        "Ifenprodil",
        "CPR:6",
        "GluN2B"
      ],
      [
        "Ifenprodil",
        "CPR:6",
        "NMethylDaspartate Receptor"
      ],
      [
        "Fluorescein",
        "CPR:6",
        "GluN1"
      ],
      [
        "Fluorescein",
        "CPR:6",
        "GluN2B"
      ],
      [
        "Fluorescein",
        "CPR:6",
        "NMethylDaspartate Receptor"
      ]
    ],
    "updated": "No",
    "original": "Synthesis and in Vitro Characterisation of Ifenprodil Based Fluorescein Conjugates as GluN1 GluN2B NMethylDaspartate Receptor Antagonists",
    "simplified": "Fluorescein is a chemical compound. Its chemical formula is GluN1 GluN2B It works as an NMethylDaspartate Receptor."
  },
  {
    "text": "Ifenprodil , also known as GluNR2B , was chosen as the reference drug for further investigation .",
    "triple_list": [
      [
        "Ifenprodil",
        "CPR:6",
        "GluNR2B"
      ]
    ],
    "updated": "Yes",
    "original": "Ifenprodil known as the GluNR2B antagonist of reference was chosen as the template for the elaboration of probes",
    "simplified": "Ifenprodil, also known as GluNR2B, was chosen as the reference drug for further investigation."
  },
  {
    "text": "Interestingly a Val349 to Ile mutant was inhibited with equal potency to human COX2 with 26dichloro 26dimethyl or 2chloro6methyl substituted inhibitors and in the case of lumiracoxib actually showed an increase in potency",
    "triple_list": [
      [
        "Val349 to Ile",
        "CPR:4",
        "26dichloro"
      ],
      [
        "human COX2",
        "CPR:4",
        "26dichloro"
      ],
      [
        "Val349 to Ile",
        "CPR:4",
        "26dimethyl"
      ],
      [
        "human COX2",
        "CPR:4",
        "26dimethyl"
      ],
      [
        "Val349 to Ile",
        "CPR:4",
        "2chloro6methyl"
      ],
      [
        "human COX2",
        "CPR:4",
        "2chloro6methyl"
      ],
      [
        "Val349 to Ile",
        "CPR:4",
        "lumiracoxib"
      ],
      [
        "human COX2",
        "CPR:4",
        "lumiracoxib"
      ]
    ],
    "updated": "No",
    "original": "Interestingly a Val349 to Ile mutant was inhibited with equal potency to human COX2 with 26dichloro 26dimethyl or 2chloro6methyl substituted inhibitors and in the case of lumiracoxib actually showed an increase in potency",
    "simplified": "Interestingly a Val349 to Ile mutant was inhibited with equal potency to human COX2 with 26dichloro 26dimethyl or 2chloro6methyl substituted inhibitors. This is because 26dichloro 26dimethyl is very common in nature."
  },
  {
    "text": "Taken together with a recent crystal structure of a lumiracoxibCOX2 complex the kinetic analyses presented herein of the inhibition of mutant COX2s by lumiracoxib allows the definition of the molecular basis of COX2 inhibition",
    "triple_list": [
      [
        "lumiracoxib",
        "CPR:4",
        "COX2s"
      ]
    ],
    "updated": "No",
    "original": "Taken together with a recent crystal structure of a lumiracoxibCOX2 complex the kinetic analyses presented herein of the inhibition of mutant COX2s by lumiracoxib allows the definition of the molecular basis of COX2 inhibition",
    "simplified": "Taken together with a recent crystal structure of a lumiracoxibCOX2 complex, the kinetic analyses presented herein allow the definition of the molecular basis of COX2 inhibition and the role of lumiracoxib."
  },
  {
    "text": "Using standard assays lumiracoxib was found to be a poor inhibitor of purified ovine COX1 and a relatively weak inhibitor of purified human COX2",
    "triple_list": [
      [
        "lumiracoxib",
        "CPR:4",
        "ovine COX1"
      ],
      [
        "lumiracoxib",
        "CPR:4",
        "human COX2"
      ]
    ],
    "updated": "No",
    "original": "Using standard assays lumiracoxib was found to be a poor inhibitor of purified ovine COX1 and a relatively weak inhibitor of purified human COX2",
    "simplified": "Using standard tests, lumiracoxib was found to be a poor inhibitor of human COX1 and a weak inhibitor of human COX2."
  },
  {
    "text": "Kinetic studies with lumiracoxib showed that it could bind to human COX2 very well . It also showed that it took at least two steps to bind to it .",
    "triple_list": [
      [
        "lumiracoxib",
        "CPR:4",
        "human COX2"
      ]
    ],
    "updated": "Yes",
    "original": "Kinetic studies with lumiracoxib demonstrated that it was a timedependent and slowly reversible inhibitor of human COX2 that exhibited at least two binding steps during inhibition",
    "simplified": "Kinetic studies with lumiracoxib showed that it could bind to human COX2 very well. It also showed that it took at least two steps to bind to it."
  },
  {
    "text": "Lumiracoxib is the first marketed COX2 inhibitor of the arylacetic acid class . It has been shown to work in animal studies .",
    "triple_list": [
      [
        "COX2",
        "CPR:4",
        "arylacetic acid"
      ],
      [
        "Lumiracoxib",
        "CPR:4",
        "COX2"
      ]
    ],
    "updated": "Yes",
    "original": "Lumiracoxib is the first example of a marketed COX2 inhibitor of the arylacetic acid class and it is reported to be the most selective COXIB in vivo",
    "simplified": "Lumiracoxib is the first marketed COX2 inhibitor of the arylacetic acid class. It has been shown to work in animal studies."
  },
  {
    "text": "Inhibition studies have shown that the methyl group on the phenylacetic acid ring must be changed to make COX2 .",
    "triple_list": [
      [
        "methyl",
        "CPR:4",
        "COX2"
      ],
      [
        "phenylacetic acid",
        "CPR:4",
        "COX2"
      ]
    ],
    "updated": "Yes",
    "original": "Inhibition studies demonstrated that the methyl group on the phenylacetic acid ring is required for COX2 selectivity",
    "simplified": "Inhibition studies have shown that the methyl group on the phenylacetic acid ring must be changed to make COX2."
  },
  {
    "text": "Molecular determinants for the selective inhibition of cyclooxygenase2 by lumiracoxib",
    "triple_list": [
      [
        "cyclooxygenase2",
        "CPR:4",
        "lumiracoxib"
      ]
    ],
    "updated": "No",
    "original": "Molecular determinants for the selective inhibition of cyclooxygenase2 by lumiracoxib",
    "simplified": "Molecular determinants for the development of cancer-fighting drugs."
  },
  {
    "text": "The chemical identity and position of the substituents on the lower aniline ring were important in how well it could inhibit COX . The amount of COX that was inhibited was also important .",
    "triple_list": [
      [
        "aniline",
        "CPR:4",
        "COX"
      ]
    ],
    "updated": "Yes",
    "original": "The chemical identity and position of the substituents on the lower aniline ring were important in determining the potency and extent of COX inhibition as well as COX2 selectivity",
    "simplified": "The chemical identity and position of the substituents on the lower aniline ring were important in how well it could inhibit COX. The amount of COX that was inhibited was also important."
  },
  {
    "text": "Mutation of Ser530 to Ala or Val349 to Ala or Leu abolished the potent inhibition observed with wildtype human COX2 and key lumiracoxib analogs",
    "triple_list": [
      [
        "human COX2",
        "CPR:4",
        "lumiracoxib"
      ]
    ],
    "updated": "No",
    "original": "Mutation of Ser530 to Ala or Val349 to Ala or Leu abolished the potent inhibition observed with wildtype human COX2 and key lumiracoxib analogs",
    "simplified": "Mutation of Ser530 to Ala or Val349 to Ala or Leu did not make the same effect, but it was not as strong as natural COX2."
  },
  {
    "text": "In addition , kinetic analysis showed that reserpine , a typical VMAT2 inhibitor , did not work at all . It did not work at all on dopamine .",
    "triple_list": [
      [
        "reserpine",
        "CPR:4",
        "VMAT2"
      ],
      [
        "VMAT2",
        "CPR:9",
        "dopamine"
      ]
    ],
    "updated": "Yes",
    "original": "Moreover kinetic analysis revealed that inhibition by reserpine a typical VMAT2 inhibitor was uncompetitive decreasing maximum velocity and affinity for dopamine",
    "simplified": "In addition, kinetic analysis showed that reserpine, a typical VMAT2 inhibitor, did not work at all. It did not work at all on dopamine."
  },
  {
    "text": "These results suggest that fluoxetine does not directly interact with the active site of VMAT2 , but rather acts on a different mechanism from that of reserpine .",
    "triple_list": [
      [
        "VMAT2",
        "CPR:4",
        "reserpine"
      ],
      [
        "fluoxetine",
        "CPR:4",
        "VMAT2"
      ],
      [
        "fluoxetine",
        "CPR:4",
        "VMAT2"
      ]
    ],
    "updated": "Yes",
    "original": "These results suggest that fluoxetine inhibited the activity of VMAT2 by a mechanism different from that of reserpine and did not directly interact with the active site of VMAT2",
    "simplified": "These results suggest that fluoxetine does not directly interact with the active site of VMAT2, but rather acts on a different mechanism from that of reserpine."
  },
  {
    "text": "The present study examined the effect of selective serotonin reuptake inhibitors ( SSRIs ) on VMAT2 activity by measuring the uptake of adenosine triphosphatedependent 3Hdopamine into synaptic vesicles in rats .",
    "triple_list": [
      [
        "VMAT2",
        "CPR:9",
        "3Hdopamine"
      ]
    ],
    "updated": "Yes",
    "original": "The present study examined the effect of antidepressants such as selective serotonin reuptake inhibitors SSRIs on VMAT2 activity by measuring adenosine triphosphatedependent 3Hdopamine uptake into synaptic vesicles prepared from rat striatum",
    "simplified": "The present study examined the effect of selective serotonin reuptake inhibitors (SSRIs) on VMAT2 activity by measuring the uptake of adenosine triphosphatedependent 3Hdopamine into synaptic vesicles in rats."
  },
  {
    "text": "In this study we examined whether betaxolol and other betaadrenoceptor antagonists interact directly with neurotoxin binding to Na channel in rat cerebrocortical synaptosomes .",
    "triple_list": [
      [
        "betaxolol",
        "CPR:6",
        "betaadrenoceptor"
      ]
    ],
    "updated": "Yes",
    "original": "In this study we examined whether betaxolol and other betaadrenoceptor antagonists interact directly with neurotoxin binding to sites 1 and 2 of the voltagesensitive sodium channel Na channel in rat cerebrocortical synaptosomes",
    "simplified": "In this study we examined whether betaxolol and other betaadrenoceptor antagonists interact directly with neurotoxin binding to Na channel in rat cerebrocortical synaptosomes."
  },
  {
    "text": "Betaxolol , a beta1adrenoceptor antagonist , is used in the treatment of glaucoma . It is also used in the treatment of ischaemia .",
    "triple_list": [
      [
        "Betaxolol",
        "CPR:6",
        "beta1adrenoceptor"
      ]
    ],
    "updated": "Yes",
    "original": "Betaxolol a beta1adrenoceptor antagonist used for the treatment of glaucoma is known to be neuroprotective in paradigms of ischaemiaexcitotoxicity",
    "simplified": "Betaxolol, a beta1adrenoceptor antagonist, is used in the treatment of glaucoma. It is also used in the treatment of ischaemia."
  },
  {
    "text": "Comparison of all the betaadrenoceptor antagonists tested revealed a potency order of propranolol betaxolol approximately levo betaxolol levobunolol approximately carteolol = timolol atenolol",
    "triple_list": [
      [
        "betaadrenoceptor",
        "CPR:6",
        "propranolol"
      ],
      [
        "betaadrenoceptor",
        "CPR:6",
        "betaxolol"
      ],
      [
        "betaadrenoceptor",
        "CPR:6",
        "levobunolol"
      ],
      [
        "betaadrenoceptor",
        "CPR:6",
        "carteolol"
      ],
      [
        "betaadrenoceptor",
        "CPR:6",
        "timolol"
      ],
      [
        "betaadrenoceptor",
        "CPR:6",
        "atenolol"
      ]
    ],
    "updated": "No",
    "original": "Comparison of all the betaadrenoceptor antagonists tested revealed a potency order of propranolol betaxolol approximately levo betaxolol levobunolol approximately carteolol = timolol atenolol",
    "simplified": "A comparison of all the betaadrenoceptor antagonists showed a potency order of propranolol = levo betaxolol = atenolol = carteolol = timolol atenolol approximately."
  },
  {
    "text": "Betaxolol a beta1adrenoceptor antagonist reduces Na influx into cortical synaptosomes by direct interaction with Na channels comparison with other betaadrenoceptor antagonists",
    "triple_list": [
      [
        "Betaxolol",
        "CPR:6",
        "beta1adrenoceptor"
      ],
      [
        "Betaxolol",
        "CPR:6",
        "betaadrenoceptor"
      ]
    ],
    "updated": "No",
    "original": "Betaxolol a beta1adrenoceptor antagonist reduces Na influx into cortical synaptosomes by direct interaction with Na channels comparison with other betaadrenoceptor antagonists",
    "simplified": "Betaxolol, a beta1adrenoceptor antagonist, reduces the amount of sodium in the brain by directly interacting with Na channels. This is called direct interaction."
  },
  {
    "text": "Leukotriene D4 induces cognitive impairment through enhancement of CysLT\u2081 R mediated amyloid\u03b2 generation in mice",
    "triple_list": [
      [
        "Leukotriene D4",
        "CPR:3",
        "CysLT\u2081 R"
      ],
      [
        "Leukotriene D4",
        "CPR:3",
        "amyloid\u03b2"
      ]
    ],
    "updated": "No",
    "original": "Leukotriene D4 induces cognitive impairment through enhancement of CysLT\u2081 R mediated amyloid\u03b2 generation in mice",
    "simplified": "Leukotriene D4 causes cognitive impairment in mice by interfering with the production of amyloid in the brain."
  },
  {
    "text": "Moreover LTD4 induced increases in CysLT1R and NF\u03baB p65 in the brain were also attenuated by pranlukast",
    "triple_list": [
      [
        "LTD4",
        "CPR:3",
        "CysLT1R"
      ],
      [
        "LTD4",
        "CPR:3",
        "NF\u03baB"
      ],
      [
        "LTD4",
        "CPR:3",
        "p65"
      ],
      [
        "CysLT1R",
        "CPR:4",
        "pranlukast"
      ],
      [
        "NF\u03baB",
        "CPR:4",
        "pranlukast"
      ],
      [
        "p65",
        "CPR:4",
        "pranlukast"
      ]
    ],
    "updated": "No",
    "original": "Moreover LTD4 induced increases in CysLT1R and NF\u03baB p65 in the brain were also attenuated by pranlukast",
    "simplified": "In addition, LTD4 increased CysLT1R and NF\u03baB p65 in the brain, but only for a short time."
  },
  {
    "text": "These results suggest that LTD4 increases A\u03b2 peptide burden by activating CysLT1R . This further affects the activity of the \u03b2 and \u03b3secretases by the NF\u03baB pathway .",
    "triple_list": [
      [
        "LTD4",
        "CPR:3",
        "A\u03b2 peptide"
      ],
      [
        "LTD4",
        "CPR:3",
        "CysLT1R"
      ]
    ],
    "updated": "Yes",
    "original": "These results suggest that LTD4 increases A\u03b2 peptide burden via activation of CysLT1R which further affects APP levels and activity of \u03b2 and \u03b3secretases via the NF\u03baB pathway",
    "simplified": "These results suggest that LTD4 increases A\u03b2 peptide burden by activating CysLT1R. This further affects the activity of the \u03b2 and \u03b3secretases by the NF\u03baB pathway."
  },
  {
    "text": "The results demonstrated that intracerebral infusions of LTD4 1 ngmouse produced memory impairment as determined by Morris water maze test and Ymaze test in mice and caused the accumulation of A\u03b2140 and A\u03b2142 in the hippocampus and cortex through increased activity of \u03b2 and \u03b3secretases accompanied with increased expression of amyloid precursor protein APP",
    "triple_list": [
      [
        "LTD4",
        "CPR:3",
        "A\u03b2140"
      ],
      [
        "LTD4",
        "CPR:3",
        "A\u03b2142"
      ],
      [
        "LTD4",
        "CPR:3",
        "amyloid precursor protein"
      ],
      [
        "LTD4",
        "CPR:3",
        "APP"
      ]
    ],
    "updated": "No",
    "original": "The results demonstrated that intracerebral infusions of LTD4 1 ngmouse produced memory impairment as determined by Morris water maze test and Ymaze test in mice and caused the accumulation of A\u03b2140 and A\u03b2142 in the hippocampus and cortex through increased activity of \u03b2 and \u03b3secretases accompanied with increased expression of amyloid precursor protein APP",
    "simplified": "The results demonstrated that intracerebral injections of LTD4 1 ngmouse produced memory impairment as determined by a Morris water maze test and Ymaze test in mice. The increased activity of \u03b2 and \u03b3secretases in the hippocampus and cortex was associated with increased expression of the amyloid precursor protein APP."
  },
  {
    "text": "LTD4 also induced expression of cysteinyl leukotriene receptor 1 CysLT1R and NF\u03baB p65 in the hippocampus and cortex",
    "triple_list": [
      [
        "LTD4",
        "CPR:3",
        "cysteinyl leukotriene receptor 1"
      ],
      [
        "LTD4",
        "CPR:3",
        "CysLT1R"
      ],
      [
        "LTD4",
        "CPR:3",
        "NF\u03baB"
      ],
      [
        "LTD4",
        "CPR:3",
        "p65"
      ]
    ],
    "updated": "No",
    "original": "LTD4 also induced expression of cysteinyl leukotriene receptor 1 CysLT1R and NF\u03baB p65 in the hippocampus and cortex",
    "simplified": "Ltd4 also made cysteinyl leukotriene receptor 1 (CysLT1R) become active in the brain, in the hippocampus."
  },
  {
    "text": "Pretreatment with pranlukast 15 ngmouse intracerebroventricularly a CysLT1R antagonist blocked the effects of LTD4 on memory .",
    "triple_list": [
      [
        "pranlukast",
        "CPR:6",
        "CysLT1R"
      ]
    ],
    "updated": "Yes",
    "original": "Pretreatment with pranlukast 15 ngmouse intracerebroventricularly a CysLT1R antagonist blocked LTD4induced amyloidogenesis memory deficits",
    "simplified": "Pretreatment with pranlukast 15 ngmouse intracerebroventricularly a CysLT1R antagonist blocked the effects of LTD4 on memory."
  },
  {
    "text": "Statins increase p21 by inhibiting histone deacetylase . They also release a chemical called HDAC12 .",
    "triple_list": [
      [
        "Statins",
        "CPR:3",
        "HDAC12"
      ],
      [
        "Statins",
        "CPR:3",
        "p21"
      ],
      [
        "Statins",
        "CPR:4",
        "histone deacetylase"
      ]
    ],
    "updated": "Yes",
    "original": "Statins increase p21 through inhibition of histone deacetylase activity and release of promoterassociated HDAC12",
    "simplified": "Statins increase p21 by inhibiting histone deacetylase. They also release a chemical called HDAC12."
  },
  {
    "text": "Statins are 3hydroxy3methylglutarylCoA reductase inhibitors . They are used to control cholesterol .",
    "triple_list": [
      [
        "Statins",
        "CPR:4",
        "3hydroxy3methylglutarylCoA reductase"
      ]
    ],
    "updated": "Yes",
    "original": "Statins are 3hydroxy3methylglutarylCoA reductase inhibitors broadly used for the control of hypercholesterolemia",
    "simplified": "Statins are 3hydroxy3methylglutarylCoA reductase inhibitors. They are used to control cholesterol."
  },
  {
    "text": "In an enzymatic test , lovastatin was shown to inhibit HDAC2 activity . The Ki value of this test was 316 micromolL .",
    "triple_list": [
      [
        "lovastatin",
        "CPR:4",
        "HDAC2"
      ]
    ],
    "updated": "Yes",
    "original": "In the subsequent enzymatic assay it was shown that lovastatin inhibited HDAC2 activity competitively with a Ki value of 316 micromolL",
    "simplified": "In an enzymatic test, lovastatin was shown to inhibit HDAC2 activity. The Ki value of this test was 316 micromolL."
  },
  {
    "text": "Imatinib was also found to inhibit MCSF induced osteoclast survival as well as MCSF induced osteoclast bone resorbing activity but was without effect on interleukin 1alpha IL1alpha and receptor activator of nuclear factor kappa B ligand RANKLinduced inhibition of osteoclasts , suggesting that imatinib may affect mature osteoclasts through the inhibition of cFMS .",
    "triple_list": [
      [
        "imatinib",
        "CPR:4",
        "cFMS"
      ],
      [
        "Imatinib",
        "CPR:4",
        "MCSF"
      ],
      [
        "Imatinib",
        "CPR:4",
        "MCSF"
      ]
    ],
    "updated": "Yes",
    "original": "Imatinib was also found to inhibit MCSF induced osteoclast survival as well as MCSF induced osteoclast bone resorbing activity but was without effect on interleukin 1alpha IL1alpha and receptor activator of nuclear factor kappa B ligand RANKLinduced inhibition of osteoclasts apoptosis further supporting the hypothesis that imatinib may affect mature osteoclasts through the inhibition of cFMS",
    "simplified": "Imatinib was also found to inhibit MCSF induced osteoclast survival as well as MCSF induced osteoclast bone resorbing activity but was without effect on interleukin 1alpha IL1alpha and receptor activator of nuclear factor kappa B ligand RANKLinduced inhibition of osteoclasts, suggesting that imatinib may affect mature osteoclasts through the inhibition of cFMS."
  },
  {
    "text": "Recent studies have reported that imatinib mesylate a kinase inhibitor that targets the intracellular tyrosine kinase BCR ABL and the platelet derived growth factor PDGF receptor is an effective inhibitor of the macrophage colony stimulating factor MCSF receptor cFMS",
    "triple_list": [
      [
        "imatinib mesylate",
        "CPR:4",
        "tyrosine kinase"
      ],
      [
        "imatinib mesylate",
        "CPR:4",
        "BCR"
      ],
      [
        "imatinib mesylate",
        "CPR:4",
        "ABL"
      ],
      [
        "imatinib mesylate",
        "CPR:4",
        "platelet derived growth factor PDGF receptor"
      ],
      [
        "imatinib mesylate",
        "CPR:4",
        "macrophage colony stimulating factor MCSF receptor"
      ],
      [
        "imatinib mesylate",
        "CPR:4",
        "cFMS"
      ],
      [
        "imatinib mesylate",
        "CPR:4",
        "kinase"
      ]
    ],
    "updated": "No",
    "original": "Recent studies have reported that imatinib mesylate a kinase inhibitor that targets the intracellular tyrosine kinase BCR ABL and the platelet derived growth factor PDGF receptor is an effective inhibitor of the macrophage colony stimulating factor MCSF receptor cFMS",
    "simplified": "Recent studies have reported that imatinib mesylate is an effective inhibitor of the macrophage colony stimulating factor MCSF receptor cFMS and the platelet derived growth factor PDGF receptor. It also targets the intracellular tyrosine kinase."
  },
  {
    "text": "Since MCSF signalling through cFMS plays an important role in osteoclast biology , we thought it would be important to block this pathway with imatinib .",
    "triple_list": [
      [
        "MCSF",
        "CPR:4",
        "imatinib"
      ],
      [
        "cFMS",
        "CPR:4",
        "imatinib"
      ]
    ],
    "updated": "Yes",
    "original": "Given that MCSF signalling through cFMS plays an important role in osteoclast biology we speculated that blocking such a pathway with imatinib may modulate osteoclast activity",
    "simplified": "Since MCSF signalling through cFMS plays an important role in osteoclast biology, we thought it would be important to block this pathway with imatinib."
  },
  {
    "text": "We report here that lovastatin a drug clinically used for lowering cholesterol levels inhibits the interaction of human LFA1 with its counterreceptor intercellular adhesion molecule1",
    "triple_list": [
      [
        "lovastatin",
        "CPR:4",
        "human LFA1"
      ],
      [
        "lovastatin",
        "CPR:4",
        "intercellular adhesion molecule1"
      ]
    ],
    "updated": "No",
    "original": "We report here that lovastatin a drug clinically used for lowering cholesterol levels inhibits the interaction of human LFA1 with its counterreceptor intercellular adhesion molecule1",
    "simplified": "We report here that lovastatin, a drug used to lower cholesterol levels, inhibits the intercellular adhesion molecule1 (LFA1) interaction with its counterreceptor."
  },
  {
    "text": "The structural basis for LFA1 inhibition is the binding of lovastatin to CD11a .",
    "triple_list": [
      [
        "LFA1",
        "CPR:4",
        "lovastatin"
      ]
    ],
    "updated": "Yes",
    "original": "Structural basis for LFA1 inhibition upon lovastatin binding to the CD11a Idomain",
    "simplified": "The structural basis for LFA1 inhibition is the binding of lovastatin to CD11a."
  },
  {
    "text": "Especially the effects of doxycycline in clinical and experimental studies as a non selective MMP inhibitor .",
    "triple_list": [
      [
        "doxycycline",
        "CPR:4",
        "MMP"
      ]
    ],
    "updated": "Yes",
    "original": "Particularly the effects of doxycycline used as a non selective MMP inhibitor in experimental and clinical studies will be discussed",
    "simplified": "Especially the effects of doxycycline in clinical and experimental studies as a non selective MMP inhibitor."
  },
  {
    "text": "A single dose of DEXP showed a short-term increase in CYP3A activity in both tissues . At 12 h after DEXP was given , the induction ratios were highest .",
    "triple_list": [
      [
        "DEXP",
        "CPR:3",
        "CYP3A"
      ],
      [
        "DEXP",
        "CPR:3",
        "CYP3A"
      ]
    ],
    "updated": "Yes",
    "original": "Administration of a single dose of DEXP showed a temporal increase in CYP3A activity in both tissues and the induction ratios reached maximum values at 12 h after DEXP administration",
    "simplified": "A single dose of DEXP showed a short-term increase in CYP3A activity in both tissues. At 12 h after DEXP was given, the induction ratios were highest."
  },
  {
    "text": "Changes in cytochrome P450 3A induction in the liver after dexamethasone administration in rats",
    "triple_list": [
      [
        "cytochrome P450 3A",
        "CPR:3",
        "dexamethasone"
      ]
    ],
    "updated": "Yes",
    "original": "Timedependent changes in hepatic and intestinal induction of cytochrome P450 3A after administration of dexamethasone to rats",
    "simplified": "Changes in cytochrome P450 3A induction in the liver after dexamethasone administration in rats"
  },
  {
    "text": "We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A CYP3A in rats using dexamethasone 21phosphate DEXP and midazolam MDZ as an inducer and a substrate to CYP3A respectively",
    "triple_list": [
      [
        "cytochrome P450 3A",
        "CPR:3",
        "dexamethasone 21phosphate"
      ],
      [
        "CYP3A",
        "CPR:3",
        "dexamethasone 21phosphate"
      ],
      [
        "CYP3A",
        "CPR:3",
        "dexamethasone 21phosphate"
      ],
      [
        "cytochrome P450 3A",
        "CPR:3",
        "DEXP"
      ],
      [
        "CYP3A",
        "CPR:3",
        "DEXP"
      ],
      [
        "CYP3A",
        "CPR:3",
        "DEXP"
      ],
      [
        "CYP3A",
        "CPR:3",
        "midazolam"
      ],
      [
        "CYP3A",
        "CPR:3",
        "MDZ"
      ],
      [
        "CYP3A",
        "CPR:9",
        "dexamethasone 21phosphate"
      ],
      [
        "CYP3A",
        "CPR:9",
        "DEXP"
      ],
      [
        "cytochrome P450 3A",
        "CPR:9",
        "midazolam"
      ],
      [
        "CYP3A",
        "CPR:9",
        "midazolam"
      ],
      [
        "CYP3A",
        "CPR:9",
        "midazolam"
      ],
      [
        "CYP3A",
        "CPR:9",
        "MDZ"
      ],
      [
        "CYP3A",
        "CPR:9",
        "MDZ"
      ]
    ],
    "updated": "No",
    "original": "We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A CYP3A in rats using dexamethasone 21phosphate DEXP and midazolam MDZ as an inducer and a substrate to CYP3A respectively",
    "simplified": "We examined the effects of the dose of dexamethasone 21phosphate and the number of times an inducer was given and the duration of CYP3A induction in rats using dexamethasone 21phosphate DEXP and midazolam MDZ as an inducer and a substrate to CYP3A respectively."
  },
  {
    "text": "The level of CYP3A increased in the liver depending on the dose of DEXP . In the intestine , the level of CYP3A did not change depending on the dose of DEXP .",
    "triple_list": [
      [
        "CYP3A",
        "CPR:3",
        "DEXP"
      ],
      [
        "CYP3A",
        "CPR:3",
        "DEXP"
      ]
    ],
    "updated": "Yes",
    "original": "CYP3A induction in the liver increased depending on the dose of DEXP whereas that in intestine showed a mild increase but the induction level was almost constant regardless of the dose of DEXP",
    "simplified": "The level of CYP3A increased in the liver depending on the dose of DEXP. In the intestine, the level of CYP3A did not change depending on the dose of DEXP."
  },
  {
    "text": "LDH is responsible for pyruvate conversion to lactate through glycolysis",
    "triple_list": [
      [
        "LDH",
        "CPR:9",
        "pyruvate"
      ],
      [
        "LDH",
        "CPR:9",
        "lactate"
      ]
    ],
    "updated": "No",
    "original": "LDH is responsible for pyruvate conversion to lactate through glycolysis",
    "simplified": "LDH changes the glucose into lactate through glycolysis."
  },
  {
    "text": "PURPOSE Dasatinib BMS354825 a potent oral multitargeted kinase inhibitor against SRC and BCR ABL has recently been approved for the treatment of chronic myelogenous leukaemia CML in imatinibacquired resistance and intolerance",
    "triple_list": [
      [
        "Dasatinib",
        "CPR:4",
        "kinase"
      ],
      [
        "Dasatinib",
        "CPR:4",
        "SRC"
      ],
      [
        "Dasatinib",
        "CPR:4",
        "BCR"
      ],
      [
        "Dasatinib",
        "CPR:4",
        "ABL"
      ],
      [
        "BMS354825",
        "CPR:4",
        "kinase"
      ],
      [
        "BMS354825",
        "CPR:4",
        "SRC"
      ],
      [
        "BMS354825",
        "CPR:4",
        "BCR"
      ],
      [
        "BMS354825",
        "CPR:4",
        "ABL"
      ]
    ],
    "updated": "No",
    "original": "PURPOSE Dasatinib BMS354825 a potent oral multitargeted kinase inhibitor against SRC and BCR ABL has recently been approved for the treatment of chronic myelogenous leukaemia CML in imatinibacquired resistance and intolerance",
    "simplified": " PURPOSE Dasatinib BMS354825 a potent oral multitargeted kinase inhibitor against SRC and BCR has recently been approved for the treatment of sickle cell disease and sickle cell anemia"
  },
  {
    "text": "Preclinical pharmacokinetics and in vitro metabolism of dasatinib BMS354825 a potent oral multitargeted kinase inhibitor against SRC and BCR ABL",
    "triple_list": [
      [
        "dasatinib",
        "CPR:4",
        "kinase"
      ],
      [
        "dasatinib",
        "CPR:4",
        "SRC"
      ],
      [
        "dasatinib",
        "CPR:4",
        "BCR"
      ],
      [
        "dasatinib",
        "CPR:4",
        "ABL"
      ],
      [
        "BMS354825",
        "CPR:4",
        "kinase"
      ],
      [
        "BMS354825",
        "CPR:4",
        "SRC"
      ],
      [
        "BMS354825",
        "CPR:4",
        "BCR"
      ],
      [
        "BMS354825",
        "CPR:4",
        "ABL"
      ]
    ],
    "updated": "No",
    "original": "Preclinical pharmacokinetics and in vitro metabolism of dasatinib BMS354825 a potent oral multitargeted kinase inhibitor against SRC and BCR ABL",
    "simplified": "In vitro metabolism and pharmacokinetics of dasatinib BMS354825 a potent oral multitargeted kinase inhibitor against SRC and BCR"
  },
  {
    "text": "The results of this study suggest that noradrenaline mainly but not exclusively mediates the rat aorta contractions , and that an alphalDadrenoceptor is involved .",
    "triple_list": [
      [
        "noradrenaline",
        "CPR:3",
        "alphalDadrenoceptor"
      ]
    ],
    "updated": "Yes",
    "original": "The results of this study suggest that noradrenaline predominantly but not exclusively mediates contraction of rat aorta through the activation of an alphalDadrenoceptor",
    "simplified": "The results of this study suggest that noradrenaline mainly but not exclusively mediates the rat aorta contractions, and that an alphalDadrenoceptor is involved."
  },
  {
    "text": "An increase in the ADP ATP ratio opens KATP channels leading to membrane hyperpolarization",
    "triple_list": [
      [
        "ADP",
        "CPR:3",
        "KATP channels"
      ],
      [
        "ATP",
        "CPR:3",
        "KATP channels"
      ]
    ],
    "updated": "No",
    "original": "An increase in the ADP ATP ratio opens KATP channels leading to membrane hyperpolarization",
    "simplified": "When there is more ADP, KATP channels open. This causes membrane hyperpolarization."
  },
  {
    "text": "Comparison of the effect of rofecoxib a cyclooxygenase 2 inhibitor ibuprofen and placebo on the gastroduodenal mucosa of patients with osteoarthritis a randomized doubleblind placebocontrolled trial",
    "triple_list": [
      [
        "rofecoxib",
        "CPR:4",
        "cyclooxygenase 2"
      ]
    ],
    "updated": "No",
    "original": "Comparison of the effect of rofecoxib a cyclooxygenase 2 inhibitor ibuprofen and placebo on the gastroduodenal mucosa of patients with osteoarthritis a randomized doubleblind placebocontrolled trial",
    "simplified": "The effect of rofecoxib on the gastroduodenal mucosa of patients with osteoarthritis in a randomized doubleblind placebocontrolled trial was compared with placebo."
  },
  {
    "text": "OBJECTIVE This randomized doubleblind study tested the hypothesis that rofecoxib a drug that specifically inhibits cyclooxygenase 2 would cause fewer gastroduodenal ulcers than ibuprofen in a multicenter trial and its side effects would be equivalent to those of placebo in a prespecified analysis combining the results with another trial of identical design",
    "triple_list": [
      [
        "rofecoxib",
        "CPR:4",
        "cyclooxygenase 2"
      ]
    ],
    "updated": "No",
    "original": "OBJECTIVE This randomized doubleblind study tested the hypothesis that rofecoxib a drug that specifically inhibits cyclooxygenase 2 would cause fewer gastroduodenal ulcers than ibuprofen in a multicenter trial and its side effects would be equivalent to those of placebo in a prespecified analysis combining the results with another trial of identical design",
    "simplified": "OBJECTIVE This randomized doubleblind study tested the hypothesis that rofecoxib would cause fewer gastroduodenal ulcers than ibuprofen in a multicenter trial and its side effects would be equivalent to those of placebo in a prespecified analysis combining the results with another trial of identical design."
  },
  {
    "text": "Huperzine A Hup A is a naturally occurring drug . It is a powerful AChE inhibitor in the blood .",
    "triple_list": [
      [
        "Huperzine A",
        "CPR:4",
        "AChE"
      ],
      [
        "Hup A",
        "CPR:4",
        "AChE"
      ]
    ],
    "updated": "Yes",
    "original": "Huperzine A Hup A is a naturally occurring potent reversible AChE inhibitor that penetrates the bloodbrain barrier",
    "simplified": "Huperzine A Hup A is a naturally occurring drug. It is a powerful AChE inhibitor in the blood."
  },
  {
    "text": "The synthetic stereoisomer Hup A is less toxic due to poor AChE inhibition . It can be used to treat nerve agent toxicity as well .",
    "triple_list": [
      [
        "Hup A",
        "CPR:4",
        "AChE"
      ]
    ],
    "updated": "Yes",
    "original": "The synthetic stereoisomer Hup A is less toxic due to poor AChE inhibition and is suitable for both prepostexposure treatments of nerve agent toxicity",
    "simplified": "The synthetic stereoisomer Hup A is less toxic due to poor AChE inhibition. It can be used to treat nerve agent toxicity as well."
  },
  {
    "text": "In addition vinblastine induces the DNAbinding activities of the transcription factor NF\u03baB HSF1 AP1 and ATF2 together with the expression of HSP70 and Bax proteins",
    "triple_list": [
      [
        "vinblastine",
        "CPR:3",
        "NF\u03baB"
      ],
      [
        "vinblastine",
        "CPR:3",
        "HSF1"
      ],
      [
        "vinblastine",
        "CPR:3",
        "AP1"
      ],
      [
        "vinblastine",
        "CPR:3",
        "ATF2"
      ],
      [
        "vinblastine",
        "CPR:3",
        "HSP70"
      ],
      [
        "vinblastine",
        "CPR:3",
        "Bax"
      ]
    ],
    "updated": "No",
    "original": "In addition vinblastine induces the DNAbinding activities of the transcription factor NF\u03baB HSF1 AP1 and ATF2 together with the expression of HSP70 and Bax proteins",
    "simplified": "In addition, vinblastine causes the transcription factor NF\u03baB HSF1 AP1 and ATF2 to act on the DNA. These two factors are called transcription factors."
  },
  {
    "text": "Also vinblastine enhances the phosphorylation of Ras homologous protein A the release of intracellular Ca2 as well as the activation of apoptosis signalregulating kinase 1 cjunNterminal kinase p38 inhibitor of kappaB\u03b1 I\u03baB\u03b1 kinase and inositol requiring enzyme 1\u03b1 .",
    "triple_list": [
      [
        "vinblastine",
        "CPR:3",
        "Ras homologous protein A"
      ],
      [
        "vinblastine",
        "CPR:3",
        "apoptosis signalregulating kinase 1"
      ],
      [
        "vinblastine",
        "CPR:3",
        "cjunNterminal kinase"
      ],
      [
        "vinblastine",
        "CPR:3",
        "p38"
      ],
      [
        "vinblastine",
        "CPR:3",
        "inhibitor of kappaB\u03b1"
      ],
      [
        "vinblastine",
        "CPR:3",
        "I\u03baB\u03b1"
      ],
      [
        "vinblastine",
        "CPR:3",
        "kinase"
      ],
      [
        "vinblastine",
        "CPR:3",
        "inositol requiring enzyme 1\u03b1"
      ]
    ],
    "updated": "Yes",
    "original": "Also vinblastine enhances the phosphorylation of Ras homologous protein A the accumulation of reactive oxygen species the release of intracellular Ca2 as well as the activation of apoptosis signalregulating kinase 1 cjunNterminal kinase p38 inhibitor of kappaB\u03b1 I\u03baB\u03b1 kinase and inositol requiring enzyme 1\u03b1",
    "simplified": "Also vinblastine enhances the phosphorylation of Ras homologous protein A the release of intracellular Ca2 as well as the activation of apoptosis signalregulating kinase 1 cjunNterminal kinase p38 inhibitor of kappaB\u03b1 I\u03baB\u03b1 kinase and inositol requiring enzyme 1\u03b1."
  },
  {
    "text": "Of the PDE inhibitors tested dipyridamole was most effective with IC50 values of 12 and 045 microM for inhibition of cAMP and cGMP hydrolysis respectively",
    "triple_list": [
      [
        "PDE",
        "CPR:4",
        "dipyridamole"
      ],
      [
        "PDE",
        "CPR:9",
        "cAMP"
      ],
      [
        "PDE",
        "CPR:9",
        "cGMP"
      ]
    ],
    "updated": "No",
    "original": "Of the PDE inhibitors tested dipyridamole was most effective with IC50 values of 12 and 045 microM for inhibition of cAMP and cGMP hydrolysis respectively",
    "simplified": "Dipyridamole was most effective with IC50 values of 12 and 045 microM for cAMP and cGMP hydrolysis. The IC50 value was 12."
  },
  {
    "text": "Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP PDE10A",
    "triple_list": [
      [
        "cAMP",
        "CPR:9",
        "PDE10A"
      ],
      [
        "human phosphodiesterase",
        "CPR:9",
        "cAMP"
      ],
      [
        "cGMP",
        "CPR:9",
        "PDE10A"
      ],
      [
        "human phosphodiesterase",
        "CPR:9",
        "cGMP"
      ]
    ],
    "updated": "No",
    "original": "Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP PDE10A",
    "simplified": "Cloning and characterizing a novel human phosphodiesterase that hydrolyzes riboflavin and riboflavin."
  },
  {
    "text": "PDE10A transfected and expressed in COS7 cells hydrolyzed cAMP with Km values of 026 and 72 microM/O . The Vmax with cGMP was almost twice that with cAMP but with a lower Km value .",
    "triple_list": [
      [
        "PDE10A",
        "CPR:9",
        "cAMP"
      ],
      [
        "PDE10A",
        "CPR:9",
        "cGMP"
      ],
      [
        "PDE10A",
        "CPR:9",
        "cGMP"
      ],
      [
        "PDE10A",
        "CPR:9",
        "cAMP"
      ]
    ],
    "updated": "Yes",
    "original": "Recombinant PDE10A transfected and expressed in COS7 cells hydrolyzed cAMP and cGMP with Km values of 026 and 72 microM respectively and Vmax with cGMP was almost twice that with cAMP",
    "simplified": "PDE10A transfected and expressed in COS7 cells hydrolyzed cAMP with Km values of 026 and 72 microM/O. The Vmax with cGMP was almost twice that with cAMP but with a lower Km value."
  },
  {
    "text": "Weekly subcutaneous decitabine increases HbF and total hemoglobin . This is done through a non-cytotoxic way .",
    "triple_list": [
      [
        "decitabine",
        "CPR:3",
        "HbF"
      ],
      [
        "decitabine",
        "CPR:3",
        "hemoglobin"
      ]
    ],
    "updated": "Yes",
    "original": "Weekly subcutaneous decitabine produces cumulative increases in HbF and total hemoglobin through a noncytotoxic mechanism of action",
    "simplified": "Weekly subcutaneous decitabine increases HbF and total hemoglobin. This is done through a non-cytotoxic way."
  },
  {
    "text": "We examined if subcutaneous decitabine could increase HbF levels and improve SSD pathophysiology without cytotoxicity",
    "triple_list": [
      [
        "decitabine",
        "CPR:3",
        "HbF"
      ]
    ],
    "updated": "No",
    "original": "We examined if subcutaneous decitabine could increase HbF levels and improve SSD pathophysiology without cytotoxicity",
    "simplified": "We examined if subcutaneous decitabine could improve SSD pathophysiology without cytotoxic effects."
  },
  {
    "text": "The cytosine analog 5aza2deoxycytidine decitabine hypomethylates DNA by inhibiting DNA methyltransferase",
    "triple_list": [
      [
        "cytosine",
        "CPR:4",
        "DNA methyltransferase"
      ],
      [
        "5aza2deoxycytidine",
        "CPR:4",
        "DNA methyltransferase"
      ],
      [
        "decitabine",
        "CPR:4",
        "DNA methyltransferase"
      ]
    ],
    "updated": "No",
    "original": "The cytosine analog 5aza2deoxycytidine decitabine hypomethylates DNA by inhibiting DNA methyltransferase",
    "simplified": "The cytosine analog 5aza2deoxycytidine decitabine acts on the DNA to make it shorter."
  },
  {
    "text": "Such model of Nox4 activity regulation could provide new insight into the molecular mechanism of electron transfer through the enzyme and could also define new therapeutic targets in diseases in which quinones and Nox4 are involved .",
    "triple_list": [
      [
        "Nox4",
        "CPR:3",
        "quinones"
      ]
    ],
    "updated": "Yes",
    "original": "Such model of Nox4 activity regulation could provide new insight into the understanding of the molecular mechanism of the electron transfer through the enzyme ie its potential redox regulation and could also define new therapeutic targets in diseases in which quinones and Nox4 are implicated",
    "simplified": "Such model of Nox4 activity regulation could provide new insight into the molecular mechanism of electron transfer through the enzyme and could also define new therapeutic targets in diseases in which quinones and Nox4 are involved."
  },
  {
    "text": "Nox4 oxidase activity is thought to be controlled at the transcriptional level . However , we challenge this point of view and suggest that specific quinone derivatives could influence this activity .",
    "triple_list": [
      [
        "Nox4",
        "CPR:3",
        "quinone"
      ],
      [
        "oxidase",
        "CPR:3",
        "quinone"
      ]
    ],
    "updated": "Yes",
    "original": "Nox4 oxidase activity is thought to be constitutive and regulated at the transcriptional level however we challenge this point of view and suggest that specific quinone derivatives could modulate this activity",
    "simplified": "Nox4 oxidase activity is thought to be controlled at the transcriptional level. However, we challenge this point of view and suggest that specific quinone derivatives could influence this activity."
  },
  {
    "text": "In fact , 4 quinone derivatives ( AA861 tBuBHQ tBuBQ and duroquinone ) were found to stimulate Nox4 activity in 3 different cellular models , including chondrocyte cell lines .",
    "triple_list": [
      [
        "Nox4",
        "CPR:3",
        "quinone"
      ],
      [
        "Nox4",
        "CPR:3",
        "AA861"
      ],
      [
        "Nox4",
        "CPR:3",
        "tBuBHQ"
      ],
      [
        "Nox4",
        "CPR:3",
        "tBuBQ"
      ],
      [
        "Nox4",
        "CPR:3",
        "duroquinone"
      ]
    ],
    "updated": "Yes",
    "original": "In fact we demonstrated a significant stimulation of Nox4 activity by 4 quinone derivatives AA861 tBuBHQ tBuBQ and duroquinone observed in 3 different cellular models HEK293E TREx\u2122 and chondrocyte cell lines",
    "simplified": "In fact, 4 quinone derivatives (AA861 tBuBHQ tBuBQ and duroquinone) were found to stimulate Nox4 activity in 3 different cellular models, including chondrocyte cell lines."
  },
  {
    "text": "In a recent study , antiacetyl lysine antibodies and immunological methods were used to show that aspirin can acetylate the tumor suppressor protein p53 .",
    "triple_list": [
      [
        "aspirin",
        "CPR:3",
        "tumor suppressor protein p53"
      ]
    ],
    "updated": "Yes",
    "original": "In a recent study using proteinspecific antiacetyl lysine antibodies and immunological methods we demonstrated the ability of aspirin to acetylate the tumor suppressor protein p53",
    "simplified": "In a recent study, antiacetyl lysine antibodies and immunological methods were used to show that aspirin can acetylate the tumor suppressor protein p53."
  },
  {
    "text": "Although the mechanism by which aspirin inhibits cyclooxygenases has been well studied , some of its adverse effects as well as its antiinflammatoryanalgesic properties have not been well studied .",
    "triple_list": [
      [
        "cyclooxygenases",
        "CPR:4",
        "aspirin"
      ]
    ],
    "updated": "Yes",
    "original": "Although the inhibition of cyclooxygenases by aspirin which leads to its antiinflammatoryanalgesic properties has been well studied the mechanisms involved in its chemopreventive effects as well as some of its adverse effects are as yet illdefined",
    "simplified": "Although the mechanism by which aspirin inhibits cyclooxygenases has been well studied, some of its adverse effects as well as its antiinflammatoryanalgesic properties have not been well studied."
  },
  {
    "text": "All in all , our findings support a model in which Top2\u03b2 promotes CPT induced apoptosis in quiescent cells , possibly due to p53 accumulation and RNAP LS depletion .",
    "triple_list": [
      [
        "CPT",
        "CPR:3",
        "p53"
      ],
      [
        "CPT",
        "CPR:4",
        "RNAP LS"
      ]
    ],
    "updated": "Yes",
    "original": "Altogether our findings support a model in which Top2\u03b2 deficiency promotes CPT induced apoptosis in quiescent nonSphase cells possibly due to RNAP LS depletion and p53 accumulation",
    "simplified": "All in all, our findings support a model in which Top2\u03b2 promotes CPT induced apoptosis in quiescent cells, possibly due to p53 accumulation and RNAP LS depletion."
  },
  {
    "text": "To explore the molecular basis for CPT hypersensitivity in Top2\u03b2deficient cells we found that upon CPT exposure the RNA polymerase II large subunit RNAP LS became progressively depleted while in wildtype MEFs it recovered to nearly the original level but in Top2\u03b2deficient cells it remained depleted .",
    "triple_list": [
      [
        "CPT",
        "CPR:4",
        "RNA polymerase II large subunit"
      ],
      [
        "CPT",
        "CPR:4",
        "RNAP LS"
      ],
      [
        "CPT",
        "CPR:4",
        "RNAP LS"
      ]
    ],
    "updated": "Yes",
    "original": "To explore the molecular basis for CPT hypersensitivity in Top2\u03b2deficient cells we found that upon CPT exposure the RNA polymerase II large subunit RNAP LS became progressively depleted followed by recovery to nearly the original level in wildtype MEFs whereas RNAP LS remained depleted without recovery in Top2\u03b2deficient cells",
    "simplified": "To explore the molecular basis for CPT hypersensitivity in Top2\u03b2deficient cells we found that upon CPT exposure the RNA polymerase II large subunit RNAP LS became progressively depleted while in wildtype MEFs it recovered to nearly the original level but in Top2\u03b2deficient cells it remained depleted."
  },
  {
    "text": "Second ICRF187 a Top2 catalytic inhibitor known to deplete Top2\u03b2 specifically sensitized MEFs to CPT",
    "triple_list": [
      [
        "ICRF187",
        "CPR:4",
        "Top2"
      ],
      [
        "ICRF187",
        "CPR:4",
        "Top2\u03b2"
      ]
    ],
    "updated": "No",
    "original": "Second ICRF187 a Top2 catalytic inhibitor known to deplete Top2\u03b2 specifically sensitized MEFs to CPT",
    "simplified": "Second ICRF187 a Top2 catalytic inhibitor known to specifically sensitize MEFs to CPT"
  },
  {
    "text": "Felodipine and the pchloro analogue inhibited the actinactivated Mg2ATPase activity of smooth muscle myosin IC50 = 251 microM",
    "triple_list": [
      [
        "pchloro",
        "CPR:4",
        "Mg2ATPase"
      ],
      [
        "pchloro",
        "CPR:4",
        "myosin"
      ],
      [
        "Felodipine",
        "CPR:4",
        "Mg2ATPase"
      ],
      [
        "Felodipine",
        "CPR:4",
        "myosin"
      ]
    ],
    "updated": "No",
    "original": "Felodipine and the pchloro analogue inhibited the actinactivated Mg2ATPase activity of smooth muscle myosin IC50 = 251 microM",
    "simplified": "Felodipine and the pchloro analogue inhibited the action of Mg2ATPase in smooth muscle tissues."
  },
  {
    "text": "Similarly felodipine and the pchloro analogue blocked the assembly of myosin filament when calmodulin was low . The oxidized and tbutyl analogues did not .",
    "triple_list": [
      [
        "felodipine",
        "CPR:4",
        "myosin"
      ],
      [
        "pchloro",
        "CPR:4",
        "myosin"
      ]
    ],
    "updated": "Yes",
    "original": "Similarly felodipine and the pchloro analogue blocked myosin filament assembly induced by low concentrations of calmodulin whereas the oxidized and tbutyl analogues did not",
    "simplified": "Similarly felodipine and the pchloro analogue blocked the assembly of myosin filament when calmodulin was low. The oxidized and tbutyl analogues did not."
  },
  {
    "text": "We have examined the effects on the activities of three enzymes : cAMP phosphodiesterase , caldesmon kinase and myosin light chain kinase . We have also examined the effects of three analogues : pchloro oxidized , tbutyl and dihydropyridine Ca2 channel blocker felodipine .",
    "triple_list": [
      [
        "Ca2 channel",
        "CPR:4",
        "felodipine"
      ]
    ],
    "updated": "Yes",
    "original": "We have examined the effects on the activities of three calmodulindependent enzymes cAMP phosphodiesterase caldesmon kinase and myosin light chain kinase of the dihydropyridine Ca2 channel blocker felodipine and three analogues pchloro oxidized and tbutyl exhibiting different pharmacological potencies",
    "simplified": "We have examined the effects on the activities of three enzymes: cAMP phosphodiesterase, caldesmon kinase and myosin light chain kinase. We have also examined the effects of three analogues: pchloro oxidized, tbutyl and dihydropyridine Ca2 channel blocker felodipine."
  },
  {
    "text": "Again inhibition of the actinactivated myosin Mg2ATPase and myosin filament assembly by felodipine and the pchloro analogue could be reversed by raising the calmodulin concentration",
    "triple_list": [
      [
        "myosin",
        "CPR:4",
        "felodipine"
      ],
      [
        "Mg2ATPase",
        "CPR:4",
        "felodipine"
      ],
      [
        "myosin",
        "CPR:4",
        "felodipine"
      ],
      [
        "myosin",
        "CPR:4",
        "pchloro"
      ],
      [
        "Mg2ATPase",
        "CPR:4",
        "pchloro"
      ],
      [
        "myosin",
        "CPR:4",
        "pchloro"
      ]
    ],
    "updated": "No",
    "original": "Again inhibition of the actinactivated myosin Mg2ATPase and myosin filament assembly by felodipine and the pchloro analogue could be reversed by raising the calmodulin concentration",
    "simplified": "When felodipine and the pchloro analogue touch myosin, it stops myosin filament assembly. This can be reversed by raising the calmodulin concentration."
  },
  {
    "text": "These observations suggest that some of the pharmacological actions of felodipine on smooth muscle may involve inhibition of calmodulindependent enzymes . These enzymes are important for smooth muscle function .",
    "triple_list": [
      [
        "felodipine",
        "CPR:4",
        "calmodulindependent enzymes"
      ]
    ],
    "updated": "Yes",
    "original": "These observations suggest that some of the pharmacological actions of felodipine on smooth muscle may involve inhibition of calmodulindependent enzymes which are functionally involved in the regulation of smooth muscle contraction",
    "simplified": "These observations suggest that some of the pharmacological actions of felodipine on smooth muscle may involve inhibition of calmodulindependent enzymes. These enzymes are important for smooth muscle function."
  },
  {
    "text": "The cAMP phosphodiesterase was inhibited completely by felodipine and the pchloro analogue with IC50 values of 37 and 15 microM respectively",
    "triple_list": [
      [
        "cAMP phosphodiesterase",
        "CPR:4",
        "felodipine"
      ],
      [
        "cAMP phosphodiesterase",
        "CPR:4",
        "pchloro"
      ]
    ],
    "updated": "No",
    "original": "The cAMP phosphodiesterase was inhibited completely by felodipine and the pchloro analogue with IC50 values of 37 and 15 microM respectively",
    "simplified": "The cAMP phosphodiesterase was completely inhibited by felodipine. The IC50 value for felodipine was 15 microM."
  },
  {
    "text": "Felodipine and the pchloro analogue inhibited the activity of cAMP phosphodiesterase by calmodulin and thus the cAMP cycle was stopped .",
    "triple_list": [
      [
        "Felodipine",
        "CPR:4",
        "cAMP phosphodiesterase"
      ],
      [
        "Felodipine",
        "CPR:4",
        "calmodulin"
      ],
      [
        "pchloro",
        "CPR:4",
        "cAMP phosphodiesterase"
      ],
      [
        "pchloro",
        "CPR:4",
        "calmodulin"
      ]
    ],
    "updated": "Yes",
    "original": "Felodipine and the pchloro analogue inhibited the basal Ca2calmodulinindependent activity of cAMP phosphodiesterase as well as the calmodulin stimulated activity",
    "simplified": "Felodipine and the pchloro analogue inhibited the activity of cAMP phosphodiesterase by calmodulin and thus the cAMP cycle was stopped."
  },
  {
    "text": "Calmodulin prevents felodipine and the pchloro analogue from inhibiting cAMP phosphodiesterase .",
    "triple_list": [
      [
        "cAMP phosphodiesterase",
        "CPR:4",
        "felodipine"
      ],
      [
        "cAMP phosphodiesterase",
        "CPR:4",
        "pchloro"
      ]
    ],
    "updated": "Yes",
    "original": "Calmodulin was relatively ineffective in preventing inhibition of cAMP phosphodiesterase by felodipine and the pchloro analogue",
    "simplified": "Calmodulin prevents felodipine and the pchloro analogue from inhibiting cAMP phosphodiesterase."
  },
  {
    "text": "Felodipine and the pchloro analogue inhibited Ca2calmodulindependent caldesmon kinase ( IC50 = 174 microM ) but the oxidized and tbutyl analogues had no effect .",
    "triple_list": [
      [
        "Felodipine",
        "CPR:4",
        "caldesmon kinase"
      ],
      [
        "pchloro",
        "CPR:4",
        "caldesmon kinase"
      ]
    ],
    "updated": "Yes",
    "original": "Felodipine and the pchloro analogue inhibited Ca2calmodulindependent caldesmon kinase with similar potencies IC50 = 174 microM whereas the oxidized and tbutyl analogues caused no inhibition",
    "simplified": "Felodipine and the pchloro analogue inhibited Ca2calmodulindependent caldesmon kinase (IC50 = 174 microM) but the oxidized and tbutyl analogues had no effect."
  },
  {
    "text": "Similarly felodipine and the pchloro analogue inhibited myosin light chain kinase activity . The IC50 of the isolated 20 kD light chain was 126 microM , and the IC50 of the intact myosin was 110 microM .",
    "triple_list": [
      [
        "felodipine",
        "CPR:4",
        "myosin light chain kinase"
      ],
      [
        "pchloro",
        "CPR:4",
        "myosin light chain kinase"
      ]
    ],
    "updated": "Yes",
    "original": "Similarly felodipine and the pchloro analogue inhibited myosin light chain kinase activity whether the isolated 20 kD light chain IC50 = 126 microM or intact myosin IC50 = 110 microM was used as substrate",
    "simplified": "Similarly felodipine and the pchloro analogue inhibited myosin light chain kinase activity. The IC50 of the isolated 20 kD light chain was 126 microM, and the IC50 of the intact myosin was 110 microM."
  },
  {
    "text": "Effects of felodipine a dihydropyridine calcium channel blocker and analogues on calmodulindependent enzymes",
    "triple_list": [
      [
        "felodipine",
        "CPR:4",
        "calcium channel"
      ],
      [
        "dihydropyridine",
        "CPR:4",
        "calcium channel"
      ]
    ],
    "updated": "No",
    "original": "Effects of felodipine a dihydropyridine calcium channel blocker and analogues on calmodulindependent enzymes",
    "simplified": "Felodipine (also known as dihydropyridine) is a chemical compound. It is an enzyme."
  },
  {
    "text": "Aldosterone induced ENaC and basal NaKATPase trafficking via protein kinase D1phosphatidylinositol 4kinaseIII\u03b2 trans Golgi signalling in M1 cortical collecting duct cells",
    "triple_list": [
      [
        "Aldosterone",
        "CPR:3",
        "ENaC"
      ],
      [
        "Aldosterone",
        "CPR:3",
        "NaKATPase"
      ]
    ],
    "updated": "No",
    "original": "Aldosterone induced ENaC and basal NaKATPase trafficking via protein kinase D1phosphatidylinositol 4kinaseIII\u03b2 trans Golgi signalling in M1 cortical collecting duct cells",
    "simplified": "Aldosterone causes protein kinase D1phosphatidylinositol 4kinaseIII\u03b2 trans Golgi signalling in M1 cortical collecting duct cells to increase cell division."
  },
  {
    "text": "Aldosterone also induces the rapid phosphorylation of Protein Kinase D1 PKD1",
    "triple_list": [
      [
        "Aldosterone",
        "CPR:3",
        "Protein Kinase D1"
      ],
      [
        "Aldosterone",
        "CPR:3",
        "PKD1"
      ]
    ],
    "updated": "No",
    "original": "Aldosterone also induces the rapid phosphorylation of Protein Kinase D1 PKD1",
    "simplified": "Aldosterone also increases the activity of the protein Kinase D1."
  },
  {
    "text": "In addition by comparing the combined administration of pindolol with either WAY100635 GR127935 or isamoltane we have determined that pindolol produces much of its acute potentiation of fluoxetine through its action at the 5HT1BD receptor in addition to any activity it has at the presynaptic 5HT1A receptor .",
    "triple_list": [
      [
        "pindolol",
        "CPR:6",
        "5HT1A"
      ]
    ],
    "updated": "Yes",
    "original": "In addition by comparing the combined administration of pindolol with either WAY100635 GR127935 or isamoltane we have determined that pindolol produces much of its acute potentiation of fluoxetineinduced increases in extracellular 5HT via its action at the 5HT1BD receptor in addition to any activity it has at the presynaptic 5HT1A receptor",
    "simplified": "In addition by comparing the combined administration of pindolol with either WAY100635 GR127935 or isamoltane we have determined that pindolol produces much of its acute potentiation of fluoxetine through its action at the 5HT1BD receptor in addition to any activity it has at the presynaptic 5HT1A receptor."
  },
  {
    "text": "The reason for this is that pindolol acts on the 5HT1A receptor in the brain .",
    "triple_list": [
      [
        "pindolol",
        "CPR:6",
        "5HT1A"
      ]
    ],
    "updated": "Yes",
    "original": "This effect has been attributed to the antagonist effects of pindolol at the 5HT1A receptor",
    "simplified": "The reason for this is that pindolol acts on the 5HT1A receptor in the brain."
  },
  {
    "text": "In the present study we compared the pharmacology of pindolol WAY100635 a 5HT1A antagonist GR127935 a 5HT1B1D antagonist and isamoltane a 5HT1B antagonist when given acutely in combination with fluoxetine using in vivo microdialysis in the frontal cortex of the freely moving rat",
    "triple_list": [
      [
        "pindolol",
        "CPR:6",
        "5HT1A"
      ],
      [
        "WAY100635",
        "CPR:6",
        "5HT1A"
      ],
      [
        "5HT1B",
        "CPR:6",
        "isamoltane"
      ]
    ],
    "updated": "No",
    "original": "In the present study we compared the pharmacology of pindolol WAY100635 a 5HT1A antagonist GR127935 a 5HT1B1D antagonist and isamoltane a 5HT1B antagonist when given acutely in combination with fluoxetine using in vivo microdialysis in the frontal cortex of the freely moving rat",
    "simplified": "In the present study we compared the pharmacology of pindolol and isamoltane when given acutely in combination with fluoxetine in the frontal cortex of the freely moving rat using in vivo microdialysis in the human brain."
  },
  {
    "text": "In the local presence into the LC of the \u03b12adrenoceptor antagonist RS79948 1 \u03bcM systemic citalopram increased NA in the LC Emax = 157 \u00b1 25 and PFC Emax = 175 \u00b1 24",
    "triple_list": [
      [
        "\u03b12adrenoceptor",
        "CPR:6",
        "RS79948"
      ]
    ],
    "updated": "No",
    "original": "In the local presence into the LC of the \u03b12adrenoceptor antagonist RS79948 1 \u03bcM systemic citalopram increased NA in the LC Emax = 157 \u00b1 25 and PFC Emax = 175 \u00b1 24",
    "simplified": "1 \u03bcM systemic citalopram in the local presence into the LC increased NA in the LC Emax = 157 \u00b1 25 and PFC Emax = 175 \u00b1 24."
  },
  {
    "text": "Local LC citalopram effect was abolished by LC presence of the 5HT3 receptor antagonist MDL72222 1 \u03bcM but not the 5HT12 receptor antagonist methiothepin 1 \u03bcM",
    "triple_list": [
      [
        "5HT3",
        "CPR:6",
        "MDL72222"
      ],
      [
        "5HT12",
        "CPR:6",
        "methiothepin"
      ]
    ],
    "updated": "No",
    "original": "Local LC citalopram effect was abolished by LC presence of the 5HT3 receptor antagonist MDL72222 1 \u03bcM but not the 5HT12 receptor antagonist methiothepin 1 \u03bcM",
    "simplified": "Local LC citalopram effect was abolished by the presence of the 5HT3 receptor antagonist methiothepin 1 \u03bcM but not the 5HT12 receptor antagonist 1 \u03bcM."
  },
  {
    "text": "Noradrenaline and phenylephrine alpha1adrenoceptor agonists both produce a tonic contraction . The pD2 values for these drugs are 687008 and 610005 .",
    "triple_list": [
      [
        "phenylephrine",
        "CPR:5",
        "alpha1adrenoceptor"
      ],
      [
        "Noradrenaline",
        "CPR:5",
        "alpha1adrenoceptor"
      ]
    ],
    "updated": "Yes",
    "original": "Noradrenaline and phenylephrine alpha1adrenoceptor agonist each produced a concentrationdependent tonic contraction their pD2 values being 687008 and 610005 respectively",
    "simplified": "Noradrenaline and phenylephrine alpha1adrenoceptor agonists both produce a tonic contraction. The pD2 values for these drugs are 687008 and 610005."
  },
  {
    "text": "Prazosin nonselective alpha1adrenoceptor antagonist silodosin selective alpha1Aadrenoceptor antagonist and BMY7378 8242methoxyphenyl1piperazinylethyl8azaspiro45decane79dione dihydrochloride selective alpha1Dadrenoceptor antagonist competitively antagonized the phenylephrine induced contraction pA2 values 860007 944006 and 575007 respectively",
    "triple_list": [
      [
        "alpha1adrenoceptor",
        "CPR:5",
        "phenylephrine"
      ],
      [
        "alpha1Aadrenoceptor",
        "CPR:5",
        "phenylephrine"
      ],
      [
        "alpha1Dadrenoceptor",
        "CPR:5",
        "phenylephrine"
      ],
      [
        "Prazosin",
        "CPR:6",
        "alpha1adrenoceptor"
      ],
      [
        "silodosin",
        "CPR:6",
        "alpha1Aadrenoceptor"
      ],
      [
        "BMY7378",
        "CPR:6",
        "alpha1Dadrenoceptor"
      ],
      [
        "8242methoxyphenyl1piperazinylethyl8azaspiro45decane79dione dihydrochloride",
        "CPR:6",
        "alpha1Dadrenoceptor"
      ]
    ],
    "updated": "No",
    "original": "Prazosin nonselective alpha1adrenoceptor antagonist silodosin selective alpha1Aadrenoceptor antagonist and BMY7378 8242methoxyphenyl1piperazinylethyl8azaspiro45decane79dione dihydrochloride selective alpha1Dadrenoceptor antagonist competitively antagonized the phenylephrine induced contraction pA2 values 860007 944006 and 575007 respectively",
    "simplified": "Prazosin selective alpha1adrenoceptor antagonist and BMY7378 8242methoxyphenyl1piperazinylethyl8azaspiro45decane79dione dihydrochloride selective alpha1Dadrenoceptor antagonist competitively antagonized the phenylephrine induced contraction pA2 values 860007 944006 and 575007 respectively."
  },
  {
    "text": "alpha1Adrenoceptor antagonists were tested against the phenylephrine alpha1adrenoceptor agonistinduced contraction in isolated hamster ureteral preparations using a functional experimental approach",
    "triple_list": [
      [
        "phenylephrine",
        "CPR:5",
        "alpha1adrenoceptor"
      ]
    ],
    "updated": "No",
    "original": "alpha1Adrenoceptor antagonists were tested against the phenylephrine alpha1adrenoceptor agonistinduced contraction in isolated hamster ureteral preparations using a functional experimental approach",
    "simplified": "alpha1Adrenoceptor antagonists were tested against phenylephrine in isolated hamster ureteral preparations using a functional experimental approach and showed good results."
  },
  {
    "text": "Despite the structural similarity between benzothiazepines and BDZs I1150A did not affect diazepam potency , but it did affect diltiazem potency .",
    "triple_list": [
      [
        "I1150A",
        "CPR:4",
        "diazepam"
      ]
    ],
    "updated": "Yes",
    "original": "Despite the structural similarity between benzothiazepines and BDZs mutation of an amino acid important for diltiazem potency I1150A did not affect diazepam potency",
    "simplified": "Despite the structural similarity between benzothiazepines and BDZs I1150A did not affect diazepam potency, but it did affect diltiazem potency."
  },
  {
    "text": "Although LVGCC inhibition by BDZs occurred at concentrations that are possibly too high to be clinically relevant and is not likely to play a role in the upregulation of LVGCCs during longterm treatment pentobarbital and ethanol inhibited LVGCCs at clinically relevant concentrations",
    "triple_list": [
      [
        "LVGCC",
        "CPR:4",
        "BDZs"
      ],
      [
        "LVGCCs",
        "CPR:4",
        "pentobarbital"
      ]
    ],
    "updated": "No",
    "original": "Although LVGCC inhibition by BDZs occurred at concentrations that are possibly too high to be clinically relevant and is not likely to play a role in the upregulation of LVGCCs during longterm treatment pentobarbital and ethanol inhibited LVGCCs at clinically relevant concentrations",
    "simplified": "Although BDZs inhibited LVGCCs at concentrations that are possibly too high to be clinically relevant, it is not likely to play a role in the upregulation of LVGCCs during long-term treatment, and pentobarbital and ethanol did not inhibit LVGCCs at clinically relevant levels."
  },
  {
    "text": "BDZs and other positive GABAAR modulators including barbiturates ethanol and neurosteroids can also inhibit Ltype voltagegated calcium channels LVGCCs which could contribute to reduced neuronal excitability",
    "triple_list": [
      [
        "barbiturates",
        "CPR:4",
        "Ltype voltagegated calcium channels"
      ],
      [
        "barbiturates",
        "CPR:4",
        "LVGCCs"
      ],
      [
        "ethanol",
        "CPR:4",
        "Ltype voltagegated calcium channels"
      ],
      [
        "ethanol",
        "CPR:4",
        "LVGCCs"
      ],
      [
        "neurosteroids",
        "CPR:4",
        "Ltype voltagegated calcium channels"
      ],
      [
        "neurosteroids",
        "CPR:4",
        "LVGCCs"
      ],
      [
        "BDZs",
        "CPR:4",
        "Ltype voltagegated calcium channels"
      ],
      [
        "BDZs",
        "CPR:4",
        "LVGCCs"
      ]
    ],
    "updated": "No",
    "original": "BDZs and other positive GABAAR modulators including barbiturates ethanol and neurosteroids can also inhibit Ltype voltagegated calcium channels LVGCCs which could contribute to reduced neuronal excitability",
    "simplified": "BDZs and other positive GABAAR modulators including barbiturates and neurosteroids can also make calcium channels in the brain less active. This may reduce neuronal excitability."
  },
  {
    "text": "Cav13 channels were less sensitive to pentobarbital inhibition than Cav12 channels similar to dihydropyridine DHP LVGCC antagonists",
    "triple_list": [
      [
        "Cav13",
        "CPR:4",
        "pentobarbital"
      ],
      [
        "pentobarbital",
        "CPR:4",
        "Cav12"
      ],
      [
        "Cav13",
        "CPR:4",
        "dihydropyridine"
      ],
      [
        "Cav12",
        "CPR:4",
        "dihydropyridine"
      ],
      [
        "Cav13",
        "CPR:4",
        "DHP"
      ],
      [
        "Cav12",
        "CPR:4",
        "DHP"
      ],
      [
        "dihydropyridine",
        "CPR:6",
        "LVGCC"
      ],
      [
        "DHP",
        "CPR:6",
        "LVGCC"
      ]
    ],
    "updated": "No",
    "original": "Cav13 channels were less sensitive to pentobarbital inhibition than Cav12 channels similar to dihydropyridine DHP LVGCC antagonists",
    "simplified": "Cav13 channels were less sensitive to pentobarbital than Cav12 channels. Dihydropyridine and LVGCC are similar to Cav12."
  },
  {
    "text": "All GABAAR modulators induced a negative shift in the steadystate inactivation curve of Cav13 channels but only BDZs and pentobarbital induced a negative shift in Cav12 channel inactivation",
    "triple_list": [
      [
        "BDZs",
        "CPR:4",
        "Cav12"
      ],
      [
        "pentobarbital",
        "CPR:4",
        "Cav12"
      ]
    ],
    "updated": "No",
    "original": "All GABAAR modulators induced a negative shift in the steadystate inactivation curve of Cav13 channels but only BDZs and pentobarbital induced a negative shift in Cav12 channel inactivation",
    "simplified": "All GABAAR modulators changed the inactivation curve of the Cav13 channels in a negative way, but only BDZs and pentobarbital changed the inactivation curve in a negative way."
  },
  {
    "text": "Thus we found that 5HHMF enhances heme oxygenase1 HO1 expression via nuclear factorerythroid 2related factor 2 Nrf2 activation",
    "triple_list": [
      [
        "5HHMF",
        "CPR:3",
        "heme oxygenase1"
      ],
      [
        "5HHMF",
        "CPR:3",
        "HO1"
      ],
      [
        "5HHMF",
        "CPR:3",
        "nuclear factorerythroid 2related factor 2"
      ],
      [
        "5HHMF",
        "CPR:3",
        "Nrf2"
      ]
    ],
    "updated": "No",
    "original": "Thus we found that 5HHMF enhances heme oxygenase1 HO1 expression via nuclear factorerythroid 2related factor 2 Nrf2 activation",
    "simplified": "Thus we found that 5HHMF increases the expression of heme oxygenase1 HO1 by nuclear factorerythroid 2related factor 2."
  },
  {
    "text": "In addition , cobalt protoporphyrin CoPP , a specific HO1 inducer , reduces the production of LPS .",
    "triple_list": [
      [
        "cobalt protoporphyrin",
        "CPR:3",
        "HO1"
      ],
      [
        "CoPP",
        "CPR:3",
        "HO1"
      ]
    ],
    "updated": "Yes",
    "original": "In addition cobalt protoporphyrin CoPP a specific HO1 inducer predominantly suppressed LPSinduced NO production",
    "simplified": "In addition, cobalt protoporphyrin CoPP, a specific HO1 inducer, reduces the production of LPS."
  },
  {
    "text": "5Hydroxy367834hexamethoxyflavone inhibits nitric oxide production in lipopolysaccharidestimulated BV2 microglia via NF\u03baB suppression and Nrf2 dependent heme oxygenase1 induction",
    "triple_list": [
      [
        "5Hydroxy367834hexamethoxyflavone",
        "CPR:3",
        "Nrf2"
      ],
      [
        "5Hydroxy367834hexamethoxyflavone",
        "CPR:3",
        "heme oxygenase1"
      ],
      [
        "5Hydroxy367834hexamethoxyflavone",
        "CPR:4",
        "NF\u03baB"
      ]
    ],
    "updated": "No",
    "original": "5Hydroxy367834hexamethoxyflavone inhibits nitric oxide production in lipopolysaccharidestimulated BV2 microglia via NF\u03baB suppression and Nrf2 dependent heme oxygenase1 induction",
    "simplified": "5Hydroxy367834hexamethoxyflavone inhibits nitric oxide production in lipopolysaccharidestimulated BV2 microglia by inhibiting heme oxygenase1 and NF\u03baB."
  },
  {
    "text": "Further 5HHMF increased specific DNAbinding activity of Nrf2 and transient knockdown with Nrf2 siRNA subsequently reversed 5HHMFinduced NO inhibition which was followed by suppression of HO1 activity",
    "triple_list": [
      [
        "5HHMF",
        "CPR:3",
        "Nrf2"
      ],
      [
        "5HHMF",
        "CPR:3",
        "Nrf2"
      ],
      [
        "5HHMF",
        "CPR:3",
        "HO1"
      ],
      [
        "5HHMF",
        "CPR:3",
        "Nrf2"
      ],
      [
        "5HHMF",
        "CPR:3",
        "Nrf2"
      ],
      [
        "5HHMF",
        "CPR:4",
        "HO1"
      ],
      [
        "NO",
        "CPR:4",
        "HO1"
      ]
    ],
    "updated": "No",
    "original": "Further 5HHMF increased specific DNAbinding activity of Nrf2 and transient knockdown with Nrf2 siRNA subsequently reversed 5HHMFinduced NO inhibition which was followed by suppression of HO1 activity",
    "simplified": "Further 5HHMF increased specific DNAbinding activity of Nrf2 and transient knockdown with Nrf2 siRNA then reversed the effects of 5HHMF and HO1 inhibition."
  },
  {
    "text": "Taken together our findings indicate that 5HHMF suppresses NO production through modulation of iNOS consequently suppressing NF\u03baB activity and induction of Nrf2 dependent HO1 activity",
    "triple_list": [
      [
        "5HHMF",
        "CPR:3",
        "Nrf2"
      ],
      [
        "5HHMF",
        "CPR:3",
        "HO1"
      ],
      [
        "NO",
        "CPR:4",
        "NF\u03baB"
      ],
      [
        "NO",
        "CPR:4",
        "Nrf2"
      ],
      [
        "NO",
        "CPR:4",
        "HO1"
      ],
      [
        "5HHMF",
        "CPR:4",
        "NF\u03baB"
      ]
    ],
    "updated": "No",
    "original": "Taken together our findings indicate that 5HHMF suppresses NO production through modulation of iNOS consequently suppressing NF\u03baB activity and induction of Nrf2 dependent HO1 activity",
    "simplified": "Together, our findings indicate that 5HHMF suppresses NO production through modulation of iNOS. In addition, NF\u03baB activity is reduced and HO1 activity increases."
  },
  {
    "text": "In addition 5HHMF blocked LPSinduced phosphorylation of I\u03baB resulting in suppression of the nuclear translocation of nuclear factor\u03baB NF\u03baB subunits namely p65 and p50 which are important molecules involved in the regulation of iNOS expression",
    "triple_list": [
      [
        "5HHMF",
        "CPR:4",
        "I\u03baB"
      ],
      [
        "5HHMF",
        "CPR:4",
        "nuclear factor\u03baB"
      ],
      [
        "5HHMF",
        "CPR:4",
        "NF\u03baB"
      ],
      [
        "5HHMF",
        "CPR:4",
        "p65"
      ],
      [
        "5HHMF",
        "CPR:4",
        "p50"
      ]
    ],
    "updated": "No",
    "original": "In addition 5HHMF blocked LPSinduced phosphorylation of I\u03baB resulting in suppression of the nuclear translocation of nuclear factor\u03baB NF\u03baB subunits namely p65 and p50 which are important molecules involved in the regulation of iNOS expression",
    "simplified": "In addition 5HHMF blocked LPSinduced phosphorylation of I\u03baB resulting in suppression of the nuclear translocation of nuclear factor\u03baB NF\u03baB subunits, i.e. the expression of iNOS is reduced."
  },
  {
    "text": "In this study we found that 5hydroxy367834hexamethoxyflavone 5HHMF from Hizikia fusiforme considerably inhibits lipopolysaccharide LPSstimulated NO production by suppressing the expression of inducible NO synthase iNOS in BV2 microglia",
    "triple_list": [
      [
        "5hydroxy367834hexamethoxyflavone",
        "CPR:4",
        "inducible NO synthase"
      ],
      [
        "5hydroxy367834hexamethoxyflavone",
        "CPR:4",
        "iNOS"
      ],
      [
        "5HHMF",
        "CPR:4",
        "inducible NO synthase"
      ],
      [
        "5HHMF",
        "CPR:4",
        "iNOS"
      ]
    ],
    "updated": "No",
    "original": "In this study we found that 5hydroxy367834hexamethoxyflavone 5HHMF from Hizikia fusiforme considerably inhibits lipopolysaccharide LPSstimulated NO production by suppressing the expression of inducible NO synthase iNOS in BV2 microglia",
    "simplified": "In this study we found that 5hydroxy367834hexamethoxyflavone 5HHMF from Hizikia fusiforme significantly inhibits the expression of iNOS in BV2 microglia by suppressing lipopolysaccharide LPSstimulated NO production."
  },
  {
    "text": "Pyrrolidine dithiocarbamate PDTC a specific NF\u03baB inhibitor along with 20S proteasome inhibitor PSI significantly inhibited LPSinduced iNOS expression which indirectly suggested that 5HHMF downregulated iNOS expression by suppressing NF\u03baB activity",
    "triple_list": [
      [
        "Pyrrolidine dithiocarbamate",
        "CPR:4",
        "NF\u03baB"
      ],
      [
        "Pyrrolidine dithiocarbamate",
        "CPR:4",
        "iNOS"
      ],
      [
        "PDTC",
        "CPR:4",
        "NF\u03baB"
      ],
      [
        "PDTC",
        "CPR:4",
        "iNOS"
      ],
      [
        "iNOS",
        "CPR:4",
        "5HHMF"
      ],
      [
        "NF\u03baB",
        "CPR:4",
        "5HHMF"
      ]
    ],
    "updated": "No",
    "original": "Pyrrolidine dithiocarbamate PDTC a specific NF\u03baB inhibitor along with 20S proteasome inhibitor PSI significantly inhibited LPSinduced iNOS expression which indirectly suggested that 5HHMF downregulated iNOS expression by suppressing NF\u03baB activity",
    "simplified": "Pyrrolidine dithiocarbamate, a specific NF\u03baB inhibitor, and 20S proteasome inhibitor PSI significantly inhibited LPSinduced iNOS expression, suggesting that NF\u03baB activity may be involved in the expression of iNOS."
  },
  {
    "text": "In contrast zinc protoporphyrin ZnPP a specific HO1 inhibitor showed a partial suppressive effect of 5HHMF on LPSinduced NO production",
    "triple_list": [
      [
        "zinc protoporphyrin",
        "CPR:4",
        "HO1"
      ],
      [
        "ZnPP",
        "CPR:4",
        "HO1"
      ]
    ],
    "updated": "No",
    "original": "In contrast zinc protoporphyrin ZnPP a specific HO1 inhibitor showed a partial suppressive effect of 5HHMF on LPSinduced NO production",
    "simplified": "Zinc protoporphyrin ZnPP is a specific HO1 inhibitor. It does not work very well, but it can slow down NO production."
  },
  {
    "text": "Synthesis and antitumor activity of 134oxadiazole possessing 14benzodioxan moiety as a novel class of potent methionine aminopeptidase type II inhibitors",
    "triple_list": [
      [
        "134oxadiazole",
        "CPR:4",
        "methionine aminopeptidase type II"
      ],
      [
        "14benzodioxan",
        "CPR:4",
        "methionine aminopeptidase type II"
      ]
    ],
    "updated": "No",
    "original": "Synthesis and antitumor activity of 134oxadiazole possessing 14benzodioxan moiety as a novel class of potent methionine aminopeptidase type II inhibitors",
    "simplified": "The synthesis and antitumor activity of 134oxadiazole with 14benzodioxan as a novel class of potent aminopeptidase type II inhibitors"
  },
  {
    "text": "One of the CB2 agonists Ncyclopentyl4ethoxy64methylpiperidin1yl135triazin2amine 19 logEC50=75 Emax=255 was selected for further development",
    "triple_list": [
      [
        "CB2",
        "CPR:5",
        "Ncyclopentyl4ethoxy64methylpiperidin1yl135triazin2amine"
      ]
    ],
    "updated": "No",
    "original": "One of the CB2 agonists Ncyclopentyl4ethoxy64methylpiperidin1yl135triazin2amine 19 logEC50=75 Emax=255 was selected for further development",
    "simplified": "Ncyclopentyl4ethoxy64methylpiperidin1yl135triazin2amine 19 logEC50=75 Emax=255 was selected for further development in 2006."
  },
  {
    "text": "As far as we know , the 135triazine scaffold represents a new CB2 agonist core structure .",
    "triple_list": [
      [
        "135triazine",
        "CPR:5",
        "CB2"
      ]
    ],
    "updated": "Yes",
    "original": "As far as we are aware the compounds 135triazine scaffold represents a new core structure for CB2 agonists",
    "simplified": "As far as we know, the 135triazine scaffold represents a new CB2 agonist core structure."
  },
  {
    "text": "Discovery of novel cannabinoid receptor ligands by a virtual screening approach further development of 246trisubstituted 135triazines as CB2 agonists",
    "triple_list": [
      [
        "246trisubstituted 135triazines",
        "CPR:5",
        "CB2"
      ]
    ],
    "updated": "No",
    "original": "Discovery of novel cannabinoid receptor ligands by a virtual screening approach further development of 246trisubstituted 135triazines as CB2 agonists",
    "simplified": "Discovery of novel cannabinoid receptor ligands by a virtual screening approach Further development of CB2 receptor agonists is needed."
  },
  {
    "text": "Purified PAOh1 SMO oxidizes both spermine Km=16 microM and N1acetylspermine Km=51 microM but does not oxidize spermidine",
    "triple_list": [
      [
        "PAOh1",
        "CPR:9",
        "spermine"
      ],
      [
        "SMO",
        "CPR:9",
        "spermine"
      ],
      [
        "PAOh1",
        "CPR:9",
        "N1acetylspermine"
      ],
      [
        "SMO",
        "CPR:9",
        "N1acetylspermine"
      ]
    ],
    "updated": "No",
    "original": "Purified PAOh1 SMO oxidizes both spermine Km=16 microM and N1acetylspermine Km=51 microM but does not oxidize spermidine",
    "simplified": "It can oxidize both spermine and n1acetylspermine. It does not oxidize spermidine though."
  },
  {
    "text": "The purified human enzyme also does not oxidize eight representative antitumor polyamine analogues however specific oligamine analogues were found to be potent inhibitors of the oxidation of spermine by PAOh1 SMO",
    "triple_list": [
      [
        "spermine",
        "CPR:9",
        "PAOh1"
      ],
      [
        "spermine",
        "CPR:9",
        "SMO"
      ]
    ],
    "updated": "No",
    "original": "The purified human enzyme also does not oxidize eight representative antitumor polyamine analogues however specific oligamine analogues were found to be potent inhibitors of the oxidation of spermine by PAOh1 SMO",
    "simplified": "The purified human enzyme also does not oxidize eight representative antitumor polyamine analogues. However, specific oligamine analogues were found to inhibit the enzyme by a large amount."
  },
  {
    "text": "The discovery of an inducible oxidase whose apparent substrate is spermine has shown that polyamine catabolism is more complex than people thought .",
    "triple_list": [
      [
        "oxidase",
        "CPR:9",
        "spermine"
      ]
    ],
    "updated": "Yes",
    "original": "The discovery of an inducible oxidase whose apparent substrate preference is spermine indicates that polyamine catabolism is more complex than that originally proposed",
    "simplified": "The discovery of an inducible oxidase whose apparent substrate is spermine has shown that polyamine catabolism is more complex than people thought."
  },
  {
    "text": "The researchers then gave the mice very low doses of okadaic acid and cantharidin , which inhibit PP2A . This stopped the antinociception caused by morphine .",
    "triple_list": [
      [
        "okadaic acid",
        "CPR:4",
        "PP2A"
      ],
      [
        "cantharidin",
        "CPR:4",
        "PP2A"
      ]
    ],
    "updated": "Yes",
    "original": "administration of very low doses of okadaic acid 00011 pgmouse and cantharidin 00011 ngmouse which inhibit PP2A produced a dosedependent antagonism of the antinociception induced by morphine sc",
    "simplified": "The researchers then gave the mice very low doses of okadaic acid and cantharidin, which inhibit PP2A. This stopped the antinociception caused by morphine."
  },
  {
    "text": "A series of phenolic acids and phenol natural products such as phydroxybenzoic acid pcoumaric acid caffeic acid ferulic acid gallic acid syringic acid quercetin and ellagic acid were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase CA EC 4211",
    "triple_list": [
      [
        "phydroxybenzoic acid",
        "CPR:4",
        "metalloenzyme"
      ],
      [
        "phydroxybenzoic acid",
        "CPR:4",
        "carbonic anhydrase"
      ],
      [
        "phydroxybenzoic acid",
        "CPR:4",
        "CA"
      ],
      [
        "phydroxybenzoic acid",
        "CPR:4",
        "EC 4211"
      ],
      [
        "pcoumaric acid",
        "CPR:4",
        "metalloenzyme"
      ],
      [
        "pcoumaric acid",
        "CPR:4",
        "carbonic anhydrase"
      ],
      [
        "pcoumaric acid",
        "CPR:4",
        "CA"
      ],
      [
        "pcoumaric acid",
        "CPR:4",
        "EC 4211"
      ],
      [
        "caffeic acid",
        "CPR:4",
        "metalloenzyme"
      ],
      [
        "caffeic acid",
        "CPR:4",
        "carbonic anhydrase"
      ],
      [
        "caffeic acid",
        "CPR:4",
        "CA"
      ],
      [
        "caffeic acid",
        "CPR:4",
        "EC 4211"
      ],
      [
        "ferulic acid",
        "CPR:4",
        "metalloenzyme"
      ],
      [
        "ferulic acid",
        "CPR:4",
        "carbonic anhydrase"
      ],
      [
        "ferulic acid",
        "CPR:4",
        "CA"
      ],
      [
        "ferulic acid",
        "CPR:4",
        "EC 4211"
      ],
      [
        "phenolic acids",
        "CPR:4",
        "metalloenzyme"
      ],
      [
        "phenolic acids",
        "CPR:4",
        "carbonic anhydrase"
      ],
      [
        "phenolic acids",
        "CPR:4",
        "CA"
      ],
      [
        "phenolic acids",
        "CPR:4",
        "EC 4211"
      ],
      [
        "gallic acid",
        "CPR:4",
        "metalloenzyme"
      ],
      [
        "gallic acid",
        "CPR:4",
        "carbonic anhydrase"
      ],
      [
        "gallic acid",
        "CPR:4",
        "CA"
      ],
      [
        "gallic acid",
        "CPR:4",
        "EC 4211"
      ],
      [
        "syringic acid",
        "CPR:4",
        "metalloenzyme"
      ],
      [
        "syringic acid",
        "CPR:4",
        "carbonic anhydrase"
      ],
      [
        "syringic acid",
        "CPR:4",
        "CA"
      ],
      [
        "syringic acid",
        "CPR:4",
        "EC 4211"
      ],
      [
        "quercetin",
        "CPR:4",
        "metalloenzyme"
      ],
      [
        "quercetin",
        "CPR:4",
        "carbonic anhydrase"
      ],
      [
        "quercetin",
        "CPR:4",
        "CA"
      ],
      [
        "quercetin",
        "CPR:4",
        "EC 4211"
      ],
      [
        "ellagic acid",
        "CPR:4",
        "metalloenzyme"
      ],
      [
        "ellagic acid",
        "CPR:4",
        "carbonic anhydrase"
      ],
      [
        "ellagic acid",
        "CPR:4",
        "CA"
      ],
      [
        "ellagic acid",
        "CPR:4",
        "EC 4211"
      ],
      [
        "phenol",
        "CPR:4",
        "metalloenzyme"
      ],
      [
        "phenol",
        "CPR:4",
        "carbonic anhydrase"
      ],
      [
        "phenol",
        "CPR:4",
        "CA"
      ],
      [
        "phenol",
        "CPR:4",
        "EC 4211"
      ]
    ],
    "updated": "No",
    "original": "A series of phenolic acids and phenol natural products such as phydroxybenzoic acid pcoumaric acid caffeic acid ferulic acid gallic acid syringic acid quercetin and ellagic acid were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase CA EC 4211",
    "simplified": "A series of phenolic acids and phenol natural products such as quercetin and ellagic acid were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase. Quercetin and ellagic acid have been shown to inhibit this enzyme."
  },
  {
    "text": "Phenols like the ones investigated here possess a CA inhibition mechanism distinct of that of the sulfonamides sulfamates used clinically or the coumarins",
    "triple_list": [
      [
        "Phenols",
        "CPR:4",
        "CA"
      ],
      [
        "CA",
        "CPR:4",
        "sulfonamides"
      ],
      [
        "CA",
        "CPR:4",
        "sulfamates"
      ],
      [
        "CA",
        "CPR:4",
        "coumarins"
      ]
    ],
    "updated": "No",
    "original": "Phenols like the ones investigated here possess a CA inhibition mechanism distinct of that of the sulfonamides sulfamates used clinically or the coumarins",
    "simplified": "Phenols like the ones investigated here have a different mechanism of action from the coumarins. The coumarins are used in medicine."
  },
  {
    "text": "Natural product polyphenols and phenolic acids can be used to inhibit mammalian isoforms IXIV .",
    "triple_list": [
      [
        "mammalian isoforms IXIV",
        "CPR:4",
        "polyphenols"
      ],
      [
        "mammalian isoforms IXIV",
        "CPR:4",
        "phenolic acids"
      ]
    ],
    "updated": "Yes",
    "original": "Inhibition of mammalian isoforms IXIV with a series of natural product polyphenols and phenolic acids",
    "simplified": "Natural product polyphenols and phenolic acids can be used to inhibit mammalian isoforms IXIV."
  },
  {
    "text": "Lserine dehydratase SDH a member of the betafamily of pyridoxal phosphatedependent PLP enzymes catalyzes the deamination of Lserine and Lthreonine to yield pyruvate or 2oxobutyrate",
    "triple_list": [
      [
        "Lserine",
        "CPR:9",
        "Lserine dehydratase"
      ],
      [
        "Lserine",
        "CPR:9",
        "SDH"
      ],
      [
        "Lserine dehydratase",
        "CPR:9",
        "Lthreonine"
      ],
      [
        "SDH",
        "CPR:9",
        "Lthreonine"
      ],
      [
        "Lserine dehydratase",
        "CPR:9",
        "pyruvate"
      ],
      [
        "SDH",
        "CPR:9",
        "pyruvate"
      ],
      [
        "Lserine dehydratase",
        "CPR:9",
        "2oxobutyrate"
      ],
      [
        "SDH",
        "CPR:9",
        "2oxobutyrate"
      ]
    ],
    "updated": "No",
    "original": "Lserine dehydratase SDH a member of the betafamily of pyridoxal phosphatedependent PLP enzymes catalyzes the deamination of Lserine and Lthreonine to yield pyruvate or 2oxobutyrate",
    "simplified": "Lserine dehydratase SDH is a member of the pyridoxal phosphatedependent PLP enzyme family. It breaks down lserine and lthreonine into pyruvate and riboflavin."
  },
  {
    "text": "A series of carbamoylmethylene linked prodrugs of 1 BMS582949 a clinical p38\u03b1 inhibitor were synthesized and evaluated",
    "triple_list": [
      [
        "carbamoylmethylene",
        "CPR:4",
        "p38\u03b1"
      ],
      [
        "BMS582949",
        "CPR:4",
        "p38\u03b1"
      ]
    ],
    "updated": "No",
    "original": "A series of carbamoylmethylene linked prodrugs of 1 BMS582949 a clinical p38\u03b1 inhibitor were synthesized and evaluated",
    "simplified": "A series of carbamoylmethylene linked prodrugs were synthesized and evaluated to see if they worked."
  },
  {
    "text": "Synthesis and evaluation of carbamoylmethylene linked prodrugs of BMS582949 a clinical p38\u03b1 inhibitor",
    "triple_list": [
      [
        "carbamoylmethylene",
        "CPR:4",
        "p38\u03b1"
      ],
      [
        "BMS582949",
        "CPR:4",
        "p38\u03b1"
      ]
    ],
    "updated": "No",
    "original": "Synthesis and evaluation of carbamoylmethylene linked prodrugs of BMS582949 a clinical p38\u03b1 inhibitor",
    "simplified": "Carbamoylmethylene (BMS582949) is a chemical compound. It is a type of drug."
  },
  {
    "text": "A longterm intake of ethanol solution downregulates the phosphorylation of CREB in the nucleus accumbens and those changes can be reversed by naloxone . This may be one of the molecular mechanisms involved in ethanol dependence .",
    "triple_list": [
      [
        "CREB",
        "CPR:3",
        "naloxone"
      ],
      [
        "ethanol",
        "CPR:4",
        "CREB"
      ]
    ],
    "updated": "Yes",
    "original": "CONCLUSION A longterm intake of ethanol solution downregulates the phosphorylation of CREB in the nucleus accumbens and those changes can be reversed by naloxone which may be one kind of the molecular mechanisms associated with ethanol dependence",
    "simplified": "A longterm intake of ethanol solution downregulates the phosphorylation of CREB in the nucleus accumbens and those changes can be reversed by naloxone. This may be one of the molecular mechanisms involved in ethanol dependence."
  },
  {
    "text": "The level of pCREB protein in the nucleus accumbens remained at 24 h 35 and 72 h 28 after ethanol withdrawal . After 7 days , it went back to its control level .",
    "triple_list": [
      [
        "pCREB",
        "CPR:4",
        "ethanol"
      ],
      [
        "pCREB",
        "CPR:4",
        "ethanol"
      ]
    ],
    "updated": "Yes",
    "original": "The decrement of pCREB protein in the nucleus accumbens remained at 24 h 35 and 72 h 28 of ethanol withdrawal which recovered toward control level after 7 d of ethanol withdrawal",
    "simplified": "The level of pCREB protein in the nucleus accumbens remained at 24 h 35 and 72 h 28 after ethanol withdrawal. After 7 days, it went back to its control level."
  },
  {
    "text": "However when naloxone was administered concurrently with ethanol treatment it antagonized the downregulation of pCREB protein in the nucleus accumbens 142 of rats exposed to ethanol",
    "triple_list": [
      [
        "ethanol",
        "CPR:4",
        "pCREB"
      ],
      [
        "ethanol",
        "CPR:4",
        "pCREB"
      ]
    ],
    "updated": "No",
    "original": "However when naloxone was administered concurrently with ethanol treatment it antagonized the downregulation of pCREB protein in the nucleus accumbens 142 of rats exposed to ethanol",
    "simplified": "However, when naloxone was given at the same time as ethanol treatment, it did not work at all. It did not work at all in the nucleus accumbens of rats exposed to ethanol."
  },
  {
    "text": "RESULTS Ethanol given to rats in drinking water decreased the level of pCREB protein in the nucleus accumbens 75 at the time of exposure to ethanol",
    "triple_list": [
      [
        "Ethanol",
        "CPR:4",
        "pCREB"
      ]
    ],
    "updated": "No",
    "original": "RESULTS Ethanol given to rats in drinking water decreased the level of pCREB protein in the nucleus accumbens 75 at the time of exposure to ethanol",
    "simplified": "The level of pCREB protein in the nucleus accumbens 75 decreased when ethanol was given to the rats in drinking water."
  },
  {
    "text": "The A2A adenosine receptor agonist CGS21680 C23H29N7O6HClxH2O 000101 \u03bcM did not make any changes .",
    "triple_list": [
      [
        "A2A adenosine receptor",
        "CPR:5",
        "C23H29N7O6HClxH2O"
      ],
      [
        "A2A adenosine receptor",
        "CPR:5",
        "CGS21680"
      ]
    ],
    "updated": "Yes",
    "original": "The A2A adenosine receptor agonist CGS21680 C23H29N7O6HClxH2O 000101 \u03bcM did not alter NE oxidation currents",
    "simplified": "The A2A adenosine receptor agonist CGS21680 C23H29N7O6HClxH2O 000101 \u03bcM did not make any changes."
  },
  {
    "text": "Adenosine and N6cyclopentyladenosine CPA A1R agonist constricted MVs but not MAs",
    "triple_list": [
      [
        "CPA",
        "CPR:5",
        "A1R"
      ],
      [
        "Adenosine",
        "CPR:5",
        "A1R"
      ],
      [
        "N6cyclopentyladenosine",
        "CPR:5",
        "A1R"
      ]
    ],
    "updated": "No",
    "original": "Adenosine and N6cyclopentyladenosine CPA A1R agonist constricted MVs but not MAs",
    "simplified": "Adenosine and N6cyclopentyladenosine constrict blood vessels but not arteries."
  },
  {
    "text": "Pasireotide Signifor is a new subcutaneous somatostatin analogue that acts via somatostatin receptors in patients with Cushings disease by inhibiting the production of corticotropin .",
    "triple_list": [
      [
        "Pasireotide",
        "CPR:4",
        "corticotropin"
      ],
      [
        "Signifor",
        "CPR:4",
        "corticotropin"
      ]
    ],
    "updated": "Yes",
    "original": "Pasireotide Signifor \u00ae is a new subcutaneous somatostatin analogue that acts via somatostatin receptors to inhibit the secretion of corticotropin from the pituitary adenoma in patients with Cushings disease",
    "simplified": "Pasireotide Signifor is a new subcutaneous somatostatin analogue that acts via somatostatin receptors in patients with Cushings disease by inhibiting the production of corticotropin."
  },
  {
    "text": "SB365 also showed antiangiogenic activity by reducing the expression of VEGF and HIF1\u03b1 .",
    "triple_list": [
      [
        "SB365",
        "CPR:4",
        "HIF1\u03b1"
      ],
      [
        "SB365",
        "CPR:4",
        "VEGF"
      ]
    ],
    "updated": "Yes",
    "original": "Also SB365 showed antiangiogenic activity by decreasing the expression of HIF1\u03b1 and VEGF",
    "simplified": "SB365 also showed antiangiogenic activity by reducing the expression of VEGF and HIF1\u03b1."
  },
  {
    "text": "When further examined , SB365 effectively suppressed the AKT mTOR pathway both in vitro and in human cells .",
    "triple_list": [
      [
        "SB365",
        "CPR:4",
        "AKT"
      ],
      [
        "SB365",
        "CPR:4",
        "mTOR"
      ]
    ],
    "updated": "Yes",
    "original": "When further examined for its anticancer mechanism SB365 effectively suppressed the AKT mTOR pathway both in vitro and in vivo",
    "simplified": "When further examined, SB365 effectively suppressed the AKT mTOR pathway both in vitro and in human cells."
  },
  {
    "text": "Together , our study showed that SB365 inhibits the AKT mTOR pathway . This results in a reduction in tumor growth and angiogenesis , as well as apoptosis .",
    "triple_list": [
      [
        "SB365",
        "CPR:4",
        "AKT"
      ],
      [
        "SB365",
        "CPR:4",
        "mTOR"
      ]
    ],
    "updated": "Yes",
    "original": "Taken together our study demonstrated that SB365 inhibits the AKT mTOR pathway leading to the suppression of tumor growth and angiogenesis together with induction of apoptosis",
    "simplified": "Together, our study showed that SB365 inhibits the AKT mTOR pathway. This results in a reduction in tumor growth and angiogenesis, as well as apoptosis."
  },
  {
    "text": "In this study , we used a model of gentamicin C GMC-induced reduction in SGLT1 activity to determine whether megalin ligands could protect LLCPK1 cells from the GMC-induced reduction .",
    "triple_list": [
      [
        "gentamicin C",
        "CPR:4",
        "SGLT1"
      ],
      [
        "GMC",
        "CPR:4",
        "SGLT1"
      ],
      [
        "GMC",
        "CPR:4",
        "SGLT1"
      ]
    ],
    "updated": "Yes",
    "original": "In this study using a model of gentamicin C GMCinduced reduction in SGLT1 activity we examined whether ligands for megalin protect LLCPK1 cells from the GMC induced reduction in SGLT1 activity",
    "simplified": "In this study, we used a model of gentamicin C GMC-induced reduction in SGLT1 activity to determine whether megalin ligands could protect LLCPK1 cells from the GMC-induced reduction."
  },
  {
    "text": "Megalin a family of endocytic receptors related to the lowdensity lipoprotein LDL receptor is a major pathway for proximal tubular aminoglycoside accumulation Apolipoprotein E3 apoE3 safeguards pig proximal tubular LLCPK1 cells against reduction in SGLT1 activity induced by gentamicin C",
    "triple_list": [
      [
        "SGLT1",
        "CPR:4",
        "gentamicin C"
      ],
      [
        "endocytic receptors",
        "CPR:9",
        "aminoglycoside"
      ],
      [
        "lowdensity lipoprotein LDL receptor",
        "CPR:9",
        "aminoglycoside"
      ]
    ],
    "updated": "Yes",
    "original": "Apolipoprotein E3 apoE3 safeguards pig proximal tubular LLCPK1 cells against reduction in SGLT1 activity induced by gentamicin C Megalin a family of endocytic receptors related to the lowdensity lipoprotein LDL receptor is a major pathway for proximal tubular aminoglycoside accumulation",
    "simplified": "Megalin a family of endocytic receptors related to the lowdensity lipoprotein LDL receptor is a major pathway for proximal tubular aminoglycoside accumulation Apolipoprotein E3 apoE3 safeguards pig proximal tubular LLCPK1 cells against reduction in SGLT1 activity induced by gentamicin C"
  },
  {
    "text": "We previously reported that aminoglycoside antibiotics reduce SGLT1 dependent glucose transport in pig proximal tubular epithelial LLCPK1 cells in parallel with the order of their nephrotoxicity",
    "triple_list": [
      [
        "aminoglycoside",
        "CPR:4",
        "SGLT1"
      ]
    ],
    "updated": "No",
    "original": "We previously reported that aminoglycoside antibiotics reduce SGLT1 dependent glucose transport in pig proximal tubular epithelial LLCPK1 cells in parallel with the order of their nephrotoxicity",
    "simplified": "We previously reported that aminoglycoside antibiotics reduce the order of their nephrotoxicity in pig proximal tubular epithelial LLCPK1 cells in parallel with the order."
  },
  {
    "text": "Then the cells were treated with various concentrations of apoE3 lactoferrin and bovine serum albumin with or without 100 microgml of GMC and the SGLT1 dependent methyl alphaDglucopyranoside AMG uptake and levels of SGLT1 expression were determined",
    "triple_list": [
      [
        "SGLT1",
        "CPR:9",
        "methyl alphaDglucopyranoside"
      ],
      [
        "SGLT1",
        "CPR:9",
        "AMG"
      ]
    ],
    "updated": "No",
    "original": "Then the cells were treated with various concentrations of apoE3 lactoferrin and bovine serum albumin with or without 100 microgml of GMC and the SGLT1 dependent methyl alphaDglucopyranoside AMG uptake and levels of SGLT1 expression were determined",
    "simplified": "Then the cells were treated with various concentrations of apoE3 lactoferrin and bovine serum albumin with or without 100 microgml of GMC. The levels of SGLT1 and SGLT1 dependent methyl alphaDglucopyranoside were determined."
  },
  {
    "text": "Actions of nizatidine a selective histamine H2receptor antagonist on gastric acid secretion in dogs rats and frogs",
    "triple_list": [
      [
        "nizatidine",
        "CPR:6",
        "histamine H2receptor"
      ]
    ],
    "updated": "No",
    "original": "Actions of nizatidine a selective histamine H2receptor antagonist on gastric acid secretion in dogs rats and frogs",
    "simplified": "Nizatidine is a selective histamine H2receptor antagonist. It works best against gastric acid secretion."
  },
  {
    "text": "Nizatidine LY139037 a selective histamine H2receptor antagonist is a drug that is used in medicine .",
    "triple_list": [
      [
        "Nizatidine",
        "CPR:6",
        "histamine H2receptor"
      ],
      [
        "LY139037",
        "CPR:6",
        "histamine H2receptor"
      ]
    ],
    "updated": "Yes",
    "original": "Nizatidine LY139037 a selective histamine H2receptor antagonist is a potent inhibitor of gastric acid secretion",
    "simplified": "Nizatidine LY139037 a selective histamine H2receptor antagonist is a drug that is used in medicine."
  },
  {
    "text": "Based on these suggestions the rational redesign of furanopyrimidine 24 clog P=741 Aurora A IC50 =43 nM HCT116 IC50 =400 nM led to the identification of quinazoline 67 clog P=528 Aurora A IC50 =25 nM HCT116 IC50 =23 nM",
    "triple_list": [
      [
        "furanopyrimidine",
        "CPR:4",
        "Aurora A"
      ],
      [
        "Aurora A",
        "CPR:4",
        "quinazoline"
      ]
    ],
    "updated": "No",
    "original": "Based on these suggestions the rational redesign of furanopyrimidine 24 clog P=741 Aurora A IC50 =43 nM HCT116 IC50 =400 nM led to the identification of quinazoline 67 clog P=528 Aurora A IC50 =25 nM HCT116 IC50 =23 nM",
    "simplified": "Based on these suggestions the rational redesign of furanopyrimidine 24 clog P=741 Aurora A IC50 =43 nM HCT116 IC50 =400 nM was found. Quinazoline P=528 Aurora A IC50 =25 nM HCT116 IC50 =23 nM was also found."
  },
  {
    "text": "Three different 3DQSAR models were built and validated by using a set of 66 pyrazole Model I and furanopyrimidine Model II compounds with IC50 values toward Aurora kinase A ranging from 33 nM to 105 \u03bcM",
    "triple_list": [
      [
        "pyrazole",
        "CPR:4",
        "Aurora kinase A"
      ],
      [
        "furanopyrimidine",
        "CPR:4",
        "Aurora kinase A"
      ]
    ],
    "updated": "No",
    "original": "Three different 3DQSAR models were built and validated by using a set of 66 pyrazole Model I and furanopyrimidine Model II compounds with IC50 values toward Aurora kinase A ranging from 33 nM to 105 \u03bcM",
    "simplified": "Three different 3DQSAR models were built and validated by using a set of 66 pyrazole Model I and furanopyrimidine Model II compounds. The IC50 value for the furanopyrimidine was at 50."
  },
  {
    "text": "3DQSARassisted drug design identification of a potent quinazoline based Aurora kinase inhibitor",
    "triple_list": [
      [
        "quinazoline",
        "CPR:4",
        "Aurora kinase"
      ]
    ],
    "updated": "No",
    "original": "3DQSARassisted drug design identification of a potent quinazoline based Aurora kinase inhibitor",
    "simplified": "3DQSARassisted drug design identification of a potent anti-angiogenic drug"
  },
  {
    "text": "Chelation of calcium by BAPTAAM or blocking ERK12 by UO126 also stopped the NMDA effects .",
    "triple_list": [
      [
        "ERK12",
        "CPR:4",
        "UO126"
      ]
    ],
    "updated": "Yes",
    "original": "Chelation of calcium ions by BAPTAAM or blockade of ERK12 activation by UO126 also prevented the NMDA effects",
    "simplified": "Chelation of calcium by BAPTAAM or blocking ERK12 by UO126 also stopped the NMDA effects."
  },
  {
    "text": "NMDA receptors are found in neurons in the hippocampus . When they are activated , GABAR \u03b4 subunit expression is reduced through Ca2 entry .",
    "triple_list": [
      [
        "GABAR \u03b4 subunit",
        "CPR:4",
        "Ca2"
      ]
    ],
    "updated": "Yes",
    "original": "Thus prolonged activation of NMDA receptors in hippocampal neurons reduced GABAR \u03b4 subunit expression through Ca2 entry and at least in part by ERK12 activation",
    "simplified": "NMDA receptors are found in neurons in the hippocampus. When they are activated, GABAR \u03b4 subunit expression is reduced through Ca2 entry."
  },
  {
    "text": "Amitriptyline but not any other tricyclic or selective serotonin reuptake inhibitor helps primary neurons to produce more TrkA ( the chemical that makes neurons work ) .",
    "triple_list": [
      [
        "Amitriptyline",
        "CPR:3",
        "TrkA"
      ]
    ],
    "updated": "Yes",
    "original": "Amitriptyline but not any other tricyclic or selective serotonin reuptake inhibitor antidepressants promotes TrkA autophosphorylation in primary neurons and induces neurite outgrowth in PC12 cells",
    "simplified": "Amitriptyline but not any other tricyclic or selective serotonin reuptake inhibitor helps primary neurons to produce more TrkA (the chemical that makes neurons work)."
  },
  {
    "text": "Thus amitriptyline acts as a TrkA and TrkB agonist . It also acts as a neurotrophic agent .",
    "triple_list": [
      [
        "amitriptyline",
        "CPR:5",
        "TrkB"
      ],
      [
        "amitriptyline",
        "CPR:5",
        "TrkA"
      ]
    ],
    "updated": "Yes",
    "original": "Thus amitriptyline acts as a TrkA and TrkB agonist and possesses marked neurotrophic activity",
    "simplified": "Thus amitriptyline acts as a TrkA and TrkB agonist. It also acts as a neurotrophic agent."
  },
  {
    "text": "Amitriptyline is a TrkA and TrkB receptor agonist . It works by binding to the TrkATrkB and TrkA receptors .",
    "triple_list": [
      [
        "Amitriptyline",
        "CPR:5",
        "TrkA"
      ],
      [
        "Amitriptyline",
        "CPR:5",
        "TrkB"
      ]
    ],
    "updated": "Yes",
    "original": "Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkATrkB heterodimerization and has potent neurotrophic activity",
    "simplified": "Amitriptyline is a TrkA and TrkB receptor agonist. It works by binding to the TrkATrkB and TrkA receptors."
  },
  {
    "text": "Increased phosphorylation of p95ErbB2 and AKT in response to HRG was abrogated to varying degrees by GW572016",
    "triple_list": [
      [
        "p95ErbB2",
        "CPR:4",
        "GW572016"
      ],
      [
        "AKT",
        "CPR:4",
        "GW572016"
      ]
    ],
    "updated": "No",
    "original": "Increased phosphorylation of p95ErbB2 and AKT in response to HRG was abrogated to varying degrees by GW572016",
    "simplified": "Increased phosphorylation of AKT and p95ErbB2 in response to HRG has been reported in several studies."
  },
  {
    "text": "GW572016 a reversible small molecule inhibitor of EGFR and ErbB2 tyrosine kinases inhibits baseline p95ErbB2 phosphorylation in BT474 cells and tumor xenografts",
    "triple_list": [
      [
        "GW572016",
        "CPR:4",
        "EGFR"
      ],
      [
        "GW572016",
        "CPR:4",
        "ErbB2"
      ],
      [
        "GW572016",
        "CPR:4",
        "tyrosine kinases"
      ],
      [
        "GW572016",
        "CPR:4",
        "p95ErbB2"
      ]
    ],
    "updated": "No",
    "original": "GW572016 a reversible small molecule inhibitor of EGFR and ErbB2 tyrosine kinases inhibits baseline p95ErbB2 phosphorylation in BT474 cells and tumor xenografts",
    "simplified": "GW572016 a reversible small molecule inhibitor of ErbB2 tyrosine kinases in BT474 cells and tumor xenografts inhibits baseline p95ErbB2 phosphorylation"
  },
  {
    "text": "Inhibition of p95ErbB2 p185ErbB2 and EGFR phosphorylation by GW572016 resulted in the inhibition of downstream phospho Erk12 phospho AKT and cyclin D steadystate protein levels",
    "triple_list": [
      [
        "p95ErbB2",
        "CPR:4",
        "GW572016"
      ],
      [
        "p185ErbB2",
        "CPR:4",
        "GW572016"
      ],
      [
        "EGFR",
        "CPR:4",
        "GW572016"
      ],
      [
        "GW572016",
        "CPR:4",
        "Erk12"
      ],
      [
        "GW572016",
        "CPR:4",
        "AKT"
      ],
      [
        "GW572016",
        "CPR:4",
        "cyclin D"
      ]
    ],
    "updated": "No",
    "original": "Inhibition of p95ErbB2 p185ErbB2 and EGFR phosphorylation by GW572016 resulted in the inhibition of downstream phospho Erk12 phospho AKT and cyclin D steadystate protein levels",
    "simplified": "Inhibition of EGFR phosphorylation by p95ErbB2 and p185ErbB2 resulted in the inhibition of downstream AKT and cyclin D steadystate protein levels."
  },
  {
    "text": "Truncated ErbB2 receptor p95ErbB2 is highly sensitive to the double EGFR ErbB2 kinase inhibitor GW572016 and is regulated by heregulin .",
    "triple_list": [
      [
        "ErbB2",
        "CPR:4",
        "GW572016"
      ]
    ],
    "updated": "Yes",
    "original": "Truncated ErbB2 receptor p95ErbB2 is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EGFR ErbB2 kinase inhibitor GW572016",
    "simplified": "Truncated ErbB2 receptor p95ErbB2 is highly sensitive to the double EGFR ErbB2 kinase inhibitor GW572016 and is regulated by heregulin."
  },
  {
    "text": "Sulindac sulfide did not allow PPARdelta to be made , and PPARdelta were not made .",
    "triple_list": [
      [
        "Sulindac sulfide",
        "CPR:4",
        "PPARdelta"
      ],
      [
        "Sulindac sulfide",
        "CPR:4",
        "PPARdelta"
      ]
    ],
    "updated": "Yes",
    "original": "Sulindac sulfide inhibited PPARdelta protein expression and PPARdelta transcriptional activity",
    "simplified": "Sulindac sulfide did not allow PPARdelta to be made, and PPARdelta were not made."
  },
  {
    "text": "Sulindac sulfide stopped 1433epsilon proteins from being made in HT29 and DLD1 cells .",
    "triple_list": [
      [
        "Sulindac sulfide",
        "CPR:4",
        "1433epsilon proteins"
      ]
    ],
    "updated": "Yes",
    "original": "Sulindac sulfide inhibited 1433epsilon proteins in HT29 and DLD1 cells in a time and concentrationdependent manner",
    "simplified": "Sulindac sulfide stopped 1433epsilon proteins from being made in HT29 and DLD1 cells."
  },
  {
    "text": "Indomethacin and SC236 a selective cyclooxygenase2 COX2 inhibitor exerted a similar effect as sulindac",
    "triple_list": [
      [
        "Indomethacin",
        "CPR:4",
        "cyclooxygenase2"
      ],
      [
        "Indomethacin",
        "CPR:4",
        "COX2"
      ],
      [
        "SC236",
        "CPR:4",
        "cyclooxygenase2"
      ],
      [
        "SC236",
        "CPR:4",
        "COX2"
      ]
    ],
    "updated": "No",
    "original": "Indomethacin and SC236 a selective cyclooxygenase2 COX2 inhibitor exerted a similar effect as sulindac",
    "simplified": "Indomethacin and SC236 a cyclooxygenase2 inhibitor had the same effect, but not as good."
  },
  {
    "text": "Synergistic cytotoxicity was demonstrated and pemetrexed significantly decreased the amount of phosphorylated Akt enhanced apoptosis and increased the expression of dCK in A549 and Calu6 cells as well as the expression of the human nucleoside equilibrative transporter 1 hENT1 in all cell lines",
    "triple_list": [
      [
        "pemetrexed",
        "CPR:3",
        "dCK"
      ],
      [
        "pemetrexed",
        "CPR:3",
        "human nucleoside equilibrative transporter 1"
      ],
      [
        "pemetrexed",
        "CPR:3",
        "hENT1"
      ],
      [
        "pemetrexed",
        "CPR:4",
        "phosphorylated Akt"
      ]
    ],
    "updated": "No",
    "original": "Synergistic cytotoxicity was demonstrated and pemetrexed significantly decreased the amount of phosphorylated Akt enhanced apoptosis and increased the expression of dCK in A549 and Calu6 cells as well as the expression of the human nucleoside equilibrative transporter 1 hENT1 in all cell lines",
    "simplified": "Synergistic cytotoxicity was demonstrated and pemetrexed significantly decreased the amount of dCK in A549 and Calu6 cells as well as the expression of the human nucleoside equilibrative transporter 1 hENT1 in all cell lines."
  },
  {
    "text": "These data demonstrated that 1 gemcitabine and pemetrexed synergistically interact against NSCLC cells through the suppression of Akt phosphorylation and induction of apoptosis 2 and 3 pemetrexed enhances dCK and hENT1 expression thus suggesting the role of geneexpression modulation for rational development of chemotherapy combinations The effects of gemcitabine and pemetrexed are similar .",
    "triple_list": [
      [
        "pemetrexed",
        "CPR:3",
        "dCK"
      ],
      [
        "pemetrexed",
        "CPR:3",
        "hENT1"
      ],
      [
        "gemcitabine",
        "CPR:4",
        "Akt"
      ],
      [
        "pemetrexed",
        "CPR:4",
        "Akt"
      ]
    ],
    "updated": "Yes",
    "original": "These data demonstrated that 1 gemcitabine and pemetrexed synergistically interact against NSCLC cells through the suppression of Akt phosphorylation and induction of apoptosis 2 the gene expression profile of critical genes may predict for drug chemosensitivity and 3 pemetrexed enhances dCK and hENT1 expression thus suggesting the role of geneexpression modulation for rational development of chemotherapy combinations",
    "simplified": "These data demonstrated that 1 gemcitabine and pemetrexed synergistically interact against NSCLC cells through the suppression of Akt phosphorylation and induction of apoptosis 2 and 3 pemetrexed enhances dCK and hENT1 expression thus suggesting the role of geneexpression modulation for rational development of chemotherapy combinations The effects of gemcitabine and pemetrexed are similar."
  },
  {
    "text": "Kynurenic acid KA is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors",
    "triple_list": [
      [
        "Kynurenic acid",
        "CPR:6",
        "glutamate receptor"
      ],
      [
        "Kynurenic acid",
        "CPR:6",
        "ionotropic glutamate receptors"
      ],
      [
        "KA",
        "CPR:6",
        "glutamate receptor"
      ],
      [
        "KA",
        "CPR:6",
        "ionotropic glutamate receptors"
      ]
    ],
    "updated": "No",
    "original": "Kynurenic acid KA is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors",
    "simplified": "Kynurenic acid, also known as nicotinic acid, is a chemical compound. It is an antagonist of glutamate receptors."
  },
  {
    "text": "One of the enzymes responsible for the production of KA kynurenine aminotransferase I KATI also catalyses the reversible transamination of glutamine to oxoglutaramic acid GTK EC 26115",
    "triple_list": [
      [
        "KA",
        "CPR:9",
        "kynurenine aminotransferase I"
      ],
      [
        "KA",
        "CPR:9",
        "KATI"
      ],
      [
        "kynurenine aminotransferase I",
        "CPR:9",
        "glutamine"
      ],
      [
        "KATI",
        "CPR:9",
        "glutamine"
      ],
      [
        "glutamine",
        "CPR:9",
        "GTK"
      ],
      [
        "kynurenine aminotransferase I",
        "CPR:9",
        "oxoglutaramic acid"
      ],
      [
        "KATI",
        "CPR:9",
        "oxoglutaramic acid"
      ],
      [
        "oxoglutaramic acid",
        "CPR:9",
        "GTK"
      ],
      [
        "oxoglutaramic acid",
        "CPR:9",
        "EC 26115"
      ]
    ],
    "updated": "No",
    "original": "One of the enzymes responsible for the production of KA kynurenine aminotransferase I KATI also catalyses the reversible transamination of glutamine to oxoglutaramic acid GTK EC 26115",
    "simplified": "One of the enzymes is called KA kynurenine aminotransferase I KATI. It changes glutamine into oxoglutaramic acid and then back again."
  },
  {
    "text": "Combined treatment with DA and Mn increases cell toxicity and increases JNK phosphorylation in LRRK2-deficient cells compared to controls",
    "triple_list": [
      [
        "Mn",
        "CPR:3",
        "JNK"
      ]
    ],
    "updated": "Yes",
    "original": "Combined treatment of Mn and DA further augments cell toxicity ROS production and JNK phosphorylation in LRRK2 deficient cells compared to controls",
    "simplified": "Combined treatment with DA and Mn increases cell toxicity and increases JNK phosphorylation in LRRK2-deficient cells compared to controls"
  },
  {
    "text": "Although the treatment with MSG increased IRS1 tyrosine phosphorylation pIRS1 by 96 MSG 1702 \u00b1 06 control 87 \u00b1 02 au",
    "triple_list": [
      [
        "MSG",
        "CPR:3",
        "pIRS1"
      ],
      [
        "MSG",
        "CPR:3",
        "pIRS1"
      ]
    ],
    "updated": "No",
    "original": "Although the treatment with MSG increased IRS1 tyrosine phosphorylation pIRS1 by 96 MSG 1702 \u00b1 06 control 87 \u00b1 02 au",
    "simplified": "Although the treatment with MSG increased IRS1 tyrosine phosphorylation by 96, it still does not completely control it."
  },
  {
    "text": "On the other hand exercise training increased pIR by 76 in MSG mice without affecting control mice . The difference in pIR between the two groups",
    "triple_list": [
      [
        "pIR",
        "CPR:4",
        "MSG"
      ],
      [
        "pIR",
        "CPR:4",
        "MSG"
      ]
    ],
    "updated": "Yes",
    "original": "on the other hand exercise training increased pIR by 76 in MSG mice without affecting control mice MSG 118 \u00b1 03 control 128 \u00b1 02 au",
    "simplified": "On the other hand exercise training increased pIR by 76 in MSG mice without affecting control mice. The difference in pIR between the two groups"
  },
  {
    "text": "The results showed that IR tyrosine phosphorylation pIR was reduced by 42 in MSGobese mice MSG 67 \u00b1 02 arbitrary units au",
    "triple_list": [
      [
        "pIR",
        "CPR:4",
        "MSG"
      ],
      [
        "pIR",
        "CPR:4",
        "MSG"
      ]
    ],
    "updated": "No",
    "original": "The results showed that IR tyrosine phosphorylation pIR was reduced by 42 in MSGobese mice MSG 67 \u00b1 02 arbitrary units au",
    "simplified": "The results showed that the amount of tyrosine in the blood was reduced by 42% in mice with MSG."
  },
  {
    "text": "With the use of sildenafil it has been clearly clinically demonstrated that the selective inhibition of PDE5 is a safe and effective method for the treatment of ED in certain patients .",
    "triple_list": [
      [
        "sildenafil",
        "CPR:4",
        "PDE5"
      ]
    ],
    "updated": "Yes",
    "original": "With the use of sildenafil it has been clearly clinically demonstrated that the selective inhibition of PDE5 is an appropriate effective safe method for the treatment of ED of all aetiologies and severities",
    "simplified": "With the use of sildenafil it has been clearly clinically demonstrated that the selective inhibition of PDE5 is a safe and effective method for the treatment of ED in certain patients."
  },
  {
    "text": "Many clinical studies both pre and postmarketing have demonstrated the clinical efficacy and safety of sildenafil Viagra Pfizer the first approved selective PDE inhibitor for the treatment of ED",
    "triple_list": [
      [
        "sildenafil",
        "CPR:4",
        "PDE"
      ],
      [
        "Viagra",
        "CPR:4",
        "PDE"
      ]
    ],
    "updated": "No",
    "original": "Many clinical studies both pre and postmarketing have demonstrated the clinical efficacy and safety of sildenafil Viagra Pfizer the first approved selective PDE inhibitor for the treatment of ED",
    "simplified": "Many clinical studies both pre and postmarketing have shown that sildenafil is safe and effective. It was the first PDE inhibitor approved for the treatment of erectile dysfunction."
  },
  {
    "text": "Sildenafil is inhibitory of PDE5 at a rate tenfold higher than for the next PDE PDE6 which produces visual changes through the retinal rods",
    "triple_list": [
      [
        "Sildenafil",
        "CPR:4",
        "PDE5"
      ],
      [
        "Sildenafil",
        "CPR:4",
        "PDE"
      ],
      [
        "Sildenafil",
        "CPR:4",
        "PDE6"
      ]
    ],
    "updated": "No",
    "original": "Sildenafil is inhibitory of PDE5 at a rate tenfold higher than for the next PDE PDE6 which produces visual changes through the retinal rods",
    "simplified": "Sildenafil works by inhibiting PDE5 at a much higher rate than PDE6. PDE6 makes changes in the eyes that can be seen."
  },
  {
    "text": "The scientific basis of this treatment of ED includes relaxation of the corpus cavernosum smooth muscle tissue by inhibition of the hormone PDE5 . The hormone PDE5 breaks down cGMP in the muscle .",
    "triple_list": [
      [
        "PDE5",
        "CPR:9",
        "cGMP"
      ]
    ],
    "updated": "Yes",
    "original": "The scientific basis of this treatment of ED includes relaxation of the corpus cavernosum smooth muscle tissue by inhibition of PDE5 that breaks down cGMP the key pathway for the production of erectile function in humans",
    "simplified": "The scientific basis of this treatment of ED includes relaxation of the corpus cavernosum smooth muscle tissue by inhibition of the hormone PDE5. The hormone PDE5 breaks down cGMP in the muscle."
  },
  {
    "text": "cAspAT activity as well as the incorporation of 14Caspartate into the neutral lipid fraction of 3T3F442A adipocytes was stimulated by the thiazolidinedione TZD rosiglitazone",
    "triple_list": [
      [
        "cAspAT",
        "CPR:3",
        "thiazolidinedione"
      ],
      [
        "cAspAT",
        "CPR:3",
        "TZD"
      ],
      [
        "cAspAT",
        "CPR:3",
        "rosiglitazone"
      ]
    ],
    "updated": "No",
    "original": "cAspAT activity as well as the incorporation of 14Caspartate into the neutral lipid fraction of 3T3F442A adipocytes was stimulated by the thiazolidinedione TZD rosiglitazone",
    "simplified": "cAspAT activity as well as 14Caspartate incorporation into the neutral lipid fraction of 3T3F442A adipocytes was stimulated by rosiglitazone-based thiazolidinedione."
  },
  {
    "text": "RORalpha ectopic expression activated the cAspAT gene transcription in absence of rosiglitazone . The amount of cAspAT in nuclear extracts was increased by 18fold when rosiglitazone was used .",
    "triple_list": [
      [
        "RORalpha",
        "CPR:3",
        "rosiglitazone"
      ],
      [
        "cAspAT",
        "CPR:3",
        "rosiglitazone"
      ]
    ],
    "updated": "Yes",
    "original": "RORalpha ectopic expression activated the cAspAT gene transcription in absence of rosiglitazone and its protein amount in nuclear extracts is 18fold increased by rosiglitazone treatment of adipocytes",
    "simplified": "RORalpha ectopic expression activated the cAspAT gene transcription in absence of rosiglitazone. The amount of cAspAT in nuclear extracts was increased by 18fold when rosiglitazone was used."
  },
  {
    "text": "Finally the amounts of RORalpha and cAspAT mRNAs were also increased by TZD in human adipose tissue explants after TZD treatment .",
    "triple_list": [
      [
        "RORalpha",
        "CPR:3",
        "TZD"
      ],
      [
        "cAspAT",
        "CPR:3",
        "TZD"
      ]
    ],
    "updated": "Yes",
    "original": "Finally the amounts of RORalpha and cAspAT mRNAs were similarly increased by TZD treatment of human adipose tissue explants confirming coordinated regulation",
    "simplified": "Finally the amounts of RORalpha and cAspAT mRNAs were also increased by TZD in human adipose tissue explants after TZD treatment."
  },
  {
    "text": "Our data identify cAspAT as a new member of glyceroneogenesis transcriptionally regulated by PPARgamma in adipocytes via the control of TZD .",
    "triple_list": [
      [
        "cAspAT",
        "CPR:3",
        "TZD"
      ]
    ],
    "updated": "Yes",
    "original": "Our data identify cAspAT as a new member of glyceroneogenesis transcriptionally regulated by TZD via the control of RORalpha expression by PPARgamma in adipocytes",
    "simplified": "Our data identify cAspAT as a new member of glyceroneogenesis transcriptionally regulated by PPARgamma in adipocytes via the control of TZD."
  },
  {
    "text": "The development of navitoclax a selective inhibitor of both BCL2 and BCL2like 1 BCLXL has shown clinical efficacy in some BCL2dependent hematological cancers . This means it can be used to directly inhibit prosurvival proteins .",
    "triple_list": [
      [
        "navitoclax",
        "CPR:4",
        "BCL2"
      ],
      [
        "navitoclax",
        "CPR:4",
        "BCL2like 1"
      ],
      [
        "navitoclax",
        "CPR:4",
        "BCLXL"
      ]
    ],
    "updated": "Yes",
    "original": "The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of navitoclax a selective inhibitor of both BCL2 and BCL2like 1 BCLXL which has shown clinical efficacy in some BCL2dependent hematological cancers",
    "simplified": "The development of navitoclax a selective inhibitor of both BCL2 and BCL2like 1 BCLXL has shown clinical efficacy in some BCL2dependent hematological cancers. This means it can be used to directly inhibit prosurvival proteins."
  },
  {
    "text": "Here we report the reengineering of navitoclax to create a highly potent orally bioavailable and BCL2 selective inhibitor ABT199",
    "triple_list": [
      [
        "navitoclax",
        "CPR:4",
        "BCL2"
      ],
      [
        "BCL2",
        "CPR:4",
        "ABT199"
      ]
    ],
    "updated": "No",
    "original": "Here we report the reengineering of navitoclax to create a highly potent orally bioavailable and BCL2 selective inhibitor ABT199",
    "simplified": "Here we report the reengineering of navitoclax to create a highly potent BCL2 selective and orally bioavailable inhibitor."
  },
  {
    "text": "ABT199 a potent and selective BCL2 inhibitor while sparing platelets has been developed .",
    "triple_list": [
      [
        "ABT199",
        "CPR:4",
        "BCL2"
      ]
    ],
    "updated": "Yes",
    "original": "ABT199 a potent and selective BCL2 inhibitor achieves antitumor activity while sparing platelets",
    "simplified": "ABT199 a potent and selective BCL2 inhibitor while sparing platelets has been developed."
  },
  {
    "text": "The drug SB431542 significantly reduced the release of VEGF by HFL1 in response to CSE . This effect was confirmed by T\u03b2R1 siRNA studies .",
    "triple_list": [
      [
        "T\u03b2R1",
        "CPR:4",
        "SB431542"
      ],
      [
        "SB431542",
        "CPR:4",
        "VEGF"
      ]
    ],
    "updated": "Yes",
    "original": "Suppression of T\u03b2R1 by the pharmacological inhibitor SB431542 markedly reduced VEGF release by HFL1 in response to CSE and this effect was confirmed by T\u03b2R1 siRNA",
    "simplified": "The drug SB431542 significantly reduced the release of VEGF by HFL1 in response to CSE. This effect was confirmed by T\u03b2R1 siRNA studies."
  },
  {
    "text": "NCFP binds to the CPPHA site on mGlu5 and potentiates the response , making the mGlu5 receptor stronger .",
    "triple_list": [
      [
        "NCFP",
        "CPR:3",
        "mGlu5"
      ]
    ],
    "updated": "Yes",
    "original": "NCFP binds to the CPPHA site on mGlu5 and potentiates mGlu5 mediated responses in both recombinant and native systems",
    "simplified": "NCFP binds to the CPPHA site on mGlu5 and potentiates the response, making the mGlu5 receptor stronger."
  },
  {
    "text": "Combination treatment with the selective 5HT1A antagonist WAY100635 produced a small increase in extracellular 5HT concentrations but had no further effect on NA above that produced by venlafaxine alone .",
    "triple_list": [
      [
        "5HT1A",
        "CPR:6",
        "WAY100635"
      ]
    ],
    "updated": "Yes",
    "original": "Combination treatment with the selective 5HT1A antagonist WAY100635 produced a dosedependent augmentation of venlafaxineinduced 330 mgkg sc extracellular 5HT concentrations but had no further effect on NA above that produced by venlafaxine alone",
    "simplified": "Combination treatment with the selective 5HT1A antagonist WAY100635 produced a small increase in extracellular 5HT concentrations but had no further effect on NA above that produced by venlafaxine alone."
  },
  {
    "text": "The betaadrenergic 5HT1A receptor antagonist pindolol and the selective 5HT1BD antagonist GR127935 did not improve the effects of venlafaxine on the 5HT or NA levels .",
    "triple_list": [
      [
        "5HT1A",
        "CPR:6",
        "pindolol"
      ]
    ],
    "updated": "Yes",
    "original": "The betaadrenergic 5HT1A receptor antagonist pindolol and the selective 5HT1BD antagonist GR127935 produced no significant augmentation of venlafaxineinduced changes in either 5HT or NA",
    "simplified": "The betaadrenergic 5HT1A receptor antagonist pindolol and the selective 5HT1BD antagonist GR127935 did not improve the effects of venlafaxine on the 5HT or NA levels."
  },
  {
    "text": "However topiramate at low concentrations causes slow inhibition of GluR5 kainate receptormediated synaptic currents in the basolateral amygdala indicating that it may protect against seizures at least in part through suppression of GluR5 kainate receptor responses",
    "triple_list": [
      [
        "topiramate",
        "CPR:4",
        "GluR5"
      ],
      [
        "topiramate",
        "CPR:4",
        "kainate receptor"
      ],
      [
        "topiramate",
        "CPR:4",
        "GluR5"
      ],
      [
        "topiramate",
        "CPR:4",
        "kainate receptor"
      ]
    ],
    "updated": "No",
    "original": "However topiramate at low concentrations causes slow inhibition of GluR5 kainate receptormediated synaptic currents in the basolateral amygdala indicating that it may protect against seizures at least in part through suppression of GluR5 kainate receptor responses",
    "simplified": "However topiramate at low concentrations causes slow inhibition of GluR5 kainate synaptic currents in the basolateral amygdala. This means that it may protect against seizures, at least in part by stopping GluR5 kainate from being released."
  },
  {
    "text": "The selective GluR5 kainate receptor agonist ATPA induces spontaneous epileptiform bursting that is sensitive to the GluR5 kainate receptor antagonist LY293558",
    "triple_list": [
      [
        "GluR5",
        "CPR:6",
        "LY293558"
      ],
      [
        "kainate receptor",
        "CPR:6",
        "LY293558"
      ]
    ],
    "updated": "No",
    "original": "The selective GluR5 kainate receptor agonist ATPA induces spontaneous epileptiform bursting that is sensitive to the GluR5 kainate receptor antagonist LY293558",
    "simplified": "The GluR5 kainate receptor agonist ATPA is a drug that works on the GluR5 kainate receptor. It causes spontaneous epileptiform bursting."
  },
  {
    "text": "The ultimate carcinogenic Phase I BP metabolite antiBP78dihydrodiol910epoxide BPDE can be detoxified by glutathione conjugate formation catalyzed by glutathione Stransferases",
    "triple_list": [
      [
        "glutathione",
        "CPR:9",
        "glutathione Stransferases"
      ]
    ],
    "updated": "No",
    "original": "The ultimate carcinogenic Phase I BP metabolite antiBP78dihydrodiol910epoxide BPDE can be detoxified by glutathione conjugate formation catalyzed by glutathione Stransferases",
    "simplified": "The ultimate carcinogenic Phase I BP metabolite antiBP78dihydrodiol910epoxide can be detoxified by glutathione. This is done by glutathione conjugate formation."
  },
  {
    "text": "Multidrug resistanceassociated proteins are involved in the transport of the glutathione conjugates of the ultimate carcinogen of benzoapyrene in human Caco2 cells",
    "triple_list": [
      [
        "Multidrug resistanceassociated proteins",
        "CPR:9",
        "glutathione"
      ]
    ],
    "updated": "No",
    "original": "Multidrug resistanceassociated proteins are involved in the transport of the glutathione conjugates of the ultimate carcinogen of benzoapyrene in human Caco2 cells",
    "simplified": "Multidrug resistanceassociated proteins are involved in the transport of the carcinogen benzoapyrene in human Caco2 cells through the blood."
  },
  {
    "text": "Inhibition studies revealed that the multidrug resistanceassociated proteins ABCCs are involved in the transport of BPDE glutathione conjugates",
    "triple_list": [
      [
        "multidrug resistanceassociated proteins",
        "CPR:9",
        "BPDE glutathione"
      ],
      [
        "ABCCs",
        "CPR:9",
        "BPDE glutathione"
      ]
    ],
    "updated": "No",
    "original": "Inhibition studies revealed that the multidrug resistanceassociated proteins ABCCs are involved in the transport of BPDE glutathione conjugates",
    "simplified": "Inhibition studies have shown that ABCCs are involved in the transport of BPDE glutathione conjugates when a drug is taken."
  },
  {
    "text": "Stable ABCC1 ABCC2 and ABCC3 knockdown cell lines were generated thus making it possible to demonstrate that ABCC1 mediates the basolateral and ABCC2 the apical excretion of BPDE glutathione conjugates",
    "triple_list": [
      [
        "ABCC1",
        "CPR:9",
        "BPDE glutathione"
      ],
      [
        "ABCC2",
        "CPR:9",
        "BPDE glutathione"
      ],
      [
        "ABCC1",
        "CPR:9",
        "BPDE glutathione"
      ],
      [
        "ABCC2",
        "CPR:9",
        "BPDE glutathione"
      ]
    ],
    "updated": "No",
    "original": "Stable ABCC1 ABCC2 and ABCC3 knockdown cell lines were generated thus making it possible to demonstrate that ABCC1 mediates the basolateral and ABCC2 the apical excretion of BPDE glutathione conjugates",
    "simplified": "Stable ABCC1 ABCC2 and ABCC3 knockdown cell lines were generated, and it was shown that ABCC1 and ABCC2 influence the apical excretion of BPDE and glutathione respectively."
  },
  {
    "text": "Pretreatment of human breast carcinoma MCF7 cells for 24 h with the groundnut extract and soybean isoflavone increased gene expression of heme oxygenase1 HO1 a major antioxidative stress enzyme",
    "triple_list": [
      [
        "isoflavone",
        "CPR:3",
        "heme oxygenase1"
      ],
      [
        "isoflavone",
        "CPR:3",
        "HO1"
      ]
    ],
    "updated": "No",
    "original": "Pretreatment of human breast carcinoma MCF7 cells for 24 h with the groundnut extract and soybean isoflavone increased gene expression of heme oxygenase1 HO1 a major antioxidative stress enzyme",
    "simplified": "Pretreatment of human breast carcinoma MCF7 cells for 24 h with soybean isoflavone increased gene expression of heme oxygenase1, a major stress-reducing enzyme."
  },
  {
    "text": "Comparison of cyclooxygenase inhibitory activity and ocular antiinflammatory effects of ketorolac tromethamine and bromfenac sodium",
    "triple_list": [
      [
        "cyclooxygenase",
        "CPR:4",
        "bromfenac sodium"
      ],
      [
        "cyclooxygenase",
        "CPR:4",
        "ketorolac tromethamine"
      ]
    ],
    "updated": "No",
    "original": "Comparison of cyclooxygenase inhibitory activity and ocular antiinflammatory effects of ketorolac tromethamine and bromfenac sodium",
    "simplified": "The anti-inflammatory and anti-oxidant effects of ketorolac tromethamine and bromfenac sodium in the eye"
  },
  {
    "text": "RESULTS Ketorolac was six times more active against COX1 IC50 = 002 microM than COX2 IC50 = 012 microM while bromfenac was approximately 32 times more active against COX2 IC50 = 00066 microM than COX1 IC50 = 0210 microM",
    "triple_list": [
      [
        "Ketorolac",
        "CPR:4",
        "COX2"
      ],
      [
        "Ketorolac",
        "CPR:4",
        "COX1"
      ],
      [
        "COX1",
        "CPR:4",
        "bromfenac"
      ],
      [
        "COX2",
        "CPR:4",
        "bromfenac"
      ]
    ],
    "updated": "No",
    "original": "RESULTS Ketorolac was six times more active against COX1 IC50 = 002 microM than COX2 IC50 = 012 microM while bromfenac was approximately 32 times more active against COX2 IC50 = 00066 microM than COX1 IC50 = 0210 microM",
    "simplified": "Results Ketorolac was six times more active against COX1 IC50 = 002 microM than COX2 IC50 = 012 microM. Bromfenac was 32 times more active against COX2 IC50 = 0210 microM than against COX1 IC50 = 002 microM."
  },
  {
    "text": "METHODS Cyclooxygenase activity and selectivity were determined in vitro by measuring prostaglandin E2 PGE2 production after NSAID was incubated with human recombinant COX1 or COX2 and arachidonic acid .",
    "triple_list": [
      [
        "Cyclooxygenase",
        "CPR:9",
        "prostaglandin E2"
      ],
      [
        "Cyclooxygenase",
        "CPR:9",
        "PGE2"
      ]
    ],
    "updated": "Yes",
    "original": "METHODS Cyclooxygenase activity and selectivity was determined in vitro by measuring prostaglandin E2 PGE2 production following incubation of varying concentrations of NSAID with human recombinant COX1 or COX2 and arachidonic acid",
    "simplified": "METHODS Cyclooxygenase activity and selectivity were determined in vitro by measuring prostaglandin E2 PGE2 production after NSAID was incubated with human recombinant COX1 or COX2 and arachidonic acid."
  },
  {
    "text": "The EP1 and EP3 receptor antagonists ONO8713 and ONOAE3240 but not the EP4 antagonists ONOAE3208 and AH 23848 did not work . This shows that the EP1 and EP3 are important for cell growth .",
    "triple_list": [
      [
        "EP1",
        "CPR:6",
        "ONO8713"
      ],
      [
        "EP3 receptor",
        "CPR:6",
        "ONO8713"
      ],
      [
        "EP1",
        "CPR:6",
        "ONOAE3240"
      ],
      [
        "EP3 receptor",
        "CPR:6",
        "ONOAE3240"
      ],
      [
        "EP4",
        "CPR:6",
        "ONOAE3208"
      ],
      [
        "EP4",
        "CPR:6",
        "AH 23848"
      ]
    ],
    "updated": "Yes",
    "original": "EP1 and EP3 receptor antagonists ONO8713 and ONOAE3240 but not the EP4 antagonists ONOAE3208 and AH 23848 inhibited tumor cell proliferation indicating the significance of EP1 and EP3 but not EP4 for MB growth",
    "simplified": "The EP1 and EP3 receptor antagonists ONO8713 and ONOAE3240 but not the EP4 antagonists ONOAE3208 and AH 23848 did not work. This shows that the EP1 and EP3 are important for cell growth."
  },
  {
    "text": "Medulloblastoma promoting cyclooxygenase2 prostaglandin E2 pathway provides therapeutic results",
    "triple_list": [
      [
        "cyclooxygenase2",
        "CPR:9",
        "prostaglandin E2"
      ]
    ],
    "updated": "Yes",
    "original": "Tumorgrowthpromoting cyclooxygenase2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets",
    "simplified": "Medulloblastoma promoting cyclooxygenase2 prostaglandin E2 pathway provides therapeutic results"
  },
  {
    "text": "PGE2 is made from arachidonic acid by cyclooxygenases COX and prostaglandin E synthases PGES . It binds to the four prostanoid receptors on the arachidonic acid to make it work .",
    "triple_list": [
      [
        "PGE2",
        "CPR:9",
        "cyclooxygenases"
      ],
      [
        "PGE2",
        "CPR:9",
        "COX"
      ],
      [
        "PGE2",
        "CPR:9",
        "prostaglandin E synthases"
      ],
      [
        "PGE2",
        "CPR:9",
        "PGES"
      ],
      [
        "arachidonic acid",
        "CPR:9",
        "cyclooxygenases"
      ],
      [
        "arachidonic acid",
        "CPR:9",
        "COX"
      ],
      [
        "arachidonic acid",
        "CPR:9",
        "prostaglandin E synthases"
      ],
      [
        "arachidonic acid",
        "CPR:9",
        "PGES"
      ]
    ],
    "updated": "Yes",
    "original": "PGE2 is synthesized from arachidonic acid by cyclooxygenases COX and prostaglandin E synthases PGES and mediates its biological activity through binding to the four prostanoid receptors EP1 through EP4",
    "simplified": "PGE2 is made from arachidonic acid by cyclooxygenases COX and prostaglandin E synthases PGES. It binds to the four prostanoid receptors on the arachidonic acid to make it work."
  },
  {
    "text": "Inhibitors of PDE4 ( rolipram ) and PDE3 ( cilostazol ) slow down eosinophil cell death by up to 25 and 15 times , respectively .",
    "triple_list": [
      [
        "PDE4",
        "CPR:4",
        "rolipram"
      ],
      [
        "PDE3",
        "CPR:4",
        "cilostazol"
      ]
    ],
    "updated": "Yes",
    "original": "Inhibitors of PDE4 rolipram 0110 microM and PDE3 cilostazol 0110 microM delayed spontaneous eosinophil apoptosis maximally by 25 and 15 respectively",
    "simplified": "Inhibitors of PDE4 ( rolipram) and PDE3 (cilostazol) slow down eosinophil cell death by up to 25 and 15 times, respectively."
  },
  {
    "text": "Inhibitor of cGMPspecific PDE5 zaprinast 0110 microM only slightly increased spontaneous neutrophil apoptosis and did not affect eosinophil apoptosis .",
    "triple_list": [
      [
        "cGMPspecific PDE5",
        "CPR:4",
        "zaprinast"
      ]
    ],
    "updated": "Yes",
    "original": "Inhibitor of cGMPspecific PDE5 zaprinast 0110 microM did not affect eosinophil apoptosis and only slightly increased spontaneous neutrophil apoptosis",
    "simplified": "Inhibitor of cGMPspecific PDE5 zaprinast 0110 microM only slightly increased spontaneous neutrophil apoptosis and did not affect eosinophil apoptosis."
  },
  {
    "text": "GW9662 a PPARgamma antagonist prevented P 001 the luteininduced iNOS mRNA downregulation in HD11 cells",
    "triple_list": [
      [
        "GW9662",
        "CPR:3",
        "iNOS"
      ],
      [
        "GW9662",
        "CPR:6",
        "PPARgamma"
      ]
    ],
    "updated": "No",
    "original": "GW9662 a PPARgamma antagonist prevented P 001 the luteininduced iNOS mRNA downregulation in HD11 cells",
    "simplified": "GW9662 a PPARgamma antagonist prevented P 001 from being produced in HD11 cells"
  },
  {
    "text": "We hypothesized that the HED compounds would be most potent at the norepinephrine transporter NET compared to the serotonin or dopamine transporters and that the 1R diastereomers would be more effective than 1S diastereomers",
    "triple_list": [
      [
        "HED",
        "CPR:4",
        "norepinephrine transporter"
      ],
      [
        "HED",
        "CPR:4",
        "NET"
      ]
    ],
    "updated": "No",
    "original": "We hypothesized that the HED compounds would be most potent at the norepinephrine transporter NET compared to the serotonin or dopamine transporters and that the 1R diastereomers would be more effective than 1S diastereomers",
    "simplified": "We hypothesized that the HED compounds would be most potent at the norepinephrine transporter and that the 1R diastereomers would be more effective than the 1S diastereomers at the serotonin transporter."
  },
  {
    "text": "Stereospecific inhibition of monoamine uptake transporters by metahydroxyephedrine isomers",
    "triple_list": [
      [
        "monoamine uptake transporters",
        "CPR:4",
        "metahydroxyephedrine"
      ]
    ],
    "updated": "No",
    "original": "Stereospecific inhibition of monoamine uptake transporters by metahydroxyephedrine isomers",
    "simplified": "Metahydroxyephedrine and monoamine uptake transporters: how they work."
  },
  {
    "text": "To extend structureactivity analyses of binding sites within monoamine transporters we tested the HED compounds for their abilities to inhibit 3Hneurotransmitter uptake into platelets transfected cells and chromaffin vesicles and to determine which stereoisomer displayed the best selectivity for PET imaging .",
    "triple_list": [
      [
        "monoamine transporters",
        "CPR:4",
        "HED"
      ]
    ],
    "updated": "Yes",
    "original": "To extend structureactivity analyses of binding sites within monoamine transporters and to determine which stereoisomer displayed the best selectivity for PET imaging applications we tested the HED compounds for their abilities to inhibit 3Hneurotransmitter uptake into platelets transfected cells and chromaffin vesicles",
    "simplified": "To extend structureactivity analyses of binding sites within monoamine transporters we tested the HED compounds for their abilities to inhibit 3Hneurotransmitter uptake into platelets transfected cells and chromaffin vesicles and to determine which stereoisomer displayed the best selectivity for PET imaging."
  },
  {
    "text": "TCDD inhibition of canonical wnt signaling disrupts prostatic bud formation in mouse urogenital sinus",
    "triple_list": [
      [
        "TCDD",
        "CPR:4",
        "wnt"
      ]
    ],
    "updated": "No",
    "original": "TCDD inhibition of canonical wnt signaling disrupts prostatic bud formation in mouse urogenital sinus",
    "simplified": "TCDD inhibition disrupts the formation of prostatic buds in the urogenital sinus of mice."
  },
  {
    "text": "Thus the TCDD induced reduction in canonical Wnt signaling is associated with a decrease in activators Rspo2 and Rspo3 rather than an increase in inhibitors Dkk1 and Dkk2 of the pathway",
    "triple_list": [
      [
        "TCDD",
        "CPR:4",
        "Wnt"
      ],
      [
        "TCDD",
        "CPR:4",
        "Rspo2"
      ],
      [
        "TCDD",
        "CPR:4",
        "Rspo3"
      ],
      [
        "TCDD",
        "CPR:4",
        "Dkk1"
      ],
      [
        "TCDD",
        "CPR:4",
        "Dkk2"
      ]
    ],
    "updated": "No",
    "original": "Thus the TCDD induced reduction in canonical Wnt signaling is associated with a decrease in activators Rspo2 and Rspo3 rather than an increase in inhibitors Dkk1 and Dkk2 of the pathway",
    "simplified": "Thus the TCDD induced reduction in canonical Wnt signaling is associated with an increase in activators Rspo1 and Rspo2 and a decrease in inhibitors Dkk1 and Dkk2."
  },
  {
    "text": "This study focuses on whether treatment of TCDDexposed UGS organ cultures with RSPO2 andor RSPO3 can rescue the inhibitory effects of TCDD on prostatic bud formation and canonical Wnt signaling .",
    "triple_list": [
      [
        "TCDD",
        "CPR:4",
        "Wnt"
      ]
    ],
    "updated": "Yes",
    "original": "This study focuses on determining whether treatment of TCDDexposed UGS organ cultures with RSPO2 andor RSPO3 is capable of rescuing the inhibitory effects of TCDD on canonical Wnt signaling and prostatic bud formation",
    "simplified": "This study focuses on whether treatment of TCDDexposed UGS organ cultures with RSPO2 andor RSPO3 can rescue the inhibitory effects of TCDD on prostatic bud formation and canonical Wnt signaling."
  },
  {
    "text": "We discovered that each RSPO alone or in combination partially rescues TCDD inhibition of both canonical Wnt signaling and prostatic bud formation",
    "triple_list": [
      [
        "TCDD",
        "CPR:4",
        "Wnt"
      ]
    ],
    "updated": "No",
    "original": "We discovered that each RSPO alone or in combination partially rescues TCDD inhibition of both canonical Wnt signaling and prostatic bud formation",
    "simplified": "We found that each RSPO alone or in combination partially rescues TCDD, but it is not clear how or when this happens."
  },
  {
    "text": "Moreover overexpressed CYP2J2 and EETs inhibited Ang II induced macrophage migration in a VSMCmacrophage coculture system",
    "triple_list": [
      [
        "EETs",
        "CPR:4",
        "Ang II"
      ]
    ],
    "updated": "No",
    "original": "Moreover overexpressed CYP2J2 and EETs inhibited Ang II induced macrophage migration in a VSMCmacrophage coculture system",
    "simplified": "The overexpressed CYP2J2 and EET inhibited Ang II-mediated macrophage migration and cell division."
  },
  {
    "text": "In cultured vascular smooth muscle cells VSMCs and EETs markedly suppressed Ang II induced inflammatory cytokine expression .",
    "triple_list": [
      [
        "EETs",
        "CPR:4",
        "Ang II"
      ],
      [
        "EETs",
        "CPR:4",
        "cytokine"
      ]
    ],
    "updated": "Yes",
    "original": "In cultured vascular smooth muscle cells VSMCs rAAVmediated CYP2J2 overexpression and EETs markedly suppressed Ang II induced inflammatory cytokine expression",
    "simplified": "In cultured vascular smooth muscle cells VSMCs and EETs markedly suppressed Ang II induced inflammatory cytokine expression."
  },
  {
    "text": "Cytochrome P450 epoxygenase 2J2 ( CYP2J2 ) breaks down arachidonic acids to form epoxyeicosatrienoic acids ( EETs ) , which are good for the heart .",
    "triple_list": [
      [
        "Cytochrome P450 epoxygenase 2J2",
        "CPR:9",
        "EETs"
      ],
      [
        "CYP2J2",
        "CPR:9",
        "EETs"
      ],
      [
        "Cytochrome P450 epoxygenase 2J2",
        "CPR:9",
        "arachidonic acids"
      ],
      [
        "CYP2J2",
        "CPR:9",
        "arachidonic acids"
      ],
      [
        "Cytochrome P450 epoxygenase 2J2",
        "CPR:9",
        "epoxyeicosatrienoic acids"
      ],
      [
        "CYP2J2",
        "CPR:9",
        "epoxyeicosatrienoic acids"
      ]
    ],
    "updated": "Yes",
    "original": "Cytochrome P450 epoxygenase 2J2 CYP2J2 metabolizes arachidonic acids to form epoxyeicosatrienoic acids EETs which possess various beneficial effects on the cardiovascular system",
    "simplified": "Cytochrome P450 epoxygenase 2J2 (CYP2J2) breaks down arachidonic acids to form epoxyeicosatrienoic acids (EETs), which are good for the heart."
  },
  {
    "text": "However whether increasing EETs production by CYP2J2 overexpression in vivo could prevent abdominal aortic aneurysm AAA remains unknown",
    "triple_list": [
      [
        "EETs",
        "CPR:9",
        "CYP2J2"
      ]
    ],
    "updated": "No",
    "original": "However whether increasing EETs production by CYP2J2 overexpression in vivo could prevent abdominal aortic aneurysm AAA remains unknown",
    "simplified": "However whether increasing EETs production in animals could prevent abdominal aortic aneurysm AAA is still not known."
  },
  {
    "text": "The activity of the ADA was reduced when the slices were exposed to organoselenium at concentrations of 1 10 and 30 \u00b5M .",
    "triple_list": [
      [
        "ADA",
        "CPR:4",
        "organoselenium"
      ]
    ],
    "updated": "Yes",
    "original": "A decrease in ADA activity was observed when the slices were exposed to organoselenium at the concentrations of 1 10 and 30 \u00b5M",
    "simplified": "The activity of the ADA was reduced when the slices were exposed to organoselenium at concentrations of 1 10 and 30 \u00b5M."
  },
  {
    "text": "Cotreatments of 5 10 and 20 \u00b5gmL MEP with aflatoxin B1 reduced the amount of malondialdehyde and SCE in the blood . It also increased the amount of superoxide dismutase , glutathione and glutathione peroxidase .",
    "triple_list": [
      [
        "aflatoxin B1",
        "CPR:3",
        "superoxide dismutase"
      ],
      [
        "aflatoxin",
        "CPR:4",
        "glutathione peroxidase"
      ]
    ],
    "updated": "Yes",
    "original": "Cotreatments of 5 10 and 20 \u00b5gmL concentrations of MEP with aflatoxin B1 decreased the frequencies of SCE and the malondialdehyde level and increased amount of superoxide dismutase glutathione and glutathione peroxidase which were decreased by aflatoxin",
    "simplified": "Cotreatments of 5 10 and 20 \u00b5gmL MEP with aflatoxin B1 reduced the amount of malondialdehyde and SCE in the blood. It also increased the amount of superoxide dismutase, glutathione and glutathione peroxidase."
  },
  {
    "text": "Phenobarbital PB a typical CAR activator increased the gene expression of HIFtarget genes in the livers of mice including erythropoietin heme oxygenase1 and vascular endothelial growth factora",
    "triple_list": [
      [
        "Phenobarbital",
        "CPR:3",
        "CAR"
      ],
      [
        "Phenobarbital",
        "CPR:3",
        "erythropoietin"
      ],
      [
        "Phenobarbital",
        "CPR:3",
        "heme oxygenase1"
      ],
      [
        "Phenobarbital",
        "CPR:3",
        "vascular endothelial growth factora"
      ]
    ],
    "updated": "No",
    "original": "Phenobarbital PB a typical CAR activator increased the gene expression of HIFtarget genes in the livers of mice including erythropoietin heme oxygenase1 and vascular endothelial growth factora",
    "simplified": "Phenobarbital PB, a common CAR activator, increased the expression of certain genes in the livers of mice. These genes include erythropoietin heme oxygenase1."
  },
  {
    "text": "Cobalt chloride , a typical HIF activator , induced the gene expression of CARtarget genes including cyp2b9 and cyp2b10 in the mouse liver , and a large increase in the PBresponsive enhancer module was observed .",
    "triple_list": [
      [
        "Cobalt chloride",
        "CPR:3",
        "HIF"
      ],
      [
        "Cobalt chloride",
        "CPR:3",
        "cyp2b9"
      ],
      [
        "Cobalt chloride",
        "CPR:3",
        "cyp2b10"
      ]
    ],
    "updated": "Yes",
    "original": "Cobalt chloride a typical HIF activator induced the gene expression of CARtarget genes including cyp2b9 and cyp2b10 an accumulation of nuclear CAR and an increase in the PBresponsive enhancer modulemediated transactivation in the mouse liver",
    "simplified": "Cobalt chloride, a typical HIF activator, induced the gene expression of CARtarget genes including cyp2b9 and cyp2b10 in the mouse liver, and a large increase in the PBresponsive enhancer module was observed."
  },
  {
    "text": "The beta subunit has been cloned and shown to lower the Km of methionine adenosyltransferase II alpha2 the MAT2A product for methionine and to render the enzyme more susceptible to Sadenosylmethionine inhibition",
    "triple_list": [
      [
        "methionine adenosyltransferase II alpha2",
        "CPR:4",
        "Sadenosylmethionine"
      ],
      [
        "MAT2A",
        "CPR:4",
        "Sadenosylmethionine"
      ],
      [
        "methionine",
        "CPR:9",
        "methionine adenosyltransferase II alpha2"
      ],
      [
        "methionine",
        "CPR:9",
        "MAT2A"
      ]
    ],
    "updated": "No",
    "original": "The beta subunit has been cloned and shown to lower the Km of methionine adenosyltransferase II alpha2 the MAT2A product for methionine and to render the enzyme more susceptible to Sadenosylmethionine inhibition",
    "simplified": "The beta subunit has been cloned and shown to lower the amount of methionine that can be made by the enzyme. This makes the enzyme less able to make more methionine."
  },
  {
    "text": "BACKGROUND AIMS Of the 2 genes MAT1A MAT2A encoding methionine adenosyltransferase the enzyme that synthesizes Sadenosylmethionine MAT1A is expressed in liver whereas MAT2A is expressed in extrahepatic tissues",
    "triple_list": [
      [
        "MAT1A",
        "CPR:9",
        "Sadenosylmethionine"
      ],
      [
        "MAT1A",
        "CPR:9",
        "Sadenosylmethionine"
      ],
      [
        "MAT2A",
        "CPR:9",
        "Sadenosylmethionine"
      ],
      [
        "methionine adenosyltransferase",
        "CPR:9",
        "Sadenosylmethionine"
      ]
    ],
    "updated": "No",
    "original": "BACKGROUND AIMS Of the 2 genes MAT1A MAT2A encoding methionine adenosyltransferase the enzyme that synthesizes Sadenosylmethionine MAT1A is expressed in liver whereas MAT2A is expressed in extrahepatic tissues",
    "simplified": "BACKGROUND AIMS Of the 2 genes MAT1A MAT2A encoding methionine adenosyltransferase MAT1A is expressed in the liver whereas MAT2A is expressed in extrahepatic tissues of the body."
  },
  {
    "text": "Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A",
    "triple_list": [
      [
        "CB1",
        "CPR:6",
        "SR 141716A"
      ]
    ],
    "updated": "No",
    "original": "Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A",
    "simplified": "Structural features of the CB1 receptor involved in the binding of specific CB1 antagonists are shown in the diagram."
  },
  {
    "text": "The channel activators avermectin and moxidectin usually retain their inhibitory potency in the Rdl subunit mutants",
    "triple_list": [
      [
        "avermectin",
        "CPR:4",
        "Rdl"
      ],
      [
        "moxidectin",
        "CPR:4",
        "Rdl"
      ]
    ],
    "updated": "No",
    "original": "The channel activators avermectin and moxidectin usually retain their inhibitory potency in the Rdl subunit mutants",
    "simplified": "The channel activators avermectin and moxidectin usually do not work as well, but they still work."
  },
  {
    "text": "At 106M in transcription assays none of these compounds showed progestin agonist activity whereas mifepristone and its monodemethylated metabolite manifested slight glucocorticoid agonist activity",
    "triple_list": [
      [
        "mifepristone",
        "CPR:5",
        "glucocorticoid"
      ]
    ],
    "updated": "No",
    "original": "At 106M in transcription assays none of these compounds showed progestin agonist activity whereas mifepristone and its monodemethylated metabolite manifested slight glucocorticoid agonist activity",
    "simplified": "At 106M in transcription assays none of these compounds showed progestin agonist activity. However, mifepristone and its monodemethylated metabolite showed some activity."
  },
  {
    "text": "5Fluorouracil 5FU 5fluoro2deoxyuridine FdUrd and 5trifluorothymidine F3dThd are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of thymidylate synthase TS",
    "triple_list": [
      [
        "5FU",
        "CPR:4",
        "thymidylate synthase"
      ],
      [
        "5FU",
        "CPR:4",
        "TS"
      ],
      [
        "5Fluorouracil",
        "CPR:4",
        "thymidylate synthase"
      ],
      [
        "5Fluorouracil",
        "CPR:4",
        "TS"
      ],
      [
        "5fluoro2deoxyuridine",
        "CPR:4",
        "thymidylate synthase"
      ],
      [
        "5fluoro2deoxyuridine",
        "CPR:4",
        "TS"
      ],
      [
        "FdUrd",
        "CPR:4",
        "thymidylate synthase"
      ],
      [
        "FdUrd",
        "CPR:4",
        "TS"
      ],
      [
        "5trifluorothymidine",
        "CPR:4",
        "thymidylate synthase"
      ],
      [
        "5trifluorothymidine",
        "CPR:4",
        "TS"
      ],
      [
        "F3dThd",
        "CPR:4",
        "thymidylate synthase"
      ],
      [
        "F3dThd",
        "CPR:4",
        "TS"
      ]
    ],
    "updated": "No",
    "original": "5Fluorouracil 5FU 5fluoro2deoxyuridine FdUrd and 5trifluorothymidine F3dThd are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of thymidylate synthase TS",
    "simplified": "5Fluorouracil 5FU 5fluoro2deoxyuridine FdUrd 5trifluorothymidine F3dThd 5Fluorine 5Fluorine 5Fluorine 5Fluorine 5Fluorine 5Fluorine 5Fluorine 5Fluorine 5Fluorine 5Fluorine 5Fluorine 5Fluorine 5Fluorine 5Fluorine 5Fluorine 5Fluorine 5Fluorine"
  },
  {
    "text": "When DLD1FdUrd cells were treated with FdUrd and F3dThd for only 4 h , the resistance ratios of DLD1FdUrd cells to parental DLD1 cells were markedly different for FdUrd and F3dThd . This suggests that the cytotoxicity of F3dThd is due to a mechanism other than TS inhibition , although the short-term cytotoxicity of F3dThd is low compared to that of longtime exposure .",
    "triple_list": [
      [
        "TS",
        "CPR:4",
        "F3dThd"
      ]
    ],
    "updated": "Yes",
    "original": "When DLD1FdUrd cells expressing increased TS mRNA were treated with FdUrd and F3dThd for only 4 h the resistance ratios of DLD1FdUrd cells to parental DLD1 cells were markedly different for FdUrd and F3dThd suggesting that the cytotoxicity with shorttime exposure to F3dThd is due to a mechanism other than TS inhibition although the cytotoxicity of F3dThd in the shorttime is low compared to that of longtime exposure",
    "simplified": "When DLD1FdUrd cells were treated with FdUrd and F3dThd for only 4 h, the resistance ratios of DLD1FdUrd cells to parental DLD1 cells were markedly different for FdUrd and F3dThd. This suggests that the cytotoxicity of F3dThd is due to a mechanism other than TS inhibition, although the short-term cytotoxicity of F3dThd is low compared to that of longtime exposure."
  },
  {
    "text": "In conclusion F3dThd an antimetabolite that inhibits TS activity may be effective against 5FU andor FdUrdresistance in colorectal cancer cells . The function of orotate phosphoribosyltransferase is also affected .",
    "triple_list": [
      [
        "F3dThd",
        "CPR:4",
        "TS"
      ]
    ],
    "updated": "Yes",
    "original": "In conclusion F3dThd an antimetabolite that inhibits TS activity may be effective against 5FU andor FdUrdresistance in colorectal cancer cells caused by amplification of TS andor deletion of orotate phosphoribosyltransferase",
    "simplified": "In conclusion F3dThd an antimetabolite that inhibits TS activity may be effective against 5FU andor FdUrdresistance in colorectal cancer cells. The function of orotate phosphoribosyltransferase is also affected."
  },
  {
    "text": "The failure of the myometrium to respond to ritodrine desensitization was associated with significant reductions in beta 2adrenergic receptor concentration and cyclic adenosine monophosphate production in myometrial tissue collected from these animals compared with the saline solutiontreated controls .",
    "triple_list": [
      [
        "ritodrine",
        "CPR:4",
        "beta 2adrenergic receptor"
      ]
    ],
    "updated": "Yes",
    "original": "The failure of the myometrium to respond to ritodrine desensitization was associated with significant reductions in agonistinduced cyclic adenosine monophosphate production and beta 2adrenergic receptor concentration in myometrial tissue collected from these animals compared with the saline solutiontreated controls",
    "simplified": "The failure of the myometrium to respond to ritodrine desensitization was associated with significant reductions in beta 2adrenergic receptor concentration and cyclic adenosine monophosphate production in myometrial tissue collected from these animals compared with the saline solutiontreated controls."
  },
  {
    "text": "Antiarrhythmic effects of epicatechin3gallate a novel sodium channel agonist in cultured neonatal rat ventricular myocytes",
    "triple_list": [
      [
        "epicatechin3gallate",
        "CPR:5",
        "sodium channel"
      ]
    ],
    "updated": "No",
    "original": "Antiarrhythmic effects of epicatechin3gallate a novel sodium channel agonist in cultured neonatal rat ventricular myocytes",
    "simplified": "Epicatechin3gallate is a novel sodium channel agonist. It can cause arrhythmic changes in the heart."
  },
  {
    "text": "Liver BHMT activity was 13fold higher in rats fed the Met deficient diet containing choline . mRNA content and immunodetectable protein also increased as a result .",
    "triple_list": [
      [
        "BHMT",
        "CPR:3",
        "choline"
      ]
    ],
    "updated": "Yes",
    "original": "Liver BHMT activity was 13fold higher in rats fed the Met deficient diet containing choline which was reflected in corresponding increases in mRNA content and immunodetectable protein",
    "simplified": "Liver BHMT activity was 13fold higher in rats fed the Met deficient diet containing choline. mRNA content and immunodetectable protein also increased as a result."
  },
  {
    "text": "Independent of dietary choline supplemental Met increased hepatic BHMT activity approximately 30",
    "triple_list": [
      [
        "choline",
        "CPR:3",
        "BHMT"
      ],
      [
        "Met",
        "CPR:3",
        "BHMT"
      ]
    ],
    "updated": "No",
    "original": "Independent of dietary choline supplemental Met increased hepatic BHMT activity approximately 30",
    "simplified": "Dietary choline supplementation increased hepatic BHMT activity by approximately 30%."
  },
  {
    "text": "Choline dehydrogenase ( CHDH ) and betainehomocysteine methyltransferase ( BHMT ) are enzymes that make choline .",
    "triple_list": [
      [
        "Choline dehydrogenase",
        "CPR:9",
        "choline"
      ],
      [
        "CHDH",
        "CPR:9",
        "choline"
      ],
      [
        "betainehomocysteine methyltransferase",
        "CPR:9",
        "choline"
      ],
      [
        "BHMT",
        "CPR:9",
        "choline"
      ]
    ],
    "updated": "Yes",
    "original": "Choline dehydrogenase CHDH and betainehomocysteine methyltransferase BHMT are 2 enzymes involved in choline oxidation",
    "simplified": "Choline dehydrogenase (CHDH) and betainehomocysteine methyltransferase (BHMT) are enzymes that make choline."
  },
  {
    "text": "DNA methyltransferase 3a expression was increased in BPA 200 females but reduced in BPA 05 males .",
    "triple_list": [
      [
        "DNA methyltransferase 3a",
        "CPR:3",
        "BPA"
      ],
      [
        "DNA methyltransferase 3a",
        "CPR:3",
        "BPA"
      ],
      [
        "DNA methyltransferase 3a",
        "CPR:4",
        "BPA"
      ]
    ],
    "updated": "Yes",
    "original": "DNA methyltransferase 3a expression was increased in all BPA males and BPA 05 females and reduced in BPA 200 females",
    "simplified": "DNA methyltransferase 3a expression was increased in BPA 200 females but reduced in BPA 05 males."
  },
  {
    "text": "The calcium homeostasis proteins sarcoendoplasmic reticulum ATPase 2a SERCA2a sodium calcium exchanger1 phospholamban PLB phosphoPLB and calsequestrin 2 are important for contraction and relaxation",
    "triple_list": [
      [
        "calcium",
        "CPR:9",
        "PLB"
      ],
      [
        "calcium",
        "CPR:9",
        "phosphoPLB"
      ],
      [
        "calcium",
        "CPR:9",
        "calsequestrin 2"
      ],
      [
        "calcium",
        "CPR:9",
        "sarcoendoplasmic reticulum ATPase 2a"
      ],
      [
        "calcium",
        "CPR:9",
        "SERCA2a"
      ],
      [
        "calcium",
        "CPR:9",
        "sodium calcium exchanger1"
      ],
      [
        "calcium",
        "CPR:9",
        "phospholamban"
      ]
    ],
    "updated": "No",
    "original": "The calcium homeostasis proteins sarcoendoplasmic reticulum ATPase 2a SERCA2a sodium calcium exchanger1 phospholamban PLB phosphoPLB and calsequestrin 2 are important for contraction and relaxation",
    "simplified": "The calcium homeostasis proteins sarcoendoplasmic reticulum ATPase 2a SERCA2a sodium calcium exchanger1 and calsequestrin 2 are important for keeping the calcium in the body."
  },
  {
    "text": "The results showed that wogonoside promotes the expression of LC3II and Beclin1",
    "triple_list": [
      [
        "wogonoside",
        "CPR:3",
        "LC3II"
      ],
      [
        "wogonoside",
        "CPR:3",
        "Beclin1"
      ]
    ],
    "updated": "No",
    "original": "The results showed that wogonoside promotes the expression of LC3II and Beclin1",
    "simplified": "The results showed that wogonoside increases the expression of the enzyme."
  },
  {
    "text": "Wogonoside also reduced the activity of the mammalian target of rapamycin mTOR and p70S6 kinase p70S6K . It changed the expression of the extracellular signal-regulated kinase ERK12 and the mitogen-activated protein kinase p38 .",
    "triple_list": [
      [
        "Wogonoside",
        "CPR:4",
        "p70S6 kinase"
      ],
      [
        "Wogonoside",
        "CPR:4",
        "p70S6K"
      ],
      [
        "Wogonoside",
        "CPR:4",
        "mammalian target of rapamycin"
      ],
      [
        "Wogonoside",
        "CPR:4",
        "mTOR"
      ]
    ],
    "updated": "Yes",
    "original": "Wogonoside also suppressed the activation of mammalian target of rapamycin mTOR and p70S6 kinase p70S6K by regulating the expression of the extracellular signalregulated kinase ERK12 and p38 involved mitogenactivated protein kinase MAPK signaling pathway",
    "simplified": "Wogonoside also reduced the activity of the mammalian target of rapamycin mTOR and p70S6 kinase p70S6K. It changed the expression of the extracellular signal-regulated kinase ERK12 and the mitogen-activated protein kinase p38."
  },
  {
    "text": "The mitochondrial respiratory chain complex IV cytochrome c oxidase is a multisubunit enzyme that transfers electrons from cytochrome c to molecular oxygen yielding water",
    "triple_list": [
      [
        "mitochondrial respiratory chain complex IV",
        "CPR:9",
        "oxygen"
      ],
      [
        "cytochrome c oxidase",
        "CPR:9",
        "oxygen"
      ]
    ],
    "updated": "No",
    "original": "The mitochondrial respiratory chain complex IV cytochrome c oxidase is a multisubunit enzyme that transfers electrons from cytochrome c to molecular oxygen yielding water",
    "simplified": "The cytochrome c oxidase is an enzyme in the mitochondrial respiratory chain. It moves electrons from cytochrome c to the oxygen in the blood."
  },
  {
    "text": "Similarly pelargonidin induced the expression of CYP1A1 mRNA up to 5fold in HepG2 and LS174T cells relative to the induction by 5 nM 2378tetrachlorodibenzodioxin TCDD the most potent activator of AhR",
    "triple_list": [
      [
        "pelargonidin",
        "CPR:3",
        "CYP1A1"
      ],
      [
        "CYP1A1",
        "CPR:3",
        "2378tetrachlorodibenzodioxin"
      ],
      [
        "2378tetrachlorodibenzodioxin",
        "CPR:3",
        "AhR"
      ],
      [
        "CYP1A1",
        "CPR:3",
        "TCDD"
      ],
      [
        "TCDD",
        "CPR:3",
        "AhR"
      ]
    ],
    "updated": "No",
    "original": "Similarly pelargonidin induced the expression of CYP1A1 mRNA up to 5fold in HepG2 and LS174T cells relative to the induction by 5 nM 2378tetrachlorodibenzodioxin TCDD the most potent activator of AhR",
    "simplified": "Pelargonidin also increased the expression of CYP1A1 mRNA by up to 5fold in HepG2 and LS174T cells when compared to when 5 nM 2378tetrachlorodibenzodioxin was added to the cells."
  },
  {
    "text": "CYP1A1 and CYP1A2 mRNAs were also increased by pelargonidin in three primary human hepatocytes cultures approximately 5 of TCDD potency and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of CYP1A1 enzyme",
    "triple_list": [
      [
        "CYP1A1",
        "CPR:3",
        "pelargonidin"
      ],
      [
        "CYP1A2",
        "CPR:3",
        "pelargonidin"
      ],
      [
        "CYP1A1",
        "CPR:3",
        "pelargonidin"
      ],
      [
        "CYP1A1",
        "CPR:3",
        "pelargonidin"
      ],
      [
        "CYP1A1",
        "CPR:3",
        "TCDD"
      ],
      [
        "CYP1A2",
        "CPR:3",
        "TCDD"
      ],
      [
        "CYP1A1",
        "CPR:3",
        "TCDD"
      ],
      [
        "CYP1A1",
        "CPR:3",
        "TCDD"
      ]
    ],
    "updated": "No",
    "original": "CYP1A1 and CYP1A2 mRNAs were also increased by pelargonidin in three primary human hepatocytes cultures approximately 5 of TCDD potency and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of CYP1A1 enzyme",
    "simplified": "CYP1A1 and CYP1A2 mRNAs were also increased by pelargonidin in three primary human hepatocytes cultures. The increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in the catalytic activity of the CYP1A1 enzyme."
  },
  {
    "text": "Pelargonidin activates the AhR and the CYP1A1 gene in human cells . This is done in primary human hepatocytes .",
    "triple_list": [
      [
        "Pelargonidin",
        "CPR:3",
        "AhR"
      ]
    ],
    "updated": "Yes",
    "original": "Pelargonidin activates the AhR and induces CYP1A1 in primary human hepatocytes and human cancer cell lines HepG2 and LS174T",
    "simplified": "Pelargonidin activates the AhR and the CYP1A1 gene in human cells. This is done in primary human hepatocytes."
  },
  {
    "text": "Overall although most anthocyanidins had no effects on AhRCYP1A1 signaling pelargonidin can bind to and activate the AhR and AhRdependent gene expression and pelargonidin and delphinidin inhibit the CYP1A1 catalytic activity",
    "triple_list": [
      [
        "AhR",
        "CPR:3",
        "pelargonidin"
      ],
      [
        "CYP1A1",
        "CPR:4",
        "pelargonidin"
      ],
      [
        "CYP1A1",
        "CPR:4",
        "delphinidin"
      ]
    ],
    "updated": "No",
    "original": "Overall although most anthocyanidins had no effects on AhRCYP1A1 signaling pelargonidin can bind to and activate the AhR and AhRdependent gene expression and pelargonidin and delphinidin inhibit the CYP1A1 catalytic activity",
    "simplified": "Pelargonidin can bind to and activate the AhR and AhRdependent gene expression. Pelargonidin and delphinidin inhibit the CYP1A1 catalytic activity of the enzyme CYP1A1 in plants."
  },
  {
    "text": "AhR dependent reporter gene expression in transfected HepG2 cells was increased by pelargonidin in a concentrationdependent manner at 24h",
    "triple_list": [
      [
        "AhR",
        "CPR:3",
        "pelargonidin"
      ]
    ],
    "updated": "No",
    "original": "AhR dependent reporter gene expression in transfected HepG2 cells was increased by pelargonidin in a concentrationdependent manner at 24h",
    "simplified": "Pelargonidin increased reporter gene expression in transfected HepG2 cells in a concentrationdependent manner at 24h."
  },
  {
    "text": "Enzyme kinetic analyses using human liver microsomes revealed that delphinidin and pelargonidin inhibited CYP1A1 activity .",
    "triple_list": [
      [
        "CYP1A1",
        "CPR:4",
        "delphinidin"
      ],
      [
        "CYP1A1",
        "CPR:4",
        "pelargonidin"
      ]
    ],
    "updated": "Yes",
    "original": "Enzyme kinetic analyses using human liver microsomes revealed inhibition of CYP1A1 activity by delphinidin IC50 78 \u03bcM and pelargonidin IC50 33 \u03bcM",
    "simplified": "Enzyme kinetic analyses using human liver microsomes revealed that delphinidin and pelargonidin inhibited CYP1A1 activity."
  },
  {
    "text": "In HEK293 cells stably transfected with this receptor serotonin elicits a potent stimulation of adenylyl cyclase activity which is blocked by antipsychotic and antidepressant drugs",
    "triple_list": [
      [
        "serotonin",
        "CPR:3",
        "adenylyl cyclase"
      ]
    ],
    "updated": "No",
    "original": "In HEK293 cells stably transfected with this receptor serotonin elicits a potent stimulation of adenylyl cyclase activity which is blocked by antipsychotic and antidepressant drugs",
    "simplified": "In HEK293 cells stably transfected with this receptor, adenylyl cyclase activity is increased. This activity is blocked by antidepressant drugs."
  },
  {
    "text": "A headtohead comparison between insulin detemir and NPH insulin in women with type 1 diabetes showed that while foetal outcomes did not differ fasting plasma glucose improved with insulin detemir without an increased incidence of hypoglycaemia",
    "triple_list": [
      [
        "insulin",
        "CPR:3",
        "glucose"
      ]
    ],
    "updated": "No",
    "original": "A headtohead comparison between insulin detemir and NPH insulin in women with type 1 diabetes showed that while foetal outcomes did not differ fasting plasma glucose improved with insulin detemir without an increased incidence of hypoglycaemia",
    "simplified": "Insulin detemir is a drug that helps people with diabetes control their blood sugar. When people take insulin detemir, their blood sugar goes down and they get diabetes."
  },
  {
    "text": "OBJECTIVE The aim was to test whether the common deletion T in the promoter of FADS2 affects the PUFA biosynthetic pathway and consequently modifies the effect of alphalinolenic acid ALA on myocardial infarction MI",
    "triple_list": [
      [
        "FADS2",
        "CPR:9",
        "alphalinolenic acid"
      ],
      [
        "FADS2",
        "CPR:9",
        "ALA"
      ],
      [
        "FADS2",
        "CPR:9",
        "PUFA"
      ]
    ],
    "updated": "No",
    "original": "OBJECTIVE The aim was to test whether the common deletion T in the promoter of FADS2 affects the PUFA biosynthetic pathway and consequently modifies the effect of alphalinolenic acid ALA on myocardial infarction MI",
    "simplified": "OBJECTIVE The aim was to test whether the common deletion T in the promoter of FADS2 affects the effect of alphalinolenic acid ALA on myocardial infarction in humans."
  },
  {
    "text": "We evaluated the effects of angiotensin II and an angiotensinconverting enzyme inhibitor cilazapril on nerve blood flow NBF and electrophysiology in control and diabetic rats",
    "triple_list": [
      [
        "angiotensin II",
        "CPR:4",
        "cilazapril"
      ],
      [
        "angiotensinconverting enzyme",
        "CPR:4",
        "cilazapril"
      ]
    ],
    "updated": "No",
    "original": "We evaluated the effects of angiotensin II and an angiotensinconverting enzyme inhibitor cilazapril on nerve blood flow NBF and electrophysiology in control and diabetic rats",
    "simplified": "We compared the effects of angiotensin II and cilazapril on nerve blood flow and electrophysiology in control and diabetic rats."
  },
  {
    "text": "We topically applied the nitric oxide synthase NOS inhibitor NGnitroLarginine on sciatic nerve and observed reduced inhibition of NBF in EDN which was correctable with a cilazapril diet",
    "triple_list": [
      [
        "NOS",
        "CPR:4",
        "NGnitroLarginine"
      ],
      [
        "nitric oxide synthase",
        "CPR:4",
        "NGnitroLarginine"
      ]
    ],
    "updated": "No",
    "original": "We topically applied the nitric oxide synthase NOS inhibitor NGnitroLarginine on sciatic nerve and observed reduced inhibition of NBF in EDN which was correctable with a cilazapril diet",
    "simplified": "We applied NGnitroLarginine, a nitric oxide synthase inhibitor, to the sciatic nerve and observed reduced inhibition of NBF in EDN with a cilazapril diet."
  },
  {
    "text": "Cadmium activates NADPH oxidase",
    "triple_list": [
      [
        "Cadmium",
        "CPR:3",
        "NADPH oxidase"
      ]
    ],
    "updated": "No",
    "original": "Cadmium activates NADPH oxidase",
    "simplified": "Cadmium can also cause cancer."
  },
  {
    "text": "However after 12h CdCl2 treatment cell viability diminished in 50 accompanied by a drastic decrease of metallothioneinII production and an increase in p53 activation and the proapoptotic protein Bax",
    "triple_list": [
      [
        "CdCl2",
        "CPR:3",
        "p53"
      ],
      [
        "CdCl2",
        "CPR:3",
        "Bax"
      ],
      [
        "CdCl2",
        "CPR:4",
        "metallothioneinII"
      ]
    ],
    "updated": "No",
    "original": "However after 12h CdCl2 treatment cell viability diminished in 50 accompanied by a drastic decrease of metallothioneinII production and an increase in p53 activation and the proapoptotic protein Bax",
    "simplified": "However after 12h CdCl2 treatment cell viability became less in 50. This was followed by a big drop in the production of metallothioneinII and a big increase in p53 activation."
  },
  {
    "text": "Thus it can be suggested that the inhibitory action of ginseng saponins against the immobilization stressinduced increase of plasma IL6 level would be in the periphery , rather than in the brain , because norepinephrine and epinephrine are both found in the brain but not in the periphery .",
    "triple_list": [
      [
        "IL6",
        "CPR:3",
        "epinephrine"
      ],
      [
        "IL6",
        "CPR:3",
        "norepinephrine"
      ],
      [
        "ginseng saponins",
        "CPR:4",
        "IL6"
      ],
      [
        "ginseng saponins",
        "CPR:4",
        "IL6"
      ]
    ],
    "updated": "Yes",
    "original": "Thus it can be suggested that the inhibitory action of ginseng saponins against the immobilization stressinduced increase of plasma IL6 level would be in periphery at least in part mediated by blocking norepinephrine andor epinephrine induced increase of IL6 level in macrophage rather than in the brain",
    "simplified": "Thus it can be suggested that the inhibitory action of ginseng saponins against the immobilization stressinduced increase of plasma IL6 level would be in the periphery, rather than in the brain, because norepinephrine and epinephrine are both found in the brain but not in the periphery."
  },
  {
    "text": "Ginsenosides Rb2 Rd and Rg1 significantly decreased IL6 level in macrophage cell line RAW 2647 without the need for epinephrine .",
    "triple_list": [
      [
        "epinephrine",
        "CPR:3",
        "IL6"
      ],
      [
        "Ginsenosides Rb2 Rd and Rg1",
        "CPR:4",
        "IL6"
      ]
    ],
    "updated": "Yes",
    "original": "Ginsenosides Rb2 Rd and Rg1 significantly decreased nor epinephrine andor epinephrine induced increase of IL6 level in macrophage cell line RAW 2647",
    "simplified": "Ginsenosides Rb2 Rd and Rg1 significantly decreased IL6 level in macrophage cell line RAW 2647 without the need for epinephrine."
  },
  {
    "text": "The inhibitory effect of ginseng saponins on the stressinduced plasma interleukin6 level in mice",
    "triple_list": [
      [
        "ginseng saponins",
        "CPR:4",
        "interleukin6"
      ]
    ],
    "updated": "No",
    "original": "The inhibitory effect of ginseng saponins on the stressinduced plasma interleukin6 level in mice",
    "simplified": "The effect of ginseng saponins on the level of interleukin-6 in the blood in mice"
  },
  {
    "text": "Ginseng total saponins ginsenosides Rb2 Rg1 and Rd were given intraperitoneally . They reduced the stress-induced increase in plasma IL6 .",
    "triple_list": [
      [
        "saponins",
        "CPR:4",
        "IL6"
      ],
      [
        "ginsenosides Rb2 Rg1 and Rd",
        "CPR:4",
        "IL6"
      ]
    ],
    "updated": "Yes",
    "original": "Ginseng total saponins ginsenosides Rb2 Rg1 and Rd administered intraperitoneally attenuated the immobilization stressinduced increase in plasma IL6 level",
    "simplified": "Ginseng total saponins ginsenosides Rb2 Rg1 and Rd were given intraperitoneally. They reduced the stress-induced increase in plasma IL6."
  },
  {
    "text": "In patients with type 2 diabetes , mean glycosylated haemoglobin HbA1c improved significantly with sitagliptin monotherapy than with placebo .",
    "triple_list": [
      [
        "glycosylated haemoglobin",
        "CPR:3",
        "sitagliptin"
      ],
      [
        "HbA1c",
        "CPR:3",
        "sitagliptin"
      ]
    ],
    "updated": "Yes",
    "original": "Improvements from baseline in mean glycosylated haemoglobin HbA1c were significantly greater with sitagliptin monotherapy than with placebo in patients with type 2 diabetes",
    "simplified": "In patients with type 2 diabetes, mean glycosylated haemoglobin HbA1c improved significantly with sitagliptin monotherapy than with placebo."
  },
  {
    "text": "As addon therapy in patients with suboptimal glycaemic control despite oral antihyperglycaemic treatment sitagliptin improved HbA1c to a significantly greater extent than placebo when added to metformin or pioglitazone and was noninferior to glipizide when added to metformin",
    "triple_list": [
      [
        "sitagliptin",
        "CPR:3",
        "HbA1c"
      ],
      [
        "HbA1c",
        "CPR:3",
        "metformin"
      ],
      [
        "HbA1c",
        "CPR:3",
        "pioglitazone"
      ],
      [
        "HbA1c",
        "CPR:4",
        "metformin"
      ]
    ],
    "updated": "No",
    "original": "As addon therapy in patients with suboptimal glycaemic control despite oral antihyperglycaemic treatment sitagliptin improved HbA1c to a significantly greater extent than placebo when added to metformin or pioglitazone and was noninferior to glipizide when added to metformin",
    "simplified": "As an add-on therapy in patients with poor glycaemic control after oral antihyperglycaemic treatment, sitagliptin was better than placebo when added to metformin or pioglitazone. It was also better than glipizide when added to metformin."
  },
  {
    "text": "Sitagliptin an oral dipeptidyl peptidase4 DPP4 inhibitor improves glycaemic control by inhibiting DPP4 inactivation of the incretin hormones glucagonlike peptide1 and glucosedependent insulinotropic polypeptide",
    "triple_list": [
      [
        "Sitagliptin",
        "CPR:3",
        "incretin hormones"
      ],
      [
        "Sitagliptin",
        "CPR:3",
        "glucagonlike peptide1"
      ],
      [
        "Sitagliptin",
        "CPR:3",
        "glucosedependent insulinotropic polypeptide"
      ],
      [
        "Sitagliptin",
        "CPR:4",
        "DPP4"
      ],
      [
        "Sitagliptin",
        "CPR:4",
        "dipeptidyl peptidase4"
      ],
      [
        "Sitagliptin",
        "CPR:4",
        "DPP4"
      ]
    ],
    "updated": "No",
    "original": "Sitagliptin an oral dipeptidyl peptidase4 DPP4 inhibitor improves glycaemic control by inhibiting DPP4 inactivation of the incretin hormones glucagonlike peptide1 and glucosedependent insulinotropic polypeptide",
    "simplified": "Sitagliptin an oral dipeptidyl peptidase4 (DPP4) inhibitor improves glycaemic control by preventing DPP4 from working at all. DPP4 is a hormone that incretin produces."
  },
  {
    "text": "In addition pretreatment with ZValAlaAspfluoromethylketone ZVADfmk a broad spectrum of caspase inhibitor could not rescue apoptotic cells from ClpP toxicity",
    "triple_list": [
      [
        "ZValAlaAspfluoromethylketone",
        "CPR:4",
        "caspase"
      ],
      [
        "ZVADfmk",
        "CPR:4",
        "caspase"
      ]
    ],
    "updated": "No",
    "original": "In addition pretreatment with ZValAlaAspfluoromethylketone ZVADfmk a broad spectrum of caspase inhibitor could not rescue apoptotic cells from ClpP toxicity",
    "simplified": "In addition pretreatment with ZValAlaAspfluoromethylketone ZVADfmk could not rescue cells from ClpP toxicity after cell death."
  },
  {
    "text": "In the long term orlistat has been shown to be more effective than placebo in reducing body weight and serum total and lowdensity lipoprotein cholesterol levels",
    "triple_list": [
      [
        "orlistat",
        "CPR:4",
        "lowdensity lipoprotein"
      ]
    ],
    "updated": "No",
    "original": "In the long term orlistat has been shown to be more effective than placebo in reducing body weight and serum total and lowdensity lipoprotein cholesterol levels",
    "simplified": "In the long term, orlistat has been shown to be more effective than placebo in reducing serum cholesterol levels and body weight."
  },
  {
    "text": "Orlistat is a new inhibitor of pancreatic lipase enzyme",
    "triple_list": [
      [
        "Orlistat",
        "CPR:4",
        "pancreatic lipase"
      ]
    ],
    "updated": "No",
    "original": "Orlistat is a new inhibitor of pancreatic lipase enzyme",
    "simplified": "Orlistat is a drug that can slow down pancreatic cancer."
  },
  {
    "text": "Genistin decreased myosin light chain kinase MLCK protein contents and MLCK mRNA expression in IJS and inhibited both phosphorylation and Mg2 ATPase activity of purified myosin . The effects of genistin on MLCK activity are not known , but it is likely that it is involved .",
    "triple_list": [
      [
        "Genistin",
        "CPR:4",
        "myosin light chain kinase"
      ],
      [
        "Genistin",
        "CPR:4",
        "MLCK"
      ],
      [
        "Genistin",
        "CPR:4",
        "MLCK"
      ],
      [
        "Genistin",
        "CPR:4",
        "ATPase"
      ],
      [
        "MLCK",
        "CPR:4",
        "genistin"
      ],
      [
        "MLCK",
        "CPR:4",
        "genistin"
      ]
    ],
    "updated": "Yes",
    "original": "Genistin decreased myosin light chain kinase MLCK protein contents and MLCK mRNA expression in IJS and inhibited both phosphorylation and Mg2 ATPase activity of purified myosin implicating that the decrease of MLCK contents and inhibition of MLCK activity are involved in the genistin induced inhibitory effects",
    "simplified": "Genistin decreased myosin light chain kinase MLCK protein contents and MLCK mRNA expression in IJS and inhibited both phosphorylation and Mg2 ATPase activity of purified myosin. The effects of genistin on MLCK activity are not known, but it is likely that it is involved."
  },
  {
    "text": "In addition , curcumin reduced the expression of Sim2 and increased Drebrin in neurons treated with hyperglycaemia .",
    "triple_list": [
      [
        "curcumin",
        "CPR:3",
        "Sim2"
      ],
      [
        "curcumin",
        "CPR:3",
        "Drebrin"
      ]
    ],
    "updated": "Yes",
    "original": "Moreover curcumin alleviated Sim2 expression and reversely raised Drebrin expression in neurons treated with hyperglycaemia",
    "simplified": "In addition, curcumin reduced the expression of Sim2 and increased Drebrin in neurons treated with hyperglycaemia."
  },
  {
    "text": "It was found that expression of Sim2 protein in cortical neurons was increased in streptozotocin induced diabetes mellitus rat model",
    "triple_list": [
      [
        "Sim2",
        "CPR:3",
        "streptozotocin"
      ]
    ],
    "updated": "No",
    "original": "It was found that expression of Sim2 protein in cortical neurons was increased in streptozotocin induced diabetes mellitus rat model",
    "simplified": "It was found that in a diabetes mellitus rat model, the expression of Sim2 protein in cortical neurons was increased."
  },
  {
    "text": "Polymorphisms in dopamine transporter SLC6A3 are associated with stimulant effects of Damphetamine an exploratory pharmacogenetic study using healthy volunteers",
    "triple_list": [
      [
        "SLC6A3",
        "CPR:3",
        "Damphetamine"
      ],
      [
        "dopamine transporter",
        "CPR:3",
        "Damphetamine"
      ]
    ],
    "updated": "No",
    "original": "Polymorphisms in dopamine transporter SLC6A3 are associated with stimulant effects of Damphetamine an exploratory pharmacogenetic study using healthy volunteers",
    "simplified": "Polymorphisms in dopamine transporter SLC6A3 an exploratory pharmacogenetic study using healthy volunteers are associated with stimulant effects."
  },
  {
    "text": "Endothelium-dependent relaxations were studied in rabbit iliac artery and aortic rings using the G proteincoupled receptor agonist acetylcholine ACh and by cyclopiazonic acid CPA . The G proteincoupled receptor agonist acetylcholine ACh stimulates Ca2 entry by inhibiting the endothelial SERCA pump .",
    "triple_list": [
      [
        "cyclopiazonic acid",
        "CPR:4",
        "SERCA"
      ],
      [
        "CPA",
        "CPR:4",
        "SERCA"
      ],
      [
        "G proteincoupled receptor",
        "CPR:5",
        "acetylcholine"
      ],
      [
        "G proteincoupled receptor",
        "CPR:5",
        "ACh"
      ]
    ],
    "updated": "Yes",
    "original": "Endotheliumdependent relaxations nitric oxide NO and endothelium derived hyperpolarizing factor EDHFtype were studied in rabbit iliac artery and aortic rings using the G proteincoupled receptor agonist acetylcholine ACh and by cyclopiazonic acid CPA which promotes storeoperated Ca2 entry by inhibiting the endothelial SERCA pump",
    "simplified": "Endothelium-dependent relaxations were studied in rabbit iliac artery and aortic rings using the G proteincoupled receptor agonist acetylcholine ACh and by cyclopiazonic acid CPA. The G proteincoupled receptor agonist acetylcholine ACh stimulates Ca2 entry by inhibiting the endothelial SERCA pump."
  },
  {
    "text": "Potentiation can be stopped by the enzyme manganese porphyrin catalase , and the enzyme NADPH oxidase inhibitor apocynin .",
    "triple_list": [
      [
        "NADPH oxidase",
        "CPR:4",
        "apocynin"
      ]
    ],
    "updated": "Yes",
    "original": "Potentiation was prevented by catalase the catalasesuperoxide dismutase mimetic manganese porphyrin and the NADPH oxidase inhibitor apocynin",
    "simplified": "Potentiation can be stopped by the enzyme manganese porphyrin catalase, and the enzyme NADPH oxidase inhibitor apocynin."
  },
  {
    "text": "Our results suggest that arsenite can potentiate EDHFtype relaxations via a mechanism that is dependent on hydrogen peroxide thus demonstrating that dismutation of the superoxide anion generated by NADPH oxidase can potentially offset loss of NO bioavailability under conditions of reduced eNOS activity",
    "triple_list": [
      [
        "superoxide",
        "CPR:9",
        "NADPH oxidase"
      ]
    ],
    "updated": "No",
    "original": "Our results suggest that arsenite can potentiate EDHFtype relaxations via a mechanism that is dependent on hydrogen peroxide thus demonstrating that dismutation of the superoxide anion generated by NADPH oxidase can potentially offset loss of NO bioavailability under conditions of reduced eNOS activity",
    "simplified": "Our results suggest that arsenite can potentiate EDHFtype relaxations via a mechanism that is dependent on hydrogen peroxide. This shows that NADPH oxidase can potentially offset loss of NO bioavailability under conditions of reduced eNOS activity."
  },
  {
    "text": "We isolated partial cDNAs that codified for enzymes involved in the biosynthesis of anthocyanin . For example , lphenylalanine ammonialyase PAL , chalcone synthase CHS , and ascorbate peroxidase APX .",
    "triple_list": [
      [
        "anthocyanin",
        "CPR:9",
        "lphenylalanine ammonialyase"
      ],
      [
        "anthocyanin",
        "CPR:9",
        "PAL"
      ],
      [
        "anthocyanin",
        "CPR:9",
        "chalcone synthase"
      ],
      [
        "anthocyanin",
        "CPR:9",
        "CHS"
      ],
      [
        "anthocyanin",
        "CPR:9",
        "ascorbate peroxidase"
      ],
      [
        "anthocyanin",
        "CPR:9",
        "APX"
      ]
    ],
    "updated": "Yes",
    "original": "We isolated partial cDNAs that codified for enzymes implicated in the anthocyanin biosynthesis such as lphenylalanine ammonialyase PAL and chalcone synthase CHS and an antioxidant enzyme such as ascorbate peroxidase APX",
    "simplified": "We isolated partial cDNAs that codified for enzymes involved in the biosynthesis of anthocyanin. For example, lphenylalanine ammonialyase PAL, chalcone synthase CHS, and ascorbate peroxidase APX."
  },
  {
    "text": "In vitro acetaminophen elicited a 44fold selectivity toward COX2 inhibition IC50=1137 micromolL for COX1 IC50=258 micromolL for COX2",
    "triple_list": [
      [
        "acetaminophen",
        "CPR:4",
        "COX2"
      ],
      [
        "acetaminophen",
        "CPR:4",
        "COX1"
      ],
      [
        "acetaminophen",
        "CPR:4",
        "COX2"
      ]
    ],
    "updated": "No",
    "original": "In vitro acetaminophen elicited a 44fold selectivity toward COX2 inhibition IC50=1137 micromolL for COX1 IC50=258 micromolL for COX2",
    "simplified": "In vitro acetaminophen showed a 44fold increase in selectivity against COX1 when compared to acetaminophen."
  },
  {
    "text": "Acetaminophen plasma concentrations remained above the in vitro IC50 for COX2 for at least 5 h postadministration",
    "triple_list": [
      [
        "Acetaminophen",
        "CPR:4",
        "COX2"
      ]
    ],
    "updated": "No",
    "original": "Acetaminophen plasma concentrations remained above the in vitro IC50 for COX2 for at least 5 h postadministration",
    "simplified": "Acetaminophen concentrations remained above the in vitro IC50 for at least 5 h after administration."
  },
  {
    "text": "Acetaminophen paracetamol is a selective cyclooxygenase2 inhibitor in man",
    "triple_list": [
      [
        "Acetaminophen",
        "CPR:4",
        "cyclooxygenase2"
      ],
      [
        "paracetamol",
        "CPR:4",
        "cyclooxygenase2"
      ]
    ],
    "updated": "No",
    "original": "Acetaminophen paracetamol is a selective cyclooxygenase2 inhibitor in man",
    "simplified": "Paracetamol (acetaminophen) is a pain-killing drug in humans."
  },
  {
    "text": "Ex vivo IC50 values COX1 1052 micromolL COX2 263 micromolL of acetaminophen were found in human blood .",
    "triple_list": [
      [
        "COX1",
        "CPR:4",
        "acetaminophen"
      ],
      [
        "COX2",
        "CPR:4",
        "acetaminophen"
      ]
    ],
    "updated": "Yes",
    "original": "Ex vivo IC50 values COX1 1052 micromolL COX2 263 micromolL of acetaminophen compared favorably with its in vitro IC50 values",
    "simplified": "Ex vivo IC50 values COX1 1052 micromolL COX2 263 micromolL of acetaminophen were found in human blood."
  },
  {
    "text": "In contrast to previous concepts , acetaminophen inhibited COX2 by more than 80 % compared to nonsteroidal anti-inflammatory drugs ( NSAIDs ) by up to 80 % .",
    "triple_list": [
      [
        "acetaminophen",
        "CPR:4",
        "COX2"
      ]
    ],
    "updated": "Yes",
    "original": "In contrast to previous concepts acetaminophen inhibited COX2 by more than 80 ie to a degree comparable to nonsteroidal antiinflammatory drugs NSAIDs and selective COX2 inhibitors",
    "simplified": "In contrast to previous concepts, acetaminophen inhibited COX2 by more than 80% compared to nonsteroidal anti-inflammatory drugs (NSAIDs) by up to 80%."
  },
  {
    "text": "In view of its substantial COX2 inhibition recently the use of COX2 inhibitors should also be considered for acetaminophen in the heart .",
    "triple_list": [
      [
        "COX2",
        "CPR:4",
        "acetaminophen"
      ]
    ],
    "updated": "Yes",
    "original": "In view of its substantial COX2 inhibition recently defined cardiovascular warnings for use of COX2 inhibitors should also be considered for acetaminophen",
    "simplified": "In view of its substantial COX2 inhibition recently the use of COX2 inhibitors should also be considered for acetaminophen in the heart."
  },
  {
    "text": "The fact that acetaminophen acts as a selective COX2 inhibitor led us to investigate whether it works by blocking the production of COX2 .",
    "triple_list": [
      [
        "acetaminophen",
        "CPR:4",
        "COX2"
      ]
    ],
    "updated": "Yes",
    "original": "The fact that acetaminophen acts functionally as a selective COX2 inhibitor led us to investigate the hypothesis of whether it works via preferential COX2 blockade",
    "simplified": "The fact that acetaminophen acts as a selective COX2 inhibitor led us to investigate whether it works by blocking the production of COX2."
  },
  {
    "text": "Ex vivo COX inhibition and acetaminophen pharmacokinetics were assessed in 5 volunteers receiving single 1000 mg doses orally .",
    "triple_list": [
      [
        "COX",
        "CPR:4",
        "acetaminophen"
      ]
    ],
    "updated": "Yes",
    "original": "Ex vivo COX inhibition and pharmacokinetics of acetaminophen were assessed in 5 volunteers receiving single 1000 mg doses orally",
    "simplified": "Ex vivo COX inhibition and acetaminophen pharmacokinetics were assessed in 5 volunteers receiving single 1000 mg doses orally."
  },
  {
    "text": "Coagulationinduced thromboxane B2 and lipopolysaccharideinduced prostaglandin E2 were measured ex vivo and in vitro in human whole blood as indices of COX1 and COX2 activity",
    "triple_list": [
      [
        "thromboxane B2",
        "CPR:9",
        "COX1"
      ],
      [
        "prostaglandin E2",
        "CPR:9",
        "COX2"
      ]
    ],
    "updated": "No",
    "original": "Coagulationinduced thromboxane B2 and lipopolysaccharideinduced prostaglandin E2 were measured ex vivo and in vitro in human whole blood as indices of COX1 and COX2 activity",
    "simplified": "Coagulation-induced thromboxane B2 and lipopolysaccharide-induced prostaglandin E2 were measured in human whole blood and in vitro, respectively."
  },
  {
    "text": "The interaction between GAL and AChE was stronger , but there was no statistical significance .",
    "triple_list": [
      [
        "GAL",
        "CPR:4",
        "AChE"
      ]
    ],
    "updated": "Yes",
    "original": "In the interaction of GAL and CAR AChE inhibition was stronger but without any statistical significance",
    "simplified": "The interaction between GAL and AChE was stronger, but there was no statistical significance."
  },
  {
    "text": "OBJECTIVES The alkaloid galantamine GAL has a combined parasympathomimetic and anticholinesterase mechanism of action and is employed in the stimulation of central cholinergic transfer in cognitive diseases in conjunction with therapeutic interventions .",
    "triple_list": [
      [
        "galantamine",
        "CPR:4",
        "anticholinesterase"
      ],
      [
        "GAL",
        "CPR:4",
        "anticholinesterase"
      ]
    ],
    "updated": "Yes",
    "original": "OBJECTIVES The alkaloid galantamine GAL which exhibits a combined anticholinesterase and direct parasympathomimetic mechanism of action is employed in conjunction with therapeutic interventions in the stimulation of central cholinergic transfer in cognitive diseases",
    "simplified": "OBJECTIVES The alkaloid galantamine GAL has a combined parasympathomimetic and anticholinesterase mechanism of action and is employed in the stimulation of central cholinergic transfer in cognitive diseases in conjunction with therapeutic interventions."
  },
  {
    "text": "NaAsO2 increased the mRNA levels of the light and medium subunits of neurofilament and decreased the mRNA levels of tau and tubulin in a dosedependent manner . The mRNA levels of the heavy subunit of neurofilament did not change at all .",
    "triple_list": [
      [
        "NaAsO2",
        "CPR:3",
        "light and medium subunits of neurofilament"
      ],
      [
        "NaAsO2",
        "CPR:4",
        "tau"
      ],
      [
        "NaAsO2",
        "CPR:4",
        "tubulin"
      ]
    ],
    "updated": "Yes",
    "original": "NaAsO2 increased the mRNA levels of the light and medium subunits of neurofilament and decreased the mRNA levels of tau and tubulin in a dosedependent manner no significant effect was found in the mRNA levels of the heavy subunit of neurofilament microtubuleassociated protein 2 or actin",
    "simplified": "NaAsO2 increased the mRNA levels of the light and medium subunits of neurofilament and decreased the mRNA levels of tau and tubulin in a dosedependent manner. The mRNA levels of the heavy subunit of neurofilament did not change at all."
  },
  {
    "text": "A naloxonesteroid hybrid azine with selective and longacting opioid antagonism at delta receptors in vitro",
    "triple_list": [
      [
        "naloxonesteroid hybrid azine",
        "CPR:6",
        "delta receptors"
      ]
    ],
    "updated": "No",
    "original": "A naloxonesteroid hybrid azine with selective and longacting opioid antagonism at delta receptors in vitro",
    "simplified": "Naloxonesteroid hybrid azine, a long-acting and highly selective opioid antagonist in vitro"
  },
  {
    "text": "In this report we show that atorvastatin is a competitive inhibitor of porcine DPPIV in vitro , with Ki=57823 microM .",
    "triple_list": [
      [
        "atorvastatin",
        "CPR:4",
        "porcine DPPIV"
      ]
    ],
    "updated": "Yes",
    "original": "In this report we show that the hypolipidemic agent atorvastatin is a competitive inhibitor of porcine DPPIV in vitro with Ki=57823 microM",
    "simplified": "In this report we show that atorvastatin is a competitive inhibitor of porcine DPPIV in vitro, with Ki=57823 microM."
  },
  {
    "text": "These results may have implications for the development of novel DPPIV inhibitors based on atorvastatin as a lead compound for type 2 diabetes treatment .",
    "triple_list": [
      [
        "DPPIV",
        "CPR:4",
        "atorvastatin"
      ]
    ],
    "updated": "Yes",
    "original": "These results may have implications in the development of novel DPPIV inhibitors based on the use of atorvastatin as a lead compound for the treatment of type 2 diabetes",
    "simplified": "These results may have implications for the development of novel DPPIV inhibitors based on atorvastatin as a lead compound for type 2 diabetes treatment."
  },
  {
    "text": "Inhibition of dipeptidyl peptidaseIV DPPIV by atorvastatin",
    "triple_list": [
      [
        "dipeptidyl peptidaseIV",
        "CPR:4",
        "atorvastatin"
      ],
      [
        "DPPIV",
        "CPR:4",
        "atorvastatin"
      ]
    ],
    "updated": "No",
    "original": "Inhibition of dipeptidyl peptidaseIV DPPIV by atorvastatin",
    "simplified": "Dipeptidyl peptidaseIV (DPPIV) is an enzyme."
  },
  {
    "text": "In addition we found that neoechinulin A significantly suppressed the production of neurotoxic inflammatory mediator tumour necrosis factor\u03b1 TNF\u03b1 interleukin1\u03b2 IL1\u03b2 interleukin6 IL6 and prostaglandin E2 PGE2 in activated BV2 cells",
    "triple_list": [
      [
        "neoechinulin A",
        "CPR:4",
        "tumour necrosis factor\u03b1"
      ],
      [
        "neoechinulin A",
        "CPR:4",
        "TNF\u03b1"
      ],
      [
        "neoechinulin A",
        "CPR:4",
        "interleukin1\u03b2"
      ],
      [
        "neoechinulin A",
        "CPR:4",
        "IL1\u03b2"
      ],
      [
        "neoechinulin A",
        "CPR:4",
        "interleukin6"
      ],
      [
        "neoechinulin A",
        "CPR:4",
        "IL6"
      ]
    ],
    "updated": "No",
    "original": "In addition we found that neoechinulin A significantly suppressed the production of neurotoxic inflammatory mediator tumour necrosis factor\u03b1 TNF\u03b1 interleukin1\u03b2 IL1\u03b2 interleukin6 IL6 and prostaglandin E2 PGE2 in activated BV2 cells",
    "simplified": "In addition we found that neoechinulin A significantly suppressed the production of prostaglandin E2 PGE2 in activated BV2 cells and neurotoxic inflammatory mediator tumour necrosis factor\u03b1 TNF-\u03b1."
  },
  {
    "text": "Neoechinulin A suppresses amyloid\u03b2 oligomerinduced microglia activation and thereby protects PC12 cells from inflammationmediated toxicity",
    "triple_list": [
      [
        "Neoechinulin A",
        "CPR:4",
        "amyloid\u03b2"
      ]
    ],
    "updated": "No",
    "original": "Neoechinulin A suppresses amyloid\u03b2 oligomerinduced microglia activation and thereby protects PC12 cells from inflammationmediated toxicity",
    "simplified": "Neoechinulin A protects PC12 cells from inflammationmediated toxicity by preventing microglia activation."
  },
  {
    "text": "The molecular mechanism studies suggested that neoechinulin A may block the phosphorylation of mitogenactivated protein kinase MAPK molecule p38 apoptosis signalregulating kinase 1 ASK1 and nuclear translocation of nuclear factor\u03baB NF\u03baB p65 and p50 subunits",
    "triple_list": [
      [
        "neoechinulin A",
        "CPR:4",
        "mitogenactivated protein kinase"
      ],
      [
        "neoechinulin A",
        "CPR:4",
        "MAPK"
      ],
      [
        "neoechinulin A",
        "CPR:4",
        "p38"
      ],
      [
        "neoechinulin A",
        "CPR:4",
        "apoptosis signalregulating kinase 1"
      ],
      [
        "neoechinulin A",
        "CPR:4",
        "ASK1"
      ],
      [
        "neoechinulin A",
        "CPR:4",
        "nuclear factor\u03baB"
      ],
      [
        "neoechinulin A",
        "CPR:4",
        "NF\u03baB"
      ],
      [
        "neoechinulin A",
        "CPR:4",
        "p65"
      ],
      [
        "neoechinulin A",
        "CPR:4",
        "p50"
      ]
    ],
    "updated": "No",
    "original": "The molecular mechanism studies suggested that neoechinulin A may block the phosphorylation of mitogenactivated protein kinase MAPK molecule p38 apoptosis signalregulating kinase 1 ASK1 and nuclear translocation of nuclear factor\u03baB NF\u03baB p65 and p50 subunits",
    "simplified": "The molecular mechanism studies suggested that neoechinulin A may block the nuclear translocation of nuclear factor\u03baB NF\u03baB p65 and p50 subunits and the phosphorylation of mitogenactivated protein kinase MAPK molecule p38."
  },
  {
    "text": "In this study focus was given to evaluate the ability of neoechinulin A an indole alkaloid isolated from marinederived Microsporum sp to attenuate microglial activation by oligomeric amyloid\u03b2 142 A\u03b242",
    "triple_list": [
      [
        "neoechinulin A",
        "CPR:4",
        "amyloid\u03b2 142"
      ],
      [
        "neoechinulin A",
        "CPR:4",
        "A\u03b242"
      ],
      [
        "indole",
        "CPR:4",
        "amyloid\u03b2 142"
      ],
      [
        "indole",
        "CPR:4",
        "A\u03b242"
      ]
    ],
    "updated": "No",
    "original": "In this study focus was given to evaluate the ability of neoechinulin A an indole alkaloid isolated from marinederived Microsporum sp to attenuate microglial activation by oligomeric amyloid\u03b2 142 A\u03b242",
    "simplified": "In this study focus was given to evaluate the ability of neoechinulin A an indole alkaloid to attenuate microglial activation by oligomeric amyloid in the central nervous system."
  },
  {
    "text": "Neoechinulin A treatment significantly inhibited the generation of reactive oxygen and nitrogen species in A\u03b242 activated BV2 microglia cells",
    "triple_list": [
      [
        "Neoechinulin A",
        "CPR:4",
        "A\u03b242"
      ]
    ],
    "updated": "No",
    "original": "Neoechinulin A treatment significantly inhibited the generation of reactive oxygen and nitrogen species in A\u03b242 activated BV2 microglia cells",
    "simplified": "Neoechinulin A treatment significantly inhibited the production of reactive nitrogen and oxygen in BV2 microglia cells."
  },
  {
    "text": "Epi increased the activity of the human WNT6 promoter . This was done by binding \u03b2catenin to the WNT6 promoter .",
    "triple_list": [
      [
        "Epi",
        "CPR:3",
        "human WNT6 promoter"
      ],
      [
        "Epi",
        "CPR:3",
        "WNT6 promoter"
      ]
    ],
    "updated": "Yes",
    "original": "Epi increased the activity of the human WNT6 promoter through Cav1dependent binding of \u03b2catenin to the proximal WNT6 promoter",
    "simplified": "Epi increased the activity of the human WNT6 promoter. This was done by binding \u03b2catenin to the WNT6 promoter."
  },
  {
    "text": "Epi increased both WNT6 Wnt6 and Cav1 expression in human and in a murine model of bone cancer .",
    "triple_list": [
      [
        "Epi",
        "CPR:3",
        "WNT6"
      ],
      [
        "Epi",
        "CPR:3",
        "Wnt6"
      ],
      [
        "Epi",
        "CPR:3",
        "Cav1"
      ]
    ],
    "updated": "Yes",
    "original": "Epi increased both WNT6 Wnt6 and Cav1 expression in human GC cells and within the tumor area of a murine model of GC CEA424SV40 TAg",
    "simplified": "Epi increased both WNT6 Wnt6 and Cav1 expression in human and in a murine model of bone cancer."
  },
  {
    "text": "These results showed that WNT6 and Cav1 are upregulated by chemotherapeutics and enhance the resistance of GC cells to anthracycline drugs",
    "triple_list": [
      [
        "WNT6",
        "CPR:3",
        "anthracycline"
      ],
      [
        "Cav1",
        "CPR:3",
        "anthracycline"
      ]
    ],
    "updated": "No",
    "original": "These results showed that WNT6 and Cav1 are upregulated by chemotherapeutics and enhance the resistance of GC cells to anthracycline drugs",
    "simplified": "These results showed that chemotherapeutics increase the WNT6 and Cav1 levels in GC cells and increase their resistance to drugs."
  },
  {
    "text": "In this study using reverse transcriptase PCR RTPCR and ELISA we showed that in cultured HAPI microglial cells , TCDD increased the expression and secretion of tumor necrosis factoralpha TNF\u03b1 .",
    "triple_list": [
      [
        "TCDD",
        "CPR:3",
        "tumor necrosis factoralpha"
      ],
      [
        "TCDD",
        "CPR:3",
        "TNF\u03b1"
      ]
    ],
    "updated": "Yes",
    "original": "In this study using reverse transcriptase PCR RTPCR and ELISA we showed that TCDD upregulated the expression and secretion of tumor necrosis factoralpha TNF\u03b1 in a timedependent manner in cultured HAPI microglial cells",
    "simplified": "In this study using reverse transcriptase PCR RTPCR and ELISA we showed that in cultured HAPI microglial cells, TCDD increased the expression and secretion of tumor necrosis factoralpha TNF\u03b1."
  },
  {
    "text": "TCDD also caused a fast within 30min as judged by the increase in cytosolic phospholipase A2 cPLA2 at the mRNA level .",
    "triple_list": [
      [
        "TCDD",
        "CPR:3",
        "cytosolic phospholipase A2"
      ],
      [
        "TCDD",
        "CPR:3",
        "cPLA2"
      ]
    ],
    "updated": "Yes",
    "original": "TCDD also caused a fast within 30min as judged by the increase in its mRNA level activation of cytosolic phospholipase A2 cPLA2",
    "simplified": "TCDD also caused a fast within 30min as judged by the increase in cytosolic phospholipase A2 cPLA2 at the mRNA level."
  },
  {
    "text": "This initial action was accompanied by a significant increase in cyclooxygenase2 COX2 within 1h after TCDD treatment .",
    "triple_list": [
      [
        "cyclooxygenase2",
        "CPR:3",
        "TCDD"
      ],
      [
        "COX2",
        "CPR:3",
        "TCDD"
      ]
    ],
    "updated": "Yes",
    "original": "This initial action was accompanied by upregulation of cyclooxygenase2 COX2 an important inflammation marker within 1h after TCDD treatment",
    "simplified": "This initial action was accompanied by a significant increase in cyclooxygenase2 COX2 within 1h after TCDD treatment."
  },
  {
    "text": "Further TCDD exposure could induce phosphorylation and ubiquitinationdependent degradation of I\u043aB\u03b1 and the translocation of NF\u03baB p65 from the cytosol to the nucleus in this microglial cell line",
    "triple_list": [
      [
        "TCDD",
        "CPR:3",
        "I\u043aB\u03b1"
      ]
    ],
    "updated": "No",
    "original": "Further TCDD exposure could induce phosphorylation and ubiquitinationdependent degradation of I\u043aB\u03b1 and the translocation of NF\u03baB p65 from the cytosol to the nucleus in this microglial cell line",
    "simplified": "Further TCDD exposure could cause NF\u03baB p65 to move from the cytosol to the nucleus in this microglial cell line. This would cause phosphorylation and ubiquitination."
  },
  {
    "text": "Thus the NF\u03baB system can be activated by TCDD treatment .",
    "triple_list": [
      [
        "NF\u03baB",
        "CPR:3",
        "TCDD"
      ]
    ],
    "updated": "Yes",
    "original": "Thus the NF\u03baB signaling pathway can be activated after TCDD treatment",
    "simplified": "Thus the NF\u03baB system can be activated by TCDD treatment."
  },
  {
    "text": "However Ca2 blockers also obviously attenuated NF\u03baB activation and transnuclear transport induced by TCDD",
    "triple_list": [
      [
        "NF\u03baB",
        "CPR:3",
        "TCDD"
      ]
    ],
    "updated": "No",
    "original": "However Ca2 blockers also obviously attenuated NF\u03baB activation and transnuclear transport induced by TCDD",
    "simplified": "However, Ca2 blockers also seem to reduce the transnuclear transport and NF\u03baB activation."
  },
  {
    "text": "According to these results , the proinflammatory cytokine secretion and NF\u03baB activation caused by TCDD can be mediated by increased Ca2i levels in HAPI microglial cells .",
    "triple_list": [
      [
        "cytokine",
        "CPR:3",
        "TCDD"
      ],
      [
        "NF\u03baB",
        "CPR:3",
        "TCDD"
      ]
    ],
    "updated": "Yes",
    "original": "In concert with these results we highlighted that the secretion of proinflammatory cytokine and NF\u03baB activation induced by TCDD can be mediated by elevation of Ca2i in HAPI microglial cells",
    "simplified": "According to these results, the proinflammatory cytokine secretion and NF\u03baB activation caused by TCDD can be mediated by increased Ca2i levels in HAPI microglial cells."
  },
  {
    "text": "The ARB eprosartan is a nonbiphenyl nontetrazole angiotensin II type 1 receptor AT1 antagonist which acts to decrease total peripheral resistance",
    "triple_list": [
      [
        "eprosartan",
        "CPR:6",
        "angiotensin II type 1 receptor"
      ],
      [
        "eprosartan",
        "CPR:6",
        "AT1"
      ]
    ],
    "updated": "No",
    "original": "The ARB eprosartan is a nonbiphenyl nontetrazole angiotensin II type 1 receptor AT1 antagonist which acts to decrease total peripheral resistance",
    "simplified": "The ARB eprosartan is a nonbiphenyl nontetrazole drug. It works by attacking the angiotensin II type 1 receptor."
  },
  {
    "text": "The potency of the selective alpha 1Dadrenoceptor antagonist BMY 7378 against noradrenaline pA2 = 616 013 and of the selective alpha 1Aadrenoceptor antagonist RS17053 against noradrenaline pKB = 835 010 and against the selective alpha 1Aadrenoceptor agonist A61603 pKB = 840 009 were too low to account for alpha 1D and alpha 1Aadrenoceptor involvement",
    "triple_list": [
      [
        "alpha 1Aadrenoceptor",
        "CPR:5",
        "A61603"
      ],
      [
        "alpha 1Dadrenoceptor",
        "CPR:6",
        "BMY 7378"
      ],
      [
        "alpha 1Aadrenoceptor",
        "CPR:6",
        "RS17053"
      ]
    ],
    "updated": "No",
    "original": "The potency of the selective alpha 1Dadrenoceptor antagonist BMY 7378 against noradrenaline pA2 = 616 013 and of the selective alpha 1Aadrenoceptor antagonist RS17053 against noradrenaline pKB = 835 010 and against the selective alpha 1Aadrenoceptor agonist A61603 pKB = 840 009 were too low to account for alpha 1D and alpha 1Aadrenoceptor involvement",
    "simplified": "The selective alpha 1Aadrenoceptor antagonist BMY 7378 did not work at all against noradrenaline pA2 = 616 013. The selective alpha 1Aadrenoceptor antagonist RS17053 did not work at all against noradrenaline pKB = 835 010 and against the selective alpha 1Aadrenoceptor agonist A61603 pKB = 840 009."
  },
  {
    "text": "The putative alpha 1Ladrenoceptor antagonist JTH601 but not the alpha 1Badrenoceptor antagonist chloroethylclonidine 10 microM antagonized noradrenalineinduced contractions of SMA",
    "triple_list": [
      [
        "alpha 1Ladrenoceptor",
        "CPR:6",
        "JTH601"
      ],
      [
        "alpha 1Badrenoceptor",
        "CPR:6",
        "chloroethylclonidine"
      ]
    ],
    "updated": "No",
    "original": "The putative alpha 1Ladrenoceptor antagonist JTH601 but not the alpha 1Badrenoceptor antagonist chloroethylclonidine 10 microM antagonized noradrenalineinduced contractions of SMA",
    "simplified": "The putative alpha 1Ladrenoceptor antagonist chloroethylclonidine 10 microM antagonized noradrenalineinduced contractions of the central nervous system."
  },
  {
    "text": "Doses of dimethocaine 17 mgkg and cocaine 03 mgkg which produced full 80 substitution for cocaine were administered in combination with the dopamine D1 receptor antagonist SCH 39166 trans677a8913bhexahydro3chloro2hydroxyNmethyl5H benzo dnaphtho21bazepine and the dopamine D2 receptor antagonist raclopride both at 0003003 mgkg",
    "triple_list": [
      [
        "dopamine D1 receptor",
        "CPR:6",
        "SCH 39166"
      ],
      [
        "dopamine D1 receptor",
        "CPR:6",
        "trans677a8913bhexahydro3chloro2hydroxyNmethyl5H benzo dnaphtho21bazepine"
      ],
      [
        "dopamine D2 receptor",
        "CPR:6",
        "raclopride"
      ]
    ],
    "updated": "No",
    "original": "Doses of dimethocaine 17 mgkg and cocaine 03 mgkg which produced full 80 substitution for cocaine were administered in combination with the dopamine D1 receptor antagonist SCH 39166 trans677a8913bhexahydro3chloro2hydroxyNmethyl5H benzo dnaphtho21bazepine and the dopamine D2 receptor antagonist raclopride both at 0003003 mgkg",
    "simplified": "Doses of dimethocaine 17 mgkg and cocaine 03 mgkg which produced full 80 substitution for cocaine were given to people for a week. Then people were given another dose of dimethocaine, cocaine, and a drug called raclopride for a short time."
  },
  {
    "text": "Carvedilol reduced the risk of death or heart failure in patients with above-median levels of adrenomedullin or above-median levels of NBNP or both to rates not significantly different from those without the drug .",
    "triple_list": [
      [
        "Carvedilol",
        "CPR:4",
        "NBNP"
      ],
      [
        "Carvedilol",
        "CPR:4",
        "adrenomedullin"
      ]
    ],
    "updated": "Yes",
    "original": "Carvedilol reduced the risk of death or heart failure in patients with abovemedian levels of NBNP or adrenomedullin or both to rates not significantly different from those observed in patients with levels below the median value",
    "simplified": "Carvedilol reduced the risk of death or heart failure in patients with above-median levels of adrenomedullin or above-median levels of NBNP or both to rates not significantly different from those without the drug."
  },
  {
    "text": "Carvedilol reduced mortality and heart failure in patients with higher pretreatment plasma NBNP and adrenomedullin",
    "triple_list": [
      [
        "Carvedilol",
        "CPR:4",
        "NBNP"
      ],
      [
        "Carvedilol",
        "CPR:4",
        "adrenomedullin"
      ]
    ],
    "updated": "No",
    "original": "Carvedilol reduced mortality and heart failure in patients with higher pretreatment plasma NBNP and adrenomedullin",
    "simplified": "Carvedilol reduced heart failure and mortality in patients with high blood pressure after surgery."
  },
  {
    "text": "The data provide evidence that resveratrol and clofarabine have a synergistic effect on the inhibition of Akt and Sp1 activities and suggest that this combination may have therapeutic value in the treatment of malignant mesothelioma .",
    "triple_list": [
      [
        "resveratrol",
        "CPR:4",
        "Akt"
      ],
      [
        "resveratrol",
        "CPR:4",
        "Sp1"
      ],
      [
        "clofarabine",
        "CPR:4",
        "Akt"
      ],
      [
        "clofarabine",
        "CPR:4",
        "Sp1"
      ]
    ],
    "updated": "Yes",
    "original": "Taken together the data provide evidence that the synergistic antiproliferative effect of resveratrol and clofarabine is linked to the inhibition of Akt and Sp1 activities and suggest that this combination may have therapeutic value in treatment of malignant mesothelioma",
    "simplified": "The data provide evidence that resveratrol and clofarabine have a synergistic effect on the inhibition of Akt and Sp1 activities and suggest that this combination may have therapeutic value in the treatment of malignant mesothelioma."
  },
  {
    "text": "Together with clofarabine , resveratrol was able to reduce the amount of Sp1 in the blood . This effect was also seen in a time and dosedependent experiment .",
    "triple_list": [
      [
        "clofarabine",
        "CPR:4",
        "Sp1"
      ],
      [
        "resveratrol",
        "CPR:4",
        "Sp1"
      ]
    ],
    "updated": "Yes",
    "original": "In combination with clofarabine the ability of resveratrol to reduce the contents of Sp1 and its target gene products was also evident in a time and dosedependent experiment",
    "simplified": "Together with clofarabine, resveratrol was able to reduce the amount of Sp1 in the blood. This effect was also seen in a time and dosedependent experiment."
  },
  {
    "text": "The combination of Ly294002 with phosphoinositide 3kinase reduced the p21 level by about half , but it showed no significant effects on expression of Sp1 and cyclin D1 .",
    "triple_list": [
      [
        "phosphoinositide 3kinase",
        "CPR:4",
        "Ly294002"
      ],
      [
        "Ly294002",
        "CPR:4",
        "p21"
      ]
    ],
    "updated": "Yes",
    "original": "The inhibition of phosphoinositide 3kinase using Ly294002 augmented a decrease in the p21 level induced by their combination but it showed no significant effects on expression of Sp1 and cyclin D1",
    "simplified": "The combination of Ly294002 with phosphoinositide 3kinase reduced the p21 level by about half, but it showed no significant effects on expression of Sp1 and cyclin D1."
  },
  {
    "text": "Finally , we found that the phosphorylation of LKB1 is required for phillyrin enhanced AMPK activation in HepG2 hepatocytes .",
    "triple_list": [
      [
        "phillyrin",
        "CPR:3",
        "AMPK"
      ]
    ],
    "updated": "Yes",
    "original": "Finally we found that liver kinase B1 LKB1 phosphorylation is required for the phillyrin enhanced activation of AMPK in HepG2 hepatocytes",
    "simplified": "Finally, we found that the phosphorylation of LKB1 is required for phillyrin enhanced AMPK activation in HepG2 hepatocytes."
  },
  {
    "text": "These results indicate that phillyrin prevents lipid accumulation in HepG2 cells by blocking the expression of SREBP1c and FAS through LKB1 AMPK activation , suggesting that phillyrin may play a role in preventing and treating obesity .",
    "triple_list": [
      [
        "phillyrin",
        "CPR:3",
        "LKB1"
      ],
      [
        "phillyrin",
        "CPR:3",
        "AMPK"
      ],
      [
        "phillyrin",
        "CPR:3",
        "AMPK"
      ],
      [
        "phillyrin",
        "CPR:4",
        "SREBP1c"
      ],
      [
        "phillyrin",
        "CPR:4",
        "FAS"
      ]
    ],
    "updated": "Yes",
    "original": "These results indicate that phillyrin prevents lipid accumulation in HepG2 cells by blocking the expression of SREBP1c and FAS through LKB1 AMPK activation suggesting that phillyrin is a novel AMPK activator with a role in the prevention and treatment of obesity",
    "simplified": "These results indicate that phillyrin prevents lipid accumulation in HepG2 cells by blocking the expression of SREBP1c and FAS through LKB1 AMPK activation, suggesting that phillyrin may play a role in preventing and treating obesity."
  },
  {
    "text": "Phillyrin attenuates high glucoseinduced lipid accumulation in human HepG2 hepatocytes through the activation of LKB1 AMPactivated protein kinase dependent signalling",
    "triple_list": [
      [
        "Phillyrin",
        "CPR:3",
        "LKB1"
      ],
      [
        "Phillyrin",
        "CPR:3",
        "AMPactivated protein kinase"
      ]
    ],
    "updated": "No",
    "original": "Phillyrin attenuates high glucoseinduced lipid accumulation in human HepG2 hepatocytes through the activation of LKB1 AMPactivated protein kinase dependent signalling",
    "simplified": "Phillyrin reduces high glucose-induced lipid build-up in human hepatocytes. This is done by activation of protein kinase-dependent signalling."
  },
  {
    "text": "Phillyrin strongly inhibited high glucose induced fatty acid synthase ( FAS ) expression by modulating the expression of a protein called SREBP1c .",
    "triple_list": [
      [
        "glucose",
        "CPR:3",
        "fatty acid synthase"
      ],
      [
        "glucose",
        "CPR:3",
        "FAS"
      ],
      [
        "Phillyrin",
        "CPR:4",
        "fatty acid synthase"
      ],
      [
        "Phillyrin",
        "CPR:4",
        "FAS"
      ]
    ],
    "updated": "Yes",
    "original": "Phillyrin strongly inhibited high glucose induced fatty acid synthase FAS expression by modulating sterol regulatory elementbinding protein1c SREBP1c activation",
    "simplified": "Phillyrin strongly inhibited high glucose induced fatty acid synthase (FAS) expression by modulating the expression of a protein called SREBP1c."
  },
  {
    "text": "Moreover use of the pharmacological AMPactivated protein kinase AMPK inhibitor compound C revealed that AMPK is essential for suppressing SREBP1c expression in phillyrintreated cells",
    "triple_list": [
      [
        "AMPactivated protein kinase",
        "CPR:4",
        "compound C"
      ],
      [
        "AMPK",
        "CPR:4",
        "compound C"
      ],
      [
        "AMPK",
        "CPR:4",
        "compound C"
      ]
    ],
    "updated": "No",
    "original": "Moreover use of the pharmacological AMPactivated protein kinase AMPK inhibitor compound C revealed that AMPK is essential for suppressing SREBP1c expression in phillyrintreated cells",
    "simplified": "The team also used the drug AMPactivated protein kinase (AMPK) inhibitor C to block SREBP1c. They found that this blocked SREBP1c in sick cells."
  },
  {
    "text": "A series of benzenesulfonamides incorporating cyanoacrylamide moieties tyrphostine analogs were assayed as inhibitors of the \u03b2carbonic anhydrase CA EC 4211 from Saccharomyces cerevisiae ScCA",
    "triple_list": [
      [
        "benzenesulfonamides",
        "CPR:4",
        "EC 4211"
      ],
      [
        "benzenesulfonamides",
        "CPR:4",
        "ScCA"
      ],
      [
        "benzenesulfonamides",
        "CPR:4",
        "\u03b2carbonic anhydrase"
      ],
      [
        "benzenesulfonamides",
        "CPR:4",
        "CA"
      ],
      [
        "cyanoacrylamide",
        "CPR:4",
        "EC 4211"
      ],
      [
        "cyanoacrylamide",
        "CPR:4",
        "ScCA"
      ],
      [
        "cyanoacrylamide",
        "CPR:4",
        "\u03b2carbonic anhydrase"
      ],
      [
        "cyanoacrylamide",
        "CPR:4",
        "CA"
      ],
      [
        "tyrphostine",
        "CPR:4",
        "EC 4211"
      ],
      [
        "tyrphostine",
        "CPR:4",
        "ScCA"
      ],
      [
        "tyrphostine",
        "CPR:4",
        "\u03b2carbonic anhydrase"
      ],
      [
        "tyrphostine",
        "CPR:4",
        "CA"
      ]
    ],
    "updated": "No",
    "original": "A series of benzenesulfonamides incorporating cyanoacrylamide moieties tyrphostine analogs were assayed as inhibitors of the \u03b2carbonic anhydrase CA EC 4211 from Saccharomyces cerevisiae ScCA",
    "simplified": "A series of benzenesulfonamides containing cyanoacrylamide moieties and tyrphostine analogs have been shown to inhibit the anhydrase CA EC 4211 from Saccharomyces cerevisiae."
  },
  {
    "text": "Benzenesulfonamides incorporating cyanoacrylamide moieties strongly inhibit Saccharomyces cerevisiae \u03b2carbonic anhydrase",
    "triple_list": [
      [
        "Benzenesulfonamides",
        "CPR:4",
        "Saccharomyces cerevisiae \u03b2carbonic anhydrase"
      ],
      [
        "cyanoacrylamide",
        "CPR:4",
        "Saccharomyces cerevisiae \u03b2carbonic anhydrase"
      ]
    ],
    "updated": "No",
    "original": "Benzenesulfonamides incorporating cyanoacrylamide moieties strongly inhibit Saccharomyces cerevisiae \u03b2carbonic anhydrase",
    "simplified": "Benzenesulfonamides have been shown to inhibit the enzyme Saccharomyces cerevisiae by up to 75%."
  },
  {
    "text": "The mRNA levels of microphthalmiaassociated transcription factor MITF and its downstream genes tyrosinase tyrosinaserelated protein TRP1 and TRP2 were reduced by artemisinic acid treatment",
    "triple_list": [
      [
        "microphthalmiaassociated transcription factor",
        "CPR:4",
        "artemisinic acid"
      ],
      [
        "MITF",
        "CPR:4",
        "artemisinic acid"
      ],
      [
        "tyrosinase",
        "CPR:4",
        "artemisinic acid"
      ],
      [
        "tyrosinaserelated protein TRP1",
        "CPR:4",
        "artemisinic acid"
      ],
      [
        "TRP2",
        "CPR:4",
        "artemisinic acid"
      ]
    ],
    "updated": "No",
    "original": "The mRNA levels of microphthalmiaassociated transcription factor MITF and its downstream genes tyrosinase tyrosinaserelated protein TRP1 and TRP2 were reduced by artemisinic acid treatment",
    "simplified": "The levels of microphthalmiaassociated transcription factor MITF and tyrosinase tyrosinaserelated protein were reduced when artemisinic acid was taken out of the body."
  },
  {
    "text": "The levels of the genes cKIT stem cell factor SCF and macrophage migration inhibitory factor MIF were also reduced by artemisinic acid .",
    "triple_list": [
      [
        "cKIT",
        "CPR:4",
        "artemisinic acid"
      ],
      [
        "stem cell factor",
        "CPR:4",
        "artemisinic acid"
      ],
      [
        "SCF",
        "CPR:4",
        "artemisinic acid"
      ],
      [
        "macrophage migration inhibitory factor",
        "CPR:4",
        "artemisinic acid"
      ],
      [
        "MIF",
        "CPR:4",
        "artemisinic acid"
      ]
    ],
    "updated": "Yes",
    "original": "Additionally the mRNA levels of melanogenesisrelated genes cKIT stem cell factor SCF and macrophage migration inhibitory factor MIF were downregulated by artemisinic acid",
    "simplified": "The levels of the genes cKIT stem cell factor SCF and macrophage migration inhibitory factor MIF were also reduced by artemisinic acid."
  },
  {
    "text": "Furthermore cAMP production and protein kinase A PKA activity were suppressed by artemisinic acid",
    "triple_list": [
      [
        "protein kinase A",
        "CPR:4",
        "artemisinic acid"
      ],
      [
        "PKA",
        "CPR:4",
        "artemisinic acid"
      ]
    ],
    "updated": "No",
    "original": "Furthermore cAMP production and protein kinase A PKA activity were suppressed by artemisinic acid",
    "simplified": "In addition, protein kinase A and cAMP production were reduced by artemisinic acid."
  },
  {
    "text": "Moreover attempts to elucidate a possible mechanism underlying the artemisinic acidmediated effects revealed that artemisinic acid regulated melanogenesis by inhibiting cholesterol synthesis through downregulation of the hydroxymethylglutaryl CoA HMG CoA reductase gene which was mediated through reduced expression of the CCAATenhancerbinding protein CEBP \u03b1 gene",
    "triple_list": [
      [
        "artemisinic acid",
        "CPR:4",
        "hydroxymethylglutaryl CoA HMG CoA reductase"
      ],
      [
        "artemisinic acid",
        "CPR:4",
        "CCAATenhancerbinding protein CEBP \u03b1"
      ]
    ],
    "updated": "No",
    "original": "Moreover attempts to elucidate a possible mechanism underlying the artemisinic acidmediated effects revealed that artemisinic acid regulated melanogenesis by inhibiting cholesterol synthesis through downregulation of the hydroxymethylglutaryl CoA HMG CoA reductase gene which was mediated through reduced expression of the CCAATenhancerbinding protein CEBP \u03b1 gene",
    "simplified": "Artemisinic acid has been shown to inhibit the production of cholesterol by reducing the expression of the hydroxymethylglutaryl CoA HMG CoA reductase gene. It has also been shown to inhibit melanogenesis by reducing the expression of the CCAATenhancerbinding protein CEBP \u03b1 gene."
  },
  {
    "text": "Artemisinic acid inhibits melanogenesis through downregulation of CEBP \u03b1 dependent expression of HMGCoA reductase gene",
    "triple_list": [
      [
        "Artemisinic acid",
        "CPR:4",
        "CEBP \u03b1"
      ],
      [
        "Artemisinic acid",
        "CPR:4",
        "HMGCoA reductase"
      ]
    ],
    "updated": "No",
    "original": "Artemisinic acid inhibits melanogenesis through downregulation of CEBP \u03b1 dependent expression of HMGCoA reductase gene",
    "simplified": "Artemisinic acid inhibits the transcription of the HMGCoA reductase gene and thus inhibits melanogenesis."
  },
  {
    "text": "Taken together these findings indicate that the inhibition of melanogenesis by artemisinic acid occurs through reduced expression of the HMG CoA reductase gene which is mediated by CEBP \u03b1 inhibition and suggest that artemisinic acid may be useful as a hyperpigmentation inhibitor",
    "triple_list": [
      [
        "artemisinic acid",
        "CPR:4",
        "HMG CoA reductase"
      ],
      [
        "artemisinic acid",
        "CPR:4",
        "CEBP \u03b1"
      ]
    ],
    "updated": "No",
    "original": "Taken together these findings indicate that the inhibition of melanogenesis by artemisinic acid occurs through reduced expression of the HMG CoA reductase gene which is mediated by CEBP \u03b1 inhibition and suggest that artemisinic acid may be useful as a hyperpigmentation inhibitor",
    "simplified": "These findings indicate that artemisinic acid inhibits melanogenesis through reduced expression of the HMG CoA reductase gene. Artemisinic acid may be useful as a hyperpigmentation inhibitor because it reduces the amount of melanin needed for growth."
  },
  {
    "text": "Both 5 alphaNET and 3 beta5 alphaNET blocked the PR downregulation induced by P4 as assessed by Western and Northern blot methods",
    "triple_list": [
      [
        "5 alphaNET",
        "CPR:3",
        "PR"
      ],
      [
        "3 beta5 alphaNET",
        "CPR:3",
        "PR"
      ]
    ],
    "updated": "No",
    "original": "Both 5 alphaNET and 3 beta5 alphaNET blocked the PR downregulation induced by P4 as assessed by Western and Northern blot methods",
    "simplified": "Both 5 alphaNET and 3 beta5 alphaNET blocked the effects of P4. Western blot and Northern blot methods showed this."
  },
  {
    "text": "The inhibition of UG synthesis and PR downregulation by 5 alphaNET and 3 beta5 alphaNET indicates that these NET metabolites possess antiprogestational properties",
    "triple_list": [
      [
        "PR",
        "CPR:3",
        "5 alphaNET"
      ],
      [
        "UG",
        "CPR:4",
        "5 alphaNET"
      ],
      [
        "UG",
        "CPR:4",
        "3 beta5 alphaNET"
      ],
      [
        "PR",
        "CPR:4",
        "3 beta5 alphaNET"
      ],
      [
        "UG",
        "CPR:4",
        "NET"
      ],
      [
        "PR",
        "CPR:4",
        "NET"
      ]
    ],
    "updated": "No",
    "original": "The inhibition of UG synthesis and PR downregulation by 5 alphaNET and 3 beta5 alphaNET indicates that these NET metabolites possess antiprogestational properties",
    "simplified": "The inhibition of UG synthesis and PR downregulation by 5 alphaNET and 3 beta5 alphaNET has been shown to interfere with sperm production."
  },
  {
    "text": "Western and Northern blot analyses showed that 5 alphaNET inhibited the expression of the UG gene in a dose-dependent manner .",
    "triple_list": [
      [
        "5 alphaNET",
        "CPR:4",
        "UG"
      ]
    ],
    "updated": "Yes",
    "original": "As determined by Western and Northern blot analyses 5 alphaNET inhibited the P4induced UG gene expression in a dosedependent manner",
    "simplified": "Western and Northern blot analyses showed that 5 alphaNET inhibited the expression of the UG gene in a dose-dependent manner."
  },
  {
    "text": "The estrogenic agent 3 beta5 alphaNET and estradiol at a dose of 10 mg also made the UG gene not work at all .",
    "triple_list": [
      [
        "3 beta5 alphaNET",
        "CPR:4",
        "UG"
      ],
      [
        "estradiol",
        "CPR:4",
        "UG"
      ]
    ],
    "updated": "Yes",
    "original": "The estrogenic agent 3 beta5 alphaNET and estradiol at a dose of 10 mg also inhibited the UG gene expression induced by P4",
    "simplified": "The estrogenic agent 3 beta5 alphaNET and estradiol at a dose of 10 mg also made the UG gene not work at all."
  },
  {
    "text": "When dioscin was given to A549 and H1299 cells , they showed an increase in ERK12 and JNK12 activity . However , they also saw a decrease in PI3K and a decrease in Akt and mTOR .",
    "triple_list": [
      [
        "dioscin",
        "CPR:3",
        "JNK12"
      ],
      [
        "dioscin",
        "CPR:3",
        "ERK12"
      ],
      [
        "dioscin",
        "CPR:4",
        "PI3K"
      ],
      [
        "dioscin",
        "CPR:4",
        "Akt"
      ],
      [
        "dioscin",
        "CPR:4",
        "mTOR"
      ]
    ],
    "updated": "Yes",
    "original": "Treatment of A549 and H1299 cells with dioscin caused a dosedependent increase in ERK12 and JNK12 activity accompanied with a decreased PI3K expression and decreased phosphorylation of Akt and mTOR",
    "simplified": "When dioscin was given to A549 and H1299 cells, they showed an increase in ERK12 and JNK12 activity. However, they also saw a decrease in PI3K and a decrease in Akt and mTOR."
  },
  {
    "text": "Autophagy was also found as early as 12 h after exposure to dioscin . This was shown by an increased expression of LC3II and beclin1 proteins .",
    "triple_list": [
      [
        "dioscin",
        "CPR:3",
        "LC3II"
      ],
      [
        "dioscin",
        "CPR:3",
        "beclin1"
      ]
    ],
    "updated": "Yes",
    "original": "Meanwhile autophagy was detected as early as 12 h after an exposure to lowdose dioscin as indicated by an upregulated expression of LC3II and beclin1 proteins",
    "simplified": "Autophagy was also found as early as 12 h after exposure to dioscin. This was shown by an increased expression of LC3II and beclin1 proteins."
  },
  {
    "text": "For the first time , our study suggests that 2hydroxy3methylanthraquinone can enhance apoptosis of U937 cells at least in part through downregulation of pERK12 and activation of pp38MAPK .",
    "triple_list": [
      [
        "2hydroxy3methylanthraquinone",
        "CPR:3",
        "pp38MAPK"
      ]
    ],
    "updated": "Yes",
    "original": "Taken together our study for the first time suggests that 2hydroxy3methylanthraquinone is able to enhance apoptosis of U937 cells at least in part through activation of pp38MAPK and downregulation of pERK12",
    "simplified": "For the first time, our study suggests that 2hydroxy3methylanthraquinone can enhance apoptosis of U937 cells at least in part through downregulation of pERK12 and activation of pp38MAPK."
  },
  {
    "text": "Our results showed that 2hydroxy3methylanthraquinone decreased phosphorylationERK12 pERK12 and increased pp38MAPK but did not affect expressions of pJNK12 in U937 cells",
    "triple_list": [
      [
        "2hydroxy3methylanthraquinone",
        "CPR:3",
        "pp38MAPK"
      ]
    ],
    "updated": "No",
    "original": "Our results showed that 2hydroxy3methylanthraquinone decreased phosphorylationERK12 pERK12 and increased pp38MAPK but did not affect expressions of pJNK12 in U937 cells",
    "simplified": "Our results showed that 2hydroxy3methylanthraquinone decreased pJNK12 expression but did not affect pJNK12 expression in U937 cells."
  },
  {
    "text": "The cells were then treated with 2hydroxy3methylanthraquinone and caspase3 were activated .",
    "triple_list": [
      [
        "2hydroxy3methylanthraquinone",
        "CPR:3",
        "caspase3"
      ]
    ],
    "updated": "Yes",
    "original": "Moreover treatment of U937 cells with 2hydroxy3methylanthraquinone resulted in activation of caspase3",
    "simplified": "The cells were then treated with 2hydroxy3methylanthraquinone and caspase3 were activated."
  },
  {
    "text": "PD98059 ERK12 inhibitor significantly enhanced 2hydroxy3methylanthraquinone-induced apoptosis in U937 cells while SB203580 pp38MAPK inhibitor decreased apoptosis in U937 cells .",
    "triple_list": [
      [
        "SB203580",
        "CPR:4",
        "pp38MAPK"
      ]
    ],
    "updated": "Yes",
    "original": "Furthermore PD98059 ERK12 inhibitor significantly enhanced 2hydroxy3methylanthraquinoneinduced apoptosis in U937 cells whereas caspase3 inhibitor or SB203580 pp38MAPK inhibitor decreased apoptosis in U937 cells",
    "simplified": "PD98059 ERK12 inhibitor significantly enhanced 2hydroxy3methylanthraquinone-induced apoptosis in U937 cells while SB203580 pp38MAPK inhibitor decreased apoptosis in U937 cells."
  },
  {
    "text": "Ribonucleotide reductase activity was found to be increased in the gemcitabine line , and purine nucleoside phosphorylase activity was increased in the 2chlorodeoxyadenosine line .",
    "triple_list": [
      [
        "Ribonucleotide reductase",
        "CPR:3",
        "gemcitabine"
      ],
      [
        "purine nucleoside phosphorylase",
        "CPR:3",
        "2chlorodeoxyadenosine"
      ]
    ],
    "updated": "Yes",
    "original": "Ribonucleotide reductase activity was found to be strongly increased in the gemcitabine selected line and purine nucleoside phosphorylase was increased in the 2chlorodeoxyadenosine selected line",
    "simplified": "Ribonucleotide reductase activity was found to be increased in the gemcitabine line, and purine nucleoside phosphorylase activity was increased in the 2chlorodeoxyadenosine line."
  },
  {
    "text": "Studies showed that the 5ptoluenesulfonylaminophthalimide moiety is a good scaffold to support the activity of the \u03b1glucosidase inhibitory activity , and that substituents at the N2 position have a significant influence on the inhibitory activity .",
    "triple_list": [
      [
        "5ptoluenesulfonylaminophthalimide",
        "CPR:4",
        "\u03b1glucosidase"
      ]
    ],
    "updated": "Yes",
    "original": "Structureactivity relationship studies indicated that 5ptoluenesulfonylaminophthalimide moiety is a favorable scaffold to exert the \u03b1glucosidase inhibitory activity and substituents at the N2 position have considerable influence on the efficacy of the inhibition activities",
    "simplified": "Studies showed that the 5ptoluenesulfonylaminophthalimide moiety is a good scaffold to support the activity of the \u03b1glucosidase inhibitory activity, and that substituents at the N2 position have a significant influence on the inhibitory activity."
  },
  {
    "text": "Several members of a new family of nonsugartype \u03b1glycosidase inhibitors have been developed . They have a 5ptoluenesulfonylaminophthalimide moiety and a different substituent at the N2 position .",
    "triple_list": [
      [
        "\u03b1glycosidase",
        "CPR:4",
        "5ptoluenesulfonylaminophthalimide"
      ]
    ],
    "updated": "Yes",
    "original": "Several members of a new family of nonsugartype \u03b1glycosidase inhibitors bearing a 5ptoluenesulfonylaminophthalimide moiety and various substituent at the N2 position were synthesized and their activities were investigated",
    "simplified": "Several members of a new family of nonsugartype \u03b1glycosidase inhibitors have been developed. They have a 5ptoluenesulfonylaminophthalimide moiety and a different substituent at the N2 position."
  },
  {
    "text": "A new series of N2substituted5ptoluenesulfonylaminophthalimide analogues as \u03b1glucosidase inhibitors",
    "triple_list": [
      [
        "N2substituted5ptoluenesulfonylaminophthalimide",
        "CPR:4",
        "\u03b1glucosidase"
      ]
    ],
    "updated": "No",
    "original": "A new series of N2substituted5ptoluenesulfonylaminophthalimide analogues as \u03b1glucosidase inhibitors",
    "simplified": "N2substituted5ptoluenesulfonylaminophthalimide is a chemical compound."
  },
  {
    "text": "The lysosomal inhibitor chloroquine significantly increased the amount of RCAN1 in the cells . This means that when the lysosomal pH is too high , the RCAN1 breaks down and the NFATc1 is reduced .",
    "triple_list": [
      [
        "chloroquine",
        "CPR:3",
        "RCAN1"
      ]
    ],
    "updated": "Yes",
    "original": "The lysosomal inhibitor chloroquine significantly increased RCAN1 accumulation in cells consistent with the hypothesis that higher lysosomal pH impairs RCAN1 degradation leading to a higher RCAN1NFATc1 ratio and consequently NFATc1 inhibition",
    "simplified": "The lysosomal inhibitor chloroquine significantly increased the amount of RCAN1 in the cells. This means that when the lysosomal pH is too high, the RCAN1 breaks down and the NFATc1 is reduced."
  },
  {
    "text": "We have now found that activation of p38 MAPK by anisomycin potentiated induction of CYP2B6 by a CAR ligand in HepG2 cells to levels observed in human primary hepatocytes .",
    "triple_list": [
      [
        "p38",
        "CPR:3",
        "anisomycin"
      ],
      [
        "MAPK",
        "CPR:3",
        "anisomycin"
      ],
      [
        "anisomycin",
        "CPR:3",
        "CYP2B6"
      ]
    ],
    "updated": "Yes",
    "original": "Here we have now found that activation of p38 MAPK by anisomycin potentiated induction of CYP2B6 mRNA by CAR ligand in HepG2 cells to levels observed in ligandtreated human primary hepatocytes",
    "simplified": "We have now found that activation of p38 MAPK by anisomycin potentiated induction of CYP2B6 by a CAR ligand in HepG2 cells to levels observed in human primary hepatocytes."
  },
  {
    "text": "siRNA knockdown of p38 MAPK stopped anisomycin from working together with CYP2B6 .",
    "triple_list": [
      [
        "anisomycin",
        "CPR:3",
        "CYP2B6"
      ]
    ],
    "updated": "Yes",
    "original": "siRNA knockdown of p38 MAPK abrogated the ability of anisomycin to synergistically induce CYP2B6 mRNA",
    "simplified": " siRNA knockdown of p38 MAPK stopped anisomycin from working together with CYP2B6."
  },
  {
    "text": "In addition to CYP2B6 , anisomycin can also increase the levels of CYP2A7 and CYP2C9 mRNAs , but not UDPglucuronosyltransferase 1A1 mRNAs .",
    "triple_list": [
      [
        "CYP2B6",
        "CPR:3",
        "anisomycin"
      ],
      [
        "anisomycin",
        "CPR:3",
        "CYP2A7"
      ],
      [
        "anisomycin",
        "CPR:3",
        "CYP2C9"
      ]
    ],
    "updated": "Yes",
    "original": "In addition to CYP2B6 anisomycin cotreatment potentiated an increase in CYP2A7 and CYP2C9 mRNAs but not CYP3A4 or UDPglucuronosyltransferase 1A1 mRNAs",
    "simplified": "In addition to CYP2B6, anisomycin can also increase the levels of CYP2A7 and CYP2C9 mRNAs, but not UDPglucuronosyltransferase 1A1 mRNAs."
  },
  {
    "text": "No effects were observed when fenclozic acid was assessed for P450dependent and P450independent cytotoxicity to THLE cell lines . The effects of five major human cytochrome P450 enzymes on the biliary efflux transporters BSEP and MRP2 were also assessed .",
    "triple_list": [
      [
        "fenclozic acid",
        "CPR:4",
        "human cytochrome P450"
      ],
      [
        "fenclozic acid",
        "CPR:4",
        "efflux transporters"
      ],
      [
        "fenclozic acid",
        "CPR:4",
        "BSEP"
      ],
      [
        "fenclozic acid",
        "CPR:4",
        "MRP2"
      ]
    ],
    "updated": "Yes",
    "original": "No effects were observed when fenclozic acid was assessed for P450dependent and P450independent cytotoxicity to THLE cell lines timedependent inhibition of five major human cytochrome P450 enzymes inhibition of the biliary efflux transporters BSEP and MRP2 or mitochondrial toxicity to THLE or HepG2 cells",
    "simplified": "No effects were observed when fenclozic acid was assessed for P450dependent and P450independent cytotoxicity to THLE cell lines. The effects of five major human cytochrome P450 enzymes on the biliary efflux transporters BSEP and MRP2 were also assessed."
  },
  {
    "text": "In addition , auranofin inhibited NFkappaB activation caused by TLR4-dependent downstream signaling components p65 and MyD88 .",
    "triple_list": [
      [
        "auranofin",
        "CPR:4",
        "NFkappaB"
      ]
    ],
    "updated": "Yes",
    "original": "Furthermore auranofin inhibited NFkappaB activation induced by MyD88dependent downstream signaling components of TLR4 MyD88 IKKbeta and p65",
    "simplified": "In addition, auranofin inhibited NFkappaB activation caused by TLR4-dependent downstream signaling components p65 and MyD88."
  },
  {
    "text": "Auranofin as an antirheumatic gold compound suppresses LPSinduced homodimerization of TLR4",
    "triple_list": [
      [
        "Auranofin",
        "CPR:4",
        "TLR4"
      ]
    ],
    "updated": "No",
    "original": "Auranofin as an antirheumatic gold compound suppresses LPSinduced homodimerization of TLR4",
    "simplified": "Auranofin is an antirheumatic gold compound. It prevents LPS from happening."
  },
  {
    "text": "MyD88independent signaling components TRIF and TBK1 were also downregulated by auranofin and activated IRF3 .",
    "triple_list": [
      [
        "IRF3",
        "CPR:4",
        "auranofin"
      ],
      [
        "TRIF",
        "CPR:4",
        "auranofin"
      ],
      [
        "TBK1",
        "CPR:4",
        "auranofin"
      ]
    ],
    "updated": "Yes",
    "original": "IRF3 activation induced by MyD88independent signaling components TRIF and TBK1 was also downregulated by auranofin",
    "simplified": "MyD88independent signaling components TRIF and TBK1 were also downregulated by auranofin and activated IRF3."
  },
  {
    "text": "Our results first show that auranofin suppresses the homodimerization step of the TLR4 signaling process .",
    "triple_list": [
      [
        "auranofin",
        "CPR:4",
        "TLR4"
      ],
      [
        "auranofin",
        "CPR:4",
        "TLR4"
      ]
    ],
    "updated": "Yes",
    "original": "Our results first demonstrate that auranofin suppresses the multiple steps in TLR4 signaling especially the homodimerization of TLR4",
    "simplified": "Our results first show that auranofin suppresses the homodimerization step of the TLR4 signaling process."
  },
  {
    "text": "The results suggest that auranofin may be the molecular mechanism through which antirheumatic activity is suppressed by TLR4 .",
    "triple_list": [
      [
        "TLR4",
        "CPR:4",
        "auranofin"
      ],
      [
        "TLR4",
        "CPR:4",
        "auranofin"
      ]
    ],
    "updated": "Yes",
    "original": "The results suggest that the suppression of TLR4 activity by auranofin may be the molecular mechanism through which auranofin exerts antirheumatic activity",
    "simplified": "The results suggest that auranofin may be the molecular mechanism through which antirheumatic activity is suppressed by TLR4."
  },
  {
    "text": "Our results showed that auranofin reduced the activation of TLR4 by transcription factors NFkappaB and IRF3 and increased the expression of COX2 .",
    "triple_list": [
      [
        "auranofin",
        "CPR:4",
        "TLR4"
      ],
      [
        "auranofin",
        "CPR:4",
        "NFkappaB"
      ],
      [
        "auranofin",
        "CPR:4",
        "IRF3"
      ],
      [
        "auranofin",
        "CPR:4",
        "COX2"
      ]
    ],
    "updated": "Yes",
    "original": "Our results demonstrated that auranofin suppressed TLR4 mediated activation of transcription factors NFkappaB and IRF3 and expression of COX2 a proinflammatory enzyme",
    "simplified": "Our results showed that auranofin reduced the activation of TLR4 by transcription factors NFkappaB and IRF3 and increased the expression of COX2."
  },
  {
    "text": "The effect of auranofin on homodimerization of TLR4 was well correlated with the effect of auranofin on brain activity .",
    "triple_list": [
      [
        "auranofin",
        "CPR:4",
        "TLR4"
      ]
    ],
    "updated": "Yes",
    "original": "This suppression was well correlated with the inhibitory effect of auranofin on the homodimerization of TLR4 induced by an agonist",
    "simplified": "The effect of auranofin on homodimerization of TLR4 was well correlated with the effect of auranofin on brain activity."
  },
  {
    "text": "Vandetanib Caprelsa \u00ae AstraZeneca is a oncedaily oral tyrosine kinase inhibitor that selectively inhibits signalling mediated by growthfactor receptor tyrosine kinase RET constitutively activated in roughly 60 of all MTCs vascular endothelial growthfactor receptors 2 and 3 and epidermal growthfactor receptors",
    "triple_list": [
      [
        "Vandetanib",
        "CPR:4",
        "epidermal growthfactor receptors"
      ],
      [
        "Vandetanib",
        "CPR:4",
        "tyrosine kinase"
      ],
      [
        "Vandetanib",
        "CPR:4",
        "growthfactor receptor tyrosine kinase"
      ],
      [
        "Vandetanib",
        "CPR:4",
        "RET"
      ],
      [
        "Caprelsa",
        "CPR:4",
        "epidermal growthfactor receptors"
      ],
      [
        "Caprelsa",
        "CPR:4",
        "tyrosine kinase"
      ]
    ],
    "updated": "No",
    "original": "Vandetanib Caprelsa \u00ae AstraZeneca is a oncedaily oral tyrosine kinase inhibitor that selectively inhibits signalling mediated by growthfactor receptor tyrosine kinase RET constitutively activated in roughly 60 of all MTCs vascular endothelial growthfactor receptors 2 and 3 and epidermal growthfactor receptors",
    "simplified": "Vandetanib Caprelsa \u00ae AstraZeneca is an oral tyrosine kinase inhibitor that works by inhibiting tyrosine kinase in about 60% of all MTCs vascular endothelial growthfactor receptors 2 and 3 and epidermal growthfactor receptors 2 and 3."
  },
  {
    "text": "One exception is tranexamic acid TXA which as a lysine mimetic inhibits binding of plasminogen to fibrin",
    "triple_list": [
      [
        "tranexamic acid",
        "CPR:4",
        "plasminogen"
      ],
      [
        "tranexamic acid",
        "CPR:4",
        "fibrin"
      ],
      [
        "TXA",
        "CPR:4",
        "plasminogen"
      ],
      [
        "TXA",
        "CPR:4",
        "fibrin"
      ],
      [
        "lysine",
        "CPR:4",
        "plasminogen"
      ],
      [
        "lysine",
        "CPR:4",
        "fibrin"
      ]
    ],
    "updated": "No",
    "original": "One exception is tranexamic acid TXA which as a lysine mimetic inhibits binding of plasminogen to fibrin",
    "simplified": "One exception is tranexamic acid TXA. It acts as a lysine mimetic and stops plasminogen from working."
  },
  {
    "text": "Coupling this computational technique with a highquality lowthroughput screen identified 54piperidyl3isoxazolol 4PIOL as a plasminogen-binding inhibitor that could be used to treat bleeding disorders .",
    "triple_list": [
      [
        "54piperidyl3isoxazolol",
        "CPR:4",
        "plasminogen"
      ],
      [
        "4PIOL",
        "CPR:4",
        "plasminogen"
      ]
    ],
    "updated": "Yes",
    "original": "Coupling this computational technique with a highquality lowthroughput screen identified 54piperidyl3isoxazolol 4PIOL as a potent plasminogen binding inhibitor with the potential for the treatment of various bleeding disorders",
    "simplified": "Coupling this computational technique with a highquality lowthroughput screen identified 54piperidyl3isoxazolol 4PIOL as a plasminogen-binding inhibitor that could be used to treat bleeding disorders."
  },
  {
    "text": "Epididymal tissue from wildtype mice responded in vitro to noradrenaline and isoprenaline with increased glycerol release reduced IL6 release and increased cAMP accumulation",
    "triple_list": [
      [
        "noradrenaline",
        "CPR:4",
        "IL6"
      ],
      [
        "isoprenaline",
        "CPR:4",
        "IL6"
      ]
    ],
    "updated": "No",
    "original": "Epididymal tissue from wildtype mice responded in vitro to noradrenaline and isoprenaline with increased glycerol release reduced IL6 release and increased cAMP accumulation",
    "simplified": "Epididymal tissue from wildtype mice responded in vitro to either isoprenaline or noradrenaline. Isoprenaline increased the production of glycerol."
  },
  {
    "text": "Phospholipase A2 inhibitors pbromophenacyl bromide and arachidonyl trifluoromethyl ketone suppressed interleukin2 IL2 expression in murine primary splenocytes",
    "triple_list": [
      [
        "Phospholipase A2",
        "CPR:3",
        "pbromophenacyl bromide"
      ],
      [
        "pbromophenacyl bromide",
        "CPR:4",
        "interleukin2"
      ],
      [
        "pbromophenacyl bromide",
        "CPR:4",
        "IL2"
      ],
      [
        "Phospholipase A2",
        "CPR:4",
        "arachidonyl trifluoromethyl ketone"
      ],
      [
        "arachidonyl trifluoromethyl ketone",
        "CPR:4",
        "interleukin2"
      ],
      [
        "arachidonyl trifluoromethyl ketone",
        "CPR:4",
        "IL2"
      ]
    ],
    "updated": "No",
    "original": "Phospholipase A2 inhibitors pbromophenacyl bromide and arachidonyl trifluoromethyl ketone suppressed interleukin2 IL2 expression in murine primary splenocytes",
    "simplified": "Pbromophenacyl bromide and arachidonyl trifluoromethyl ketone inhibited interleukin2 (IL2) production in murine primary splenocytes."
  },
  {
    "text": "When the splenocytes were pretreated with both BPB and AACOCF3 , phorbol 12myristate 13acetate and ionomycin reduced the production of IL2 .",
    "triple_list": [
      [
        "phorbol 12myristate 13acetate",
        "CPR:3",
        "IL2"
      ],
      [
        "BPB",
        "CPR:4",
        "IL2"
      ],
      [
        "AACOCF3",
        "CPR:4",
        "IL2"
      ]
    ],
    "updated": "Yes",
    "original": "Pretreatment of the splenocytes with both BPB and AACOCF3 suppressed phorbol 12myristate 13acetate plus ionomycininduced IL2 secretion in a concentrationdependent manner",
    "simplified": "When the splenocytes were pretreated with both BPB and AACOCF3, phorbol 12myristate 13acetate and ionomycin reduced the production of IL2."
  },
  {
    "text": "Both PLA2 inhibitors inhibited IL2 steadystate mRNA expression in a concentrationdependent fashion with 90 inhibition at 1 microM BPB and 20 microM AACOCF3",
    "triple_list": [
      [
        "IL2",
        "CPR:4",
        "BPB"
      ],
      [
        "PLA2",
        "CPR:4",
        "BPB"
      ],
      [
        "IL2",
        "CPR:4",
        "AACOCF3"
      ],
      [
        "PLA2",
        "CPR:4",
        "AACOCF3"
      ]
    ],
    "updated": "Yes",
    "original": "Likewise IL2 steadystate mRNA expression was inhibited by both PLA2 inhibitors in a concentrationdependent fashion with 90 inhibition at 1 microM BPB and 20 microM AACOCF3",
    "simplified": "Both PLA2 inhibitors inhibited IL2 steadystate mRNA expression in a concentrationdependent fashion with 90 inhibition at 1 microM BPB and 20 microM AACOCF3"
  },
  {
    "text": "Together , these data demonstrated that the PLA2 inhibitors BPB and AACOCF3 are highly effective at inhibiting IL2 expression at both the mRNA and protein levels .",
    "triple_list": [
      [
        "PLA2",
        "CPR:4",
        "BPB"
      ],
      [
        "BPB",
        "CPR:4",
        "IL2"
      ],
      [
        "PLA2",
        "CPR:4",
        "AACOCF3"
      ],
      [
        "AACOCF3",
        "CPR:4",
        "IL2"
      ]
    ],
    "updated": "Yes",
    "original": "Taken together these data demonstrated that PLA2 inhibitors BPB and AACOCF3 are robust inhibitors of IL2 expression at both the mRNA and protein levels in murine splenocytes",
    "simplified": "Together, these data demonstrated that the PLA2 inhibitors BPB and AACOCF3 are highly effective at inhibiting IL2 expression at both the mRNA and protein levels."
  },
  {
    "text": "Therefore the objective of the present study was to investigate the effects of PLA2 inhibitors pbromophenacyl bromide BPB and arachidonyl trifluoromethyl ketone AACOCF3 on interleukin2 IL2 expression in murine primary splenocytes",
    "triple_list": [
      [
        "PLA2",
        "CPR:4",
        "pbromophenacyl bromide"
      ],
      [
        "PLA2",
        "CPR:4",
        "BPB"
      ],
      [
        "PLA2",
        "CPR:4",
        "arachidonyl trifluoromethyl ketone"
      ],
      [
        "PLA2",
        "CPR:4",
        "AACOCF3"
      ]
    ],
    "updated": "No",
    "original": "Therefore the objective of the present study was to investigate the effects of PLA2 inhibitors pbromophenacyl bromide BPB and arachidonyl trifluoromethyl ketone AACOCF3 on interleukin2 IL2 expression in murine primary splenocytes",
    "simplified": "The aim of the present study was to investigate the effects of pbromophenacyl bromide and arachidonyl trifluoromethyl ketone in murine primary splenocytes on the expression of interleukin2 and IL2."
  },
  {
    "text": "Inhibition of IL2 secretion was observed at 10 microM AACOCF3 and 1 microM BPB compared to vehicle control .",
    "triple_list": [
      [
        "IL2",
        "CPR:4",
        "BPB"
      ],
      [
        "IL2",
        "CPR:4",
        "AACOCF3"
      ]
    ],
    "updated": "Yes",
    "original": "Inhibition 90 of IL2 secretion was observed at 1 microM BPB and 10 microM AACOCF3 compared to the respective vehicle control",
    "simplified": "Inhibition of IL2 secretion was observed at 10 microM AACOCF3 and 1 microM BPB compared to vehicle control."
  },
  {
    "text": "The two basic mainstays of gastrointestinal stromal tumours GIST treatment are surgery and imatinib a selective tyrosine kinase inhibitor that allows achieving a stable or responding disease in about 80 of patients with unresectablemetastatic GIST",
    "triple_list": [
      [
        "imatinib",
        "CPR:4",
        "tyrosine kinase"
      ]
    ],
    "updated": "No",
    "original": "The two basic mainstays of gastrointestinal stromal tumours GIST treatment are surgery and imatinib a selective tyrosine kinase inhibitor that allows achieving a stable or responding disease in about 80 of patients with unresectablemetastatic GIST",
    "simplified": "The two basic mainstays of gastrointestinal stromal tumours GIST treatment are surgery and imatinib. Imatinib allows a stable or responding disease to be achieved in about 80 of patients with unresectablemetastatic GIST."
  },
  {
    "text": "TZDs also stopped the enzyme alkaline phosphatase from working , and osteocalcin production .",
    "triple_list": [
      [
        "TZDs",
        "CPR:4",
        "alkaline phosphatase"
      ],
      [
        "TZDs",
        "CPR:4",
        "osteocalcin"
      ]
    ],
    "updated": "Yes",
    "original": "TZDs also inhibited alkaline phosphatase activity 5875 p0046 and osteocalcin production 5275 p0031",
    "simplified": "TZDs also stopped the enzyme alkaline phosphatase from working, and osteocalcin production."
  },
  {
    "text": "TZD effects on osteoblast viability oleic acid uptake alkaline phosphatase and osteocalcin production are independent of their effects on aromatase",
    "triple_list": [
      [
        "TZD",
        "CPR:4",
        "aromatase"
      ]
    ],
    "updated": "No",
    "original": "TZD effects on osteoblast viability oleic acid uptake alkaline phosphatase and osteocalcin production are independent of their effects on aromatase",
    "simplified": "Oleic acid uptake alkaline phosphatase and osteocalcin production TZD effects on osteoblast viability are independent of each other."
  },
  {
    "text": "We have previously reported that TZDs reduce the production of estrogen by aromatase in human granulosa cells .",
    "triple_list": [
      [
        "TZDs",
        "CPR:4",
        "aromatase"
      ],
      [
        "estrogen",
        "CPR:9",
        "aromatase"
      ]
    ],
    "updated": "Yes",
    "original": "We have previously reported that TZDs reduce estrogen synthesis by inhibiting aromatase activity in human granulosa cells HGC",
    "simplified": "We have previously reported that TZDs reduce the production of estrogen by aromatase in human granulosa cells."
  },
  {
    "text": "We studied mouse osteoblasts alone or in a coculture with HGC to determine whether TZD inhibition of aromatase plays a role in their effects on bone metabolism",
    "triple_list": [
      [
        "TZD",
        "CPR:4",
        "aromatase"
      ]
    ],
    "updated": "No",
    "original": "We studied mouse osteoblasts alone or in a coculture with HGC to determine whether TZD inhibition of aromatase plays a role in their effects on bone metabolism",
    "simplified": "We studied mouse osteoblasts alone or in a coculture with HGC to determine their effects on bone metabolism and whether TZD plays a role."
  },
  {
    "text": "The M564G mutated CrAT showed higher activity toward longer chain acylCoAs activity toward myristoylCoA was 1250fold higher than that of the wildtype CrAT and lower activity toward its natural substrate acetylCoA",
    "triple_list": [
      [
        "M564G",
        "CPR:9",
        "acetylCoA"
      ],
      [
        "CrAT",
        "CPR:9",
        "acetylCoA"
      ],
      [
        "CrAT",
        "CPR:9",
        "acetylCoA"
      ],
      [
        "M564G",
        "CPR:9",
        "acylCoAs"
      ],
      [
        "CrAT",
        "CPR:9",
        "acylCoAs"
      ],
      [
        "CrAT",
        "CPR:9",
        "acylCoAs"
      ],
      [
        "M564G",
        "CPR:9",
        "myristoylCoA"
      ],
      [
        "CrAT",
        "CPR:9",
        "myristoylCoA"
      ],
      [
        "CrAT",
        "CPR:9",
        "myristoylCoA"
      ]
    ],
    "updated": "No",
    "original": "The M564G mutated CrAT showed higher activity toward longer chain acylCoAs activity toward myristoylCoA was 1250fold higher than that of the wildtype CrAT and lower activity toward its natural substrate acetylCoA",
    "simplified": "The M564G mutated CrAT showed higher activity toward acetylCoA. The M564G mutated CrAT showed higher activity toward acetylCoA but lower activity toward myristoylCoA."
  },
  {
    "text": "Kinetic constants of the mutant CrAT showed modification in favor of longer acylCoAs as substrates",
    "triple_list": [
      [
        "CrAT",
        "CPR:9",
        "acylCoAs"
      ]
    ],
    "updated": "No",
    "original": "Kinetic constants of the mutant CrAT showed modification in favor of longer acylCoAs as substrates",
    "simplified": "Kinetic constants of the mutant CrAT showed that the base was changed to be longer."
  },
  {
    "text": "In the reverse case mutation of the orthologous glycine Gly553 to methionine in carnitine octanoyltransferase COT increased activity toward medium and longchain acylCoAs and reduced activity toward shortchain acylCoAs .",
    "triple_list": [
      [
        "carnitine octanoyltransferase",
        "CPR:9",
        "acylCoAs"
      ],
      [
        "COT",
        "CPR:9",
        "acylCoAs"
      ],
      [
        "carnitine octanoyltransferase",
        "CPR:9",
        "acylCoAs"
      ],
      [
        "COT",
        "CPR:9",
        "acylCoAs"
      ]
    ],
    "updated": "Yes",
    "original": "In the reverse case mutation of the orthologous glycine Gly553 to methionine in carnitine octanoyltransferase COT decreased activity toward its natural substrates medium and longchain acylCoAs and increased activity toward shortchain acylCoAs",
    "simplified": "In the reverse case mutation of the orthologous glycine Gly553 to methionine in carnitine octanoyltransferase COT increased activity toward medium and longchain acylCoAs and reduced activity toward shortchain acylCoAs."
  },
  {
    "text": "We conclude that Met564 blocks the entry of long-chain acylCoAs to the CrAT catalytic unit .",
    "triple_list": [
      [
        "acylCoAs",
        "CPR:9",
        "CrAT"
      ]
    ],
    "updated": "Yes",
    "original": "We conclude that Met564 blocks the entry of medium and longchain acylCoAs to the catalytic site of CrAT",
    "simplified": "We conclude that Met564 blocks the entry of long-chain acylCoAs to the CrAT catalytic unit."
  },
  {
    "text": "Carnitine acetyltransferases CrAT catalyze the reversible conversion of acetylCoA and carnitine to acetylcarnitine and free CoA",
    "triple_list": [
      [
        "Carnitine acetyltransferases",
        "CPR:9",
        "acetylCoA"
      ],
      [
        "CrAT",
        "CPR:9",
        "acetylCoA"
      ],
      [
        "Carnitine acetyltransferases",
        "CPR:9",
        "carnitine"
      ],
      [
        "CrAT",
        "CPR:9",
        "carnitine"
      ],
      [
        "Carnitine acetyltransferases",
        "CPR:9",
        "acetylcarnitine"
      ],
      [
        "CrAT",
        "CPR:9",
        "acetylcarnitine"
      ]
    ],
    "updated": "No",
    "original": "Carnitine acetyltransferases CrAT catalyze the reversible conversion of acetylCoA and carnitine to acetylcarnitine and free CoA",
    "simplified": "Carnitine acetyltransferases (CrAT) are enzymes that change acetylCoA into carnitine and free CoA."
  },
  {
    "text": "Catecholamines adrenaline noradrenaline and dopamine are potent inhibitors of phenylalanine 4monooxygenase phenylalanine hydroxylase EC 114161",
    "triple_list": [
      [
        "adrenaline",
        "CPR:4",
        "phenylalanine hydroxylase"
      ],
      [
        "adrenaline",
        "CPR:4",
        "EC 114161"
      ],
      [
        "adrenaline",
        "CPR:4",
        "phenylalanine 4monooxygenase"
      ],
      [
        "noradrenaline",
        "CPR:4",
        "phenylalanine hydroxylase"
      ],
      [
        "noradrenaline",
        "CPR:4",
        "EC 114161"
      ],
      [
        "noradrenaline",
        "CPR:4",
        "phenylalanine 4monooxygenase"
      ],
      [
        "dopamine",
        "CPR:4",
        "phenylalanine hydroxylase"
      ],
      [
        "dopamine",
        "CPR:4",
        "EC 114161"
      ],
      [
        "dopamine",
        "CPR:4",
        "phenylalanine 4monooxygenase"
      ],
      [
        "Catecholamines",
        "CPR:4",
        "phenylalanine hydroxylase"
      ],
      [
        "Catecholamines",
        "CPR:4",
        "EC 114161"
      ],
      [
        "Catecholamines",
        "CPR:4",
        "phenylalanine 4monooxygenase"
      ]
    ],
    "updated": "No",
    "original": "Catecholamines adrenaline noradrenaline and dopamine are potent inhibitors of phenylalanine 4monooxygenase phenylalanine hydroxylase EC 114161",
    "simplified": "Catecholamines adrenaline and noradrenaline make it hard for the enzyme phenylalanine hydroxylase to work."
  },
  {
    "text": "Central and peripheral administration of kisspeptin stimulates the hypothalamic-pituitary-gonadal axis , while pre-administration of a gonadotrophin releasing hormone ( GnRH ) has the opposite effect .",
    "triple_list": [
      [
        "kisspeptin",
        "CPR:4",
        "gonadotrophin releasing hormone"
      ],
      [
        "kisspeptin",
        "CPR:4",
        "GnRH"
      ]
    ],
    "updated": "Yes",
    "original": "Central and peripheral administration of kisspeptin stimulates the hypothalamicpituitarygonadal HPG axis whilst preadministration of a gonadotrophin releasing hormone GnRH antagonist abolishes this effect",
    "simplified": "Central and peripheral administration of kisspeptin stimulates the hypothalamic-pituitary-gonadal axis, while pre-administration of a gonadotrophin releasing hormone (GnRH) has the opposite effect."
  },
  {
    "text": "The esterified DEX however had only partial transactivation agonistic activity in cells transfected with rat GR . The esterified BM however had full transactivation agonistic activity .",
    "triple_list": [
      [
        "BM",
        "CPR:5",
        "rat GR"
      ],
      [
        "rat GR",
        "CPR:5",
        "DEX"
      ],
      [
        "BM",
        "CPR:5",
        "rat GR"
      ]
    ],
    "updated": "Yes",
    "original": "The esterified BM however had only partial transactivation agonistic activity in cells transfected with rat GR whereas BM and esterified DEX had full transactivation agonistic activity",
    "simplified": "The esterified DEX however had only partial transactivation agonistic activity in cells transfected with rat GR. The esterified BM however had full transactivation agonistic activity."
  },
  {
    "text": "Moreover in rat hepatoma H4IIE cells the esterified BM failed to induce tyrosine aminotransferase which is regulated by GR mediated transactivation activity",
    "triple_list": [
      [
        "BM",
        "CPR:5",
        "GR"
      ]
    ],
    "updated": "No",
    "original": "Moreover in rat hepatoma H4IIE cells the esterified BM failed to induce tyrosine aminotransferase which is regulated by GR mediated transactivation activity",
    "simplified": "In rat hepatoma H4IIE cells, the esterified BM did not cause tyrosine aminotransferase. This enzyme is important for healthy cells."
  },
  {
    "text": "Consistent with the weak transactivation activity of esterified BM mediated by rat GR there were few side effects evaluated by thymus involution and body weight loss in an antigeninduced asthmatic model in rats",
    "triple_list": [
      [
        "BM",
        "CPR:5",
        "rat GR"
      ]
    ],
    "updated": "No",
    "original": "Consistent with the weak transactivation activity of esterified BM mediated by rat GR there were few side effects evaluated by thymus involution and body weight loss in an antigeninduced asthmatic model in rats",
    "simplified": "There were few side effects evaluated by thymus involution and body weight loss in an antigeninduced asthmatic model. These effects were consistent with the weak transactivation activity of esterified BM."
  },
  {
    "text": "Dexamethasone DEX betamethasone BM and their esterifiedderivatives had full transrepression agonistic activity in a reporter assay using CV1 cells transfected with either human or rat GR",
    "triple_list": [
      [
        "Dexamethasone",
        "CPR:5",
        "human or rat GR"
      ],
      [
        "DEX",
        "CPR:5",
        "human or rat GR"
      ],
      [
        "betamethasone",
        "CPR:5",
        "human or rat GR"
      ],
      [
        "BM",
        "CPR:5",
        "human or rat GR"
      ]
    ],
    "updated": "No",
    "original": "Dexamethasone DEX betamethasone BM and their esterifiedderivatives had full transrepression agonistic activity in a reporter assay using CV1 cells transfected with either human or rat GR",
    "simplified": "Dexamethasone DEX betamethasone BM and their esterifiedderivatives had full transrepression agonistic activity in a reporter test. The test was done on human and rat cells."
  },
  {
    "text": "Moreover IGFBPrP2 noticeably increased in response to TGFbeta1 and alltrans retinoic acid atRA in HPEC and PC3 cells and it decreased in response to IGFI in HPEC",
    "triple_list": [
      [
        "IGFBPrP2",
        "CPR:3",
        "alltrans retinoic acid"
      ],
      [
        "IGFBPrP2",
        "CPR:3",
        "atRA"
      ]
    ],
    "updated": "No",
    "original": "Moreover IGFBPrP2 noticeably increased in response to TGFbeta1 and alltrans retinoic acid atRA in HPEC and PC3 cells and it decreased in response to IGFI in HPEC",
    "simplified": "In addition, IGFBPrP2 increased in response to TGFbeta1 and alltrans retinoic acid in PC3 cells but decreased in response to IGFI in HPEC."
  },
  {
    "text": "Although the data collected on IGFBPrP3 in prostate are modest its role as a growth stimulator is supported by its downregulation by atRA and its preferential expression in cancerous cells .",
    "triple_list": [
      [
        "IGFBPrP3",
        "CPR:4",
        "atRA"
      ]
    ],
    "updated": "Yes",
    "original": "Although the data collected on IGFBPrP3 in prostate are modest its role as a growth stimulator andor protooncogene is supported by its preferential expression in cancerous cells and its downregulation by atRA",
    "simplified": "Although the data collected on IGFBPrP3 in prostate are modest its role as a growth stimulator is supported by its downregulation by atRA and its preferential expression in cancerous cells."
  },
  {
    "text": "On the basis of FIP1L1PDGFRa fusion gene hypereosinophilic syndrome would be classified as a clonal disease . The tyrosine kinase inhibitor imatinib mesylate Glivec would be effective in some cases .",
    "triple_list": [
      [
        "tyrosine kinase",
        "CPR:4",
        "imatinib mesylate"
      ]
    ],
    "updated": "Yes",
    "original": "On the basis of FIP1L1PDGFRa fusion gene hypereosinophilic syndrome would be classified as a clonal disease and in the FIP1L1PDGFRa positive cases the tyrosine kinase inhibitor imatinib mesylate Glivec would be effective",
    "simplified": "On the basis of FIP1L1PDGFRa fusion gene hypereosinophilic syndrome would be classified as a clonal disease. The tyrosine kinase inhibitor imatinib mesylate Glivec would be effective in some cases."
  },
  {
    "text": "Uptake of the radiolabeled model substrates estradiol 17\u03b2glucuronide estrone 3sulfate and dehydroepiandrosterone sulfate DHEAS was determined in the absence and presence of compounds 16 using Chinese hamster ovary CHO cells stably expressing either OATP1B1 or OATP1B3",
    "triple_list": [
      [
        "estradiol 17\u03b2glucuronide",
        "CPR:9",
        "OATP1B1"
      ],
      [
        "estradiol 17\u03b2glucuronide",
        "CPR:9",
        "OATP1B3"
      ],
      [
        "estrone 3sulfate",
        "CPR:9",
        "OATP1B1"
      ],
      [
        "estrone 3sulfate",
        "CPR:9",
        "OATP1B3"
      ],
      [
        "dehydroepiandrosterone sulfate",
        "CPR:9",
        "OATP1B1"
      ],
      [
        "dehydroepiandrosterone sulfate",
        "CPR:9",
        "OATP1B3"
      ],
      [
        "DHEAS",
        "CPR:9",
        "OATP1B1"
      ],
      [
        "DHEAS",
        "CPR:9",
        "OATP1B3"
      ]
    ],
    "updated": "No",
    "original": "Uptake of the radiolabeled model substrates estradiol 17\u03b2glucuronide estrone 3sulfate and dehydroepiandrosterone sulfate DHEAS was determined in the absence and presence of compounds 16 using Chinese hamster ovary CHO cells stably expressing either OATP1B1 or OATP1B3",
    "simplified": "Uptake of the radiolabeled model substrates estradiol 17\u03b2glucuronide estrone 3sulfate and dehydroepiandrosterone sulfate was determined using Chinese hamster ovary CHO cells stably expressing either OATP1B1 or OATP1B3 in the absence and presence of compounds 16."
  },
  {
    "text": "Compound 6 increases the uptake of estradiol 17\u03b2glucuronide by OATP1B3 by increasing the affinity of OATP1B3 for its substrate",
    "triple_list": [
      [
        "OATP1B3",
        "CPR:9",
        "estradiol 17\u03b2glucuronide"
      ],
      [
        "OATP1B3",
        "CPR:9",
        "estradiol 17\u03b2glucuronide"
      ]
    ],
    "updated": "Yes",
    "original": "Compound 6 stimulated OATP1B3 mediated estradiol 17\u03b2glucuronide uptake by increasing the apparent affinity of OATP1B3 for its substrate",
    "simplified": "Compound 6 increases the uptake of estradiol 17\u03b2glucuronide by OATP1B3 by increasing the affinity of OATP1B3 for its substrate"
  },
  {
    "text": "Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3Ogallate and several quercetin derivatives",
    "triple_list": [
      [
        "OATP1B1",
        "CPR:9",
        "quercetin"
      ],
      [
        "OATP1B3",
        "CPR:9",
        "quercetin"
      ],
      [
        "OATP1B1",
        "CPR:9",
        "epigallocatechin 3Ogallate"
      ],
      [
        "OATP1B3",
        "CPR:9",
        "epigallocatechin 3Ogallate"
      ]
    ],
    "updated": "No",
    "original": "Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3Ogallate and several quercetin derivatives",
    "simplified": "OATP1B1 and OATP1B3 help quercetin be more toxic to cells. Quercetin is a chemical compound."
  },
  {
    "text": "Cytotoxicity tests showed that epigallocatechin 3Ogallate EGCG and most compounds 16 killed cells with OATP in them .",
    "triple_list": [
      [
        "epigallocatechin 3Ogallate",
        "CPR:9",
        "OATP"
      ],
      [
        "EGCG",
        "CPR:9",
        "OATP"
      ]
    ],
    "updated": "Yes",
    "original": "Cytotoxicity assays demonstrated that epigallocatechin 3Ogallate EGCG and most of compounds 16 killed preferentially OATP expressing CHO cells",
    "simplified": "Cytotoxicity tests showed that epigallocatechin 3Ogallate EGCG and most compounds 16 killed cells with OATP in them."
  },
  {
    "text": "EGCG 1 and EGCG 3 are very good at killing cells . EGCG 3 is especially good at killing OATP1B3 cells .",
    "triple_list": [
      [
        "EGCG",
        "CPR:9",
        "OATP1B3"
      ]
    ],
    "updated": "Yes",
    "original": "EGCG 1 and 3 were the most potent cytotoxic compounds with EGCG and 3 selectively killing OATP1B3 expressing cells",
    "simplified": "EGCG 1 and EGCG 3 are very good at killing cells. EGCG 3 is especially good at killing OATP1B3 cells."
  },
  {
    "text": "Reboxetine a selective norepinephrine reuptake inhibitor exhibits high affinity and selectivity for the human norepinephrine transporter",
    "triple_list": [
      [
        "Reboxetine",
        "CPR:4",
        "human norepinephrine transporter"
      ]
    ],
    "updated": "No",
    "original": "Reboxetine a selective norepinephrine reuptake inhibitor exhibits high affinity and selectivity for the human norepinephrine transporter",
    "simplified": "Reboxetine is a selective norepinephrine reuptake inhibitor. This means that it does not work at all when taken by itself."
  },
  {
    "text": "We previously employed a chemical genomic strategy to identify a novel small molecule MAC13243 as a likely inhibitor of the bacterial lipoprotein targeting chaperone LolA",
    "triple_list": [
      [
        "MAC13243",
        "CPR:4",
        "bacterial lipoprotein"
      ],
      [
        "MAC13243",
        "CPR:4",
        "chaperone"
      ],
      [
        "MAC13243",
        "CPR:4",
        "LolA"
      ]
    ],
    "updated": "No",
    "original": "We previously employed a chemical genomic strategy to identify a novel small molecule MAC13243 as a likely inhibitor of the bacterial lipoprotein targeting chaperone LolA",
    "simplified": "A chemical genomic strategy was used to identify a novel small molecule MAC13243 as a likely inhibitor of the chaperone-targeting bacterial lipoprotein."
  },
  {
    "text": "Our results showed that low dose BPA and E2 could influence the expression level of Oct4 and Nanog proteins while only BPA could downregulate the expression of Ecadherin protein in iDMECs .",
    "triple_list": [
      [
        "BPA",
        "CPR:3",
        "Oct4"
      ],
      [
        "BPA",
        "CPR:3",
        "Nanog"
      ],
      [
        "BPA",
        "CPR:4",
        "Ecadherin"
      ]
    ],
    "updated": "Yes",
    "original": "Our results showed that low dose BPA and E2 could influence the mammosphere area of iDMECs and upregulate the expression level of Oct4 and Nanog proteins while only BPA could downregulate the expression of Ecadherin protein",
    "simplified": "Our results showed that low dose BPA and E2 could influence the expression level of Oct4 and Nanog proteins while only BPA could downregulate the expression of Ecadherin protein in iDMECs."
  },
  {
    "text": "Thus in 158N cells the ability of oxysterols to trigger a mode of cell death by apoptosis involving GSK3 and caspase3 is independent of the level of Ca2 in the cell and does not change when the Ca2 level goes up .",
    "triple_list": [
      [
        "oxysterols",
        "CPR:3",
        "GSK3"
      ],
      [
        "oxysterols",
        "CPR:3",
        "caspase3"
      ]
    ],
    "updated": "Yes",
    "original": "Thus in 158N cells the ability of oxysterols to trigger a mode of cell death by apoptosis involving GSK3 and caspase3 activation is independent of the increase in the Ca2 level and of their accumulation in lipid raft microdomains",
    "simplified": "Thus in 158N cells the ability of oxysterols to trigger a mode of cell death by apoptosis involving GSK3 and caspase3 is independent of the level of Ca2 in the cell and does not change when the Ca2 level goes up."
  },
  {
    "text": "To this end 158N murine oligodendrocytes were treated with 7KC or 7\u03b2OHC inducing an apoptotic mode of cell death characterized by condensationfragmentation of the nuclei dephosphorylation of Akt and GSK3 mitochondrial depolarization involving Mcl1 and caspase3 activation",
    "triple_list": [
      [
        "7KC",
        "CPR:3",
        "Mcl1"
      ],
      [
        "7KC",
        "CPR:3",
        "caspase3"
      ],
      [
        "7\u03b2OHC",
        "CPR:3",
        "Mcl1"
      ],
      [
        "7\u03b2OHC",
        "CPR:3",
        "caspase3"
      ]
    ],
    "updated": "No",
    "original": "To this end 158N murine oligodendrocytes were treated with 7KC or 7\u03b2OHC inducing an apoptotic mode of cell death characterized by condensationfragmentation of the nuclei dephosphorylation of Akt and GSK3 mitochondrial depolarization involving Mcl1 and caspase3 activation",
    "simplified": "To do this, 158N murine oligodendrocytes were treated with 7KC or 7\u03b2OHC. This caused an apoptotic (cell death) mode of cell death where the cells die because the nuclei are broken up and dephosphorylation of Akt and GSK3 takes place."
  },
  {
    "text": "EGF stimulated phosphorylation of ERK and Bad is blocked by pretreatment with U0126 a selective MAP kinase kinase MKK12 inhibitor",
    "triple_list": [
      [
        "U0126",
        "CPR:4",
        "MAP kinase kinase MKK12"
      ],
      [
        "EGF",
        "CPR:4",
        "U0126"
      ],
      [
        "ERK",
        "CPR:4",
        "U0126"
      ],
      [
        "Bad",
        "CPR:4",
        "U0126"
      ]
    ],
    "updated": "No",
    "original": "EGF stimulated phosphorylation of ERK and Bad is blocked by pretreatment with U0126 a selective MAP kinase kinase MKK12 inhibitor",
    "simplified": "EGF stimulates the phosphorylation of ERK and Bad, but when pretreatment with MKK12 is used, this does not work."
  },
  {
    "text": "Similarly , when sulindac sulfide is pretreated , it blocks the ability of EGF to make Bad proteins , but it also reduces total Bad protein levels .",
    "triple_list": [
      [
        "sulindac sulfide",
        "CPR:4",
        "EGF"
      ],
      [
        "sulindac sulfide",
        "CPR:4",
        "Bad"
      ],
      [
        "sulindac sulfide",
        "CPR:4",
        "Bad"
      ]
    ],
    "updated": "Yes",
    "original": "Similarly pretreatment with sulindac sulfide blocks the ability of EGF to induce ERK12 and Bad phosphorylation but also downregulates total Bad but not ERK12 protein levels",
    "simplified": "Similarly, when sulindac sulfide is pretreated, it blocks the ability of EGF to make Bad proteins, but it also reduces total Bad protein levels."
  },
  {
    "text": "The ability of sulindac to block ERK12 signaling by the EGF receptor may be why it works so well against cancer .",
    "triple_list": [
      [
        "sulindac",
        "CPR:4",
        "ERK12"
      ],
      [
        "sulindac",
        "CPR:4",
        "EGF receptor"
      ]
    ],
    "updated": "Yes",
    "original": "The ability of sulindac to block ERK12 signaling by the EGF receptor may account for at least part of its potent growthinhibitory effects against cancer cells",
    "simplified": "The ability of sulindac to block ERK12 signaling by the EGF receptor may be why it works so well against cancer."
  },
  {
    "text": "Sulindac and selective cyclooxygenase COX2 inhibitors can help some patients with polyps in the colon .",
    "triple_list": [
      [
        "Sulindac",
        "CPR:4",
        "cyclooxygenase COX2"
      ]
    ],
    "updated": "Yes",
    "original": "Sulindac and selective cyclooxygenase COX2 inhibitors cause regression of colonic polyps in familial polyposis patients",
    "simplified": "Sulindac and selective cyclooxygenase COX2 inhibitors can help some patients with polyps in the colon."
  },
  {
    "text": "Sulindac and other nonsteroidal anti-inflammatory drugs inhibit the transcription of ERK12 in human colon cancer cells .",
    "triple_list": [
      [
        "Sulindac",
        "CPR:4",
        "ERK12"
      ]
    ],
    "updated": "Yes",
    "original": "Sulindac metabolites and other nonsteroidal antiinflammatory drugs selectively inhibit ERK12 phosphorylation in human colon cancer cells",
    "simplified": "Sulindac and other nonsteroidal anti-inflammatory drugs inhibit the transcription of ERK12 in human colon cancer cells."
  },
  {
    "text": "Sulindac sulfide inhibits epidermal growth factor induced phosphorylation of extracellularregulated kinase 12 and Bad in human colon cancer cells",
    "triple_list": [
      [
        "Sulindac sulfide",
        "CPR:4",
        "Bad"
      ],
      [
        "Sulindac sulfide",
        "CPR:4",
        "epidermal growth factor"
      ]
    ],
    "updated": "No",
    "original": "Sulindac sulfide inhibits epidermal growth factor induced phosphorylation of extracellularregulated kinase 12 and Bad in human colon cancer cells",
    "simplified": "Sulindac sulfide inhibits the activity of extracellularregulated kinase 12 and epidermal growth factor in human colon cancer cells."
  },
  {
    "text": "After inflammation was established mice were dosed with the H4R antagonist JNJ 7777120 or antiIL13 antibody for comparison",
    "triple_list": [
      [
        "H4R",
        "CPR:6",
        "JNJ 7777120"
      ]
    ],
    "updated": "No",
    "original": "After inflammation was established mice were dosed with the H4R antagonist JNJ 7777120 or antiIL13 antibody for comparison",
    "simplified": "After inflammation was established, anti-IL13 antibody or the H4R antagonist was given to the mice."
  },
  {
    "text": "The activity of polymerases containing mutations known to confer resistance to foscarnet V715M T700A and N495K was inhibited by concentrations of foscarnet eight to 14 times higher than those required to inhibit wildtype polymerases",
    "triple_list": [
      [
        "polymerases",
        "CPR:4",
        "foscarnet"
      ],
      [
        "foscarnet",
        "CPR:4",
        "V715M"
      ],
      [
        "foscarnet",
        "CPR:4",
        "T700A"
      ],
      [
        "foscarnet",
        "CPR:4",
        "N495K"
      ],
      [
        "polymerases",
        "CPR:4",
        "foscarnet"
      ]
    ],
    "updated": "No",
    "original": "The activity of polymerases containing mutations known to confer resistance to foscarnet V715M T700A and N495K was inhibited by concentrations of foscarnet eight to 14 times higher than those required to inhibit wildtype polymerases",
    "simplified": "The activity of polymerases containing mutations known to confer resistance to foscarnet was inhibited eight to 14 times as much as those required to inhibit wildtype polymerases by concentrations of foscarnet."
  },
  {
    "text": "A nonradioactive DNA polymerase test for studying cytomegalovirus resistance to foscarnet has been developed .",
    "triple_list": [
      [
        "DNA polymerase",
        "CPR:4",
        "foscarnet"
      ]
    ],
    "updated": "Yes",
    "original": "Development and validation of a nonradioactive DNA polymerase assay for studying cytomegalovirus resistance to foscarnet",
    "simplified": "A nonradioactive DNA polymerase test for studying cytomegalovirus resistance to foscarnet has been developed."
  },
  {
    "text": "Absorption and secretion of fluoride increase at acid pH levels possibly because of its nonionized state at these pHs andor because of participation of a FH cotransporter or a FOH antiporter",
    "triple_list": [
      [
        "fluoride",
        "CPR:9",
        "FOH antiporter"
      ],
      [
        "fluoride",
        "CPR:9",
        "FH cotransporter"
      ]
    ],
    "updated": "No",
    "original": "Absorption and secretion of fluoride increase at acid pH levels possibly because of its nonionized state at these pHs andor because of participation of a FH cotransporter or a FOH antiporter",
    "simplified": "Fluorine absorption and secretion increase at acid pH levels. This is probably because the fluoride is in its nonionized state at these pHs."
  },
  {
    "text": "An investigation is detailed of the structure activity relationships SAR of two sulfone side chains of compound 1a SCH 900229 a potent PS1 selective \u03b3secretase inhibitor and clinical candidate for the treatment of Alzheimers disease",
    "triple_list": [
      [
        "SCH 900229",
        "CPR:4",
        "PS1"
      ],
      [
        "SCH 900229",
        "CPR:4",
        "\u03b3secretase"
      ]
    ],
    "updated": "No",
    "original": "An investigation is detailed of the structure activity relationships SAR of two sulfone side chains of compound 1a SCH 900229 a potent PS1 selective \u03b3secretase inhibitor and clinical candidate for the treatment of Alzheimers disease",
    "simplified": "An investigation is detailed of the structure activity relationships of two sulfone side chains of compound 1a SCH 900229 a drug candidate for the treatment of Alzheimers disease and related conditions."
  },
  {
    "text": "Structure activity relationship studies of tricyclic bispyran sulfone \u03b3secretase inhibitors",
    "triple_list": [
      [
        "tricyclic bispyran sulfone",
        "CPR:4",
        "\u03b3secretase"
      ]
    ],
    "updated": "No",
    "original": "Structure activity relationship studies of tricyclic bispyran sulfone \u03b3secretase inhibitors",
    "simplified": "Tricyclic bispyran sulfone is a chemical compound. It is an acid."
  },
  {
    "text": "Culture of HepG2 cells with griseofulvin has now been shown to increase the amount of K18 in the cells . This means that K18 and K18 mRNA are both in the cells .",
    "triple_list": [
      [
        "griseofulvin",
        "CPR:3",
        "K18"
      ],
      [
        "griseofulvin",
        "CPR:3",
        "K18"
      ]
    ],
    "updated": "Yes",
    "original": "Culture of HepG2 cells with griseofulvin has now been shown to induce both the formation of intracellular aggregates containing K18 as well as an increase in the abundance of K18 mRNA",
    "simplified": "Culture of HepG2 cells with griseofulvin has now been shown to increase the amount of K18 in the cells. This means that K18 and K18 mRNA are both in the cells."
  },
  {
    "text": "This observation suggests that MDMA-induced reductions in SERT density do not represent neuroadaptive responses to serotonin levels in the brain , but rather a response to some other stimulus or to the neurotoxic effects of MDMA .",
    "triple_list": [
      [
        "MDMA",
        "CPR:4",
        "SERT"
      ]
    ],
    "updated": "Yes",
    "original": "This observation suggests that MDMA induced reductions in SERT density do not represent neuroadaptive responses to decreased levels of brain serotonin but may occur in response to some other stimulus or to the neurotoxic effects of MDMA",
    "simplified": "This observation suggests that MDMA-induced reductions in SERT density do not represent neuroadaptive responses to serotonin levels in the brain, but rather a response to some other stimulus or to the neurotoxic effects of MDMA."
  },
  {
    "text": "Low levels of serotonin may reduce the density of the serotonin transporter SERT . SERT is a protein that transports serotonin from one place to another .",
    "triple_list": [
      [
        "serotonin",
        "CPR:4",
        "serotonin transporter"
      ],
      [
        "serotonin",
        "CPR:4",
        "SERT"
      ]
    ],
    "updated": "Yes",
    "original": "Low levels of serotonin may reduce the density of the serotonin transporter SERT by either increasing trafficking or reducing synthesis a neuroadaptive response",
    "simplified": "Low levels of serotonin may reduce the density of the serotonin transporter SERT. SERT is a protein that transports serotonin from one place to another."
  },
  {
    "text": "To determine whether 34methylenedioxymethamphetamine MDMA induced reductions in SERT density could be related to such a mechanism pchlorophenylalanine or MDMA was administered to rats and brain serotonin and SERT density were measured",
    "triple_list": [
      [
        "34methylenedioxymethamphetamine",
        "CPR:4",
        "SERT"
      ],
      [
        "MDMA",
        "CPR:4",
        "SERT"
      ]
    ],
    "updated": "No",
    "original": "To determine whether 34methylenedioxymethamphetamine MDMA induced reductions in SERT density could be related to such a mechanism pchlorophenylalanine or MDMA was administered to rats and brain serotonin and SERT density were measured",
    "simplified": "To determine whether pchlorophenylalanine or MDMA could cause reductions in SERT density, pchlorophenylalanine was administered to rats and brain serotonin and SERT density were measured."
  },
  {
    "text": "However only MDMA reduced SERT density",
    "triple_list": [
      [
        "MDMA",
        "CPR:4",
        "SERT"
      ]
    ],
    "updated": "No",
    "original": "However only MDMA reduced SERT density",
    "simplified": "However, it only reduced SERT levels."
  },
  {
    "text": "This study explored whether curcumin improves colonic inflammation in a rat colitis model by inhibiting IL27 expression and the TLR4 NF\u03baB pathway .",
    "triple_list": [
      [
        "curcumin",
        "CPR:4",
        "TLR4"
      ],
      [
        "curcumin",
        "CPR:4",
        "NF\u03baB"
      ],
      [
        "curcumin",
        "CPR:4",
        "IL27"
      ]
    ],
    "updated": "Yes",
    "original": "This study explored whether curcumin improves colonic inflammation in a rat colitis model through inhibition of the TLR4 NF\u03baB signaling pathway and IL27 expression",
    "simplified": "This study explored whether curcumin improves colonic inflammation in a rat colitis model by inhibiting IL27 expression and the TLR4 NF\u03baB pathway."
  },
  {
    "text": "Compared with the untreated colitis group the curcumin treated group showed significant decreases in the disease activity index colonic mucosa damage index histological score myeloperoxidase activity and expressions of NF\u03baB mRNA IL27 mRNA TLR4 protein NF\u03baB p65 protein and IL27 p28 protein p 005",
    "triple_list": [
      [
        "curcumin",
        "CPR:4",
        "NF\u03baB"
      ],
      [
        "curcumin",
        "CPR:4",
        "IL27"
      ],
      [
        "curcumin",
        "CPR:4",
        "TLR4"
      ],
      [
        "curcumin",
        "CPR:4",
        "NF\u03baB"
      ],
      [
        "curcumin",
        "CPR:4",
        "p65"
      ],
      [
        "curcumin",
        "CPR:4",
        "IL27"
      ],
      [
        "curcumin",
        "CPR:4",
        "p28"
      ],
      [
        "curcumin",
        "CPR:4",
        "myeloperoxidase"
      ]
    ],
    "updated": "No",
    "original": "Compared with the untreated colitis group the curcumin treated group showed significant decreases in the disease activity index colonic mucosa damage index histological score myeloperoxidase activity and expressions of NF\u03baB mRNA IL27 mRNA TLR4 protein NF\u03baB p65 protein and IL27 p28 protein p 005",
    "simplified": "Compared with the untreated group, the curcumin treated group showed significant decreases in myeloperoxidase activity and expressions of NF\u03baB p65 protein and IL27 p28 protein compared with the untreated group. The disease activity index was also reduced."
  },
  {
    "text": "Curcumin improves TNBSinduced colitis in rats by inhibiting IL27 expression via the TLR4 NF\u03baB signaling pathway",
    "triple_list": [
      [
        "Curcumin",
        "CPR:4",
        "IL27"
      ],
      [
        "Curcumin",
        "CPR:4",
        "TLR4"
      ],
      [
        "Curcumin",
        "CPR:4",
        "NF\u03baB"
      ]
    ],
    "updated": "No",
    "original": "Curcumin improves TNBSinduced colitis in rats by inhibiting IL27 expression via the TLR4 NF\u03baB signaling pathway",
    "simplified": "Curcumin has been shown to improve colitis in rats. It does this by inhibiting the IL27 gene."
  },
  {
    "text": "There was no difference between the groups in TLR4 NF\u03baB and IL27 mRNA and proteins between curcumin and sulfasalazine .",
    "triple_list": [
      [
        "TLR4",
        "CPR:4",
        "curcumin"
      ],
      [
        "NF\u03baB",
        "CPR:4",
        "curcumin"
      ],
      [
        "IL27",
        "CPR:4",
        "curcumin"
      ],
      [
        "TLR4",
        "CPR:4",
        "sulfasalazine"
      ],
      [
        "NF\u03baB",
        "CPR:4",
        "sulfasalazine"
      ],
      [
        "IL27",
        "CPR:4",
        "sulfasalazine"
      ]
    ],
    "updated": "Yes",
    "original": "There was no significant difference in TLR4 NF\u03baB and IL27 mRNA and proteins between curcumin treated and sulfasalazine treated groups",
    "simplified": "There was no difference between the groups in TLR4 NF\u03baB and IL27 mRNA and proteins between curcumin and sulfasalazine."
  },
  {
    "text": "The antiinflammatory actions of curcumin on colitis may involve inhibition of the TLR4 NF\u03baB signaling pathway and of IL27 expression",
    "triple_list": [
      [
        "curcumin",
        "CPR:4",
        "TLR4"
      ],
      [
        "curcumin",
        "CPR:4",
        "NF\u03baB"
      ],
      [
        "curcumin",
        "CPR:4",
        "IL27"
      ]
    ],
    "updated": "No",
    "original": "The antiinflammatory actions of curcumin on colitis may involve inhibition of the TLR4 NF\u03baB signaling pathway and of IL27 expression",
    "simplified": "The antiinflammatory actions of curcumin on colitis may involve the expression of the gene TLR4, but the exact mechanism is unknown."
  },
  {
    "text": "Under isotonic conditions Nethylmaleimide NEM produced KCC activation and transient cell shrinkage",
    "triple_list": [
      [
        "Nethylmaleimide",
        "CPR:3",
        "KCC"
      ],
      [
        "NEM",
        "CPR:3",
        "KCC"
      ]
    ],
    "updated": "No",
    "original": "Under isotonic conditions Nethylmaleimide NEM produced KCC activation and transient cell shrinkage",
    "simplified": "Under isotonic conditions Nethylmaleimide can change cell division and cell size."
  },
  {
    "text": "A KCC inhibitor , dihydroindenyloxy alkanoic acid ( DIOA ) , worked better .",
    "triple_list": [
      [
        "KCC",
        "CPR:4",
        "dihydroindenyloxy alkanoic acid"
      ],
      [
        "KCC",
        "CPR:4",
        "DIOA"
      ]
    ],
    "updated": "Yes",
    "original": "A KCC inhibitor dihydroindenyloxy alkanoic acid DIOA blocked RVD more in HCEC than RCEC",
    "simplified": "A KCC inhibitor, dihydroindenyloxy alkanoic acid (DIOA), worked better."
  },
  {
    "text": "Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists",
    "triple_list": [
      [
        "lorglumide",
        "CPR:6",
        "cholecystokinin"
      ]
    ],
    "updated": "No",
    "original": "Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists",
    "simplified": "Lorglumide is a chemical compound. It is a member of the cholecystokinin family."
  },
  {
    "text": "The most potent compound , DL434dichlorobenzoylamino5dipentylamino5oxopen tanoic acid lorglumide CR 1409 , has a great affinity for the pancreatic CCK receptors and is a competitive specific and potent CCK antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig , although it does not work as well on the liver .",
    "triple_list": [
      [
        "DL434dichlorobenzoylamino5dipentylamino5oxopen tanoic acid",
        "CPR:6",
        "CCK"
      ],
      [
        "lorglumide",
        "CPR:6",
        "CCK"
      ],
      [
        "CR 1409",
        "CPR:6",
        "CCK"
      ]
    ],
    "updated": "Yes",
    "original": "The most potent compound DL434dichlorobenzoylamino5dipentylamino5oxopen tanoic acid lorglumide CR 1409 has a great affinity for the pancreatic CCK receptors and is a competitive specific and potent CCK antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig and on the CCKinduced amylase secretion of isolated pancreatic acini",
    "simplified": "The most potent compound, DL434dichlorobenzoylamino5dipentylamino5oxopen tanoic acid lorglumide CR 1409, has a great affinity for the pancreatic CCK receptors and is a competitive specific and potent CCK antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig, although it does not work as well on the liver."
  },
  {
    "text": "Derivatives of 5dipentylamino5oxopentanoic acid are a new class of nonpeptide cholecystokinin CCK antagonists",
    "triple_list": [
      [
        "5dipentylamino5oxopentanoic acid",
        "CPR:6",
        "CCK"
      ],
      [
        "5dipentylamino5oxopentanoic acid",
        "CPR:6",
        "cholecystokinin"
      ]
    ],
    "updated": "No",
    "original": "Derivatives of 5dipentylamino5oxopentanoic acid are a new class of nonpeptide cholecystokinin CCK antagonists",
    "simplified": "5dipentylamino5oxopentanoic acid is a chemical compound. It is a type of acid."
  },
  {
    "text": "The most effective in vitro DASI found is an imidazole compound . It worked against aromatase and steroid sulfatase very well in a JEG3 cell .",
    "triple_list": [
      [
        "imidazole",
        "CPR:4",
        "aromatase"
      ],
      [
        "imidazole",
        "CPR:4",
        "steroid sulfatase"
      ]
    ],
    "updated": "Yes",
    "original": "The most potent in vitro DASI discovered is an imidazole derivative with IC50 values against aromatase and steroid sulfatase in a JEG3 cell preparation of 02 and 25 nM respectively",
    "simplified": "The most effective in vitro DASI found is an imidazole compound. It worked against aromatase and steroid sulfatase very well in a JEG3 cell."
  },
  {
    "text": "The parent phenol of this compound inhibits aromatase with an IC50 value of 0028 nM in the same assay",
    "triple_list": [
      [
        "phenol",
        "CPR:4",
        "aromatase"
      ]
    ],
    "updated": "No",
    "original": "The parent phenol of this compound inhibits aromatase with an IC50 value of 0028 nM in the same assay",
    "simplified": "This compound inhibits aromatase. The IC50 value of this compound is 0028 nM in the same test"
  },
  {
    "text": "44Cyanophenyl4H124triazol4ylaminomethylphenyl sulfamate and its orthohalogenated F Cl Br derivatives are firstgeneration dual aromatase and sulfatase inhibitors DASIs",
    "triple_list": [
      [
        "F",
        "CPR:4",
        "aromatase"
      ],
      [
        "F",
        "CPR:4",
        "sulfatase"
      ],
      [
        "44Cyanophenyl4H124triazol4ylaminomethylphenyl sulfamate",
        "CPR:4",
        "aromatase"
      ],
      [
        "44Cyanophenyl4H124triazol4ylaminomethylphenyl sulfamate",
        "CPR:4",
        "sulfatase"
      ],
      [
        "Cl",
        "CPR:4",
        "aromatase"
      ],
      [
        "Cl",
        "CPR:4",
        "sulfatase"
      ],
      [
        "Br",
        "CPR:4",
        "aromatase"
      ],
      [
        "Br",
        "CPR:4",
        "sulfatase"
      ]
    ],
    "updated": "No",
    "original": "44Cyanophenyl4H124triazol4ylaminomethylphenyl sulfamate and its orthohalogenated F Cl Br derivatives are firstgeneration dual aromatase and sulfatase inhibitors DASIs",
    "simplified": "44Cyanophenyl4H124triazol4ylaminomethylphenyl sulfamate is a chemical compound. Its chemical formula is F Cl Br."
  },
  {
    "text": "Synthesis and StructureActivity Relationship Studies of Derivatives of the Dual Aromatase Sulfatase Inhibitor 44Cyanophenyl4H124triazol4ylaminomethylphenyl sulfamate",
    "triple_list": [
      [
        "Aromatase",
        "CPR:4",
        "44Cyanophenyl4H124triazol4ylaminomethylphenyl sulfamate"
      ],
      [
        "Sulfatase",
        "CPR:4",
        "44Cyanophenyl4H124triazol4ylaminomethylphenyl sulfamate"
      ]
    ],
    "updated": "No",
    "original": "Synthesis and StructureActivity Relationship Studies of Derivatives of the Dual Aromatase Sulfatase Inhibitor 44Cyanophenyl4H124triazol4ylaminomethylphenyl sulfamate",
    "simplified": "It works by inhibiting the enzyme aromatase. Synthesis and Structure Studies of Derivatives of the Dual Aromatase Sulfatase Inhibitor 44"
  },
  {
    "text": "These findings demonstrate that cinnamon polyphenols can exert the hypoglycemic and hypolipidemic effects through the mechanisms that may be associated with repairing pancreatic beta cells in diabetic mice and attenuating cytotoxicity by iNOS NF\u03baB activation , as well as improving its antioxidative capacity .",
    "triple_list": [
      [
        "polyphenols",
        "CPR:4",
        "iNOS"
      ],
      [
        "polyphenols",
        "CPR:4",
        "NF\u03baB"
      ]
    ],
    "updated": "Yes",
    "original": "These findings demonstrate that cinnamon polyphenols can exert the hypoglycemic and hypolipidemic effects through the mechanisms that may be associated with repairing pancreatic beta cells in diabetic mice and improving its antioxidative capacity as well as attenuating cytotoxicity via inhibition of iNOS NF\u03baB activation",
    "simplified": "These findings demonstrate that cinnamon polyphenols can exert the hypoglycemic and hypolipidemic effects through the mechanisms that may be associated with repairing pancreatic beta cells in diabetic mice and attenuating cytotoxicity by iNOS NF\u03baB activation, as well as improving its antioxidative capacity."
  },
  {
    "text": "Both dimethyldiguanide DC 06gkg1d1 and CPS 03 06 12gkg1d1 treatments significantly resulted in downregulation of blood glucose and insulin levels in serum while the levels of oxidative stress markers were markedly lowered through ELISA assay .",
    "triple_list": [
      [
        "dimethyldiguanide",
        "CPR:4",
        "insulin"
      ]
    ],
    "updated": "Yes",
    "original": "As revealed by glucose oxidase GOD and radioimmunoassay RIA both dimethyldiguanide DC 06gkg1d1 and CPS 03 06 12gkg1d1 treatments significantly resulted in downregulation of blood glucose and insulin levels in serum while the levels of oxidative stress markers were markedly lowered through ELISA assay",
    "simplified": "Both dimethyldiguanide DC 06gkg1d1 and CPS 03 06 12gkg1d1 treatments significantly resulted in downregulation of blood glucose and insulin levels in serum while the levels of oxidative stress markers were markedly lowered through ELISA assay."
  },
  {
    "text": "These nonadrenoceptor binding sites may serve as markers of imidazoline receptors in humans These nonadrenoceptor binding sites may explain certain novel platelet aggregatory properties previously ascribed to clonidine .",
    "triple_list": [
      [
        "clonidine",
        "CPR:3",
        "imidazoline receptors"
      ]
    ],
    "updated": "Yes",
    "original": "These nonadrenoceptor binding sites may explain certain novel platelet aggregatory properties previously ascribed to clonidine and endogenous clonidinedisplacing substances and may serve as markers of imidazoline receptors in humans",
    "simplified": "These nonadrenoceptor binding sites may serve as markers of imidazoline receptors in humans These nonadrenoceptor binding sites may explain certain novel platelet aggregatory properties previously ascribed to clonidine."
  },
  {
    "text": "ORF 17583 a histamine H2receptor antagonist inhibited gastric acid production in pylorusligated rats . ORF 17583 a histamine H2receptor antagonist .",
    "triple_list": [
      [
        "ORF 17583",
        "CPR:6",
        "histamine H2receptor"
      ]
    ],
    "updated": "Yes",
    "original": "ORF 17583 a histamine H2receptor antagonist inhibited gastric acid secretion in pylorusligated rats ED50 = 49 mgkg intraduodenal 34 mgkg po",
    "simplified": "ORF 17583 a histamine H2receptor antagonist inhibited gastric acid production in pylorusligated rats. ORF 17583 a histamine H2receptor antagonist."
  },
  {
    "text": "Effects of ORF 17583 other histamine H2receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs",
    "triple_list": [
      [
        "ORF 17583",
        "CPR:6",
        "histamine H2receptor"
      ]
    ],
    "updated": "No",
    "original": "Effects of ORF 17583 other histamine H2receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs",
    "simplified": "Other histamine H2receptor antagonists and omeprazole have different effects on gastric secretory systems."
  },
  {
    "text": "Differences in magnitude of Na dependent lalanine uptake through ASCT2 between WKY and SHR PTE cells correlated positively with differences in ASCT2 protein expression this being more abundant in WKY PTE cells",
    "triple_list": [
      [
        "Na",
        "CPR:3",
        "ASCT2"
      ],
      [
        "lalanine",
        "CPR:3",
        "ASCT2"
      ],
      [
        "lalanine",
        "CPR:9",
        "ASCT2"
      ]
    ],
    "updated": "No",
    "original": "Differences in magnitude of Na dependent lalanine uptake through ASCT2 between WKY and SHR PTE cells correlated positively with differences in ASCT2 protein expression this being more abundant in WKY PTE cells",
    "simplified": "Differences in how much lalanine is taken in through ASCT2 between WKY and SHR PTE cells were found to be related to how much lalanine is in the cells blood."
  },
  {
    "text": "In conclusion immortalized SHR and WKY PTE cells take up lalanine mainly through a highaffinity Na dependent amino acid transporter with functional features of ASCT2 transport",
    "triple_list": [
      [
        "Na",
        "CPR:3",
        "ASCT2"
      ],
      [
        "amino acid",
        "CPR:3",
        "ASCT2"
      ],
      [
        "lalanine",
        "CPR:9",
        "ASCT2"
      ]
    ],
    "updated": "No",
    "original": "In conclusion immortalized SHR and WKY PTE cells take up lalanine mainly through a highaffinity Na dependent amino acid transporter with functional features of ASCT2 transport",
    "simplified": "In conclusion immortalized SHR and WKY PTE cells take up lalanine mainly through a highaffinity Na dependent amino acid transporter, which is not found in normal cells."
  },
  {
    "text": "Nadependent lalanine uptake in WKY and SHR PTE cells was inhibited by alanine serine and cysteine in the presence of the system L inhibitor BCH which is consistent with amino acid transport through ASCT2",
    "triple_list": [
      [
        "alanine",
        "CPR:4",
        "ASCT2"
      ],
      [
        "serine",
        "CPR:4",
        "ASCT2"
      ],
      [
        "cysteine",
        "CPR:4",
        "ASCT2"
      ],
      [
        "lalanine",
        "CPR:9",
        "ASCT2"
      ],
      [
        "amino acid",
        "CPR:9",
        "ASCT2"
      ]
    ],
    "updated": "Yes",
    "original": "In the presence of the system L inhibitor BCH Nadependent lalanine uptake in WKY and SHR PTE cells was inhibited by alanine serine and cysteine which is consistent with amino acid transport through ASCT2",
    "simplified": "Nadependent lalanine uptake in WKY and SHR PTE cells was inhibited by alanine serine and cysteine in the presence of the system L inhibitor BCH which is consistent with amino acid transport through ASCT2"
  },
  {
    "text": "This study examined the inward transport of l14Calanine an ASCT2 preferential substrate in monolayers of immortalized renal proximal tubular epithelial PTE cells from WistarKyoto WKY and spontaneously hypertensive SHR rats",
    "triple_list": [
      [
        "l14Calanine",
        "CPR:9",
        "ASCT2"
      ]
    ],
    "updated": "No",
    "original": "This study examined the inward transport of l14Calanine an ASCT2 preferential substrate in monolayers of immortalized renal proximal tubular epithelial PTE cells from WistarKyoto WKY and spontaneously hypertensive SHR rats",
    "simplified": "This study examined the inward transport of l14Calanine in monolayers of immortalized renal proximal tubular epithelial PTE cells from WistarKyoto WKY and spontaneously hypertensive SHR rats."
  },
  {
    "text": "The antipsychotic drugs sertindole and pimozide block erg3 a human brain K channel",
    "triple_list": [
      [
        "sertindole",
        "CPR:4",
        "erg3"
      ],
      [
        "sertindole",
        "CPR:4",
        "human brain K channel"
      ],
      [
        "pimozide",
        "CPR:4",
        "erg3"
      ],
      [
        "pimozide",
        "CPR:4",
        "human brain K channel"
      ]
    ],
    "updated": "No",
    "original": "The antipsychotic drugs sertindole and pimozide block erg3 a human brain K channel",
    "simplified": "The anti-psychotic drugs pimozide and sertindole block this part of the brain."
  },
  {
    "text": "Block of erg3 by sertindole also displayed a positive voltagedependence",
    "triple_list": [
      [
        "erg3",
        "CPR:4",
        "sertindole"
      ]
    ],
    "updated": "No",
    "original": "Block of erg3 by sertindole also displayed a positive voltagedependence",
    "simplified": "A block of sertindole also showed a positive electric field."
  },
  {
    "text": "Pimozide blocked erg3 channel currents with an IC50 of 103 nM/O . At a concentration of 10 nM , it did not work at all .",
    "triple_list": [
      [
        "Pimozide",
        "CPR:4",
        "erg3"
      ]
    ],
    "updated": "Yes",
    "original": "Pimozide blocked erg3 channel currents with an IC50 of 103 nM and significant inhibition was noted at concentrations of 10 nM and higher",
    "simplified": "Pimozide blocked erg3 channel currents with an IC50 of 103 nM/O. At a concentration of 10 nM, it did not work at all."
  },
  {
    "text": "Some antipsychotic drugs , like sertindole and pimozide can block erg3 in certain people .",
    "triple_list": [
      [
        "erg3",
        "CPR:4",
        "sertindole"
      ],
      [
        "erg3",
        "CPR:4",
        "pimozide"
      ]
    ],
    "updated": "Yes",
    "original": "We conclude that erg3 can be blocked by certain antipsychotic drugs like sertindole and pimozide",
    "simplified": "Some antipsychotic drugs, like sertindole and pimozide can block erg3 in certain people."
  },
  {
    "text": "The antipsychotic drugs sertindole and pimozide are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K channel known as HERG human etheragogorelated gene erg1",
    "triple_list": [
      [
        "sertindole",
        "CPR:4",
        "cardiac K channel"
      ],
      [
        "sertindole",
        "CPR:4",
        "HERG"
      ],
      [
        "sertindole",
        "CPR:4",
        "human etheragogorelated gene"
      ],
      [
        "sertindole",
        "CPR:4",
        "erg1"
      ],
      [
        "pimozide",
        "CPR:4",
        "cardiac K channel"
      ],
      [
        "pimozide",
        "CPR:4",
        "HERG"
      ],
      [
        "pimozide",
        "CPR:4",
        "human etheragogorelated gene"
      ],
      [
        "pimozide",
        "CPR:4",
        "erg1"
      ]
    ],
    "updated": "No",
    "original": "The antipsychotic drugs sertindole and pimozide are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K channel known as HERG human etheragogorelated gene erg1",
    "simplified": "The antipsychotic drugs sertindole and pimozide lengthen the QT interval on the electrocardiogram. This is because they block a gene in the K channel of the heart, called HERG."
  },
  {
    "text": "A polyethylene glycol-based amphiphile also activated the lectin pathway , but only through the recognition of Lficolin .",
    "triple_list": [
      [
        "polyethylene glycol",
        "CPR:3",
        "lectin"
      ]
    ],
    "updated": "Yes",
    "original": "An amphiphile with branched polyethylene glycol architecture also activated the lectin pathway but only through Lficolin recognition",
    "simplified": "A polyethylene glycol-based amphiphile also activated the lectin pathway, but only through the recognition of Lficolin."
  },
  {
    "text": "The structural basis for the physiological effects of vardenafil and sildenafil is a combination of phosphodiesterase5 and inhibitors .",
    "triple_list": [
      [
        "phosphodiesterase5",
        "CPR:4",
        "sildenafil"
      ]
    ],
    "updated": "Yes",
    "original": "Conformational variations of both phosphodiesterase5 and inhibitors provide the structural basis for the physiological effects of vardenafil and sildenafil",
    "simplified": "The structural basis for the physiological effects of vardenafil and sildenafil is a combination of phosphodiesterase5 and inhibitors."
  },
  {
    "text": "Later , it was found that cucurbitacin I strongly activates RhoA and the Rho effector Rho kinase ROCK in breast cancer cells . This causes stress fibers to grow .",
    "triple_list": [
      [
        "cucurbitacin I",
        "CPR:3",
        "RhoA"
      ],
      [
        "cucurbitacin I",
        "CPR:3",
        "Rho"
      ],
      [
        "cucurbitacin I",
        "CPR:3",
        "Rho kinase"
      ],
      [
        "cucurbitacin I",
        "CPR:3",
        "ROCK"
      ]
    ],
    "updated": "Yes",
    "original": "Subsequent analysis revealed that cucurbitacin I strongly activates RhoA and the Rho effector Rho kinase ROCK in breast cancer cells and induces the formation of stress fibers",
    "simplified": "Later, it was found that cucurbitacin I strongly activates RhoA and the Rho effector Rho kinase ROCK in breast cancer cells. This causes stress fibers to grow."
  },
  {
    "text": "Finally , we found that cucurbitacin I can activate RhoA through reactive oxygen species .",
    "triple_list": [
      [
        "RhoA",
        "CPR:3",
        "cucurbitacin I"
      ]
    ],
    "updated": "Yes",
    "original": "Lastly we found that RhoA activation by cucurbitacin I is mediated by reactive oxygen species ROS",
    "simplified": "Finally, we found that cucurbitacin I can activate RhoA through reactive oxygen species."
  },
  {
    "text": "The antioxidant MitoTEMPO and the ROS scavenger Nacetyl lcysteine rescued the inhibitory effect of cucurbitacin I on Rac1 .",
    "triple_list": [
      [
        "Nacetyl lcysteine",
        "CPR:3",
        "Rac1"
      ],
      [
        "cucurbitacin I",
        "CPR:4",
        "Rac1"
      ]
    ],
    "updated": "Yes",
    "original": "The ROS scavenger Nacetyl lcysteine and the mitochondrial antioxidant MitoTEMPO rescued the inhibitory effect of cucurbitacin I on Rac1 activation",
    "simplified": "The antioxidant MitoTEMPO and the ROS scavenger Nacetyl lcysteine rescued the inhibitory effect of cucurbitacin I on Rac1."
  },
  {
    "text": "Cucurbitacin I inhibits the action of rac1 in breast cancer cells by a mechanism different from that of janus tyrosine kinase 2 and prex1 .",
    "triple_list": [
      [
        "Cucurbitacin I",
        "CPR:4",
        "rac1"
      ]
    ],
    "updated": "Yes",
    "original": "Cucurbitacin I inhibits rac1 activation in breast cancer cells by a reactive oxygen speciesmediated mechanism and independently of janus tyrosine kinase 2 and prex1",
    "simplified": "Cucurbitacin I inhibits the action of rac1 in breast cancer cells by a mechanism different from that of janus tyrosine kinase 2 and prex1."
  },
  {
    "text": "The RhoAROCK pathway has been shown to inhibit the inhibitory effect of cucurbitacin I on Rac1 by heregulin .",
    "triple_list": [
      [
        "cucurbitacin I",
        "CPR:4",
        "Rac1"
      ]
    ],
    "updated": "Yes",
    "original": "Interestingly disruption of the RhoAROCK pathway prevented the inhibitory effect of cucurbitacin I on Rac1 activation by heregulin",
    "simplified": "The RhoAROCK pathway has been shown to inhibit the inhibitory effect of cucurbitacin I on Rac1 by heregulin."
  },
  {
    "text": "They also showed that the inhibitory effect of cucurbitacin I on Rac1 activity is changed by a change in the balance of Rho and Rac .",
    "triple_list": [
      [
        "cucurbitacin I",
        "CPR:4",
        "Rac1"
      ]
    ],
    "updated": "Yes",
    "original": "Moreover they established that the inhibitory effect of cucurbitacin I on Rac1 activity involves the alteration of the balance between Rho and Rac",
    "simplified": "They also showed that the inhibitory effect of cucurbitacin I on Rac1 activity is changed by a change in the balance of Rho and Rac."
  },
  {
    "text": "The anticancer agent cucurbitacin I a Jak2 inhibitor was found to reduce Rac1 and motility in breast cancer cells when ErbB3 ligand heregulin was used .",
    "triple_list": [
      [
        "cucurbitacin I",
        "CPR:4",
        "Jak2"
      ],
      [
        "cucurbitacin I",
        "CPR:4",
        "Rac1"
      ]
    ],
    "updated": "Yes",
    "original": "Here we found that the anticancer agent cucurbitacin I a Jak2 inhibitor reduced the activation of Rac1 and motility in response to the ErbB3 ligand heregulin in breast cancer cells",
    "simplified": "The anticancer agent cucurbitacin I a Jak2 inhibitor was found to reduce Rac1 and motility in breast cancer cells when ErbB3 ligand heregulin was used."
  },
  {
    "text": "These results suggest that the antiallodynia effect of CP101606 is caused by NR2B receptors being blocked in the brain but not in the spinal cord .",
    "triple_list": [
      [
        "CP101606",
        "CPR:4",
        "NR2B"
      ]
    ],
    "updated": "Yes",
    "original": "These findings suggest that the antiallodynia effect of CP101606 is ascribable to blockade of NR2B receptors at the brain but not at the spinal cord",
    "simplified": "These results suggest that the antiallodynia effect of CP101606 is caused by NR2B receptors being blocked in the brain but not in the spinal cord."
  },
  {
    "text": "In order to examine the site of action of an NR2B subtypeselective NMDA antagonist CP101606 we investigated its analgesic effect in a rat model of neuropathic pain at various routes of administration",
    "triple_list": [
      [
        "NR2B",
        "CPR:6",
        "CP101606"
      ],
      [
        "NMDA",
        "CPR:6",
        "CP101606"
      ]
    ],
    "updated": "No",
    "original": "In order to examine the site of action of an NR2B subtypeselective NMDA antagonist CP101606 we investigated its analgesic effect in a rat model of neuropathic pain at various routes of administration",
    "simplified": "In order to examine the site of action of an NMDA antagonist, we investigated its analgesic effect in a rat model of neuropathic pain at various routes of administration."
  },
  {
    "text": "Brain but not spinal NR2B receptor is responsible for the antiallodynic effect of an NR2B subunitselective antagonist CP101606 in a rat chronic constriction injury model",
    "triple_list": [
      [
        "NR2B",
        "CPR:6",
        "CP101606"
      ],
      [
        "NR2B",
        "CPR:6",
        "CP101606"
      ]
    ],
    "updated": "No",
    "original": "Brain but not spinal NR2B receptor is responsible for the antiallodynic effect of an NR2B subunitselective antagonist CP101606 in a rat chronic constriction injury model",
    "simplified": "The NR2B receptor is found in the brain but not in the spinal cord. An NR2B antagonist can cause an antiallodynic effect in a rat."
  },
  {
    "text": "In contrast intrathecal injection of a nonselective NMDA antagonist memantine significantly inhibited CCIinduced mechanical allodynia at a dose of 300 nmol indicating the difference in the site of action between the nonselective NMDA antagonist and the NR2Bspecific NMDA antagonist",
    "triple_list": [
      [
        "NMDA",
        "CPR:6",
        "memantine"
      ]
    ],
    "updated": "No",
    "original": "In contrast intrathecal injection of a nonselective NMDA antagonist memantine significantly inhibited CCIinduced mechanical allodynia at a dose of 300 nmol indicating the difference in the site of action between the nonselective NMDA antagonist and the NR2Bspecific NMDA antagonist",
    "simplified": "In contrast intrathecal injection of a nonselective NMDA antagonist significantly inhibited CCIinduced mechanical allodynia at a dose of 300 nmol. The difference between a NR2Bspecific NMDA antagonist and a nonselective NMDA antagonist was noted."
  },
  {
    "text": "Rasagiline does not modify CNS monoamine tissue levels or monoamineinduced behavioural syndromes at doses which selectively inhibit MAOB but not MAOA",
    "triple_list": [
      [
        "Rasagiline",
        "CPR:4",
        "MAOB"
      ],
      [
        "Rasagiline",
        "CPR:4",
        "MAOA"
      ]
    ],
    "updated": "No",
    "original": "Rasagiline does not modify CNS monoamine tissue levels or monoamineinduced behavioural syndromes at doses which selectively inhibit MAOB but not MAOA",
    "simplified": "Rasagiline does not modify the levels of monoamine in the central nervous system. It does, however, inhibit the action of MAOB."
  },
  {
    "text": "Rasagiline Npropargyl1Raminoindan TVP1012 is a potent irreversible monoamine oxidase MAO inhibitor which is being developed for the treatment of Parkinson 's disease .",
    "triple_list": [
      [
        "Rasagiline",
        "CPR:4",
        "monoamine oxidase"
      ],
      [
        "Rasagiline",
        "CPR:4",
        "MAO"
      ],
      [
        "TVP1012",
        "CPR:4",
        "monoamine oxidase"
      ],
      [
        "TVP1012",
        "CPR:4",
        "MAO"
      ],
      [
        "Npropargyl1Raminoindan",
        "CPR:4",
        "monoamine oxidase"
      ],
      [
        "Npropargyl1Raminoindan",
        "CPR:4",
        "MAO"
      ]
    ],
    "updated": "Yes",
    "original": "Rasagiline Npropargyl1Raminoindan TVP1012 is a potent irreversible monoamine oxidase MAO inhibitor with selectivity for type B of the enzyme which is being developed for treatment of Parkinsons disease",
    "simplified": "Rasagiline Npropargyl1Raminoindan TVP1012 is a potent irreversible monoamine oxidase MAO inhibitor which is being developed for the treatment of Parkinson's disease."
  },
  {
    "text": "Reserpineinduced ptosis was reversed by rasagiline at doses above 2 mg x kg1 ip which inhibit MAOA as well as MAOB but not at MAOBselective doses",
    "triple_list": [
      [
        "rasagiline",
        "CPR:4",
        "MAOA"
      ],
      [
        "rasagiline",
        "CPR:4",
        "MAOB"
      ]
    ],
    "updated": "No",
    "original": "Reserpineinduced ptosis was reversed by rasagiline at doses above 2 mg x kg1 ip which inhibit MAOA as well as MAOB but not at MAOBselective doses",
    "simplified": "Reserpineinduced ptosis was reversed by rasagiline at doses above 2 mg/kg-1 ip/O. However, rasagiline does not work at high doses."
  },
  {
    "text": "did not induce the behavioural hyperactivity syndrome which is seen following inhibition of both MAOA and MAOB by tranylcypromine together with the monoamine precursors",
    "triple_list": [
      [
        "MAOA",
        "CPR:4",
        "tranylcypromine"
      ],
      [
        "MAOB",
        "CPR:4",
        "tranylcypromine"
      ],
      [
        "MAOA",
        "CPR:4",
        "monoamine"
      ],
      [
        "MAOB",
        "CPR:4",
        "monoamine"
      ]
    ],
    "updated": "No",
    "original": "did not induce the behavioural hyperactivity syndrome which is seen following inhibition of both MAOA and MAOB by tranylcypromine together with the monoamine precursors",
    "simplified": "It does not cause the behavioural hyperactivity syndrome. This happens when both MAOA and MAOB are taken out of the system, along with the monoamine precursors."
  },
  {
    "text": "Omega class GSTs have dehydroascorbate reductase and thioltransferase activities and also catalyze the reduction of monomethylarsonate an intermediate in the pathway of arsenic biotransformation",
    "triple_list": [
      [
        "Omega class GSTs",
        "CPR:9",
        "monomethylarsonate"
      ]
    ],
    "updated": "No",
    "original": "Omega class GSTs have dehydroascorbate reductase and thioltransferase activities and also catalyze the reduction of monomethylarsonate an intermediate in the pathway of arsenic biotransformation",
    "simplified": "Omega class GSTs have dehydroascorbate reductase and thioltransferase activities. They also help in the biotransformation of arsenic into arsenic (III) sulfate."
  },
  {
    "text": "The latter reaction catalyzed by aspartoacylase ASPA produces acetyl groups plus aspartate and has been proposed to occur in both soluble and membranous subfractions of white matter",
    "triple_list": [
      [
        "aspartoacylase",
        "CPR:9",
        "acetyl"
      ],
      [
        "ASPA",
        "CPR:9",
        "acetyl"
      ],
      [
        "aspartoacylase",
        "CPR:9",
        "aspartate"
      ],
      [
        "ASPA",
        "CPR:9",
        "aspartate"
      ]
    ],
    "updated": "No",
    "original": "The latter reaction catalyzed by aspartoacylase ASPA produces acetyl groups plus aspartate and has been proposed to occur in both soluble and membranous subfractions of white matter",
    "simplified": "The reaction between aspartoacylase and aspartate produces acetyl groups plus aspartate. This reaction has been proposed to occur in both soluble and membranous parts of white matter."
  },
  {
    "text": "It is not yet clear whether tamoxifen can reduce the risk of breast cancer in women with BRCA1 or BRCA2 mutations , but early evidence suggests that it can help some people .",
    "triple_list": [
      [
        "tamoxifen",
        "CPR:4",
        "BRCA2"
      ],
      [
        "tamoxifen",
        "CPR:4",
        "BRCA2"
      ]
    ],
    "updated": "Yes",
    "original": "It is not yet clear whether tamoxifen can reduce breast cancer incidence in women with BRCA1 and BRCA2 mutations although preliminary evidence favors benefit for at least those with a BRCA2 mutation",
    "simplified": "It is not yet clear whether tamoxifen can reduce the risk of breast cancer in women with BRCA1 or BRCA2 mutations, but early evidence suggests that it can help some people."
  },
  {
    "text": "Troglitazone inhibited the antigeninduced production of LTB4 C4 and E4 and the potency of the inhibition was comparable to that of zileuton a specific inhibitor of 5lipoxygenase 5LOX and a clinically used antiasthmatic drug",
    "triple_list": [
      [
        "zileuton",
        "CPR:4",
        "5lipoxygenase"
      ],
      [
        "zileuton",
        "CPR:4",
        "5LOX"
      ]
    ],
    "updated": "No",
    "original": "Troglitazone inhibited the antigeninduced production of LTB4 C4 and E4 and the potency of the inhibition was comparable to that of zileuton a specific inhibitor of 5lipoxygenase 5LOX and a clinically used antiasthmatic drug",
    "simplified": "Troglitazone inhibited the antigeninduced production of LTB4 C4 and E4. The potency of the inhibition was comparable to that of a drug called zileuton, which is used to treat asthma."
  },
  {
    "text": "Troglitazone inhibited LTB4 production by the supernatant fraction of RBL2H3 cell lysate with similar potency to zileuton suggesting that troglitazone inhibits LT production by direct inhibition of 5LOX activity",
    "triple_list": [
      [
        "zileuton",
        "CPR:4",
        "5LOX"
      ],
      [
        "troglitazone",
        "CPR:4",
        "5LOX"
      ]
    ],
    "updated": "No",
    "original": "Troglitazone inhibited LTB4 production by the supernatant fraction of RBL2H3 cell lysate with similar potency to zileuton suggesting that troglitazone inhibits LT production by direct inhibition of 5LOX activity",
    "simplified": "Troglitazone inhibited LTB4 production by the supernatant fraction of RBL2H3 cell lysate with similar potency to zileuton. This means that troglitazone may be able to directly inhibit LT production."
  },
  {
    "text": "These findings suggest that troglitazone directly inhibits 5LOX activity in the IgEsensitized RBL2H3 cells and A23187stimulated rat peritoneal neutrophils by direct inhibition .",
    "triple_list": [
      [
        "troglitazone",
        "CPR:4",
        "5LOX"
      ]
    ],
    "updated": "Yes",
    "original": "These findings suggest that troglitazone inhibits antigeninduced LT production in the IgEsensitized RBL2H3 cells and A23187stimulated rat peritoneal neutrophils by direct inhibition of 5LOX activity",
    "simplified": "These findings suggest that troglitazone directly inhibits 5LOX activity in the IgEsensitized RBL2H3 cells and A23187stimulated rat peritoneal neutrophils by direct inhibition."
  },
  {
    "text": "The positive correlation between vitamin A and immunoglobulin A concentrations might be the result of the vitamin A inductive effect during immunoglobulins A synthesis",
    "triple_list": [
      [
        "vitamin A",
        "CPR:3",
        "immunoglobulin A"
      ],
      [
        "vitamin A",
        "CPR:3",
        "immunoglobulins A"
      ],
      [
        "vitamin A",
        "CPR:3",
        "immunoglobulin A"
      ],
      [
        "vitamin A",
        "CPR:3",
        "immunoglobulins A"
      ]
    ],
    "updated": "No",
    "original": "The positive correlation between vitamin A and immunoglobulin A concentrations might be the result of the vitamin A inductive effect during immunoglobulins A synthesis",
    "simplified": "The positive correlation between vitamin A and the level of immunoglobulin A shows that vitamin A is necessary for good health."
  },
  {
    "text": "Experimental as well as clinical reports support the hypothesis that calcium channel blockers such as verapamil may be an appropriate therapeutic approach in LQTS",
    "triple_list": [
      [
        "calcium channel",
        "CPR:4",
        "verapamil"
      ]
    ],
    "updated": "No",
    "original": "Experimental as well as clinical reports support the hypothesis that calcium channel blockers such as verapamil may be an appropriate therapeutic approach in LQTS",
    "simplified": "Experimental and clinical studies have shown that calcium channel blockers can help people with LQTS. Verapamil is an example of this medicine."
  },
  {
    "text": "METHODS AND RESULTS In 8 Langendorffperfused rabbit hearts veratridine 01 microM an inhibitor of sodium channel inactivation led to a marked increase in QTinterval . MAPs p 005 were recorded at the same time and were similar to LQT3 .",
    "triple_list": [
      [
        "veratridine",
        "CPR:4",
        "sodium channel"
      ]
    ],
    "updated": "Yes",
    "original": "METHODS AND RESULTS In 8 Langendorffperfused rabbit hearts veratridine 01 microM an inhibitor of sodium channel inactivation led to a marked increase in QTinterval and simultaneously recorded monophasic ventricular action potentials MAPs p 005 thereby mimicking LQT3",
    "simplified": "METHODS AND RESULTS In 8 Langendorffperfused rabbit hearts veratridine 01 microM an inhibitor of sodium channel inactivation led to a marked increase in QTinterval. MAPs p 005 were recorded at the same time and were similar to LQT3."
  },
  {
    "text": "Unlike mouse RetSat mRetSat zRetSat A had an altered bond specificity saturating either the 1314 or 78 double bonds of alltransretinol to produce either alltrans1314dihydroretinol or alltrans78dihydroretinol respectively",
    "triple_list": [
      [
        "zRetSat A",
        "CPR:9",
        "alltransretinol"
      ],
      [
        "zRetSat A",
        "CPR:9",
        "alltrans1314dihydroretinol"
      ],
      [
        "zRetSat A",
        "CPR:9",
        "alltrans78dihydroretinol"
      ]
    ],
    "updated": "No",
    "original": "Unlike mouse RetSat mRetSat zRetSat A had an altered bond specificity saturating either the 1314 or 78 double bonds of alltransretinol to produce either alltrans1314dihydroretinol or alltrans78dihydroretinol respectively",
    "simplified": "Unlike mouse RetSat mRetSat zRetSat A had an altered bond specificity. It could not break either the 1314 or 78 double bonds of alltransretinol, but it could make alltrans1314dihydroretinol."
  },
  {
    "text": "Alltrans1314dihydroretinol is oxidized to alltrans1314dihydroretinoic acid by the Cyp26 enzymes in order to make alltrans1314dihydroretinol .",
    "triple_list": [
      [
        "alltrans1314dihydroretinol",
        "CPR:9",
        "Cyp26"
      ]
    ],
    "updated": "Yes",
    "original": "Specifically alltrans1314dihydroretinol is transiently oxidized to alltrans1314dihydroretinoic acid before being oxidized further by Cyp26 enzymes",
    "simplified": "Alltrans1314dihydroretinol is oxidized to alltrans1314dihydroretinoic acid by the Cyp26 enzymes in order to make alltrans1314dihydroretinol."
  },
  {
    "text": "Specificity of zebrafish retinol saturase formation of alltrans1314dihydroretinol and alltrans78 dihydroretinol",
    "triple_list": [
      [
        "zebrafish retinol saturase",
        "CPR:9",
        "alltrans1314dihydroretinol"
      ],
      [
        "zebrafish retinol saturase",
        "CPR:9",
        "alltrans78 dihydroretinol"
      ]
    ],
    "updated": "No",
    "original": "Specificity of zebrafish retinol saturase formation of alltrans1314dihydroretinol and alltrans78 dihydroretinol",
    "simplified": "Zebrafish can make alltrans1314dihydroretinol and alltrans78 dihydroretinol on their own."
  },
  {
    "text": "zRetSat A also saturated the 1314 or 78 double bonds of alltrans34didehydroretinol vitamin A2 a second endogenous form of vitamin A in zebrafish",
    "triple_list": [
      [
        "zRetSat A",
        "CPR:9",
        "alltrans34didehydroretinol"
      ],
      [
        "zRetSat A",
        "CPR:9",
        "vitamin A2"
      ]
    ],
    "updated": "No",
    "original": "zRetSat A also saturated the 1314 or 78 double bonds of alltrans34didehydroretinol vitamin A2 a second endogenous form of vitamin A in zebrafish",
    "simplified": "It also breaks down the 1314 or 78 double bonds in alltrans34didehydroretinol to make vitamin A and vitamin A2 in the body."
  },
  {
    "text": "Rasagiline is a novel potent and irreversible monoamine oxidase type B MAOB inhibitor which has been approved for treatment of PD",
    "triple_list": [
      [
        "Rasagiline",
        "CPR:4",
        "monoamine oxidase type B"
      ],
      [
        "Rasagiline",
        "CPR:4",
        "MAOB"
      ]
    ],
    "updated": "No",
    "original": "Rasagiline is a novel potent and irreversible monoamine oxidase type B MAOB inhibitor which has been approved for treatment of PD",
    "simplified": "Rasagiline is a novel monoamine oxidase type B inhibitor that has been approved for the treatment of peptic ulcer disease."
  },
  {
    "text": "Rasagiline inhibits MAOB more effectively than selegiline . Rasagiline can be taken on a daily basis .",
    "triple_list": [
      [
        "Rasagiline",
        "CPR:4",
        "MAOB"
      ]
    ],
    "updated": "Yes",
    "original": "Rasagiline inhibits MAOB more potently than selegiline and has the advantage of oncedaily dosing",
    "simplified": "Rasagiline inhibits MAOB more effectively than selegiline. Rasagiline can be taken on a daily basis."
  },
  {
    "text": "Science 9266 1994 17091713 greatly attenuates the lithium induced potentiation of GluR3",
    "triple_list": [
      [
        "lithium",
        "CPR:3",
        "GluR3"
      ]
    ],
    "updated": "No",
    "original": "Science 9266 1994 17091713 greatly attenuates the lithium induced potentiation of GluR3",
    "simplified": "Science 9266 1994 17091713 This effect is called lithium-induced potentiation."
  },
  {
    "text": "Neuron 21 1998 907918 showed that lithium helps GluR3 to work better . This is because lithium does not work as well if it is not used .",
    "triple_list": [
      [
        "lithium",
        "CPR:3",
        "GluR3"
      ]
    ],
    "updated": "Yes",
    "original": "Neuron 21 1998 907918 further confirms that lithium enhances GluR3 responses by reducing desensitization since lithiums effects are reversed in this mutant",
    "simplified": "Neuron 21 1998 907918 showed that lithium helps GluR3 to work better. This is because lithium does not work as well if it is not used."
  },
  {
    "text": "Analysis of splice variants and sitedirected mutants of the AMPA receptor GluR3 expressed in Xenopus oocytes has shown that lithium produces a large potentiation of the GluR3 flop splice variant . Karkanias N and Papke R Subtypespecific effects of lithium on glutamate receptor function The amount of lithium in a person 's blood has an effect on the amount of glutamate in the blood .",
    "triple_list": [
      [
        "lithium",
        "CPR:3",
        "GluR3 flop"
      ],
      [
        "lithium",
        "CPR:3",
        "GluR3 flop"
      ]
    ],
    "updated": "Yes",
    "original": "Analysis of splice variants and sitedirected mutants of the AMPA receptor GluR3 expressed in Xenopus oocytes has shown that lithium produces a large potentiation of the GluR3 flop splice variant and suggested that lithium might inhibit rapid desensitization which is characteristic of this receptor Karkanias N and Papke R Subtypespecific effects of lithium on glutamate receptor function",
    "simplified": "Analysis of splice variants and sitedirected mutants of the AMPA receptor GluR3 expressed in Xenopus oocytes has shown that lithium produces a large potentiation of the GluR3 flop splice variant. Karkanias N and Papke R Subtypespecific effects of lithium on glutamate receptor function The amount of lithium in a person's blood has an effect on the amount of glutamate in the blood."
  },
  {
    "text": "Specifically aniracetam which potentiates wildtype AMPA receptors is ineffective on the nondesensitizing GluR3 L507Y mutant but has synergistic effects with lithium on wildtype receptors",
    "triple_list": [
      [
        "aniracetam",
        "CPR:3",
        "AMPA receptors"
      ],
      [
        "GluR3",
        "CPR:3",
        "lithium"
      ],
      [
        "L507Y",
        "CPR:3",
        "lithium"
      ]
    ],
    "updated": "No",
    "original": "Specifically aniracetam which potentiates wildtype AMPA receptors is ineffective on the nondesensitizing GluR3 L507Y mutant but has synergistic effects with lithium on wildtype receptors",
    "simplified": "Aniracetam can work on some AMPA receptors, but not all of them. It does not work on the GluR3 L507Y mutant, but it does work on some other receptors."
  },
  {
    "text": "The BH4 treatment was associated with a 2fold increase in eNOS activity and a 70 % reduction in endothelial production compared to normal rats .",
    "triple_list": [
      [
        "BH4",
        "CPR:3",
        "eNOS"
      ]
    ],
    "updated": "Yes",
    "original": "The BH4 treatment was associated with a 2fold increase in eNOS activity as well as a 70 reduction in endothelial O2 production compared with those in fructosefed rats",
    "simplified": "The BH4 treatment was associated with a 2fold increase in eNOS activity and a 70% reduction in endothelial production compared to normal rats."
  },
  {
    "text": "The BH4 treatment also partially improved the blood pressure and insulin sensitivity in the fructosefed rats , but only a little .",
    "triple_list": [
      [
        "BH4",
        "CPR:3",
        "insulin"
      ]
    ],
    "updated": "Yes",
    "original": "The BH4 treatment also partially improved the insulin sensitivity and blood pressure as well as the serum triglyceride concentration in the fructosefed rats",
    "simplified": "The BH4 treatment also partially improved the blood pressure and insulin sensitivity in the fructosefed rats, but only a little."
  },
  {
    "text": "Moreover BH4 treatment of the fructose fed rats markedly reduced the lipid peroxide content of both aortic and cardiac tissues and inhibited the activation of 2 redoxsensitive transcription factors nuclear factorkappaB and activating protein1 which were increased in fructosefed rats",
    "triple_list": [
      [
        "fructose",
        "CPR:3",
        "nuclear factorkappaB"
      ],
      [
        "fructose",
        "CPR:3",
        "activating protein1"
      ],
      [
        "fructose",
        "CPR:3",
        "nuclear factorkappaB"
      ],
      [
        "fructose",
        "CPR:3",
        "activating protein1"
      ],
      [
        "BH4",
        "CPR:4",
        "nuclear factorkappaB"
      ],
      [
        "BH4",
        "CPR:4",
        "activating protein1"
      ]
    ],
    "updated": "No",
    "original": "Moreover BH4 treatment of the fructose fed rats markedly reduced the lipid peroxide content of both aortic and cardiac tissues and inhibited the activation of 2 redoxsensitive transcription factors nuclear factorkappaB and activating protein1 which were increased in fructosefed rats",
    "simplified": "In addition, BH4 treatment significantly reduced the lipid peroxide content of both aortic and cardiac tissues and in fructose fed rats the activation of 2 redoxsensitive transcription factors and activating protein1 was significantly increased."
  },
  {
    "text": "We confirm the correlation between higher hCTR1 levels and higher Pt drug uptake in tumor cells sensitive to the drug",
    "triple_list": [
      [
        "hCTR1",
        "CPR:9",
        "Pt"
      ]
    ],
    "updated": "No",
    "original": "We confirm the correlation between higher hCTR1 levels and higher Pt drug uptake in tumor cells sensitive to the drug",
    "simplified": "We found that higher hCTR1 levels were associated with higher drug uptake in tumor cells sensitive to it."
  },
  {
    "text": "The human high affinity copper transporter ( hCTR1 ) is the major entry pathway for cDDP and related drugs , but it is not clear how it works .",
    "triple_list": [
      [
        "hCTR1",
        "CPR:9",
        "cDDP"
      ],
      [
        "human high affinity copper transporter",
        "CPR:9",
        "cDDP"
      ]
    ],
    "updated": "Yes",
    "original": "It has been claimed that hCTR1 the human high affinity copper transporter is the major entry pathway for cDDP and related drugs via a mechanism that mimics copper",
    "simplified": "The human high affinity copper transporter (hCTR1) is the major entry pathway for cDDP and related drugs, but it is not clear how it works."
  },
  {
    "text": "Compared with aripiprazole , brexpiprazole showed less efficacy at D2 receptors . It significantly inhibited the firing activity of VTA DA neurons .",
    "triple_list": [
      [
        "brexpiprazole",
        "CPR:4",
        "D2 receptors"
      ]
    ],
    "updated": "Yes",
    "original": "Compared with aripiprazole which significantly inhibited the firing activity of VTA DA neurons brexpiprazole displayed less efficacy at D2 receptors",
    "simplified": "Compared with aripiprazole, brexpiprazole showed less efficacy at D2 receptors. It significantly inhibited the firing activity of VTA DA neurons."
  },
  {
    "text": "In the DRN brexpiprazole completely inhibited the firing of 5HT neurons via 5HT1A agonism and was more potent than aripiprazole ED50 = 230 and 700 mugkg respectively",
    "triple_list": [
      [
        "brexpiprazole",
        "CPR:5",
        "5HT1A"
      ],
      [
        "5HT1A",
        "CPR:5",
        "aripiprazole"
      ]
    ],
    "updated": "No",
    "original": "In the DRN brexpiprazole completely inhibited the firing of 5HT neurons via 5HT1A agonism and was more potent than aripiprazole ED50 = 230 and 700 mugkg respectively",
    "simplified": "In the DRN brexpiprazole completely inhibited the firing of 5HT neurons. It was more potent than aripiprazole, which was used in the past."
  },
  {
    "text": "In the locus coeruleus brexpiprazole changed the inhibitory effect of DOI 25dimethoxy4iodoamphetamine on norepinephrine neurons . ED50 = 110 mugkg showing that 5HT2A does not work as well as it used to .",
    "triple_list": [
      [
        "5HT2A",
        "CPR:5",
        "DOI"
      ],
      [
        "5HT2A",
        "CPR:5",
        "25dimethoxy4iodoamphetamine"
      ]
    ],
    "updated": "Yes",
    "original": "In the locus coeruleus brexpiprazole reversed the inhibitory effect of the preferential 5HT2A receptor agonist DOI 25dimethoxy4iodoamphetamine on norepinephrine neuronal firing ED50 = 110 mugkg demonstrating 5HT2A antagonistic action",
    "simplified": "In the locus coeruleus brexpiprazole changed the inhibitory effect of DOI 25dimethoxy4iodoamphetamine on norepinephrine neurons. ED50 = 110 mugkg showing that 5HT2A does not work as well as it used to."
  },
  {
    "text": "Brexpiprazole reversed the inhibitory effect of the DA agonist apomorphine on VTA DA neurons ED50 = 61 mugkg whereas it was ineffective when administered alone indicating partial agonistic action on D2 receptors",
    "triple_list": [
      [
        "apomorphine",
        "CPR:5",
        "D2 receptors"
      ]
    ],
    "updated": "No",
    "original": "Brexpiprazole reversed the inhibitory effect of the DA agonist apomorphine on VTA DA neurons ED50 = 61 mugkg whereas it was ineffective when administered alone indicating partial agonistic action on D2 receptors",
    "simplified": "Bxpiprazole reversed the inhibitory effect of the DA agonist apomorphine on VTA DA neurons ED50 = 61 mugkg but was not effective when administered alone, suggesting that D2 may be involved."
  },
  {
    "text": "In the hippocampus brexpiprazole acted as a full agonist at 5HT1A and 5HT2 receptors .",
    "triple_list": [
      [
        "brexpiprazole",
        "CPR:5",
        "5HT1A"
      ]
    ],
    "updated": "Yes",
    "original": "In the hippocampus brexpiprazole acted as a full agonist at 5HT1A receptors on pyramidal neurons",
    "simplified": "In the hippocampus brexpiprazole acted as a full agonist at 5HT1A and 5HT2 receptors."
  },
  {
    "text": "In the lateral geniculate nucleus brexpiprazole displayed alpha1Badrenoceptor antagonistic action",
    "triple_list": [
      [
        "brexpiprazole",
        "CPR:6",
        "alpha1Badrenoceptor"
      ]
    ],
    "updated": "No",
    "original": "In the lateral geniculate nucleus brexpiprazole displayed alpha1Badrenoceptor antagonistic action",
    "simplified": "In the lateral geniculate nucleus brexpiprazole showed two different types of action."
  },
  {
    "text": "For AII and ET1 MAP was also increased for the fenofibrate group but not as much as it should be .",
    "triple_list": [
      [
        "AII",
        "CPR:3",
        "fenofibrate"
      ],
      [
        "ET1",
        "CPR:3",
        "fenofibrate"
      ]
    ],
    "updated": "Yes",
    "original": "For AII and ET1 MAP was also increased for the fenofibrate group but not in a dosedependent fashion",
    "simplified": "For AII and ET1 MAP was also increased for the fenofibrate group but not as much as it should be."
  },
  {
    "text": "Nanobodyalbumin nanoparticles NANAPs for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells",
    "triple_list": [
      [
        "multikinase",
        "CPR:4",
        "17864"
      ]
    ],
    "updated": "No",
    "original": "Nanobodyalbumin nanoparticles NANAPs for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells",
    "simplified": "Nanobodyalbumin nanoparticles NANAPs for the delivery of a multikinase inhibitor to damaged blood vessels"
  },
  {
    "text": "Glutaraldehyde crosslinked albumin nanoparticles were loaded with the multikinase inhibitor 17864 Lxa platinumbound sunitinib analoguewhich couples the drug to methionine residues of albumin and is released in a way that makes the drug work even better .",
    "triple_list": [
      [
        "multikinase",
        "CPR:4",
        "17864"
      ]
    ],
    "updated": "Yes",
    "original": "Glutaraldehyde crosslinked albumin nanoparticles with a size of approximately 100nm were loaded with the multikinase inhibitor 17864 Lxa platinumbound sunitinib analoguewhich couples the drug to methionine residues of albumin and is released in a reductive environment",
    "simplified": "Glutaraldehyde crosslinked albumin nanoparticles were loaded with the multikinase inhibitor 17864 Lxa platinumbound sunitinib analoguewhich couples the drug to methionine residues of albumin and is released in a way that makes the drug work even better."
  },
  {
    "text": "Endogenously produced arginine are competitive inhibitors of three types of nitric oxide synthase : NOS , NOS2 , and NOS3 .",
    "triple_list": [
      [
        "arginine",
        "CPR:4",
        "nitric oxide synthase"
      ],
      [
        "arginine",
        "CPR:4",
        "NOS"
      ]
    ],
    "updated": "Yes",
    "original": "Endogenously produced asymmetrically methylated arginine residues are competitive inhibitors of all three isoforms of nitric oxide synthase NOS",
    "simplified": "Endogenously produced arginine are competitive inhibitors of three types of nitric oxide synthase: NOS, NOS2, and NOS3."
  },
  {
    "text": "The enzyme dimethylarginine dimethylaminohydrolase DDAH changes arginine into citrulline and methylamines , and then back to arginine .",
    "triple_list": [
      [
        "dimethylarginine dimethylaminohydrolase",
        "CPR:9",
        "arginine"
      ],
      [
        "arginine",
        "CPR:9",
        "DDAH"
      ]
    ],
    "updated": "Yes",
    "original": "The enzyme dimethylarginine dimethylaminohydrolase DDAH specifically hydrolyzes these asymmetrically methylated arginine residues to citrulline and methylamines",
    "simplified": "The enzyme dimethylarginine dimethylaminohydrolase DDAH changes arginine into citrulline and methylamines, and then back to arginine."
  },
  {
    "text": "Previously we have proposed that DDAH may provide a novel mechanism for the regulation of NOS activity in vivo by regulating asymmetric methylarginine concentration .",
    "triple_list": [
      [
        "methylarginine",
        "CPR:9",
        "DDAH"
      ]
    ],
    "updated": "Yes",
    "original": "Previously we have proposed that regulation of asymmetric methylarginine concentration by DDAH may provide a novel mechanism for the regulation of NOS activity in vivo",
    "simplified": "Previously we have proposed that DDAH may provide a novel mechanism for the regulation of NOS activity in vivo by regulating asymmetric methylarginine concentration."
  },
  {
    "text": "A series of dihydroisoquinoline BACE1 inhibitors is described in detail",
    "triple_list": [
      [
        "dihydroisoquinoline",
        "CPR:4",
        "BACE1"
      ]
    ],
    "updated": "Yes",
    "original": "The structureactivity relationship of a series of dihydroisoquinoline BACE1 inhibitors is described",
    "simplified": "A series of dihydroisoquinoline BACE1 inhibitors is described in detail"
  },
  {
    "text": "A novel structure-based design of dihydroisoquinoline BACE1 inhibitors that does not involve aspartates .",
    "triple_list": [
      [
        "dihydroisoquinoline",
        "CPR:4",
        "BACE1"
      ]
    ],
    "updated": "Yes",
    "original": "Structurebased design of novel dihydroisoquinoline BACE1 inhibitors that do not engage the catalytic aspartates",
    "simplified": "A novel structure-based design of dihydroisoquinoline BACE1 inhibitors that does not involve aspartates."
  },
  {
    "text": "Tissuetype plasminogen activator tPA a serine protease well known for generating plasmin has been shown to cause matrix metalloproteinase9 ( MMP9 ) gene expression in human renal fibroblasts .",
    "triple_list": [
      [
        "serine",
        "CPR:3",
        "matrix metalloproteinase9"
      ],
      [
        "plasmin",
        "CPR:3",
        "serine"
      ]
    ],
    "updated": "Yes",
    "original": "Tissuetype plasminogen activator tPA a serine protease well known for generating plasmin has been demonstrated to induce matrix metalloproteinase9 MMP9 gene expression and protein secretion in renal interstitial fibroblasts",
    "simplified": "Tissuetype plasminogen activator tPA a serine protease well known for generating plasmin has been shown to cause matrix metalloproteinase9 (MMP9) gene expression in human renal fibroblasts."
  },
  {
    "text": "In addition , tPA caused rapid tyrosine phosphorylation on the beta subunit of LRP1 . This caused Mek1 and its downstream Erk1 and 2 to become active .",
    "triple_list": [
      [
        "tyrosine",
        "CPR:3",
        "Mek1"
      ],
      [
        "tyrosine",
        "CPR:3",
        "Erk1 and 2"
      ]
    ],
    "updated": "Yes",
    "original": "Furthermore tPA induced rapid tyrosine phosphorylation on the beta subunit of LRP1 which was followed by the activation of Mek1 and its downstream Erk1 and 2",
    "simplified": "In addition, tPA caused rapid tyrosine phosphorylation on the beta subunit of LRP1. This caused Mek1 and its downstream Erk1 and 2 to become active."
  },
  {
    "text": "The data show that CPcPh is less effective than benzoapyrene BaP at changing the gene expression of CYP1A in rainbow trout .",
    "triple_list": [
      [
        "CPcPh",
        "CPR:3",
        "CYP1A"
      ],
      [
        "CYP1A",
        "CPR:3",
        "benzoapyrene"
      ],
      [
        "CYP1A",
        "CPR:3",
        "BaP"
      ]
    ],
    "updated": "Yes",
    "original": "The data show that CPcPh is less potent at inducing CYP1A gene expression in rainbow trout than benzoapyrene BaP a wellknown Ahreceptor agonist",
    "simplified": "The data show that CPcPh is less effective than benzoapyrene BaP at changing the gene expression of CYP1A in rainbow trout."
  },
  {
    "text": "The CPcPh dependent upregulation of CYP1A mRNA is positively correlated with clastogenic changes in rainbow trout erythrocytes , but not in humans .",
    "triple_list": [
      [
        "CPcPh",
        "CPR:3",
        "CYP1A"
      ]
    ],
    "updated": "Yes",
    "original": "Interestingly the CPcPh dependent upregulation of CYP1A mRNA is positively correlated with the incidences of clastogenic changes in rainbow trout erythrocytes",
    "simplified": "The CPcPh dependent upregulation of CYP1A mRNA is positively correlated with clastogenic changes in rainbow trout erythrocytes, but not in humans."
  },
  {
    "text": "CPcPh has comparably to BaP a potential to repress expression of tumor suppressor p53 in the head kidney of rainbow trout",
    "triple_list": [
      [
        "CPcPh",
        "CPR:4",
        "tumor suppressor p53"
      ],
      [
        "BaP",
        "CPR:4",
        "tumor suppressor p53"
      ]
    ],
    "updated": "No",
    "original": "CPcPh has comparably to BaP a potential to repress expression of tumor suppressor p53 in the head kidney of rainbow trout",
    "simplified": "CPcPh can inhibit the expression of the tumor suppressor p53 in the head kidney of rainbow trout."
  },
  {
    "text": "Identification of benzofuran central cores for the inhibition of leukotriene A4 hydrolase",
    "triple_list": [
      [
        "benzofuran",
        "CPR:4",
        "leukotriene A4 hydrolase"
      ]
    ],
    "updated": "No",
    "original": "Identification of benzofuran central cores for the inhibition of leukotriene A4 hydrolase",
    "simplified": "Benzofuran central cores can be used to inhibit leukotriene A4 hydrolase."
  },
  {
    "text": "This paper describes the synthesis and identification of LTH4H inhibitors as substituted benzofurans .",
    "triple_list": [
      [
        "benzofurans",
        "CPR:4",
        "LTH4H"
      ]
    ],
    "updated": "Yes",
    "original": "This paper describes the identification and synthesis of substituted benzofurans as LTH4H inhibitors",
    "simplified": "This paper describes the synthesis and identification of LTH4H inhibitors as substituted benzofurans."
  },
  {
    "text": "Benzofuran 28 showed dose responsive target engagement and provides a useful tool to explore a LTA4H inhibitor for the treatment of inflammatory diseases such as inflammatory bowel disease ( IBD ) .",
    "triple_list": [
      [
        "Benzofuran",
        "CPR:4",
        "LTA4H"
      ]
    ],
    "updated": "Yes",
    "original": "Benzofuran 28 showed dose responsive target engagement and provides a useful tool to explore a LTA4H inhibitor for the treatment of inflammatory diseases such as asthma and inflammatory bowel disease IBD",
    "simplified": "Benzofuran 28 showed dose responsive target engagement and provides a useful tool to explore a LTA4H inhibitor for the treatment of inflammatory diseases such as inflammatory bowel disease (IBD)."
  },
  {
    "text": "Leukotriene A4 hydrolase LTA4H is a cystolic enzyme that stereospecifically catalyzes the transformation of LTA4 to LTB4",
    "triple_list": [
      [
        "LTA4",
        "CPR:9",
        "LTA4H"
      ],
      [
        "Leukotriene A4 hydrolase",
        "CPR:9",
        "LTA4"
      ],
      [
        "LTA4H",
        "CPR:9",
        "LTB4"
      ],
      [
        "Leukotriene A4 hydrolase",
        "CPR:9",
        "LTB4"
      ]
    ],
    "updated": "No",
    "original": "Leukotriene A4 hydrolase LTA4H is a cystolic enzyme that stereospecifically catalyzes the transformation of LTA4 to LTB4",
    "simplified": "Leukotriene A4 hydrolase, also known as LTA4H, is an enzyme. It helps to change Leukotriene A4 to LTB4."
  },
  {
    "text": "Minocycline treatment prevents caspase3 from being activated , which is a known cause of apoptosis . The treatment also stops a calpain cleaved substrate from being formed .",
    "triple_list": [
      [
        "Minocycline",
        "CPR:4",
        "caspase3"
      ]
    ],
    "updated": "Yes",
    "original": "Minocycline treatment prevents the formation of activated caspase3 a known effector of apoptosis as well as the appearance of a calpain cleaved substrate a marker of excitotoxicnecrotic cell death",
    "simplified": "Minocycline treatment prevents caspase3 from being activated, which is a known cause of apoptosis. The treatment also stops a calpain cleaved substrate from being formed."
  },
  {
    "text": "When the rats were treated with PLZ , the MAO inhibitor tranylcypromine did not work . However , it did not stop the effect of VIG on GABA .",
    "triple_list": [
      [
        "MAO",
        "CPR:4",
        "tranylcypromine"
      ]
    ],
    "updated": "Yes",
    "original": "Pretreatment of rats with the MAO inhibitor tranylcypromine prevented the increase in brain GABA and ALA levels with PLZ but did not block the effect of VIG on GABA",
    "simplified": "When the rats were treated with PLZ, the MAO inhibitor tranylcypromine did not work. However, it did not stop the effect of VIG on GABA."
  },
  {
    "text": "The effects of PLZ on both amino acids and their transaminases were blocked by pretreatment with the MAO inhibitor tranylcypromine",
    "triple_list": [
      [
        "MAO",
        "CPR:4",
        "tranylcypromine"
      ],
      [
        "transaminases",
        "CPR:4",
        "tranylcypromine"
      ]
    ],
    "updated": "No",
    "original": "The effects of PLZ on both amino acids and their transaminases were blocked by pretreatment with the MAO inhibitor tranylcypromine",
    "simplified": "The effects of PLZ on both amino acids and their transaminases can be stopped by taking a drug called tranylcypromine."
  },
  {
    "text": "PURPOSE To compare phenelzine PLZ an antidepressant drug with anxiolytic properties which inhibits monoamine oxidase MAO but also elevates rat brain levels of the amino acids aminobutyric acid GABA and alanine ALA with vigabatrin VIG an anticonvulsant which elevates brain GABA by inhibition of GABA transaminase GABAT with regard to their actions on brain levels of GABA and ALA and on activities of MAO GABAT and ALA transaminase ALAT",
    "triple_list": [
      [
        "phenelzine",
        "CPR:4",
        "monoamine oxidase"
      ],
      [
        "phenelzine",
        "CPR:4",
        "MAO"
      ],
      [
        "vigabatrin",
        "CPR:4",
        "GABA transaminase"
      ],
      [
        "vigabatrin",
        "CPR:4",
        "GABAT"
      ],
      [
        "VIG",
        "CPR:4",
        "GABA transaminase"
      ],
      [
        "VIG",
        "CPR:4",
        "GABAT"
      ],
      [
        "PLZ",
        "CPR:4",
        "monoamine oxidase"
      ],
      [
        "PLZ",
        "CPR:4",
        "MAO"
      ]
    ],
    "updated": "No",
    "original": "PURPOSE To compare phenelzine PLZ an antidepressant drug with anxiolytic properties which inhibits monoamine oxidase MAO but also elevates rat brain levels of the amino acids aminobutyric acid GABA and alanine ALA with vigabatrin VIG an anticonvulsant which elevates brain GABA by inhibition of GABA transaminase GABAT with regard to their actions on brain levels of GABA and ALA and on activities of MAO GABAT and ALA transaminase ALAT",
    "simplified": " PURPOSE To compare phenelzine PLZ an antidepressant drug with anxiolytic properties with vigabatrin VIG an anticonvulsant which elevates brain GABA by inhibition of GABA transaminase GABAT with regard to their actions on brain levels of the amino acids GABA and ALA and on activities of MAO GABAT and ALA transaminase MAO."
  },
  {
    "text": "Results Both PLZ and VIG reduced GABAT and increased GABA levels .",
    "triple_list": [
      [
        "PLZ",
        "CPR:4",
        "GABAT"
      ],
      [
        "VIG",
        "CPR:4",
        "GABAT"
      ]
    ],
    "updated": "Yes",
    "original": "RESULTS Both PLZ and VIG inhibited GABAT and elevated GABA levels",
    "simplified": "Results Both PLZ and VIG reduced GABAT and increased GABA levels."
  },
  {
    "text": "Only PLZ increased ALA and MAO levels , but not ALAT .",
    "triple_list": [
      [
        "PLZ",
        "CPR:4",
        "MAO"
      ],
      [
        "PLZ",
        "CPR:4",
        "ALAT"
      ]
    ],
    "updated": "Yes",
    "original": "Only PLZ inhibited MAO and ALAT and elevated ALA levels",
    "simplified": "Only PLZ increased ALA and MAO levels, but not ALAT."
  },
  {
    "text": "Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine A comparison with vigabatrin",
    "triple_list": [
      [
        "monoamine oxidase",
        "CPR:4",
        "phenelzine"
      ]
    ],
    "updated": "No",
    "original": "Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine A comparison with vigabatrin",
    "simplified": "Neurochemical effects of phenelzine on brain GABA and alanine The effects of phenelzine on the brain"
  },
  {
    "text": "This pretreament had no effect on the brain GABA levels or on the inhibition of GABAT or VIG .",
    "triple_list": [
      [
        "GABAT",
        "CPR:4",
        "VIG"
      ]
    ],
    "updated": "Yes",
    "original": "This pretreament had no effect on the inhibition of GABAT or the elevation of brain GABA levels produced by VIG",
    "simplified": "This pretreament had no effect on the brain GABA levels or on the inhibition of GABAT or VIG."
  },
  {
    "text": "At the doses studied , PLZ was as effective as VIG at increasing brain GABA levels . Unlike VIG , PLZ also did not work at all on MAO and ALAT .",
    "triple_list": [
      [
        "VIG",
        "CPR:4",
        "MAO"
      ],
      [
        "VIG",
        "CPR:4",
        "ALAT"
      ]
    ],
    "updated": "Yes",
    "original": "CONCLUSIONS At the doses studied PLZ was as effective as VIG at elevating brain GABA levels but unlike VIG also inhibited MAO and ALAT and increased brain ALA levels",
    "simplified": "At the doses studied, PLZ was as effective as VIG at increasing brain GABA levels. Unlike VIG, PLZ also did not work at all on MAO and ALAT."
  },
  {
    "text": "Clinical pharmacology of enalkiren a novel dipeptide renin inhibitor",
    "triple_list": [
      [
        "enalkiren",
        "CPR:4",
        "renin"
      ],
      [
        "dipeptide",
        "CPR:4",
        "renin"
      ]
    ],
    "updated": "No",
    "original": "Clinical pharmacology of enalkiren a novel dipeptide renin inhibitor",
    "simplified": "Enalkiren (a novel dipeptide renin inhibitor) is a drug."
  },
  {
    "text": "Enalkiren A64662 is a potent dipeptide renin inhibitor . It works by changing the state of the human renin .",
    "triple_list": [
      [
        "Enalkiren",
        "CPR:4",
        "renin"
      ],
      [
        "Enalkiren",
        "CPR:4",
        "human renin"
      ],
      [
        "A64662",
        "CPR:4",
        "renin"
      ],
      [
        "A64662",
        "CPR:4",
        "human renin"
      ],
      [
        "dipeptide",
        "CPR:4",
        "renin"
      ],
      [
        "dipeptide",
        "CPR:4",
        "human renin"
      ]
    ],
    "updated": "Yes",
    "original": "Enalkiren A64662 a potent dipeptide renin inhibitor mimics the transition state of the human renin substrate angiotensinogen",
    "simplified": "Enalkiren A64662 is a potent dipeptide renin inhibitor. It works by changing the state of the human renin."
  },
  {
    "text": "The results of clinical trials with enalkiren are encouraging . They suggest that renin inhibitors may be a safe and effective treatment for hypertension .",
    "triple_list": [
      [
        "enalkiren",
        "CPR:4",
        "renin"
      ]
    ],
    "updated": "Yes",
    "original": "The results of clinical trials with enalkiren are encouraging and suggest that renin inhibitors may be safe useful therapeutic agents in the management of hypertension",
    "simplified": "The results of clinical trials with enalkiren are encouraging. They suggest that renin inhibitors may be a safe and effective treatment for hypertension."
  },
  {
    "text": "Enalkiren has been shown to produce doserelated suppression of plasma renin activity PRA and angiotensin II when administered intravenously",
    "triple_list": [
      [
        "Enalkiren",
        "CPR:4",
        "renin"
      ],
      [
        "Enalkiren",
        "CPR:4",
        "angiotensin II"
      ]
    ],
    "updated": "No",
    "original": "Enalkiren has been shown to produce doserelated suppression of plasma renin activity PRA and angiotensin II when administered intravenously",
    "simplified": "Enalkiren has been shown to reduce the levels of angiotensin and renin in the blood when it is given intravenously."
  },
  {
    "text": "Also in contrast to effects of multiple METH injections 1 MDMA caused little or no decrease in binding of the DAT ligand WIN35428 and 2 neither prevention of hyperthermia nor prior depletion of DA prevented the MDMAinduced reduction in plasmalemmal DA transport",
    "triple_list": [
      [
        "METH",
        "CPR:4",
        "DAT"
      ],
      [
        "MDMA",
        "CPR:4",
        "DAT"
      ],
      [
        "DA",
        "CPR:9",
        "DAT"
      ],
      [
        "DA",
        "CPR:9",
        "DAT"
      ]
    ],
    "updated": "No",
    "original": "Also in contrast to effects of multiple METH injections 1 MDMA caused little or no decrease in binding of the DAT ligand WIN35428 and 2 neither prevention of hyperthermia nor prior depletion of DA prevented the MDMAinduced reduction in plasmalemmal DA transport",
    "simplified": "Also in contrast to effects of multiple METH injections 1 MDMA caused little or no decrease in binding of the DAT ligand WIN35428 and 2 The effects of multiple METH injections 1 and 2 on the DAT ligand WIN35428 and 2 were similar."
  },
  {
    "text": "In addition to affecting DAT function , MDMA rapidly decreased vesicular DA transport in striatal vesicles after treatment with it .",
    "triple_list": [
      [
        "DA",
        "CPR:9",
        "DAT"
      ]
    ],
    "updated": "Yes",
    "original": "In addition to affecting DAT function MDMA rapidly decreased vesicular DA transport as assessed in striatal vesicles prepared from treated rats",
    "simplified": "In addition to affecting DAT function, MDMA rapidly decreased vesicular DA transport in striatal vesicles after treatment with it."
  },
  {
    "text": "Concentrationdependent inhibitory effects of baicalin on the metabolism of dextromethorphan a dual probe of CYP2D and CYP3A in rats",
    "triple_list": [
      [
        "baicalin",
        "CPR:4",
        "CYP2D"
      ],
      [
        "baicalin",
        "CPR:4",
        "CYP3A"
      ],
      [
        "dextromethorphan",
        "CPR:9",
        "CYP2D"
      ],
      [
        "dextromethorphan",
        "CPR:9",
        "CYP3A"
      ]
    ],
    "updated": "No",
    "original": "Concentrationdependent inhibitory effects of baicalin on the metabolism of dextromethorphan a dual probe of CYP2D and CYP3A in rats",
    "simplified": "The concentrationdependent inhibitory effects of baicalin on CYP2D and CYP3A metabolism in rats and mice"
  },
  {
    "text": "The activity of CYP3A in the liver of rats after multiple treatment with baicalin was significantly reduced . The control group had no obvious effect on the activity of CYP2D after multiple doses of baicalin .",
    "triple_list": [
      [
        "CYP3A",
        "CPR:4",
        "baicalin"
      ]
    ],
    "updated": "Yes",
    "original": "The activity of CYP3A in excised liver samples from rats following multiple baicalin treatment was significantly decreased compared to that of the control group P005 whereas multiple doses of baicalin had no obvious effect on the activity of CYP2D",
    "simplified": "The activity of CYP3A in the liver of rats after multiple treatment with baicalin was significantly reduced. The control group had no obvious effect on the activity of CYP2D after multiple doses of baicalin."
  },
  {
    "text": "Together , these data show that baicalin inhibits DXM metabolism in rats in a concentration-dependent manner . This may be because it inhibits hepatic CYP2D and CYP3A activities .",
    "triple_list": [
      [
        "baicalin",
        "CPR:4",
        "CYP2D"
      ],
      [
        "baicalin",
        "CPR:4",
        "CYP3A"
      ],
      [
        "DXM",
        "CPR:9",
        "CYP2D"
      ],
      [
        "DXM",
        "CPR:9",
        "CYP3A"
      ]
    ],
    "updated": "Yes",
    "original": "Taken together these data demonstrate that baicalin inhibits the metabolism of DXM in a concentrationdependent manner in rats possibly through inhibiting hepatic CYP2D and CYP3A activities",
    "simplified": "Together, these data show that baicalin inhibits DXM metabolism in rats in a concentration-dependent manner. This may be because it inhibits hepatic CYP2D and CYP3A activities."
  },
  {
    "text": "In the current study we reveal the inhibitory effects of baicalin on the metabolism of dextromethorphan DXM a dual probe substrate of CYP2D and CYP3A in rats",
    "triple_list": [
      [
        "baicalin",
        "CPR:4",
        "CYP2D"
      ],
      [
        "baicalin",
        "CPR:4",
        "CYP3A"
      ],
      [
        "dextromethorphan",
        "CPR:9",
        "CYP2D"
      ],
      [
        "dextromethorphan",
        "CPR:9",
        "CYP3A"
      ],
      [
        "DXM",
        "CPR:9",
        "CYP2D"
      ],
      [
        "DXM",
        "CPR:9",
        "CYP3A"
      ]
    ],
    "updated": "No",
    "original": "In the current study we reveal the inhibitory effects of baicalin on the metabolism of dextromethorphan DXM a dual probe substrate of CYP2D and CYP3A in rats",
    "simplified": "In the current study, we showed that baicalin inhibits the metabolism of dextromethorphan in rats by interfering with its CYP2D and CYP3A function."
  },
  {
    "text": "LineweaverBurk plots showed that baicalin did not interfere with CYP2D and CYP3A in the liver , but it did not do anything at all .",
    "triple_list": [
      [
        "baicalin",
        "CPR:4",
        "CYP2D"
      ],
      [
        "baicalin",
        "CPR:4",
        "CYP3A"
      ]
    ],
    "updated": "Yes",
    "original": "LineweaverBurk plots demonstrated that baicalin inhibited the activities of CYP2D and CYP3A in a noncompetitive manner in rat liver microsomes RLMs",
    "simplified": "LineweaverBurk plots showed that baicalin did not interfere with CYP2D and CYP3A in the liver, but it did not do anything at all."
  },
  {
    "text": "Identification of a novel benzimidazole derivative as a highly potent NPY Y5 receptor antagonist with an antiobesity profile",
    "triple_list": [
      [
        "benzimidazole",
        "CPR:6",
        "NPY Y5 receptor"
      ]
    ],
    "updated": "No",
    "original": "Identification of a novel benzimidazole derivative as a highly potent NPY Y5 receptor antagonist with an antiobesity profile",
    "simplified": "A novel benzimidazole derivative with an antiobesity profile has been identified and is highly potent."
  },
  {
    "text": "We evaluated the clinical effectiveness of esmolol , an ultrashortacting beta 1adrenergic receptor blocking drug to control the increase in arterial blood pressure caused by electroconvulsive therapy ( ECT ) .",
    "triple_list": [
      [
        "esmolol",
        "CPR:4",
        "beta 1adrenergic receptor"
      ]
    ],
    "updated": "Yes",
    "original": "We evaluated the clinical effectiveness of esmolol an ultrashortacting beta 1adrenergic receptor blocking drug to control the sinus tachycardia and increase in arterial blood pressures induced by electroconvulsive therapy ECT",
    "simplified": "We evaluated the clinical effectiveness of esmolol, an ultrashortacting beta 1adrenergic receptor blocking drug to control the increase in arterial blood pressure caused by electroconvulsive therapy (ECT)."
  },
  {
    "text": "The beta2adrenoceptor beta2AR agonists clenbuterol and fenoterol have similar beneficial effects in animal models of heart failure",
    "triple_list": [
      [
        "beta2AR",
        "CPR:5",
        "clenbuterol"
      ],
      [
        "beta2adrenoceptor",
        "CPR:5",
        "clenbuterol"
      ],
      [
        "beta2AR",
        "CPR:5",
        "fenoterol"
      ],
      [
        "beta2adrenoceptor",
        "CPR:5",
        "fenoterol"
      ]
    ],
    "updated": "No",
    "original": "The beta2adrenoceptor beta2AR agonists clenbuterol and fenoterol have similar beneficial effects in animal models of heart failure",
    "simplified": "Clenbuterol and fenoterol have similar beneficial effects in animal models of heart failure and stroke."
  },
  {
    "text": "beta1Adrenoceptor antagonism 10 mg kg1 bisoprolol prevented 92 P 005 of apoptosis induced by all three agonists but clenbuterolinduced apoptosis could also be prevented by 96 P 005 by beta2AR antagonism 10 mg kg1 ICI 118 551",
    "triple_list": [
      [
        "beta1Adrenoceptor",
        "CPR:6",
        "bisoprolol"
      ]
    ],
    "updated": "No",
    "original": "beta1Adrenoceptor antagonism 10 mg kg1 bisoprolol prevented 92 P 005 of apoptosis induced by all three agonists but clenbuterolinduced apoptosis could also be prevented by 96 P 005 by beta2AR antagonism 10 mg kg1 ICI 118 551",
    "simplified": "10 mg kg1 bisoprolol prevented 92 P 005 of apoptosis induced by all three agonists but 96 P 005 by beta2AR antagonism could also be prevented by 10 mg kg1 ICI 118 551 However, this did not prevent programmed cell death."
  },
  {
    "text": "The mouse CYP2J subfamily includes members that have wide tissue distribution and are active in the metabolism of arachidonic acid AA linoleic acid LA and other lipids and xenobiotics",
    "triple_list": [
      [
        "CYP2J",
        "CPR:9",
        "arachidonic acid"
      ],
      [
        "CYP2J",
        "CPR:9",
        "linoleic acid"
      ]
    ],
    "updated": "No",
    "original": "The mouse CYP2J subfamily includes members that have wide tissue distribution and are active in the metabolism of arachidonic acid AA linoleic acid LA and other lipids and xenobiotics",
    "simplified": "The subfamily includes members that have wide tissue distribution and are active in the metabolism of other lipids and xenobiotics, as well as arachidonic acid."
  },
  {
    "text": "CPT I carnitine palmitoyltransferase I catalyzes the conversion of palmitoylCoA into palmitoylcarnitine in the presence of lcarnitine . This process is important for cell division .",
    "triple_list": [
      [
        "CPT I",
        "CPR:9",
        "palmitoylcarnitine"
      ],
      [
        "carnitine palmitoyltransferase I",
        "CPR:9",
        "palmitoylcarnitine"
      ],
      [
        "CPT I",
        "CPR:9",
        "palmitoylCoA"
      ],
      [
        "carnitine palmitoyltransferase I",
        "CPR:9",
        "palmitoylCoA"
      ]
    ],
    "updated": "Yes",
    "original": "CPT I carnitine palmitoyltransferase I catalyses the conversion of palmitoylCoA into palmitoylcarnitine in the presence of Lcarnitine facilitating the entry of fatty acids into mitochondria",
    "simplified": "CPT I carnitine palmitoyltransferase I catalyzes the conversion of palmitoylCoA into palmitoylcarnitine in the presence of lcarnitine. This process is important for cell division."
  },
  {
    "text": "Cholesterol uptake from lipoproteins intracellular vesicle transport and lipid transfer are also modified by oxysterols",
    "triple_list": [
      [
        "Cholesterol",
        "CPR:9",
        "lipoproteins"
      ]
    ],
    "updated": "No",
    "original": "Cholesterol uptake from lipoproteins intracellular vesicle transport and lipid transfer are also modified by oxysterols",
    "simplified": "The intracellular vesicle transport of cholesterol and the lipid transfer are also changed by oxysterols."
  },
  {
    "text": "In addition the new compound perviridicin B 2 three known rocaglate derivatives 9 11 12 and a known sesquiterpene 2oxaisodauc5en12al 17 showed significant NF\u03baB p65 inhibitory activity in an ELISA assay",
    "triple_list": [
      [
        "perviridicin B",
        "CPR:4",
        "NF\u03baB"
      ],
      [
        "perviridicin B",
        "CPR:4",
        "p65"
      ],
      [
        "rocaglate",
        "CPR:4",
        "NF\u03baB"
      ],
      [
        "rocaglate",
        "CPR:4",
        "p65"
      ],
      [
        "sesquiterpene",
        "CPR:4",
        "NF\u03baB"
      ],
      [
        "sesquiterpene",
        "CPR:4",
        "p65"
      ],
      [
        "2oxaisodauc5en12al",
        "CPR:4",
        "NF\u03baB"
      ],
      [
        "2oxaisodauc5en12al",
        "CPR:4",
        "p65"
      ]
    ],
    "updated": "No",
    "original": "In addition the new compound perviridicin B 2 three known rocaglate derivatives 9 11 12 and a known sesquiterpene 2oxaisodauc5en12al 17 showed significant NF\u03baB p65 inhibitory activity in an ELISA assay",
    "simplified": "In addition the new compound perviridicin B 2 and three known rocaglate derivatives 9 11 12 and a known sesquiterpene 2oxaisodauc5en12al 17 showed that they could not be used in this way."
  },
  {
    "text": "In further evaluation the representative compound NNdiethylN2Nmethyltetradecanamidoethylprop2en1aminium bromide 3b exhibited potent proapoptotic activity through RhoB activation in HeLa cells",
    "triple_list": [
      [
        "NNdiethylN2Nmethyltetradecanamidoethylprop2en1aminium bromide",
        "CPR:3",
        "RhoB"
      ]
    ],
    "updated": "No",
    "original": "In further evaluation the representative compound NNdiethylN2Nmethyltetradecanamidoethylprop2en1aminium bromide 3b exhibited potent proapoptotic activity through RhoB activation in HeLa cells",
    "simplified": "Further, the representative compound NNdiethylN2Nmethyltetradecanamidoethylprop2en1aminium bromide 3b was found to have potent proapoptotic activity in HeLa cells."
  },
  {
    "text": "These results suggest that epinastine acts as a 5HT1 agonist and inhibits noncholinergic contraction in guineapig airways through stimulation of a prejunctional 5HT1like receptor located to sensory nerves .",
    "triple_list": [
      [
        "epinastine",
        "CPR:3",
        "5HT1like receptor"
      ],
      [
        "epinastine",
        "CPR:5",
        "5HT1"
      ]
    ],
    "updated": "Yes",
    "original": "These results suggest that epinastine although identified as a 5HT antagonist acts as a 5HT1 agonist and that it inhibits the noncholinergic contraction in guineapig airways through stimulation of a prejunctional 5HT1like receptor located to sensory nerves",
    "simplified": "These results suggest that epinastine acts as a 5HT1 agonist and inhibits noncholinergic contraction in guineapig airways through stimulation of a prejunctional 5HT1like receptor located to sensory nerves."
  },
  {
    "text": "When the tissues were pretreated with 5HT1 and 5HT2 antagonists , methysergide 1 microM or methiothepin 01 microM , the noncholinergic effect of epinastine was significantly reduced .",
    "triple_list": [
      [
        "5HT1",
        "CPR:5",
        "epinastine"
      ],
      [
        "5HT2",
        "CPR:5",
        "epinastine"
      ],
      [
        "5HT1",
        "CPR:6",
        "methysergide"
      ],
      [
        "5HT2",
        "CPR:6",
        "methysergide"
      ],
      [
        "5HT1",
        "CPR:6",
        "methiothepin"
      ],
      [
        "5HT2",
        "CPR:6",
        "methiothepin"
      ]
    ],
    "updated": "Yes",
    "original": "Pretreatment of the tissues with combined 5HT1 5HT2 antagonists methysergide 1 microM or methiothepin 01 microM significantly attenuated the inhibitory effect of epinastine on the noncholinergic contraction",
    "simplified": "When the tissues were pretreated with 5HT1 and 5HT2 antagonists, methysergide 1 microM or methiothepin 01 microM, the noncholinergic effect of epinastine was significantly reduced."
  },
  {
    "text": "Pretreatment with tropisetron 1 microM a 5HT3 antagonist ketanserin 10 microM a 5HT2 antagonist thioperamide 10 microM a histamine H3 antagonist or phentolamine 10 microM an alphaadrenergic antagonist however had no effect",
    "triple_list": [
      [
        "tropisetron",
        "CPR:6",
        "5HT3"
      ],
      [
        "ketanserin",
        "CPR:6",
        "5HT2"
      ],
      [
        "thioperamide",
        "CPR:6",
        "histamine H3"
      ]
    ],
    "updated": "No",
    "original": "Pretreatment with tropisetron 1 microM a 5HT3 antagonist ketanserin 10 microM a 5HT2 antagonist thioperamide 10 microM a histamine H3 antagonist or phentolamine 10 microM an alphaadrenergic antagonist however had no effect",
    "simplified": "Pretreatment with tropisetron 1 microM a 5HT3 antagonist ketanserin 10 microM a histamine H3 antagonist or phentolamine 10 microM an alphaadrenergic antagonist however had no effect on the volunteers."
  },
  {
    "text": "Chlorpheniramine 10 microM , another histamine H1 receptor antagonist , had no effect on the eNANC , but it did have an effect on the 5HT receptor .",
    "triple_list": [
      [
        "Chlorpheniramine",
        "CPR:6",
        "histamine H1 receptor"
      ]
    ],
    "updated": "Yes",
    "original": "Chlorpheniramine 10 microM another histamine H1 receptor antagonist without significant 5HT receptor binding affinity did not produce any inhibition of the eNANC contraction",
    "simplified": "Chlorpheniramine 10 microM, another histamine H1 receptor antagonist, had no effect on the eNANC, but it did have an effect on the 5HT receptor."
  },
  {
    "text": "We observed a significant reduction in CSE induced luciferase expression NF\u03baB DNA binding I\u03baB\u03b5 degradation and cRel nuclear translocation in cells pretreated with vitamin C To further validate the result we examined subcellular distribution of cRel in lungs of CSexposed guinea pigs treated or untreated with vitamin C We showed that vitamin C treatment significantly reduced the amount of cRel in the lungs of CSexposed guinea pigs .",
    "triple_list": [
      [
        "cRel",
        "CPR:4",
        "vitamin C"
      ],
      [
        "I\u03baB\u03b5",
        "CPR:4",
        "vitamin C"
      ]
    ],
    "updated": "Yes",
    "original": "We observed a significant reduction in CSE induced luciferase expression NF\u03baB DNA binding I\u03baB\u03b5 degradation and cRel nuclear translocation in cells pretreated with vitamin C To further validate the result we examined subcellular distribution of cRel in lungs of CSexposed guinea pigs treated or untreated with vitamin C Result showed that vitamin C treatment resulted in markedly reduced cRel nuclear translocation",
    "simplified": "We observed a significant reduction in CSE induced luciferase expression NF\u03baB DNA binding I\u03baB\u03b5 degradation and cRel nuclear translocation in cells pretreated with vitamin C To further validate the result we examined subcellular distribution of cRel in lungs of CSexposed guinea pigs treated or untreated with vitamin C We showed that vitamin C treatment significantly reduced the amount of cRel in the lungs of CSexposed guinea pigs."
  },
  {
    "text": "All these results show that vitamin C prevents CSE and NF\u03baB from being activated . Therefore , vitamin C could be used to prevent inflammatory diseases .",
    "triple_list": [
      [
        "vitamin C",
        "CPR:4",
        "NF\u03baB"
      ]
    ],
    "updated": "Yes",
    "original": "All these results demonstrate that vitamin C prevents CSEinduced NF\u03baB activation and thus it could be used for the prevention of CSinduced inflammatory diseases",
    "simplified": "All these results show that vitamin C prevents CSE and NF\u03baB from being activated. Therefore, vitamin C could be used to prevent inflammatory diseases."
  },
  {
    "text": "It is possible that vitamin C an antioxidant may prevent cigarette smoke CSinduced NF\u03baB activation that involves degradation of I\u03baB\u03b5 and nuclear translocation of cRelp50 in alveolar epithelial cells",
    "triple_list": [
      [
        "vitamin C",
        "CPR:4",
        "NF\u03baB"
      ],
      [
        "vitamin C",
        "CPR:4",
        "I\u03baB\u03b5"
      ]
    ],
    "updated": "No",
    "original": "It is possible that vitamin C an antioxidant may prevent cigarette smoke CSinduced NF\u03baB activation that involves degradation of I\u03baB\u03b5 and nuclear translocation of cRelp50 in alveolar epithelial cells",
    "simplified": "It is possible that vitamin C an antioxidant may prevent cigarette smoke CSinduced I\u03baB\u03b5 and nuclear translocation of cRelp50 in alveolar epithelial cells from being released into the air."
  },
  {
    "text": "Vitamin C forestalls cigarette smoke induced NF\u03baB activation in alveolar epithelial cells",
    "triple_list": [
      [
        "Vitamin C",
        "CPR:4",
        "NF\u03baB"
      ]
    ],
    "updated": "No",
    "original": "Vitamin C forestalls cigarette smoke induced NF\u03baB activation in alveolar epithelial cells",
    "simplified": "Vitamin C blocks the effects of cigarette smoke on alveolar epithelial cells."
  },
  {
    "text": "Catalpol also suppressed AGEinduced phosphorylation of mitogen activated protein MAP kinases degradation of I\u03baB\u03b1 and the nuclear localization of NF\u03baB",
    "triple_list": [
      [
        "Catalpol",
        "CPR:4",
        "NF\u03baB"
      ],
      [
        "Catalpol",
        "CPR:4",
        "mitogen activated protein MAP kinases"
      ],
      [
        "Catalpol",
        "CPR:4",
        "I\u03baB\u03b1"
      ]
    ],
    "updated": "No",
    "original": "Catalpol also suppressed AGEinduced phosphorylation of mitogen activated protein MAP kinases degradation of I\u03baB\u03b1 and the nuclear localization of NF\u03baB",
    "simplified": "Catalpol also reduced the phosphorylation of mitogen-activated protein MAP kinases and the nuclear localization of NF\u03baB in the nucleus."
  },
  {
    "text": "In addition , the production of intracellular reactive oxygen species ( ROS ) caused by AGE was also reduced by catalpol treatment . This was because the treatment reduced NADPH oxidase activity .",
    "triple_list": [
      [
        "catalpol",
        "CPR:4",
        "NADPH oxidase"
      ]
    ],
    "updated": "Yes",
    "original": "Moreover the production of intracellular reactive oxygen species ROS elicited by AGE was also suppressed by catalpol treatment through dual action of reducing ROS itself and inhibiting NADPH oxidase activity",
    "simplified": "In addition, the production of intracellular reactive oxygen species (ROS) caused by AGE was also reduced by catalpol treatment. This was because the treatment reduced NADPH oxidase activity."
  },
  {
    "text": "Our results indicate that catalpol suppresses inflammation by inhibiting NF\u03baB activity and ROS production .",
    "triple_list": [
      [
        "catalpol",
        "CPR:4",
        "NF\u03baB"
      ]
    ],
    "updated": "Yes",
    "original": "Our findings indicate that catalpol suppresses AGEmediated inflammation by inhibiting ROS production and NF\u03baB activity",
    "simplified": "Our results indicate that catalpol suppresses inflammation by inhibiting NF\u03baB activity and ROS production."
  },
  {
    "text": "Catalpol reduced the expression of proinflammatory mediates such as monocyte chemotactic protein1 MCP1 tumor necrosis factor\u03b1 TNF\u03b1 inducible NO synthase iNOS and receptor for AGE RAGE",
    "triple_list": [
      [
        "Catalpol",
        "CPR:4",
        "monocyte chemotactic protein1"
      ],
      [
        "Catalpol",
        "CPR:4",
        "MCP1"
      ],
      [
        "Catalpol",
        "CPR:4",
        "tumor necrosis factor\u03b1"
      ],
      [
        "Catalpol",
        "CPR:4",
        "TNF\u03b1"
      ],
      [
        "Catalpol",
        "CPR:4",
        "inducible NO synthase"
      ],
      [
        "Catalpol",
        "CPR:4",
        "iNOS"
      ],
      [
        "Catalpol",
        "CPR:4",
        "receptor for AGE"
      ],
      [
        "Catalpol",
        "CPR:4",
        "RAGE"
      ]
    ],
    "updated": "No",
    "original": "Catalpol reduced the expression of proinflammatory mediates such as monocyte chemotactic protein1 MCP1 tumor necrosis factor\u03b1 TNF\u03b1 inducible NO synthase iNOS and receptor for AGE RAGE",
    "simplified": "Catalpol reduced the expression of certain proinflammatory mediates. These include monocyte chemotactic protein1 (MCP1), tumor necrosis factor (TNF), and iNOS."
  },
  {
    "text": "Promoter and electromobility shift studies showed that catalpol treatment significantly reduced NF\u03baB transcription , but not AP1 .",
    "triple_list": [
      [
        "NF\u03baB",
        "CPR:4",
        "catalpol"
      ]
    ],
    "updated": "Yes",
    "original": "Promoter and electromobility shift assays showed that transcriptional activation of NF\u03baB was significantly reduced by catalpol treatment while AP1 was not",
    "simplified": "Promoter and electromobility shift studies showed that catalpol treatment significantly reduced NF\u03baB transcription, but not AP1."
  },
  {
    "text": "Apoptosis studies showed that caspase 3 activity and DAPI staining were increased when MXF and VP16 were added .",
    "triple_list": [
      [
        "caspase 3",
        "CPR:3",
        "MXF"
      ],
      [
        "caspase 3",
        "CPR:3",
        "VP16"
      ],
      [
        "caspase 3",
        "CPR:3",
        "VP16"
      ]
    ],
    "updated": "Yes",
    "original": "Apoptosis studies DAPI staining and caspase 3 activity showed a marked increase in the presence of MXF and VP16 compared to VP16 alone",
    "simplified": "Apoptosis studies showed that caspase 3 activity and DAPI staining were increased when MXF and VP16 were added."
  },
  {
    "text": "In conclusion , the results suggest that the combined MXF VP16 treatment increased the reduction of topo II activity , probably due to an increase in the level of the DNAenzyme cleavable complexes formed by both drugs .",
    "triple_list": [
      [
        "topo II",
        "CPR:4",
        "MXF"
      ],
      [
        "topo II",
        "CPR:4",
        "VP16"
      ]
    ],
    "updated": "Yes",
    "original": "In conclusion the results suggest that the enhancement in the reduction of topo II activity by the combined MXF VP16 treatments was probably due to the increase in the level of the DNAenzyme cleavable complexes formed by both drugs",
    "simplified": "In conclusion, the results suggest that the combined MXF VP16 treatment increased the reduction of topo II activity, probably due to an increase in the level of the DNAenzyme cleavable complexes formed by both drugs."
  },
  {
    "text": "Etoposide VP16 is a topoisomeraseII topo II inhibitor chemotherapeutic agent",
    "triple_list": [
      [
        "Etoposide",
        "CPR:4",
        "topoisomeraseII"
      ],
      [
        "Etoposide",
        "CPR:4",
        "topo II"
      ],
      [
        "VP16",
        "CPR:4",
        "topoisomeraseII"
      ],
      [
        "VP16",
        "CPR:4",
        "topo II"
      ]
    ],
    "updated": "No",
    "original": "Etoposide VP16 is a topoisomeraseII topo II inhibitor chemotherapeutic agent",
    "simplified": "Etoposide VP16 is a chemical compound. It is a topoisomeraseII inhibitor."
  },
  {
    "text": "MXF or VP16 slightly affected cellular topo II activity in nuclear extracts from drug-treated cells . The combination increased inhibitory activity by reducing the number of bands in the cell .",
    "triple_list": [
      [
        "MXF",
        "CPR:4",
        "topo II"
      ],
      [
        "VP16",
        "CPR:4",
        "topo II"
      ]
    ],
    "updated": "Yes",
    "original": "MXF or VP16 slightly affected cellular topo II activity in nuclear extracts derived from drugtreated cells while the combination enhanced inhibitory activity and the reduction in band depletion of topo II",
    "simplified": "MXF or VP16 slightly affected cellular topo II activity in nuclear extracts from drug-treated cells. The combination increased inhibitory activity by reducing the number of bands in the cell."
  },
  {
    "text": "TAS102 currently undergoing clinical trials has been shown to work by two different ways . It can prevent TS and put it in the DNA .",
    "triple_list": [
      [
        "TAS102",
        "CPR:4",
        "TS"
      ]
    ],
    "updated": "Yes",
    "original": "TAS102 currently undergoing clinical trials has been demonstrated to have at least two mechanisms inhibition of TS and incorporation into DNA",
    "simplified": "TAS102 currently undergoing clinical trials has been shown to work by two different ways. It can prevent TS and put it in the DNA."
  },
  {
    "text": "The enzyme activity of thymidine kinase TK and thymidilate synthase TS was measured in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of TAS102 .",
    "triple_list": [
      [
        "thymidilate synthase",
        "CPR:4",
        "TAS102"
      ],
      [
        "TS",
        "CPR:4",
        "TAS102"
      ]
    ],
    "updated": "Yes",
    "original": "In the present study we measured the enzyme activity of thymidine kinase TK thymidine phosphorylase TP and thymidilate synthase TS in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of TAS102",
    "simplified": "The enzyme activity of thymidine kinase TK and thymidilate synthase TS was measured in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of TAS102."
  },
  {
    "text": "Because human immunodeficiency virus protease inhibitors saquinavir and ritonavir have already been used in clinical studies , we used these in vivo data to evaluate the in vitro results and the reliability of the models used as screening tools for forecasting the potential of firstpass intestinal metabolism changes .",
    "triple_list": [
      [
        "human immunodeficiency virus protease",
        "CPR:4",
        "saquinavir"
      ],
      [
        "human immunodeficiency virus protease",
        "CPR:4",
        "ritonavir"
      ]
    ],
    "updated": "Yes",
    "original": "Because clinical studies investigating interactions between garlic and human immunodeficiency virus protease inhibitors saquinavir and ritonavir have already been performed we used these in vivo data to evaluate the in vitro results and the reliability of the models employed as screening tools for forecasting the potential of firstpass intestinal metabolism changes",
    "simplified": "Because human immunodeficiency virus protease inhibitors saquinavir and ritonavir have already been used in clinical studies, we used these in vivo data to evaluate the in vitro results and the reliability of the models used as screening tools for forecasting the potential of firstpass intestinal metabolism changes."
  },
  {
    "text": "Labetalol or = 3 x 108 M and dilevalol or = 108 M caused surmountable antagonism of the isoprenaline responses of the atria and the pA2 values were 860 and 898 at the beta 1adrenoceptors of the rat left atria and 790 and 831 respectively on the guineapig left atria which has functional beta 1 and beta 2adrenoceptors",
    "triple_list": [
      [
        "isoprenaline",
        "CPR:5",
        "beta 1adrenoceptors"
      ],
      [
        "Labetalol",
        "CPR:6",
        "beta 1adrenoceptors"
      ],
      [
        "dilevalol",
        "CPR:6",
        "beta 1adrenoceptors"
      ]
    ],
    "updated": "No",
    "original": "Labetalol or = 3 x 108 M and dilevalol or = 108 M caused surmountable antagonism of the isoprenaline responses of the atria and the pA2 values were 860 and 898 at the beta 1adrenoceptors of the rat left atria and 790 and 831 respectively on the guineapig left atria which has functional beta 1 and beta 2adrenoceptors",
    "simplified": "The pA2 values were 860 and 898 at the beta 1adrenoceptors of the rat left atria and 790 and 831 respectively on the guineapig left atria. The pA2 values were 860 and 898 at the beta 1adrenoceptors of the rat left atria and 790 and 831 respectively on the guineapig left atria which has functional beta 1 and beta 2adrenoceptors"
  },
  {
    "text": "The isoprenaline response of the portal vein was inhibited by both labetalol and dilevalol at or = 107 M. The pA2 value for the labetalol at beta 2adrenoceptors was 759 .",
    "triple_list": [
      [
        "labetalol",
        "CPR:6",
        "beta 2adrenoceptors"
      ]
    ],
    "updated": "Yes",
    "original": "The isoprenaline attenuation responses of the portal vein were inhibited by labetalol and dilevalol both at or = 107 M and the pA2 value for the labetalol at beta 2adrenoceptors was 759",
    "simplified": "The isoprenaline response of the portal vein was inhibited by both labetalol and dilevalol at or = 107 M. The pA2 value for the labetalol at beta 2adrenoceptors was 759."
  },
  {
    "text": "It is concluded that labetalol and dilevalol are beta 1adrenoceptor selective antagonists",
    "triple_list": [
      [
        "labetalol",
        "CPR:6",
        "beta 1adrenoceptor"
      ],
      [
        "dilevalol",
        "CPR:6",
        "beta 1adrenoceptor"
      ]
    ],
    "updated": "No",
    "original": "It is concluded that labetalol and dilevalol are beta 1adrenoceptor selective antagonists",
    "simplified": "It has been shown that labetalol and dilevalol work against the beta-1adrenoceptor."
  },
  {
    "text": "PR mRNA abundance in both myometruim and leiomyomata center and marginal area was significantly decreased in 4 patients after treatment with mifepristone but not in the other 2 patients after treatment with RU486 .",
    "triple_list": [
      [
        "PR mRNA",
        "CPR:4",
        "mifepristone"
      ]
    ],
    "updated": "Yes",
    "original": "PR mRNA abundance in both myometruim and leiomyomata center and marginal area was significantly decreased in 4 patients continuing mifepristone treatment before the operation but not in the other 2 patients stopping RU486 1 month before operation",
    "simplified": "PR mRNA abundance in both myometruim and leiomyomata center and marginal area was significantly decreased in 4 patients after treatment with mifepristone but not in the other 2 patients after treatment with RU486."
  },
  {
    "text": "The action of mifepristone on the leiomyomata may be related to the expression of the PR gene , and thus to cell division .",
    "triple_list": [
      [
        "mifepristone",
        "CPR:4",
        "PR gene"
      ]
    ],
    "updated": "Yes",
    "original": "One of the mechanism of mifepristone action on decreasing leiomyomata volume may be related to suppression on expression of PR gene",
    "simplified": "The action of mifepristone on the leiomyomata may be related to the expression of the PR gene, and thus to cell division."
  },
  {
    "text": "The cystathionine gammalyase inhibitor DLpropargylglycine has been shown to cause cystathioninuria in rats .",
    "triple_list": [
      [
        "cystathionine gammalyase",
        "CPR:4",
        "DLpropargylglycine"
      ]
    ],
    "updated": "Yes",
    "original": "Experimental cystathioninuria was induced in rats by administration of the cystathionine gammalyase inhibitor DLpropargylglycine",
    "simplified": "The cystathionine gammalyase inhibitor DLpropargylglycine has been shown to cause cystathioninuria in rats."
  },
  {
    "text": "The nonselective adenosine receptor antagonist caffeine and the selective adenosine A1 receptor antagonist DPCPX injected 15 min before the application of pentetrazole and flumazenil were able to intensify BDZ withdrawal signs in mice",
    "triple_list": [
      [
        "adenosine receptor",
        "CPR:6",
        "caffeine"
      ],
      [
        "adenosine A1 receptor",
        "CPR:6",
        "DPCPX"
      ]
    ],
    "updated": "No",
    "original": "The nonselective adenosine receptor antagonist caffeine and the selective adenosine A1 receptor antagonist DPCPX injected 15 min before the application of pentetrazole and flumazenil were able to intensify BDZ withdrawal signs in mice",
    "simplified": "The nonselective adenosine receptor antagonist DPCPX and the selective adenosine A1 receptor antagonist DPCPX were able to make BDZ withdrawal signs worse in mice given the drug pentetrazole for 15 min."
  },
  {
    "text": "The concomitant application of subconvulsive dose of pentetrazole 550 mgkg with low dose of flumazenil 50 mgkg a BDZ receptor antagonist immediately induced BDZ withdrawal signs in these animals",
    "triple_list": [
      [
        "flumazenil",
        "CPR:6",
        "BDZ receptor"
      ]
    ],
    "updated": "No",
    "original": "The concomitant application of subconvulsive dose of pentetrazole 550 mgkg with low dose of flumazenil 50 mgkg a BDZ receptor antagonist immediately induced BDZ withdrawal signs in these animals",
    "simplified": "When a subconvulsive dose of pentetrazole 550 mgkg was given to the animals, a low dose of flumazenil 50 mgkg was given at the same time. This caused BDZ withdrawal signs."
  },
  {
    "text": "Here we show that one BLT 12methoxyphenyl3naphthalen2ylurea BLT4 blocked ABCA1 mediated cholesterol efflux to lipidpoor apoAI approximately 5560 microM/O . This is similar to what SRBI IC50 does .",
    "triple_list": [
      [
        "BLT4",
        "CPR:4",
        "ABCA1"
      ],
      [
        "BLT4",
        "CPR:4",
        "SRBI"
      ],
      [
        "BLT",
        "CPR:4",
        "ABCA1"
      ],
      [
        "BLT",
        "CPR:4",
        "SRBI"
      ],
      [
        "12methoxyphenyl3naphthalen2ylurea",
        "CPR:4",
        "ABCA1"
      ],
      [
        "12methoxyphenyl3naphthalen2ylurea",
        "CPR:4",
        "SRBI"
      ],
      [
        "ABCA1",
        "CPR:9",
        "cholesterol"
      ]
    ],
    "updated": "Yes",
    "original": "Here we show that one BLT 12methoxyphenyl3naphthalen2ylurea BLT4 blocked ABCA1 mediated cholesterol efflux to lipidpoor apoAI at a potency similar to that for its inhibition of SRBI IC50 approximately 5560 microM",
    "simplified": "Here we show that one BLT 12methoxyphenyl3naphthalen2ylurea BLT4 blocked ABCA1 mediated cholesterol efflux to lipidpoor apoAI approximately 5560 microM/O. This is similar to what SRBI IC50 does."
  },
  {
    "text": "Reciprocally glyburide blocked SRBI mediated selective lipid uptake and efflux approximately 275300 microM at a potency similar to that for ABCA1 IC50 .",
    "triple_list": [
      [
        "glyburide",
        "CPR:4",
        "ABCA1"
      ],
      [
        "glyburide",
        "CPR:4",
        "SRBI"
      ]
    ],
    "updated": "Yes",
    "original": "Reciprocally glyburide blocked SRBI mediated selective lipid uptake and efflux at a potency similar to that for its inhibition of ABCA1 IC50 approximately 275300 microM",
    "simplified": "Reciprocally glyburide blocked SRBI mediated selective lipid uptake and efflux approximately 275300 microM at a potency similar to that for ABCA1 IC50."
  },
  {
    "text": "Crossinhibition of SRBI and ABCA1 mediated cholesterol transport by the small molecules BLT4 and glyburide",
    "triple_list": [
      [
        "SRBI",
        "CPR:4",
        "glyburide"
      ],
      [
        "ABCA1",
        "CPR:4",
        "glyburide"
      ],
      [
        "SRBI",
        "CPR:9",
        "cholesterol"
      ],
      [
        "ABCA1",
        "CPR:9",
        "cholesterol"
      ]
    ],
    "updated": "No",
    "original": "Crossinhibition of SRBI and ABCA1 mediated cholesterol transport by the small molecules BLT4 and glyburide",
    "simplified": "Cholesterol transport by the small molecules BLT4 and glyburide is inhibited by SRBI."
  },
  {
    "text": "The fact that BLT4 and glyburide can also inhibit SRBI and ABCA1 suggests that these proteins may share similar or common steps in their lipid transport .",
    "triple_list": [
      [
        "SRBI",
        "CPR:4",
        "glyburide"
      ],
      [
        "ABCA1",
        "CPR:4",
        "glyburide"
      ]
    ],
    "updated": "Yes",
    "original": "The reciprocal inhibition of SRBI and ABCA1 by BLT4 and glyburide raises the possibility that these proteins may share similar or common steps in their mechanisms of lipid transport",
    "simplified": "The fact that BLT4 and glyburide can also inhibit SRBI and ABCA1 suggests that these proteins may share similar or common steps in their lipid transport."
  },
  {
    "text": "The activities of ABCA1 and other ATP binding cassette superfamily members are blocked by the drug glyburide . Small molecule inhibitors called BLTs stop these activities .",
    "triple_list": [
      [
        "ABCA1",
        "CPR:4",
        "glyburide"
      ],
      [
        "ATP binding cassette superfamily",
        "CPR:4",
        "glyburide"
      ]
    ],
    "updated": "Yes",
    "original": "The activities of ABCA1 and other ATP binding cassette superfamily members are inhibited by the drug glyburide and SRBImediated lipid transport is blocked by small molecule inhibitors called BLTs",
    "simplified": "The activities of ABCA1 and other ATP binding cassette superfamily members are blocked by the drug glyburide. Small molecule inhibitors called BLTs stop these activities."
  },
  {
    "text": "SRBI is a receptor that binds HDL with high affinity and mediates both the selective lipid uptake of cholesteryl esters from lipidrich HDL to cells and the efflux of unesterified cholesterol from cells to HDL",
    "triple_list": [
      [
        "SRBI",
        "CPR:9",
        "cholesteryl esters"
      ],
      [
        "SRBI",
        "CPR:9",
        "cholesterol"
      ]
    ],
    "updated": "No",
    "original": "SRBI is a receptor that binds HDL with high affinity and mediates both the selective lipid uptake of cholesteryl esters from lipidrich HDL to cells and the efflux of unesterified cholesterol from cells to HDL",
    "simplified": "The SRBI is a receptor that binds HDL with high affinity and mediates both the uptake of lipid by HDL-rich cells and the efflux of unesterified cholesterol from cells to HDL-rich cells."
  },
  {
    "text": "ABCA1 causes cholesterol and phospholipids to move from the heart to other parts of the body . AI apoAI",
    "triple_list": [
      [
        "ABCA1",
        "CPR:9",
        "cholesterol"
      ]
    ],
    "updated": "Yes",
    "original": "ABCA1 mediates the efflux of unesterified cholesterol and phospholipids from cells to lipidpoor apolipoprotein AI apoAI",
    "simplified": "ABCA1 causes cholesterol and phospholipids to move from the heart to other parts of the body. AI apoAI"
  },
  {
    "text": "The treatment of mice with FeNTA alone increased ornithine decarboxylase activity to 46 folds , DNA synthesis increased up to 29 folds and antioxidants and antioxidant enzymes decreased to 1825 folds compared with the corresponding salinetreated controls . The effect of FeNTA on ornithine decarboxylase activity is not known .",
    "triple_list": [
      [
        "FeNTA",
        "CPR:3",
        "ornithine decarboxylase"
      ]
    ],
    "updated": "Yes",
    "original": "The treatment of mice with FeNTA alone enhances ornithine decarboxylase activity to 46 folds protein carbonyl formation increased up to 29 folds and DNA synthesis expressed in terms of 3H thymidine incorporation increased to 32 folds and antioxidants and antioxidant enzymes decreased to 1825 folds compared with the corresponding salinetreated controls",
    "simplified": "The treatment of mice with FeNTA alone increased ornithine decarboxylase activity to 46 folds, DNA synthesis increased up to 29 folds and antioxidants and antioxidant enzymes decreased to 1825 folds compared with the corresponding salinetreated controls. The effect of FeNTA on ornithine decarboxylase activity is not known."
  },
  {
    "text": "Exposure to PAHs their metabolites and ROS further increase AKRs isoform expression that may amplify oxidative damage",
    "triple_list": [
      [
        "PAHs",
        "CPR:3",
        "AKRs"
      ]
    ],
    "updated": "No",
    "original": "Exposure to PAHs their metabolites and ROS further increase AKRs isoform expression that may amplify oxidative damage",
    "simplified": "Exposure to PAHs and their metabolites increases the expression of the AKR isoform, which can cause damage."
  },
  {
    "text": "Aldoketo reductases AKRs work with a wide range of substrates , including polycyclic aromatic hydrocarbons ( PAHs ) , reactive oxygen species ( ROS ) , and oquinones to produce a wide range of metabolites .",
    "triple_list": [
      [
        "Aldoketo reductases",
        "CPR:9",
        "polycyclic aromatic hydrocarbons"
      ],
      [
        "AKRs",
        "CPR:9",
        "polycyclic aromatic hydrocarbons"
      ],
      [
        "Aldoketo reductases",
        "CPR:9",
        "PAHs"
      ],
      [
        "AKRs",
        "CPR:9",
        "PAHs"
      ],
      [
        "Aldoketo reductases",
        "CPR:9",
        "oquinones"
      ],
      [
        "AKRs",
        "CPR:9",
        "oquinones"
      ],
      [
        "Aldoketo reductases",
        "CPR:9",
        "oxygen"
      ],
      [
        "AKRs",
        "CPR:9",
        "oxygen"
      ]
    ],
    "updated": "Yes",
    "original": "Aldoketo reductases AKRs metabolize a wide range of substrates including polycyclic aromatic hydrocarbons PAHs generating metabolites oquinones and reactive oxygen species ROS which are capable of initiating and promoting carcinogenesis",
    "simplified": "Aldoketo reductases AKRs work with a wide range of substrates, including polycyclic aromatic hydrocarbons (PAHs), reactive oxygen species (ROS), and oquinones to produce a wide range of metabolites."
  },
  {
    "text": "Although AKRs are important in the metabolism of PAHs , there are no studies that look at how AKRs are affected by PAHs in general human populations .",
    "triple_list": [
      [
        "AKRs",
        "CPR:9",
        "PAHs"
      ]
    ],
    "updated": "Yes",
    "original": "Despite the importance of AKRs in PAHs metabolism there are no studies that evaluate in general human populations the effect of PAHs on AKRs expression in peripheral blood lymphocytes PBLs",
    "simplified": "Although AKRs are important in the metabolism of PAHs, there are no studies that look at how AKRs are affected by PAHs in general human populations."
  },
  {
    "text": "The pretreatment with 20 mg L1 LaIII could alleviate the effects of UVB radiation on the activities of nitrate reductase glutamine synthetase glutamate synthase and glutamate dehydrogenase promoting amino acid conversion and protein synthesis in soybean seedlings",
    "triple_list": [
      [
        "LaIII",
        "CPR:4",
        "nitrate reductase"
      ],
      [
        "LaIII",
        "CPR:4",
        "glutamine synthetase"
      ],
      [
        "LaIII",
        "CPR:4",
        "glutamate synthase"
      ],
      [
        "LaIII",
        "CPR:4",
        "glutamate dehydrogenase"
      ]
    ],
    "updated": "No",
    "original": "The pretreatment with 20 mg L1 LaIII could alleviate the effects of UVB radiation on the activities of nitrate reductase glutamine synthetase glutamate synthase and glutamate dehydrogenase promoting amino acid conversion and protein synthesis in soybean seedlings",
    "simplified": "The pretreatment with 20 mg L1 LaIII could reduce the effects of UVB radiation on the activities of glutamine synthetase, nitrate reductase, and glutamate dehydrogenase when soybean seedlings were exposed to it for a short time."
  },
  {
    "text": "Based on recent reports that the small molecules isatin and phthalimide are suitable scaffolds for the design of high potency monoamine oxidase MAO inhibitors , a series of phthalide 2benzofuran13Hone analogues has been developed .",
    "triple_list": [
      [
        "isatin",
        "CPR:4",
        "monoamine oxidase"
      ],
      [
        "isatin",
        "CPR:4",
        "MAO"
      ],
      [
        "phthalimide",
        "CPR:4",
        "monoamine oxidase"
      ],
      [
        "phthalimide",
        "CPR:4",
        "MAO"
      ],
      [
        "MAO",
        "CPR:4",
        "phthalide"
      ],
      [
        "MAO",
        "CPR:4",
        "2benzofuran13Hone"
      ]
    ],
    "updated": "Yes",
    "original": "Based on recent reports that the small molecules isatin and phthalimide are suitable scaffolds for the design of high potency monoamine oxidase MAO inhibitors the present study examines the MAO inhibitory properties of a series of phthalide 2benzofuran13Hone analogues",
    "simplified": "Based on recent reports that the small molecules isatin and phthalimide are suitable scaffolds for the design of high potency monoamine oxidase MAO inhibitors, a series of phthalide 2benzofuran13Hone analogues has been developed."
  },
  {
    "text": "In most instances C6substituted phthalides exhibit MAOB specific inhibition",
    "triple_list": [
      [
        "phthalides",
        "CPR:4",
        "MAOB"
      ]
    ],
    "updated": "No",
    "original": "In most instances C6substituted phthalides exhibit MAOB specific inhibition",
    "simplified": "In most cases, C6substituted phthalides do not work as well."
  },
  {
    "text": "The general order of potency was CF3 I Br Cl F CH3 H. The results also show that the binding modes of representative phthalides are reversible and competitive at both MAO isoforms Among a series of 6benzyloxyphthalides bearing substituents on the para position of the phenyl ring .",
    "triple_list": [
      [
        "phthalides",
        "CPR:4",
        "MAO"
      ]
    ],
    "updated": "Yes",
    "original": "Among a series of 6benzyloxyphthalides bearing substituents on the para position of the phenyl ring the general order of potency was CF3 I Br Cl F CH3 H The results also show that the binding modes of representative phthalides are reversible and competitive at both MAO isoforms",
    "simplified": "The general order of potency was CF3 I Br Cl F CH3 H. The results also show that the binding modes of representative phthalides are reversible and competitive at both MAO isoforms Among a series of 6benzyloxyphthalides bearing substituents on the para position of the phenyl ring."
  },
  {
    "text": "Inhibition of monoamine oxidase by phthalide analogues",
    "triple_list": [
      [
        "monoamine oxidase",
        "CPR:4",
        "phthalide"
      ]
    ],
    "updated": "No",
    "original": "Inhibition of monoamine oxidase by phthalide analogues",
    "simplified": "Phthalide analogues can inhibit monoamine oxidase."
  },
  {
    "text": "The binding of the agonist angiotensin II AngII and inverse agonist losartan in wild-type AT1R changed the reporter cysteines . The ligandspecific lid conformations of ECL2 were also changed .",
    "triple_list": [
      [
        "losartan",
        "CPR:5",
        "AT1R"
      ]
    ],
    "updated": "Yes",
    "original": "Binding of the agonist angiotensin II AngII and inverse agonist losartan in wildtype AT1R changed the accessibility of reporter cysteines and the pattern was consistent with ligandspecific lid conformations of ECL2",
    "simplified": "The binding of the agonist angiotensin II AngII and inverse agonist losartan in wild-type AT1R changed the reporter cysteines. The ligandspecific lid conformations of ECL2 were also changed."
  },
  {
    "text": "TAS102 is a novel drug containing trifluorothymidine which is phosphorylated by TK1 to its active monophosphated form that in turn can inhibit TS",
    "triple_list": [
      [
        "TAS102",
        "CPR:4",
        "TS"
      ],
      [
        "TAS102",
        "CPR:9",
        "TK1"
      ],
      [
        "trifluorothymidine",
        "CPR:9",
        "TK1"
      ]
    ],
    "updated": "No",
    "original": "TAS102 is a novel drug containing trifluorothymidine which is phosphorylated by TK1 to its active monophosphated form that in turn can inhibit TS",
    "simplified": "TAS102 is a novel drug. It contains trifluorothymidine. TK1 changes the trifluorothymidine into an active monophosphated form."
  },
  {
    "text": "Thymidine kinase1 TK1 and thymidylate synthase TS are key enzymes for salvage and de novo pyrimidine synthesis respectively",
    "triple_list": [
      [
        "Thymidine kinase1",
        "CPR:9",
        "pyrimidine"
      ],
      [
        "TK1",
        "CPR:9",
        "pyrimidine"
      ],
      [
        "thymidylate synthase",
        "CPR:9",
        "pyrimidine"
      ],
      [
        "TS",
        "CPR:9",
        "pyrimidine"
      ]
    ],
    "updated": "No",
    "original": "Thymidine kinase1 TK1 and thymidylate synthase TS are key enzymes for salvage and de novo pyrimidine synthesis respectively",
    "simplified": "Thymidine kinase1 (TK1) and thymidylate synthase TS (TS) are two important enzymes in the body."
  },
  {
    "text": "The pyrimidine synthetic enzymes thymidine kinase1 and thymidylate synthase are important in the immune system .",
    "triple_list": [
      [
        "pyrimidine",
        "CPR:9",
        "thymidine kinase1"
      ],
      [
        "pyrimidine",
        "CPR:9",
        "thymidylate synthase"
      ]
    ],
    "updated": "Yes",
    "original": "Immunohistochemical characterization of pyrimidine synthetic enzymes thymidine kinase1 and thymidylate synthase in various types of cancer",
    "simplified": "The pyrimidine synthetic enzymes thymidine kinase1 and thymidylate synthase are important in the immune system."
  },
  {
    "text": "Gastrointestinal adenocarcinomas and squamous cell uterine carcinomas were often accompanied by high TS expression . This means that pyrimidine synthesis was probably involved .",
    "triple_list": [
      [
        "TS",
        "CPR:9",
        "pyrimidine"
      ]
    ],
    "updated": "Yes",
    "original": "Gastrointestinal adenocarcinomas and squamous cell uterine carcinomas were often accompanied by high TS expression indicating activation of pyrimidine synthesis through both the salvage and de novo pathways",
    "simplified": "Gastrointestinal adenocarcinomas and squamous cell uterine carcinomas were often accompanied by high TS expression. This means that pyrimidine synthesis was probably involved."
  },
  {
    "text": "The 5HT contractions were inhibited by ketanserin and alosetron . This shows that 5HT2A and 5HT3 are involved .",
    "triple_list": [
      [
        "ketanserin",
        "CPR:4",
        "5HT2A"
      ],
      [
        "alosetron",
        "CPR:4",
        "5HT3"
      ]
    ],
    "updated": "Yes",
    "original": "The contractions to 5HT were inhibited by ketanserin and alosetron indicating involvement of 5HT2A and 5HT3 receptors respectively",
    "simplified": "The 5HT contractions were inhibited by ketanserin and alosetron. This shows that 5HT2A and 5HT3 are involved."
  },
  {
    "text": "Regarding urease inhibition , nbutanol was the most effective part IC50",
    "triple_list": [
      [
        "urease",
        "CPR:4",
        "nbutanol"
      ]
    ],
    "updated": "Yes",
    "original": "Regarding urease inhibition nbutanol was the most potent fraction IC50 97 \u00b5gmL",
    "simplified": "Regarding urease inhibition, nbutanol was the most effective part IC50"
  },
  {
    "text": "The current US military and civilian oxime countermeasure 2hydroxyiminomethyl1methylpyridin1ium chloride 2PAM is under consideration for replacement with a more effective acetylcholinesterase reactivator 11methylenebis4hydroxyiminomethylpyridinium dimethanesulfonate MMB4",
    "triple_list": [
      [
        "acetylcholinesterase",
        "CPR:3",
        "11methylenebis4hydroxyiminomethylpyridinium dimethanesulfonate"
      ],
      [
        "acetylcholinesterase",
        "CPR:3",
        "MMB4"
      ]
    ],
    "updated": "No",
    "original": "The current US military and civilian oxime countermeasure 2hydroxyiminomethyl1methylpyridin1ium chloride 2PAM is under consideration for replacement with a more effective acetylcholinesterase reactivator 11methylenebis4hydroxyiminomethylpyridinium dimethanesulfonate MMB4",
    "simplified": "The current US military and civilian oxime countermeasure 2hydroxyiminomethyl1methylpyridin1ium chloride 2PAM is not as effective as a more effective acetylcholinesterase reactivator, but it is still used by the military."
  },
  {
    "text": "Methylationspecific PCR and bisulfite sequencing identified methylation of this CpG mCpG island of the glut3 gene . The frequency of methylation increased 25fold with advancing postnatal age , and with a 16fold increase in DNA methyl transferase 3a .",
    "triple_list": [
      [
        "CpG",
        "CPR:3",
        "DNA methyl transferase 3a"
      ],
      [
        "mCpG",
        "CPR:3",
        "DNA methyl transferase 3a"
      ]
    ],
    "updated": "Yes",
    "original": "Methylationspecific PCR and bisulfite sequencing identified methylation of this CpG mCpG island of the glut3 gene frequency of methylation increasing 25fold with a 16fold increase in DNA methyl transferase 3a concentrations noted with advancing postnatal age PN14 vs PN3",
    "simplified": "Methylationspecific PCR and bisulfite sequencing identified methylation of this CpG mCpG island of the glut3 gene. The frequency of methylation increased 25fold with advancing postnatal age, and with a 16fold increase in DNA methyl transferase 3a."
  },
  {
    "text": "5flanking region of glut3luciferase reporter transient transfection in HT22 hippocampal neurons showed that mCpGs reduce the expression of glut3 .",
    "triple_list": [
      [
        "glut3",
        "CPR:4",
        "mCpGs"
      ]
    ],
    "updated": "Yes",
    "original": "5flanking region of glut3luciferase reporter transient transfection in HT22 hippocampal neurons demonstrated that mCpGs inhibit glut3 transcription",
    "simplified": "5flanking region of glut3luciferase reporter transient transfection in HT22 hippocampal neurons showed that mCpGs reduce the expression of glut3."
  },
  {
    "text": "Separate 5aza2deoxycytidine pretreatment or in combination with trichostatin A reduced mCpG and specific small interference RNAs targeting Mecp2 and Creb1 separately or together depleting Mecp2 andor Creb1 binding of glut3mCpGs reduced glut3 expression in HT22 cells",
    "triple_list": [
      [
        "5aza2deoxycytidine",
        "CPR:4",
        "Mecp2"
      ],
      [
        "5aza2deoxycytidine",
        "CPR:4",
        "Creb1"
      ],
      [
        "trichostatin A",
        "CPR:4",
        "Mecp2"
      ],
      [
        "trichostatin A",
        "CPR:4",
        "Creb1"
      ]
    ],
    "updated": "No",
    "original": "Separate 5aza2deoxycytidine pretreatment or in combination with trichostatin A reduced mCpG and specific small interference RNAs targeting Mecp2 and Creb1 separately or together depleting Mecp2 andor Creb1 binding of glut3mCpGs reduced glut3 expression in HT22 cells",
    "simplified": "Trichostatin A reduced mCpG and specific small interference RNAs targeting Mecp2 and Creb1 separately or together reduced glut3 expression in HT22 cells. 5aza2deoxycytidine reduced mCpG and specific small interference RNAs targeting Mecp2 and Creb1."
  },
  {
    "text": "A pronounced NET knockoutinduced shortening of the immobility time in the TST by ca 50 compared to WT mice was not reduced any further by NET inhibiting ADs such as reboxetine desipramine and imipramine",
    "triple_list": [
      [
        "NET",
        "CPR:4",
        "reboxetine"
      ],
      [
        "NET",
        "CPR:4",
        "desipramine"
      ],
      [
        "NET",
        "CPR:4",
        "imipramine"
      ]
    ],
    "updated": "No",
    "original": "A pronounced NET knockoutinduced shortening of the immobility time in the TST by ca 50 compared to WT mice was not reduced any further by NET inhibiting ADs such as reboxetine desipramine and imipramine",
    "simplified": "A pronounced shortening of the immobility time by ca 50 compared to WT mice was not reduced any further by NET inhibiting ADs such as imipramine or reboxetine."
  },
  {
    "text": "In conclusion of the seven NSAIDs investigated niflumic acid was the most potent inhibitor of recombinant UGT1A9 via 4MUG in a competitive manner",
    "triple_list": [
      [
        "niflumic acid",
        "CPR:4",
        "UGT1A9"
      ]
    ],
    "updated": "No",
    "original": "In conclusion of the seven NSAIDs investigated niflumic acid was the most potent inhibitor of recombinant UGT1A9 via 4MUG in a competitive manner",
    "simplified": "Niflumic acid was the most potent inhibitor of recombinant UGT1A9 via 4MUG in a competitive manner of the seven NSAIDs investigated."
  },
  {
    "text": "In vitro inhibitory effects of nonsteroidal antiinflammatory drugs on 4methylumbelliferone glucuronidation in recombinant human UDPglucuronosyltransferase 1A9 potent inhibition by niflumic acid",
    "triple_list": [
      [
        "human UDPglucuronosyltransferase 1A9",
        "CPR:4",
        "niflumic acid"
      ]
    ],
    "updated": "No",
    "original": "In vitro inhibitory effects of nonsteroidal antiinflammatory drugs on 4methylumbelliferone glucuronidation in recombinant human UDPglucuronosyltransferase 1A9 potent inhibition by niflumic acid",
    "simplified": "In vitro inhibitory effects of nonsteroidal antiinflammatory drugs on UDPglucuronosyltransferase 1A9 potent inhibition by niflumic acid in recombinant human UDPglucuronosyltransferase"
  },
  {
    "text": "MNU induced lesions presented markers indicative of an aggressive phenotype loss of Ecadherin and high MGMT staining MNU induced lesions presented markers indicative of an aggressive phenotype .",
    "triple_list": [
      [
        "MNU",
        "CPR:3",
        "MGMT"
      ],
      [
        "MNU",
        "CPR:4",
        "Ecadherin"
      ]
    ],
    "updated": "Yes",
    "original": "MNU induced lesions presented markers indicative of an aggressive phenotype lack of basal cells rupture of the smooth muscle cell layer loss of Ecadherin and high MGMT staining",
    "simplified": "MNU induced lesions presented markers indicative of an aggressive phenotype loss of Ecadherin and high MGMT staining MNU induced lesions presented markers indicative of an aggressive phenotype."
  },
  {
    "text": "The treatment with arsenic exhibited a significant increase in some serum hepatic and renal biochemical parameters alanine aminotransferase aspartate aminotransferase alkaline phosphatase total protein albumin bilirubin cholesterol urea and creatinine",
    "triple_list": [
      [
        "arsenic",
        "CPR:3",
        "alanine aminotransferase"
      ],
      [
        "arsenic",
        "CPR:3",
        "aspartate aminotransferase"
      ],
      [
        "arsenic",
        "CPR:3",
        "alkaline phosphatase"
      ],
      [
        "arsenic",
        "CPR:3",
        "albumin"
      ]
    ],
    "updated": "No",
    "original": "The treatment with arsenic exhibited a significant increase in some serum hepatic and renal biochemical parameters alanine aminotransferase aspartate aminotransferase alkaline phosphatase total protein albumin bilirubin cholesterol urea and creatinine",
    "simplified": "The treatment with arsenic showed a significant increase in some serum biochemical parameters alanine total protein albumin bilirubin cholesterol urea creatinine alanine aminotransferase aspartate alkaline phosphatase creatinine"
  },
  {
    "text": "However recent clinical studies have shown that a single lowdose injection of ketamine an Nmethyl daspartate receptor NMDAR antagonist has rapid antidepressant effects that are observed within hours and are long lasting",
    "triple_list": [
      [
        "ketamine",
        "CPR:6",
        "Nmethyl daspartate receptor"
      ],
      [
        "ketamine",
        "CPR:6",
        "NMDAR"
      ]
    ],
    "updated": "No",
    "original": "However recent clinical studies have shown that a single lowdose injection of ketamine an Nmethyl daspartate receptor NMDAR antagonist has rapid antidepressant effects that are observed within hours and are long lasting",
    "simplified": "However, recent clinical studies have shown that a single lowdose injection of ketamine has rapid antidepressant effects. These effects are seen within hours and are long lasting."
  },
  {
    "text": "The slower CL was due to the reduction of doxorubicin and hepatic CYP3A subfamilymediated metabolism . 670 decrease and hepatic biliary excretion .",
    "triple_list": [
      [
        "CYP3A",
        "CPR:9",
        "doxorubicin"
      ]
    ],
    "updated": "Yes",
    "original": "The slower CL was due to the reduction of hepatic biliary excretion 670 decrease and hepatic CYP3A subfamilymediated metabolism 219 decrease of doxorubicin",
    "simplified": "The slower CL was due to the reduction of doxorubicin and hepatic CYP3A subfamilymediated metabolism. 670 decrease and hepatic biliary excretion."
  },
  {
    "text": "Doxorubicin is mainly excreted into the bile via Pglycoprotein Pgp and multidrug resistanceassociated protein 2 Mrp2 in hepatobiliary route and metabolized via cytochrome P450 CYP 3A subfamily",
    "triple_list": [
      [
        "Doxorubicin",
        "CPR:9",
        "Pglycoprotein"
      ],
      [
        "Doxorubicin",
        "CPR:9",
        "Pgp"
      ],
      [
        "Doxorubicin",
        "CPR:9",
        "multidrug resistanceassociated protein 2"
      ],
      [
        "Doxorubicin",
        "CPR:9",
        "Mrp2"
      ],
      [
        "Doxorubicin",
        "CPR:9",
        "cytochrome P450 CYP 3A"
      ]
    ],
    "updated": "No",
    "original": "Doxorubicin is mainly excreted into the bile via Pglycoprotein Pgp and multidrug resistanceassociated protein 2 Mrp2 in hepatobiliary route and metabolized via cytochrome P450 CYP 3A subfamily",
    "simplified": "Doxorubicin is mainly excreted into the bile by the liver through the hepatobiliary route. It is metabolized by the cytochrome P450 CYP 3A subfamily in the liver."
  },
  {
    "text": "Interestingly ursolic acid increased the phosphorylation of AMPK and coenzyme A carboxylase but decreased the phosphorylation of AKT and mTOR in HepG2 cells . It also increased the phosphorylation of GSK3\u03b2 at inactive form serine 9 .",
    "triple_list": [
      [
        "ursolic acid",
        "CPR:3",
        "AMPK"
      ],
      [
        "ursolic acid",
        "CPR:3",
        "coenzyme A carboxylase"
      ],
      [
        "ursolic acid",
        "CPR:3",
        "GSK3\u03b2"
      ],
      [
        "ursolic acid",
        "CPR:4",
        "AKT"
      ],
      [
        "ursolic acid",
        "CPR:4",
        "mTOR"
      ]
    ],
    "updated": "Yes",
    "original": "Interestingly ursolic acid increased the phosphorylation of AMPK and coenzyme A carboxylase and also enhanced phosphorylation of GSK3\u03b2 at inactive form serine 9 whereas ursolic acid attenuated the phosphorylation of AKT and mTOR in HepG2 cells",
    "simplified": "Interestingly ursolic acid increased the phosphorylation of AMPK and coenzyme A carboxylase but decreased the phosphorylation of AKT and mTOR in HepG2 cells. It also increased the phosphorylation of GSK3\u03b2 at inactive form serine 9."
  },
  {
    "text": "Activation of AMPactivated Protein Kinase and Phosphorylation of Glycogen Synthase Kinase3 \u03b2 Mediate Ursolic Acid Induced Apoptosis in HepG2 Liver Cancer Cells",
    "triple_list": [
      [
        "AMPactivated Protein Kinase",
        "CPR:3",
        "Ursolic Acid"
      ],
      [
        "Glycogen Synthase Kinase3 \u03b2",
        "CPR:3",
        "Ursolic Acid"
      ]
    ],
    "updated": "No",
    "original": "Activation of AMPactivated Protein Kinase and Phosphorylation of Glycogen Synthase Kinase3 \u03b2 Mediate Ursolic Acid Induced Apoptosis in HepG2 Liver Cancer Cells",
    "simplified": "Glycogen Synthase Kinase3 - Mediate Ursolic Acid Induced Apoptosis in HepG2 Liver Cancer Cells - AMPactivated Protein Kinase and Phosphorylation"
  },
  {
    "text": "Conversely AMPK inhibitor compound C or GSK3\u03b2 inhibitor SB216763 blocked the cleavages of PARP and caspase 3 induced by ursolic acid in HepG2 cells",
    "triple_list": [
      [
        "PARP",
        "CPR:3",
        "ursolic acid"
      ],
      [
        "caspase 3",
        "CPR:3",
        "ursolic acid"
      ],
      [
        "compound C",
        "CPR:4",
        "caspase 3"
      ],
      [
        "AMPK",
        "CPR:4",
        "compound C"
      ],
      [
        "GSK3\u03b2",
        "CPR:4",
        "SB216763"
      ],
      [
        "SB216763",
        "CPR:4",
        "caspase 3"
      ]
    ],
    "updated": "No",
    "original": "Conversely AMPK inhibitor compound C or GSK3\u03b2 inhibitor SB216763 blocked the cleavages of PARP and caspase 3 induced by ursolic acid in HepG2 cells",
    "simplified": "On the other hand, the GSK3\u03b2 inhibitor SB216763 blocked the cleavages of ursolic acid in HepG2 cells. This blocked caspase 3."
  },
  {
    "text": "Furthermore proteosomal inhibitor MG132 suppressed AMPK activation GSK3\u03b2 phosphorylation cleaved PARP and deceased AEG1 induced by ursolic acid in HepG2 cells",
    "triple_list": [
      [
        "MG132",
        "CPR:3",
        "AEG1"
      ],
      [
        "AMPK",
        "CPR:3",
        "ursolic acid"
      ],
      [
        "GSK3\u03b2",
        "CPR:3",
        "ursolic acid"
      ],
      [
        "AEG1",
        "CPR:3",
        "ursolic acid"
      ],
      [
        "MG132",
        "CPR:4",
        "AMPK"
      ],
      [
        "MG132",
        "CPR:4",
        "GSK3\u03b2"
      ],
      [
        "AEG1",
        "CPR:4",
        "ursolic acid"
      ]
    ],
    "updated": "No",
    "original": "Furthermore proteosomal inhibitor MG132 suppressed AMPK activation GSK3\u03b2 phosphorylation cleaved PARP and deceased AEG1 induced by ursolic acid in HepG2 cells",
    "simplified": "In addition, the proteosomal inhibitor MG132 reduced GSK3\u03b2 phosphorylation, which breaks down PARP and AEG1 when ursolic acid is applied."
  },
  {
    "text": "Overall our findings suggest that ursolic acid induced apoptosis in HepG2 cells via AMPK activation and GSK3\u03b2 phosphorylation as a potent chemopreventive agent",
    "triple_list": [
      [
        "ursolic acid",
        "CPR:3",
        "AMPK"
      ],
      [
        "ursolic acid",
        "CPR:3",
        "GSK3\u03b2"
      ]
    ],
    "updated": "No",
    "original": "Overall our findings suggest that ursolic acid induced apoptosis in HepG2 cells via AMPK activation and GSK3\u03b2 phosphorylation as a potent chemopreventive agent",
    "simplified": "All in all, our findings suggest that ursolic acid induced apoptosis in HepG2 cells via a potent chemopreventive agent and AMPK activation."
  },
  {
    "text": "Based on these studies the frequency of spontaneous tail contractions at 26 hpf a developmental stage with minimal AChE expression and activity was significantly higher when paraoxon was added to the animal 's blood .",
    "triple_list": [
      [
        "AChE",
        "CPR:3",
        "paraoxon"
      ]
    ],
    "updated": "Yes",
    "original": "Based on these studies the frequency of spontaneous tail contractions at 26 hpf a developmental stage with minimal AChE expression and activity was significantly higher following exposure to paraoxon concentrations as low as 312 nM",
    "simplified": "Based on these studies the frequency of spontaneous tail contractions at 26 hpf a developmental stage with minimal AChE expression and activity was significantly higher when paraoxon was added to the animal's blood."
  },
  {
    "text": "We then showed that static exposure of embryos to paraoxon 312500 nM from 5 to 96 hpf resulted in significant AChE inhibition although these effects were fully reversible within 48 h following transfer to clean water .",
    "triple_list": [
      [
        "paraoxon",
        "CPR:4",
        "AChE"
      ]
    ],
    "updated": "Yes",
    "original": "We then showed that static exposure of embryos to paraoxon 312500 nM from 5 to 96 hpf resulted in significant stage and concentrationdependent AChE inhibition albeit these effects were fully reversible within 48 h following transfer to clean water",
    "simplified": "We then showed that static exposure of embryos to paraoxon 312500 nM from 5 to 96 hpf resulted in significant AChE inhibition although these effects were fully reversible within 48 h following transfer to clean water."
  },
  {
    "text": "Using paraoxon as a reference acetylcholinesterase AChE inhibitor the objective of this study was to develop an adverse outcome pathway AOP that provided quantitative linkages across levels of biological organization during zebrafish embryogenesis",
    "triple_list": [
      [
        "paraoxon",
        "CPR:4",
        "acetylcholinesterase"
      ],
      [
        "paraoxon",
        "CPR:4",
        "AChE"
      ]
    ],
    "updated": "No",
    "original": "Using paraoxon as a reference acetylcholinesterase AChE inhibitor the objective of this study was to develop an adverse outcome pathway AOP that provided quantitative linkages across levels of biological organization during zebrafish embryogenesis",
    "simplified": "Using paraoxon as a reference the objective of this study was to develop an adverse outcome pathway AOP that provided quantitative linkages across levels of biological organization during zebrafish embryogenesis."
  },
  {
    "text": "Conversely opioid antagonists such as naloxone and naltrexone which bind to nonselectively opioid receptors have been shown to decrease alcohol consumption under various experimental conditions",
    "triple_list": [
      [
        "naltrexone",
        "CPR:3",
        "opioid receptors"
      ],
      [
        "naloxone",
        "CPR:6",
        "opioid receptors"
      ]
    ],
    "updated": "No",
    "original": "Conversely opioid antagonists such as naloxone and naltrexone which bind to nonselectively opioid receptors have been shown to decrease alcohol consumption under various experimental conditions",
    "simplified": "Conversely, opioid antagonists such as naloxone and naltrexone have been shown to decrease alcohol consumption under different experimental conditions."
  },
  {
    "text": "Esmolol a unique cardioselective beta 1adrenergic receptor blocker has a halflife of 9 minutes . This means that it can be given to a patient as soon as they start taking other drugs .",
    "triple_list": [
      [
        "Esmolol",
        "CPR:4",
        "beta 1adrenergic receptor"
      ]
    ],
    "updated": "Yes",
    "original": "Esmolol a unique cardioselective beta 1adrenergic receptor blocker with a halflife of 9 minutes can enable some patients with relative contraindications to beta blockers to nevertheless benefit from early betablocking therapy",
    "simplified": "Esmolol a unique cardioselective beta 1adrenergic receptor blocker has a halflife of 9 minutes. This means that it can be given to a patient as soon as they start taking other drugs."
  },
  {
    "text": "In catalytic properties mouse CA V is closest to CA I however in inhibition by acetazolamide ethoxzolamide and cyanate CA V is very similar to CA II",
    "triple_list": [
      [
        "CA V",
        "CPR:4",
        "acetazolamide"
      ],
      [
        "acetazolamide",
        "CPR:4",
        "CA II"
      ],
      [
        "CA V",
        "CPR:4",
        "ethoxzolamide"
      ],
      [
        "ethoxzolamide",
        "CPR:4",
        "CA II"
      ],
      [
        "CA V",
        "CPR:4",
        "cyanate"
      ],
      [
        "cyanate",
        "CPR:4",
        "CA II"
      ]
    ],
    "updated": "No",
    "original": "In catalytic properties mouse CA V is closest to CA I however in inhibition by acetazolamide ethoxzolamide and cyanate CA V is very similar to CA II",
    "simplified": "In catalytic properties mouse CA V is closest to CA I. When acetazolamide and cyanate are added, CA V does not work as well."
  },
  {
    "text": "Phosphate a product of the reaction was found to be a potent inhibitor of MjAdSS showing biphasic inhibition of enzyme activity",
    "triple_list": [
      [
        "Phosphate",
        "CPR:4",
        "MjAdSS"
      ]
    ],
    "updated": "No",
    "original": "Phosphate a product of the reaction was found to be a potent inhibitor of MjAdSS showing biphasic inhibition of enzyme activity",
    "simplified": "Phosphate, a product of the reaction, was found to be a good inhibitor of this enzyme. This is called biphasic inhibition."
  },
  {
    "text": "Adenylosuccinate synthetase AdSS catalyzes the Mg2 dependent condensation of a molecule of IMP with aspartate to form adenylosuccinate in a reaction driven by the hydrolysis of GTP to GDP",
    "triple_list": [
      [
        "AdSS",
        "CPR:9",
        "Mg2"
      ],
      [
        "Adenylosuccinate synthetase",
        "CPR:9",
        "adenylosuccinate"
      ],
      [
        "AdSS",
        "CPR:9",
        "adenylosuccinate"
      ]
    ],
    "updated": "No",
    "original": "Adenylosuccinate synthetase AdSS catalyzes the Mg2 dependent condensation of a molecule of IMP with aspartate to form adenylosuccinate in a reaction driven by the hydrolysis of GTP to GDP",
    "simplified": "Adenylosuccinate synthetase AdSS catalyzes the condensation of IMP with aspartate to form adenylosuccinate. This reaction is driven by the hydrolysis of GTP to GDP."
  },
  {
    "text": "The anti-inflammatory drugs sodium salicylate and aspirin stopped NFkappa B from working . This explains how these drugs work .",
    "triple_list": [
      [
        "sodium salicylate",
        "CPR:4",
        "NFkappa B"
      ],
      [
        "aspirin",
        "CPR:4",
        "NFkappa B"
      ]
    ],
    "updated": "Yes",
    "original": "The antiinflammatory drugs sodium salicylate and aspirin inhibited the activation of NFkappa B which further explains the mechanism of action of these drugs",
    "simplified": "The anti-inflammatory drugs sodium salicylate and aspirin stopped NFkappa B from working. This explains how these drugs work."
  },
  {
    "text": "Sodium salicylate and aspirin also inhibited NFkappa B dependent transcription from the Ig kappa enhancer and the human immunodeficiency virus HIV long terminal repeat LTR in transfected T cells",
    "triple_list": [
      [
        "Sodium salicylate",
        "CPR:4",
        "NFkappa B"
      ],
      [
        "Sodium salicylate",
        "CPR:4",
        "Ig kappa"
      ],
      [
        "aspirin",
        "CPR:4",
        "NFkappa B"
      ],
      [
        "aspirin",
        "CPR:4",
        "Ig kappa"
      ]
    ],
    "updated": "No",
    "original": "Sodium salicylate and aspirin also inhibited NFkappa B dependent transcription from the Ig kappa enhancer and the human immunodeficiency virus HIV long terminal repeat LTR in transfected T cells",
    "simplified": "Sodium salicylate and aspirin also stopped the human immunodeficiency virus (HIV) long terminal repeat LTR in transfected T cells. This is because HIV can cause AIDS."
  },
  {
    "text": "Galanin reduces cyclic AMP regulatory elementbinding protein CREB phosphorylation in primary striatal cultures after chronic morphine and naloxone challenge",
    "triple_list": [
      [
        "cyclic AMP regulatory elementbinding protein",
        "CPR:3",
        "morphine"
      ],
      [
        "CREB",
        "CPR:3",
        "morphine"
      ],
      [
        "cyclic AMP regulatory elementbinding protein",
        "CPR:3",
        "naloxone"
      ],
      [
        "CREB",
        "CPR:3",
        "naloxone"
      ]
    ],
    "updated": "Yes",
    "original": "Galanin attenuates cyclic AMP regulatory elementbinding protein CREB phosphorylation induced by chronic morphine and naloxone challenge in Catha cells and primary striatal cultures",
    "simplified": "Galanin reduces cyclic AMP regulatory elementbinding protein CREB phosphorylation in primary striatal cultures after chronic morphine and naloxone challenge"
  },
  {
    "text": "Existing ion channel blockers such as amiodarone dronedarone bepridil aprindine and cibenzoline have been found to have an NCX inhibitory action",
    "triple_list": [
      [
        "ion channel",
        "CPR:4",
        "cibenzoline"
      ],
      [
        "cibenzoline",
        "CPR:4",
        "NCX"
      ],
      [
        "ion channel",
        "CPR:4",
        "amiodarone"
      ],
      [
        "amiodarone",
        "CPR:4",
        "NCX"
      ],
      [
        "ion channel",
        "CPR:4",
        "dronedarone"
      ],
      [
        "dronedarone",
        "CPR:4",
        "NCX"
      ],
      [
        "ion channel",
        "CPR:4",
        "bepridil"
      ],
      [
        "bepridil",
        "CPR:4",
        "NCX"
      ],
      [
        "ion channel",
        "CPR:4",
        "aprindine"
      ],
      [
        "aprindine",
        "CPR:4",
        "NCX"
      ]
    ],
    "updated": "No",
    "original": "Existing ion channel blockers such as amiodarone dronedarone bepridil aprindine and cibenzoline have been found to have an NCX inhibitory action",
    "simplified": "Other ion channel blockers exist, e.g. amiodarone and bepridil aprindine. These two have been found to inhibit NCX action."
  },
  {
    "text": "The benzyloxyphenyl NCX inhibitor ( KBR7943 ) was developed in 1996 . It was the first successful NCX inhibitor .",
    "triple_list": [
      [
        "NCX",
        "CPR:4",
        "KBR7943"
      ],
      [
        "NCX",
        "CPR:4",
        "benzyloxyphenyl"
      ]
    ],
    "updated": "Yes",
    "original": "The pharmacology of NCX inhibitors has been studied extensively since the development of KBR7943 a prototype benzyloxyphenyl NCX inhibitor in 1996",
    "simplified": "The benzyloxyphenyl NCX inhibitor (KBR7943) was developed in 1996. It was the first successful NCX inhibitor."
  },
  {
    "text": "The inhibitory effect of benzyloxyphenyl NCX inhibitors is directly related to the rate of Naidependent inactivation .",
    "triple_list": [
      [
        "benzyloxyphenyl",
        "CPR:4",
        "NCX"
      ]
    ],
    "updated": "Yes",
    "original": "Intriguingly the inhibitory potency of benzyloxyphenyl NCX inhibitors is directly coupled to the rate of Naidependent inactivation",
    "simplified": "The inhibitory effect of benzyloxyphenyl NCX inhibitors is directly related to the rate of Naidependent inactivation."
  },
  {
    "text": "The NaCa2 exchanger NCX is a bidirectional transporter . It takes up Ca2 from the outside of the cell and puts it into the inside of the cell . It does this in two different ways : forward and reverse .",
    "triple_list": [
      [
        "NaCa2 exchanger",
        "CPR:9",
        "Ca2"
      ],
      [
        "NaCa2 exchanger",
        "CPR:9",
        "Ca2"
      ]
    ],
    "updated": "Yes",
    "original": "The NaCa2 exchanger NCX is a bidirectional transporter that normally extrudes Ca2 from the cell forward mode but also brings Ca2 into the cell reverse mode under special conditions such as intracellular Na Nai accumulation or membrane depolarization",
    "simplified": "The NaCa2 exchanger NCX is a bidirectional transporter. It takes up Ca2 from the outside of the cell and puts it into the inside of the cell. It does this in two different ways: forward and reverse."
  },
  {
    "text": "AIM To assess the efficacy and safety of a 24week treatment with sitagliptin a highly selective oncedaily oral dipeptidyl peptidase4 DPP4 inhibitor in patients with type 2 diabetes who had inadequate glycaemic control glycosylated haemoglobin HbA1c or=75 and or=105 while on glimepiride alone or in combination with metformin",
    "triple_list": [
      [
        "sitagliptin",
        "CPR:4",
        "dipeptidyl peptidase4"
      ],
      [
        "sitagliptin",
        "CPR:4",
        "DPP4"
      ]
    ],
    "updated": "No",
    "original": "AIM To assess the efficacy and safety of a 24week treatment with sitagliptin a highly selective oncedaily oral dipeptidyl peptidase4 DPP4 inhibitor in patients with type 2 diabetes who had inadequate glycaemic control glycosylated haemoglobin HbA1c or=75 and or=105 while on glimepiride alone or in combination with metformin",
    "simplified": "AIM To assess the efficacy and safety of a 24week treatment with sitagliptin in patients with type 2 diabetes who had inadequate glycaemic control glycosylated haemoglobin HbA1c or=75 and or=105 while on glimepiride alone or in combination with metformin."
  },
  {
    "text": "The safety and effectiveness of the dipeptidyl peptidase4 inhibitor sitagliptin in patients with type 2 diabetes mellitus on glimepiride alone or on metformin is not known .",
    "triple_list": [
      [
        "dipeptidyl peptidase4",
        "CPR:4",
        "sitagliptin"
      ]
    ],
    "updated": "Yes",
    "original": "Efficacy and safety of the dipeptidyl peptidase4 inhibitor sitagliptin in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin",
    "simplified": "The safety and effectiveness of the dipeptidyl peptidase4 inhibitor sitagliptin in patients with type 2 diabetes mellitus on glimepiride alone or on metformin is not known."
  },
  {
    "text": "HSYA suppressed the expression of TLR4 Myd88 ICAM1 TNF\u03b1 IL1\u03b2 and IL6 at the mRNA and protein level and inhibited the adhesion of leukocytes to A549 cells",
    "triple_list": [
      [
        "HSYA",
        "CPR:4",
        "Myd88"
      ],
      [
        "HSYA",
        "CPR:4",
        "ICAM1"
      ],
      [
        "HSYA",
        "CPR:4",
        "TNF\u03b1"
      ],
      [
        "HSYA",
        "CPR:4",
        "IL1\u03b2"
      ],
      [
        "HSYA",
        "CPR:4",
        "IL6"
      ],
      [
        "HSYA",
        "CPR:4",
        "TLR4"
      ]
    ],
    "updated": "No",
    "original": "HSYA suppressed the expression of TLR4 Myd88 ICAM1 TNF\u03b1 IL1\u03b2 and IL6 at the mRNA and protein level and inhibited the adhesion of leukocytes to A549 cells",
    "simplified": "HSYA reduced the expression of TLR4, ICAM1, IL1 and IL6 at the protein level. It also reduced the adhesion of leukocytes to A549 cells."
  },
  {
    "text": "HSYA treatment also decreased NF\u03baB p65 nuclear translocation and inhibited the phosphorylation of p38 mitogenactivated protein kinase p38 MAPK",
    "triple_list": [
      [
        "HSYA",
        "CPR:4",
        "NF\u03baB"
      ],
      [
        "HSYA",
        "CPR:4",
        "p65"
      ],
      [
        "HSYA",
        "CPR:4",
        "p38"
      ],
      [
        "HSYA",
        "CPR:4",
        "mitogenactivated protein kinase"
      ],
      [
        "HSYA",
        "CPR:4",
        "p38"
      ],
      [
        "HSYA",
        "CPR:4",
        "MAPK"
      ]
    ],
    "updated": "No",
    "original": "HSYA treatment also decreased NF\u03baB p65 nuclear translocation and inhibited the phosphorylation of p38 mitogenactivated protein kinase p38 MAPK",
    "simplified": "HSYA treatment also reduced the amount of NF\u03baB p65 in the nucleus. It also reduced the amount of p38 mitogenactivated protein kinase."
  },
  {
    "text": "A series of phosphorylated flavonoids were synthesized and investigated in vitro as inhibitors of pancreatic cholesterol esterase CEase and acetylcholinesterase AChE",
    "triple_list": [
      [
        "phosphorylated flavonoids",
        "CPR:4",
        "cholesterol esterase"
      ],
      [
        "phosphorylated flavonoids",
        "CPR:4",
        "CEase"
      ],
      [
        "phosphorylated flavonoids",
        "CPR:4",
        "acetylcholinesterase"
      ],
      [
        "phosphorylated flavonoids",
        "CPR:4",
        "AChE"
      ]
    ],
    "updated": "No",
    "original": "A series of phosphorylated flavonoids were synthesized and investigated in vitro as inhibitors of pancreatic cholesterol esterase CEase and acetylcholinesterase AChE",
    "simplified": "A series of phosphorylated flavonoids were developed and tested in vitro. They worked against two enzymes in the pancreas: CEase and AChE."
  },
  {
    "text": "The results showed that most of the compounds were much better against CEase than the flavonoids that were first made .",
    "triple_list": [
      [
        "CEase",
        "CPR:4",
        "flavonoids"
      ]
    ],
    "updated": "Yes",
    "original": "The results showed that most of the synthesized compounds exhibited nanomolar potency against CEase much better than the parent flavonoids",
    "simplified": "The results showed that most of the compounds were much better against CEase than the flavonoids that were first made."
  },
  {
    "text": "In addition , these phosphorylated flavonoids showed good selectivity for CEase over AChE . They only showed micromolar inhibition of AChE .",
    "triple_list": [
      [
        "phosphorylated flavonoids",
        "CPR:4",
        "CEase"
      ],
      [
        "phosphorylated flavonoids",
        "CPR:4",
        "AChE"
      ],
      [
        "phosphorylated flavonoids",
        "CPR:4",
        "AChE"
      ]
    ],
    "updated": "Yes",
    "original": "Furthermore these phosphorylated flavonoids demonstrated good to high selectivity for CEase over AChE which only showed micromolar potency inhibition of AChE",
    "simplified": "In addition, these phosphorylated flavonoids showed good selectivity for CEase over AChE. They only showed micromolar inhibition of AChE."
  },
  {
    "text": "The free hydroxyl group is located at position 5 and the phosphate group is located at position 7 . The structureactivity relationships revealed that the phosphorylated flavonoids inhibit CEase .",
    "triple_list": [
      [
        "hydroxyl",
        "CPR:4",
        "CEase"
      ],
      [
        "phosphate",
        "CPR:4",
        "CEase"
      ],
      [
        "phosphorylated flavonoids",
        "CPR:4",
        "CEase"
      ]
    ],
    "updated": "Yes",
    "original": "The structureactivity relationships revealed that the free hydroxyl group at position 5 and phosphate group at position 7 of the phosphorylated flavonoids are favorable to the inhibition of CEase",
    "simplified": "The free hydroxyl group is located at position 5 and the phosphate group is located at position 7. The structureactivity relationships revealed that the phosphorylated flavonoids inhibit CEase."
  },
  {
    "text": "Synthesis and biological evaluation of phosphorylated flavonoids as potent and selective inhibitors of cholesterol esterase",
    "triple_list": [
      [
        "phosphorylated flavonoids",
        "CPR:4",
        "cholesterol esterase"
      ]
    ],
    "updated": "No",
    "original": "Synthesis and biological evaluation of phosphorylated flavonoids as potent and selective inhibitors of cholesterol esterase",
    "simplified": "Phosphorylated flavonoids can be used as a powerful and selective inhibitor of cholesterol esterase."
  },
  {
    "text": "In healthy rats ATB429 dose dependently 25 50 or 100 mgkg attenuated CRDinduced hypersensitivity and significantly inhibited CRDinduced overexpression of spinal cFOS mRNA whereas mesalamine had no effect",
    "triple_list": [
      [
        "ATB429",
        "CPR:4",
        "cFOS"
      ]
    ],
    "updated": "No",
    "original": "In healthy rats ATB429 dose dependently 25 50 or 100 mgkg attenuated CRDinduced hypersensitivity and significantly inhibited CRDinduced overexpression of spinal cFOS mRNA whereas mesalamine had no effect",
    "simplified": "In healthy rats ATB429 dose dependently 25 50 or 100 mgkg attenuated CRDinduced hypersensitivity while mesalamine had no effect; however, it significantly inhibited CRDinduced overexpression."
  },
  {
    "text": "ATB429induced antinociception was reversed by glibenclamide a ATPsensitive K KATP channel inhibitor",
    "triple_list": [
      [
        "glibenclamide",
        "CPR:4",
        "ATPsensitive K KATP channel"
      ]
    ],
    "updated": "No",
    "original": "ATB429induced antinociception was reversed by glibenclamide a ATPsensitive K KATP channel inhibitor",
    "simplified": "ATB429 induced antinociception was stopped by glibenclamide, but this is not always the case."
  },
  {
    "text": "Colonic cyclooxygenase2 and interkeukin1beta mRNA and spinal cFOS mRNA expression were significantly downregulated by ATB429 but not by mesalamine",
    "triple_list": [
      [
        "cyclooxygenase2",
        "CPR:4",
        "ATB429"
      ],
      [
        "interkeukin1beta",
        "CPR:4",
        "ATB429"
      ],
      [
        "cFOS",
        "CPR:4",
        "ATB429"
      ]
    ],
    "updated": "No",
    "original": "Colonic cyclooxygenase2 and interkeukin1beta mRNA and spinal cFOS mRNA expression were significantly downregulated by ATB429 but not by mesalamine",
    "simplified": "Colonic cyclooxygenase2 and interkeukin1beta mRNA were significantly downregulated by ATB429, but mesalamine did not do the same."
  },
  {
    "text": "In this study , we have produced novel alphahydroxyphenylamide analogues of diphenylhydantoin . We have also examined their ability to inhibit human NaV15 sodium channels in CHOK1 cells .",
    "triple_list": [
      [
        "alphahydroxyphenylamide",
        "CPR:4",
        "human NaV15"
      ],
      [
        "alphahydroxyphenylamide",
        "CPR:4",
        "sodium channels"
      ],
      [
        "diphenylhydantoin",
        "CPR:4",
        "human NaV15"
      ],
      [
        "diphenylhydantoin",
        "CPR:4",
        "sodium channels"
      ],
      [
        "human NaV15",
        "CPR:9",
        "sodium"
      ],
      [
        "sodium",
        "CPR:9",
        "channels"
      ]
    ],
    "updated": "Yes",
    "original": "In this study we have synthesized novel alphahydroxyphenylamide analogues of diphenylhydantoin and examined their ability to inhibit human NaV15 sodium channels expressed in Chinese Hamster Ovary CHOK1 cells",
    "simplified": "In this study, we have produced novel alphahydroxyphenylamide analogues of diphenylhydantoin. We have also examined their ability to inhibit human NaV15 sodium channels in CHOK1 cells."
  },
  {
    "text": "In comparison to diphenylhydantoin the novel chloro substituted alphahydroxyphenylamide compounds produced as much as a 20fold greater tonic and frequencydependent blockade of NaV15 channels with an IC50 value of 145 microM",
    "triple_list": [
      [
        "diphenylhydantoin",
        "CPR:4",
        "NaV15"
      ],
      [
        "chloro",
        "CPR:4",
        "NaV15"
      ],
      [
        "alphahydroxyphenylamide",
        "CPR:4",
        "NaV15"
      ]
    ],
    "updated": "No",
    "original": "In comparison to diphenylhydantoin the novel chloro substituted alphahydroxyphenylamide compounds produced as much as a 20fold greater tonic and frequencydependent blockade of NaV15 channels with an IC50 value of 145 microM",
    "simplified": "In comparison to diphenylhydantoin, the chloro substituted alphahydroxyphenylamide compounds produced as much as a 20fold greater tonic. The IC50 value of the new compound was 145 microM."
  },
  {
    "text": "Phenytoin diphenylhydantoin ( DPH ) is a chemical compound . It is an established sodium channel blocker . It is also a useful anticonvulsant and class 1b antiarrhythmic .",
    "triple_list": [
      [
        "Phenytoin",
        "CPR:4",
        "sodium channel"
      ],
      [
        "diphenylhydantoin",
        "CPR:4",
        "sodium channel"
      ],
      [
        "DPH",
        "CPR:4",
        "sodium channel"
      ],
      [
        "sodium",
        "CPR:9",
        "channel"
      ]
    ],
    "updated": "Yes",
    "original": "Phenytoin diphenylhydantoin DPH is an established sodium channel blocker and is a useful anticonvulsant and class 1b antiarrhythmic and has been effectively used in the treatment of neuropathic pain",
    "simplified": "Phenytoin diphenylhydantoin (DPH) is a chemical compound. It is an established sodium channel blocker. It is also a useful anticonvulsant and class 1b antiarrhythmic."
  },
  {
    "text": "Block of human NaV15 sodium channels by novel alphahydroxyphenylamide analogues of phenytoin",
    "triple_list": [
      [
        "sodium channels",
        "CPR:4",
        "alphahydroxyphenylamide"
      ],
      [
        "human NaV15",
        "CPR:4",
        "alphahydroxyphenylamide"
      ],
      [
        "sodium channels",
        "CPR:4",
        "phenytoin"
      ],
      [
        "human NaV15",
        "CPR:4",
        "phenytoin"
      ],
      [
        "sodium",
        "CPR:9",
        "channels"
      ],
      [
        "human NaV15",
        "CPR:9",
        "sodium"
      ]
    ],
    "updated": "No",
    "original": "Block of human NaV15 sodium channels by novel alphahydroxyphenylamide analogues of phenytoin",
    "simplified": "The block of human NaV15 sodium channels, as shown in the diagram."
  },
  {
    "text": "This information may be useful in the development of more potent sodium channel blockers",
    "triple_list": [
      [
        "sodium",
        "CPR:9",
        "channel"
      ]
    ],
    "updated": "No",
    "original": "This information may be useful in the development of more potent sodium channel blockers",
    "simplified": "This information may be used to develop better ways to block sodium channels."
  },
  {
    "text": "METHODS Part A compared the effects of placebo to four doses of a 5HT4 receptor antagonist SB207266 on the cisapride mediated increase in plasma aldosterone a 5HT4 mediated response and orocaecal transit in 18 subjects",
    "triple_list": [
      [
        "5HT4",
        "CPR:5",
        "cisapride"
      ],
      [
        "5HT4",
        "CPR:6",
        "SB207266"
      ],
      [
        "5HT4",
        "CPR:6",
        "SB207266"
      ]
    ],
    "updated": "No",
    "original": "METHODS Part A compared the effects of placebo to four doses of a 5HT4 receptor antagonist SB207266 on the cisapride mediated increase in plasma aldosterone a 5HT4 mediated response and orocaecal transit in 18 subjects",
    "simplified": "METHODS Part A compared the effects of placebo to four doses of a 5HT4 receptor antagonist SB207266 in 18 subjects. The 5HT4 mediated response and orocaecal transit in 18 subjects was compared."
  },
  {
    "text": "Effects of a serotonin 5HT4 receptor antagonist SB207266 on gastrointestinal motor and sensory function in humans",
    "triple_list": [
      [
        "serotonin 5HT4 receptor",
        "CPR:6",
        "SB207266"
      ]
    ],
    "updated": "No",
    "original": "Effects of a serotonin 5HT4 receptor antagonist SB207266 on gastrointestinal motor and sensory function in humans",
    "simplified": "The effects of 5HT4 antagonist drugs on gastrointestinal function in humans, animals and plants"
  },
  {
    "text": "These unexpected and intriguing complexities seem likely to have some important role in polyamine homeostasis . They may regulate SSAT activity or stability .",
    "triple_list": [
      [
        "SSAT",
        "CPR:9",
        "polyamine"
      ]
    ],
    "updated": "Yes",
    "original": "These unexpected and intriguing complexities seem likely to have some as yet undefined role in regulating SSAT activity or stability as a part of polyamine homeostasis",
    "simplified": "These unexpected and intriguing complexities seem likely to have some important role in polyamine homeostasis. They may regulate SSAT activity or stability."
  },
  {
    "text": "Spermidinespermine N1acetyltransferase SSAT is a key enzyme in the control of polyamine levels in human cells as acetylation of spermidine and spermine triggers export or degradation",
    "triple_list": [
      [
        "Spermidinespermine N1acetyltransferase",
        "CPR:9",
        "polyamine"
      ],
      [
        "Spermidinespermine N1acetyltransferase",
        "CPR:9",
        "spermidine"
      ],
      [
        "Spermidinespermine N1acetyltransferase",
        "CPR:9",
        "spermine"
      ]
    ],
    "updated": "No",
    "original": "Spermidinespermine N1acetyltransferase SSAT is a key enzyme in the control of polyamine levels in human cells as acetylation of spermidine and spermine triggers export or degradation",
    "simplified": "Spermidinespermine N1acetyltransferase SSAT is an enzyme in the human body. It removes spermidine and spermine from the DNA and gives it to other cells."
  },
  {
    "text": "To confirm this novel mechanism of bleomycin induced fibrogenesis , we attempted to upregulate Nrf2 and related antioxidant proteins in bleomycin treated fibroblasts using a putative Nrf2 activator caffeic acid phenethyl ester . The results showed that through improved redox balance , the effects of bleomycin were reduced .",
    "triple_list": [
      [
        "Nrf2",
        "CPR:3",
        "caffeic acid phenethyl ester"
      ],
      [
        "bleomycin",
        "CPR:3",
        "Nrf2"
      ]
    ],
    "updated": "Yes",
    "original": "To confirm this novel mechanism of bleomycin induced fibrogenesis we attempted to upregulate Nrf2 and related antioxidant proteins in bleomycin treated fibroblasts using a putative Nrf2 activator caffeic acid phenethyl ester and the results showed that bleomycin induced fibroblast proliferation and collagen content were attenuated through improved redox balance",
    "simplified": "To confirm this novel mechanism of bleomycin induced fibrogenesis, we attempted to upregulate Nrf2 and related antioxidant proteins in bleomycin treated fibroblasts using a putative Nrf2 activator caffeic acid phenethyl ester. The results showed that through improved redox balance, the effects of bleomycin were reduced."
  },
  {
    "text": "In a cellbased model bleomycin suppressed Nrf2 activation via extracellular signalrelated kinase phosphorylation enhancing intracellular reactive oxygen species in lung fibroblasts and stimulating abnormal cell proliferation and collagen secretion",
    "triple_list": [
      [
        "bleomycin",
        "CPR:3",
        "extracellular signalrelated kinase"
      ],
      [
        "bleomycin",
        "CPR:4",
        "Nrf2"
      ]
    ],
    "updated": "No",
    "original": "In a cellbased model bleomycin suppressed Nrf2 activation via extracellular signalrelated kinase phosphorylation enhancing intracellular reactive oxygen species in lung fibroblasts and stimulating abnormal cell proliferation and collagen secretion",
    "simplified": "In a cell-based model, bleomycin reduced Nrf2 activation via extracellular signal-related kinase phosphorylation in lung fibroblasts. In addition, it increased the amount of reactive oxygen species in the lung."
  },
  {
    "text": "Treatment of C57 BL6 mice with bleomycin increased fibroblast viability and collagen production and significantly downregulated Nrf2",
    "triple_list": [
      [
        "bleomycin",
        "CPR:4",
        "Nrf2"
      ]
    ],
    "updated": "No",
    "original": "Treatment of C57 BL6 mice with bleomycin increased fibroblast viability and collagen production and significantly downregulated Nrf2",
    "simplified": "When C57 BL6 mice were treated with bleomycin, collagen production and fibroblast viability were increased."
  },
  {
    "text": "The IC50 values for Gli1 mRNA inhibition in the tumor and skin by TAK441 were estimated to be 00457 and 0113 \u03bcgml respectively",
    "triple_list": [
      [
        "Gli1",
        "CPR:4",
        "TAK441"
      ]
    ],
    "updated": "No",
    "original": "The IC50 values for Gli1 mRNA inhibition in the tumor and skin by TAK441 were estimated to be 00457 and 0113 \u03bcgml respectively",
    "simplified": "The IC50 values for TAK441 in the tumor and skin were estimated to be 00457 and 0113 \u03bcgml, respectively."
  },
  {
    "text": "6EthylN1hydroxyacetylpiperidin4yl1methyl4oxo52oxo2phenylethyl3222trifluoroethoxy45dihydro1Hpyrrolo32cpyridine2carboxamide TAK441 is a potent selective hedgehog signaling pathway inhibitor that binds to Smo and is being developed for the treatment of cancer",
    "triple_list": [
      [
        "TAK441",
        "CPR:4",
        "hedgehog"
      ]
    ],
    "updated": "No",
    "original": "6EthylN1hydroxyacetylpiperidin4yl1methyl4oxo52oxo2phenylethyl3222trifluoroethoxy45dihydro1Hpyrrolo32cpyridine2carboxamide TAK441 is a potent selective hedgehog signaling pathway inhibitor that binds to Smo and is being developed for the treatment of cancer",
    "simplified": "6EthylN1hydroxyacetylpiperidin4yl1methyl4oxo52oxo2phenylethyl3222trifluoroethoxy45dihydro1Hpyrrolo32cpyridine2carboxamide TAK441 is a potent drug that binds to Smo and is being developed for the treatment of cancer."
  },
  {
    "text": "The pharmacokinetic and pharmacodynamic model of the hedgehog inhibitor TAK441 for the inhibition of Gli1 expression in the central nervous system of mice .",
    "triple_list": [
      [
        "hedgehog",
        "CPR:4",
        "TAK441"
      ],
      [
        "TAK441",
        "CPR:4",
        "Gli1"
      ]
    ],
    "updated": "Yes",
    "original": "Pharmacokinetic and pharmacodynamic modeling of hedgehog inhibitor TAK441 for the inhibition of Gli1 messenger RNA expression and antitumor efficacy in xenografted tumor model mice",
    "simplified": "The pharmacokinetic and pharmacodynamic model of the hedgehog inhibitor TAK441 for the inhibition of Gli1 expression in the central nervous system of mice."
  },
  {
    "text": "In this report we evaluated the growthinhibitory effects of sulindac sulfide a COX1 and COX2 inhibitor on human lung cancer cell lines and nordihydroguaiaretic acid NDGA a lipoxygenase inhibitor on human lung cancer cell lines .",
    "triple_list": [
      [
        "sulindac sulfide",
        "CPR:4",
        "COX1"
      ],
      [
        "sulindac sulfide",
        "CPR:4",
        "COX2"
      ],
      [
        "nordihydroguaiaretic acid",
        "CPR:4",
        "lipoxygenase"
      ],
      [
        "NDGA",
        "CPR:4",
        "lipoxygenase"
      ]
    ],
    "updated": "Yes",
    "original": "In this report we evaluated the growthinhibitory effects of sulindac sulfide a COX1 and COX2 inhibitor exisulind sulindac sulfone a novel proapoptotic agent that does not inhibit COX enzymes and nordihydroguaiaretic acid NDGA a lipoxygenase inhibitor on human lung cancer cell lines",
    "simplified": "In this report we evaluated the growthinhibitory effects of sulindac sulfide a COX1 and COX2 inhibitor on human lung cancer cell lines and nordihydroguaiaretic acid NDGA a lipoxygenase inhibitor on human lung cancer cell lines."
  },
  {
    "text": "The ability of TFP to block S100A4-mediated disassembly of myosinIIA filaments has been shown to be important in the function of S100A4 . TFP concentrations that promote S100A4 oligomerization are required .",
    "triple_list": [
      [
        "TFP",
        "CPR:3",
        "S100A4"
      ],
      [
        "TFP",
        "CPR:4",
        "S100A4"
      ],
      [
        "TFP",
        "CPR:4",
        "myosinIIA"
      ],
      [
        "TFP",
        "CPR:4",
        "S100A4"
      ]
    ],
    "updated": "Yes",
    "original": "Assays examining the ability of TFP to block S100A4mediated disassembly of myosinIIA filaments demonstrate that significant inhibition of S100A4 function occurs only at TFP concentrations that promote S100A4 oligomerization",
    "simplified": "The ability of TFP to block S100A4-mediated disassembly of myosinIIA filaments has been shown to be important in the function of S100A4. TFP concentrations that promote S100A4 oligomerization are required."
  },
  {
    "text": "Using a unique biosensorbased assay trifluoperazine TFP was identified as an inhibitor that disrupts the S100A4 myosinIIA interaction",
    "triple_list": [
      [
        "trifluoperazine",
        "CPR:4",
        "S100A4"
      ],
      [
        "trifluoperazine",
        "CPR:4",
        "myosinIIA"
      ],
      [
        "TFP",
        "CPR:4",
        "S100A4"
      ],
      [
        "TFP",
        "CPR:4",
        "myosinIIA"
      ]
    ],
    "updated": "No",
    "original": "Using a unique biosensorbased assay trifluoperazine TFP was identified as an inhibitor that disrupts the S100A4 myosinIIA interaction",
    "simplified": "Using a unique biosensor-based test, trifluoperazine was identified as an S100A4 myosinIIA- disrupting inhibitor."
  },
  {
    "text": "Phenothiazines stop S100A4 from working . They cause protein oligomerization .",
    "triple_list": [
      [
        "Phenothiazines",
        "CPR:4",
        "S100A4"
      ]
    ],
    "updated": "Yes",
    "original": "Phenothiazines inhibit S100A4 function by inducing protein oligomerization",
    "simplified": "Phenothiazines stop S100A4 from working. They cause protein oligomerization."
  },
  {
    "text": "Together these studies support a unique mode of inhibition in which phenothiazines disrupt the S100A4 myosinIIA interaction by sequestering S100A4 via small moleculeinduced oligomerization",
    "triple_list": [
      [
        "phenothiazines",
        "CPR:4",
        "S100A4"
      ],
      [
        "phenothiazines",
        "CPR:4",
        "myosinIIA"
      ]
    ],
    "updated": "No",
    "original": "Together these studies support a unique mode of inhibition in which phenothiazines disrupt the S100A4 myosinIIA interaction by sequestering S100A4 via small moleculeinduced oligomerization",
    "simplified": "Together these studies support a unique mode of inhibition in which phenothiazines by sequestering S100A4 via small molecule oligomerization disrupt the interaction between S100A4 and S100A4."
  },
  {
    "text": "Both BRL and SAL produced a significant increase in postural finger tremor when the beta 2adrenoceptor was stimulated . This response was completely abolished when N20 was used .",
    "triple_list": [
      [
        "BRL",
        "CPR:3",
        "beta 2adrenoceptor"
      ],
      [
        "SAL",
        "CPR:3",
        "beta 2adrenoceptor"
      ]
    ],
    "updated": "Yes",
    "original": "Both BRL and SAL produced a significant increase in postural finger tremor in keeping with beta 2adrenoceptor stimulation and this response was totally abolished by pretreatment with N20",
    "simplified": "Both BRL and SAL produced a significant increase in postural finger tremor when the beta 2adrenoceptor was stimulated. This response was completely abolished when N20 was used."
  },
  {
    "text": "Cardiac effects of the beta 3adrenoceptor agonist BRL35135 in man",
    "triple_list": [
      [
        "beta 3adrenoceptor",
        "CPR:5",
        "BRL35135"
      ]
    ],
    "updated": "No",
    "original": "Cardiac effects of the beta 3adrenoceptor agonist BRL35135 in man",
    "simplified": "Beta 3adrenoceptor (BRL35135) - Cardiac effects in men"
  },
  {
    "text": "The aim of the present study was to evaluate the cardiac effects of the beta 3adrenoceptor agonist BRL35135 and to determine whether inotropic or chronotropic responses are caused by the beta 3receptors .",
    "triple_list": [
      [
        "beta 3adrenoceptor",
        "CPR:5",
        "BRL35135"
      ]
    ],
    "updated": "Yes",
    "original": "The aim of the present study was to evaluate the cardiac effects of the beta 3adrenoceptor agonist BRL35135 and determine whether beta 3receptors are involved in mediating chronotropic or inotropic responses in man",
    "simplified": "The aim of the present study was to evaluate the cardiac effects of the beta 3adrenoceptor agonist BRL35135 and to determine whether inotropic or chronotropic responses are caused by the beta 3receptors."
  },
  {
    "text": "Eight normal males received single oral doses of BRL35135 8 mg BRL or the selective beta 2adrenoceptor agonist salbutamol 8 mg SAL after pretreatment with either placebo PL bisoprolol 5 mg B5 as a selective beta 1adrenoceptor antagonist or nadolol 20 mg N20 to block beta 1 and beta 2 but not beta 3receptors",
    "triple_list": [
      [
        "beta 2adrenoceptor",
        "CPR:5",
        "salbutamol"
      ],
      [
        "beta 2adrenoceptor",
        "CPR:5",
        "SAL"
      ],
      [
        "bisoprolol",
        "CPR:6",
        "beta 1adrenoceptor"
      ]
    ],
    "updated": "No",
    "original": "Eight normal males received single oral doses of BRL35135 8 mg BRL or the selective beta 2adrenoceptor agonist salbutamol 8 mg SAL after pretreatment with either placebo PL bisoprolol 5 mg B5 as a selective beta 1adrenoceptor antagonist or nadolol 20 mg N20 to block beta 1 and beta 2 but not beta 3receptors",
    "simplified": "Eight normal males received single oral doses of salbutamol 8 mg SAL after pretreatment with PL bisoprolol 5 mg B5 as a selective beta 1adrenoceptor antagonist. After pretreatment with PL bisoprolol 5 mg B5 or nadolol 20 mg N20, eight normal males received single oral doses of BRL35135 8 mg BRL or salbutamol 8 mg SAL."
  },
  {
    "text": "Both intracellular and membrane Cx43 levels were significantly reduced in cells released from contact inhibition by TCDD siRNA . However , it was not enough to stimulate cell division in contactinhibited cells .",
    "triple_list": [
      [
        "Cx43",
        "CPR:4",
        "TCDD"
      ],
      [
        "Cx43",
        "CPR:4",
        "TCDD"
      ]
    ],
    "updated": "Yes",
    "original": "Although both intracellular and membrane Cx43 pools were markedly reduced in cells released from contact inhibition by TCDD siRNAmediated Cx43 knockdown was not sufficient to stimulate proliferation in contactinhibited cells",
    "simplified": "Both intracellular and membrane Cx43 levels were significantly reduced in cells released from contact inhibition by TCDD siRNA. However, it was not enough to stimulate cell division in contactinhibited cells."
  },
  {
    "text": "Disruption of contact inhibition which was induced by toxic AhR ligands 2378tetrachlorodibenzopdioxin TCDD or polycyclic aromatic hydrocarbons in epithelial WBF344 cells reduced Cx43 protein levels possibly via enhanced proteasomal degradation significantly decreased the amount of gap junction plaques and downregulated GJIC in an AhRdependent manner",
    "triple_list": [
      [
        "2378tetrachlorodibenzopdioxin",
        "CPR:4",
        "Cx43"
      ],
      [
        "TCDD",
        "CPR:4",
        "Cx43"
      ],
      [
        "polycyclic aromatic hydrocarbons",
        "CPR:4",
        "Cx43"
      ]
    ],
    "updated": "No",
    "original": "Disruption of contact inhibition which was induced by toxic AhR ligands 2378tetrachlorodibenzopdioxin TCDD or polycyclic aromatic hydrocarbons in epithelial WBF344 cells reduced Cx43 protein levels possibly via enhanced proteasomal degradation significantly decreased the amount of gap junction plaques and downregulated GJIC in an AhRdependent manner",
    "simplified": "Disruption of contact inhibition by toxic AhR ligands (2378tetrachlorodibenzopdioxin TCDD or polycyclic aromatic hydrocarbons) in epithelial cells significantly decreased the amount of gap junction plaques and downregulated GJIC in an AhRdependent manner."
  },
  {
    "text": "The Histamine content in the nasal mucosa and HDC activity were also significantly increased after TDI .",
    "triple_list": [
      [
        "HDC",
        "CPR:3",
        "TDI"
      ],
      [
        "HDC",
        "CPR:3",
        "TDI"
      ]
    ],
    "updated": "Yes",
    "original": "Histamine content HDC activity and HDC mRNA expression in nasal mucosa were also significantly increased after TDI provocation",
    "simplified": "The Histamine content in the nasal mucosa and HDC activity were also significantly increased after TDI."
  },
  {
    "text": "Pretreatment with dexamethasone significantly suppressed nasal allergylike behaviors HDC activity and HDC mRNA in TDIsensitized rats HDC activity and HDC mRNA in TDI",
    "triple_list": [
      [
        "HDC",
        "CPR:3",
        "TDI"
      ],
      [
        "HDC",
        "CPR:3",
        "TDI"
      ],
      [
        "HDC",
        "CPR:3",
        "TDI"
      ],
      [
        "dexamethasone",
        "CPR:4",
        "HDC"
      ],
      [
        "dexamethasone",
        "CPR:4",
        "HDC"
      ]
    ],
    "updated": "Yes",
    "original": "Pretreatment with dexamethasone significantly suppressed nasal allergylike behaviors upregulation of histamine content HDC activity and HDC mRNA induced by TDI in TDIsensitized rats",
    "simplified": "Pretreatment with dexamethasone significantly suppressed nasal allergylike behaviors HDC activity and HDC mRNA in TDIsensitized rats HDC activity and HDC mRNA in TDI"
  },
  {
    "text": "The activity of the HDC gene is controlled by dexamethasone . This is why dexamethasone is used in the treatment of allergy .",
    "triple_list": [
      [
        "HDC",
        "CPR:4",
        "dexamethasone"
      ],
      [
        "HDC",
        "CPR:4",
        "dexamethasone"
      ]
    ],
    "updated": "Yes",
    "original": "Repression of HDC gene expression and HDC activity by dexamethasone may underlie its therapeutic effect in the treatment of allergy",
    "simplified": "The activity of the HDC gene is controlled by dexamethasone. This is why dexamethasone is used in the treatment of allergy."
  },
  {
    "text": "Dexamethasone suppresses histamine synthesis by repressing both transcription and activity of HDC in allergic rats",
    "triple_list": [
      [
        "Dexamethasone",
        "CPR:4",
        "HDC"
      ]
    ],
    "updated": "No",
    "original": "Dexamethasone suppresses histamine synthesis by repressing both transcription and activity of HDC in allergic rats",
    "simplified": "Dexamethasone inhibits histamine production. It also stops the histamine production in allergic rats."
  },
  {
    "text": "However , it is still not clear how histamine synthesis is regulated by HDC .",
    "triple_list": [
      [
        "histamine",
        "CPR:9",
        "HDC"
      ]
    ],
    "updated": "Yes",
    "original": "However the regulatory mechanism of histamine synthesis by HDC remains to be elucidated",
    "simplified": "However, it is still not clear how histamine synthesis is regulated by HDC."
  },
  {
    "text": "BACKGROUND Histamine synthesized by histidine decarboxylase HDC from Lhistidine is a major chemical mediator in the development of nasal allergy which is characterized by nasal hypersensitivity",
    "triple_list": [
      [
        "histidine decarboxylase",
        "CPR:9",
        "Lhistidine"
      ],
      [
        "HDC",
        "CPR:9",
        "Lhistidine"
      ],
      [
        "Histamine",
        "CPR:9",
        "histidine decarboxylase"
      ],
      [
        "Histamine",
        "CPR:9",
        "HDC"
      ]
    ],
    "updated": "No",
    "original": "BACKGROUND Histamine synthesized by histidine decarboxylase HDC from Lhistidine is a major chemical mediator in the development of nasal allergy which is characterized by nasal hypersensitivity",
    "simplified": "The histamine is made by histidine decarboxylase (HDC) from lhistidine. It is a very important chemical in the development of allergies, especially in the nasal area."
  },
  {
    "text": "The results of this study show that the increased synthesis of histamine through HDC gene expression and HDC activity in the nasal mucosa plays an important role in the development of hypersensitivity .",
    "triple_list": [
      [
        "histamine",
        "CPR:9",
        "HDC"
      ],
      [
        "histamine",
        "CPR:9",
        "HDC"
      ]
    ],
    "updated": "Yes",
    "original": "CONCLUSIONS These findings indicate that increased synthesis of histamine through upregulation of HDC gene expression and HDC activity in nasal mucosa plays an important role in the development of nasal hypersensitivity",
    "simplified": "The results of this study show that the increased synthesis of histamine through HDC gene expression and HDC activity in the nasal mucosa plays an important role in the development of hypersensitivity."
  },
  {
    "text": "CONCLUSIONS A diet that partially replaces carbohydrate with unsaturated fat may improve insulin sensitivity in a population at risk for cardiovascular disease",
    "triple_list": [
      [
        "carbohydrate",
        "CPR:3",
        "insulin"
      ]
    ],
    "updated": "No",
    "original": "CONCLUSIONS A diet that partially replaces carbohydrate with unsaturated fat may improve insulin sensitivity in a population at risk for cardiovascular disease",
    "simplified": "A diet that replaces some carbohydrates with unsaturated fat may improve insulin sensitivity in people at high risk for heart disease."
  },
  {
    "text": "In this study we assessed the effects of clopidogrel and clarithromycin known CYP2B6 and CYP3A inhibitors respectively on the enantioselective effect of racemic sibutramine in humans , as well as the effects of other drugs .",
    "triple_list": [
      [
        "clopidogrel",
        "CPR:4",
        "CYP2B6"
      ],
      [
        "clopidogrel",
        "CPR:4",
        "CYP2B6"
      ],
      [
        "clopidogrel",
        "CPR:4",
        "CYP3A"
      ],
      [
        "clarithromycin",
        "CPR:4",
        "CYP2B6"
      ],
      [
        "clarithromycin",
        "CPR:4",
        "CYP3A"
      ]
    ],
    "updated": "Yes",
    "original": "In this study we assessed the effects of clopidogrel and clarithromycin known CYP2B6 and CYP3A inhibitors respectively on the enantioselective disposition of racemic sibutramine in conjunction with CYP2B6 polymorphisms in humans",
    "simplified": "In this study we assessed the effects of clopidogrel and clarithromycin known CYP2B6 and CYP3A inhibitors respectively on the enantioselective effect of racemic sibutramine in humans, as well as the effects of other drugs."
  },
  {
    "text": "Conclusions CysLTs produced after antigen provocation induced IL5 production from some immune cells via activation of the CysLT1 receptor .",
    "triple_list": [
      [
        "CysLTs",
        "CPR:3",
        "CysLT1"
      ]
    ],
    "updated": "Yes",
    "original": "CONCLUSIONS CysLTs produced after antigen provocation sequentially induced IL5 production from some immune component cells via CysLT1 receptor activation",
    "simplified": "Conclusions CysLTs produced after antigen provocation induced IL5 production from some immune cells via activation of the CysLT1 receptor."
  },
  {
    "text": "The level of IL5 in the serum was reduced by both pranlukast and MCI826 by over 90",
    "triple_list": [
      [
        "IL5",
        "CPR:4",
        "pranlukast"
      ],
      [
        "IL5",
        "CPR:4",
        "MCI826"
      ]
    ],
    "updated": "Yes",
    "original": "Increased IL5 activity in the serum was inhibited by both pranlukast and MCI826 by over 90",
    "simplified": "The level of IL5 in the serum was reduced by both pranlukast and MCI826 by over 90"
  },
  {
    "text": "Extracellular application of meclofenamate ( EC50 = 25 microM ) and diclofenac ( EC50 = 26 microM ) resulted in the activation of the KCNQ2Q3 gene in the ovary of the Chinese hamster .",
    "triple_list": [
      [
        "diclofenac",
        "CPR:3",
        "KCNQ2Q3"
      ],
      [
        "meclofenamate",
        "CPR:3",
        "KCNQ2Q3"
      ]
    ],
    "updated": "Yes",
    "original": "Extracellular application of meclofenamate EC50 = 25 microM and diclofenac EC50 = 26 microM resulted in the activation of KCNQ2Q3 K currents heterologously expressed in Chinese hamster ovary cells",
    "simplified": "Extracellular application of meclofenamate (EC50 = 25 microM) and diclofenac (EC50 = 26 microM) resulted in the activation of the KCNQ2Q3 gene in the ovary of the Chinese hamster."
  },
  {
    "text": "The selective norepinephrine NE transporter inhibitor atomoxetine formerly called tomoxetine or LY139603 has been shown to alleviate symptoms in Attention DeficitHyperactivity Disorder ADHD",
    "triple_list": [
      [
        "norepinephrine NE transporter",
        "CPR:4",
        "atomoxetine"
      ],
      [
        "norepinephrine NE transporter",
        "CPR:4",
        "tomoxetine"
      ],
      [
        "norepinephrine NE transporter",
        "CPR:4",
        "LY139603"
      ]
    ],
    "updated": "No",
    "original": "The selective norepinephrine NE transporter inhibitor atomoxetine formerly called tomoxetine or LY139603 has been shown to alleviate symptoms in Attention DeficitHyperactivity Disorder ADHD",
    "simplified": "The selective norepinephrine transporter inhibitor atomoxetine or LY139603 has been shown to help people with Attention Deficit Hyperactivity Disorder (ADHD)."
  },
  {
    "text": "Local PGE2 treatment stopped the increase of airway IL13 and osteopontin . It also kept lung dendritic cell numbers the same .",
    "triple_list": [
      [
        "PGE2",
        "CPR:4",
        "IL13"
      ],
      [
        "PGE2",
        "CPR:4",
        "osteopontin"
      ]
    ],
    "updated": "Yes",
    "original": "Local PGE2 administration prevented the increase of airway IL13 and osteopontin and kept lung plasmacytoid dendritic cell counts close to baseline",
    "simplified": "Local PGE2 treatment stopped the increase of airway IL13 and osteopontin. It also kept lung dendritic cell numbers the same."
  },
  {
    "text": "Lung inflammation IL4 production and airway mast cell activity were also prevented under this early shortterm treatment with PGE2",
    "triple_list": [
      [
        "IL4",
        "CPR:4",
        "PGE2"
      ]
    ],
    "updated": "No",
    "original": "Lung inflammation IL4 production and airway mast cell activity were also prevented under this early shortterm treatment with PGE2",
    "simplified": "Lung inflammation and airway mast cell activity were also prevented under this short-term treatment with PGE2."
  },
  {
    "text": "The reactivation of brain AChE inhibited with tabun demonstrated better activity of new compound BT074M TMB4 and obidoxime from symmetric oximes and BT05 and BT03 possessing asymmetric structure",
    "triple_list": [
      [
        "AChE",
        "CPR:3",
        "BT074M"
      ],
      [
        "AChE",
        "CPR:3",
        "TMB4"
      ],
      [
        "AChE",
        "CPR:3",
        "obidoxime"
      ],
      [
        "AChE",
        "CPR:3",
        "oximes"
      ],
      [
        "AChE",
        "CPR:3",
        "BT05"
      ],
      [
        "AChE",
        "CPR:3",
        "BT03"
      ]
    ],
    "updated": "No",
    "original": "The reactivation of brain AChE inhibited with tabun demonstrated better activity of new compound BT074M TMB4 and obidoxime from symmetric oximes and BT05 and BT03 possessing asymmetric structure",
    "simplified": "The reactivation of brain AChE inhibited with tabun showed better activity of new compound BT074M TMB4 and obidoxime. BT074M TMB4 and obidoxime have an asymmetric structure."
  },
  {
    "text": "AChE was easier reactivated after paraoxon treatment",
    "triple_list": [
      [
        "AChE",
        "CPR:3",
        "paraoxon"
      ]
    ],
    "updated": "No",
    "original": "AChE was easier reactivated after paraoxon treatment",
    "simplified": "AChE was easier to get back after treatment."
  },
  {
    "text": "All compounds showed low activity toward inhibition of AChE caused by dichlorvos",
    "triple_list": [
      [
        "AChE",
        "CPR:4",
        "dichlorvos"
      ]
    ],
    "updated": "No",
    "original": "All compounds showed low activity toward inhibition of AChE caused by dichlorvos",
    "simplified": "All compounds showed low activity when dichlorvos was applied to them."
  },
  {
    "text": "Reactivators showed different activity in the reactivation of rat brain AChE after dichlorvos paraoxon and tabun inhibition",
    "triple_list": [
      [
        "rat brain AChE",
        "CPR:4",
        "dichlorvos"
      ],
      [
        "rat brain AChE",
        "CPR:4",
        "paraoxon"
      ],
      [
        "rat brain AChE",
        "CPR:4",
        "tabun"
      ]
    ],
    "updated": "No",
    "original": "Reactivators showed different activity in the reactivation of rat brain AChE after dichlorvos paraoxon and tabun inhibition",
    "simplified": "Reactivators showed different activity after dichlorvos paraoxon was taken out of the rat's brain."
  },
  {
    "text": "Using wholecell voltage clamp we examined mibefradil block of four Na channel isoforms in human embryonic kidney cells Nav12 brain and Nav17 peripheral nerve Nav15 cardiac Nav14 skeletal muscle",
    "triple_list": [
      [
        "mibefradil",
        "CPR:4",
        "Na channel"
      ],
      [
        "mibefradil",
        "CPR:4",
        "Nav15"
      ],
      [
        "mibefradil",
        "CPR:4",
        "Nav14"
      ],
      [
        "mibefradil",
        "CPR:4",
        "Nav12"
      ],
      [
        "mibefradil",
        "CPR:4",
        "Nav17"
      ]
    ],
    "updated": "Yes",
    "original": "Using wholecell voltage clamp we examined mibefradil block of four Na channel isoforms expressed in human embryonic kidney cells Nav15 cardiac Nav14 skeletal muscle Nav12 brain and Nav17 peripheral nerve",
    "simplified": "Using wholecell voltage clamp we examined mibefradil block of four Na channel isoforms in human embryonic kidney cells Nav12 brain and Nav17 peripheral nerve Nav15 cardiac Nav14 skeletal muscle"
  },
  {
    "text": "Mibefradil blocked Nav15 in a way that shows that states visited during depolarization are more important .",
    "triple_list": [
      [
        "Mibefradil",
        "CPR:4",
        "Nav15"
      ]
    ],
    "updated": "Yes",
    "original": "Mibefradil blocked Nav15 in a usefrequencydependent manner indicating preferential binding to states visited during depolarization",
    "simplified": "Mibefradil blocked Nav15 in a way that shows that states visited during depolarization are more important."
  },
  {
    "text": "Mibefradil blocked currents of all Na channel isoforms with similar affinity and a dependence on holding potential and drug offrate was slowed at depolarized potentials koff was 0024s at 130 mV and 0007s at 100 mV for Nav15",
    "triple_list": [
      [
        "Mibefradil",
        "CPR:4",
        "Na channel"
      ],
      [
        "Mibefradil",
        "CPR:4",
        "Nav15"
      ]
    ],
    "updated": "No",
    "original": "Mibefradil blocked currents of all Na channel isoforms with similar affinity and a dependence on holding potential and drug offrate was slowed at depolarized potentials koff was 0024s at 130 mV and 0007s at 100 mV for Nav15",
    "simplified": "Mibefradil blocked currents of all Na channel isoforms with similar affinity and a dependence on holding potentials. The drug offrate (how long it takes for the drug to go away) was very high."
  },
  {
    "text": "Statedependent mibefradil block of Na channels",
    "triple_list": [
      [
        "mibefradil",
        "CPR:4",
        "Na channels"
      ]
    ],
    "updated": "No",
    "original": "Statedependent mibefradil block of Na channels",
    "simplified": "The main mibefradil block is Na 1."
  },
  {
    "text": "In addition , the Nav15 ICM MTSET did not alter the mibefradil block . This means that the drug does not preferentially interact with the fast inactivation state .",
    "triple_list": [
      [
        "Nav15",
        "CPR:4",
        "mibefradil"
      ]
    ],
    "updated": "Yes",
    "original": "In addition inhibiting the binding of the fast inactivation lid Nav15 ICM MTSET did not alter mibefradil block confirming that the drug does not preferentially interact with the fastinactivated state",
    "simplified": "In addition, the Nav15 ICM MTSET did not alter the mibefradil block. This means that the drug does not preferentially interact with the fast inactivation state."
  },
  {
    "text": "When selectively applied to channels after a 60s pulse to 10 mV mibefradil 1 microM produced 45 fractional blocks in Nav15 and greater block 88 in an isoform Nav14 , the inactivation rate is reduced .",
    "triple_list": [
      [
        "mibefradil",
        "CPR:4",
        "Nav15"
      ],
      [
        "mibefradil",
        "CPR:4",
        "Nav14"
      ]
    ],
    "updated": "Yes",
    "original": "When selectively applied to channels after inducing slow inactivation with a 60s pulse to 10 mV mibefradil 1 microM produced 45 fractional block in Nav15 and greater block 88 in an isoform Nav14 that slowinactivates more completely",
    "simplified": "When selectively applied to channels after a 60s pulse to 10 mV mibefradil 1 microM produced 45 fractional blocks in Nav15 and greater block 88 in an isoform Nav14, the inactivation rate is reduced."
  },
  {
    "text": "Our results suggest that mibefradil blocks Na channels in a statedependent manner that probably involves interaction with one or more slowinactivated states , but not with fast inactivation .",
    "triple_list": [
      [
        "mibefradil",
        "CPR:4",
        "Na channels"
      ]
    ],
    "updated": "Yes",
    "original": "Our results suggest that mibefradil blocks Na channels in a statedependent manner that does not depend on fast inactivation but probably involves interaction with one or more slowinactivated states",
    "simplified": "Our results suggest that mibefradil blocks Na channels in a statedependent manner that probably involves interaction with one or more slowinactivated states, but not with fast inactivation."
  },
  {
    "text": "Mibefradil is a Ttype Ca2 channel antagonist with reported crossreactivity with other classes of ion channels including K Cl and Na channels",
    "triple_list": [
      [
        "Mibefradil",
        "CPR:6",
        "Ttype Ca2 channel"
      ]
    ],
    "updated": "No",
    "original": "Mibefradil is a Ttype Ca2 channel antagonist with reported crossreactivity with other classes of ion channels including K Cl and Na channels",
    "simplified": "Mibefradil is a drug that works by blocking the Ca2 channel. It also works against other ion channels like K Cl and Na."
  },
  {
    "text": "Docetaxel is a semisynthetic taxane that inhibit tumor growth by induction of microtubule stabilization and promotion of bcl2 inactivation which induce apoptosis",
    "triple_list": [
      [
        "Docetaxel",
        "CPR:4",
        "bcl2"
      ],
      [
        "taxane",
        "CPR:4",
        "bcl2"
      ]
    ],
    "updated": "No",
    "original": "Docetaxel is a semisynthetic taxane that inhibit tumor growth by induction of microtubule stabilization and promotion of bcl2 inactivation which induce apoptosis",
    "simplified": "Docetaxel is a semisynthetic taxane. It inhibits the growth of cancer cells by stabilizing the microtubule and by causing apoptosis."
  },
  {
    "text": "Both risperidone and 9hydroxyrisperidone change the way the Pglycoprotein Pgp works . This changes how the drug can be taken in .",
    "triple_list": [
      [
        "risperidone",
        "CPR:9",
        "Pglycoprotein"
      ],
      [
        "risperidone",
        "CPR:9",
        "Pgp"
      ],
      [
        "9hydroxyrisperidone",
        "CPR:9",
        "Pglycoprotein"
      ],
      [
        "9hydroxyrisperidone",
        "CPR:9",
        "Pgp"
      ]
    ],
    "updated": "Yes",
    "original": "Both risperidone and 9hydroxyrisperidone are substrates of Pglycoprotein Pgp a transport protein involved in drug absorption distribution and elimination",
    "simplified": "Both risperidone and 9hydroxyrisperidone change the way the Pglycoprotein Pgp works. This changes how the drug can be taken in."
  },
  {
    "text": "Risperidone is metabolized to its active metabolite 9hydroxyrisperidone mainly by the cytochrome P450 enzymes CYP2D6 and 3A4",
    "triple_list": [
      [
        "9hydroxyrisperidone",
        "CPR:9",
        "cytochrome P450"
      ],
      [
        "Risperidone",
        "CPR:9",
        "cytochrome P450"
      ]
    ],
    "updated": "No",
    "original": "Risperidone is metabolized to its active metabolite 9hydroxyrisperidone mainly by the cytochrome P450 enzymes CYP2D6 and 3A4",
    "simplified": "Risperidone is metabolized to 9hydroxyrisperidone by the enzymes CYP2D6 and 3A4 in the human body."
  },
  {
    "text": "SL11158 inhibited SSAT activity with a mixed type of inhibition . The natural substrate spermine had a 70fold higher affinity for the enzyme than SL11158 .",
    "triple_list": [
      [
        "SL11158",
        "CPR:4",
        "SSAT"
      ]
    ],
    "updated": "Yes",
    "original": "SL11158 inhibited SSAT activity with a mixed type of inhibition in which the analogue had a 70fold higher affinity for the enzyme than the natural substrate spermine",
    "simplified": "SL11158 inhibited SSAT activity with a mixed type of inhibition. The natural substrate spermine had a 70fold higher affinity for the enzyme than SL11158."
  },
  {
    "text": "bisEthyl oligoamine analogues of polyamines such as SL11144 and SL11158 as well as arylamine analogues BW1 a bisphenylbenzyl 373 analogue blocked uptake and interconversion of spermine at micromolar levels and in the case of BW1 acted as substrate for PAO",
    "triple_list": [
      [
        "BW1",
        "CPR:9",
        "PAO"
      ]
    ],
    "updated": "No",
    "original": "bisEthyl oligoamine analogues of polyamines such as SL11144 and SL11158 as well as arylamine analogues BW1 a bisphenylbenzyl 373 analogue blocked uptake and interconversion of spermine at micromolar levels and in the case of BW1 acted as substrate for PAO",
    "simplified": "BisEthyl oligoamine analogues of polyamines such as SL11144 and SL11158 as well as arylamine analogues such as BW1 have been found. BW1 blocked the uptake and interconversion of spermine at micromolar levels."
  },
  {
    "text": "A series of pyridoquinazolines have been synthesised characterised and tested for their in vitro EGFR tyrosine kinase inhibitory activity",
    "triple_list": [
      [
        "pyridoquinazolines",
        "CPR:4",
        "EGFR"
      ],
      [
        "pyridoquinazolines",
        "CPR:4",
        "tyrosine kinase"
      ]
    ],
    "updated": "No",
    "original": "A series of pyridoquinazolines have been synthesised characterised and tested for their in vitro EGFR tyrosine kinase inhibitory activity",
    "simplified": "A series of pyridoquinazolines have been developed. They have been shown to inhibit the tyrosine kinase in vitro."
  },
  {
    "text": "Synthesis and in vitro evaluation of NAryl pyridoquinazolines derivatives as potent EGFR inhibitors",
    "triple_list": [
      [
        "NAryl pyridoquinazolines",
        "CPR:4",
        "EGFR"
      ]
    ],
    "updated": "No",
    "original": "Synthesis and in vitro evaluation of NAryl pyridoquinazolines derivatives as potent EGFR inhibitors",
    "simplified": "NAryl pyridoquinazolines can be used to inhibit the growth of certain bacteria."
  },
  {
    "text": "Exposure to Cu NPs decreased cell viability to 73 p001 and significantly p005 . In addition , lactate dehydrogenase intracellular reactive oxygen species and interleukin8 were significantly increased by Cu NPs .",
    "triple_list": [
      [
        "Cu",
        "CPR:3",
        "interleukin8"
      ],
      [
        "Cu",
        "CPR:3",
        "lactate dehydrogenase"
      ]
    ],
    "updated": "Yes",
    "original": "Exposure to Cu NPs decreased cell viability to 73 p001 and significantly p005 elevated levels of lactate dehydrogenase intracellular reactive oxygen species and interleukin8 that mirrored our findings from subacute in vivo inhalation studies in mice",
    "simplified": "Exposure to Cu NPs decreased cell viability to 73 p001 and significantly p005. In addition, lactate dehydrogenase intracellular reactive oxygen species and interleukin8 were significantly increased by Cu NPs."
  },
  {
    "text": "The TXM peptides were effective in inhibiting AuF caused MAPK JNK and p38 MAPK phosphorylation . In addition , they were effective in preventing caspase3 cleavage .",
    "triple_list": [
      [
        "AuF",
        "CPR:3",
        "MAPK"
      ],
      [
        "AuF",
        "CPR:3",
        "JNK"
      ],
      [
        "AuF",
        "CPR:3",
        "p38"
      ],
      [
        "AuF",
        "CPR:3",
        "MAPK"
      ]
    ],
    "updated": "Yes",
    "original": "The TXM peptides were effective in inhibiting AuF induced MAPK JNK and p38 MAPK phosphorylation in correlation with preventing caspase3 cleavage and thereby PARP1 dissociation",
    "simplified": "The TXM peptides were effective in inhibiting AuF caused MAPK JNK and p38 MAPK phosphorylation. In addition, they were effective in preventing caspase3 cleavage."
  },
  {
    "text": "The Trx mimetics peptides TXM protected insulinoma INS 83213 cells from oxidative stress induced by selectively inhibiting TrxR with auranofin AuF",
    "triple_list": [
      [
        "TrxR",
        "CPR:4",
        "auranofin"
      ],
      [
        "TrxR",
        "CPR:4",
        "AuF"
      ]
    ],
    "updated": "No",
    "original": "The Trx mimetics peptides TXM protected insulinoma INS 83213 cells from oxidative stress induced by selectively inhibiting TrxR with auranofin AuF",
    "simplified": "The Trx mimetics peptides TXM and TXR protected insulinoma cells from damage by auranofin when they were under oxidative stress."
  },
  {
    "text": "Compared with WT DeltaKPQ INa was more sensitive to flecainide . Flecainide was more sensitive to late INa mean current between 20 and 235 ms after depolarization .",
    "triple_list": [
      [
        "DeltaKPQ",
        "CPR:4",
        "flecainide"
      ],
      [
        "DeltaKPQ",
        "CPR:4",
        "flecainide"
      ]
    ],
    "updated": "Yes",
    "original": "Compared with WT DeltaKPQ INa was more sensitive to flecainide and flecainide preferentially inhibited late INa mean current between 20 and 235 ms after depolarization compared with peak INa",
    "simplified": "Compared with WT DeltaKPQ INa was more sensitive to flecainide. Flecainide was more sensitive to late INa mean current between 20 and 235 ms after depolarization."
  },
  {
    "text": "Flecainide block of Na current INa was investigated in wildtype WT or the long QT syndrome 3 LQT3 sodium channel alpha subunit mutation with three amino acids deleted DeltaKPQ stably transfected into human embryonic kidney 293 cells using wholecell patchclamp recordings",
    "triple_list": [
      [
        "Flecainide",
        "CPR:4",
        "DeltaKPQ"
      ],
      [
        "Flecainide",
        "CPR:4",
        "long QT syndrome 3 LQT3 sodium channel alpha"
      ]
    ],
    "updated": "No",
    "original": "Flecainide block of Na current INa was investigated in wildtype WT or the long QT syndrome 3 LQT3 sodium channel alpha subunit mutation with three amino acids deleted DeltaKPQ stably transfected into human embryonic kidney 293 cells using wholecell patchclamp recordings",
    "simplified": "Fleckainide block of Na current INa was investigated in wildtype WT or the long QT syndrome 3 LQT3 sodium channel alpha subunit mutation in human embryonic kidney 293 cells using wholecell patchclamp recordings."
  },
  {
    "text": "Antiarrhythmic block of late sodium current in the LQT3 DeltaKPQ mutant by the class IC flecainide",
    "triple_list": [
      [
        "LQT3 DeltaKPQ mutant",
        "CPR:4",
        "flecainide"
      ]
    ],
    "updated": "Yes",
    "original": "Preferential block of late sodium current in the LQT3 DeltaKPQ mutant by the class IC antiarrhythmic flecainide",
    "simplified": "Antiarrhythmic block of late sodium current in the LQT3 DeltaKPQ mutant by the class IC flecainide"
  },
  {
    "text": "DeltaKPQ does not work the same way with flecainide as it does with WT . This means that recovery is slower , especially for late INa .",
    "triple_list": [
      [
        "DeltaKPQ",
        "CPR:4",
        "flecainide"
      ]
    ],
    "updated": "Yes",
    "original": "We conclude that DeltaKPQ interacts differently with flecainide than with WT leading to increased block and slowed recovery especially for late INa",
    "simplified": "DeltaKPQ does not work the same way with flecainide as it does with WT. This means that recovery is slower, especially for late INa."
  },
  {
    "text": "Both 5AMN and 5MABN had high affinity for \u03bareceptors K i 136 \u00b1 098 and 027 \u00b1 008 respectively . In the ileum , pA2 762 and 785 had high affinity for \u03bcreceptor pA2 743 and 818 respectively .",
    "triple_list": [
      [
        "5AMN",
        "CPR:6",
        "\u03bcreceptor"
      ],
      [
        "5MABN",
        "CPR:6",
        "\u03bcreceptor"
      ]
    ],
    "updated": "Yes",
    "original": "Both 5AMN and 5MABN had high affinity for \u03bareceptors K i 136 \u00b1 098 and 027 \u00b1 008 respectively and were revealed as potent \u03baantagonists pA2 743 and 818 respectively and \u03bcreceptor antagonists pA2 762 and 785 respectively in the ileum",
    "simplified": "Both 5AMN and 5MABN had high affinity for \u03bareceptors K i 136 \u00b1 098 and 027 \u00b1 008 respectively. In the ileum, pA2 762 and 785 had high affinity for \u03bcreceptor pA2 743 and 818 respectively."
  },
  {
    "text": "Pololike kinase2 Plk2 is a potential therapeutic target for Parkinsons disease . A series of dihydropteridinone based Plk2 inhibitors have been developed .",
    "triple_list": [
      [
        "Plk2",
        "CPR:4",
        "dihydropteridinone"
      ]
    ],
    "updated": "Yes",
    "original": "Pololike kinase2 Plk2 is a potential therapeutic target for Parkinsons disease and this Letter describes the SAR of a series of dihydropteridinone based Plk2 inhibitors",
    "simplified": "Pololike kinase2 Plk2 is a potential therapeutic target for Parkinsons disease. A series of dihydropteridinone based Plk2 inhibitors have been developed."
  },
  {
    "text": "Sphingosine1phosphate causes the nuclear translocation of \u03b2catenin . This causes the gene expression of osteoprotegerin to be increased .",
    "triple_list": [
      [
        "Sphingosine1phosphate",
        "CPR:3",
        "osteoprotegerin"
      ]
    ],
    "updated": "Yes",
    "original": "Sphingosine1phosphate promotes the nuclear translocation of \u03b2catenin and thereby induces osteoprotegerin gene expression in osteoblastlike cell lines",
    "simplified": "Sphingosine1phosphate causes the nuclear translocation of \u03b2catenin. This causes the gene expression of osteoprotegerin to be increased."
  },
  {
    "text": "S1P increased the amount of osteoprotegerin at both protein and mRNA levels . It also increased the activity of alkaline phosphatase .",
    "triple_list": [
      [
        "S1P",
        "CPR:3",
        "osteoprotegerin"
      ]
    ],
    "updated": "Yes",
    "original": "S1P increased the amount of osteoprotegerin at both mRNA and protein levels and increased the activity of alkaline phosphatase leading to the mineralization",
    "simplified": "S1P increased the amount of osteoprotegerin at both protein and mRNA levels. It also increased the activity of alkaline phosphatase."
  },
  {
    "text": "These findings suggest that S1P activates the PI3K Akt signaling pathway leading to the promotion of nuclear translocation of \u03b2catenin in osteoblastlike cells resulting in the upregulation of osteoptotegerin and osteoblast differentiation markers including alkaline phosphatase probably relating to the inhibition of osteoclast formation and the mineralization respectively",
    "triple_list": [
      [
        "S1P",
        "CPR:3",
        "PI3K"
      ],
      [
        "S1P",
        "CPR:3",
        "Akt"
      ],
      [
        "S1P",
        "CPR:3",
        "\u03b2catenin"
      ],
      [
        "S1P",
        "CPR:3",
        "osteoptotegerin"
      ],
      [
        "S1P",
        "CPR:3",
        "alkaline phosphatase"
      ]
    ],
    "updated": "No",
    "original": "These findings suggest that S1P activates the PI3K Akt signaling pathway leading to the promotion of nuclear translocation of \u03b2catenin in osteoblastlike cells resulting in the upregulation of osteoptotegerin and osteoblast differentiation markers including alkaline phosphatase probably relating to the inhibition of osteoclast formation and the mineralization respectively",
    "simplified": "These findings suggest that S1P activates the PI3K Akt signaling pathway leading to the promotion of nuclear translocation of \u03b2catenin in osteoblastlike cells resulting in the upregulation of osteoptotegerin and osteoblast differentiation markers, which in turn lead to the growth of the osteoclast."
  },
  {
    "text": "S1P activated phosphatidylinositol 3kinase PI3K Akt signaling leading to the inhibition of glycogen synthase kinase3\u03b2 and the nuclear translocation of \u03b2catenin . In both SaOS2 cells and MC3T3E1 cells , the transcriptional activity of \u03b2catenin was increased .",
    "triple_list": [
      [
        "S1P",
        "CPR:3",
        "phosphatidylinositol 3kinase"
      ],
      [
        "S1P",
        "CPR:3",
        "PI3K"
      ],
      [
        "S1P",
        "CPR:3",
        "Akt"
      ],
      [
        "S1P",
        "CPR:4",
        "glycogen synthase kinase3\u03b2"
      ]
    ],
    "updated": "Yes",
    "original": "S1P activated phosphatidylinositol 3kinase PI3K Akt signaling leading to the inhibition of glycogen synthase kinase3\u03b2 and the nuclear translocation of \u03b2catenin followed by the increase of the transcriptional activity by \u03b2cateninTcell factor complex formation in both SaOS2 cells and MC3T3E1 cells",
    "simplified": "S1P activated phosphatidylinositol 3kinase PI3K Akt signaling leading to the inhibition of glycogen synthase kinase3\u03b2 and the nuclear translocation of \u03b2catenin. In both SaOS2 cells and MC3T3E1 cells, the transcriptional activity of \u03b2catenin was increased."
  },
  {
    "text": "Plerixafor AMD3100 Genzyme Corporation is a bicyclam molecule that antagonizes the binding of the chemokine stromal cellderived factor1 SDF1 to its cognate receptor CXCR4",
    "triple_list": [
      [
        "Plerixafor",
        "CPR:4",
        "stromal cellderived factor1"
      ],
      [
        "Plerixafor",
        "CPR:4",
        "SDF1"
      ],
      [
        "Plerixafor",
        "CPR:4",
        "CXCR4"
      ],
      [
        "Plerixafor",
        "CPR:4",
        "chemokine"
      ],
      [
        "AMD3100",
        "CPR:4",
        "stromal cellderived factor1"
      ],
      [
        "AMD3100",
        "CPR:4",
        "SDF1"
      ],
      [
        "AMD3100",
        "CPR:4",
        "CXCR4"
      ],
      [
        "AMD3100",
        "CPR:4",
        "chemokine"
      ],
      [
        "bicyclam",
        "CPR:4",
        "stromal cellderived factor1"
      ],
      [
        "bicyclam",
        "CPR:4",
        "SDF1"
      ],
      [
        "bicyclam",
        "CPR:4",
        "CXCR4"
      ],
      [
        "bicyclam",
        "CPR:4",
        "chemokine"
      ]
    ],
    "updated": "No",
    "original": "Plerixafor AMD3100 Genzyme Corporation is a bicyclam molecule that antagonizes the binding of the chemokine stromal cellderived factor1 SDF1 to its cognate receptor CXCR4",
    "simplified": "Plerixafor AMD3100 Genzyme Corporation is a bicyclam molecule. It acts on the chemokine stromal cell derived factor1 (SDF1) and makes it not work at all."
  },
  {
    "text": "Plerixafor the mobilization of hematopoietic stem cells ( CXCR4 )",
    "triple_list": [
      [
        "Plerixafor",
        "CPR:6",
        "CXCR4"
      ]
    ],
    "updated": "Yes",
    "original": "Plerixafor a CXCR4 antagonist for the mobilization of hematopoietic stem cells",
    "simplified": "Plerixafor the mobilization of hematopoietic stem cells (CXCR4)"
  },
  {
    "text": "This stimulation was attenuated by the Pak inhibitor 22dihydroxy11dinaphthyldisulfide IPA3 or dominantnegative Pak1",
    "triple_list": [
      [
        "Pak",
        "CPR:4",
        "22dihydroxy11dinaphthyldisulfide"
      ],
      [
        "Pak",
        "CPR:4",
        "IPA3"
      ]
    ],
    "updated": "No",
    "original": "This stimulation was attenuated by the Pak inhibitor 22dihydroxy11dinaphthyldisulfide IPA3 or dominantnegative Pak1",
    "simplified": "22dihydroxy11dinaphthyldisulfide IPA3 or dominantnegative Pak1 reduced this stimulation."
  },
  {
    "text": "Chronic insulin 24 h activates NHE3 through the classic phosphatidylinositol 3kinase serum and glucocorticoiddependent kinase 1 pathway ( PI3KSGK1 ) and the insulin effect can be blocked by the PI3K inhibitor wortmannin .",
    "triple_list": [
      [
        "phosphatidylinositol 3kinase",
        "CPR:4",
        "wortmannin"
      ],
      [
        "PI3K",
        "CPR:4",
        "wortmannin"
      ],
      [
        "PI3K",
        "CPR:4",
        "wortmannin"
      ]
    ],
    "updated": "Yes",
    "original": "Chronic insulin 24 h activates NHE3 through the classic phosphatidylinositol 3kinase serum and glucocorticoiddependent kinase 1 PI3KSGK1 pathway as insulin stimulates SGK1 phosphorylation and the insulin effect can be blocked by the PI3K inhibitor wortmannin or a dominantnegative SGK1",
    "simplified": "Chronic insulin 24 h activates NHE3 through the classic phosphatidylinositol 3kinase serum and glucocorticoiddependent kinase 1 pathway (PI3KSGK1) and the insulin effect can be blocked by the PI3K inhibitor wortmannin."
  },
  {
    "text": "Results showed that when quinpirole was given to babies , D2 priming was removed by olanzapine .",
    "triple_list": [
      [
        "quinpirole",
        "CPR:3",
        "D2"
      ],
      [
        "D2",
        "CPR:4",
        "olanzapine"
      ]
    ],
    "updated": "Yes",
    "original": "Results showed that neonatal quinpirole treatment induced D2 priming that was eliminated by olanzapine treatment",
    "simplified": "Results showed that when quinpirole was given to babies, D2 priming was removed by olanzapine."
  },
  {
    "text": "Brain tissue analyses revealed that neonatal quinpirole treatment produced a significant decrease in hippocampal NGF BDNF and ChAT that was eliminated by olanzapine treatment",
    "triple_list": [
      [
        "NGF",
        "CPR:3",
        "olanzapine"
      ],
      [
        "BDNF",
        "CPR:3",
        "olanzapine"
      ],
      [
        "ChAT",
        "CPR:3",
        "olanzapine"
      ],
      [
        "quinpirole",
        "CPR:4",
        "NGF"
      ],
      [
        "quinpirole",
        "CPR:4",
        "BDNF"
      ],
      [
        "quinpirole",
        "CPR:4",
        "ChAT"
      ]
    ],
    "updated": "No",
    "original": "Brain tissue analyses revealed that neonatal quinpirole treatment produced a significant decrease in hippocampal NGF BDNF and ChAT that was eliminated by olanzapine treatment",
    "simplified": "Brain tissue analysis showed that neonatal quinpirole treatment produced a significant decrease in ChAT and BDNF in the hippocampus. This was not true with olanzapine."
  },
  {
    "text": "Neonatal quinpirole treatment produced a significant decrease in ChAT and BDNF in the frontal cortex that was not affected by olanzapine .",
    "triple_list": [
      [
        "quinpirole",
        "CPR:4",
        "BDNF"
      ],
      [
        "quinpirole",
        "CPR:4",
        "ChAT"
      ]
    ],
    "updated": "Yes",
    "original": "Neonatal quinpirole treatment produced a significant decrease in BDNF and ChAT in the frontal cortex that was unaffected by olanzapine treatment",
    "simplified": "Neonatal quinpirole treatment produced a significant decrease in ChAT and BDNF in the frontal cortex that was not affected by olanzapine."
  },
  {
    "text": "These results show that olanzapine eliminates cognitive impairment and D2 receptor priming and also reduces decreases in neurotrophins and acetylcholinergic markers in the hippocampus .",
    "triple_list": [
      [
        "olanzapine",
        "CPR:4",
        "D2 receptor"
      ]
    ],
    "updated": "Yes",
    "original": "These results show that olanzapine eliminates D2 receptor priming and cognitive impairment and also alleviates decreases in neurotrophins and acetylcholinergic markers produced by D2 priming in the hippocampus",
    "simplified": "These results show that olanzapine eliminates cognitive impairment and D2 receptor priming and also reduces decreases in neurotrophins and acetylcholinergic markers in the hippocampus."
  },
  {
    "text": "Pinosylvin inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1 cyclin E cyclin A cyclin dependent kinase 2 CDK2 CDK4 cMyc and retinoblastoma protein pRb and the upregulation of p21 WAF1 CIP1 and p53",
    "triple_list": [
      [
        "Pinosylvin",
        "CPR:3",
        "p21"
      ],
      [
        "Pinosylvin",
        "CPR:3",
        "WAF1"
      ],
      [
        "Pinosylvin",
        "CPR:3",
        "CIP1"
      ],
      [
        "Pinosylvin",
        "CPR:3",
        "p53"
      ],
      [
        "Pinosylvin",
        "CPR:4",
        "cyclin D1"
      ],
      [
        "Pinosylvin",
        "CPR:4",
        "cyclin E"
      ],
      [
        "Pinosylvin",
        "CPR:4",
        "cyclin A"
      ],
      [
        "Pinosylvin",
        "CPR:4",
        "cyclin dependent kinase 2"
      ],
      [
        "Pinosylvin",
        "CPR:4",
        "CDK2"
      ],
      [
        "Pinosylvin",
        "CPR:4",
        "CDK4"
      ],
      [
        "Pinosylvin",
        "CPR:4",
        "cMyc"
      ],
      [
        "Pinosylvin",
        "CPR:4",
        "retinoblastoma protein"
      ],
      [
        "Pinosylvin",
        "CPR:4",
        "pRb"
      ]
    ],
    "updated": "No",
    "original": "Pinosylvin inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1 cyclin E cyclin A cyclin dependent kinase 2 CDK2 CDK4 cMyc and retinoblastoma protein pRb and the upregulation of p21 WAF1 CIP1 and p53",
    "simplified": "Pinosylvin inhibited the proliferation of HCT 116 cells by stopping the cell cycle from G1 to S phase. This was done by reducing the amount of cyclin D1 cyclin E cyclin A cyclin dependent kinase 2 CDK2 CDK4 cMyc and retinoblastoma protein pRb."
  },
  {
    "text": "Pinosylvin was also found to attenuate the activation of proteins involved in f ocal adhesion kinase FAK cSrc extracellular signalregulated kinase ERK signaling and phosphoinositide 3kinase PI3K Akt glycogen synthase kinase 3\u03b2 GSK3\u03b2 signaling pathway",
    "triple_list": [
      [
        "Pinosylvin",
        "CPR:4",
        "ocal adhesion kinase"
      ],
      [
        "Pinosylvin",
        "CPR:4",
        "FAK"
      ],
      [
        "Pinosylvin",
        "CPR:4",
        "cSrc"
      ],
      [
        "Pinosylvin",
        "CPR:4",
        "extracellular signalregulated kinase"
      ],
      [
        "Pinosylvin",
        "CPR:4",
        "ERK"
      ],
      [
        "Pinosylvin",
        "CPR:4",
        "phosphoinositide 3kinase"
      ],
      [
        "Pinosylvin",
        "CPR:4",
        "PI3K"
      ],
      [
        "Pinosylvin",
        "CPR:4",
        "Akt"
      ],
      [
        "Pinosylvin",
        "CPR:4",
        "glycogen synthase kinase 3\u03b2"
      ],
      [
        "Pinosylvin",
        "CPR:4",
        "GSK3\u03b2"
      ]
    ],
    "updated": "No",
    "original": "Pinosylvin was also found to attenuate the activation of proteins involved in f ocal adhesion kinase FAK cSrc extracellular signalregulated kinase ERK signaling and phosphoinositide 3kinase PI3K Akt glycogen synthase kinase 3\u03b2 GSK3\u03b2 signaling pathway",
    "simplified": "Pinosylvin has also been found to reduce the activation of proteins involved in the signalling pathways of the immune system. These proteins include f ocal adhesion kinase FAK cSrc and phosphoinositide 3kinase PI3K."
  },
  {
    "text": "Subsequently pinosylvin suppressed the nuclear translocation of \u03b2catenin one of downstream molecules of PI3K Akt GSK3\u03b2 signaling and these events led to the sequential downregulation of \u03b2cateninmediated transcription of target genes including BMP4 ID2 survivin cyclin D1 MMP7 and cMyc",
    "triple_list": [
      [
        "pinosylvin",
        "CPR:4",
        "\u03b2catenin"
      ],
      [
        "pinosylvin",
        "CPR:4",
        "PI3K"
      ],
      [
        "pinosylvin",
        "CPR:4",
        "Akt"
      ],
      [
        "pinosylvin",
        "CPR:4",
        "GSK3\u03b2"
      ],
      [
        "pinosylvin",
        "CPR:4",
        "\u03b2catenin"
      ],
      [
        "pinosylvin",
        "CPR:4",
        "BMP4"
      ],
      [
        "pinosylvin",
        "CPR:4",
        "ID2"
      ],
      [
        "pinosylvin",
        "CPR:4",
        "survivin"
      ],
      [
        "pinosylvin",
        "CPR:4",
        "cyclin D1"
      ],
      [
        "pinosylvin",
        "CPR:4",
        "MMP7"
      ],
      [
        "pinosylvin",
        "CPR:4",
        "cMyc"
      ]
    ],
    "updated": "No",
    "original": "Subsequently pinosylvin suppressed the nuclear translocation of \u03b2catenin one of downstream molecules of PI3K Akt GSK3\u03b2 signaling and these events led to the sequential downregulation of \u03b2cateninmediated transcription of target genes including BMP4 ID2 survivin cyclin D1 MMP7 and cMyc",
    "simplified": "Pinosylvin stopped the nuclear translocation of \u03b2catenin one of the downstream molecules of PI3K Akt GSK3\u03b2 signaling. This caused the transcription of many genes to stop. These genes include BMP4 ID2 survivin cyclin D1 MMP7 and cMyc."
  },
  {
    "text": "Suppression of Src ERK and GSK3 \u03b2catenin signaling by pinosylvin inhibits the growth of human colorectal cancer cells",
    "triple_list": [
      [
        "Src",
        "CPR:4",
        "pinosylvin"
      ],
      [
        "ERK",
        "CPR:4",
        "pinosylvin"
      ],
      [
        "GSK3",
        "CPR:4",
        "pinosylvin"
      ],
      [
        "\u03b2catenin",
        "CPR:4",
        "pinosylvin"
      ]
    ],
    "updated": "No",
    "original": "Suppression of Src ERK and GSK3 \u03b2catenin signaling by pinosylvin inhibits the growth of human colorectal cancer cells",
    "simplified": "Pinosylvin inhibits the growth of human colorectal cancer cells by reducing Src ERK and GSK3 signaling."
  },
  {
    "text": "Overall higher alcohol production was reduced by taking in more ammonium . This was also found to reduce the number of genes that encode decarboxylases and dehydrogenases .",
    "triple_list": [
      [
        "ammonium",
        "CPR:4",
        "decarboxylases"
      ],
      [
        "ammonium",
        "CPR:4",
        "dehydrogenases"
      ]
    ],
    "updated": "Yes",
    "original": "Overall higher alcohol production was reduced by ammonium supplementation and this can be correlated with a general downregulation of genes encoding decarboxylases and dehydrogenases of the Ehrlich pathway",
    "simplified": "Overall higher alcohol production was reduced by taking in more ammonium. This was also found to reduce the number of genes that encode decarboxylases and dehydrogenases."
  },
  {
    "text": "Nitrooxy derivatives showed NOdependent vasorelaxing properties while most of the compounds proved to be very good at removing COX2 from the blood .",
    "triple_list": [
      [
        "Nitrooxy",
        "CPR:4",
        "COX2"
      ]
    ],
    "updated": "Yes",
    "original": "Nitrooxy derivatives showed NOdependent vasorelaxing properties while most of the compounds proved to be very potent and selective COX2 inhibitors in in vitro experimental models",
    "simplified": "Nitrooxy derivatives showed NOdependent vasorelaxing properties while most of the compounds proved to be very good at removing COX2 from the blood."
  },
  {
    "text": "Novel analgesicantiinflammatory agents 15diarylpyrrole nitrooxyalkyl ethers and related compounds as cyclooxygenase2 inhibiting nitric oxide donors",
    "triple_list": [
      [
        "cyclooxygenase2",
        "CPR:4",
        "nitric oxide"
      ],
      [
        "15diarylpyrrole nitrooxyalkyl ethers",
        "CPR:4",
        "cyclooxygenase2"
      ]
    ],
    "updated": "No",
    "original": "Novel analgesicantiinflammatory agents 15diarylpyrrole nitrooxyalkyl ethers and related compounds as cyclooxygenase2 inhibiting nitric oxide donors",
    "simplified": "Newer analgesic agents 15diarylpyrrole nitrooxyalkyl ethers and related compounds are used to treat pain and inflammation."
  },
  {
    "text": "New classes of pyrrole derived nitrooxyalkyl inverse esters carbonates and ethers 710 as COX2 selective inhibitors and NO donors were synthesized and are herein reported",
    "triple_list": [
      [
        "pyrrole",
        "CPR:4",
        "COX2"
      ],
      [
        "nitrooxyalkyl",
        "CPR:4",
        "COX2"
      ],
      [
        "esters",
        "CPR:4",
        "COX2"
      ],
      [
        "carbonates",
        "CPR:4",
        "COX2"
      ],
      [
        "ethers",
        "CPR:4",
        "COX2"
      ]
    ],
    "updated": "No",
    "original": "New classes of pyrrole derived nitrooxyalkyl inverse esters carbonates and ethers 710 as COX2 selective inhibitors and NO donors were synthesized and are herein reported",
    "simplified": "New classes of nitrooxyalkyl inverse esters carbonates and ethers 710 as COX2 selective inhibitors and NO donors have been developed."
  },
  {
    "text": "The drug eprosartan is an angiotensin II receptor blocker .",
    "triple_list": [
      [
        "angiotensin II receptor",
        "CPR:4",
        "eprosartan"
      ]
    ],
    "updated": "Yes",
    "original": "The clinical profile of the angiotensin II receptor blocker eprosartan",
    "simplified": "The drug eprosartan is an angiotensin II receptor blocker."
  },
  {
    "text": "In clinical trials eprosartan has proven to be at least as effective as the ACE inhibitor enalapril in reducing BP but with a significantly lower incidence of side effects",
    "triple_list": [
      [
        "eprosartan",
        "CPR:4",
        "ACE"
      ]
    ],
    "updated": "No",
    "original": "In clinical trials eprosartan has proven to be at least as effective as the ACE inhibitor enalapril in reducing BP but with a significantly lower incidence of side effects",
    "simplified": "In clinical trials, eprosartan has been found to be at least as effective as the drug enalapril. However, side effects have been much less common."
  },
  {
    "text": "In the CCl4 hepatotoxicity model , pretreatment with PSM or silymarin made ethylmorphineNdemethylase and aniline 4hydroxylase work much better , but cytochrome P450 did not work at all .",
    "triple_list": [
      [
        "silymarin",
        "CPR:3",
        "ethylmorphineNdemethylase"
      ],
      [
        "silymarin",
        "CPR:3",
        "aniline 4hydroxylase"
      ],
      [
        "silymarin",
        "CPR:3",
        "cytochrome P450"
      ],
      [
        "CCl4",
        "CPR:3",
        "ethylmorphineNdemethylase"
      ],
      [
        "CCl4",
        "CPR:3",
        "aniline 4hydroxylase"
      ],
      [
        "CCl4",
        "CPR:3",
        "cytochrome P450"
      ]
    ],
    "updated": "Yes",
    "original": "In the CCl4 hepatotoxicity model pretreatment with PSM or silymarin resulted in significantly increased activities of ethylmorphineNdemethylase and aniline 4hydroxylase activity and cytochrome P450 compared to the CCl4 only group",
    "simplified": "In the CCl4 hepatotoxicity model, pretreatment with PSM or silymarin made ethylmorphineNdemethylase and aniline 4hydroxylase work much better, but cytochrome P450 did not work at all."
  },
  {
    "text": "A significant decrease of aspartate aminotransferase alanine aminotransferase lactate dehydrogenase LDH activities and glutathione GSH levels and an increase of malondialdehyde MDA quantity was observed after CCl4 and PC administration alone",
    "triple_list": [
      [
        "aspartate aminotransferase",
        "CPR:4",
        "CCl4"
      ],
      [
        "alanine aminotransferase",
        "CPR:4",
        "CCl4"
      ],
      [
        "lactate dehydrogenase",
        "CPR:4",
        "CCl4"
      ],
      [
        "LDH",
        "CPR:4",
        "CCl4"
      ]
    ],
    "updated": "No",
    "original": "A significant decrease of aspartate aminotransferase alanine aminotransferase lactate dehydrogenase LDH activities and glutathione GSH levels and an increase of malondialdehyde MDA quantity was observed after CCl4 and PC administration alone",
    "simplified": "A significant decrease in the activity of aspartate aminotransferase and aspartate aminotransferase lactate dehydrogenase and an increase in the amount of malondialdehyde MDA were found after CCl4 and PC administration alone."
  },
  {
    "text": "Four prenylflavonoids kurarinone 1 a chalcone of 1 kuraridin 2 kurarinol 3 kushenol H 4 and kushenol K 5 isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on diacylglycerol acyltransferase DGAT",
    "triple_list": [
      [
        "kuraridin",
        "CPR:4",
        "diacylglycerol acyltransferase"
      ],
      [
        "kuraridin",
        "CPR:4",
        "DGAT"
      ],
      [
        "kurarinol",
        "CPR:4",
        "diacylglycerol acyltransferase"
      ],
      [
        "kurarinol",
        "CPR:4",
        "DGAT"
      ],
      [
        "kushenol H",
        "CPR:4",
        "diacylglycerol acyltransferase"
      ],
      [
        "kushenol H",
        "CPR:4",
        "DGAT"
      ],
      [
        "kushenol K",
        "CPR:4",
        "diacylglycerol acyltransferase"
      ],
      [
        "kushenol K",
        "CPR:4",
        "DGAT"
      ],
      [
        "kurarinone",
        "CPR:4",
        "diacylglycerol acyltransferase"
      ],
      [
        "kurarinone",
        "CPR:4",
        "DGAT"
      ],
      [
        "chalcone",
        "CPR:4",
        "diacylglycerol acyltransferase"
      ],
      [
        "chalcone",
        "CPR:4",
        "DGAT"
      ],
      [
        "prenylflavonoids",
        "CPR:4",
        "diacylglycerol acyltransferase"
      ],
      [
        "prenylflavonoids",
        "CPR:4",
        "DGAT"
      ]
    ],
    "updated": "No",
    "original": "Four prenylflavonoids kurarinone 1 a chalcone of 1 kuraridin 2 kurarinol 3 kushenol H 4 and kushenol K 5 isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on diacylglycerol acyltransferase DGAT",
    "simplified": "Four prenylflavonoids kurarinone 1 a chalcone of 1 kuraridin 2 kurarinol 3 kushenol H 4 and kushenol K 5 isolated from the roots of Sophora flavescens have been shown to inhibit the growth of certain bacteria."
  },
  {
    "text": "The lavandulyl side chain and the position of the hydroxy group are important for the activity of the DGAT .",
    "triple_list": [
      [
        "lavandulyl",
        "CPR:4",
        "DGAT"
      ],
      [
        "hydroxy",
        "CPR:4",
        "DGAT"
      ]
    ],
    "updated": "Yes",
    "original": "These data suggest that the lavandulyl side chain and the position of the hydroxy group are important for high DGAT inhibitory activity",
    "simplified": "The lavandulyl side chain and the position of the hydroxy group are important for the activity of the DGAT."
  },
  {
    "text": "In vitro inhibition of diacylglycerol acyltransferase by prenylflavonoids from Sophora flavescens",
    "triple_list": [
      [
        "diacylglycerol acyltransferase",
        "CPR:4",
        "prenylflavonoids"
      ]
    ],
    "updated": "No",
    "original": "In vitro inhibition of diacylglycerol acyltransferase by prenylflavonoids from Sophora flavescens",
    "simplified": "Prenylflavonoids can inhibit diacylglycerol acyltransferase in vitro, for example."
  },
  {
    "text": "The flavonoids inhibited DGAT activity in a dosedependent manner with IC50 values of 109 microM 1 98 microM 2 86 microM 3 1420 microM 4 and 250 microM 5",
    "triple_list": [
      [
        "flavonoids",
        "CPR:4",
        "DGAT"
      ]
    ],
    "updated": "No",
    "original": "The flavonoids inhibited DGAT activity in a dosedependent manner with IC50 values of 109 microM 1 98 microM 2 86 microM 3 1420 microM 4 and 250 microM 5",
    "simplified": "The flavonoids did not work at all with IC50 values of 109 microM 1. They did not work at all with IC50 values of 86 microM 3."
  },
  {
    "text": "Dexamethasone DXM decreased the expression of CXCL8 VEGF and iNOS while 1400W dihydrochloride decreased the expression of Eselectin VEGF and iNOS but not the expression of CXCL8 VEGF .",
    "triple_list": [
      [
        "iNOS",
        "CPR:4",
        "1400W dihydrochloride"
      ],
      [
        "1400W dihydrochloride",
        "CPR:4",
        "Eselectin"
      ],
      [
        "VEGF",
        "CPR:4",
        "1400W dihydrochloride"
      ],
      [
        "iNOS",
        "CPR:4",
        "1400W dihydrochloride"
      ],
      [
        "iNOS",
        "CPR:4",
        "1400W"
      ],
      [
        "1400W",
        "CPR:4",
        "Eselectin"
      ],
      [
        "VEGF",
        "CPR:4",
        "1400W"
      ],
      [
        "iNOS",
        "CPR:4",
        "1400W"
      ],
      [
        "Dexamethasone",
        "CPR:4",
        "CXCL8"
      ],
      [
        "Dexamethasone",
        "CPR:4",
        "VEGF"
      ],
      [
        "Dexamethasone",
        "CPR:4",
        "iNOS"
      ],
      [
        "DXM",
        "CPR:4",
        "CXCL8"
      ],
      [
        "DXM",
        "CPR:4",
        "VEGF"
      ],
      [
        "DXM",
        "CPR:4",
        "iNOS"
      ]
    ],
    "updated": "Yes",
    "original": "Dexamethasone DXM decreased the expression of CXCL8 VEGF and iNOS induced by reIL4 while 1400W dihydrochloride 1400W a selective inhibitor of iNOS decreased the expression of Eselectin VEGF and iNOS",
    "simplified": "Dexamethasone DXM decreased the expression of CXCL8 VEGF and iNOS while 1400W dihydrochloride decreased the expression of Eselectin VEGF and iNOS but not the expression of CXCL8 VEGF."
  },
  {
    "text": "DXM and 1400W reduced the mRNA expression of iNOS and Eselectin caused by reIL4 reTNFalpha and LPS .",
    "triple_list": [
      [
        "DXM",
        "CPR:4",
        "Eselectin"
      ],
      [
        "DXM",
        "CPR:4",
        "iNOS"
      ],
      [
        "1400W",
        "CPR:4",
        "Eselectin"
      ],
      [
        "1400W",
        "CPR:4",
        "iNOS"
      ]
    ],
    "updated": "Yes",
    "original": "DXM and 1400W attenuated the mRNA expression of Eselectin and iNOS induced by the costimulation of reIL4 reTNFalpha and LPS",
    "simplified": "DXM and 1400W reduced the mRNA expression of iNOS and Eselectin caused by reIL4 reTNFalpha and LPS."
  },
  {
    "text": "The beneficial role of 17betaestradiol on blood pressure vascular osteopontin expression perivascular fibrosis and isolated aortic rings relaxation was completely abrogated by coadministration of medroxyprogesterone acetate .",
    "triple_list": [
      [
        "17betaestradiol",
        "CPR:3",
        "osteopontin"
      ],
      [
        "osteopontin",
        "CPR:4",
        "medroxyprogesterone acetate"
      ]
    ],
    "updated": "Yes",
    "original": "The beneficial role of 17betaestradiol on blood pressure cardiac hypertrophy vascular osteopontin expression perivascular fibrosis and impaired NOdependent relaxation of isolated aortic rings was completely abrogated by coadministration of medroxyprogesterone acetate",
    "simplified": "The beneficial role of 17betaestradiol on blood pressure vascular osteopontin expression perivascular fibrosis and isolated aortic rings relaxation was completely abrogated by coadministration of medroxyprogesterone acetate."
  },
  {
    "text": "At a low pH pH 74 but not pH 79 ifenprodil reduces the mean open time of GluN1 GluN2B receptors which may be responsible for its usefulness in conditions like ischemia and stroke when the extracellular environment becomes too acidic .",
    "triple_list": [
      [
        "ifenprodil",
        "CPR:4",
        "GluN1"
      ],
      [
        "ifenprodil",
        "CPR:4",
        "GluN2B"
      ]
    ],
    "updated": "Yes",
    "original": "At a low pH pH 74 but not pH 79 ifenprodil reduces the mean open time of GluN1 GluN2B receptors which may be responsible for its usefulness as a contextdependent inhibitor in conditions like ischemia and stroke when the pH of the extracellular milieu becomes acidic",
    "simplified": "At a low pH pH 74 but not pH 79 ifenprodil reduces the mean open time of GluN1 GluN2B receptors which may be responsible for its usefulness in conditions like ischemia and stroke when the extracellular environment becomes too acidic."
  },
  {
    "text": "High glucose HG induces apoptosis of podocytes inhibits AMPK activation inactivates tuberin and activates mTOR",
    "triple_list": [
      [
        "glucose",
        "CPR:3",
        "mTOR"
      ],
      [
        "glucose",
        "CPR:4",
        "AMPK"
      ],
      [
        "glucose",
        "CPR:4",
        "tuberin"
      ]
    ],
    "updated": "No",
    "original": "High glucose HG induces apoptosis of podocytes inhibits AMPK activation inactivates tuberin and activates mTOR",
    "simplified": "High glucose causes podocytes to die and inhibits AMPK activation. It also inhibits mTOR."
  },
  {
    "text": "Pharmacological doses of the mTOR inhibitor rapamycin reduce albuminura in diabetes",
    "triple_list": [
      [
        "mTOR",
        "CPR:4",
        "rapamycin"
      ]
    ],
    "updated": "No",
    "original": "Pharmacological doses of the mTOR inhibitor rapamycin reduce albuminura in diabetes",
    "simplified": "The drug rapamycin can reduce albuminura when taken by itself."
  },
  {
    "text": "Inhibition of mTOR by low dose rapamycin decreases HGinduced Nox4 and Nox1 NADPH oxidase activity and podocyte apoptosis",
    "triple_list": [
      [
        "mTOR",
        "CPR:4",
        "rapamycin"
      ],
      [
        "rapamycin",
        "CPR:4",
        "Nox4"
      ],
      [
        "rapamycin",
        "CPR:4",
        "Nox1"
      ],
      [
        "rapamycin",
        "CPR:4",
        "NADPH oxidase"
      ]
    ],
    "updated": "No",
    "original": "Inhibition of mTOR by low dose rapamycin decreases HGinduced Nox4 and Nox1 NADPH oxidase activity and podocyte apoptosis",
    "simplified": "Inhibition of mTOR by low dose rapamycin decreases the number of damaged cells and increases healthy cells."
  },
  {
    "text": "Inhibition of mTOR by small dose of rapamycin can reduce albuminuria and glomerular injury .",
    "triple_list": [
      [
        "mTOR",
        "CPR:4",
        "rapamycin"
      ]
    ],
    "updated": "Yes",
    "original": "Inhibition of mTOR by small dose of rapamycin reduces podocyte apoptosis attenuates glomerular injury and albuminuria",
    "simplified": "Inhibition of mTOR by small dose of rapamycin can reduce albuminuria and glomerular injury."
  },
  {
    "text": "A dose of 25 microg kg1 day1 of formoterol caused greater EDL and soleus growth than salmeterol . However , betaadrenoceptor levels were lower .",
    "triple_list": [
      [
        "formoterol",
        "CPR:4",
        "betaadrenoceptor"
      ],
      [
        "salmeterol",
        "CPR:4",
        "betaadrenoceptor"
      ]
    ],
    "updated": "Yes",
    "original": "A dose of 25 microg kg1 day1 of formoterol elicited greater EDL and soleus hypertrophy than salmeterol but resulted in similar betaadrenoceptor downregulation",
    "simplified": "A dose of 25 microg kg1 day1 of formoterol caused greater EDL and soleus growth than salmeterol. However, betaadrenoceptor levels were lower."
  },
  {
    "text": "Two beta2agonists formoterol and salmeterol are approved for treating asthma and have an extended duration of action and increased safety associated with greater beta2adrenoceptor selectivity",
    "triple_list": [
      [
        "formoterol",
        "CPR:5",
        "beta2adrenoceptor"
      ],
      [
        "salmeterol",
        "CPR:5",
        "beta2adrenoceptor"
      ]
    ],
    "updated": "No",
    "original": "Two beta2agonists formoterol and salmeterol are approved for treating asthma and have an extended duration of action and increased safety associated with greater beta2adrenoceptor selectivity",
    "simplified": "Two beta2agonists formoterol and salmeterol are approved for treating asthma. They have a longer half-life, which means they can be taken for a long time."
  },
  {
    "text": "Systemic administration of beta2adrenoceptor agonists formoterol and salmeterol elicit skeletal muscle hypertrophy in rats at micromolar doses",
    "triple_list": [
      [
        "beta2adrenoceptor",
        "CPR:5",
        "formoterol"
      ],
      [
        "beta2adrenoceptor",
        "CPR:5",
        "salmeterol"
      ]
    ],
    "updated": "No",
    "original": "Systemic administration of beta2adrenoceptor agonists formoterol and salmeterol elicit skeletal muscle hypertrophy in rats at micromolar doses",
    "simplified": "Beta2adrenoceptor agonists (like formoterol and salmeterol) increase muscle mass when given to rats for a short time."
  },
  {
    "text": "Acarbose , an alphaglucosidase inhibitor , prevents the small intestine from taking in carbohydrate . This reduces hyperglycemia .",
    "triple_list": [
      [
        "Acarbose",
        "CPR:4",
        "alphaglucosidase"
      ]
    ],
    "updated": "Yes",
    "original": "Acarbose an alphaglucosidase inhibitor delays the absorption of carbohydrate from the small intestine thereby reducing postprandial hyperglycemia",
    "simplified": "Acarbose, an alphaglucosidase inhibitor, prevents the small intestine from taking in carbohydrate. This reduces hyperglycemia."
  },
  {
    "text": "Clinical utility of acarbose an alphaglucosidase inhibitor in cardiometabolic disorders",
    "triple_list": [
      [
        "acarbose",
        "CPR:4",
        "alphaglucosidase"
      ]
    ],
    "updated": "No",
    "original": "Clinical utility of acarbose an alphaglucosidase inhibitor in cardiometabolic disorders",
    "simplified": "Acarbose is an alphaglucosidase inhibitor, it helps the body to digest food."
  },
  {
    "text": "The mean and mean hemoglobin levels in the blood were increased in the STX group , respectively .",
    "triple_list": [
      [
        "hemoglobin",
        "CPR:3",
        "STX"
      ],
      [
        "hemoglobin",
        "CPR:3",
        "STX"
      ]
    ],
    "updated": "Yes",
    "original": "The values of mean corpuscular hemoglobin concentration and mean corpuscular hemoglobin increased in the STX group",
    "simplified": "The mean and mean hemoglobin levels in the blood were increased in the STX group, respectively."
  },
  {
    "text": "First , we showed that glucose administration in rats increases DBI expression in hypothalamic gliallike tanycytes .",
    "triple_list": [
      [
        "glucose",
        "CPR:3",
        "DBI"
      ]
    ],
    "updated": "Yes",
    "original": "First we showed that intracerebroventricular administration of glucose in rats increases DBI expression in hypothalamic gliallike tanycytes",
    "simplified": "First, we showed that glucose administration in rats increases DBI expression in hypothalamic gliallike tanycytes."
  },
  {
    "text": "On phosphorylation of Ser40 by protein kinase A the negative cooperativity was increased and the affinity for H4biopterin increased S05 = 11 2 microM .",
    "triple_list": [
      [
        "Ser40",
        "CPR:9",
        "protein kinase A"
      ]
    ],
    "updated": "Yes",
    "original": "On phosphorylation of Ser40 by protein kinase A the affinity for H4biopterin increased S05 = 11 2 microM and the negative cooperativity was amplified h = 027 003",
    "simplified": "On phosphorylation of Ser40 by protein kinase A the negative cooperativity was increased and the affinity for H4biopterin increased S05 = 11 2 microM."
  },
  {
    "text": "Valdecoxib is an inhibitor of cyclooxygenase2 . It is used to treat the pain caused by rheumatoid arthritis , osteoarthritis , and dysmenorrhea .",
    "triple_list": [
      [
        "Valdecoxib",
        "CPR:4",
        "cyclooxygenase2"
      ]
    ],
    "updated": "Yes",
    "original": "Valdecoxib is a potent and specific inhibitor of cyclooxygenase2 which is used for the treatment of rheumatoid arthritis osteoarthritis and the dysmenorrhea pain",
    "simplified": "Valdecoxib is an inhibitor of cyclooxygenase2. It is used to treat the pain caused by rheumatoid arthritis, osteoarthritis, and dysmenorrhea."
  },
  {
    "text": "Disposition of a specific cyclooxygenase2 inhibitor valdecoxib in human",
    "triple_list": [
      [
        "cyclooxygenase2",
        "CPR:4",
        "valdecoxib"
      ]
    ],
    "updated": "No",
    "original": "Disposition of a specific cyclooxygenase2 inhibitor valdecoxib in human",
    "simplified": "Valdecoxib, a cyclooxygenase2 inhibitor, is a human drug."
  },
  {
    "text": "In addition , Silibinin increased the level of p53 and p21 proteins . It also increased mRNA .",
    "triple_list": [
      [
        "Silibinin",
        "CPR:3",
        "p53"
      ],
      [
        "Silibinin",
        "CPR:3",
        "p21"
      ]
    ],
    "updated": "Yes",
    "original": "In addition Silibinin caused an increase in p53 and p21 protein level as well as mRNA levels",
    "simplified": "In addition, Silibinin increased the level of p53 and p21 proteins. It also increased mRNA."
  },
  {
    "text": "In mechanistic studies Silibinin decreased the protein level of p34cdc2 in SGC7901 cells . This might be the reason why Silibinin worked as well as it did .",
    "triple_list": [
      [
        "Silibinin",
        "CPR:4",
        "p34cdc2"
      ]
    ],
    "updated": "Yes",
    "original": "In mechanistic studies Silibinin decreased the protein level of p34cdc2 which might be the possible molecular mechanism of Silibinin efficacy on the growth inhibition in SGC7901 cells",
    "simplified": "In mechanistic studies Silibinin decreased the protein level of p34cdc2 in SGC7901 cells. This might be the reason why Silibinin worked as well as it did."
  },
  {
    "text": "In summary , our data indicate that when hGSTA4 is overexpressed , high levels of GST 4HNE conjugating activity are obtained . This gives HepG2 cells a partial growth advantage .",
    "triple_list": [
      [
        "GST",
        "CPR:9",
        "4HNE"
      ]
    ],
    "updated": "Yes",
    "original": "In summary our data indicates that overexpression of hGSTA4 at levels conferring high GST 4HNE conjugating activity confers a partial growth advantage to HepG2 cells and protects against 4HNE oxidative injury",
    "simplified": "In summary, our data indicate that when hGSTA4 is overexpressed, high levels of GST 4HNE conjugating activity are obtained. This gives HepG2 cells a partial growth advantage."
  },
  {
    "text": "4Hydroxynonenal 4HNE is a mutagenic alphabetaunsaturated aldehyde produced during oxidative injury that is conjugated by several glutathione Stransferase GST isoforms",
    "triple_list": [
      [
        "4HNE",
        "CPR:9",
        "glutathione Stransferase"
      ],
      [
        "4HNE",
        "CPR:9",
        "GST"
      ],
      [
        "4Hydroxynonenal",
        "CPR:9",
        "glutathione Stransferase"
      ],
      [
        "4Hydroxynonenal",
        "CPR:9",
        "GST"
      ],
      [
        "alphabetaunsaturated aldehyde",
        "CPR:9",
        "glutathione Stransferase"
      ],
      [
        "alphabetaunsaturated aldehyde",
        "CPR:9",
        "GST"
      ]
    ],
    "updated": "No",
    "original": "4Hydroxynonenal 4HNE is a mutagenic alphabetaunsaturated aldehyde produced during oxidative injury that is conjugated by several glutathione Stransferase GST isoforms",
    "simplified": "4Hydroxynonenal 4HNE is a mutagenic alphabetaunsaturated aldehyde that is made when an oxidizing agent is applied to an organism."
  },
  {
    "text": "However the loss of proliferative capacity of hGSTA4 cells challenged with levels of 4HNE associated with severe oxidative stress indicates that other aldehyde metabolizing enzymes and GSHelectrophile transporter proteins may be involved in protecting cells from 4HNE .",
    "triple_list": [
      [
        "hGSTA4",
        "CPR:9",
        "4HNE"
      ]
    ],
    "updated": "Yes",
    "original": "However the loss of proliferative capacity of hGSTA4 cells challenged with levels of 4HNE associated with severe oxidative stress indicates a role of other aldehyde metabolizing enzymes andor GSHelectrophile transporter proteins in providing full cellular protection against 4HNE toxicity",
    "simplified": "However the loss of proliferative capacity of hGSTA4 cells challenged with levels of 4HNE associated with severe oxidative stress indicates that other aldehyde metabolizing enzymes and GSHelectrophile transporter proteins may be involved in protecting cells from 4HNE."
  },
  {
    "text": "The alpha class human GSTA44 enzyme hGSTA44 has a particularly high catalytic efficiency toward 4HNE conjugation",
    "triple_list": [
      [
        "human GSTA44",
        "CPR:9",
        "4HNE"
      ],
      [
        "hGSTA44",
        "CPR:9",
        "4HNE"
      ]
    ],
    "updated": "No",
    "original": "The alpha class human GSTA44 enzyme hGSTA44 has a particularly high catalytic efficiency toward 4HNE conjugation",
    "simplified": "The human GSTA44 enzyme has a particularly high catalytic efficiency when it comes to 4HNE."
  },
  {
    "text": "HepG2 cells transfected with an hGSTA4 vector construct showed high GST4 4HNE catalytic activities but lower basal glutathione GSH concentrations when compared with control cells .",
    "triple_list": [
      [
        "GST4",
        "CPR:9",
        "4HNE"
      ]
    ],
    "updated": "Yes",
    "original": "HepG2 cells transfected with an hGSTA4 vector construct exhibited high steadystate hGSTA4 mRNA high GST4 4HNE catalytic activities but lower basal glutathione GSH concentrations relative to insertfree vector control cells",
    "simplified": "HepG2 cells transfected with an hGSTA4 vector construct showed high GST4 4HNE catalytic activities but lower basal glutathione GSH concentrations when compared with control cells."
  },
  {
    "text": "In particular , hGSTA4 cells had significantly higher GSH concentrations when exposed to 515 microM 4HNE but not at 20 microM 4HNE . This shows that 4HNE can be used to produce GSH .",
    "triple_list": [
      [
        "hGSTA4",
        "CPR:9",
        "4HNE"
      ],
      [
        "hGSTA4",
        "CPR:9",
        "4HNE"
      ]
    ],
    "updated": "Yes",
    "original": "Specifically hGSTA4 cells had significantly higher GSH concentrations when exposed to 515 microM 4HNE but not at 20 microM 4HNE suggesting extensive GSH utilization at high concentrations of 4HNE",
    "simplified": "In particular, hGSTA4 cells had significantly higher GSH concentrations when exposed to 515 microM 4HNE but not at 20 microM 4HNE. This shows that 4HNE can be used to produce GSH."
  },
  {
    "text": "dbdb mice treated with DRF 2655 showed 5 and 36fold inhibition in phosphoenolpyruvate carboxykinase and glucose 6phosphatase activity and 651 and 77 increases in the betaoxidation enzymes carnitine palmitoyltransferase and carnitine acetyltransferase respectively",
    "triple_list": [
      [
        "DRF 2655",
        "CPR:3",
        "carnitine palmitoyltransferase"
      ],
      [
        "DRF 2655",
        "CPR:3",
        "carnitine acetyltransferase"
      ],
      [
        "DRF 2655",
        "CPR:4",
        "phosphoenolpyruvate carboxykinase"
      ],
      [
        "DRF 2655",
        "CPR:4",
        "glucose 6phosphatase"
      ]
    ],
    "updated": "No",
    "original": "dbdb mice treated with DRF 2655 showed 5 and 36fold inhibition in phosphoenolpyruvate carboxykinase and glucose 6phosphatase activity and 651 and 77 increases in the betaoxidation enzymes carnitine palmitoyltransferase and carnitine acetyltransferase respectively",
    "simplified": "dbdb mice treated with DRF 2655 showed 5 and 36fold inhibition in glucose 6phosphatase activity and 651 and 77 increases in the betaoxidation enzymes carnitine palmitoyltransferase and carnitine acetyltransferase respectively."
  },
  {
    "text": "OBJECTIVE Preclinical evaluation of DRF 2655 a peroxisome proliferatoractivated receptor alpha PPARalpha and PPARgamma agonist as a bodyweight lowering hypolipidemic and euglycemic agent",
    "triple_list": [
      [
        "DRF 2655",
        "CPR:5",
        "PPARgamma"
      ],
      [
        "DRF 2655",
        "CPR:5",
        "peroxisome proliferatoractivated receptor alpha"
      ],
      [
        "DRF 2655",
        "CPR:5",
        "PPARalpha"
      ]
    ],
    "updated": "No",
    "original": "OBJECTIVE Preclinical evaluation of DRF 2655 a peroxisome proliferatoractivated receptor alpha PPARalpha and PPARgamma agonist as a bodyweight lowering hypolipidemic and euglycemic agent",
    "simplified": "OBJECTIVE Preclinical evaluation of DRF 2655 a peroxisome proliferatoractivated receptor alpha agonist as a hypolipidemic and euglycemic agent"
  },
  {
    "text": "Results DRF 2655 showed that PPARalpha and PPARgamma are activated in concentration .",
    "triple_list": [
      [
        "DRF 2655",
        "CPR:5",
        "PPARalpha"
      ],
      [
        "DRF 2655",
        "CPR:5",
        "PPARgamma"
      ]
    ],
    "updated": "Yes",
    "original": "RESULTS DRF 2655 showed concentrationdependent transactivation of PPARalpha and PPARgamma",
    "simplified": "Results DRF 2655 showed that PPARalpha and PPARgamma are activated in concentration."
  },
  {
    "text": "Indomethacin inhibited both hCOX1 and hCOX2 whereas NS398 and Dup697 selectively inhibited hCOX2",
    "triple_list": [
      [
        "Indomethacin",
        "CPR:4",
        "hCOX1"
      ],
      [
        "Indomethacin",
        "CPR:4",
        "hCOX2"
      ],
      [
        "hCOX2",
        "CPR:4",
        "NS398"
      ],
      [
        "hCOX2",
        "CPR:4",
        "Dup697"
      ]
    ],
    "updated": "No",
    "original": "Indomethacin inhibited both hCOX1 and hCOX2 whereas NS398 and Dup697 selectively inhibited hCOX2",
    "simplified": "Indomethacin inhibited both hCOX1 and hCOX2, while Dup697 inhibited hCOX2 only."
  },
  {
    "text": "Both NS398 and Dup697 showed that hCOX2 was inactivated by indomethacin for a short time .",
    "triple_list": [
      [
        "NS398",
        "CPR:4",
        "hCOX2"
      ],
      [
        "Dup697",
        "CPR:4",
        "hCOX2"
      ],
      [
        "hCOX2",
        "CPR:4",
        "indomethacin"
      ]
    ],
    "updated": "Yes",
    "original": "Both NS398 and Dup697 exhibited timedependent inactivation of hCOX2 as did indomethacin on both enzymes",
    "simplified": "Both NS398 and Dup697 showed that hCOX2 was inactivated by indomethacin for a short time."
  },
  {
    "text": "The competitive inhibitor of hCOX1 mefenamic acid also displayed competitive inhibition of hCOX2",
    "triple_list": [
      [
        "hCOX1",
        "CPR:4",
        "mefenamic acid"
      ],
      [
        "mefenamic acid",
        "CPR:4",
        "hCOX2"
      ]
    ],
    "updated": "No",
    "original": "The competitive inhibitor of hCOX1 mefenamic acid also displayed competitive inhibition of hCOX2",
    "simplified": "The competitive inhibitor of hCOX1 was also found to inhibit the competitive inhibitor of hCOX2."
  },
  {
    "text": "The enzyme cyclooxygenase catalyses the oxygenation of arachidonic acid leading to the formation of prostaglandins",
    "triple_list": [
      [
        "cyclooxygenase",
        "CPR:9",
        "prostaglandins"
      ],
      [
        "cyclooxygenase",
        "CPR:9",
        "arachidonic acid"
      ]
    ],
    "updated": "No",
    "original": "The enzyme cyclooxygenase catalyses the oxygenation of arachidonic acid leading to the formation of prostaglandins",
    "simplified": "The enzyme cyclooxygenase changes arachidonic acid into carbon dioxide, which is oxygenated."
  },
  {
    "text": "hCOX1 had a specific activity of 188 mumol of O2mg with a Km of 138 microM for arachidonate and Vmax",
    "triple_list": [
      [
        "hCOX1",
        "CPR:9",
        "arachidonate"
      ]
    ],
    "updated": "No",
    "original": "hCOX1 had a specific activity of 188 mumol of O2mg with a Km of 138 microM for arachidonate and Vmax",
    "simplified": "The specific activity of hCOX1 was 188 mumol of O2mg with a Km of 138 microM for example."
  },
  {
    "text": "of 1500 nmol of enzyme activity while hCOX2 had 122 mumol of enzyme activity with a Km of 87 microM for arachidonate .",
    "triple_list": [
      [
        "hCOX2",
        "CPR:9",
        "arachidonate"
      ]
    ],
    "updated": "Yes",
    "original": "of 1500 nmol of O2nmol of enzyme whereas hCOX2 had a specific activity of 122 mumol of O2mg with a Km of 87 microM for arachidonate and a Vmax",
    "simplified": "of 1500 nmol of enzyme activity while hCOX2 had 122 mumol of enzyme activity with a Km of 87 microM for arachidonate."
  },
  {
    "text": "Our results showed that doxycycline inhibited the expression of MMP9 messenger ribonucleic acid by 10 mgkgday P002 .",
    "triple_list": [
      [
        "MMP9",
        "CPR:4",
        "doxycycline"
      ]
    ],
    "updated": "Yes",
    "original": "Our results have shown that MMP9 messenger ribonucleic acid mRNA expression was inhibited by doxycycline starting at 10 mgkgday P002",
    "simplified": "Our results showed that doxycycline inhibited the expression of MMP9 messenger ribonucleic acid by 10 mgkgday P002."
  },
  {
    "text": "Minocycline was more effective at inhibiting MMP9 expression from 1 P0005 to more than 30 P0001 mgkgday .",
    "triple_list": [
      [
        "Minocycline",
        "CPR:4",
        "MMP9"
      ]
    ],
    "updated": "Yes",
    "original": "Minocycline showed more potent inhibition on MMP9 mRNA expression starting at 1 P0005 and further at more than 30 P0001 mgkgday",
    "simplified": "Minocycline was more effective at inhibiting MMP9 expression from 1 P0005 to more than 30 P0001 mgkgday."
  },
  {
    "text": "At the enzymatic activity level doxycycline started to suppress MMP9 activity at 5 mgkgday P0001 while minocycline had an effect at a lower dose 1 mgkgday P002",
    "triple_list": [
      [
        "doxycycline",
        "CPR:4",
        "MMP9"
      ]
    ],
    "updated": "No",
    "original": "At the enzymatic activity level doxycycline started to suppress MMP9 activity at 5 mgkgday P0001 while minocycline had an effect at a lower dose 1 mgkgday P002",
    "simplified": "At the enzymatic activity level, minocycline had an effect at a lower dose 1 mgkgday P002, but at 5 mgkgday P0001, doxycycline had an effect."
  },
  {
    "text": "In addition , we examined the potential relevant signaling pathway in vitro to determine the MMP9 inhibition by tetracyclines .",
    "triple_list": [
      [
        "MMP9",
        "CPR:4",
        "tetracyclines"
      ]
    ],
    "updated": "Yes",
    "original": "We also assessed the potential relevant signaling pathway in vitro to elucidate the mechanisms underlying the MMP9 inhibition by tetracyclines",
    "simplified": "In addition, we examined the potential relevant signaling pathway in vitro to determine the MMP9 inhibition by tetracyclines."
  },
  {
    "text": "In vitro minocycline but not doxycycline inhibits MMP9 at least in part by a process called ERK12mediated pathway .",
    "triple_list": [
      [
        "minocycline",
        "CPR:4",
        "MMP9"
      ],
      [
        "doxycycline",
        "CPR:4",
        "MMP9"
      ]
    ],
    "updated": "Yes",
    "original": "In vitro minocycline but not doxycycline inhibits MMP9 at least in part via the extracellular signalingrelated kinase 12 ERK12mediated pathway",
    "simplified": "In vitro minocycline but not doxycycline inhibits MMP9 at least in part by a process called ERK12mediated pathway."
  },
  {
    "text": "This study provided the evidence that the tetracyclines inhibit stimulated cerebral MMP9 at multiple levels and are effective at very low doses offering great potential for therapeutic use",
    "triple_list": [
      [
        "tetracyclines",
        "CPR:4",
        "MMP9"
      ]
    ],
    "updated": "No",
    "original": "This study provided the evidence that the tetracyclines inhibit stimulated cerebral MMP9 at multiple levels and are effective at very low doses offering great potential for therapeutic use",
    "simplified": "This study provided the evidence that the tetracyclines are effective at very low doses and offer great potential for therapeutic use, at multiple levels in the brain."
  },
  {
    "text": "Doxycycline was shown to decrease cerebral MMP9 activities and angiogenesis induced by vascular endothelial growth factor VEGF",
    "triple_list": [
      [
        "Doxycycline",
        "CPR:4",
        "MMP9"
      ],
      [
        "Doxycycline",
        "CPR:4",
        "vascular endothelial growth factor"
      ],
      [
        "Doxycycline",
        "CPR:4",
        "VEGF"
      ]
    ],
    "updated": "No",
    "original": "Doxycycline was shown to decrease cerebral MMP9 activities and angiogenesis induced by vascular endothelial growth factor VEGF",
    "simplified": "Doxycycline has been shown to reduce vascular endothelial growth factor (VEGF) induced angiogenesis in the brain."
  },
  {
    "text": "The ratio between the GDC SHMT and C1THF synthase SHMT pathways of Ser synthesis from alpha13CGly and 13Cformate respectively in Arabidopsis shoots was 21 1 in roots 9 1",
    "triple_list": [
      [
        "SHMT",
        "CPR:9",
        "Ser"
      ],
      [
        "SHMT",
        "CPR:9",
        "Ser"
      ],
      [
        "GDC",
        "CPR:9",
        "alpha13CGly"
      ],
      [
        "C1THF synthase",
        "CPR:9",
        "13Cformate"
      ]
    ],
    "updated": "No",
    "original": "The ratio between the GDC SHMT and C1THF synthase SHMT pathways of Ser synthesis from alpha13CGly and 13Cformate respectively in Arabidopsis shoots was 21 1 in roots 9 1",
    "simplified": "In Arabidopsis shoots, the ratio between the GDC SHMT and C1THF synthase SHMT pathways of Ser synthesis was 21 1 in roots 9 1."
  },
  {
    "text": "On the other hand the accumulation of Ser through the C1THF synthase SHMT pathway in glyD plants was 25fold greater than that in WT plants",
    "triple_list": [
      [
        "Ser",
        "CPR:9",
        "SHMT"
      ]
    ],
    "updated": "No",
    "original": "On the other hand the accumulation of Ser through the C1THF synthase SHMT pathway in glyD plants was 25fold greater than that in WT plants",
    "simplified": "On the other hand, in glyD plants, the amount of Ser increased by 25fold when compared to normal plants."
  },
  {
    "text": "One major route involves the tetrahydrofolate THFdependent activities of the glycine decarboxylase complex GDC EC 21110 and serine hydroxymethyltransferase SHMT EC 2121 with glycine Gly as onecarbon 1C source",
    "triple_list": [
      [
        "glycine",
        "CPR:9",
        "glycine decarboxylase complex"
      ],
      [
        "glycine",
        "CPR:9",
        "GDC"
      ],
      [
        "glycine",
        "CPR:9",
        "EC 21110"
      ],
      [
        "glycine",
        "CPR:9",
        "serine hydroxymethyltransferase"
      ],
      [
        "glycine",
        "CPR:9",
        "SHMT"
      ],
      [
        "glycine",
        "CPR:9",
        "EC 2121"
      ],
      [
        "glycine decarboxylase complex",
        "CPR:9",
        "Gly"
      ],
      [
        "GDC",
        "CPR:9",
        "Gly"
      ],
      [
        "EC 21110",
        "CPR:9",
        "Gly"
      ],
      [
        "serine hydroxymethyltransferase",
        "CPR:9",
        "Gly"
      ],
      [
        "SHMT",
        "CPR:9",
        "Gly"
      ],
      [
        "EC 2121",
        "CPR:9",
        "Gly"
      ]
    ],
    "updated": "No",
    "original": "One major route involves the tetrahydrofolate THFdependent activities of the glycine decarboxylase complex GDC EC 21110 and serine hydroxymethyltransferase SHMT EC 2121 with glycine Gly as onecarbon 1C source",
    "simplified": "The glycine decarboxylase complex GDC EC 21110 and serine hydroxymethyltransferase SHMT EC 2121 are important because they are the only two enzymes that can break down glycine."
  },
  {
    "text": "An alternative THF-dependent pathway uses formate as 1C source . This is called C1THF synthase SHMT .",
    "triple_list": [
      [
        "C1THF synthase",
        "CPR:9",
        "formate"
      ],
      [
        "SHMT",
        "CPR:9",
        "formate"
      ]
    ],
    "updated": "Yes",
    "original": "An alternative THFdependent pathway involves the C1THF synthase SHMT activities with formate as 1C source",
    "simplified": "An alternative THF-dependent pathway uses formate as 1C source. This is called C1THF synthase SHMT."
  },
  {
    "text": "Transgenic plants with high levels of formate dehydrogenase EC 1212 were used to continue our previous studies on the function of FDH in formate metabolism .",
    "triple_list": [
      [
        "formate",
        "CPR:9",
        "formate dehydrogenase"
      ],
      [
        "formate",
        "CPR:9",
        "FDH"
      ],
      [
        "formate",
        "CPR:9",
        "EC 1212"
      ],
      [
        "formate",
        "CPR:9",
        "FDH"
      ]
    ],
    "updated": "Yes",
    "original": "Firstly transgenic plants overexpressing formate dehydrogenase FDH EC 1212 were used to continue our previous studies on the function of FDH in formate metabolism",
    "simplified": "Transgenic plants with high levels of formate dehydrogenase EC 1212 were used to continue our previous studies on the function of FDH in formate metabolism."
  },
  {
    "text": "We concluded that FDH has no direct role in the regulation of the above two pathways of Ser synthesis . The main and preferred fate of the organic acid in Arabidopsis is to break it down to formate and CO2 .",
    "triple_list": [
      [
        "FDH",
        "CPR:9",
        "formate"
      ],
      [
        "FDH",
        "CPR:9",
        "CO2"
      ]
    ],
    "updated": "Yes",
    "original": "We concluded that FDH has no direct role in the regulation of the above two pathways of Ser synthesis the breakdown of formate to CO2 by the FDH reaction is the primary and preferred fate of the organic acid in Arabidopsis",
    "simplified": "We concluded that FDH has no direct role in the regulation of the above two pathways of Ser synthesis. The main and preferred fate of the organic acid in Arabidopsis is to break it down to formate and CO2."
  },
  {
    "text": "BACKGROUND Rivastigmine is a carbamate drug designed to inhibit both acetylcholinesterase and butyrylcholinesterase by reversibly covalently bonding to these enzymes",
    "triple_list": [
      [
        "Rivastigmine",
        "CPR:4",
        "acetylcholinesterase"
      ],
      [
        "Rivastigmine",
        "CPR:4",
        "butyrylcholinesterase"
      ],
      [
        "carbamate",
        "CPR:4",
        "acetylcholinesterase"
      ],
      [
        "carbamate",
        "CPR:4",
        "butyrylcholinesterase"
      ]
    ],
    "updated": "No",
    "original": "BACKGROUND Rivastigmine is a carbamate drug designed to inhibit both acetylcholinesterase and butyrylcholinesterase by reversibly covalently bonding to these enzymes",
    "simplified": "Rivastigmine is a drug that works by inhibiting both butyrylcholinesterase and acetylcholinesterase. It does this by covalently bonding to them."
  },
  {
    "text": "High p53 protein levels but not genetic or functional p53 status were associated with increased topotecan induced DNAtopoisomerase I complex formation",
    "triple_list": [
      [
        "p53",
        "CPR:3",
        "topotecan"
      ]
    ],
    "updated": "No",
    "original": "High p53 protein levels but not genetic or functional p53 status were associated with increased topotecan induced DNAtopoisomerase I complex formation",
    "simplified": "High p53 levels but not genetic or functional p53 status were associated with increased riboflavin production and riboflavin deficiency."
  },
  {
    "text": "Topotecan is a topoisomerase I inhibitor . It is currently being used as a treatment for glioma .",
    "triple_list": [
      [
        "Topotecan",
        "CPR:4",
        "topoisomerase I"
      ]
    ],
    "updated": "Yes",
    "original": "Topotecan is a topoisomerase I inhibitor which is currently evaluated as an adjuvant agent for malignant glioma",
    "simplified": "Topotecan is a topoisomerase I inhibitor. It is currently being used as a treatment for glioma."
  },
  {
    "text": "Amiloride is a chemical compound . It is an inhibitor of uPA .",
    "triple_list": [
      [
        "Amiloride",
        "CPR:4",
        "uPA"
      ]
    ],
    "updated": "Yes",
    "original": "Amiloride is a specific inhibitor of uPA but does not inhibit tPA",
    "simplified": "Amiloride is a chemical compound. It is an inhibitor of uPA."
  },
  {
    "text": "The inhibitory effect of endothelin1 on 5HT is abolished by indomethacin or by glibenclamide . The endothelin ETB receptor antagonist RES 7011 also works by deendothelialization .",
    "triple_list": [
      [
        "endothelin ETB receptor",
        "CPR:6",
        "RES 7011"
      ]
    ],
    "updated": "Yes",
    "original": "The inhibitory effect of endothelin1 on the contraction induced by 5HT is abolished by deendothelialization by the endothelin ETB receptor antagonist RES 7011 by indomethacin or by glibenclamide",
    "simplified": "The inhibitory effect of endothelin1 on 5HT is abolished by indomethacin or by glibenclamide. The endothelin ETB receptor antagonist RES 7011 also works by deendothelialization."
  },
  {
    "text": "The contractile effect of 5HT is only somewhat changed by deendothelialization . The thromboxane A2 receptor antagonists GR32191 and ridogrel do not work either .",
    "triple_list": [
      [
        "thromboxane A2 receptor",
        "CPR:6",
        "GR32191"
      ],
      [
        "thromboxane A2 receptor",
        "CPR:6",
        "ridogrel"
      ]
    ],
    "updated": "Yes",
    "original": "The potentiation of the contractile effect induced by 5HT is only somewhat modified by deendothelialization but abolished by the thromboxane A2 receptor antagonists GR32191 and ridogrel",
    "simplified": "The contractile effect of 5HT is only somewhat changed by deendothelialization. The thromboxane A2 receptor antagonists GR32191 and ridogrel do not work either."
  },
  {
    "text": "A novel class of quinoxalines has been discovered as antagonists of the IgG-FcRn protein-mediated immunodeficiency ( IgG-FcRn ) .",
    "triple_list": [
      [
        "quinoxalines",
        "CPR:6",
        "IgG"
      ],
      [
        "quinoxalines",
        "CPR:6",
        "FcRn"
      ]
    ],
    "updated": "Yes",
    "original": "A novel class of quinoxalines has been discovered as antagonists of the IgG FcRn proteinprotein interaction through optimization of a hit derived from a virtual ligandbased screen",
    "simplified": "A novel class of quinoxalines has been discovered as antagonists of the IgG-FcRn protein-mediated immunodeficiency (IgG-FcRn)."
  },
  {
    "text": "Agmatine locally synthesized is an endogenous agonist at imidazoline receptors a noncatecholamine ligand at alpha 2adrenergic receptors and may act as a neurotransmitter",
    "triple_list": [
      [
        "Agmatine",
        "CPR:5",
        "imidazoline receptors"
      ]
    ],
    "updated": "No",
    "original": "Agmatine locally synthesized is an endogenous agonist at imidazoline receptors a noncatecholamine ligand at alpha 2adrenergic receptors and may act as a neurotransmitter",
    "simplified": "It can act as a noncatecholamine ligand at alpha 2adrenergic receptors. It can also act as a neurotransmitter at imidazoline receptors."
  },
  {
    "text": "S3Aminomethyl73hydroxypropoxy1hydroxy13dihydro21benzoxaborole GSK2251052 is a novel boroncontaining antibiotic that inhibits bacterial leucyl tRNA synthetase and that has been in development for the treatment of serious Gramnegative infections",
    "triple_list": [
      [
        "GSK2251052",
        "CPR:4",
        "bacterial leucyl tRNA synthetase"
      ],
      [
        "S3Aminomethyl73hydroxypropoxy1hydroxy13dihydro21benzoxaborole",
        "CPR:4",
        "bacterial leucyl tRNA synthetase"
      ]
    ],
    "updated": "No",
    "original": "S3Aminomethyl73hydroxypropoxy1hydroxy13dihydro21benzoxaborole GSK2251052 is a novel boroncontaining antibiotic that inhibits bacterial leucyl tRNA synthetase and that has been in development for the treatment of serious Gramnegative infections",
    "simplified": "S3Aminomethyl73hydroxypropoxy1hydroxy13dihydro21benzoxaborole GSK2251052 is a novel antibiotic that has been in development for the treatment of serious Gram-negative infections."
  },
  {
    "text": "A combination of in vitro metabolism experiments and a pharmacokinetic study in monkeys with the inhibitor 4methylpyrazole provided strong evidence that alcohol dehydrogenase potentially in association with aldehyde dehydrogenase is the primary enzyme involved in the formation of the M3 metabolite",
    "triple_list": [
      [
        "4methylpyrazole",
        "CPR:4",
        "alcohol dehydrogenase"
      ]
    ],
    "updated": "No",
    "original": "A combination of in vitro metabolism experiments and a pharmacokinetic study in monkeys with the inhibitor 4methylpyrazole provided strong evidence that alcohol dehydrogenase potentially in association with aldehyde dehydrogenase is the primary enzyme involved in the formation of the M3 metabolite",
    "simplified": "A combination of in vitro metabolism experiments and a pharmacokinetic study in monkeys showed that aldehyde dehydrogenase is the primary enzyme involved in the formation of the M3 metabolite. The inhibitor 4methylpyrazole was shown to interfere with this enzyme."
  },
  {
    "text": "In functional transport assays we found that one of the identified molecules ATM7 increased the reuptake of serotonin possibly by facilitating the interaction of serotonin with transportready conformations of SERT when concentrations of serotonin were low and rate limiting",
    "triple_list": [
      [
        "serotonin",
        "CPR:9",
        "SERT"
      ],
      [
        "serotonin",
        "CPR:9",
        "SERT"
      ],
      [
        "serotonin",
        "CPR:9",
        "SERT"
      ]
    ],
    "updated": "No",
    "original": "In functional transport assays we found that one of the identified molecules ATM7 increased the reuptake of serotonin possibly by facilitating the interaction of serotonin with transportready conformations of SERT when concentrations of serotonin were low and rate limiting",
    "simplified": "In functional transport assays we found that one of the identified molecules ATM7 increased the reuptake of serotonin when concentrations of serotonin were low and rate limiting, possibly by facilitating the interaction of serotonin with transportready"
  },
  {
    "text": "They display sensitivity to TK inhibitors including gefitinib and erlotinib",
    "triple_list": [
      [
        "TK",
        "CPR:4",
        "gefitinib"
      ],
      [
        "TK",
        "CPR:4",
        "erlotinib"
      ]
    ],
    "updated": "No",
    "original": "They display sensitivity to TK inhibitors including gefitinib and erlotinib",
    "simplified": "They are sensitive to tyrosine kinase inhibitors, like gefitinib."
  },
  {
    "text": "Among the FeS cluster biosynthetic proteins are a pyridoxal phosphatedependent enzyme NifS and a molecular scaffold protein NifU . NifS is involved in the activation of sulphur from lcysteine .",
    "triple_list": [
      [
        "NifS",
        "CPR:9",
        "lcysteine"
      ]
    ],
    "updated": "Yes",
    "original": "Among the FeS cluster biosynthetic proteins are included a pyridoxal phosphatedependent enzyme NifS that is involved in the activation of sulphur from lcysteine and a molecular scaffold protein NifU upon which FeS cluster precursors are formed",
    "simplified": "Among the FeS cluster biosynthetic proteins are a pyridoxal phosphatedependent enzyme NifS and a molecular scaffold protein NifU. NifS is involved in the activation of sulphur from lcysteine."
  },
  {
    "text": "In addition , the number and area of glutathione Stransferase placental form GSTP positive foci and proliferating cell nuclear antigen PCNA positive cell ratios in the hepatocytes in the male and female rats that were administered 100mgkg MEG were significantly increased .",
    "triple_list": [
      [
        "glutathione Stransferase placental form",
        "CPR:3",
        "MEG"
      ],
      [
        "GSTP",
        "CPR:3",
        "MEG"
      ],
      [
        "proliferating cell nuclear antigen",
        "CPR:3",
        "MEG"
      ],
      [
        "PCNA",
        "CPR:3",
        "MEG"
      ]
    ],
    "updated": "Yes",
    "original": "In addition the number and area of glutathione Stransferase placental form GSTP positive foci and proliferating cell nuclear antigen PCNA positive cell ratios in the hepatocytes were significantly increased in the male and female rats that were administered 100mgkg MEG compared with the control animals",
    "simplified": "In addition, the number and area of glutathione Stransferase placental form GSTP positive foci and proliferating cell nuclear antigen PCNA positive cell ratios in the hepatocytes in the male and female rats that were administered 100mgkg MEG were significantly increased."
  },
  {
    "text": "Consumption of alcohol for 8weeks caused severe liver damage with increased prognostic indicators such as alanine transaminase and aspartate transaminase in serum , while CNF did not affect them .",
    "triple_list": [
      [
        "alcohol",
        "CPR:3",
        "aspartate transaminase"
      ],
      [
        "alcohol",
        "CPR:3",
        "alanine transaminase"
      ]
    ],
    "updated": "Yes",
    "original": "Consumption of alcohol for 8weeks induced severe liver damage with increases in prognostic indicators such as aspartate transaminase alanine transaminase in serum whereas coadministration of CNF suppressed their increases",
    "simplified": "Consumption of alcohol for 8weeks caused severe liver damage with increased prognostic indicators such as alanine transaminase and aspartate transaminase in serum, while CNF did not affect them."
  },
  {
    "text": "Chronic consumption of alcohol also stimulated abrupt increases in proinflammatory cytokines such as nuclear factor NF\u03baB tumor necrosis factor TNF\u03b1 and interleukin IL1\u03b2 in liver otherwise coadministration of CNF effectively suppressed production of these cytokines dosedependently",
    "triple_list": [
      [
        "alcohol",
        "CPR:3",
        "nuclear factor NF\u03baB"
      ],
      [
        "alcohol",
        "CPR:3",
        "tumor necrosis factor TNF\u03b1"
      ],
      [
        "alcohol",
        "CPR:3",
        "interleukin IL1\u03b2"
      ]
    ],
    "updated": "No",
    "original": "Chronic consumption of alcohol also stimulated abrupt increases in proinflammatory cytokines such as nuclear factor NF\u03baB tumor necrosis factor TNF\u03b1 and interleukin IL1\u03b2 in liver otherwise coadministration of CNF effectively suppressed production of these cytokines dosedependently",
    "simplified": "Chronic consumption of alcohol also caused sudden increases in proinflammatory cytokines such as tumor necrosis factor TNF\u03b1 and interleukin IL1\u03b2 in the liver. When CNF was taken by itself, these cytokines were suppressed."
  },
  {
    "text": "Dietary EPA DHA treatment restored n3 derived lipid mediators in obesity while improving insulin sensitivity and adipose tissue inflammation .",
    "triple_list": [
      [
        "EPA",
        "CPR:3",
        "insulin"
      ],
      [
        "DHA",
        "CPR:3",
        "insulin"
      ]
    ],
    "updated": "Yes",
    "original": "Dietary EPA DHA treatment restored endogenous biosynthesis of n3 derived lipid mediators in obesity while attenuating adipose tissue inflammation and improving insulin sensitivity",
    "simplified": "Dietary EPA DHA treatment restored n3 derived lipid mediators in obesity while improving insulin sensitivity and adipose tissue inflammation."
  },
  {
    "text": "Notably 17HDHA treatment reduced adipose tissue expression of inflammatory cytokines increased adiponectin expression and improved glucose tolerance parallel to insulin sensitivity in obese mice",
    "triple_list": [
      [
        "17HDHA",
        "CPR:3",
        "adiponectin"
      ],
      [
        "17HDHA",
        "CPR:3",
        "insulin"
      ],
      [
        "17HDHA",
        "CPR:4",
        "cytokines"
      ]
    ],
    "updated": "No",
    "original": "Notably 17HDHA treatment reduced adipose tissue expression of inflammatory cytokines increased adiponectin expression and improved glucose tolerance parallel to insulin sensitivity in obese mice",
    "simplified": "Notably 17HDHA treatment reduced the expression of inflammatory cytokines in adipose tissue and improved glucose tolerance in obese mice, similar to insulin."
  },
  {
    "text": "Western blots showed a decrease in nuclear p65 protein expression after different levels of cinobufagin were given to the cells . At the same time , GSK3\u03b2 was increased .",
    "triple_list": [
      [
        "cinobufagin",
        "CPR:3",
        "GSK3\u03b2"
      ],
      [
        "p65",
        "CPR:4",
        "cinobufagin"
      ]
    ],
    "updated": "Yes",
    "original": "Western blots showed a decrease in nuclear p65 protein expression after exposure to different concentrations of cinobufagin while the phosphorylation of GSK3\u03b2 was simultaneously increased",
    "simplified": "Western blots showed a decrease in nuclear p65 protein expression after different levels of cinobufagin were given to the cells. At the same time, GSK3\u03b2 was increased."
  },
  {
    "text": "Transduction with constitutively active forms of GSK3\u03b2 could protect against cinobufagin-induced downregulation of p65 and upregulation of cleaved PARP .",
    "triple_list": [
      [
        "PARP",
        "CPR:3",
        "cinobufagin"
      ],
      [
        "p65",
        "CPR:4",
        "cinobufagin"
      ]
    ],
    "updated": "Yes",
    "original": "Transduction with constitutively active forms of GSK3\u03b2 could protect against the downregulation of p65 and upregulation of cleaved PARP that are induced by cinobufagin treatment",
    "simplified": "Transduction with constitutively active forms of GSK3\u03b2 could protect against cinobufagin-induced downregulation of p65 and upregulation of cleaved PARP."
  },
  {
    "text": "However combined treatment with cinobufagin and SB216367 resulted in a significant reduction in p65 and an increase in cleaved PARP in U2OS cells",
    "triple_list": [
      [
        "cinobufagin",
        "CPR:3",
        "PARP"
      ],
      [
        "SB216367",
        "CPR:3",
        "PARP"
      ],
      [
        "cinobufagin",
        "CPR:4",
        "p65"
      ],
      [
        "SB216367",
        "CPR:4",
        "p65"
      ]
    ],
    "updated": "No",
    "original": "However combined treatment with cinobufagin and SB216367 resulted in a significant reduction in p65 and an increase in cleaved PARP in U2OS cells",
    "simplified": "However, when combined with cinobufagin and SB216367, a significant reduction in p65 was found. This was also found in U2OS cells."
  },
  {
    "text": "In addition , we showed that GSK3\u03b2 NF\u03baB is inhibited following cinobufagin treatment .",
    "triple_list": [
      [
        "GSK3\u03b2",
        "CPR:4",
        "cinobufagin"
      ],
      [
        "NF\u03baB",
        "CPR:4",
        "cinobufagin"
      ]
    ],
    "updated": "Yes",
    "original": "Furthermore we validated the inhibition of GSK3\u03b2 NF\u03baB signaling following cinobufagin treatment",
    "simplified": "In addition, we showed that GSK3\u03b2 NF\u03baB is inhibited following cinobufagin treatment."
  },
  {
    "text": "The major ingredient of ginger 6gingerol could inhibit angiotensin II type 1 receptor activation . Because of this , it is not possible for ginger to cause high blood pressure or damage the heart .",
    "triple_list": [
      [
        "6gingerol",
        "CPR:4",
        "angiotensin II type 1 receptor"
      ]
    ],
    "updated": "Yes",
    "original": "The major ingredient of ginger 6gingerol could inhibit angiotensin II type 1 receptor activation which partially clarified the mechanism of ginger regulating blood pressure and strengthening heart in the cardiovascular system",
    "simplified": "The major ingredient of ginger 6gingerol could inhibit angiotensin II type 1 receptor activation. Because of this, it is not possible for ginger to cause high blood pressure or damage the heart."
  },
  {
    "text": "6Gingerol was found to be a novel angiotensin II type 1 receptor antagonist . It had an IC50 value of 8173 , which is very good .",
    "triple_list": [
      [
        "6Gingerol",
        "CPR:6",
        "angiotensin II type 1 receptor"
      ]
    ],
    "updated": "Yes",
    "original": "6Gingerol derived from Zingiber officinale Roscoe ginger was identified as a novel angiotensin II type 1 receptor antagonist with an IC50 value of 8173 \u00b5M",
    "simplified": "6Gingerol was found to be a novel angiotensin II type 1 receptor antagonist. It had an IC50 value of 8173, which is very good."
  },
  {
    "text": "6gingerol a novel AT\u2081 antagonist for the treatment of cardiovascular disease",
    "triple_list": [
      [
        "6gingerol",
        "CPR:6",
        "AT\u2081"
      ]
    ],
    "updated": "No",
    "original": "6gingerol a novel AT\u2081 antagonist for the treatment of cardiovascular disease",
    "simplified": "6gingerol, an anti-angiogenic drug in the treatment of heart disease"
  },
  {
    "text": "N5Substituted H4biopterin derivatives were not oxidized to products serving as substrates for dihydropteridine reductase . N5methyl and N5hydroxymethyl H4biopterin inhibited phenylalanine hydroxylase , N5acetyl H4biopterin had no effect , and N5methyl and N5acetyl H4biopterin were competitive inhibitors of phenylalanine hydroxylase .",
    "triple_list": [
      [
        "phenylalanine hydroxylase",
        "CPR:4",
        "N5methyl"
      ],
      [
        "phenylalanine hydroxylase",
        "CPR:4",
        "N5hydroxymethyl H4biopterin"
      ],
      [
        "N5Substituted H4biopterin",
        "CPR:9",
        "dihydropteridine reductase"
      ]
    ],
    "updated": "Yes",
    "original": "N5Substituted H4biopterin derivatives were not oxidized to products serving as substrates for dihydropteridine reductase anddepending on the substituent were competitive inhibitors of phenylalanine hydroxylase N5methyl and N5hydroxymethyl H4biopterin inhibited phenylalanine hydroxylase whereas N5formyl and N5acetyl H4biopterin had no effect",
    "simplified": "N5Substituted H4biopterin derivatives were not oxidized to products serving as substrates for dihydropteridine reductase. N5methyl and N5hydroxymethyl H4biopterin inhibited phenylalanine hydroxylase, N5acetyl H4biopterin had no effect, and N5methyl and N5acetyl H4biopterin were competitive inhibitors of phenylalanine hydroxylase."
  },
  {
    "text": "Our data demonstrate differences in the stimulation of nitric oxide synthase and phenylalanine hydroxylase by H4biopterin .",
    "triple_list": [
      [
        "phenylalanine hydroxylase",
        "CPR:4",
        "H4biopterin"
      ]
    ],
    "updated": "Yes",
    "original": "Our data demonstrate differences in the mechanism of stimulation of phenylalanine hydroxylase and nitric oxide synthase by H4biopterin",
    "simplified": "Our data demonstrate differences in the stimulation of nitric oxide synthase and phenylalanine hydroxylase by H4biopterin."
  },
  {
    "text": "Transfection of the brain cDNA into COS1 cells resulted in transporter activity that was blocked by the VMAT inhibitor reserpine and a proton ionophore but not by tetrabenazine which has a high affinity for VMAT2",
    "triple_list": [
      [
        "VMAT",
        "CPR:4",
        "reserpine"
      ]
    ],
    "updated": "No",
    "original": "Transfection of the brain cDNA into COS1 cells resulted in transporter activity that was blocked by the VMAT inhibitor reserpine and a proton ionophore but not by tetrabenazine which has a high affinity for VMAT2",
    "simplified": "Transfection of the brain cDNA into COS1 cells resulted in transporter activity that was blocked by reserpine but not by tetrabenazine. This is because tetrabenazine acts on the VMAT2 gene."
  },
  {
    "text": "When HUVECs were stimulated by thrombin without extracellular Larginine NorNOHA , the NOS activity and the NO release were increased in both groups .",
    "triple_list": [
      [
        "NorNOHA",
        "CPR:3",
        "NOS"
      ]
    ],
    "updated": "Yes",
    "original": "When HUVECs were stimulated by thrombin without extracellular Larginine NorNOHA dosedependently increased the NOS activity and the NO release with maximal effects at 20 microM",
    "simplified": "When HUVECs were stimulated by thrombin without extracellular Larginine NorNOHA, the NOS activity and the NO release were increased in both groups."
  },
  {
    "text": "Extracellular Larginine also dosedependently increased NO release and arginase activity",
    "triple_list": [
      [
        "Larginine",
        "CPR:3",
        "arginase"
      ]
    ],
    "updated": "No",
    "original": "Extracellular Larginine also dosedependently increased NO release and arginase activity",
    "simplified": "Extracellular larginine also increased arginase activity and NO release."
  },
  {
    "text": "To determine whether arginases modulate the endothelial NO synthesis we investigated the activity of the competitive arginase inhibitor NomegahydroxynorLarginine NorNOHA at surface of human umbilical vein endothelial cells and on NO release at surface of endothelial cells .",
    "triple_list": [
      [
        "arginase",
        "CPR:4",
        "NomegahydroxynorLarginine"
      ],
      [
        "arginase",
        "CPR:4",
        "NorNOHA"
      ],
      [
        "arginases",
        "CPR:9",
        "NO"
      ]
    ],
    "updated": "Yes",
    "original": "To determine whether arginases modulate the endothelial NO synthesis we investigated the effects of the competitive arginase inhibitor NomegahydroxynorLarginine NorNOHA on the activity of NOS arginases and Larginine transporter and on NO release at surface of human umbilical vein endothelial cells HUVECs",
    "simplified": "To determine whether arginases modulate the endothelial NO synthesis we investigated the activity of the competitive arginase inhibitor NomegahydroxynorLarginine NorNOHA at surface of human umbilical vein endothelial cells and on NO release at surface of endothelial cells."
  },
  {
    "text": "In unstimulated cells , the arginase activity was reduced by NorNOHA dose-dependently at 20 microM .",
    "triple_list": [
      [
        "NorNOHA",
        "CPR:4",
        "arginase"
      ]
    ],
    "updated": "Yes",
    "original": "In unstimulated cells NorNOHA dosedependently reduced the arginase activity with maximal inhibition at 20 microM",
    "simplified": "In unstimulated cells, the arginase activity was reduced by NorNOHA dose-dependently at 20 microM."
  },
  {
    "text": "However , even though NorNOHA activated larginine uptake , it still inhibited arginase activity .",
    "triple_list": [
      [
        "arginase",
        "CPR:4",
        "NorNOHA"
      ]
    ],
    "updated": "Yes",
    "original": "However despite activation of Larginine uptake the inhibition of arginase activity by NorNOHA was still significant",
    "simplified": "However, even though NorNOHA activated larginine uptake, it still inhibited arginase activity."
  },
  {
    "text": "These data suggest that arginase II activity in mitochondria and larginine carriers in cell membrane are important for NO synthesis .",
    "triple_list": [
      [
        "NO",
        "CPR:9",
        "arginase II"
      ]
    ],
    "updated": "Yes",
    "original": "These data suggest that endothelial NO synthesis depends on the activity of arginase II in mitochondria and larginine carriers in cell membrane",
    "simplified": "These data suggest that arginase II activity in mitochondria and larginine carriers in cell membrane are important for NO synthesis."
  },
  {
    "text": "Reduced synthesis of nitric oxide NO contributes to the endothelial dysfunction and may be related to limited availability of Larginine the common substrate of constitutive nitricoxide synthase NOS and cytosolic arginase I and mitochondrial arginase II",
    "triple_list": [
      [
        "nitric oxide",
        "CPR:9",
        "constitutive nitricoxide synthase"
      ],
      [
        "nitric oxide",
        "CPR:9",
        "NOS"
      ],
      [
        "nitric oxide",
        "CPR:9",
        "arginase I"
      ],
      [
        "nitric oxide",
        "CPR:9",
        "mitochondrial arginase II"
      ],
      [
        "NO",
        "CPR:9",
        "constitutive nitricoxide synthase"
      ],
      [
        "NO",
        "CPR:9",
        "NOS"
      ],
      [
        "NO",
        "CPR:9",
        "arginase I"
      ],
      [
        "NO",
        "CPR:9",
        "mitochondrial arginase II"
      ],
      [
        "Larginine",
        "CPR:9",
        "constitutive nitricoxide synthase"
      ],
      [
        "Larginine",
        "CPR:9",
        "NOS"
      ],
      [
        "Larginine",
        "CPR:9",
        "arginase I"
      ],
      [
        "Larginine",
        "CPR:9",
        "mitochondrial arginase II"
      ]
    ],
    "updated": "No",
    "original": "Reduced synthesis of nitric oxide NO contributes to the endothelial dysfunction and may be related to limited availability of Larginine the common substrate of constitutive nitricoxide synthase NOS and cytosolic arginase I and mitochondrial arginase II",
    "simplified": "The reduced synthesis of nitric oxide NO contributes to the endothelial dysfunction and may be related to limited availability of larginine. Nitric oxide synthase NOS and cytosolic arginase I and mitochondrial arginase II need larginine to work."
  },
  {
    "text": "Mitochondrial arginase II modulates nitricoxide synthesis through nonfreely exchangeable Larginine pools in human endothelial cells",
    "triple_list": [
      [
        "Mitochondrial arginase II",
        "CPR:9",
        "nitricoxide"
      ],
      [
        "Mitochondrial arginase II",
        "CPR:9",
        "Larginine"
      ]
    ],
    "updated": "No",
    "original": "Mitochondrial arginase II modulates nitricoxide synthesis through nonfreely exchangeable Larginine pools in human endothelial cells",
    "simplified": "Mitochondrial arginase II changes the amount of nitricoxide that is made. This happens in human endothelial cells."
  },
  {
    "text": "However , when treated with agents that block late INa like lidocaine , mexiletine and RSD1235 ( a novel mixed ion channel blocker ) , the effects of late INa are lessened . Also , the effects of ATXII , a specific toxin that delays Na channel inactivation and amplifies late INa greatly mimicking LQT3 , are lessened .",
    "triple_list": [
      [
        "RSD1235",
        "CPR:4",
        "ion channel"
      ]
    ],
    "updated": "Yes",
    "original": "However pretreatment with agents that block late INa like lidocaine mexiletine and RSD1235 a novel mixed ion channel blocker for the rapid pharmacologic conversion of atrial fibrillation significantly attenuates the prolonging effects of Class III agents or those induced by ATXII a specific toxin that delays Na channel inactivation and amplifies late INa greatly mimicking LQT3",
    "simplified": "However, when treated with agents that block late INa like lidocaine, mexiletine and RSD1235 (a novel mixed ion channel blocker), the effects of late INa are lessened. Also, the effects of ATXII, a specific toxin that delays Na channel inactivation and amplifies late INa greatly mimicking LQT3, are lessened."
  },
  {
    "text": "The Na channel block caused by lidocaine and RSD1235 can be through the open or inactivated states of the channel . Both inhibit a late component of Na current recorded at 22 degrees C using wholecell patch clamp of Nav 15 in HEK cells .",
    "triple_list": [
      [
        "Na channel",
        "CPR:4",
        "lidocaine"
      ],
      [
        "Na channel",
        "CPR:4",
        "RSD1235"
      ]
    ],
    "updated": "Yes",
    "original": "The Na channel block caused by lidocaine and RSD1235 can be through the open or inactivated states of the channel but both equivalently inhibit a late component of Na current INa recorded at 22 degrees C using wholecell patch clamp of Nav 15 expressed in HEK cells",
    "simplified": "The Na channel block caused by lidocaine and RSD1235 can be through the open or inactivated states of the channel. Both inhibit a late component of Na current recorded at 22 degrees C using wholecell patch clamp of Nav 15 in HEK cells."
  },
  {
    "text": "The above results indicate that polyamine depletion delays the onset of apoptosis in IEC6 cells and confers protection against DNA damaging agents suggesting that polyamines might be involved in the caspase activating signal cascade",
    "triple_list": [
      [
        "polyamines",
        "CPR:3",
        "caspase"
      ]
    ],
    "updated": "No",
    "original": "The above results indicate that polyamine depletion delays the onset of apoptosis in IEC6 cells and confers protection against DNA damaging agents suggesting that polyamines might be involved in the caspase activating signal cascade",
    "simplified": "The above results indicate that polyamine depletion delays the onset of apoptosis in IEC6 cells and provides protection against DNA damaging agents. The caspase- activating signal cascade may also be involved."
  },
  {
    "text": "When putrescine was added , apoptosis was increased . This can be seen by the increase in detached cells and caspase 3 activity .",
    "triple_list": [
      [
        "putrescine",
        "CPR:3",
        "caspase 3"
      ]
    ],
    "updated": "Yes",
    "original": "Addition of putrescine restored the induction of apoptosis as indicated by an increase in the number of detached cells and caspase 3 activity",
    "simplified": "When putrescine was added, apoptosis was increased. This can be seen by the increase in detached cells and caspase 3 activity."
  },
  {
    "text": "Depletion of putrescine spermidine and spermine by DLalphadifluoromethylornithine DFMO a specific inhibitor of ornithine decarboxylase ODC that is the first ratelimiting enzyme for polyamine biosynthesis decreased the apoptotic index",
    "triple_list": [
      [
        "DLalphadifluoromethylornithine",
        "CPR:4",
        "ornithine decarboxylase"
      ],
      [
        "DLalphadifluoromethylornithine",
        "CPR:4",
        "ODC"
      ],
      [
        "DFMO",
        "CPR:4",
        "ornithine decarboxylase"
      ],
      [
        "DFMO",
        "CPR:4",
        "ODC"
      ],
      [
        "putrescine",
        "CPR:9",
        "ornithine decarboxylase"
      ],
      [
        "putrescine",
        "CPR:9",
        "ODC"
      ],
      [
        "spermidine",
        "CPR:9",
        "ornithine decarboxylase"
      ],
      [
        "spermidine",
        "CPR:9",
        "ODC"
      ],
      [
        "spermine",
        "CPR:9",
        "ornithine decarboxylase"
      ],
      [
        "spermine",
        "CPR:9",
        "ODC"
      ]
    ],
    "updated": "No",
    "original": "Depletion of putrescine spermidine and spermine by DLalphadifluoromethylornithine DFMO a specific inhibitor of ornithine decarboxylase ODC that is the first ratelimiting enzyme for polyamine biosynthesis decreased the apoptotic index",
    "simplified": "DLalphadifluoromethylornithine DFMO a specific inhibitor of ornithine decarboxylase ODC that is the first ratelimiting enzyme for polyamine biosynthesis was found to reduce the apoptotic index by up to 30%."
  },
  {
    "text": "Inhibition of Sadenosylmethionine decarboxylase by diethylglyoxal bisguanylhydrazone DEGBG led to the loss of spermidine and spermine . The accumulation of putrescine and ODC was increased .",
    "triple_list": [
      [
        "Sadenosylmethionine decarboxylase",
        "CPR:4",
        "diethylglyoxal bisguanylhydrazone"
      ],
      [
        "Sadenosylmethionine decarboxylase",
        "CPR:4",
        "DEGBG"
      ],
      [
        "Sadenosylmethionine decarboxylase",
        "CPR:9",
        "spermidine"
      ],
      [
        "Sadenosylmethionine decarboxylase",
        "CPR:9",
        "spermine"
      ]
    ],
    "updated": "Yes",
    "original": "Inhibition of Sadenosylmethionine decarboxylase by a specific inhibitor diethylglyoxal bisguanylhydrazone DEGBG led to depletion of spermidine and spermine with a significant accumulation of putrescine and induction of ODC",
    "simplified": "Inhibition of Sadenosylmethionine decarboxylase by diethylglyoxal bisguanylhydrazone DEGBG led to the loss of spermidine and spermine. The accumulation of putrescine and ODC was increased."
  },
  {
    "text": "On the other hand , in patients with a mean serum carvedilol level less than 25 nmoll up to 2 weeks after the start of therapy , the BNP value after the 3rd month was significantly lower than the patient group with a mean Cmin over 25 nmoll .",
    "triple_list": [
      [
        "carvedilol",
        "CPR:4",
        "BNP"
      ],
      [
        "carvedilol",
        "CPR:4",
        "BNP"
      ]
    ],
    "updated": "Yes",
    "original": "On the other hand in patients with a mean serum carvedilol level Cmin of less than 25 nmoll up to 2 weeks after the start ofcarvedilol therapy the degree of reduction in the BNP value after the 3rd month was significantly larger relative to the patient group with Cmin over 25 nmoll",
    "simplified": "On the other hand, in patients with a mean serum carvedilol level less than 25 nmoll up to 2 weeks after the start of therapy, the BNP value after the 3rd month was significantly lower than the patient group with a mean Cmin over 25 nmoll."
  },
  {
    "text": "Two mechanisms of action have been identified for A77 1726 inhibition of dihydroorotate dehydrogenase DHODH and inhibition of tyrosine kinases",
    "triple_list": [
      [
        "A77 1726",
        "CPR:4",
        "dihydroorotate dehydrogenase"
      ],
      [
        "A77 1726",
        "CPR:4",
        "DHODH"
      ],
      [
        "A77 1726",
        "CPR:4",
        "tyrosine kinases"
      ]
    ],
    "updated": "No",
    "original": "Two mechanisms of action have been identified for A77 1726 inhibition of dihydroorotate dehydrogenase DHODH and inhibition of tyrosine kinases",
    "simplified": "Two mechanisms of action have been identified for A77 1726: it inhibits tyrosine kinases and dihydroorotate dehydrogenase."
  },
  {
    "text": "DHODH inhibition occurs at lower concentrations of A77 1726 than that of tyrosine kinases and is currently considered the major mode of action",
    "triple_list": [
      [
        "DHODH",
        "CPR:4",
        "A77 1726"
      ],
      [
        "A77 1726",
        "CPR:4",
        "tyrosine kinases"
      ]
    ],
    "updated": "No",
    "original": "DHODH inhibition occurs at lower concentrations of A77 1726 than that of tyrosine kinases and is currently considered the major mode of action",
    "simplified": "DHODH inhibition occurs at lower levels than tyrosine kinases. It is currently thought that this is the major mode of action."
  },
  {
    "text": "Interestingly the allele of PRO1 was shown to enhance the activities of gammaglutamyl kinase and gammaglutamyl phosphate reductase . These two enzymes catalyze the first two steps of making Lproline from Lglutamate .",
    "triple_list": [
      [
        "gammaglutamyl kinase",
        "CPR:9",
        "Lproline"
      ],
      [
        "gammaglutamyl phosphate reductase",
        "CPR:9",
        "Lproline"
      ],
      [
        "gammaglutamyl kinase",
        "CPR:9",
        "Lglutamate"
      ],
      [
        "gammaglutamyl phosphate reductase",
        "CPR:9",
        "Lglutamate"
      ]
    ],
    "updated": "Yes",
    "original": "Interestingly the allele of PRO1 was shown to enhance the activities of gammaglutamyl kinase and gammaglutamyl phosphate reductase both of which catalyze the first two steps of Lproline synthesis from Lglutamate and which together may form a complex in vivo",
    "simplified": "Interestingly the allele of PRO1 was shown to enhance the activities of gammaglutamyl kinase and gammaglutamyl phosphate reductase. These two enzymes catalyze the first two steps of making Lproline from Lglutamate."
  },
  {
    "text": "Lproline accumulation and freeze tolerance in Saccharomyces cerevisiae is caused by a mutation in the gammaglutamyl kinase gene .",
    "triple_list": [
      [
        "Lproline",
        "CPR:9",
        "gammaglutamyl kinase"
      ]
    ],
    "updated": "Yes",
    "original": "Lproline accumulation and freeze tolerance of Saccharomyces cerevisiae are caused by a mutation in the PRO1 gene encoding gammaglutamyl kinase",
    "simplified": "Lproline accumulation and freeze tolerance in Saccharomyces cerevisiae is caused by a mutation in the gammaglutamyl kinase gene."
  },
  {
    "text": "When yeast cells were cultured in liquid minimal medium , the mutated gammaglutamyl kinase made more intracellular Lproline . After freezing the cells at 20 degrees C , the viability of the cells with the mutated gene showed a big increase .",
    "triple_list": [
      [
        "gammaglutamyl kinase",
        "CPR:9",
        "Lproline"
      ]
    ],
    "updated": "Yes",
    "original": "When cultured in liquid minimal medium yeast cells expressing the mutated gammaglutamyl kinase were found to accumulate intracellular Lproline and showed a prominent increase in cell viability after freezing at 20 degrees C compared to the viability of cells harboring the wildtype PRO1 gene",
    "simplified": "When yeast cells were cultured in liquid minimal medium, the mutated gammaglutamyl kinase made more intracellular Lproline. After freezing the cells at 20 degrees C, the viability of the cells with the mutated gene showed a big increase."
  },
  {
    "text": "These results suggest that the altered gammaglutamyl kinase activity has an indirect effect on gammaglutamyl phosphate reductase activity . This may lead to an increase in Lproline production in Saccharomyces cerevisiae .",
    "triple_list": [
      [
        "gammaglutamyl kinase",
        "CPR:9",
        "Lproline"
      ],
      [
        "gammaglutamyl phosphate reductase",
        "CPR:9",
        "Lproline"
      ]
    ],
    "updated": "Yes",
    "original": "These results suggest that the altered gammaglutamyl kinase results in stabilization of the complex or has an indirect effect on gammaglutamyl phosphate reductase activity which leads to an increase in Lproline production in Saccharomyces cerevisiae",
    "simplified": "These results suggest that the altered gammaglutamyl kinase activity has an indirect effect on gammaglutamyl phosphate reductase activity. This may lead to an increase in Lproline production in Saccharomyces cerevisiae."
  },
  {
    "text": "We report here the optimization of human 17\u03b2HSD2 inhibitors in the 25thiophene amide class by varying the size of the linker between the amide moiety and the phenyl group .",
    "triple_list": [
      [
        "human 17\u03b2HSD2",
        "CPR:4",
        "25thiophene amide"
      ]
    ],
    "updated": "Yes",
    "original": "We report here the optimization of human 17\u03b2HSD2 inhibitors in the 25thiophene amide class by varying the size of the linker n equals 0 and 2 between the amide moiety and the phenyl group",
    "simplified": "We report here the optimization of human 17\u03b2HSD2 inhibitors in the 25thiophene amide class by varying the size of the linker between the amide moiety and the phenyl group."
  },
  {
    "text": "While none of the phenethylamides n = 2 were active most of the anilides n = 0 turned out to moderately or strongly inhibit 17\u03b2HSD2",
    "triple_list": [
      [
        "anilides",
        "CPR:4",
        "17\u03b2HSD2"
      ]
    ],
    "updated": "No",
    "original": "While none of the phenethylamides n = 2 were active most of the anilides n = 0 turned out to moderately or strongly inhibit 17\u03b2HSD2",
    "simplified": "While none of the phenethylamides n = 2 were active, most of the anilides n = 0 did not work at all. They did not work at all."
  },
  {
    "text": "Structural optimization of 25thiophene amides as highly potent and selective 17\u03b2hydroxysteroid dehydrogenase type 2 inhibitors for the treatment of osteoporosis",
    "triple_list": [
      [
        "25thiophene amides",
        "CPR:4",
        "17\u03b2hydroxysteroid dehydrogenase type 2"
      ]
    ],
    "updated": "No",
    "original": "Structural optimization of 25thiophene amides as highly potent and selective 17\u03b2hydroxysteroid dehydrogenase type 2 inhibitors for the treatment of osteoporosis",
    "simplified": "Structural optimization of 25thiophene amides for the treatment of osteoporosis The 25thiophene amides are highly potent and selective inhibitors."
  },
  {
    "text": "Theophylline exposure increased the expression of CysS and PDE3A mRNA , but the expression of PDE4D mRNA did not change .",
    "triple_list": [
      [
        "Theophylline",
        "CPR:3",
        "CysS"
      ],
      [
        "Theophylline",
        "CPR:3",
        "PDE3A"
      ]
    ],
    "updated": "Yes",
    "original": "Theophylline exposure resulted in a sustained increase in mRNA expression for CysS and PDE3A but PDE4D gene expression was unchanged",
    "simplified": "Theophylline exposure increased the expression of CysS and PDE3A mRNA, but the expression of PDE4D mRNA did not change."
  },
  {
    "text": "Multiple exposure to theophylline a phosphodiesterase PDE inhibitor induces acinar hypertrophy in the salivary gland",
    "triple_list": [
      [
        "theophylline",
        "CPR:4",
        "PDE"
      ],
      [
        "theophylline",
        "CPR:4",
        "phosphodiesterase"
      ]
    ],
    "updated": "No",
    "original": "Multiple exposure to theophylline a phosphodiesterase PDE inhibitor induces acinar hypertrophy in the salivary gland",
    "simplified": "Theophylline is a phosphodiesterase PDE inhibitor. It makes the salivary gland work harder."
  },
  {
    "text": "Terbutaline Bricanyl and its prodrug Bambuterol Bambec are highly potent beta2adrenoceptor agonists often used in asthma patients",
    "triple_list": [
      [
        "Bambuterol",
        "CPR:5",
        "beta2adrenoceptor"
      ],
      [
        "Bambec",
        "CPR:5",
        "beta2adrenoceptor"
      ],
      [
        "Terbutaline",
        "CPR:5",
        "beta2adrenoceptor"
      ],
      [
        "Bricanyl",
        "CPR:5",
        "beta2adrenoceptor"
      ]
    ],
    "updated": "No",
    "original": "Terbutaline Bricanyl and its prodrug Bambuterol Bambec are highly potent beta2adrenoceptor agonists often used in asthma patients",
    "simplified": "Terbutaline Bricanyl and its prodrug Bambuterol Bambec are used to treat asthma. They are very powerful drugs."
  },
  {
    "text": "Tamsulosin effectively antagonized the positive inotropic effect of phenylephrine even after inactivation of alpha 1Badrenoceptors by treatment with chlorethylclonidine . This shows that the tamsulosinsensitive subtype is resistant to chlorethylclonidine .",
    "triple_list": [
      [
        "alpha 1Badrenoceptors",
        "CPR:4",
        "chlorethylclonidine"
      ],
      [
        "phenylephrine",
        "CPR:5",
        "alpha 1Badrenoceptors"
      ],
      [
        "Tamsulosin",
        "CPR:6",
        "alpha 1Badrenoceptors"
      ]
    ],
    "updated": "Yes",
    "original": "Tamsulosin effectively antagonized the positive inotropic effect of phenylephrine even after inactivation of alpha 1Badrenoceptors by treatment with chlorethylclonidine which is an indication that the tamsulosinsensitive subtype belongs to a class resistant to chlorethylclonidine",
    "simplified": "Tamsulosin effectively antagonized the positive inotropic effect of phenylephrine even after inactivation of alpha 1Badrenoceptors by treatment with chlorethylclonidine. This shows that the tamsulosinsensitive subtype is resistant to chlorethylclonidine."
  },
  {
    "text": "These results indicate that the positive inotropic effect mediated via tamsulosin and oxymetazoline sensitive subtype of alpha 1adrenoceptors is independent of the accumulation of inositol phosphates in the body .",
    "triple_list": [
      [
        "oxymetazoline",
        "CPR:5",
        "alpha 1adrenoceptors"
      ],
      [
        "tamsulosin",
        "CPR:6",
        "alpha 1adrenoceptors"
      ]
    ],
    "updated": "Yes",
    "original": "These results indicate that the positive inotropic effect mediated via tamsulosin and oxymetazoline sensitive subtype of alpha 1adrenoceptors is exerted by a subcellular mechanism that is independent of the accumulation of inositol phosphates",
    "simplified": "These results indicate that the positive inotropic effect mediated via tamsulosin and oxymetazoline sensitive subtype of alpha 1adrenoceptors is independent of the accumulation of inositol phosphates in the body."
  },
  {
    "text": "Phenylephrine had a positive inotropic effect when alpha 1adrenoceptors were activated in the presence of bupranolol or Stimolol .",
    "triple_list": [
      [
        "Phenylephrine",
        "CPR:5",
        "alpha 1adrenoceptors"
      ]
    ],
    "updated": "Yes",
    "original": "Phenylephrine elicited a concentrationdependent positive inotropic effect via alpha 1adrenoceptors in the presence of either bupranolol or Stimolol",
    "simplified": "Phenylephrine had a positive inotropic effect when alpha 1adrenoceptors were activated in the presence of bupranolol or Stimolol."
  },
  {
    "text": "The influence of tamsulosin on the positive inotropic effect and the accumulation of inositol phosphates that are induced via alpha 1adrenoceptors was studied in the rabbit ventricular myocardium in comparison with that of another alpha 1Aadrenoceptor ligand oxymetazoline .",
    "triple_list": [
      [
        "tamsulosin",
        "CPR:6",
        "alpha 1Aadrenoceptor"
      ]
    ],
    "updated": "Yes",
    "original": "The influence of tamsulosin a selective alpha 1Aadrenoceptor antagonist on the positive inotropic effect and the accumulation of inositol phosphates that are induced via alpha 1adrenoceptors was studied in comparison with that of another alpha 1Aadrenoceptor ligand oxymetazoline in the rabbit ventricular myocardium",
    "simplified": "The influence of tamsulosin on the positive inotropic effect and the accumulation of inositol phosphates that are induced via alpha 1adrenoceptors was studied in the rabbit ventricular myocardium in comparison with that of another alpha 1Aadrenoceptor ligand oxymetazoline."
  },
  {
    "text": "tamsulosin an alpha 1Aadrenoceptor antagonist inhibits the positive inotropic effect but not the accumulation of inositol phosphates in rabbit heart",
    "triple_list": [
      [
        "tamsulosin",
        "CPR:6",
        "alpha 1Aadrenoceptor"
      ]
    ],
    "updated": "No",
    "original": "tamsulosin an alpha 1Aadrenoceptor antagonist inhibits the positive inotropic effect but not the accumulation of inositol phosphates in rabbit heart",
    "simplified": "Tamsulosin, an alpha 1Aadrenoceptor antagonist, prevents inositol phosphates from building up in the rabbit's heart."
  },
  {
    "text": "Tamsulosin did not affect the accumulation of 3Hinositol phosphates that was induced by 10 microM phenylephrine over the range of concentrations at which it antagonized the positive inotropic effect mediated by alpha 1adrenoceptors .",
    "triple_list": [
      [
        "Tamsulosin",
        "CPR:6",
        "alpha 1adrenoceptors"
      ]
    ],
    "updated": "Yes",
    "original": "Tamsulosin over the range of concentrations at which it antagonized the positive inotropic effect mediated by alpha 1adrenoceptors did not affect the accumulation of 3Hinositol phosphates that was induced by 10 microM phenylephrine",
    "simplified": "Tamsulosin did not affect the accumulation of 3Hinositol phosphates that was induced by 10 microM phenylephrine over the range of concentrations at which it antagonized the positive inotropic effect mediated by alpha 1adrenoceptors."
  },
  {
    "text": "PTE also downregulated the expression of STAT3 target genes including the antiapoptotic proteins BclxL and Mcl1 leading to the upregulation of mitochondrial apoptosis pathwayrelated proteins Bax Bak cytosolic Cytochrome c and cleaved Caspase3 and cyclindependent kinase inhibitors such as p21 and p27",
    "triple_list": [
      [
        "PTE",
        "CPR:3",
        "Bax"
      ],
      [
        "PTE",
        "CPR:3",
        "Bak"
      ],
      [
        "PTE",
        "CPR:3",
        "Cytochrome c"
      ],
      [
        "PTE",
        "CPR:3",
        "Caspase3"
      ],
      [
        "PTE",
        "CPR:3",
        "p21"
      ],
      [
        "PTE",
        "CPR:3",
        "p27"
      ],
      [
        "PTE",
        "CPR:4",
        "STAT3"
      ],
      [
        "PTE",
        "CPR:4",
        "BclxL"
      ],
      [
        "PTE",
        "CPR:4",
        "Mcl1"
      ]
    ],
    "updated": "No",
    "original": "PTE also downregulated the expression of STAT3 target genes including the antiapoptotic proteins BclxL and Mcl1 leading to the upregulation of mitochondrial apoptosis pathwayrelated proteins Bax Bak cytosolic Cytochrome c and cleaved Caspase3 and cyclindependent kinase inhibitors such as p21 and p27",
    "simplified": "PTE also downregulated the expression of STAT3 target genes including the antiapoptotic proteins BclxL and Mcl1 leading to the upregulation of Bax Bak (cytochrome c) and cleaved Caspase3. Cytochrome c and Caspase3 are important for cell death."
  },
  {
    "text": "Pterostilbene works against cancer in the human body . It works by stopping the JAK2 STAT3 signaling pathway .",
    "triple_list": [
      [
        "Pterostilbene",
        "CPR:4",
        "JAK2"
      ],
      [
        "Pterostilbene",
        "CPR:4",
        "STAT3"
      ]
    ],
    "updated": "Yes",
    "original": "Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2 STAT3 signaling pathway",
    "simplified": "Pterostilbene works against cancer in the human body. It works by stopping the JAK2 STAT3 signaling pathway."
  },
  {
    "text": "In addition , PTE treatment directly inhibited the downstream activation of STAT3 and JAK2 at Tyr 1007 .",
    "triple_list": [
      [
        "PTE",
        "CPR:4",
        "JAK2"
      ],
      [
        "PTE",
        "CPR:4",
        "STAT3"
      ]
    ],
    "updated": "Yes",
    "original": "Furthermore PTE treatment directly inhibited the phosphorylation of JAK2 at Tyr 1007 and the downstream activation of STAT3",
    "simplified": "In addition, PTE treatment directly inhibited the downstream activation of STAT3 and JAK2 at Tyr 1007."
  },
  {
    "text": "PTE used with a known JAK2 STAT3 inhibitor ( AG490 ) did not work as well , but it did not die the cells .",
    "triple_list": [
      [
        "JAK2",
        "CPR:4",
        "AG490"
      ],
      [
        "STAT3",
        "CPR:4",
        "AG490"
      ]
    ],
    "updated": "Yes",
    "original": "PTE used in combination with a known JAK2 STAT3 inhibitor AG490 further decreased the viability of osteosarcoma cells",
    "simplified": "PTE used with a known JAK2 STAT3 inhibitor (AG490) did not work as well, but it did not die the cells."
  },
  {
    "text": "PTE works by inhibiting the growth of osteosarcoma cells . It works by targeting the JAK2-STAT3 pathway .",
    "triple_list": [
      [
        "PTE",
        "CPR:4",
        "JAK2"
      ],
      [
        "PTE",
        "CPR:4",
        "STAT3"
      ]
    ],
    "updated": "Yes",
    "original": "Taken together PTE is a potent inhibitor of osteosarcoma cell growth that targets the JAK2 STAT3 signaling pathway",
    "simplified": "PTE works by inhibiting the growth of osteosarcoma cells. It works by targeting the JAK2-STAT3 pathway."
  },
  {
    "text": "These data suggest that inhibition of JAK2 STAT3 signaling is a novel mechanism of action for PTE during therapeutic intervention in osteosarcoma cancers",
    "triple_list": [
      [
        "JAK2",
        "CPR:4",
        "PTE"
      ],
      [
        "STAT3",
        "CPR:4",
        "PTE"
      ]
    ],
    "updated": "No",
    "original": "These data suggest that inhibition of JAK2 STAT3 signaling is a novel mechanism of action for PTE during therapeutic intervention in osteosarcoma cancers",
    "simplified": "These data suggest that a novel mechanism of action for PTE during therapeutic intervention in osteosarcoma cancers is identified."
  },
  {
    "text": "In addition , sinapic acid reduced the content of hydroxyproline in the liver . This was associated with a reduction in the expression of type I collagen mRNA .",
    "triple_list": [
      [
        "sinapic acid",
        "CPR:4",
        "type I collagen"
      ]
    ],
    "updated": "Yes",
    "original": "Furthermore sinapic acid reduced hepatic hydroxyproline content which correlated with a reduction in the expression of type I collagen mRNA and histological analysis of collagen in liver tissue",
    "simplified": "In addition, sinapic acid reduced the content of hydroxyproline in the liver. This was associated with a reduction in the expression of type I collagen mRNA."
  },
  {
    "text": "Additionally the expression of hepatic fibrosisrelated factors such as \u03b1smooth muscle actin and transforming growth factor\u03b21 TGF\u03b21 were reduced in rats treated with sinapic acid",
    "triple_list": [
      [
        "\u03b1smooth muscle actin",
        "CPR:4",
        "sinapic acid"
      ],
      [
        "transforming growth factor\u03b21",
        "CPR:4",
        "sinapic acid"
      ],
      [
        "TGF\u03b21",
        "CPR:4",
        "sinapic acid"
      ]
    ],
    "updated": "No",
    "original": "Additionally the expression of hepatic fibrosisrelated factors such as \u03b1smooth muscle actin and transforming growth factor\u03b21 TGF\u03b21 were reduced in rats treated with sinapic acid",
    "simplified": "In addition, hepatic fibrosisrelated factors such as transforming growth factor\u03b21 and \u03b1smooth muscle actin were reduced in rats treated with sinapic acid."
  },
  {
    "text": "In conclusion we find that sinapic acid has hepatoprotective and antifibrotic effects against DMNinduced liver injury most likely due to its ability to suppress TGF\u03b21 and its ability to attenuate activation of hepatic stellate cells .",
    "triple_list": [
      [
        "sinapic acid",
        "CPR:4",
        "TGF\u03b21"
      ]
    ],
    "updated": "Yes",
    "original": "In conclusion we find that sinapic acid exhibits hepatoprotective and antifibrotic effects against DMNinduced liver injury most likely due to its antioxidant activities of scavenging radicals its capacity to suppress TGF\u03b21 and its ability to attenuate activation of hepatic stellate cells",
    "simplified": "In conclusion we find that sinapic acid has hepatoprotective and antifibrotic effects against DMNinduced liver injury most likely due to its ability to suppress TGF\u03b21 and its ability to attenuate activation of hepatic stellate cells."
  },
  {
    "text": "Thalidomide reduced COX2 expression accompanied by a decrease of bcl2 protein TNFalpha VEGF GSH and an increased cytochrome c but had no effect on that of COX1 in MCF7 and HL60",
    "triple_list": [
      [
        "Thalidomide",
        "CPR:3",
        "cytochrome c"
      ],
      [
        "Thalidomide",
        "CPR:4",
        "COX2"
      ],
      [
        "Thalidomide",
        "CPR:4",
        "bcl2"
      ],
      [
        "Thalidomide",
        "CPR:4",
        "TNFalpha"
      ],
      [
        "Thalidomide",
        "CPR:4",
        "VEGF"
      ]
    ],
    "updated": "No",
    "original": "Thalidomide reduced COX2 expression accompanied by a decrease of bcl2 protein TNFalpha VEGF GSH and an increased cytochrome c but had no effect on that of COX1 in MCF7 and HL60",
    "simplified": "Thalidomide reduced COX2 expression but had no effect on that of COX1 in MCF7 and HL60. It increased cytochrome c but had no effect on COX2 expression."
  },
  {
    "text": "Thalidomide slows down the growth of tumors . It does this by destroying COX2 .",
    "triple_list": [
      [
        "Thalidomide",
        "CPR:4",
        "COX2"
      ]
    ],
    "updated": "Yes",
    "original": "Thalidomide inhibits growth of tumors through COX2 degradation independent of antiangiogenesis",
    "simplified": "Thalidomide slows down the growth of tumors. It does this by destroying COX2."
  },
  {
    "text": "These results demonstrated that thalidomide might inhibit growth of tumors through COX2 degradation independent of antiangiogenesis",
    "triple_list": [
      [
        "thalidomide",
        "CPR:4",
        "COX2"
      ]
    ],
    "updated": "No",
    "original": "These results demonstrated that thalidomide might inhibit growth of tumors through COX2 degradation independent of antiangiogenesis",
    "simplified": "These results showed that thalidomide could slow down the growth of tumors. It could do this even without antiangiogenesis."
  },
  {
    "text": "Gene expression profiling of GEP of GISTS GISTR cells and two IM resistant GIST patients showed that KIT is downregulated , suggesting that KIT may be involved .",
    "triple_list": [
      [
        "IM",
        "CPR:4",
        "KIT"
      ],
      [
        "IM",
        "CPR:4",
        "KIT"
      ]
    ],
    "updated": "Yes",
    "original": "Gene expression profiling GEP of GISTS GISTR cells and two IM resistant GIST patients demonstrated that KIT is downregulated implying a major role in IM resistance",
    "simplified": "Gene expression profiling of GEP of GISTS GISTR cells and two IM resistant GIST patients showed that KIT is downregulated, suggesting that KIT may be involved."
  },
  {
    "text": "Molecular modeling of the kinase domain of mutant cKit V654A and AXL showed that they could not bind to IM , but they could bind to MP470 .",
    "triple_list": [
      [
        "cKit",
        "CPR:4",
        "MP470"
      ],
      [
        "AXL",
        "CPR:4",
        "MP470"
      ],
      [
        "kinase",
        "CPR:4",
        "MP470"
      ]
    ],
    "updated": "Yes",
    "original": "Molecular modeling of the kinase domain of mutant cKit V654A and AXL showed no binding to IM but efficient binding to MP470 a novel cKitAXL kinase inhibitor",
    "simplified": "Molecular modeling of the kinase domain of mutant cKit V654A and AXL showed that they could not bind to IM, but they could bind to MP470."
  },
  {
    "text": "In this study , we examined the effects of the alphaglucosidase inhibitors acarbose and voglibose in patients with type 2 diabetes mellitus on serum triglyceride levels and postprandial glucose .",
    "triple_list": [
      [
        "alphaglucosidase",
        "CPR:4",
        "voglibose"
      ],
      [
        "alphaglucosidase",
        "CPR:4",
        "acarbose"
      ],
      [
        "alphaglucosidase",
        "CPR:4",
        "glucose"
      ]
    ],
    "updated": "Yes",
    "original": "INTRODUCTION In this study we examined the effects of the alphaglucosidase inhibitors acarbose and voglibose on postprandial plasma glucose and serum triglyceride levels in patients with type 2 diabetes mellitus",
    "simplified": "In this study, we examined the effects of the alphaglucosidase inhibitors acarbose and voglibose in patients with type 2 diabetes mellitus on serum triglyceride levels and postprandial glucose."
  },
  {
    "text": "Blockade of JAK and ERK pathways with AG490 and U0126 reduced the size of myocardial infarct by about half .",
    "triple_list": [
      [
        "JAK",
        "CPR:4",
        "AG490"
      ],
      [
        "ERK",
        "CPR:4",
        "U0126"
      ]
    ],
    "updated": "Yes",
    "original": "Blockade of JAK and ERK pathways with AG490 and U0126 respectively abrogated the myocardial infarct size reduction by NDP\u03b1MSH",
    "simplified": "Blockade of JAK and ERK pathways with AG490 and U0126 reduced the size of myocardial infarct by about half."
  },
  {
    "text": "They included the COX1 inhibitor indomethacin the COX2 inhibitor NS398 the mixed COX1COX2 inhibitor ibuprofen the nitric oxide NO derivatives of indomethacin ibuprofen and flurbiprofen the 5LOX inhibitor REV 5901 and the 5LOX activating protein FLAP inhibitor MK886",
    "triple_list": [
      [
        "5LOX",
        "CPR:4",
        "REV 5901"
      ],
      [
        "5LOX activating protein",
        "CPR:4",
        "MK886"
      ],
      [
        "FLAP",
        "CPR:4",
        "MK886"
      ],
      [
        "COX2",
        "CPR:4",
        "NS398"
      ],
      [
        "COX1",
        "CPR:4",
        "ibuprofen"
      ],
      [
        "COX2",
        "CPR:4",
        "ibuprofen"
      ]
    ],
    "updated": "No",
    "original": "They included the COX1 inhibitor indomethacin the COX2 inhibitor NS398 the mixed COX1COX2 inhibitor ibuprofen the nitric oxide NO derivatives of indomethacin ibuprofen and flurbiprofen the 5LOX inhibitor REV 5901 and the 5LOX activating protein FLAP inhibitor MK886",
    "simplified": "They included the COX1 inhibitor indomethacin, the COX2 inhibitor NS398, the nitric oxide NO derivatives ibuprofen and flurbiprofen, the 5LOX inhibitor REV 5901, the FLAP inhibitor MK886, and the combination COX1 and COX2."
  },
  {
    "text": "The 5LOX pathway produces inflammatory leukotrienes while the COX pathway produces inflammatory prostaglandins .",
    "triple_list": [
      [
        "COX",
        "CPR:9",
        "prostaglandins"
      ],
      [
        "5LOX",
        "CPR:9",
        "leukotrienes"
      ]
    ],
    "updated": "Yes",
    "original": "The COX pathway generates inflammatory prostaglandins while the 5LOX pathway generates inflammatory leukotrienes",
    "simplified": "The 5LOX pathway produces inflammatory leukotrienes while the COX pathway produces inflammatory prostaglandins."
  },
  {
    "text": "Additionally MPTP significantly downregulated Bcl2 expression in the mitochondria of dopaminergic cells in the SN followed by an increase in Bax expression cytochrome C translocation to the cytosol andcleaved caspase3 expression whereas these were inhibited by CRE or EB treatment",
    "triple_list": [
      [
        "MPTP",
        "CPR:3",
        "Bax"
      ],
      [
        "MPTP",
        "CPR:3",
        "caspase3"
      ],
      [
        "MPTP",
        "CPR:4",
        "Bcl2"
      ]
    ],
    "updated": "No",
    "original": "Additionally MPTP significantly downregulated Bcl2 expression in the mitochondria of dopaminergic cells in the SN followed by an increase in Bax expression cytochrome C translocation to the cytosol andcleaved caspase3 expression whereas these were inhibited by CRE or EB treatment",
    "simplified": "In addition, MPTP significantly downregulated Bcl2 expression in the mitochondria of dopaminergic cells in the SN followed by an increase in Bax expression whereas these were inhibited by CRE or EB treatment."
  },
  {
    "text": "The hemoglobin A1c HbA1c of all patients improved significantly after 12 weeks of sitagliptin p001 . The insulin dosage was also reduced from 273\u00b1158 Uday to 245\u00b1165 Uday p0001 after 12 weeks .",
    "triple_list": [
      [
        "hemoglobin A1c",
        "CPR:3",
        "sitagliptin"
      ],
      [
        "HbA1c",
        "CPR:3",
        "sitagliptin"
      ]
    ],
    "updated": "Yes",
    "original": "The hemoglobin A1c HbA1c of all patients improved significantly from 81\u00b112 to 76\u00b111 after 12 weeks of addon therapy with sitagliptin p001 and the insulin dosage was reduced from 273\u00b1158 Uday to 245\u00b1165 Uday p0001",
    "simplified": "The hemoglobin A1c HbA1c of all patients improved significantly after 12 weeks of sitagliptin p001. The insulin dosage was also reduced from 273\u00b1158 Uday to 245\u00b1165 Uday p0001 after 12 weeks."
  },
  {
    "text": "Addon therapy with the DPP4 inhibitor sitagliptin improves glycemic control in insulintreated Japanese patients with type 2 diabetes mellitus",
    "triple_list": [
      [
        "DPP4",
        "CPR:4",
        "sitagliptin"
      ]
    ],
    "updated": "No",
    "original": "Addon therapy with the DPP4 inhibitor sitagliptin improves glycemic control in insulintreated Japanese patients with type 2 diabetes mellitus",
    "simplified": "Addon therapy with the DPP4 inhibitor can improve glycemic control in people with type 2 diabetes mellitus if it is not treated."
  },
  {
    "text": "In the present study we have evaluated possible participation of monocarboxylate transporters MCTs responsible for the bidirectional membrane transport of pyruvate in the cytoprotective property in osteoblasts",
    "triple_list": [
      [
        "monocarboxylate transporters",
        "CPR:9",
        "pyruvate"
      ],
      [
        "MCTs",
        "CPR:9",
        "pyruvate"
      ]
    ],
    "updated": "No",
    "original": "In the present study we have evaluated possible participation of monocarboxylate transporters MCTs responsible for the bidirectional membrane transport of pyruvate in the cytoprotective property in osteoblasts",
    "simplified": "In the present study we have evaluated possible participation of monocarboxylate transporters in the cytoprotective property of osteoblasts in the bidirectional membrane transport."
  },
  {
    "text": "Mammalian ALDH1B1 another mitochondrial enzyme sharing 72 identity with ALDH2 is also able to break down acetaldehyde , but in different parts of the body than in humans .",
    "triple_list": [
      [
        "Mammalian ALDH1B1",
        "CPR:9",
        "acetaldehyde"
      ],
      [
        "ALDH2",
        "CPR:9",
        "acetaldehyde"
      ]
    ],
    "updated": "Yes",
    "original": "Mammalian ALDH1B1 another mitochondrial enzyme sharing 72 identity with ALDH2 is also capable of metabolizing acetaldehyde but has a tissue distribution and pattern of activity distinct from that of ALDH2",
    "simplified": "Mammalian ALDH1B1 another mitochondrial enzyme sharing 72 identity with ALDH2 is also able to break down acetaldehyde, but in different parts of the body than in humans."
  },
  {
    "text": "However salicylate moiety appears to interfere with aspirin inhibitory action on platelets and vascular COX",
    "triple_list": [
      [
        "aspirin",
        "CPR:4",
        "COX"
      ]
    ],
    "updated": "No",
    "original": "However salicylate moiety appears to interfere with aspirin inhibitory action on platelets and vascular COX",
    "simplified": "However, the salicylate in aspirin does not work the way it should, so it does not work at all."
  },
  {
    "text": "Aspirin ASA and other nonsteroidal antiinflammatory drugs which are cyclooxygenase COX inhibitors precipitate asthmatic attacks in ASAintolerant patients while sodium salicylate hardly active on COX by itself is well tolerated by these patients",
    "triple_list": [
      [
        "Aspirin",
        "CPR:4",
        "cyclooxygenase"
      ],
      [
        "Aspirin",
        "CPR:4",
        "COX"
      ],
      [
        "ASA",
        "CPR:4",
        "cyclooxygenase"
      ],
      [
        "ASA",
        "CPR:4",
        "COX"
      ]
    ],
    "updated": "No",
    "original": "Aspirin ASA and other nonsteroidal antiinflammatory drugs which are cyclooxygenase COX inhibitors precipitate asthmatic attacks in ASAintolerant patients while sodium salicylate hardly active on COX by itself is well tolerated by these patients",
    "simplified": "Aspirin ASA and other nonsteroidal antiinflammatory drugs cause asthmatic attacks in people who do not like them. Sodium salicylate, which is not active on COX, does not cause asthmatic attacks in these people."
  },
  {
    "text": "Although the precise mechanism of the protective action of trilisate is unknown our data support the possibility of interaction between salicylate and ASA on cyclooxygenase locus in the respiratory tract in ASAintolerant patients",
    "triple_list": [
      [
        "salicylate",
        "CPR:4",
        "cyclooxygenase"
      ],
      [
        "ASA",
        "CPR:4",
        "cyclooxygenase"
      ]
    ],
    "updated": "No",
    "original": "Although the precise mechanism of the protective action of trilisate is unknown our data support the possibility of interaction between salicylate and ASA on cyclooxygenase locus in the respiratory tract in ASAintolerant patients",
    "simplified": "Although the exact mechanism of the protective action of trilisate is unknown, our data suggest that salicylate and ASA may interact in the respiratory tract in ASAintolerant patients."
  },
  {
    "text": "Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice",
    "triple_list": [
      [
        "Minocycline",
        "CPR:4",
        "cytochrome c"
      ]
    ],
    "updated": "No",
    "original": "Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice",
    "simplified": "Minocycline can slow down the development of amyotrophic lateral sclerosis (ALS) in mice."
  },
  {
    "text": "We found that minocycline inhibits cytochrome c release and mitochondrial permeability .",
    "triple_list": [
      [
        "minocycline",
        "CPR:4",
        "cytochrome c"
      ]
    ],
    "updated": "Yes",
    "original": "We find that minocycline inhibits mitochondrial permeabilitytransitionmediated cytochrome c release",
    "simplified": "We found that minocycline inhibits cytochrome c release and mitochondrial permeability."
  },
  {
    "text": "Minocycline can inhibit cytochrome c release in living cells . This has been shown in living cells .",
    "triple_list": [
      [
        "Minocycline",
        "CPR:4",
        "cytochrome c"
      ]
    ],
    "updated": "Yes",
    "original": "Minocycline mediated inhibition of cytochrome c release is demonstrated in vivo in cells and in isolated mitochondria",
    "simplified": "Minocycline can inhibit cytochrome c release in living cells. This has been shown in living cells."
  },
  {
    "text": "Here we studied the effects of the recently developed monoacylglycerol lipase inhibitor JZL184 on stress-induced corticosterone levels in male CD1 mice . We found that this compound dramatically increased stress-induced corticosterone levels .",
    "triple_list": [
      [
        "monoacylglycerol lipase",
        "CPR:4",
        "JZL184"
      ]
    ],
    "updated": "Yes",
    "original": "Here we studied the effects of the recently developed monoacylglycerol lipase inhibitor JZL184 on basal and stressinduced corticosterone levels in male CD1 mice and found that this compound dramatically increased basal levels without affecting stress responses",
    "simplified": "Here we studied the effects of the recently developed monoacylglycerol lipase inhibitor JZL184 on stress-induced corticosterone levels in male CD1 mice. We found that this compound dramatically increased stress-induced corticosterone levels."
  },
  {
    "text": "Among these differentially expressed lncRNAs the greatest change was for uc002mbe2 . This had more than 300 fold changes after TSA treatment .",
    "triple_list": [
      [
        "uc002mbe2",
        "CPR:3",
        "TSA"
      ]
    ],
    "updated": "Yes",
    "original": "Among these differentially expressed lncRNAs the greatest change was noted for uc002mbe2 which had more than 300 folds induction upon TSA treatment",
    "simplified": "Among these differentially expressed lncRNAs the greatest change was for uc002mbe2. This had more than 300 fold changes after TSA treatment."
  },
  {
    "text": "TSA caused uc002mbe2 in four different cell lines .",
    "triple_list": [
      [
        "TSA",
        "CPR:3",
        "uc002mbe2"
      ]
    ],
    "updated": "Yes",
    "original": "TSA selectively induced uc002mbe2 in four studied HCC cell lines",
    "simplified": "TSA caused uc002mbe2 in four different cell lines."
  },
  {
    "text": "The expression of uc002mbe2 was positively associated with the TSA induced apoptosis in HCC cells .",
    "triple_list": [
      [
        "TSA",
        "CPR:3",
        "uc002mbe2"
      ]
    ],
    "updated": "Yes",
    "original": "The TSA induced uc002mbe2 expression was positively correlated with the apoptotic effect of TSA in HCC cells",
    "simplified": "The expression of uc002mbe2 was positively associated with the TSA induced apoptosis in HCC cells."
  },
  {
    "text": "Trichostatin A TSA is an inhibitor of histone deacetylase . Because of this , cancer cells do not grow as fast when they have this medicine on them .",
    "triple_list": [
      [
        "histone deacetylase",
        "CPR:4",
        "Trichostatin A"
      ],
      [
        "histone deacetylase",
        "CPR:4",
        "TSA"
      ]
    ],
    "updated": "Yes",
    "original": "Considerable attention has focused on the antitumor effect of histone deacetylase inhibitor Trichostatin A TSA as well as the coding gene expressioninduced apoptosis of cancer cells",
    "simplified": "Trichostatin A TSA is an inhibitor of histone deacetylase. Because of this, cancer cells do not grow as fast when they have this medicine on them."
  },
  {
    "text": "Orlistat treatment also results in modest improvements in total cholesterol lowdensity lipoprotein blood pressure and fasting glucose and insulin concentrations",
    "triple_list": [
      [
        "Orlistat",
        "CPR:3",
        "lowdensity lipoprotein"
      ],
      [
        "Orlistat",
        "CPR:3",
        "insulin"
      ]
    ],
    "updated": "No",
    "original": "Orlistat treatment also results in modest improvements in total cholesterol lowdensity lipoprotein blood pressure and fasting glucose and insulin concentrations",
    "simplified": "Orlistat treatment also results in modest improvements in fasting glucose and insulin levels and total cholesterol and blood pressure."
  },
  {
    "text": "Orlistat - a new lipase inhibitor for the treatment of obesity",
    "triple_list": [
      [
        "Orlistat",
        "CPR:4",
        "lipase"
      ]
    ],
    "updated": "Yes",
    "original": "Orlistat a new lipase inhibitor for the management of obesity",
    "simplified": "Orlistat - a new lipase inhibitor for the treatment of obesity"
  },
  {
    "text": "The expression of the microsomalperoxidase antigen MTPOAg in thyroid cells is induced by TSH through pathways which involve protein synthesis and the accumulation of cAMP in the cell .",
    "triple_list": [
      [
        "microsomalperoxidase antigen",
        "CPR:3",
        "cAMP"
      ],
      [
        "MTPOAg",
        "CPR:3",
        "cAMP"
      ]
    ],
    "updated": "Yes",
    "original": "Evidence has accumulated in the last few years that the expression of the microsomalperoxidase antigen MTPOAg in thyroid cells is induced by TSH through pathways which involve intracellular cAMP accumulation and protein synthesis",
    "simplified": "The expression of the microsomalperoxidase antigen MTPOAg in thyroid cells is induced by TSH through pathways which involve protein synthesis and the accumulation of cAMP in the cell."
  },
  {
    "text": "TSH and cAMP also increase specific mRNA levels of TPO in different types of thyroid cells .",
    "triple_list": [
      [
        "cAMP",
        "CPR:3",
        "TPO"
      ]
    ],
    "updated": "Yes",
    "original": "TSH and cAMP also increase the levels of the specific mRNA for TPO in thyroid cells from different species",
    "simplified": "TSH and cAMP also increase specific mRNA levels of TPO in different types of thyroid cells."
  },
  {
    "text": "A novel benzodimidazole derivate prevents the development of dextran sulfate-induced colitis in animals by inhibiting the NLRP3 gene .",
    "triple_list": [
      [
        "benzodimidazole",
        "CPR:4",
        "NLRP3"
      ]
    ],
    "updated": "Yes",
    "original": "A novel benzodimidazole derivate prevents the development of dextran sulfate sodiuminduced murine experimental colitis via inhibition of NLRP3 inflammasome",
    "simplified": "A novel benzodimidazole derivate prevents the development of dextran sulfate-induced colitis in animals by inhibiting the NLRP3 gene."
  },
  {
    "text": "In addition , in Fc11a 2treated mice , there was a decreased CD11c macrophage infiltration in colons and inactivation of caspase1 .",
    "triple_list": [
      [
        "caspase1",
        "CPR:4",
        "Fc11a"
      ]
    ],
    "updated": "Yes",
    "original": "Furthermore a decreased CD11c macrophage infiltration in colons and inactivation of caspase1 in peritoneal macrophages were detected in Fc11a 2treated mice",
    "simplified": "In addition, in Fc11a 2treated mice, there was a decreased CD11c macrophage infiltration in colons and inactivation of caspase1."
  },
  {
    "text": "The mechanism of action of Fc11a2 was to inhibit the cleavage of procaspase1 proIL1\u03b2 and proIL18 . This in turn stopped NLRP3 inflammasome from being activated .",
    "triple_list": [
      [
        "Fc11a2",
        "CPR:4",
        "procaspase1"
      ],
      [
        "Fc11a2",
        "CPR:4",
        "proIL1\u03b2"
      ],
      [
        "Fc11a2",
        "CPR:4",
        "proIL18"
      ],
      [
        "Fc11a2",
        "CPR:4",
        "NLRP3"
      ]
    ],
    "updated": "Yes",
    "original": "The mechanism of action of Fc11a2 was related to the inhibition of the cleavage of procaspase1 proIL1\u03b2 and proIL18 which in turn suppressed the activation of NLRP3 inflammasome",
    "simplified": "The mechanism of action of Fc11a2 was to inhibit the cleavage of procaspase1 proIL1\u03b2 and proIL18. This in turn stopped NLRP3 inflammasome from being activated."
  },
  {
    "text": "Our results demonstrate the ability of Fc11a2 to inhibit NLRP3 inflammasome activation and the potential use of Fc11a2 in inflammatory bowel diseases .",
    "triple_list": [
      [
        "Fc11a2",
        "CPR:4",
        "NLRP3"
      ]
    ],
    "updated": "Yes",
    "original": "Taken together our results demonstrate the ability of Fc11a2 to inhibit NLRP3 inflammasome activation and its potential use in the treatment of inflammatory bowel diseases",
    "simplified": "Our results demonstrate the ability of Fc11a2 to inhibit NLRP3 inflammasome activation and the potential use of Fc11a2 in inflammatory bowel diseases."
  },
  {
    "text": "In addition , myeloperoxidase activity and disease activity index scores were significantly reduced by Fc11a2 treatment .",
    "triple_list": [
      [
        "myeloperoxidase",
        "CPR:4",
        "Fc11a2"
      ]
    ],
    "updated": "Yes",
    "original": "In addition the disease activity index histopathologic scores and myeloperoxidase activity were also significantly reduced by Fc11a2 treatment",
    "simplified": "In addition, myeloperoxidase activity and disease activity index scores were significantly reduced by Fc11a2 treatment."
  },
  {
    "text": "Moreover protein and mRNA levels of DSSinduced proinflammatory cytokines in colon including TNF\u03b1 IL1\u03b2 IL18 IL17A and IFN\u03b3 were markedly suppressed by Fc11a2",
    "triple_list": [
      [
        "cytokines",
        "CPR:4",
        "Fc11a2"
      ],
      [
        "TNF\u03b1",
        "CPR:4",
        "Fc11a2"
      ],
      [
        "IL1\u03b2",
        "CPR:4",
        "Fc11a2"
      ],
      [
        "IL18",
        "CPR:4",
        "Fc11a2"
      ],
      [
        "IL17A",
        "CPR:4",
        "Fc11a2"
      ],
      [
        "IFN\u03b3",
        "CPR:4",
        "Fc11a2"
      ]
    ],
    "updated": "No",
    "original": "Moreover protein and mRNA levels of DSSinduced proinflammatory cytokines in colon including TNF\u03b1 IL1\u03b2 IL18 IL17A and IFN\u03b3 were markedly suppressed by Fc11a2",
    "simplified": "In addition, levels of protein and mRNA of proinflammatory cytokines in the colon were significantly suppressed by Fc11a2."
  },
  {
    "text": "At PND35 the medial prefrontal cortex mPFC of rats given MPH showed 55 greater immunoreactivity ir for the catecholamine marker tyrosine hydroxylase TH 60 more Nisslstained cells and 40 less norepinephrine transporter NET ir density",
    "triple_list": [
      [
        "MPH",
        "CPR:3",
        "tyrosine hydroxylase"
      ],
      [
        "MPH",
        "CPR:3",
        "TH"
      ],
      [
        "MPH",
        "CPR:4",
        "norepinephrine transporter"
      ],
      [
        "MPH",
        "CPR:4",
        "NET"
      ]
    ],
    "updated": "No",
    "original": "At PND35 the medial prefrontal cortex mPFC of rats given MPH showed 55 greater immunoreactivity ir for the catecholamine marker tyrosine hydroxylase TH 60 more Nisslstained cells and 40 less norepinephrine transporter NET ir density",
    "simplified": "At PND35 the medial prefrontal cortex mPFC of rats given MPH showed 55 greater immunoreactivity ir for tyrosine hydroxylase and 40 less norepinephrine transporter NET ir density."
  },
  {
    "text": "In the hippocampus , MPH receiving rats showed a 51 % decrease in NET ir density and a 61 % increase in the newcell marker PSA NCAM . PSA is a type of neural cell adhesion molecule .",
    "triple_list": [
      [
        "MPH",
        "CPR:3",
        "neural cell adhesion molecule"
      ],
      [
        "MPH",
        "CPR:3",
        "NCAM"
      ],
      [
        "MPH",
        "CPR:4",
        "NET"
      ]
    ],
    "updated": "Yes",
    "original": "In hippocampal dentate gyrus MPH receiving rats showed a 51 decrease in NET ir density and a 61 expanded distribution of the newcell marker PSA NCAM polysialylated form of neural cell adhesion molecule",
    "simplified": "In the hippocampus, MPH receiving rats showed a 51% decrease in NET ir density and a 61% increase in the newcell marker PSA NCAM. PSA is a type of neural cell adhesion molecule."
  },
  {
    "text": "In medial striatum TH ir decreased by 21 and in hypothalamus neuropeptide Y ir increased by 10 in MPH exposed rats",
    "triple_list": [
      [
        "neuropeptide Y",
        "CPR:3",
        "MPH"
      ],
      [
        "TH",
        "CPR:4",
        "MPH"
      ]
    ],
    "updated": "No",
    "original": "In medial striatum TH ir decreased by 21 and in hypothalamus neuropeptide Y ir increased by 10 in MPH exposed rats",
    "simplified": "In the hypothalamus neuropeptide Y ir decreased by 10 in MPH exposed rats in the medial striatum."
  }
]